Clustering O 0 0.4216834604740143
of O 0 0.005592974368482828
missense O 1 0.9995914101600647
mutations O 1 0.9997866749763489
in O 0 0.0032442177180200815
the O 0 0.006688106805086136
ataxia B-Disease 1 0.9999995231628418
- I-Disease 1 0.9969407320022583
telangiectasia I-Disease 1 0.9999933242797852
gene O 1 0.9997943043708801
in O 0 0.0022813461255282164
a O 0 0.008819417096674442
sporadic B-Disease 1 0.9957129955291748
T I-Disease 1 0.9999654293060303
- I-Disease 1 0.9916741251945496
cell I-Disease 1 0.999854326248169
leukaemia I-Disease 1 0.9999362230300903
. O 0 0.01320604607462883

Ataxia B-Disease 1 0.9999881982803345
- I-Disease 1 0.9876261353492737
telangiectasia I-Disease 1 0.9999065399169922
( O 0 0.014035159721970558
A B-Disease 1 0.5038858652114868
- I-Disease 1 0.8158975839614868
T I-Disease 1 0.9997366070747375
) O 0 0.003196951700374484
is O 0 0.0014486421132460237
a O 0 0.012383806519210339
recessive B-Disease 1 0.9999983310699463
multi I-Disease 1 0.9951752424240112
- I-Disease 0 0.4767337143421173
system I-Disease 0 0.4301571547985077
disorder I-Disease 1 0.9999872446060181
caused O 1 0.6006001830101013
by O 0 0.005655634682625532
mutations O 1 0.9999129772186279
in O 0 0.0015116364229470491
the O 0 0.002960184356197715
ATM O 1 0.9987842440605164
gene O 1 0.9997392296791077
at O 0 0.007452248129993677
11q22 O 1 0.9973629117012024
- O 0 0.161566823720932
q23 O 1 0.9961626529693604
( O 0 0.010432875715196133
ref O 1 0.9958255290985107
. O 0 0.004228084813803434
3 O 0 0.009765110909938812
) O 0 0.004877880215644836
. O 0 0.005791012197732925

The O 0 0.00847361609339714
risk O 1 0.927100658416748
of O 0 0.0048005287535488605
cancer B-Disease 1 0.999992847442627
, O 0 0.003389910561963916
especially O 0 0.008944579400122166
lymphoid B-Disease 1 0.9999768733978271
neoplasias I-Disease 1 0.9979941844940186
, O 0 0.0018449401250109076
is O 0 0.0015182261122390628
substantially O 0 0.01944979652762413
elevated O 0 0.12347166985273361
in O 0 0.0028116139583289623
A B-Disease 1 0.8784974813461304
- I-Disease 1 0.999123752117157
T I-Disease 1 0.9999961853027344
patients O 1 0.999674916267395
and O 0 0.0014661721652373672
has O 0 0.0015463503077626228
long O 0 0.004268803633749485
been O 0 0.0019228998571634293
associated O 0 0.009542659856379032
with O 0 0.008184928447008133
chromosomal O 1 0.9999969005584717
instability O 1 0.9963076114654541
. O 0 0.009233828634023666

By O 0 0.014575021341443062
analysing O 1 0.9595025181770325
tumour B-Disease 1 0.9999877214431763
DNA O 1 0.9988411068916321
from O 0 0.007401115261018276
patients O 1 0.9976279139518738
with O 0 0.004548490047454834
sporadic B-Disease 1 0.9939422011375427
T I-Disease 1 0.9998651742935181
- I-Disease 1 0.9084969758987427
cell I-Disease 1 0.9997735619544983
prolymphocytic I-Disease 1 0.9997578263282776
leukaemia I-Disease 1 0.9999927282333374
( O 0 0.023321496322751045
T B-Disease 1 0.9998966455459595
- I-Disease 1 0.9381648898124695
PLL I-Disease 1 0.999871015548706
) O 0 0.004674096591770649
, O 0 0.0012826260644942522
a O 0 0.0050863842479884624
rare O 0 0.27521175146102905
clonal B-Disease 1 0.9998881816864014
malignancy I-Disease 1 0.9999325275421143
with O 0 0.003197904909029603
similarities O 0 0.01088300533592701
to O 0 0.0013273205840960145
a O 0 0.008432252332568169
mature B-Disease 1 0.9987272620201111
T I-Disease 1 0.9999709129333496
- I-Disease 1 0.9866610169410706
cell I-Disease 1 0.9999381303787231
leukaemia I-Disease 1 0.9999845027923584
seen O 0 0.008812050335109234
in O 0 0.003163665533065796
A B-Disease 0 0.37985286116600037
- I-Disease 1 0.912159264087677
T I-Disease 1 0.9997909665107727
, O 0 0.00198439066298306
we O 0 0.0008916478254832327
demonstrate O 0 0.004626957233995199
a O 0 0.003344614990055561
high O 0 0.004051567055284977
frequency O 0 0.017541585490107536
of O 0 0.0026429472491145134
ATM O 1 0.9986366629600525
mutations O 1 0.9999563694000244
in O 0 0.009288456290960312
T B-Disease 1 0.9997196793556213
- I-Disease 0 0.4353652000427246
PLL I-Disease 1 0.998440682888031
. O 0 0.012513911351561546

In O 0 0.00457670446485281
marked O 0 0.008468843065202236
contrast O 0 0.005410681013017893
to O 0 0.001203608582727611
the O 0 0.00226600538007915
ATM O 1 0.9994149208068848
mutation O 1 0.999974250793457
pattern O 0 0.13434109091758728
in O 0 0.0030536402482539415
A B-Disease 1 0.6138963103294373
- I-Disease 1 0.9523552656173706
T I-Disease 1 0.9998294115066528
, O 0 0.0013549852883443236
the O 0 0.0007978418143466115
most O 0 0.0013991158921271563
frequent O 0 0.03452232480049133
nucleotide O 1 0.9965496063232422
changes O 0 0.006531450431793928
in O 0 0.0013347466010600328
this O 0 0.0032194347586482763
leukaemia B-Disease 1 0.9999873638153076
were O 0 0.006157696712762117
missense O 1 0.9998812675476074
mutations O 1 0.9999105930328369
. O 0 0.011073465459048748

These O 0 0.004255211446434259
clustered O 0 0.027084162458777428
in O 0 0.0013281417777761817
the O 0 0.000988809741102159
region O 0 0.0023644855245947838
corresponding O 0 0.0059727998450398445
to O 0 0.0008711622795090079
the O 0 0.0021961138118058443
kinase O 1 0.9999638795852661
domain O 0 0.028816644102334976
, O 0 0.0009820089908316731
which O 0 0.0007147653377614915
is O 0 0.0011311161797493696
highly O 0 0.007665671873837709
conserved O 0 0.4074995219707489
in O 0 0.0027448951732367277
ATM O 1 0.9990264177322388
- O 0 0.028219711035490036
related O 0 0.018644986674189568
proteins O 1 0.9926046133041382
in O 0 0.00400262326002121
mouse O 1 0.9994589686393738
, O 0 0.005499094724655151
yeast O 1 0.9992813467979431
and O 0 0.005576695781201124
Drosophila O 1 0.9910271763801575
. O 0 0.009429099038243294

The O 0 0.0069718617014586926
resulting O 0 0.06404673308134079
amino O 1 0.9933577179908752
- O 0 0.08627455681562424
acid O 1 0.9948861002922058
substitutions O 0 0.043906837701797485
are O 0 0.0011838242644444108
predicted O 0 0.007723392453044653
to O 0 0.00161938916426152
interfere O 0 0.031220998615026474
with O 0 0.004635042976588011
ATP O 1 0.9967849254608154
binding O 0 0.09709174931049347
or O 0 0.006504734978079796
substrate O 1 0.8909839987754822
recognition O 0 0.02167368493974209
. O 0 0.006222280208021402

Two O 0 0.003623389173299074
of O 0 0.0019731721840798855
seventeen O 0 0.03480948507785797
mutated O 1 0.9999644756317139
T B-Disease 1 0.999842643737793
- I-Disease 0 0.4376327693462372
PLL I-Disease 1 0.9996165037155151
samples O 0 0.024567248299717903
had O 0 0.0017572271171957254
a O 0 0.002925667678937316
previously O 0 0.0037478748708963394
reported O 0 0.00991420354694128
A B-Disease 0 0.16868019104003906
- I-Disease 1 0.9446303844451904
T I-Disease 1 0.9998729228973389
allele O 1 0.9989429116249084
. O 0 0.01081138290464878

In O 0 0.004247314762324095
contrast O 0 0.009024162776768208
, O 0 0.001622633310034871
no O 0 0.004129187203943729
mutations O 1 0.9999487400054932
were O 0 0.0013891475973650813
detected O 0 0.11137747019529343
in O 0 0.001286625862121582
the O 0 0.0035372674465179443
p53 O 1 0.9999982118606567
gene O 1 0.9999334812164307
, O 0 0.0018683943198993802
suggesting O 0 0.009024713188409805
that O 0 0.0015278856735676527
this O 0 0.004325985908508301
tumour B-Disease 1 0.9999997615814209
suppressor O 1 0.9999855756759644
is O 0 0.002909768605604768
not O 0 0.0012763499980792403
frequently O 0 0.004083254374563694
altered O 0 0.06811852753162384
in O 0 0.0021571426186710596
this O 0 0.005805016960948706
leukaemia B-Disease 1 0.9999877214431763
. O 0 0.011492667719721794

Occasional O 0 0.15711787343025208
missense O 1 0.999305009841919
mutations O 1 0.9998077750205994
in O 0 0.004338594153523445
ATM O 1 0.6937491297721863
were O 0 0.0009652696899138391
also O 0 0.0008938372484408319
found O 0 0.004499327857047319
in O 0 0.004755354020744562
tumour B-Disease 1 0.9999990463256836
DNA O 1 0.9997307658195496
from O 0 0.004857949912548065
patients O 1 0.9992226362228394
with O 0 0.005263125989586115
B B-Disease 1 0.9985079169273376
- I-Disease 1 0.6409291625022888
cell I-Disease 1 0.9993558526039124
non I-Disease 0 0.14566229283809662
- I-Disease 1 0.9977114200592041
Hodgkins I-Disease 1 0.9999980926513672
lymphomas I-Disease 1 0.999982476234436
( O 0 0.017163921147584915
B B-Disease 1 0.9951199293136597
- I-Disease 0 0.030434900894761086
NHL I-Disease 0 0.050079040229320526
) O 0 0.002759269904345274
and O 0 0.0009746416471898556
a O 0 0.008399050682783127
B B-Disease 1 0.9963350296020508
- I-Disease 0 0.0394320972263813
NHL I-Disease 1 0.6601521968841553
cell O 1 0.9931094646453857
line O 0 0.013357297517359257
. O 0 0.0061557479202747345

The O 0 0.0028783699963241816
evidence O 0 0.0027047377079725266
of O 0 0.0006433750386349857
a O 0 0.0029581307899206877
significant O 0 0.0035012797452509403
proportion O 0 0.0071373600512743
of O 0 0.001604743185453117
loss O 1 0.5574151277542114
- O 0 0.012393400073051453
of O 0 0.0018298336071893573
- O 0 0.09365950524806976
function O 1 0.9046732187271118
mutations O 1 0.9999722242355347
and O 0 0.0011345548555254936
a O 0 0.0031316648237407207
complete O 0 0.007071300409734249
absence O 0 0.008016178384423256
of O 0 0.0005616463022306561
the O 0 0.001295661204494536
normal O 0 0.016675451770424843
copy O 0 0.01398536004126072
of O 0 0.0013636616058647633
ATM O 1 0.8878363370895386
in O 0 0.0011645439080893993
the O 0 0.0010806841310113668
majority O 0 0.0040497854351997375
of O 0 0.0035999559331685305
mutated O 1 0.9999836683273315
tumours B-Disease 1 0.999991774559021
establishes O 1 0.9835962057113647
somatic O 1 0.9997180104255676
inactivation O 1 0.9984073042869568
of O 0 0.0014423499815165997
this O 0 0.0019388729706406593
gene O 1 0.9996936321258545
in O 0 0.001356241526082158
the O 0 0.002823891816660762
pathogenesis O 1 0.9999065399169922
of O 0 0.0032475944608449936
sporadic B-Disease 1 0.9985369443893433
T I-Disease 1 0.9999399185180664
- I-Disease 1 0.6874799132347107
PLL I-Disease 1 0.9995507597923279
and O 0 0.002266049850732088
suggests O 0 0.008862961083650589
that O 0 0.0017940574325621128
ATM O 1 0.9714201092720032
acts O 0 0.0053155869245529175
as O 0 0.002406420884653926
a O 0 0.029218612238764763
tumour B-Disease 1 0.9999966621398926
suppressor O 1 0.9999016523361206
. O 0 0.012606807053089142

As O 0 0.005086891353130341
constitutional O 0 0.014869298785924911
DNA O 1 0.997542142868042
was O 0 0.0022556514013558626
not O 0 0.0008187227067537606
available O 0 0.0016308273188769817
, O 0 0.0010169990127906203
a O 0 0.007029606029391289
putative O 1 0.9996121525764465
hereditary O 1 0.999880313873291
predisposition O 1 0.9999217987060547
to O 0 0.006791842170059681
T B-Disease 1 0.9998985528945923
- I-Disease 0 0.3582282066345215
PLL I-Disease 1 0.9990614056587219
will O 0 0.0029610740020871162
require O 0 0.009066062048077583
further O 0 0.004462128970772028
investigation O 0 0.012961549684405327
. O 0 0.0036658223252743483
. O 0 0.006060753017663956

Myotonic B-Disease 1 0.9999815225601196
dystrophy I-Disease 1 0.9999964237213135
protein O 1 0.9997742772102356
kinase O 1 0.9998039603233337
is O 0 0.0035658245906233788
involved O 0 0.003954512998461723
in O 0 0.0009905239567160606
the O 0 0.001260303775779903
modulation O 1 0.8981844186782837
of O 0 0.0012948289513587952
the O 0 0.003878252347931266
Ca2 O 1 0.9999599456787109
+ O 1 0.9971780776977539
homeostasis O 1 0.9995214939117432
in O 0 0.011837821453809738
skeletal O 1 0.9999585151672363
muscle O 1 0.9999725818634033
cells O 1 0.9993532299995422
. O 0 0.009034552611410618

Myotonic B-Disease 1 0.9999816417694092
dystrophy I-Disease 1 0.9999985694885254
( O 0 0.05053137242794037
DM B-Disease 1 0.9999570846557617
) O 0 0.0056010340340435505
, O 0 0.0008729325491003692
the O 0 0.0008806040859781206
most O 0 0.0025551719591021538
prevalent O 1 0.9987208247184753
muscular B-Disease 1 0.9999979734420776
disorder I-Disease 1 0.999996542930603
in O 0 0.003672095714136958
adults O 0 0.40551427006721497
, O 0 0.001288092345930636
is O 0 0.001845112070441246
caused O 0 0.31788742542266846
by O 0 0.0031674858182668686
( O 0 0.006282127927988768
CTG O 1 0.9993796348571777
) O 0 0.0067185042425990105
n O 0 0.11742670834064484
- O 0 0.015051936730742455
repeat O 0 0.04014723375439644
expansion O 0 0.0076074423268437386
in O 0 0.0012682544765993953
a O 0 0.00685617933049798
gene O 1 0.9994785189628601
encoding O 1 0.8071819543838501
a O 0 0.015695029869675636
protein O 1 0.9993662238121033
kinase O 1 0.9995916485786438
( O 0 0.01773657277226448
DM B-Disease 1 0.9999221563339233
protein O 1 0.9996881484985352
kinase O 1 0.9998663663864136
; O 0 0.012125229462981224
DMPK O 1 0.9943201541900635
) O 0 0.0038621011190116405
and O 0 0.0013665308943018317
involves O 0 0.017913395538926125
changes O 0 0.0062044113874435425
in O 0 0.0023714867420494556
cytoarchitecture O 1 0.9845283627510071
and O 0 0.0047518545761704445
ion O 1 0.9965180158615112
homeostasis O 1 0.9994475245475769
. O 0 0.011754022911190987

To O 0 0.0036219467874616385
obtain O 0 0.008720818907022476
clues O 0 0.01278990413993597
to O 0 0.0008696788572706282
the O 0 0.0011373807210475206
normal O 0 0.019023172557353973
biological O 0 0.019719230011105537
role O 0 0.004861259367316961
of O 0 0.0016215034993365407
DMPK O 1 0.9977351427078247
in O 0 0.004581179469823837
cellular O 1 0.9998138546943665
ion O 1 0.9990857839584351
homeostasis O 1 0.9998513460159302
, O 0 0.0019434744026511908
we O 0 0.000733224384021014
have O 0 0.000899511156603694
compared O 0 0.004002995789051056
the O 0 0.0020089419558644295
resting O 1 0.8214884400367737
[ O 1 0.6181100606918335
Ca2 O 1 0.9999511241912842
+ O 1 0.9940410256385803
] O 0 0.0411757193505764
i O 0 0.002721016062423587
, O 0 0.000779329682700336
the O 0 0.0010872760321944952
amplitude O 0 0.2909751534461975
and O 0 0.0013354540569707751
shape O 0 0.012604457326233387
of O 0 0.003014612477272749
depolarization O 1 0.9999591112136841
- O 1 0.9716863632202148
induced O 1 0.9999402761459351
Ca2 O 1 0.999974250793457
+ O 1 0.9970699548721313
transients O 1 0.9947530031204224
, O 0 0.0018106942297890782
and O 0 0.0005970618221908808
the O 0 0.0008919417741708457
content O 0 0.005023516248911619
of O 0 0.0018392209894955158
ATP O 1 0.9989627599716187
- O 0 0.023698771372437477
driven O 0 0.021845845505595207
ion O 1 0.8566468358039856
pumps O 0 0.09197235107421875
in O 0 0.005650335922837257
cultured O 1 0.9991212487220764
skeletal O 1 0.999969482421875
muscle O 1 0.9999520778656006
cells O 1 0.998138427734375
of O 0 0.0023617539554834366
wild O 0 0.041063342243433
- O 0 0.02660156786441803
type O 0 0.12499676644802094
and O 0 0.0032075487542897463
DMPK O 1 0.9993407130241394
[ O 0 0.4497409164905548
- O 0 0.464915007352829
/ O 1 0.9758685231208801
- O 0 0.10826604068279266
] O 1 0.6880140900611877
knockout O 1 0.9986394047737122
mice O 1 0.9995681643486023
. O 0 0.010877247899770737

In O 0 0.010559961199760437
vitro O 1 0.9966772794723511
- O 0 0.09436286985874176
differentiated O 1 0.9960113763809204
DMPK O 1 0.9989299178123474
[ O 1 0.5846617817878723
- O 0 0.3519169092178345
/ O 1 0.9683379530906677
- O 0 0.04817713797092438
] O 0 0.06934868544340134
myotubes O 1 0.7683363556861877
exhibit O 0 0.01143641211092472
a O 0 0.005877099931240082
higher O 0 0.007274731528013945
resting O 1 0.5574686527252197
[ O 0 0.4704515039920807
Ca2 O 1 0.9998712539672852
+ O 1 0.9927052855491638
] O 0 0.030467621982097626
i O 0 0.0023158995900303125
than O 0 0.001369938370771706
do O 0 0.002543253358453512
wild O 0 0.05128096789121628
- O 0 0.15482483804225922
type O 1 0.9352840185165405
myotubes O 1 0.9913225173950195
because O 0 0.002536315005272627
of O 0 0.0006440464057959616
an O 0 0.0014129832852631807
altered O 0 0.0811314731836319
open O 0 0.006746015511453152
probability O 0 0.016812430694699287
of O 0 0.0015056983102113008
voltage O 1 0.9267343282699585
- O 0 0.024594033136963844
dependent O 0 0.029913676902651787
l O 1 0.9924597144126892
- O 0 0.11727140843868256
type O 1 0.983228862285614
Ca2 O 1 0.9997953772544861
+ O 1 0.8085919618606567
and O 0 0.00578303961083293
Na O 1 0.9953383207321167
+ O 1 0.9009978175163269
channels O 0 0.038604408502578735
. O 0 0.006809634156525135

The O 0 0.008360497653484344
mutant O 1 0.9958552718162537
myotubes O 1 0.9084705114364624
exhibit O 0 0.01607784815132618
smaller O 0 0.008908036164939404
and O 0 0.002107825595885515
slower O 1 0.7057031989097595
Ca2 O 1 0.9999364614486694
+ O 1 0.9036089181900024
responses O 0 0.020270830020308495
upon O 0 0.005070223473012447
triggering O 1 0.6834853291511536
by O 0 0.0068634916096925735
acetylcholine O 1 0.9994432330131531
or O 0 0.0053793685510754585
high O 0 0.007278375327587128
external O 0 0.03229526802897453
K O 1 0.9618176221847534
+ O 1 0.8863695859909058
. O 0 0.009722156450152397

In O 0 0.004363550338894129
addition O 0 0.004450348671525717
, O 0 0.0011648106155917048
we O 0 0.0006934795528650284
observed O 0 0.004167221952229738
that O 0 0.0012327677104622126
these O 0 0.0036008867900818586
Ca2 O 1 0.9999544620513916
+ O 1 0.9950150847434998
transients O 1 0.9971696734428406
partially O 0 0.05065125972032547
result O 0 0.006081993691623211
from O 0 0.0011418391950428486
an O 0 0.0011342224897816777
influx O 0 0.014776463620364666
of O 0 0.0019428549567237496
extracellular O 1 0.9995811581611633
Ca2 O 1 0.9998979568481445
+ O 0 0.35344550013542175
through O 0 0.003475562436506152
the O 0 0.003325660014525056
l O 1 0.9963094592094421
- O 0 0.25718072056770325
type O 1 0.9883728623390198
Ca2 O 1 0.9997016787528992
+ O 1 0.7785163521766663
channel O 0 0.039403852075338364
. O 0 0.00954680796712637

Neither O 0 0.012778380885720253
the O 0 0.0017856948543339968
content O 0 0.007700586691498756
nor O 0 0.004698264878243208
the O 0 0.0011109033366665244
activity O 0 0.005730852019041777
of O 0 0.0024936727713793516
Na O 1 0.9995115995407104
+ O 1 0.9969735145568848
/ O 1 0.7172965407371521
K O 1 0.758724570274353
+ O 1 0.9203787446022034
ATPase O 1 0.9934480786323547
and O 0 0.009656006470322609
sarcoplasmic O 1 0.9998661279678345
reticulum O 1 0.9998905658721924
Ca2 O 1 0.9998219609260559
+ O 1 0.9953058362007141
- O 0 0.16424567997455597
ATPase O 1 0.9986898303031921
are O 0 0.002728121355175972
affected O 0 0.01528908684849739
by O 0 0.00518407067283988
DMPK O 1 0.9961050748825073
absence O 0 0.038703788071870804
. O 0 0.008202110417187214

In O 0 0.005449938587844372
conclusion O 0 0.007687298581004143
, O 0 0.000992465065792203
our O 0 0.0013575236080214381
data O 0 0.003366743680089712
suggest O 0 0.007092771120369434
that O 0 0.0021391280461102724
DMPK O 1 0.9983951449394226
is O 0 0.001991216791793704
involved O 0 0.004060125909745693
in O 0 0.0016522682271897793
modulating O 1 0.9990481734275818
the O 0 0.0016249105101451278
initial O 0 0.0081388084217906
events O 0 0.002433552872389555
of O 0 0.001896706991828978
excitation O 1 0.999381422996521
- O 0 0.05389559268951416
contraction O 1 0.9887930750846863
coupling O 1 0.9973795413970947
in O 0 0.005663188640028238
skeletal O 1 0.999992847442627
muscle O 1 0.9999347925186157
. O 0 0.004747114144265652
. O 0 0.005774861667305231

Constitutional O 0 0.07360921055078506
RB1 O 1 0.9998477697372437
- O 1 0.980166494846344
gene O 1 0.9999527931213379
mutations O 1 0.9999449253082275
in O 0 0.006966816261410713
patients O 1 0.9988375306129456
with O 0 0.005582894664257765
isolated O 1 0.6064243316650391
unilateral B-Disease 1 0.9879509806632996
retinoblastoma I-Disease 1 0.999910831451416
. O 0 0.010314367711544037

In O 0 0.004631700925529003
most O 0 0.0037046154029667377
patients O 1 0.9968717694282532
with O 0 0.0046604047529399395
isolated O 1 0.5251947641372681
unilateral B-Disease 1 0.996188223361969
retinoblastoma I-Disease 1 0.9999904632568359
, O 0 0.007817934267222881
tumor B-Disease 1 0.9999880790710449
development O 0 0.006511295679956675
is O 0 0.0018623777432367206
initiated O 0 0.01770920306444168
by O 0 0.005871864501386881
somatic O 1 0.9998242259025574
inactivation O 1 0.9972086548805237
of O 0 0.0014465523418039083
both O 0 0.0026148518081754446
alleles O 1 0.9993270635604858
of O 0 0.001890775514766574
the O 0 0.005976561456918716
RB1 O 1 0.9999712705612183
gene O 1 0.9997190833091736
. O 0 0.009704901836812496

However O 0 0.004992961417883635
, O 0 0.0009899502620100975
some O 0 0.0006792645435780287
of O 0 0.0007756869890727103
these O 0 0.002230375073850155
patients O 1 0.9996585845947266
can O 0 0.0068502468056976795
transmit O 1 0.9989184141159058
retinoblastoma B-Disease 1 0.9999887943267822
predisposition O 1 0.9998043179512024
to O 0 0.0024609470274299383
their O 0 0.003880312666296959
offspring O 1 0.9921658039093018
. O 0 0.00790806207805872

To O 0 0.0032642176374793053
determine O 0 0.0052269198931753635
the O 0 0.001485525630414486
frequency O 0 0.01841948926448822
and O 0 0.0008887392468750477
nature O 0 0.003287985920906067
of O 0 0.0013158188667148352
constitutional O 0 0.02698187157511711
RB1 O 1 0.9999830722808838
- O 1 0.9912632703781128
gene O 1 0.9999855756759644
mutations O 1 0.9999642372131348
in O 0 0.006677562836557627
patients O 1 0.9980233907699585
with O 0 0.004925603978335857
isolated O 0 0.28886082768440247
unilateral B-Disease 1 0.9861937165260315
retinoblastoma I-Disease 1 0.9999526739120483
, O 0 0.0018715114565566182
we O 0 0.0011695403372868896
analyzed O 0 0.027506444603204727
DNA O 1 0.9983566403388977
from O 0 0.005580938886851072
peripheral O 1 0.9997919201850891
blood O 1 0.9990278482437134
and O 0 0.003139002015814185
from O 0 0.014196028001606464
tumor B-Disease 1 0.9999995231628418
tissue O 1 0.9999465942382812
. O 0 0.010367159731686115

The O 0 0.003722095862030983
analysis O 0 0.014085064642131329
of O 0 0.004175433423370123
tumors B-Disease 1 0.9999955892562866
from O 0 0.0038698872085660696
54 O 0 0.018486294895410538
( O 0 0.00442307535558939
71 O 0 0.02044007182121277
% O 0 0.005370624829083681
) O 0 0.0021377289667725563
of O 0 0.001236288226209581
76 O 0 0.03376636281609535
informative O 1 0.5499154329299927
patients O 1 0.9979926347732544
showed O 0 0.008920927532017231
loss O 0 0.01940961740911007
of O 0 0.0020059968810528517
constitutional O 0 0.01872773841023445
heterozygosity O 1 0.9996503591537476
( O 0 0.015804583206772804
LOH O 1 0.9993415474891663
) O 0 0.007276015356183052
at O 0 0.006445735227316618
intragenic O 1 0.9942050576210022
loci O 1 0.9963157773017883
. O 0 0.01168812159448862

Three O 0 0.0047780354507267475
of O 0 0.0017045390559360385
13 O 0 0.015121279284358025
uninformative O 1 0.9989722967147827
patients O 1 0.9981231093406677
had O 0 0.004556471016258001
constitutional O 0 0.01761714182794094
deletions O 1 0.9956316947937012
. O 0 0.008652574382722378

For O 0 0.004485496319830418
39 O 0 0.01373459305614233
randomly O 0 0.02600080706179142
selected O 0 0.011582116596400738
tumors B-Disease 1 0.9999886751174927
, O 0 0.005250031128525734
SSCP O 1 0.9986326098442078
, O 0 0.006667414680123329
hetero O 1 0.9998461008071899
- O 0 0.43764904141426086
duplex O 1 0.9990696310997009
analysis O 0 0.018086211755871773
, O 0 0.0025436722207814455
sequencing O 1 0.9970297813415527
, O 0 0.0014841892989352345
and O 0 0.0011320917401462793
Southern O 0 0.007030119188129902
blot O 1 0.9883542060852051
analysis O 0 0.012100339867174625
were O 0 0.0007494692108593881
used O 0 0.0022524346131831408
to O 0 0.0022694957442581654
identify O 0 0.07680708914995193
mutations O 1 0.9998723268508911
. O 0 0.00809908751398325

Mutations O 1 0.999649167060852
were O 0 0.004184257704764605
detected O 0 0.10128071159124374
in O 0 0.002455099718645215
21 O 0 0.009046275168657303
( O 0 0.004157757852226496
91 O 0 0.02371918223798275
% O 0 0.005500816274434328
) O 0 0.0028549835551530123
of O 0 0.001778817386366427
23 O 0 0.026240918785333633
tumors B-Disease 1 0.9999971389770508
with O 0 0.014485040679574013
LOH O 1 0.9992796778678894
. O 0 0.011884958483278751

In O 0 0.007823772728443146
6 O 0 0.011832568794488907
( O 0 0.003596535185351968
38 O 0 0.01091726403683424
% O 0 0.0040699178352952
) O 0 0.002242368645966053
of O 0 0.0013559871586039662
16 O 0 0.01878180354833603
tumors B-Disease 1 0.9999984502792358
without O 0 0.013800736516714096
LOH O 1 0.9997052550315857
, O 0 0.0017809446435421705
one O 0 0.0043278350494802
mutation O 1 0.9999873638153076
was O 0 0.004649858921766281
detected O 1 0.7595137357711792
, O 0 0.001461310195736587
and O 0 0.0008705917280167341
in O 0 0.0014411213342100382
9 O 0 0.006732660345733166
( O 0 0.003530102549120784
56 O 0 0.011483894661068916
% O 0 0.003995232749730349
) O 0 0.0015434750821441412
of O 0 0.0008915925282053649
the O 0 0.003772241761907935
tumors B-Disease 1 0.999998927116394
without O 0 0.017669128254055977
LOH O 1 0.9997488856315613
, O 0 0.0031286650337278843
both O 0 0.004616364371031523
mutations O 1 0.9999270439147949
were O 0 0.002120204269886017
found O 0 0.007424039300531149
. O 0 0.006536050233989954

Thus O 0 0.010477442294359207
, O 0 0.0015195626765489578
a O 0 0.0021948530338704586
total O 0 0.0016039533074945211
of O 0 0.0010960787767544389
45 O 0 0.010488437488675117
mutations O 1 0.9998732805252075
were O 0 0.0010090306168422103
identified O 0 0.00825475249439478
in O 0 0.0030736452899873257
tumors B-Disease 1 0.9999922513961792
of O 0 0.003059308510273695
36 O 0 0.047284919768571854
patients O 1 0.9993321299552917
. O 0 0.006798348855227232

Thirty O 0 0.02818942442536354
- O 0 0.013695762492716312
nine O 0 0.0031995864119380713
of O 0 0.0009343205019831657
the O 0 0.003538738237693906
mutations O 1 0.9999892711639404
- O 0 0.018152430653572083
including O 0 0.003072835970669985
34 O 0 0.00942173507064581
small O 0 0.008873343467712402
mutations O 1 0.9999637603759766
, O 0 0.001953958999365568
2 O 0 0.004478318151086569
large O 0 0.0043247537687420845
structural O 1 0.9676295518875122
alterations O 1 0.9714187383651733
, O 0 0.0014255985151976347
and O 0 0.0019311575451865792
hypermethylation O 1 0.9996336698532104
in O 0 0.004175516776740551
3 O 0 0.25471675395965576
tumors O 1 0.9999994039535522
- O 0 0.012746501713991165
were O 0 0.0009101575124077499
not O 0 0.0013609240995720029
detected O 0 0.2851318120956421
in O 0 0.0009728826698847115
the O 0 0.0015642206417396665
corresponding O 0 0.05776570364832878
peripheral O 1 0.9999315738677979
blood O 1 0.9997656941413879
DNA O 1 0.9990556836128235
. O 0 0.008550654165446758

In O 0 0.006138191092759371
6 O 0 0.010114530101418495
( O 0 0.0038062201347202063
17 O 0 0.00685858866199851
% O 0 0.0034271632321178913
) O 0 0.001421599998138845
of O 0 0.0004511413862928748
the O 0 0.0013744131429120898
36 O 0 0.023501256480813026
patients O 1 0.9996596574783325
, O 0 0.0017293294658884406
a O 0 0.00861266441643238
mutation O 1 0.9999868869781494
was O 0 0.0029883882962167263
detected O 0 0.22696177661418915
in O 0 0.001807302120141685
constitutional O 0 0.010008447803556919
DNA O 1 0.9997313618659973
, O 0 0.0015954647678881884
and O 0 0.0008403979009017348
1 O 0 0.0025213956832885742
of O 0 0.0007962228846736252
these O 0 0.0026000067591667175
mutations O 1 0.9999923706054688
is O 0 0.0020252109970897436
known O 0 0.0023888475261628628
to O 0 0.0009509818046353757
be O 0 0.0010315837571397424
associated O 0 0.005901158321648836
with O 0 0.0033613883424550295
reduced O 0 0.09928561002016068
expressivity O 1 0.9991357922554016
. O 0 0.009523754008114338

The O 0 0.003058922942727804
presence O 0 0.005853874608874321
of O 0 0.0009520293679088354
a O 0 0.004562068730592728
constitutional O 0 0.014492760412395
mutation O 1 0.9999724626541138
was O 0 0.002513260580599308
not O 0 0.001431767363101244
associated O 0 0.0055795046500861645
with O 0 0.001606034697033465
an O 0 0.0013468693941831589
early O 0 0.00409883726388216
age O 0 0.007190716452896595
at O 0 0.005734383128583431
treatment O 1 0.9846365451812744
. O 0 0.007060193922370672

In O 0 0.005577449686825275
1 O 0 0.013156920671463013
patient O 1 0.9970048069953918
, O 0 0.004596842918545008
somatic O 1 0.9999560117721558
mosaicism O 1 0.9997379183769226
was O 0 0.003019380383193493
demonstrated O 0 0.007957596331834793
by O 0 0.0027834123466163874
molecular O 1 0.9957984089851379
analysis O 0 0.008299027569591999
of O 0 0.0013875766890123487
DNA O 1 0.9985407590866089
and O 0 0.0031921295449137688
RNA O 1 0.9996174573898315
from O 0 0.007688039913773537
peripheral O 1 0.9998719692230225
blood O 1 0.9990482926368713
. O 0 0.009231965988874435

In O 0 0.006236345041543245
2 O 0 0.015759512782096863
patients O 1 0.997316300868988
without O 0 0.0043121157214045525
a O 0 0.006772281602025032
detectable O 1 0.9995036125183105
mutation O 1 0.9999727010726929
in O 0 0.005543475970625877
peripheral O 1 0.9999791383743286
blood O 1 0.9998949766159058
, O 0 0.004883310757577419
mosaicism O 1 0.9999465942382812
was O 0 0.002981129102408886
suggested O 0 0.006262541748583317
because O 0 0.0021033408120274544
1 O 0 0.002120240358635783
of O 0 0.0006566087249666452
the O 0 0.0032379275653511286
patients O 1 0.9998844861984253
showed O 1 0.8443071842193604
multifocal O 1 0.9999992847442627
tumors B-Disease 1 0.9999979734420776
and O 0 0.0015501287998631597
the O 0 0.0012068861396983266
other O 0 0.0012354319915175438
later O 0 0.004066563211381435
developed O 0 0.030242919921875
bilateral B-Disease 0 0.07323187589645386
retinoblastoma I-Disease 1 0.9998602867126465
. O 0 0.010392461903393269

In O 0 0.004564555361866951
conclusion O 0 0.007356281857937574
, O 0 0.0011680173920467496
our O 0 0.0018999819876626134
results O 0 0.007697081658989191
emphasize O 0 0.01140474434942007
that O 0 0.0009596458403393626
the O 0 0.0014251329703256488
manifestation O 0 0.49014681577682495
and O 0 0.002853124402463436
transmissibility O 1 0.999352753162384
of O 0 0.004586122930049896
retinoblastoma B-Disease 1 0.9999338388442993
depend O 0 0.006421324331313372
on O 0 0.000815311970654875
the O 0 0.0008137561962939799
nature O 0 0.00257350062020123
of O 0 0.0005140206776559353
the O 0 0.00101324706338346
first O 0 0.004845595918595791
mutation O 1 0.9999909400939941
, O 0 0.0014874159824103117
its O 0 0.0013239519903436303
time O 0 0.0012420790735632181
in O 0 0.0011689922539517283
development O 0 0.003616334404796362
, O 0 0.0008130543283186853
and O 0 0.0004947005654685199
the O 0 0.0006591998389922082
number O 0 0.0009537856676615775
and O 0 0.0008429455338045955
types O 0 0.00988555233925581
of O 0 0.0018430284690111876
cells O 1 0.999842643737793
that O 0 0.0015289793955162168
are O 0 0.0012645713286474347
affected O 0 0.01637207344174385
. O 0 0.0031737536191940308
. O 0 0.004843883216381073

Hereditary B-Disease 1 0.9998897314071655
deficiency I-Disease 1 0.9999768733978271
of I-Disease 0 0.0016491854330524802
the I-Disease 0 0.0015987660735845566
fifth I-Disease 0 0.008404819294810295
component I-Disease 0 0.022056762129068375
of I-Disease 0 0.0014766247477382421
complement I-Disease 0 0.14947062730789185
in O 0 0.002137039555236697
man O 0 0.012240900658071041
. O 0 0.006908389739692211

I O 0 0.020151659846305847
. O 0 0.010437262244522572

Clinical O 1 0.998390793800354
, O 0 0.007088725455105305
immunochemical O 1 0.9942268133163452
, O 0 0.0024585966020822525
and O 0 0.0019100795034319162
family O 0 0.013497361913323402
studies O 0 0.01807449199259281
. O 0 0.007002654019743204

The O 0 0.0032199749257415533
first O 0 0.0023179606068879366
recognized O 0 0.005332848057150841
human O 0 0.011012209579348564
kindred O 1 0.9989651441574097
with O 0 0.010051153600215912
hereditary B-Disease 1 0.9999898672103882
deficiency I-Disease 1 0.9999958276748657
of I-Disease 0 0.0012639571214094758
the I-Disease 0 0.0011286434018984437
fifth I-Disease 0 0.008403475396335125
component I-Disease 0 0.01871597394347191
of I-Disease 0 0.0018944153562188148
complement I-Disease 1 0.6266887187957764
( O 0 0.009189750999212265
C5 O 1 0.999826967716217
) O 0 0.004748752806335688
is O 0 0.0021801867987960577
described O 0 0.009799488820135593
. O 0 0.0060561238788068295

The O 0 0.006818139925599098
proband O 1 0.9405307769775391
, O 0 0.002212237799540162
a O 0 0.005844643339514732
20 O 0 0.007160957437008619
- O 0 0.018095314502716064
year O 0 0.00505631510168314
- O 0 0.01358252763748169
old O 0 0.01127663254737854
black O 0 0.018925976008176804
female O 0 0.16289351880550385
with O 1 0.6128685474395752
systemic B-Disease 1 0.9999998807907104
lupus I-Disease 1 1.0
erythematosus I-Disease 1 0.9999990463256836
since O 0 0.010372952558100224
age O 0 0.006175405811518431
11 O 0 0.005540072917938232
, O 0 0.002776939421892166
lacked O 0 0.20741845667362213
serum O 1 0.9999490976333618
hemolytic O 1 0.9999983310699463
complement O 1 0.7178120613098145
activity O 0 0.012484789825975895
, O 0 0.0018021727446466684
even O 0 0.0031693261116743088
during O 0 0.009340607561171055
remission O 1 0.9998047947883606
. O 0 0.009125558659434319

C5 O 1 0.995826780796051
was O 0 0.01199857983738184
undetectable O 1 0.9869500994682312
in O 0 0.003863148856908083
her O 0 0.011417105793952942
serum O 1 0.9987851977348328
by O 0 0.0033592877443879843
both O 0 0.003546810010448098
immunodiffusion O 1 0.9959028363227844
and O 0 0.008952517062425613
hemolytic O 1 0.9999990463256836
assays O 1 0.9929547905921936
. O 0 0.011505144648253918

Other O 0 0.0041840411722660065
complement O 0 0.03337239846587181
components O 0 0.010076307691633701
were O 0 0.0011216539423912764
normal O 0 0.015641270205378532
during O 0 0.008247220888733864
remission O 1 0.9999234676361084
of O 0 0.007741700392216444
lupus O 1 0.9999997615814209
, O 0 0.0039031491614878178
but O 0 0.0039023852441459894
C1 O 1 0.999914288520813
, O 0 0.004812330473214388
C4 O 1 0.9997652173042297
, O 0 0.007058221846818924
C2 O 1 0.999869704246521
, O 0 0.003007147926837206
and O 0 0.0029616497922688723
C3 O 1 0.9996198415756226
levels O 0 0.023278411477804184
fell O 0 0.016121583059430122
during O 0 0.01308742817491293
exacerbations O 1 0.999735414981842
. O 0 0.012668545357882977

A O 0 0.024446966126561165
younger O 0 0.032775286585092545
half O 0 0.0108561422675848
- O 0 0.035876013338565826
sister O 0 0.082211434841156
, O 0 0.0013180477544665337
who O 0 0.0011367920087650418
had O 0 0.00183626648504287
no O 0 0.004614322446286678
underlying O 1 0.9997403025627136
disease O 1 0.999995231628418
, O 0 0.001588236540555954
was O 0 0.001200358266942203
also O 0 0.0011291740229353309
found O 0 0.002788807963952422
to O 0 0.0017405999824404716
lack O 0 0.019229015335440636
immunochemically O 1 0.9969333410263062
detectable O 1 0.9986861348152161
C5 O 1 0.9986807703971863
. O 0 0.011164515279233456

By O 0 0.040930021554231644
hemolytic O 1 0.9999982118606567
assay O 1 0.992904007434845
, O 0 0.00367541890591383
she O 0 0.0029676640406250954
exhibited O 0 0.010204959660768509
1 O 0 0.009215794503688812
- O 0 0.014833279885351658
2 O 0 0.005474679637700319
% O 0 0.0023301346227526665
of O 0 0.0007030284032225609
the O 0 0.0019194018095731735
normal O 0 0.27528902888298035
serum O 1 0.9997920393943787
C5 O 1 0.9993218183517456
level O 0 0.006194022949784994
and O 0 0.001512434333562851
normal O 0 0.0202462337911129
concentrations O 0 0.034500498324632645
of O 0 0.0010106430854648352
other O 0 0.0020420358050614595
complement O 0 0.10549353808164597
components O 0 0.02433241344988346
. O 0 0.00677854148671031

C5 O 1 0.9983735084533691
levels O 0 0.013660713098943233
of O 0 0.0010604868875816464
other O 0 0.001025595935061574
family O 0 0.004932348616421223
members O 0 0.0011946912854909897
were O 0 0.0007806653738953173
either O 0 0.0046796235255897045
normal O 0 0.016967397183179855
or O 0 0.0028616944327950478
approximately O 0 0.003481754567474127
half O 0 0.007316621020436287
- O 0 0.025106355547904968
normal O 0 0.024010885506868362
, O 0 0.001669416786171496
consistent O 0 0.011053577065467834
with O 0 0.007705677766352892
autosomal O 1 0.9999983310699463
codominant O 1 0.9949609041213989
inheritance O 0 0.18021249771118164
of O 0 0.0013518704799935222
the O 0 0.0038121643010526896
gene O 1 0.9999148845672607
determining O 1 0.919888436794281
C5 B-Disease 1 0.9999816417694092
deficiency I-Disease 1 0.9999945163726807
. O 0 0.01377941481769085

Normal O 1 0.9693368077278137
hemolytic O 1 0.9999912977218628
titers O 1 0.9903792142868042
were O 0 0.0021920260041952133
restored O 0 0.008153263479471207
to O 0 0.001377047155983746
both O 0 0.004118328448385
homozygous O 1 0.9999566078186035
C5 B-Disease 1 0.9999877214431763
- I-Disease 1 0.9650838375091553
deficient I-Disease 1 0.9998968839645386
( O 0 0.01426998246461153
C5D B-Disease 1 0.9996939897537231
) O 0 0.006718223448842764
sera O 0 0.0987635925412178
by O 0 0.0019993113819509745
addition O 0 0.002760498085990548
of O 0 0.00109471392352134
highly O 0 0.014841866679489613
purified O 1 0.9948127269744873
human O 0 0.034842412918806076
C5 O 1 0.9983994364738464
. O 0 0.01252356730401516

In O 0 0.006036128383129835
specific O 0 0.023062847554683685
C5 O 1 0.9998890161514282
titrations O 1 0.9998145699501038
, O 0 0.0032711117528378963
however O 0 0.001990170916542411
, O 0 0.001100486028008163
it O 0 0.0008685427019372582
was O 0 0.0009589310502633452
noted O 0 0.0016924089286476374
that O 0 0.0007986770942807198
when O 0 0.0016902526840567589
limited O 0 0.003130850614979863
amounts O 0 0.005327727645635605
of O 0 0.001579969422891736
C5 O 1 0.9995388984680176
were O 0 0.0017041439423337579
assayed O 1 0.5166923403739929
in O 0 0.0012680075597018003
the O 0 0.0011333983857184649
presence O 0 0.004873023834079504
of O 0 0.0014608718920499086
low O 0 0.01757035404443741
dilutions O 1 0.9961428046226501
of O 0 0.0023916398640722036
either O 0 0.01212643925100565
C5D B-Disease 1 0.9998669624328613
serum O 1 0.999479353427887
, O 0 0.003510046983137727
curving O 0 0.12559181451797485
rather O 0 0.003798459190875292
than O 0 0.0029347757808864117
linear O 1 0.9959375858306885
dose O 1 0.9998123049736023
- O 0 0.026517044752836227
response O 0 0.01363016664981842
plots O 0 0.014632944017648697
were O 0 0.0007688221521675587
consistently O 0 0.004177978727966547
obtained O 0 0.0044156210497021675
, O 0 0.0014056386426091194
suggesting O 0 0.013400588184595108
some O 0 0.0040212939493358135
inhibitory O 1 0.9964727759361267
effect O 0 0.024237114936113358
. O 0 0.00747072696685791

Further O 0 0.010750796645879745
studies O 0 0.010758857242763042
suggested O 0 0.005732426419854164
that O 0 0.0016682047862559557
low O 0 0.017601611092686653
dilutions O 1 0.993963897228241
of O 0 0.004449097439646721
C5D B-Disease 1 0.9997144341468811
serum O 1 0.9993219375610352
contain O 0 0.01797652617096901
a O 0 0.007232380099594593
factor O 0 0.09042607992887497
( O 0 0.003291743341833353
or O 0 0.0037314239889383316
factors O 0 0.027357423678040504
) O 0 0.0030949602369219065
interfering O 0 0.03915684297680855
at O 0 0.0013376588467508554
some O 0 0.000840628519654274
step O 0 0.005998572800308466
in O 0 0.0013176245847716928
the O 0 0.0051526571623981
hemolytic O 1 0.999998927116394
assay O 1 0.9938144683837891
of O 0 0.0038185857702046633
C5 O 1 0.9997649788856506
, O 0 0.002189123071730137
rather O 0 0.002122943988069892
than O 0 0.0011547727044671774
a O 0 0.005305924918502569
true O 0 0.02119828201830387
C5 O 1 0.9998869895935059
inhibitor O 1 0.9997537732124329
or O 0 0.013894987292587757
inactivator O 1 0.9764636754989624
. O 0 0.011185860261321068

Of O 0 0.006453001406043768
clinical O 1 0.9964854717254639
interest O 0 0.0031489043030887842
are O 0 0.0009401633287779987
( O 0 0.00198765704408288
a O 0 0.0033773621544241905
) O 0 0.0013355285627767444
the O 0 0.0007859748438932002
documentation O 0 0.007347460836172104
of O 0 0.0028614792972803116
membranous O 1 0.9999772310256958
glomerulonephritis B-Disease 1 0.9999897480010986
, O 0 0.011231377720832825
vasculitis B-Disease 1 0.9999980926513672
, O 0 0.002973578404635191
and O 0 0.00423861388117075
arthritis B-Disease 1 0.9999996423721313
in O 0 0.0019001493928954005
an O 0 0.0016395826824009418
individual O 0 0.00633967574685812
lacking O 1 0.9390166997909546
C5 O 1 0.9998564720153809
( O 0 0.0026216378901153803
and O 0 0.0007964062388055027
its O 0 0.003343043150380254
biologic O 1 0.9999531507492065
functions O 0 0.012329019606113434
) O 0 0.0023056003265082836
, O 0 0.0009758711094036698
and O 0 0.0012222229270264506
( O 0 0.004166501574218273
b O 1 0.6245299577713013
) O 0 0.0018943974282592535
a O 0 0.0033748638816177845
remarkable O 0 0.010521487332880497
propensity O 1 0.9934813976287842
to O 0 0.01170974038541317
bacterial B-Disease 1 0.9999998807907104
infections I-Disease 1 0.9999978542327881
in O 0 0.0020004352554678917
the O 0 0.002788111800327897
proband O 1 0.9990541338920593
, O 0 0.001508851652033627
even O 0 0.0016042764764279127
during O 0 0.0017550068441778421
periods O 0 0.004895983263850212
of O 0 0.0012180714402347803
low O 0 0.03488827124238014
- O 0 0.25160735845565796
dose O 1 0.9985878467559814
or O 0 0.004515748005360365
alternate O 0 0.019966939464211464
- O 0 0.02475511096417904
day O 0 0.015823885798454285
corticosteroid O 1 0.9999573230743408
therapy O 1 0.9995081424713135
. O 0 0.008489579893648624

Other O 0 0.0039744325913488865
observations O 0 0.008570513688027859
indicate O 0 0.008028751239180565
that O 0 0.0011104752775281668
the O 0 0.0019118130439892411
C5D B-Disease 1 0.9985276460647583
state O 0 0.002198836300522089
is O 0 0.0014849393628537655
compatible O 0 0.02937409281730652
with O 0 0.004265137016773224
normal O 1 0.9245461821556091
coagulation O 1 0.999993085861206
function O 0 0.025143366307020187
and O 0 0.0007476844475604594
the O 0 0.0008131953072734177
capacity O 0 0.0023493156768381596
to O 0 0.0013320562429726124
mount O 0 0.008949133567512035
a O 0 0.01618299074470997
neutrophilic O 1 0.9999232292175293
leukocytosis O 1 0.999854326248169
during O 0 0.035010047256946564
pyogenic B-Disease 1 0.99997878074646
infection I-Disease 1 0.9999865293502808
. O 0 0.006202423945069313
. O 0 0.0057479869574308395

Susceptibility O 1 0.999355137348175
to O 0 0.023451700806617737
ankylosing B-Disease 1 0.9999964237213135
spondylitis I-Disease 1 0.9999891519546509
in O 0 0.0074750990606844425
twins O 1 0.9904740452766418
: O 0 0.0025465856306254864
the O 0 0.001168946735560894
role O 0 0.004468032158911228
of O 0 0.0021517814602702856
genes O 1 0.9999505281448364
, O 0 0.005165501032024622
HLA O 1 0.9999833106994629
, O 0 0.0021996682044118643
and O 0 0.0009904431644827127
the O 0 0.002059973543509841
environment O 0 0.011134465225040913
. O 0 0.005849380977451801

OBJECTIVE O 0 0.018065955489873886
To O 0 0.0013951421715319157
determine O 0 0.003857034258544445
the O 0 0.0010565525153651834
relative O 0 0.009558310732245445
effects O 0 0.04160699620842934
of O 0 0.002005054149776697
genetic O 1 0.9999290704727173
and O 0 0.0016099733766168356
environmental O 0 0.007919787429273129
factors O 0 0.013722235336899757
in O 0 0.00343320588581264
susceptibility O 1 0.9999850988388062
to O 0 0.021425209939479828
ankylosing B-Disease 1 0.9999996423721313
spondylitis I-Disease 1 0.9999979734420776
( O 0 0.009860311634838581
AS B-Disease 0 0.006199593655765057
) O 0 0.005503266118466854
. O 0 0.00545151112601161

METHODS O 0 0.06012455001473427
Twins O 1 0.9240401983261108
with O 0 0.0030379346571862698
AS B-Disease 0 0.0027187576051801443
were O 0 0.0007617477676831186
identified O 0 0.005078629590570927
from O 0 0.0009420323185622692
the O 0 0.0012643412919715047
Royal O 0 0.010187403298914433
National O 0 0.009483303874731064
Hospital O 1 0.9994864463806152
for O 0 0.03230125084519386
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999940395355225
database O 0 0.44911885261535645
. O 0 0.006746216211467981

Clinical O 1 0.9940120577812195
and O 0 0.00481221592053771
radiographic O 1 0.9982312321662903
examinations O 0 0.027145428583025932
were O 0 0.0008875722996890545
performed O 0 0.004304408561438322
to O 0 0.0017129764892160892
establish O 0 0.02127116546034813
diagnoses O 1 0.9999456405639648
, O 0 0.003859640331938863
and O 0 0.006624944042414427
disease O 1 0.999997615814209
severity O 1 0.9972440004348755
was O 0 0.002890142844989896
assessed O 0 0.010282101109623909
using O 0 0.004650711081922054
a O 0 0.004396648146212101
combination O 0 0.02790939435362816
of O 0 0.001302990480326116
validated O 0 0.1031704768538475
scoring O 0 0.014680233784019947
systems O 0 0.03304027393460274
. O 0 0.006577471736818552

HLA O 1 0.9987232089042664
typing O 1 0.9674474596977234
for O 0 0.01430129911750555
HLA O 1 0.9999384880065918
- O 0 0.2654128968715668
B27 O 1 0.994452178478241
, O 0 0.011617964133620262
HLA O 1 0.9999810457229614
- O 0 0.12451741099357605
B60 O 1 0.9784082174301147
, O 0 0.003459446132183075
and O 0 0.004383960273116827
HLA O 1 0.9999876022338867
- O 0 0.4303201138973236
DR1 O 1 0.9989569187164307
was O 0 0.003560073906555772
performed O 0 0.006115027237683535
by O 0 0.004498956259340048
polymerase O 1 0.9993475079536438
chain O 1 0.6561433672904968
reaction O 0 0.02562798373401165
with O 0 0.0032432216685265303
sequence O 1 0.522472083568573
- O 0 0.017340367659926414
specific O 0 0.009275708347558975
primers O 1 0.9928749799728394
, O 0 0.0019544351380318403
and O 0 0.001773031079210341
zygosity O 1 0.9633692502975464
was O 0 0.003844709135591984
assessed O 0 0.01794295385479927
using O 0 0.016275063157081604
microsatellite O 1 0.9984143972396851
markers O 1 0.8577927350997925
. O 0 0.00794540997594595

Genetic O 1 0.9985759258270264
and O 0 0.0029108328744769096
environmental O 0 0.01073424145579338
variance O 0 0.07888928800821304
components O 0 0.009671124629676342
were O 0 0.0006898067076690495
assessed O 0 0.00798631738871336
with O 0 0.0012752484763041139
the O 0 0.0015229261480271816
program O 0 0.01308528520166874
Mx O 1 0.9992241859436035
, O 0 0.0016827030340209603
using O 0 0.0037176674231886864
data O 0 0.0027009693440049887
from O 0 0.0009069588268175721
this O 0 0.0007765008485876024
and O 0 0.0007901389035396278
previous O 0 0.0031599379144608974
studies O 0 0.006180780939757824
of O 0 0.0014899394009262323
twins O 1 0.9966005682945251
with O 0 0.003755477722734213
AS B-Disease 0 0.005902486853301525
. O 0 0.005576915107667446

RESULTS O 0 0.02672290802001953
Six O 0 0.004671630449593067
of O 0 0.0016209656605497003
8 O 0 0.01534134242683649
monozygotic O 1 0.9998345375061035
( O 0 0.01337859220802784
MZ O 1 0.9999516010284424
) O 0 0.007438695058226585
twin O 0 0.48155710101127625
pairs O 0 0.16832630336284637
were O 0 0.0052027273923158646
disease O 1 0.9999929666519165
concordant O 1 0.999538779258728
, O 0 0.0023570533376187086
compared O 0 0.0059250700287520885
with O 0 0.0024129978846758604
4 O 0 0.004267076961696148
of O 0 0.00129074661526829
15 O 0 0.008973921649158001
B27 O 1 0.9960999488830566
- O 0 0.03145645186305046
positive O 0 0.0326252356171608
dizygotic O 1 0.9993676543235779
( O 0 0.013630908913910389
DZ O 1 0.9997631907463074
) O 0 0.007319011725485325
twin O 1 0.6678399443626404
pairs O 0 0.1637590229511261
( O 0 0.004034611862152815
27 O 0 0.008865742944180965
% O 0 0.0041590724140405655
) O 0 0.0023168306797742844
and O 0 0.0007519674254581332
4 O 0 0.003514942480251193
of O 0 0.0010631520999595523
32 O 0 0.017741424962878227
DZ O 1 0.999882698059082
twin O 1 0.9634949564933777
pairs O 0 0.14675891399383545
overall O 0 0.01221783272922039
( O 0 0.0035565660800784826
12 O 0 0.004619796294718981
. O 0 0.001750412629917264
5 O 0 0.005791335832327604
% O 0 0.005666037555783987
) O 0 0.004492957144975662
. O 0 0.005179326515644789

Nonsignificant O 1 0.9785766005516052
increases O 0 0.023219656199216843
in O 0 0.002254257909953594
similarity O 0 0.100613072514534
with O 0 0.0018537967698648572
regard O 0 0.003337674541398883
to O 0 0.0012953545665368438
age O 0 0.007457043044269085
at O 0 0.016474997624754906
disease O 1 0.9999990463256836
onset O 1 0.9999668598175049
and O 0 0.0008341450593434274
all O 0 0.0004928720300085843
of O 0 0.0010280008427798748
the O 0 0.006024269852787256
disease O 1 0.9999980926513672
severity O 1 0.9981681108474731
scores O 0 0.011377112939953804
assessed O 0 0.008238762617111206
were O 0 0.000717001676093787
noted O 0 0.0028693035710603
in O 0 0.005006496794521809
disease O 1 0.9999969005584717
- O 1 0.9354829788208008
concordant O 1 0.99981290102005
MZ O 1 0.9999752044677734
twins O 1 0.9525465369224548
compared O 0 0.013261577114462852
with O 0 0.008492711931467056
concordant O 1 0.9994008541107178
DZ O 1 0.9997920393943787
twins O 1 0.954220175743103
. O 0 0.011829356662929058

HLA O 1 0.999893307685852
- O 0 0.10973810404539108
B27 O 1 0.9598764777183533
and O 0 0.004057136829942465
B60 O 1 0.8426988124847412
were O 0 0.0014168715570122004
associated O 0 0.00545914564281702
with O 0 0.0019653975032269955
the O 0 0.0037102620117366314
disease O 1 0.9999927282333374
in O 0 0.003350611310452223
probands O 1 0.9991577863693237
, O 0 0.001284960308112204
and O 0 0.000585814006626606
the O 0 0.0010467207757756114
rate O 0 0.007252752315253019
of O 0 0.003048250451683998
disease O 1 0.999993085861206
concordance O 1 0.9973158240318298
was O 0 0.0033567347563803196
significantly O 0 0.0175763051956892
increased O 0 0.008072741329669952
among O 0 0.0060537392273545265
DZ O 1 0.9999254941940308
twin O 1 0.8795583844184875
pairs O 0 0.03082997165620327
in O 0 0.0011787370312958956
which O 0 0.0009044557809829712
the O 0 0.0023827843833714724
co O 1 0.9008293151855469
- O 0 0.05070376768708229
twin O 1 0.7175574898719788
was O 0 0.0026692585088312626
positive O 0 0.007700407411903143
for O 0 0.0013508183183148503
both O 0 0.00295233610086143
B27 O 1 0.9940041899681091
and O 0 0.005459372419863939
DR1 O 1 0.9994296431541443
. O 0 0.010925727896392345

Additive O 1 0.9959446787834167
genetic O 1 0.9994730353355408
effects O 0 0.03959834203124046
were O 0 0.0011684346245601773
estimated O 0 0.0029588621109724045
to O 0 0.0012999634491279721
contribute O 0 0.013350600376725197
97 O 0 0.016664525493979454
% O 0 0.002683248370885849
of O 0 0.0007129886653274298
the O 0 0.0014551751082763076
population O 0 0.004561746492981911
variance O 0 0.21288184821605682
. O 0 0.006355083081871271

CONCLUSION O 0 0.06250416487455368
Susceptibility O 1 0.9996139407157898
to O 0 0.0019474121509119868
AS B-Disease 0 0.002704639919102192
is O 0 0.0015368331223726273
largely O 0 0.005449628923088312
genetically O 1 0.9970921277999878
determined O 0 0.007153747137635946
, O 0 0.0008163758902810514
and O 0 0.0005553428782150149
the O 0 0.0012368018506094813
environmental O 0 0.01056275051087141
trigger O 1 0.9938961863517761
for O 0 0.0021469176281243563
the O 0 0.004894557408988476
disease O 1 0.9999957084655762
is O 0 0.002882663393393159
probably O 0 0.008286427706480026
ubiquitous O 1 0.8543713092803955
. O 0 0.007976342923939228

HLA O 1 0.9999061822891235
- O 0 0.08848762512207031
B27 O 1 0.8188124299049377
accounts O 0 0.005377383437007666
for O 0 0.0013563423417508602
a O 0 0.003208654001355171
minority O 0 0.005183205474168062
of O 0 0.0005834400653839111
the O 0 0.0013996441848576069
overall O 0 0.19334019720554352
genetic O 1 0.9999924898147583
susceptibility O 1 0.9999526739120483
to O 0 0.0021180182229727507
AS B-Disease 0 0.005611033644527197
. O 0 0.005680809263139963

Cell O 1 0.9966436624526978
cycle O 1 0.7727433443069458
- O 0 0.028071468695998192
dependent O 0 0.02594653330743313
colocalization O 1 0.7074559330940247
of O 0 0.0029687057249248028
BARD1 O 1 0.996024489402771
and O 0 0.00853507686406374
BRCA1 O 1 0.9999972581863403
proteins O 1 0.9932645559310913
in O 0 0.0034487431403249502
discrete O 0 0.09106667339801788
nuclear O 0 0.02422662079334259
domains O 0 0.17426113784313202
. O 0 0.007269006688147783

Germ O 1 0.9979308843612671
- O 0 0.040742941200733185
line O 0 0.01727013662457466
mutations O 1 0.9991245865821838
of O 0 0.0018925184849649668
the O 0 0.006421092431992292
BRCA1 O 1 0.9999996423721313
gene O 1 0.9999674558639526
predispose O 1 0.9992881417274475
women O 0 0.004948182962834835
to O 0 0.0019779971335083246
early O 0 0.014309227466583252
- O 1 0.9974079728126526
onset O 1 0.9999969005584717
breast B-Disease 1 0.9999988079071045
and I-Disease 1 0.7796779274940491
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
by O 0 0.004279929678887129
compromising O 0 0.29125866293907166
the O 0 0.0035399659536778927
genes O 1 0.9997840523719788
presumptive O 1 0.9981374740600586
function O 0 0.019922813400626183
as O 0 0.002764203818514943
a O 0 0.0358724482357502
tumor B-Disease 1 0.9999986886978149
suppressor O 1 0.9999099969863892
. O 0 0.011077445931732655

Although O 0 0.005510232876986265
the O 0 0.0024038529954850674
biochemical O 1 0.9938061237335205
properties O 0 0.013939262367784977
of O 0 0.004538530483841896
BRCA1 O 1 0.9999980926513672
polypeptides O 1 0.9953174591064453
are O 0 0.0016438310267403722
not O 0 0.001291112508624792
understood O 0 0.006855997256934643
, O 0 0.0009863205486908555
their O 0 0.001635609776712954
expression O 0 0.033908434212207794
pattern O 0 0.04017390310764313
and O 0 0.0025945897214114666
subcellular O 1 0.9917948842048645
localization O 1 0.7727435231208801
suggest O 0 0.008801152929663658
a O 0 0.004277930129319429
role O 0 0.006708817556500435
in O 0 0.0038061137311160564
cell O 1 0.9996539354324341
- O 0 0.09791270643472672
cycle O 1 0.8777152299880981
regulation O 0 0.06923529505729675
. O 0 0.007034620735794306

When O 0 0.017448656260967255
resting O 1 0.7977571487426758
cells O 1 0.9980393052101135
are O 0 0.003310974221676588
induced O 1 0.9989567995071411
to O 0 0.0031646552961319685
proliferate O 1 0.9853397011756897
, O 0 0.0013265262823551893
the O 0 0.0014242504257708788
steady O 0 0.02137749455869198
- O 0 0.010309112258255482
state O 0 0.0018635436426848173
levels O 0 0.008251665160059929
of O 0 0.0027958599384874105
BRCA1 O 1 0.9999979734420776
increase O 0 0.008299652487039566
in O 0 0.001551389810629189
late O 0 0.008311477489769459
G1 O 1 0.9998155236244202
and O 0 0.0016242176061496139
reach O 0 0.004227514378726482
a O 0 0.004159552976489067
maximum O 0 0.007621238473802805
during O 0 0.0060644387267529964
S O 1 0.6526435613632202
phase O 0 0.06368967890739441
. O 0 0.008033833466470242

Moreover O 0 0.02413548156619072
, O 0 0.0019049549009650946
in O 0 0.002204110147431493
S O 1 0.7671103477478027
phase O 1 0.6488034725189209
cells O 1 0.9992735981941223
, O 0 0.007757500279694796
BRCA1 O 1 0.9999974966049194
polypeptides O 1 0.9946012496948242
are O 0 0.002278515137732029
hyperphosphorylated O 1 0.9399839043617249
and O 0 0.002458397764712572
accumulate O 1 0.5995402932167053
into O 0 0.0066550313495099545
discrete O 0 0.27766987681388855
subnuclear O 1 0.9899116158485413
foci O 1 0.9950243830680847
termed O 0 0.19684341549873352
" O 0 0.015106317587196827
BRCA1 O 1 0.9999865293502808
nuclear O 0 0.04679613932967186
dots O 1 0.7592077851295471
. O 0 0.00870926771312952

" O 0 0.03461962938308716
BRCA1 O 1 0.9999889135360718
associates O 0 0.19541776180267334
in O 0 0.003723024157807231
vivo O 1 0.9975669384002686
with O 0 0.0024388327728956938
a O 0 0.0076038469560444355
structurally O 1 0.9639633893966675
related O 0 0.035336241126060486
protein O 1 0.9988055229187012
termed O 1 0.7558372020721436
BARD1 O 1 0.9915788173675537
. O 0 0.01111409068107605

Here O 0 0.0037786054890602827
we O 0 0.0011583903105929494
show O 0 0.0019636042416095734
that O 0 0.0010146984132006764
the O 0 0.0015292969765141606
steady O 0 0.02133544534444809
- O 0 0.011345206759870052
state O 0 0.0020875760819762945
levels O 0 0.008793119341135025
of O 0 0.002327594207599759
BARD1 O 1 0.998327910900116
, O 0 0.0019472138956189156
unlike O 0 0.006141801830381155
those O 0 0.0011181904701516032
of O 0 0.002957373857498169
BRCA1 O 1 0.9999996423721313
, O 0 0.002428628969937563
remain O 0 0.0028265691362321377
relatively O 0 0.005776671227067709
constant O 0 0.011394953355193138
during O 0 0.006069603841751814
cell O 1 0.9995241165161133
cycle O 1 0.9925864338874817
progression O 1 0.9995866417884827
. O 0 0.007867083884775639

However O 0 0.008742032572627068
, O 0 0.0036981988232582808
immunostaining O 1 0.8786433339118958
revealed O 0 0.016939138993620872
that O 0 0.0029952842742204666
BARD1 O 1 0.9946020841598511
resides O 0 0.019269254058599472
within O 0 0.008045831695199013
BRCA1 O 1 0.9999955892562866
nuclear O 0 0.0326702743768692
dots O 1 0.6126739382743835
during O 0 0.005396232940256596
S O 0 0.05324731767177582
phase O 0 0.01286869402974844
of O 0 0.0007623916026204824
the O 0 0.0027310731820762157
cell O 1 0.9998805522918701
cycle O 1 0.9812031388282776
, O 0 0.0012249688152223825
but O 0 0.0008670539245940745
not O 0 0.0006184142548590899
during O 0 0.002049980452284217
the O 0 0.0027773885522037745
G1 O 1 0.9999041557312012
phase O 0 0.11060824245214462
. O 0 0.007931133732199669

Nevertheless O 0 0.02426024340093136
, O 0 0.006548992358148098
BARD1 O 1 0.9943575263023376
polypeptides O 1 0.9663099050521851
are O 0 0.0013200866524130106
found O 0 0.0031975051388144493
exclusively O 0 0.0030473843216896057
in O 0 0.0007939443457871675
the O 0 0.0009206354734487832
nuclear O 0 0.0070566716603934765
fractions O 0 0.01824033632874489
of O 0 0.0010543126845732331
both O 0 0.003972449339926243
G1 O 1 0.999982476234436
- O 0 0.025851378217339516
and O 0 0.003006699262186885
S O 1 0.9615229368209839
- O 0 0.09954185038805008
phase O 1 0.8516756296157837
cells O 1 0.9982116222381592
. O 0 0.008046436123549938

Therefore O 0 0.011832144111394882
, O 0 0.0044142561964690685
progression O 1 0.9993089437484741
to O 0 0.0031058562453836203
S O 1 0.8091798424720764
phase O 0 0.02913617715239525
is O 0 0.0015608408721163869
accompanied O 0 0.003930046223104
by O 0 0.0014019153313711286
the O 0 0.0016777574783191085
aggregation O 1 0.9807698726654053
of O 0 0.0017331078415736556
nuclear O 0 0.021160466596484184
BARD1 O 1 0.989630401134491
polypeptides O 1 0.9530118107795715
into O 0 0.021174341440200806
BRCA1 O 1 0.9999839067459106
nuclear O 0 0.05012454465031624
dots O 1 0.8247963190078735
. O 0 0.009228781796991825

This O 0 0.009145458228886127
cell O 1 0.9970747232437134
cycle O 1 0.8812223672866821
- O 0 0.02105962112545967
dependent O 0 0.018096448853611946
colocalization O 1 0.7194622159004211
of O 0 0.002657489152625203
BARD1 O 1 0.9984753727912903
and O 0 0.0059593115001916885
BRCA1 O 1 0.9999978542327881
indicates O 0 0.024436794221401215
a O 0 0.004168776795268059
role O 0 0.005122681614011526
for O 0 0.002509832149371505
BARD1 O 1 0.9971363544464111
in O 0 0.011435349471867085
BRCA1 O 1 0.9999992847442627
- O 1 0.9883683323860168
mediated O 1 0.999835729598999
tumor B-Disease 1 0.9999873638153076
suppression O 1 0.8189767003059387
. O 0 0.009480091743171215

Ethnic O 0 0.013250068761408329
differences O 0 0.009902682155370712
in O 0 0.0018967989599332213
the O 0 0.004610254894942045
HFE O 1 0.9993613362312317
codon O 1 0.9876420497894287
282 O 1 0.7897443175315857
( O 0 0.02122887596487999
Cys O 1 0.999639630317688
/ O 1 0.9804243445396423
Tyr O 1 0.9975226521492004
) O 0 0.01553735975176096
polymorphism O 1 0.9935637712478638
. O 0 0.01029178686439991

Recent O 0 0.013076684437692165
studies O 0 0.007705553900450468
have O 0 0.001051026862114668
shown O 0 0.005185241345316172
that O 0 0.005140142980962992
hereditary B-Disease 1 0.9999984502792358
hemochromatosis I-Disease 1 0.9999998807907104
( O 0 0.02867642045021057
HH B-Disease 1 0.9999781847000122
) O 0 0.0041727363131940365
is O 0 0.0013765502953901887
likely O 0 0.0026970021426677704
to O 0 0.0006187723483890295
be O 0 0.001010968117043376
caused O 0 0.02310449257493019
by O 0 0.003325191792100668
homozygosity O 1 0.9682650566101074
for O 0 0.0022590779699385166
a O 0 0.009293214417994022
Cys282Tyr O 1 0.9991369843482971
mutation O 1 0.9998266100883484
in O 0 0.0024984527844935656
the O 0 0.005793516058474779
HFE O 1 0.9999420642852783
gene O 1 0.999178946018219
located O 0 0.007091800216585398
4 O 0 0.011272226460278034
. O 0 0.0064832791686058044

5 O 0 0.034173689782619476
Mb O 1 0.9902178645133972
telomeric O 1 0.9969978332519531
to O 0 0.010531292296946049
HLA O 1 0.9998675584793091
- O 0 0.04222981259226799
A O 0 0.021110916510224342
. O 0 0.009727033786475658

Population O 0 0.007847568020224571
studies O 0 0.0070585887879133224
of O 0 0.000792690203525126
this O 0 0.001627861987799406
polymorphism O 1 0.9988470077514648
are O 0 0.0011406769044697285
facilitated O 0 0.04233454540371895
by O 0 0.0013840034371241927
the O 0 0.0008228287915699184
fact O 0 0.0017037804936990142
that O 0 0.0008031685138121247
the O 0 0.002459813142195344
Cys282Tyr O 1 0.9995867609977722
mutation O 1 0.9999529123306274
creates O 0 0.041320279240608215
a O 0 0.010845547541975975
Rsal O 1 0.9866201877593994
restriction O 0 0.03306758403778076
site O 0 0.009552923031151295
. O 0 0.006846866104751825

We O 0 0.0028500042390078306
have O 0 0.001262138714082539
studied O 0 0.004418005235493183
the O 0 0.0032928381115198135
codon O 1 0.9888468384742737
282 O 1 0.8640583753585815
( O 0 0.018374865874648094
Cys O 1 0.9998061060905457
/ O 1 0.987553596496582
Tyr O 1 0.9991994500160217
) O 0 0.00984556507319212
polymorphism O 1 0.9938029050827026
in O 0 0.0019048486137762666
different O 0 0.001897617126815021
ethnic O 0 0.005253170151263475
groups O 0 0.0053797229193151
. O 0 0.0057494910433888435

In O 0 0.004955134820193052
agreement O 0 0.004439238458871841
with O 0 0.0019822537433356047
previous O 0 0.0029665385372936726
observations O 0 0.00708611449226737
the O 0 0.00491613382473588
Tyr O 1 0.9998475313186646
allele O 1 0.9994214773178101
appeared O 0 0.006045106798410416
to O 0 0.0010763596510514617
be O 0 0.0010990954469889402
rare O 0 0.017269624397158623
or O 0 0.0033478911500424147
absent O 0 0.04043659195303917
in O 0 0.0034314864315092564
Asiatic O 1 0.9988345503807068
( O 0 0.004866373259574175
Indian O 0 0.006347944028675556
, O 0 0.0014956004451960325
Chinese O 0 0.003500651102513075
) O 0 0.005089160054922104
populations O 0 0.03806011751294136
. O 0 0.005566276144236326

The O 0 0.004467945080250502
highest O 0 0.012717558071017265
allele O 1 0.9992170333862305
frequency O 0 0.05951789394021034
( O 0 0.004993575159460306
7 O 0 0.007168881595134735
. O 0 0.0017600749852135777
5 O 0 0.004805037286132574
% O 0 0.004823110066354275
) O 0 0.002393786795437336
was O 0 0.0012837748508900404
found O 0 0.003574448637664318
in O 0 0.002236162079498172
Swedes O 0 0.08312828838825226
. O 0 0.008076032623648643

Saamis O 1 0.9795147180557251
( O 0 0.007544470019638538
2 O 0 0.007523315958678722
% O 0 0.005229032598435879
) O 0 0.0028401007875800133
and O 0 0.002045964589342475
Mordvinians O 1 0.9986132383346558
( O 0 0.004396087024360895
1 O 0 0.004795861430466175
. O 0 0.0014680568128824234
8 O 0 0.0053160968236625195
% O 0 0.00450857263058424
) O 0 0.0022162243258208036
had O 0 0.002220463939011097
significantly O 0 0.018695764243602753
lower O 0 0.00719863548874855
frequencies O 0 0.01886139065027237
of O 0 0.001435538288205862
the O 0 0.0049917008727788925
Tyr O 1 0.9991781115531921
allele O 1 0.9990125894546509
. O 0 0.011589749716222286

Comparisons O 0 0.03172586113214493
with O 0 0.008444065228104591
allele O 1 0.9985368251800537
frequencies O 0 0.030284974724054337
based O 0 0.0036881014239042997
on O 0 0.0021195837762206793
prevalence O 1 0.9989558458328247
estimates O 0 0.008351176977157593
of O 0 0.0024164568167179823
HH B-Disease 1 0.9997096657752991
showed O 0 0.007077484391629696
some O 0 0.0012407191097736359
disagreements O 0 0.01063117478042841
with O 0 0.0018658032640814781
the O 0 0.002744794823229313
RFLP O 1 0.9998767375946045
data O 0 0.007930533029139042
, O 0 0.0015215938910841942
particularly O 0 0.003638736205175519
in O 0 0.00263436627574265
Finns O 0 0.40089690685272217
. O 0 0.00734917214140296

The O 0 0.004470531363040209
newly O 0 0.012137230485677719
described O 0 0.020106879994273186
HFE O 1 0.999789297580719
marker O 0 0.37110379338264465
provides O 0 0.008280586451292038
a O 0 0.0035482970997691154
new O 0 0.0019143878016620874
approach O 0 0.005086787510663271
to O 0 0.0009154240251518786
the O 0 0.0015870255883783102
screening O 1 0.7677308320999146
of O 0 0.003005310194566846
HH B-Disease 1 0.9997610449790955
as O 0 0.002220532391220331
well O 0 0.0011321790516376495
as O 0 0.0011217923602089286
studies O 0 0.0043043941259384155
of O 0 0.0004972779424861073
the O 0 0.0013556048506870866
relationship O 0 0.011384870857000351
between O 0 0.0026138718239963055
the O 0 0.0042373924516141415
HFE O 1 0.9999780654907227
Tyr O 1 0.9998338222503662
allele O 1 0.9994470477104187
and O 0 0.0033038819674402475
different O 0 0.007866093888878822
disorders O 1 0.9999910593032837
including O 0 0.0395931750535965
cancer B-Disease 1 0.9999873638153076

Autosomal B-Disease 1 0.9999884366989136
dominant I-Disease 1 0.9916110634803772
neurohypophyseal I-Disease 1 0.9998194575309753
diabetes I-Disease 1 0.9999990463256836
insipidus I-Disease 1 0.9999427795410156
associated O 0 0.014789055101573467
with O 0 0.0032932970207184553
a O 0 0.012304314412176609
missense O 1 0.9996802806854248
mutation O 1 0.9998772144317627
encoding O 1 0.9941766262054443
Gly23 O 1 0.9971309304237366
- O 0 0.30242833495140076
- O 0 0.21245168149471283
> O 1 0.9959254264831543
Val O 1 0.9934995174407959
in O 0 0.007289885077625513
neurophysin O 1 0.9915202260017395
II O 0 0.09273100644350052
. O 0 0.00978530291467905

Autosomal B-Disease 1 0.9999818801879883
dominant I-Disease 1 0.9880146384239197
neurohypophyseal I-Disease 1 0.9999219179153442
diabetes I-Disease 1 0.9999995231628418
insipidus I-Disease 1 0.9999771118164062
( O 0 0.014608762226998806
ADNDI B-Disease 1 0.9990479350090027
) O 0 0.0038743268232792616
is O 0 0.0021192056592553854
an O 0 0.006760225165635347
inherited B-Disease 1 0.9999939203262329
disease I-Disease 1 0.9999991655349731
caused O 1 0.9081612229347229
by O 0 0.005459771491587162
progressive O 1 0.975955605506897
degeneration O 1 0.9999740123748779
of O 0 0.0016414641868323088
the O 0 0.002697557443752885
magnocellular O 1 0.9997475743293762
neurons O 1 0.9851843118667603
of O 0 0.0013796509010717273
the O 0 0.002383766695857048
hypothalamus O 1 0.9989134073257446
leading O 0 0.007766046095639467
to O 0 0.0016605303389951587
decreased O 0 0.027851993218064308
ability O 0 0.0076442318968474865
to O 0 0.0012297291541472077
produce O 0 0.006915857084095478
the O 0 0.0043899910524487495
hormone O 1 0.9996821880340576
arginine O 1 0.9986779093742371
vasopressin O 1 0.997951090335846
( O 0 0.016797801479697227
AVP O 1 0.9980682730674744
) O 0 0.008278755471110344
. O 0 0.005932519678026438

Affected O 0 0.03476245328783989
individuals O 0 0.006221669726073742
are O 0 0.0009082602919079363
not O 0 0.00233199424110353
symptomatic O 1 0.9998229146003723
at O 0 0.003647144651040435
birth O 1 0.6360913515090942
, O 0 0.001464816858060658
but O 0 0.0016859485767781734
usually O 0 0.00840818602591753
develop O 1 0.9988571405410767
diabetes B-Disease 1 0.9999996423721313
insipidus I-Disease 1 0.999968409538269
at O 0 0.00782710500061512
1 O 0 0.012163740582764149
- O 0 0.027015715837478638
6 O 0 0.017377259209752083
yr O 1 0.996788501739502
of O 0 0.0028166905976831913
age O 0 0.009830784052610397
. O 0 0.005427072290331125

The O 0 0.007756175938993692
genetic O 1 0.9995394945144653
locus O 1 0.9952011108398438
of O 0 0.001741816638968885
the O 0 0.003642696887254715
disease O 1 0.9999799728393555
is O 0 0.0022025147918611765
the O 0 0.0033346968702971935
AVP O 1 0.9998589754104614
- O 0 0.2929784953594208
neurophysin O 1 0.9979077577590942
II O 0 0.18304672837257385
( O 0 0.00818121712654829
NPII O 1 0.9995309114456177
) O 0 0.007794685196131468
gene O 1 0.9999159574508667
, O 0 0.001621945179067552
and O 0 0.001917614950798452
mutations O 1 0.999981164932251
that O 0 0.0034118916373699903
cause O 1 0.9976264834403992
ADNDI B-Disease 1 0.9989687204360962
have O 0 0.0014035939238965511
been O 0 0.0010642791166901588
found O 0 0.0025215777568519115
in O 0 0.0007924866513349116
both O 0 0.0009518905426375568
the O 0 0.0013479897752404213
signal O 0 0.054110653698444366
peptide O 1 0.9950072765350342
of O 0 0.0011660079471766949
the O 0 0.0028369708452373743
prepro O 1 0.9993330836296082
- O 0 0.49212393164634705
AVP O 1 0.9996745586395264
- O 0 0.2655090093612671
NPII O 1 0.9960373044013977
precursor O 1 0.912713885307312
and O 0 0.002110836561769247
within O 0 0.005293999332934618
NPII O 1 0.9962211847305298
itself O 0 0.015085128135979176
. O 0 0.006194880232214928

An O 0 0.008432595990598202
affected O 0 0.02831549197435379
girl O 0 0.032594796270132065
who O 0 0.0025563242379575968
presented O 0 0.003959245048463345
at O 0 0.0022054589353501797
9 O 0 0.0059124864637851715
months O 0 0.003368016332387924
of O 0 0.0008336622850038111
age O 0 0.003950822167098522
and O 0 0.0013284279266372323
her O 0 0.005778145045042038
similarly O 0 0.020780101418495178
affected O 0 0.0260496623814106
younger O 0 0.10927724093198776
brother O 0 0.021113954484462738
and O 0 0.0012229542480781674
father O 0 0.003430586773902178
were O 0 0.0003966211515944451
all O 0 0.000563346897251904
found O 0 0.00217823451384902
to O 0 0.0007111578015610576
have O 0 0.0007727639749646187
a O 0 0.004707266576588154
novel O 0 0.06102636456489563
missense O 1 0.999962568283081
mutation O 1 0.9999661445617676
( O 0 0.010525569319725037
G1758 O 1 0.9982825517654419
- O 1 0.6556993126869202
- O 1 0.7379907369613647
> O 1 0.9988605976104736
T O 1 0.9971351623535156
) O 0 0.006180617492645979
encoding O 0 0.07120324671268463
the O 0 0.003169833682477474
amino O 1 0.9799060225486755
acid O 1 0.9969209432601929
substitution O 1 0.9715774059295654
Gly23 O 1 0.9982340335845947
- O 0 0.2900877594947815
- O 0 0.27000588178634644
> O 1 0.9969596862792969
Val O 1 0.9946816563606262
within O 0 0.011603211984038353
NPII O 1 0.9818753600120544
. O 0 0.010399890132248402

The O 0 0.010443680919706821
mutation O 1 0.9996417760848999
was O 0 0.0044939578510820866
confirmed O 0 0.009071228094398975
by O 0 0.004524783231317997
restriction O 0 0.06550924479961395
endonuclease O 1 0.9966186285018921
analysis O 0 0.03494711220264435
. O 0 0.007533669471740723

A O 0 0.04961959645152092
T1 O 1 0.9974822402000427
- O 0 0.03671908751130104
weighted O 0 0.03308252990245819
magnetic O 0 0.05021947994828224
resonance O 1 0.6857628226280212
imaging O 1 0.645518958568573
of O 0 0.0011657376307994127
the O 0 0.002486521378159523
fathers O 1 0.6065945625305176
pituitary O 1 0.9999724626541138
gland O 1 0.9998160004615784
demonstrates O 0 0.04979115352034569
an O 0 0.008568965829908848
attenuated O 1 0.999735414981842
posterior O 1 0.9998302459716797
pituitary O 1 0.9997251629829407
bright O 0 0.04661213606595993
spot O 0 0.024535438045859337
. O 0 0.008261147886514664

This O 0 0.012034180574119091
mutation O 1 0.9999767541885376
may O 0 0.004995947238057852
be O 0 0.0007845784421078861
valuable O 0 0.0038975116331130266
for O 0 0.001176223624497652
developing O 0 0.008392361924052238
models O 0 0.007218705024570227
of O 0 0.0024399987887591124
dominantly B-Disease 1 0.9997085928916931
inherited I-Disease 1 0.9999455213546753
neurodegeneration I-Disease 1 0.9999943971633911
, O 0 0.002118421485647559
as O 0 0.0010380031308159232
the O 0 0.0009629690903238952
early O 0 0.0029866728000342846
age O 0 0.003797834971919656
of O 0 0.0023566565942019224
onset O 1 0.9999614953994751
of O 0 0.003795613069087267
symptoms O 1 0.9999843835830688
suggests O 0 0.012165568768978119
that O 0 0.0012426545144990087
this O 0 0.002761172829195857
mutation O 1 0.9999964237213135
may O 0 0.004564826376736164
be O 0 0.001122678630053997
particularly O 0 0.0047222585417330265
deleterious O 1 0.9968587160110474
to O 0 0.0017944485880434513
the O 0 0.004202393349260092
magnocellular O 1 0.999658465385437
neuron O 1 0.9992932081222534
. O 0 0.0060860998928546906
. O 0 0.006118874065577984

Frequent O 0 0.09366456419229507
inactivation O 1 0.9926502108573914
of O 0 0.010314246639609337
PTEN O 1 0.9999618530273438
/ O 1 0.8833785057067871
MMAC1 O 1 0.9920544624328613
in O 0 0.008935087360441685
primary O 1 0.9989838004112244
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
. O 0 0.013553277589380741

Sporadic B-Disease 1 0.9993085861206055
prostate I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 0.9999996423721313
is O 0 0.002584790578112006
the O 0 0.0010531804291531444
most O 0 0.001557765295729041
common O 0 0.15530946850776672
male B-Disease 1 0.9996150732040405
cancer I-Disease 1 0.9999984502792358
in O 0 0.0017308860551565886
the O 0 0.0011695045977830887
Western O 0 0.00278382352553308
world O 0 0.001772884395904839
, O 0 0.0008692133123986423
yet O 0 0.0013928409898653626
many O 0 0.0003980332112405449
of O 0 0.0004349753726273775
the O 0 0.0009440985741093755
major O 0 0.007949869148433208
genetic O 1 0.9999339580535889
events O 0 0.003544168546795845
involved O 0 0.003286120481789112
in O 0 0.0007856012089177966
the O 0 0.0018642550567165017
progression O 1 0.9996371269226074
of O 0 0.0009073762921616435
this O 0 0.0015000976854935288
often O 0 0.02146151103079319
fatal O 1 0.9999983310699463
cancer B-Disease 1 0.9999979734420776
remain O 0 0.0034721402917057276
to O 0 0.0013333674287423491
be O 0 0.002828852506354451
elucidated O 1 0.9950631260871887
. O 0 0.008825345896184444

Numerous O 0 0.03337902948260307
cytogenetic O 1 0.9984602928161621
and O 0 0.005334440618753433
allelotype O 1 0.9928776621818542
studies O 0 0.011948986910283566
have O 0 0.0016133715398609638
reported O 0 0.0070658158510923386
frequent O 0 0.02180841751396656
loss O 0 0.01972215436398983
of O 0 0.0025864855851978064
heterozygosity O 1 0.9987805485725403
on O 0 0.006820081267505884
chromosomal O 1 0.9999754428863525
arm O 1 0.9784383773803711
10q O 1 0.9924139380455017
in O 0 0.010083906352519989
sporadic B-Disease 1 0.9998201727867126
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999973773956299
. O 0 0.013146474026143551

Deletion O 1 0.997100293636322
mapping O 0 0.07272358983755112
studies O 0 0.011898617260158062
have O 0 0.0018232594011351466
unambiguously O 0 0.03550320491194725
identified O 0 0.008815587498247623
a O 0 0.00390217755921185
region O 0 0.0036132207605987787
of O 0 0.0030947367195039988
chromosome O 1 0.9999929666519165
10q23 O 1 0.9924260377883911
to O 0 0.0010803877376019955
be O 0 0.0006467057392001152
the O 0 0.0011131553910672665
minimal O 0 0.020618528127670288
area O 0 0.0023435538168996572
of O 0 0.0015829961048439145
loss O 0 0.135808527469635
. O 0 0.008613258600234985

A O 0 0.022613024339079857
new O 0 0.019533442333340645
tumor B-Disease 1 0.999995231628418
suppressor O 1 0.9999687671661377
gene O 1 0.9998857975006104
, O 0 0.014419471845030785
PTEN O 1 0.9999892711639404
/ O 1 0.9889756441116333
MMAC1 O 1 0.9970898628234863
, O 0 0.0030463861767202616
was O 0 0.0027244342491030693
isolated O 0 0.025808265432715416
recently O 0 0.005358938127756119
at O 0 0.00125788152217865
this O 0 0.0007770730298943818
region O 0 0.0023736681323498487
of O 0 0.002340649953112006
chromosome O 1 0.9999926090240479
10q23 O 1 0.9955804944038391
and O 0 0.001168926595710218
found O 0 0.002135701710358262
to O 0 0.0007857909076847136
be O 0 0.0011960645206272602
inactivated O 1 0.9783614277839661
by O 0 0.005362879019230604
mutation O 1 0.9999560117721558
in O 0 0.00458564655855298
three O 0 0.38733407855033875
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cell O 1 0.9994638562202454
lines O 0 0.028713781386613846
. O 0 0.007620640564709902

We O 0 0.005998470354825258
screened O 0 0.051651280373334885
80 O 0 0.08542191982269287
prostate B-Disease 1 0.9999994039535522
tumors I-Disease 1 0.9999933242797852
by O 0 0.008472096174955368
microsatellite O 1 0.9994590878486633
analysis O 0 0.013369040563702583
and O 0 0.0016855907160788774
found O 0 0.015429245308041573
chromosome O 1 0.9999850988388062
10q23 O 1 0.9572723507881165
to O 0 0.0015746962744742632
be O 0 0.0013186440337449312
deleted O 0 0.03765740618109703
in O 0 0.002209104597568512
23 O 0 0.011108181439340115
cases O 0 0.01238013431429863
. O 0 0.00656652869656682

We O 0 0.0034941849298775196
then O 0 0.0027917535044252872
proceeded O 0 0.008984613232314587
with O 0 0.0027919034473598003
sequence O 0 0.028196582570672035
analysis O 0 0.005971954204142094
of O 0 0.0007254231022670865
the O 0 0.001941567286849022
entire O 0 0.02650102786719799
PTEN O 1 0.9999804496765137
/ O 1 0.9840635061264038
MMAC1 O 1 0.9982792139053345
coding O 1 0.99070143699646
region O 0 0.006419711746275425
and O 0 0.001604220480658114
tested O 0 0.022925186902284622
for O 0 0.0033041713759303093
homozygous O 1 0.9997864365577698
deletion O 1 0.9996438026428223
with O 0 0.003047866513952613
new O 0 0.0034143964294344187
intragenic O 1 0.9975171089172363
markers O 1 0.7292223572731018
in O 0 0.0013427631929516792
these O 0 0.001193860312923789
23 O 0 0.006856364198029041
cases O 0 0.009190723299980164
with O 0 0.004764345474541187
10q23 O 1 0.9934296011924744
loss O 0 0.03377913683652878
of O 0 0.004116282798349857
heterozygosity O 1 0.9991267323493958
. O 0 0.007749586831778288

The O 0 0.0036287123803049326
identification O 0 0.012223563157022
of O 0 0.000916246441192925
the O 0 0.001383026479743421
second O 0 0.009693611413240433
mutational O 1 0.999760091304779
event O 0 0.008835630491375923
in O 0 0.001825107028707862
10 O 0 0.0038043244276195765
( O 0 0.0028810016810894012
43 O 0 0.011800135485827923
% O 0 0.007105168886482716
) O 0 0.012829279527068138
tumors B-Disease 1 0.9999978542327881
establishes O 1 0.9980999827384949
PTEN O 1 0.9999600648880005
/ O 1 0.8645979762077332
MMAC1 O 1 0.965510904788971
as O 0 0.0018019704148173332
a O 0 0.003908692393451929
main O 0 0.006499233655631542
inactivation O 1 0.9981739521026611
target O 0 0.008873987942934036
of O 0 0.0020940357353538275
10q O 1 0.9916200637817383
loss O 0 0.24030111730098724
in O 0 0.008412620052695274
sporadic B-Disease 1 0.9999113082885742
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999982118606567
. O 0 0.0065248445607721806
. O 0 0.007054111920297146

Risk O 1 0.8360033631324768
reversals O 0 0.3047086298465729
in O 0 0.004829414188861847
predictive O 1 0.9976097345352173
testing O 1 0.6012646555900574
for O 0 0.015253891237080097
Huntington B-Disease 1 0.999992847442627
disease I-Disease 1 0.9999921321868896
. O 0 0.012716294266283512

The O 0 0.0032066397834569216
first O 0 0.0041573867201805115
predictive O 1 0.9929267764091492
testing O 0 0.3454679250717163
for O 0 0.011775068938732147
Huntington B-Disease 1 0.9999985694885254
disease I-Disease 1 0.9999990463256836
( O 0 0.010361900553107262
HD B-Disease 1 0.9981803894042969
) O 0 0.0027911043725907803
was O 0 0.0012564348289743066
based O 0 0.0015540067106485367
on O 0 0.000798130757175386
analysis O 0 0.00725604547187686
of O 0 0.0017290915129706264
linked O 1 0.9845628142356873
polymorphic O 1 0.999963641166687
DNA O 1 0.9990220069885254
markers O 0 0.16257259249687195
to O 0 0.0013156627537682652
estimate O 0 0.0038518928922712803
the O 0 0.0012767500011250377
likelihood O 0 0.025512635707855225
of O 0 0.0017350286943838
inheriting O 1 0.9918534159660339
the O 0 0.0054643121547997
mutation O 1 0.9999188184738159
for O 0 0.005778024904429913
HD B-Disease 1 0.987025797367096
. O 0 0.00974032562226057

Limits O 0 0.008540873415768147
to O 0 0.0014901116956025362
accuracy O 0 0.009361876174807549
included O 0 0.003440586617216468
recombination O 1 0.9986496567726135
between O 0 0.002008953597396612
the O 0 0.0019879464525729418
DNA O 1 0.9998080134391785
markers O 1 0.5822912454605103
and O 0 0.0012212353758513927
the O 0 0.0028835751581937075
mutation O 1 0.9999914169311523
, O 0 0.0030137498397380114
pedigree O 1 0.9965920448303223
structure O 0 0.009699514135718346
, O 0 0.0008807618287391961
and O 0 0.0008459003875032067
whether O 0 0.004612859338521957
DNA O 1 0.9994673132896423
samples O 0 0.019620578736066818
were O 0 0.0008033843478187919
available O 0 0.0022369064390659332
from O 0 0.0018918439745903015
family O 0 0.00786508060991764
members O 0 0.0036679476033896208
. O 0 0.0062803542241454124

With O 0 0.005847441032528877
direct O 0 0.009315643459558487
tests O 0 0.010734068229794502
for O 0 0.0013410518877208233
the O 0 0.002877910155802965
HD B-Disease 1 0.99979168176651
mutation O 1 0.9999840259552002
, O 0 0.0015775911742821336
we O 0 0.0006778647657483816
have O 0 0.0007385837379842997
assessed O 0 0.006320225540548563
the O 0 0.0008635156555101275
accuracy O 0 0.006168450694531202
of O 0 0.0008363332599401474
results O 0 0.007444294635206461
obtained O 0 0.00524156866595149
by O 0 0.0032570131588727236
linkage O 1 0.9974384307861328
approaches O 0 0.018515847623348236
when O 0 0.0025448629166930914
requested O 0 0.003783321939408779
to O 0 0.0009189698612317443
do O 0 0.0014446766581386328
so O 0 0.0011742225615307689
by O 0 0.0011614790419116616
the O 0 0.0015025264583528042
test O 0 0.016426051035523415
individuals O 0 0.007315228693187237
. O 0 0.005795697681605816

For O 0 0.004402912687510252
six O 0 0.004235189873725176
such O 0 0.0021870150230824947
individuals O 0 0.0037202697712928057
, O 0 0.0009050441440194845
there O 0 0.0007679097470827401
was O 0 0.001199551043100655
significant O 0 0.005165045149624348
disparity O 0 0.12327548116445541
between O 0 0.00232407683506608
the O 0 0.00224240287207067
tests O 0 0.029500439763069153
. O 0 0.006451323162764311

Three O 0 0.005445099901407957
went O 0 0.0036517735570669174
from O 0 0.0020166824106127024
a O 0 0.006415186915546656
decreased O 1 0.923870861530304
risk O 1 0.8066285848617554
to O 0 0.0010579146910458803
an O 0 0.0019223913550376892
increased O 0 0.06941521167755127
risk O 1 0.9961925745010376
, O 0 0.001178905600681901
while O 0 0.001145913265645504
in O 0 0.0009794170036911964
another O 0 0.002591572003439069
three O 0 0.0016458812169730663
the O 0 0.002405814127996564
risk O 1 0.9827178120613098
was O 0 0.0037829226348549128
decreased O 0 0.16886736452579498
. O 0 0.006844882387667894

Knowledge O 0 0.010106946341693401
of O 0 0.0009794775396585464
the O 0 0.0013517359038814902
potential O 0 0.010116253048181534
reasons O 0 0.0038007800467312336
for O 0 0.000782645249273628
these O 0 0.0008558598347008228
changes O 0 0.0038254118990153074
in O 0 0.0010535387555137277
results O 0 0.006228318437933922
and O 0 0.0008483119308948517
impact O 0 0.005242557730525732
of O 0 0.000693557143677026
these O 0 0.001909318845719099
risk O 1 0.9966212511062622
reversals O 1 0.9791331887245178
on O 0 0.0016241664998233318
both O 0 0.003266985062509775
patients O 1 0.9997308850288391
and O 0 0.000941442500334233
the O 0 0.0019668301101773977
counseling O 1 0.992706835269928
team O 0 0.0028753536753356457
can O 0 0.0020544766448438168
assist O 0 0.006769574712961912
in O 0 0.0006829234771430492
the O 0 0.0007449508993886411
development O 0 0.0027154383715242147
of O 0 0.0009354695212095976
strategies O 0 0.04741053655743599
for O 0 0.0010620532557368279
the O 0 0.002151558408513665
prevention O 1 0.9995399713516235
and O 0 0.0014006803976371884
, O 0 0.0012084977934136987
where O 0 0.0013476572930812836
necessary O 0 0.003781598526984453
, O 0 0.001153358956798911
management O 0 0.008360924199223518
of O 0 0.0010293086525052786
a O 0 0.007844175212085247
risk O 1 0.9910956621170044
reversal O 0 0.4465102553367615
in O 0 0.0014908938901498914
any O 0 0.003525779815390706
predictive O 1 0.9989901185035706
testing O 0 0.1998029202222824
program O 0 0.010946755297482014
. O 0 0.0026548856403678656
. O 0 0.0054651000536978245

A O 0 0.01971031166613102
novel O 0 0.02281627617776394
common O 0 0.03035920485854149
missense O 1 0.9998500347137451
mutation O 1 0.9999321699142456
G301C O 1 0.7763594388961792
in O 0 0.001785907195881009
the O 0 0.0025744554586708546
N O 1 0.9667840003967285
- O 0 0.22377286851406097
acetylgalactosamine O 1 0.9978170394897461
- O 0 0.031772781163454056
6 O 0 0.02330009452998638
- O 0 0.21997198462486267
sulfate O 1 0.9998012185096741
sulfatase O 1 0.9997907280921936
gene O 1 0.9991556406021118
in O 0 0.010565587319433689
mucopolysaccharidosis B-Disease 1 0.9942488670349121
IVA I-Disease 1 0.9982765913009644
. O 0 0.015470820479094982

Mucopolysaccharidosis B-Disease 1 0.9965510368347168
IVA I-Disease 1 0.9984720349311829
( O 0 0.014896214008331299
MPS B-Disease 1 0.7882073521614075
IVA I-Disease 1 0.9999040365219116
) O 0 0.004333301447331905
is O 0 0.0017234397819265723
an O 0 0.007234921213239431
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 0.9999995231628418
lysosomal I-Disease 1 0.9999796152114868
storage I-Disease 1 0.9739234447479248
disorder I-Disease 1 0.9999816417694092
caused O 0 0.0746740773320198
by O 0 0.0030438690446317196
a O 0 0.012723439373075962
genetic B-Disease 1 0.9999902248382568
defect I-Disease 1 0.9997772574424744
in O 0 0.004237456247210503
N O 1 0.9124829173088074
- O 0 0.062458883970975876
acetylgalactosamine O 1 0.9966025352478027
- O 0 0.04011625796556473
6 O 0 0.024213558062911034
- O 0 0.34291592240333557
sulfate O 1 0.9997451901435852
sulfatase O 1 0.9998268485069275
( O 0 0.019173482432961464
GALNS O 1 0.996087908744812
) O 0 0.008683794178068638
. O 0 0.007055073976516724

In O 0 0.003914434928447008
previous O 0 0.004963375627994537
studies O 0 0.009426845237612724
, O 0 0.0007431180565617979
we O 0 0.00048708717804402113
have O 0 0.0005274880095385015
found O 0 0.0023395747411996126
two O 0 0.0019835266284644604
common O 0 0.18980999290943146
mutations O 1 0.9999910593032837
in O 0 0.00314280460588634
Caucasians O 1 0.9978278279304504
and O 0 0.0018862023716792464
Japanese O 0 0.0054976181127130985
, O 0 0.0017698218580335379
respectively O 0 0.005873674061149359
. O 0 0.006132288370281458

To O 0 0.005178612656891346
characterize O 0 0.051798466593027115
the O 0 0.005262714345008135
mutational O 1 0.9994319081306458
spectrum O 0 0.040260136127471924
in O 0 0.001373480772599578
various O 0 0.0013001689221709967
ethnic O 0 0.0037696445360779762
groups O 0 0.0038543783593922853
, O 0 0.0028748041950166225
mutations O 1 0.9999316930770874
in O 0 0.0016404461348429322
the O 0 0.0023782593198120594
GALNS O 1 0.9996986389160156
gene O 1 0.9996753931045532
in O 0 0.003301752032712102
Colombian O 0 0.20913100242614746
MPS B-Disease 1 0.982021689414978
IVA I-Disease 1 0.9999892711639404
patients O 1 0.9992637038230896
were O 0 0.0015221561770886183
investigated O 0 0.013285339809954166
, O 0 0.0015096679562702775
and O 0 0.0020220254082232714
genetic O 1 0.9997982382774353
backgrounds O 0 0.009753636084496975
were O 0 0.0009618065087124705
extensively O 0 0.006333730649203062
analyzed O 0 0.011526672169566154
to O 0 0.0009749194141477346
identify O 0 0.007880757562816143
racial O 0 0.009404146112501621
origin O 0 0.005079299211502075
, O 0 0.000891217147000134
based O 0 0.0020025153644382954
on O 0 0.0024077328853309155
mitochondrial O 1 0.9999125003814697
DNA O 1 0.9994739890098572
( O 0 0.009531687945127487
mtDNA O 1 0.9996053576469421
) O 0 0.008478209376335144
lineages O 1 0.9953756332397461
. O 0 0.0073358747176826

Three O 0 0.009440493769943714
novel O 0 0.06837195158004761
missense O 1 0.9999023675918579
mutations O 1 0.9999517202377319
never O 0 0.006787963677197695
identified O 0 0.007443389389663935
previously O 0 0.0024417531676590443
in O 0 0.0008800920913927257
other O 0 0.0012390586780384183
populations O 0 0.019322965294122696
and O 0 0.0009544924250803888
found O 0 0.003341715782880783
in O 0 0.001116314553655684
16 O 0 0.0036305286921560764
out O 0 0.001984262140467763
of O 0 0.0012000700226053596
19 O 0 0.011625687591731548
Colombian O 0 0.0858495756983757
MPS B-Disease 1 0.7571945786476135
IVA I-Disease 1 0.9999169111251831
unrelated O 1 0.9756630063056946
alleles O 1 0.9992467164993286
account O 0 0.0067221675999462605
for O 0 0.002609256422147155
84 O 0 0.027751702815294266
. O 0 0.006593312136828899

2 O 0 0.012629859149456024
% O 0 0.0037505573127418756
of O 0 0.0010104957036674023
the O 0 0.002580571686848998
alleles O 1 0.9998478889465332
in O 0 0.002077769720926881
this O 0 0.0018582650227472186
study O 0 0.00976127851754427
. O 0 0.005906838923692703

The O 0 0.00789922010153532
G301C O 1 0.9211152791976929
and O 0 0.005766254849731922
S162F O 1 0.9975209832191467
mutations O 1 0.9998272061347961
account O 0 0.006528548896312714
for O 0 0.0023111996706575155
68 O 0 0.028811970725655556
. O 0 0.007322629448026419

4 O 0 0.020388498902320862
% O 0 0.007005271036177874
and O 0 0.0021904651075601578
10 O 0 0.006103344727307558
. O 0 0.005819214042276144

5 O 0 0.009882107377052307
% O 0 0.00479225255548954
of O 0 0.003374886466190219
mutations O 1 0.9999896287918091
, O 0 0.001877848175354302
respectively O 0 0.003690948011353612
, O 0 0.0011720508337020874
whereas O 0 0.006939781364053488
the O 0 0.0012851565843448043
remaining O 0 0.006044464651495218
F69V O 1 0.9991886019706726
is O 0 0.001394217018969357
limited O 0 0.00226434669457376
to O 0 0.0009209692943841219
a O 0 0.005392471794039011
single O 0 0.01814679615199566
allele O 1 0.999281108379364
. O 0 0.009492951445281506

The O 0 0.006417449563741684
skewed O 1 0.6091891527175903
prevalence O 1 0.9869446158409119
of O 0 0.0028105780947953463
G301C O 1 0.9453242421150208
in O 0 0.0018961329478770494
only O 0 0.0025042144116014242
Colombian O 0 0.4384379982948303
patients O 1 0.9991225600242615
and O 0 0.0034175156615674496
haplotype O 1 0.9999070167541504
analysis O 0 0.01263602264225483
by O 0 0.00237235426902771
restriction O 0 0.03040310926735401
fragment O 1 0.7376183271408081
length O 0 0.02428780309855938
polymorphisms O 1 0.999329686164856
in O 0 0.002472317311912775
the O 0 0.003461346961557865
GALNS O 1 0.9995461106300354
gene O 1 0.9997460246086121
suggest O 0 0.010764531791210175
that O 0 0.0024039139971137047
G301C O 1 0.9741449952125549
originated O 0 0.014322328381240368
from O 0 0.0018568671075627208
a O 0 0.005152813158929348
common O 0 0.015352144837379456
ancestor O 1 0.5349456071853638
. O 0 0.007492865435779095

Investigation O 0 0.019421402364969254
of O 0 0.0011029592715203762
the O 0 0.0023932261392474174
genetic O 1 0.9998365640640259
background O 0 0.0077054742723703384
by O 0 0.0014124592998996377
means O 0 0.002853071317076683
of O 0 0.0015840197447687387
mtDNA O 1 0.9999325275421143
lineages O 1 0.9990529417991638
indicate O 0 0.007712886203080416
that O 0 0.0008141474099829793
all O 0 0.0007629774045199156
our O 0 0.003640191862359643
patients O 1 0.9993011951446533
are O 0 0.0008140946156345308
probably O 0 0.0026949646417051554
of O 0 0.0008370114373974502
native O 0 0.0046916319988667965
American O 0 0.008338794112205505
descent O 0 0.07426618039608002

Low O 0 0.0320461131632328
frequency O 0 0.03168365731835365
of O 0 0.006653114687651396
BRCA1 O 1 0.999998927116394
germline O 1 0.9999802112579346
mutations O 1 0.9998325109481812
in O 0 0.0027259313501417637
45 O 0 0.011528856121003628
German O 1 0.9400517344474792
breast B-Disease 1 0.9999995231628418
/ I-Disease 1 0.9999805688858032
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
families O 0 0.0194559283554554
. O 0 0.008397482335567474

In O 0 0.004070899449288845
this O 0 0.001544686616398394
study O 0 0.004682678263634443
we O 0 0.0012786934385076165
investigated O 0 0.013777341693639755
45 O 0 0.012077696621418
German O 1 0.9577668905258179
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999817609786987
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999972581863403
families O 0 0.009192543104290962
for O 0 0.005848718341439962
germline O 1 0.9999954700469971
mutations O 1 0.9998924732208252
in O 0 0.0035526237916201353
the O 0 0.007293377537280321
BRCA1 O 1 0.9999988079071045
gene O 1 0.9996461868286133
. O 0 0.012423164211213589

We O 0 0.0037831743247807026
identified O 0 0.00971334520727396
four O 0 0.0076853204518556595
germline O 1 0.999975323677063
mutations O 1 0.9999423027038574
in O 0 0.003094177693128586
three O 0 0.039974793791770935
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999986886978149
families O 0 0.004659517668187618
and O 0 0.0007887832471169531
in O 0 0.0016294955275952816
one O 0 0.1147967055439949
breast B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999803304672241
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
family O 0 0.018115973100066185
. O 0 0.0015579633181914687
among O 0 0.0010891944402828813
these O 0 0.0006639863713644445
were O 0 0.0005922195268794894
one O 0 0.004457371775060892
frameshift O 1 0.9999939203262329
mutation O 1 0.9999762773513794
, O 0 0.0021264792885631323
one O 0 0.002786603756248951
nonsense O 1 0.9711282849311829
mutation O 1 0.999941349029541
, O 0 0.002156272530555725
one O 0 0.0019290633499622345
novel O 0 0.023551590740680695
splice O 1 0.9995725750923157
site O 0 0.023256879299879074
mutation O 1 0.999935507774353
, O 0 0.0021056230179965496
and O 0 0.0012790034525096416
one O 0 0.005411153193563223
missense O 1 0.9998043179512024
mutation O 1 0.9998254179954529
. O 0 0.01082693226635456

The O 0 0.01543701346963644
missense O 1 0.999672532081604
mutation O 1 0.9999555349349976
was O 0 0.0035884345415979624
also O 0 0.00162732123862952
found O 0 0.0038625099696218967
in O 0 0.002236979315057397
2 O 0 0.010394178330898285
. O 0 0.005939255468547344

8 O 0 0.014594211243093014
% O 0 0.0041960845701396465
of O 0 0.0007378063164651394
the O 0 0.0009679137147031724
general O 0 0.001892565400339663
population O 0 0.002076777396723628
, O 0 0.001090319245122373
suggesting O 0 0.009954255074262619
that O 0 0.000833930098451674
it O 0 0.0008780307252891362
is O 0 0.0019232714548707008
not O 0 0.004788674414157867
disease O 1 0.9999877214431763
associated O 0 0.022631553933024406
. O 0 0.006553545128554106

The O 0 0.0040170070715248585
average O 0 0.006187615916132927
age O 0 0.007180348038673401
of O 0 0.0052780103869736195
disease O 1 0.999998927116394
onset O 1 0.9998899698257446
in O 0 0.0017730487743392587
those O 0 0.0016469362890347838
families O 0 0.011066033504903316
harbouring O 1 0.9992560744285583
causative O 1 0.9999212026596069
mutations O 1 0.9999487400054932
was O 0 0.0035785508807748556
between O 0 0.0031133447773754597
32 O 0 0.014938900247216225
. O 0 0.006161019206047058

3 O 0 0.01749265007674694
and O 0 0.003449193434789777
37 O 0 0.019770460203289986
. O 0 0.007597736548632383

4 O 0 0.013701239600777626
years O 0 0.0030319574289023876
, O 0 0.00136555393692106
whereas O 0 0.00672427611425519
the O 0 0.0014123194850981236
family O 0 0.009160170331597328
harbouring O 1 0.9263885617256165
the O 0 0.005945007316768169
missense O 1 0.99994957447052
mutation O 1 0.999964714050293
had O 0 0.0026207976043224335
an O 0 0.0015306809218600392
average O 0 0.003962439019232988
age O 0 0.004750357009470463
of O 0 0.0021738281939178705
onset O 1 0.9997738003730774
of O 0 0.0029589743353426456
51 O 0 0.025664810091257095
. O 0 0.007436583284288645

2 O 0 0.020941777154803276
years O 0 0.006370774004608393
. O 0 0.007058248855173588

These O 0 0.00322885625064373
findings O 0 0.009250528179109097
show O 0 0.003811923786997795
that O 0 0.003212734591215849
BRCA1 O 1 0.9999973773956299
is O 0 0.004680556245148182
implicated O 0 0.4781232476234436
in O 0 0.0011023449478670955
a O 0 0.002877824939787388
small O 0 0.003711838275194168
fraction O 0 0.019096719101071358
of O 0 0.008196131326258183
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999891519546509
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.999998927116394
families O 0 0.008000655099749565
suggesting O 0 0.009606847539544106
the O 0 0.001293213339522481
involvement O 0 0.01198100671172142
of O 0 0.001531363814137876
another O 0 0.026575708761811256
susceptibility O 1 0.9999953508377075
gene O 1 0.9999500513076782
( O 0 0.010156447067856789
s O 0 0.08548338711261749
) O 0 0.011107568629086018

Paternal O 1 0.9831244945526123
transmission O 1 0.9930237531661987
of O 0 0.024550415575504303
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 0.9999979734420776
dystrophy I-Disease 1 0.9999974966049194
. O 0 0.021443894132971764

We O 0 0.0029528304003179073
report O 0 0.002314989687874913
a O 0 0.004185279831290245
rare O 0 0.012916993349790573
case O 0 0.005524693988263607
of O 0 0.003952402155846357
paternally O 1 0.9999253749847412
transmitted O 1 0.9999667406082153
congenital B-Disease 1 0.9999998807907104
myotonic I-Disease 1 0.9999996423721313
dystrophy I-Disease 1 0.9999995231628418
( O 0 0.04879078269004822
DM B-Disease 1 0.9999558925628662
) O 0 0.00988924503326416
. O 0 0.006205960642546415

The O 0 0.006398328114300966
proband O 1 0.9548659324645996
is O 0 0.00307568721473217
a O 0 0.0051995571702718735
23 O 0 0.0071693360805511475
year O 0 0.002939277794212103
old O 0 0.01003738958388567
, O 0 0.004479627590626478
mentally B-Disease 1 0.9987230896949768
retarded I-Disease 1 0.9980183839797974
male O 0 0.4346946179866791
who O 0 0.012770136818289757
suffers O 1 0.9999167919158936
severe O 1 0.9998528957366943
muscular B-Disease 1 0.9999607801437378
weakness I-Disease 1 0.9927055239677429
. O 0 0.011239646933972836

He O 0 0.003926514182239771
presented O 0 0.007162981200963259
with O 0 0.010299395769834518
respiratory O 1 0.9999878406524658
and O 0 0.0038279187865555286
feeding O 1 0.7807568907737732
difficulties O 0 0.028645331040024757
at O 0 0.0047213309444487095
birth O 1 0.6861152052879333
. O 0 0.006782819051295519

His O 0 0.011404852382838726
two O 0 0.010343956761062145
sibs O 1 0.9985951781272888
suffer O 1 0.9541999101638794
from O 0 0.013103067874908447
childhood O 1 0.9979192614555359
onset O 1 0.999954104423523
DM B-Disease 1 0.9998106360435486
. O 0 0.02250797487795353

Their O 0 0.004935775883495808
late O 0 0.006283559836447239
father O 0 0.005653867963701487
had O 0 0.0016220215475186706
the O 0 0.0015712976455688477
adult O 0 0.2261113077402115
type O 0 0.4593333899974823
of O 0 0.0035137629602104425
DM B-Disease 1 0.99998939037323
, O 0 0.003091954393312335
with O 0 0.005430809687823057
onset O 1 0.9997043013572693
around O 0 0.003040782641619444
30 O 0 0.005182995926588774
years O 0 0.003499769838526845
. O 0 0.005439569242298603

Only O 0 0.0028324031736701727
six O 0 0.003102649701759219
other O 0 0.0010845818324014544
cases O 0 0.0044975243508815765
of O 0 0.0017923766281455755
paternal O 1 0.9980521202087402
transmission O 1 0.9991938471794128
of O 0 0.010424013249576092
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999717473983765
have O 0 0.003274325281381607
been O 0 0.002493098843842745
reported O 0 0.010085020214319229
recently O 0 0.011567669920623302
. O 0 0.005652119871228933

We O 0 0.0026574740186333656
review O 0 0.0033701423089951277
the O 0 0.0017780748894438148
sex O 0 0.024611439555883408
related O 0 0.014512456022202969
effects O 0 0.03718698024749756
on O 0 0.0025071240961551666
transmission O 1 0.998816728591919
of O 0 0.012309004552662373
congenital B-Disease 1 0.9999998807907104
DM I-Disease 1 0.9999343156814575
. O 0 0.016840798780322075

Decreased O 0 0.23436322808265686
fertility O 1 0.6631870865821838
of O 0 0.0032451320439577103
males O 0 0.022713616490364075
with O 0 0.007377374451607466
adult O 1 0.9967108964920044
onset O 1 0.999993085861206
DM B-Disease 1 0.9999704360961914
and O 0 0.0029691688250750303
contraction O 1 0.5055657625198364
of O 0 0.001065326971001923
the O 0 0.0015817545354366302
repeat O 0 0.06439141184091568
upon O 0 0.00345905520953238
male O 1 0.5559703707695007
transmission O 1 0.9969137907028198
contribute O 0 0.01309162937104702
to O 0 0.001142479944974184
the O 0 0.001093186205253005
almost O 0 0.0031460465397685766
absent O 0 0.024239031597971916
occurrence O 0 0.04525073990225792
of O 0 0.002770674414932728
paternal O 1 0.997641921043396
transmission O 1 0.997550904750824
of O 0 0.015122629702091217
congenital B-Disease 1 0.9999997615814209
DM I-Disease 1 0.9999164342880249
. O 0 0.01691792719066143

Also O 0 0.0030434865038841963
the O 0 0.0013666845625266433
fathers O 0 0.010777529329061508
of O 0 0.001000286196358502
the O 0 0.0018776807701215148
reported O 0 0.01815292425453663
congenitally O 1 0.9995983242988586
affected O 0 0.03188890218734741
children O 0 0.007594462018460035
showed O 0 0.006667364854365587
, O 0 0.0011548069305717945
on O 0 0.00121608329936862
average O 0 0.005525998771190643
, O 0 0.002406913321465254
shorter O 0 0.4191412925720215
CTG O 1 0.9985781908035278
repeat O 0 0.4402032196521759
lengths O 0 0.03506779670715332
and O 0 0.0019294884987175465
hence O 0 0.013044686056673527
less O 0 0.011573205702006817
severe O 1 0.9999436140060425
clinical O 1 0.99998939037323
symptoms O 1 0.9999579191207886
than O 0 0.0017967731691896915
the O 0 0.0016286829486489296
mothers O 0 0.17182788252830505
of O 0 0.0014907198492437601
children O 0 0.01647881604731083
with O 0 0.129456028342247
congenital B-Disease 1 0.9999997615814209
DM I-Disease 1 0.9999351501464844
. O 0 0.015900464728474617

We O 0 0.0042062425054609776
conclude O 0 0.014809593558311462
that O 0 0.001988483825698495
paternal O 1 0.9901032447814941
transmission O 1 0.9981871247291565
of O 0 0.01057614665478468
congenital B-Disease 1 1.0
DM I-Disease 1 0.9999890327453613
is O 0 0.004506600089371204
rare O 0 0.015269987285137177
and O 0 0.001951048499904573
preferentially O 1 0.9811466932296753
occurs O 0 0.09937594085931778
with O 0 0.005728676449507475
onset O 1 0.9998311996459961
of O 0 0.00448736222460866
DM B-Disease 1 0.9999663829803467
past O 0 0.005261338781565428
30 O 0 0.004357247147709131
years O 0 0.001595895504578948
in O 0 0.0011168704368174076
the O 0 0.0018272845773026347
father O 0 0.009058644995093346
. O 0 0.0033619198948144913
. O 0 0.00566365011036396

The O 0 0.01974574662744999
RB1 O 1 0.9998911619186401
gene O 1 0.9998899698257446
mutation O 1 0.9997814297676086
in O 0 0.0028267749585211277
a O 0 0.0062741851434111595
child O 0 0.024407457560300827
with O 0 0.016035588458180428
ectopic B-Disease 1 0.9999986886978149
intracranial I-Disease 1 0.9999954700469971
retinoblastoma I-Disease 1 0.9999076128005981
. O 0 0.013593520037829876

The O 0 0.017543788999319077
RB1 O 1 0.9999344348907471
gene O 1 0.9999374151229858
mutation O 1 0.9998633861541748
was O 0 0.0030667027458548546
investigated O 0 0.009910627268254757
in O 0 0.0011366117978468537
a O 0 0.004609317984431982
child O 0 0.02107539214193821
with O 0 0.012974487617611885
ectopic B-Disease 1 0.9999986886978149
intracranial I-Disease 1 0.9999945163726807
retinoblastoma I-Disease 1 0.9999579191207886
using O 0 0.014734608121216297
DNA O 1 0.9985263347625732
obtained O 0 0.004420990124344826
from O 0 0.000995874055661261
both O 0 0.0009245233377441764
the O 0 0.0023396294564008713
pineal B-Disease 1 0.999882698059082
and I-Disease 0 0.007856226526200771
retinal I-Disease 1 0.999998927116394
tumours I-Disease 1 0.9999829530715942
of O 0 0.0025898406747728586
the O 0 0.004447716288268566
patient O 1 0.9980691075325012
. O 0 0.008146571926772594

A O 0 0.027505548670887947
nonsense O 0 0.4476015865802765
mutation O 1 0.9995211362838745
in O 0 0.005676751025021076
exon O 1 0.9923209547996521
17 O 0 0.015809739008545876
( O 0 0.006790674291551113
codon O 1 0.9862682819366455
556 O 0 0.2583334743976593
) O 0 0.002945051994174719
of O 0 0.0012054351391270757
the O 0 0.0047536385245621204
RB1 O 1 0.9999924898147583
gene O 1 0.9998576641082764
was O 0 0.0023351293057203293
found O 0 0.0022891578264534473
to O 0 0.0006281801615841687
be O 0 0.0007523788372054696
present O 0 0.0026187270414084196
homozygously O 1 0.9624740481376648
in O 0 0.0012554419226944447
both O 0 0.00175581406801939
the O 0 0.004175721202045679
retinal B-Disease 1 0.9999741315841675
and I-Disease 0 0.0033496764954179525
the I-Disease 0 0.007027643267065287
pineal I-Disease 1 0.9998996257781982
tumours I-Disease 1 0.9999648332595825
. O 0 0.013569442555308342

The O 0 0.005052209831774235
same O 0 0.007298116572201252
mutation O 1 0.9999499320983887
was O 0 0.002506875665858388
present O 0 0.0030279126949608326
heterozygously O 1 0.9674394130706787
in O 0 0.0010935550089925528
the O 0 0.0017727079102769494
DNA O 1 0.9982171654701233
from O 0 0.001468241331167519
the O 0 0.001362233771942556
constitutional O 0 0.009054695256054401
cells O 1 0.9979479908943176
of O 0 0.0011424805270507932
the O 0 0.003007038962095976
patient O 1 0.9994505047798157
, O 0 0.0019573839381337166
proving O 0 0.019198760390281677
it O 0 0.0007720510475337505
to O 0 0.0007345881895162165
be O 0 0.0009262820240110159
of O 0 0.0022215682547539473
germline O 1 0.9999303817749023
origin O 0 0.014385086484253407
. O 0 0.0058494010008871555

The O 0 0.006217137444764376
initial O 0 0.04326402023434639
mutation O 1 0.9999319314956665
was O 0 0.0033182965125888586
shown O 0 0.004582460969686508
to O 0 0.0008107762550935149
have O 0 0.0010451080743223429
occurred O 0 0.006635166704654694
in O 0 0.001402879599481821
the O 0 0.0034724443685263395
paternally O 1 0.9977074861526489
derived O 1 0.5721408724784851
RB1 O 1 0.9998511075973511
allele O 1 0.9981297850608826
. O 0 0.014577610418200493

The O 0 0.011221766471862793
mutation O 1 0.9998626708984375
is O 0 0.0022217901423573494
in O 0 0.0011167459888383746
an O 0 0.000977777410298586
area O 0 0.0013279452687129378
of O 0 0.0006604408263228834
the O 0 0.0025587985292077065
gene O 1 0.9996169805526733
that O 0 0.0019478515023365617
encodes O 1 0.9245367050170898
the O 0 0.004490108694881201
protein O 1 0.9998192191123962
- O 0 0.03490818664431572
binding O 0 0.08768851310014725
region O 0 0.003421770641580224
known O 0 0.0024589751847088337
as O 0 0.000999842188321054
the O 0 0.0015195626765489578
pocket O 1 0.9180105924606323
region O 0 0.0038674743846058846
and O 0 0.0009482901659794152
has O 0 0.0010580921079963446
been O 0 0.0016251117922365665
detected O 0 0.2708233594894409
in O 0 0.0013272552751004696
other O 0 0.0014232124667614698
cases O 0 0.007656797766685486
of O 0 0.003351754741743207
retinoblastoma B-Disease 1 0.9999551773071289
. O 0 0.005592985078692436
. O 0 0.006377294659614563

Low O 0 0.028657373040914536
levels O 0 0.010905222967267036
of O 0 0.002625306136906147
beta O 1 0.9929571151733398
hexosaminidase O 1 0.9864597320556641
A O 0 0.010971429757773876
in O 0 0.002545886905863881
healthy O 1 0.8328732848167419
individuals O 0 0.0041746231727302074
with O 0 0.0046240962110459805
apparent O 1 0.9987947940826416
deficiency O 1 0.9999927282333374
of O 0 0.001708223600871861
this O 0 0.003179725492373109
enzyme O 1 0.9995517134666443
. O 0 0.00858487281948328

Appreciable O 1 0.9349069595336914
beta O 1 0.9388657808303833
hexosaminidase O 1 0.9230607151985168
A O 0 0.012587021104991436
( O 0 0.004845039453357458
hex O 1 0.5511628985404968
A O 0 0.010655827820301056
) O 0 0.003005614271387458
activity O 0 0.0049372706562280655
has O 0 0.0008640136220492423
been O 0 0.0014563825679942966
detected O 0 0.28439199924468994
in O 0 0.003888149978592992
cultured O 1 0.9996836185455322
skin O 1 0.9999942779541016
fibroblasts O 1 0.9999724626541138
and O 0 0.030155612155795097
melanoma B-Disease 1 0.9999998807907104
tissue O 1 0.9999533891677856
from O 0 0.005653803702443838
healthy O 1 0.9685325026512146
individuals O 0 0.004395029041916132
previously O 0 0.0036188061349093914
reported O 0 0.005596138536930084
as O 0 0.0020507387816905975
having O 0 0.010877144522964954
deficiency B-Disease 1 0.999995231628418
of I-Disease 0 0.0022572858724743128
hex I-Disease 1 0.6834821701049805
A I-Disease 0 0.008502655662596226
activity O 0 0.00962231308221817
indistinguishable O 0 0.04300493746995926
from O 0 0.0011451664613559842
that O 0 0.0008012994658201933
of O 0 0.0015862364089116454
patients O 1 0.9998658895492554
with O 0 0.24276141822338104
Tay B-Disease 1 0.9999995231628418
- I-Disease 1 0.9995542168617249
Sachs I-Disease 1 0.9999866485595703
disease I-Disease 1 0.9999935626983643
( O 0 0.01845601201057434
TSD B-Disease 1 0.9998961687088013
) O 0 0.008929064497351646
. O 0 0.005370046012103558

Identification O 0 0.03499426692724228
and O 0 0.0028150787111371756
quantitation O 1 0.9860314130783081
of O 0 0.0021933538373559713
hex O 0 0.3845740854740143
A O 0 0.01218262780457735
, O 0 0.0021587505470961332
amounting O 0 0.016089273616671562
to O 0 0.0021629605907946825
3 O 0 0.010239638388156891
. O 0 0.0059588258154690266

5 O 0 0.022744210436940193
% O 0 0.014405924826860428
- O 0 0.026528703048825264
6 O 0 0.01696273684501648
. O 0 0.0077903009951114655

9 O 0 0.013938069343566895
% O 0 0.0033673178404569626
of O 0 0.00099303072784096
total O 0 0.00470268027856946
beta O 1 0.9971047043800354
hexosaminidase O 1 0.9945744872093201
activity O 0 0.011452071368694305
, O 0 0.0009867282351478934
has O 0 0.0007432684651575983
been O 0 0.001006288337521255
obtained O 0 0.004088112618774176
by O 0 0.004305379465222359
cellulose O 1 0.9995417594909668
acetate O 1 0.9996566772460938
gel O 1 0.9997733235359192
electrophoresis O 1 0.9987075328826904
, O 0 0.00877118669450283
DEAE O 1 0.9981663823127747
- O 0 0.1775348037481308
cellulose O 1 0.9989732503890991
ion O 1 0.9866088032722473
- O 0 0.029631640762090683
exchange O 0 0.014655920676887035
chromatography O 1 0.9943926334381104
, O 0 0.006484609562903643
radial O 1 0.9993552565574646
immunodiffusion O 1 0.994734525680542
, O 0 0.002966927830129862
and O 0 0.0030074110254645348
radioimmunoassay O 1 0.9808233976364136
. O 0 0.011293450370430946

Previous O 0 0.01683681458234787
family O 0 0.015097408555448055
studies O 0 0.011054527014493942
suggested O 0 0.0053048208355903625
that O 0 0.000995497452095151
these O 0 0.0010878826724365354
individuals O 0 0.003488300833851099
may O 0 0.0028874205891042948
be O 0 0.001339814974926412
compound O 0 0.0800393670797348
heterozygotes O 1 0.9983252882957458
for O 0 0.001342632109299302
the O 0 0.0015399687690660357
common O 0 0.03974561393260956
mutant O 1 0.9998432397842407
TSD B-Disease 1 0.9999363422393799
gene O 1 0.9996386766433716
and O 0 0.0019865024369210005
a O 0 0.005622445605695248
rare O 0 0.022716475650668144
( O 0 0.0069677699357271194
allelic O 1 0.9993999004364014
) O 0 0.014670751988887787
mutant O 1 0.9996352195739746
gene O 1 0.9994999170303345
. O 0 0.010254188440740108

Thus O 0 0.010875580832362175
, O 0 0.0016296881949529052
the O 0 0.0015996249858289957
postulated O 1 0.6085001826286316
rate O 0 0.022305913269519806
mutant O 1 0.9998142123222351
gene O 1 0.9999127388000488
appears O 0 0.010222467593848705
to O 0 0.0010202412959188223
code O 0 0.005506875924766064
for O 0 0.000956017873249948
the O 0 0.0012387702008709311
expression O 0 0.015913521870970726
of O 0 0.0011524113360792398
low O 0 0.01005758997052908
amounts O 0 0.008149470202624798
of O 0 0.0016369207296520472
hex O 1 0.7994893789291382
A O 0 0.017170952633023262
. O 0 0.007384070660918951

Heterozygotes O 1 0.975860059261322
for O 0 0.002556198975071311
the O 0 0.0026227363850921392
rare O 0 0.07825607061386108
mutant O 1 0.9992437362670898
may O 0 0.0063681406900286674
be O 0 0.0017181229777634144
indistinguishable O 0 0.1791299432516098
from O 0 0.0038556563667953014
heterozygotes O 1 0.9949818253517151
for O 0 0.0016375607810914516
the O 0 0.0020671719685196877
common O 0 0.13843514025211334
TSD B-Disease 1 0.9999245405197144
mutant O 1 0.9963640570640564
. O 0 0.014861365780234337

However O 0 0.00774181354790926
, O 0 0.0019126374972984195
direct O 0 0.009236062876880169
visualization O 0 0.15142932534217834
and O 0 0.0028439979068934917
quantitation O 1 0.9941934943199158
of O 0 0.002032390097156167
hex O 1 0.5511739253997803
A O 0 0.006165820639580488
by O 0 0.0016331730876117945
the O 0 0.0011074697831645608
methods O 0 0.006724511738866568
described O 0 0.006801125127822161
may O 0 0.004702287260442972
prevent O 0 0.1541222631931305
false O 0 0.0206147450953722
- O 0 0.064808189868927
positive O 1 0.8956286907196045
prenatal O 1 0.9999949932098389
diagnosis O 1 0.9999294281005859
of O 0 0.004084675572812557
TSD B-Disease 1 0.9999003410339355
in O 0 0.005133436527103186
fetuses O 1 0.9991076588630676
having O 0 0.0038038433995097876
the O 0 0.0013137845089659095
incomplete O 0 0.030664892867207527
hex B-Disease 1 0.9610161185264587
A I-Disease 0 0.09627334028482437
deficiency I-Disease 1 0.9999885559082031
of O 0 0.0013155974447727203
the O 0 0.001798582961782813
type O 0 0.4581005275249481
described O 0 0.005002595484256744
in O 0 0.0010298466077074409
the O 0 0.0015252111479640007
four O 0 0.00478754099458456
healthy O 1 0.8940925598144531
individuals O 0 0.020207129418849945

The O 0 0.021505748853087425
tumor B-Disease 1 0.9999932050704956
suppressor O 1 0.9999760389328003
gene O 1 0.9999483823776245
Smad4 O 1 0.999311089515686
/ O 1 0.9692883491516113
Dpc4 O 1 0.9841687679290771
is O 0 0.0018202324863523245
required O 0 0.0033994722180068493
for O 0 0.002206456381827593
gastrulation O 1 0.9997413754463196
and O 0 0.0013255801750347018
later O 0 0.002167509403079748
for O 0 0.002363534178584814
anterior O 1 0.9995667338371277
development O 0 0.004428258165717125
of O 0 0.001062805880792439
the O 0 0.003986412193626165
mouse O 1 0.9997677206993103
embryo O 1 0.9986445307731628
. O 0 0.009406784549355507

Mutations O 1 0.9992311000823975
in O 0 0.0037449633236974478
the O 0 0.004243442788720131
SMAD4 O 1 0.9994764924049377
/ O 1 0.9966637492179871
DPC4 O 1 0.9998859167098999
tumor B-Disease 1 0.9999985694885254
suppressor O 1 0.9999874830245972
gene O 1 0.9998451471328735
, O 0 0.0021571358665823936
a O 0 0.003839008044451475
key O 0 0.00626468425616622
signal O 0 0.03153480961918831
transducer O 1 0.9614955186843872
in O 0 0.0016205180436372757
most O 0 0.002690378110855818
TGFbeta O 1 0.9995760321617126
- O 0 0.181355282664299
related O 0 0.09507419914007187
pathways O 1 0.9997759461402893
, O 0 0.0014215342234820127
are O 0 0.0007333536632359028
involved O 0 0.00399058498442173
in O 0 0.0012193751754239202
50 O 0 0.003967867232859135
% O 0 0.0065156095661222935
of O 0 0.008014359511435032
pancreatic B-Disease 1 0.9999986886978149
cancers I-Disease 1 0.9999922513961792
. O 0 0.010511004365980625

Homozygous O 1 0.9965639710426331
Smad4 O 1 0.989504337310791
mutant O 1 0.9992071986198425
mice O 1 0.9998763799667358
die O 1 0.7187691330909729
before O 0 0.004810239188373089
day O 0 0.005103521514683962
7 O 0 0.012606612406671047
. O 0 0.006245430558919907

5 O 0 0.01703239418566227
of O 0 0.00538482004776597
embryogenesis O 1 0.9938096404075623
. O 0 0.009248335845768452

Mutant O 1 0.9959184527397156
embryos O 0 0.4926409423351288
have O 0 0.003420487744733691
reduced O 0 0.01570756547152996
size O 0 0.007935084402561188
, O 0 0.00185218988917768
fail O 0 0.022807391360402107
to O 0 0.0021627272944897413
gastrulate O 1 0.9744663834571838
or O 0 0.003989582881331444
express O 0 0.013145465403795242
a O 0 0.010401793755590916
mesodermal O 1 0.9997740387916565
marker O 1 0.8233116269111633
, O 0 0.0016239347169175744
and O 0 0.0012282945681363344
show O 0 0.008727842010557652
abnormal O 1 0.9996743202209473
visceral O 1 0.998297393321991
endoderm O 1 0.9977530837059021
development O 0 0.013907157815992832
. O 0 0.006370702292770147

Growth B-Disease 0 0.23498742282390594
retardation I-Disease 1 0.9954107403755188
of O 0 0.002260608598589897
the O 0 0.004388411995023489
Smad4 O 1 0.9981050491333008
- O 1 0.5529783368110657
deficient O 1 0.9987366795539856
embryos O 1 0.8675834536552429
results O 0 0.01196443010121584
from O 0 0.003043913980945945
reduced O 0 0.05472230538725853
cell O 1 0.9995032548904419
proliferation O 1 0.7157118320465088
rather O 0 0.003929429221898317
than O 0 0.0023599041160196066
increased O 0 0.02507934905588627
apoptosis O 1 0.9998642206192017
. O 0 0.01054221298545599

Aggregation O 0 0.2773439884185791
of O 0 0.006368571426719427
mutant O 1 0.9976634979248047
Smad4 O 1 0.9965457320213318
ES O 1 0.9939431548118591
cells O 1 0.9962294697761536
with O 0 0.005151527468115091
wild O 0 0.034323424100875854
- O 0 0.053542885929346085
type O 1 0.6689671277999878
tetraploid O 1 0.9973347783088684
morulae O 1 0.9801927208900452
rescues O 1 0.5377657413482666
the O 0 0.008827748708426952
gastrulation B-Disease 1 0.999174177646637
defect I-Disease 1 0.9988136291503906
. O 0 0.013620489276945591

These O 0 0.0038766057696193457
results O 0 0.008718807250261307
indicate O 0 0.00780487759038806
that O 0 0.0021119394805282354
Smad4 O 1 0.9960724115371704
is O 0 0.0016173857729882002
initially O 0 0.002910611219704151
required O 0 0.0021665566600859165
for O 0 0.0006425370229408145
the O 0 0.0013385242782533169
differentiation O 1 0.9958725571632385
of O 0 0.0009203666704706848
the O 0 0.0019404414342716336
visceral O 1 0.9992108345031738
endoderm O 1 0.9993506073951721
and O 0 0.0015757130458950996
that O 0 0.001148782903328538
the O 0 0.002718311734497547
gastrulation B-Disease 1 0.9998679161071777
defect I-Disease 1 0.9995226860046387
in O 0 0.0019023084314540029
the O 0 0.0025290425401180983
epiblast O 1 0.9995736479759216
is O 0 0.002443844685330987
secondary O 0 0.01824437826871872
and O 0 0.001680467976257205
non O 0 0.011592011898756027
- O 0 0.283394992351532
cell O 1 0.997495710849762
autonomous O 0 0.01857820712029934
. O 0 0.006545635871589184

Rescued O 0 0.14591814577579498
embryos O 1 0.8062484264373779
show O 0 0.019411485642194748
severe O 1 0.9975243210792542
anterior O 1 0.9997339844703674
truncations O 1 0.9980869293212891
, O 0 0.002816298045217991
indicating O 0 0.015632688999176025
a O 0 0.003884520847350359
second O 0 0.003030320629477501
important O 0 0.0021377066150307655
role O 0 0.005795774050056934
for O 0 0.003113973420113325
Smad4 O 1 0.9953039884567261
in O 0 0.007726579904556274
anterior O 1 0.9997846484184265
patterning O 1 0.9992856383323669
during O 0 0.017227206379175186
embryogenesis O 1 0.9964304566383362
. O 0 0.011032450944185257

Prevalence O 1 0.9592108726501465
of O 0 0.007785780355334282
p16 O 1 0.9980834722518921
and O 0 0.007194292265921831
CDK4 O 1 0.999229907989502
germline O 1 0.9999804496765137
mutations O 1 0.9999128580093384
in O 0 0.0065231723710894585
48 O 1 0.8572452068328857
melanoma B-Disease 1 0.9999997615814209
- O 1 0.6182606220245361
prone O 1 0.9320694208145142
families O 0 0.006807015743106604
in O 0 0.002503291703760624
France O 0 0.008628305047750473
. O 0 0.00686663156375289

The O 0 0.008932270109653473
French O 1 0.5157553553581238
Familial B-Disease 1 0.9999985694885254
Melanoma I-Disease 1 0.9999988079071045
Study O 0 0.026441635563969612
Group O 0 0.012080530636012554
. O 0 0.006465263199061155

Germline O 1 0.999890923500061
mutations O 1 0.9994468092918396
in O 0 0.0030080885626375675
the O 0 0.0038095798809081316
p16 O 1 0.9997155070304871
and O 0 0.005154045764356852
CDK4 O 1 0.9995699524879456
genes O 1 0.9991030693054199
have O 0 0.0013184832641854882
been O 0 0.0012243767268955708
reported O 0 0.003798612393438816
in O 0 0.0009850417263805866
a O 0 0.004558627028018236
subset O 1 0.5160176157951355
of O 0 0.006050125230103731
melanoma B-Disease 1 0.9999995231628418
pedigrees O 1 0.99826580286026
, O 0 0.0018642020877450705
but O 0 0.0012339007807895541
their O 0 0.002546669216826558
prevalence O 1 0.9998152852058411
is O 0 0.0016379770822823048
not O 0 0.0008740036864764988
well O 0 0.0016063039656728506
known O 0 0.005776841193437576
. O 0 0.005538454279303551

We O 0 0.0032997692469507456
searched O 0 0.011438018642365932
for O 0 0.0020971219055354595
such O 0 0.004720467608422041
germline O 1 0.9999867677688599
mutations O 1 0.9999032020568848
in O 0 0.003029369981959462
48 O 0 0.01900636777281761
French O 1 0.9801162481307983
melanoma B-Disease 1 0.9999998807907104
- O 1 0.7087676525115967
prone O 1 0.9429854154586792
families O 0 0.005038950592279434
selected O 0 0.0021143851336091757
according O 0 0.001219445955939591
to O 0 0.0007686558528803289
two O 0 0.001457455102354288
major O 0 0.004302655346691608
criteria O 0 0.006993525195866823
families O 0 0.003573928726837039
with O 0 0.0014353879960253835
at O 0 0.0012586519587785006
least O 0 0.0023364517837762833
three O 0 0.0018605341902002692
affected O 0 0.010190742090344429
members O 0 0.0018309428123757243
( O 0 0.004347559530287981
n O 0 0.4696131646633148
= O 0 0.12829463183879852
20 O 0 0.004274746868759394
) O 0 0.002504137111827731
or O 0 0.001935826614499092
families O 0 0.0026923196855932474
with O 0 0.0013866982189938426
two O 0 0.0014911522157490253
affected O 0 0.009137311950325966
members O 0 0.0011990622151643038
, O 0 0.0007221265113912523
one O 0 0.0008112044306471944
of O 0 0.0006418098928406835
them O 0 0.0011756933527067304
affected O 0 0.009173084981739521
before O 0 0.0014371474971994758
the O 0 0.0008703723433427513
age O 0 0.0025382961612194777
of O 0 0.0008675022982060909
50 O 0 0.004729544743895531
( O 0 0.004858657717704773
n O 0 0.3491800129413605
= O 0 0.13063843548297882
28 O 0 0.008591835387051105
) O 0 0.0025559011846780777
, O 0 0.0009382635471411049
and O 0 0.0006858148262836039
one O 0 0.0015551568940281868
additional O 0 0.0061047994531691074
minor O 0 0.06426210701465607
criterion O 0 0.10080776363611221
. O 0 0.007142809219658375

Sixteen O 0 0.03159615769982338
different O 0 0.01485047210007906
p16 O 1 0.9997979998588562
germline O 1 0.9999681711196899
mutations O 1 0.9998471736907959
were O 0 0.0017596427351236343
found O 0 0.004001178778707981
in O 0 0.0014801773941144347
21 O 0 0.006120434496551752
families O 0 0.004421519581228495
, O 0 0.0011761249043047428
while O 0 0.0018309939187020063
one O 0 0.005550775211304426
germline O 1 0.9999945163726807
mutation O 1 0.9999850988388062
, O 0 0.004894273821264505
Arg24His O 1 0.997147262096405
, O 0 0.0017763626528903842
was O 0 0.0023234421387314796
detected O 0 0.12872767448425293
in O 0 0.0018616545712575316
the O 0 0.0040397788397967815
CDK4 O 1 0.9995644688606262
gene O 1 0.9997056126594543
. O 0 0.009175226092338562

The O 0 0.005230111535638571
frequency O 0 0.026587430387735367
of O 0 0.004055920988321304
p16 O 1 0.9999661445617676
gene O 1 0.9999687671661377
mutation O 1 0.9998993873596191
in O 0 0.0018002918222919106
our O 0 0.002546014031395316
sample O 0 0.018182070925831795
( O 0 0.003549487330019474
44 O 0 0.010348496958613396
% O 0 0.005429609678685665
) O 0 0.002410352462902665
is O 0 0.0008079762337729335
among O 0 0.0010260003618896008
the O 0 0.0007925237296149135
highest O 0 0.003418510314077139
rates O 0 0.009072549641132355
yet O 0 0.002963665407150984
reported O 0 0.0038523669354617596
and O 0 0.0008674584096297622
the O 0 0.0024953505489975214
CDK4 O 1 0.9998691082000732
mutation O 1 0.9999539852142334
is O 0 0.0016681768465787172
the O 0 0.0012993741547688842
second O 0 0.01217245776206255
mutation O 1 0.999996542930603
detected O 1 0.8617396354675293
in O 0 0.0019112481968477368
this O 0 0.003117584390565753
gene O 1 0.9999148845672607
worldwide O 0 0.025298641994595528
. O 0 0.005579314660280943

In O 0 0.005610025487840176
summary O 0 0.01869841478765011
, O 0 0.0014541716082021594
our O 0 0.001985702896490693
results O 0 0.005998899694532156
show O 0 0.0034415607806295156
frequent O 0 0.014928588643670082
involvement O 0 0.010586060583591461
of O 0 0.0010189422173425555
the O 0 0.003403852926567197
p16 O 1 0.9999854564666748
gene O 1 0.9999631643295288
in O 0 0.012337285093963146
familial B-Disease 1 0.9999996423721313
melanoma I-Disease 1 0.9999995231628418
and O 0 0.0021869202610105276
confirm O 0 0.0060904682613909245
the O 0 0.0009593719732947648
role O 0 0.0034860901068896055
of O 0 0.0007842013728804886
the O 0 0.003665580414235592
CDK4 O 1 0.9995294809341431
gene O 1 0.9996999502182007
as O 0 0.0043594068847596645
a O 0 0.15859436988830566
melanoma B-Disease 1 0.9999988079071045
- O 1 0.9892603158950806
predisposing O 1 0.9999263286590576
gene O 1 0.9998471736907959
. O 0 0.004516334738582373
. O 0 0.006117528770118952

Progression O 1 0.9900381565093994
of O 0 0.006726343184709549
somatic O 1 0.9993467926979065
CTG O 1 0.9952681660652161
repeat O 0 0.11551622301340103
length O 0 0.021253343671560287
heterogeneity O 1 0.9758661389350891
in O 0 0.0017585777677595615
the O 0 0.0041100033558905125
blood O 1 0.9998346567153931
cells O 1 0.9994736313819885
of O 0 0.016254279762506485
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999996423721313
patients O 1 0.9995480179786682
. O 0 0.01221389602869749

The O 0 0.008352989330887794
genetic O 1 0.9943994879722595
basis O 0 0.007643280550837517
of O 0 0.008021621964871883
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999996423721313
( O 0 0.038329143077135086
DM B-Disease 1 0.9999741315841675
) O 0 0.004236675798892975
is O 0 0.0009681078372523189
the O 0 0.0008653836557641625
expansion O 0 0.005331947468221188
of O 0 0.0008803884265944362
an O 0 0.003323343815281987
unstable O 1 0.9973633885383606
CTG O 1 0.9986377358436584
repeat O 0 0.07621311396360397
in O 0 0.0014934742357581854
the O 0 0.0015794181963428855
34 O 0 0.012731553055346012
UTR O 1 0.8317740559577942
of O 0 0.002091464586555958
the O 0 0.005490282084792852
DM B-Disease 1 0.9999734163284302
protein O 1 0.9998313188552856
kinase O 1 0.9999029636383057
gene O 1 0.9993473887443542
on O 0 0.00723913824185729
chromosome O 1 0.9998787641525269
19 O 0 0.017654625698924065
. O 0 0.006021794397383928

One O 0 0.0031731927301734686
of O 0 0.0008387338602915406
the O 0 0.0010852592531591654
principal O 0 0.004911808297038078
features O 0 0.0033951327204704285
of O 0 0.0011467726435512304
the O 0 0.005909945350140333
DM B-Disease 1 0.9999978542327881
mutation O 1 0.9999849796295166
is O 0 0.0023482879623770714
an O 0 0.0017693653935566545
extraordinarily O 0 0.03060508333146572
high O 0 0.0035945314448326826
level O 0 0.0030607269145548344
of O 0 0.0024853646755218506
somatic O 1 0.999985933303833
mosaicism O 1 0.9999723434448242
, O 0 0.00259863561950624
due O 0 0.003490761388093233
to O 0 0.0008521207491867244
an O 0 0.0012854774249717593
extremely O 0 0.007124005351215601
high O 0 0.003723351750522852
degree O 0 0.006193975917994976
of O 0 0.002217703964561224
somatic O 1 0.9999421834945679
instability O 1 0.9703611135482788
both O 0 0.0014205368934199214
within O 0 0.0014553455403074622
and O 0 0.0007556910859420896
between O 0 0.0022723597940057516
different O 0 0.0048841447569429874
tissues O 1 0.9997400641441345
. O 0 0.006464763544499874

This O 0 0.0078006284311413765
instability O 1 0.9112734198570251
appears O 0 0.0094875767827034
to O 0 0.0010457405587658286
be O 0 0.0010623220587149262
biased O 0 0.013242390938103199
towards O 0 0.002921540755778551
further O 0 0.0024733489844948053
expansion O 0 0.00672108493745327
and O 0 0.0009712027385830879
continuous O 0 0.014520409516990185
throughout O 0 0.001586486236192286
the O 0 0.0009628866100683808
life O 0 0.002397864358499646
of O 0 0.0006034332909621298
an O 0 0.0012054673861712217
individual O 0 0.003431729506701231
, O 0 0.0008991058566607535
features O 0 0.0028019538149237633
that O 0 0.0007978646317496896
could O 0 0.00155179004650563
be O 0 0.0009231801959685981
associated O 0 0.004554279614239931
with O 0 0.0014601917937397957
the O 0 0.0012722264509648085
progressive O 0 0.10898619890213013
nature O 0 0.004922835621982813
of O 0 0.0015473245875909925
the O 0 0.0062480950728058815
disease O 1 0.9999854564666748
. O 0 0.008249109610915184

Although O 0 0.00775907514616847
increasing O 0 0.009760136716067791
measured O 0 0.018752772361040115
allele O 1 0.9991637468338013
size O 0 0.010910357348620892
between O 0 0.005582801997661591
patients O 1 0.9994530081748962
clearly O 0 0.005730034783482552
correlates O 1 0.9365402460098267
with O 0 0.0017686092760413885
an O 0 0.001402882393449545
increased O 0 0.009329608641564846
severity O 1 0.998202919960022
of O 0 0.0033258465118706226
symptoms O 1 0.9999864101409912
and O 0 0.001078567118383944
an O 0 0.0011136274551972747
earlier O 0 0.002555021084845066
age O 0 0.0036838934756815434
of O 0 0.002155107446014881
onset O 1 0.999971866607666
, O 0 0.001685546012595296
this O 0 0.0015516887651756406
correlation O 1 0.9715562462806702
is O 0 0.0013028514804318547
not O 0 0.0010793055407702923
precise O 0 0.011407261714339256
and O 0 0.0014836997725069523
measured O 0 0.017684560269117355
allele O 1 0.9998262524604797
length O 0 0.012843461707234383
cannot O 0 0.0025042325723916292
be O 0 0.0006514439010061324
used O 0 0.0013030736008659005
as O 0 0.0007926358375698328
an O 0 0.0014561947900801897
accurate O 0 0.011707703582942486
predictor O 1 0.9966469407081604
of O 0 0.0012985817156732082
age O 0 0.004951304290443659
of O 0 0.003477430669590831
onset O 1 0.9997796416282654
. O 0 0.008095434866845608

In O 0 0.0036604583729058504
order O 0 0.003314435016363859
to O 0 0.0009458966669626534
further O 0 0.002891018521040678
characterize O 0 0.035634372383356094
the O 0 0.0020158763509243727
dynamics O 0 0.08637291193008423
of O 0 0.004200668074190617
DM B-Disease 1 0.9999781847000122
CTG O 1 0.9993366599082947
repeat O 1 0.9936981797218323
somatic O 1 0.9999023675918579
instability O 1 0.9815178513526917
, O 0 0.0013971140142530203
we O 0 0.0007821199833415449
have O 0 0.0010596768697723746
studied O 0 0.006048623006790876
repeat O 0 0.20755966007709503
length O 0 0.008252028375864029
changes O 0 0.0042840768583118916
over O 0 0.0011529575567692518
time O 0 0.0018923628376796842
in O 0 0.004331991542130709
111 O 1 0.9976091384887695
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999998807907104
patients O 1 0.99972003698349
with O 0 0.006571834906935692
varying O 0 0.02707330882549286
clinical O 1 0.9996592998504639
severity O 1 0.9912857413291931
and O 0 0.0041648042388260365
CTG O 1 0.9991982579231262
repeat O 0 0.3031971752643585
size O 0 0.006068047601729631
over O 0 0.001614354900084436
time O 0 0.0016501756617799401
intervals O 0 0.014618877321481705
of O 0 0.0012901450973004103
1 O 0 0.009611953049898148
- O 0 0.017028994858264923
7 O 0 0.009759205393493176
years O 0 0.003992714453488588
. O 0 0.005059102550148964

We O 0 0.002447133418172598
have O 0 0.0010255108354613185
found O 0 0.0033753577154129744
a O 0 0.004151949658989906
direct O 0 0.009173223748803139
progression O 1 0.9984899759292603
of O 0 0.0007845814106985927
the O 0 0.0013335489202290773
size O 0 0.009669545106589794
heterogeneity O 1 0.9924958944320679
over O 0 0.001928203389979899
time O 0 0.0019192546606063843
related O 0 0.006882437039166689
to O 0 0.001829860731959343
initial O 0 0.027021974325180054
CTG O 1 0.999089241027832
repeat O 0 0.39449045062065125
size O 0 0.00633388664573431
and O 0 0.0007946565747261047
the O 0 0.0009443980525247753
time O 0 0.0019644745625555515
interval O 0 0.1470305472612381
and O 0 0.0010783558245748281
always O 0 0.0021819458343088627
biased O 0 0.016521543264389038
towards O 0 0.0039041575510054827
further O 0 0.004856762941926718
expansion O 0 0.016580313444137573
. O 0 0.006980345118790865

Attempts O 0 0.02089756354689598
to O 0 0.0019953905139118433
mathematically O 0 0.02451378107070923
model O 0 0.008413981646299362
the O 0 0.0020353980362415314
dynamics O 0 0.2831423878669739
have O 0 0.001225935760885477
proved O 0 0.006136387586593628
only O 0 0.0011014998890459538
partially O 0 0.03596911206841469
successful O 0 0.007984118536114693
suggesting O 0 0.007823691703379154
that O 0 0.0007037557079456747
individual O 0 0.002956448821350932
specific O 0 0.00913869496434927
genetic O 1 0.9999728202819824
and O 0 0.002590363146737218
/ O 1 0.9172643423080444
or O 0 0.0036223253700882196
environmental O 0 0.008162107318639755
factors O 0 0.011788647621870041
also O 0 0.0009998211171478033
play O 0 0.002409577602520585
a O 0 0.003924797289073467
role O 0 0.007083548232913017
in O 0 0.004854744300246239
somatic O 1 0.9999381303787231
mosaicism O 1 0.9997815489768982
. O 0 0.006331333890557289
. O 0 0.00612962432205677

Aspartylglucosaminuria B-Disease 1 0.9486085772514343
among O 0 0.009546568617224693
Palestinian O 0 0.01777477003633976
Arabs O 0 0.018059799447655678
. O 0 0.007753239944577217

Aspartylglucosaminuria B-Disease 1 0.9953917264938354
( O 0 0.02416086569428444
AGU B-Disease 1 0.9999269247055054
) O 0 0.005756836384534836
is O 0 0.0019689220935106277
a O 0 0.006929988507181406
rare O 0 0.3752398192882538
disorder B-Disease 1 0.9999092817306519
of I-Disease 0 0.004081906285136938
glycoprotein I-Disease 1 0.9999030828475952
metabolism I-Disease 1 0.9999443292617798
caused O 0 0.0681833028793335
by O 0 0.0019576672930270433
the O 0 0.0030304903630167246
deficiency B-Disease 1 0.9999854564666748
of I-Disease 0 0.0014167183544486761
the I-Disease 0 0.004386087413877249
lysosomal I-Disease 1 0.9999845027923584
enzyme I-Disease 1 0.9998699426651001
aspartylglucosaminidase I-Disease 1 0.9948318004608154
( O 0 0.011064700782299042
AGA O 1 0.9984679818153381
) O 0 0.008087038062512875
. O 0 0.005938349757343531

AGU B-Disease 1 0.9994636178016663
is O 0 0.008565652184188366
inherited O 1 0.8749222755432129
as O 0 0.002556662308052182
an O 0 0.008841733448207378
autosomal O 1 0.9999998807907104
recessive O 1 0.9999996423721313
trait O 1 0.9997861981391907
and O 0 0.0021318576764315367
occurs O 0 0.03291318565607071
with O 0 0.001789637142792344
a O 0 0.0035232659429311752
high O 0 0.00434950040653348
frequency O 0 0.02404908649623394
in O 0 0.0014173411764204502
Finland O 0 0.006418860051780939
because O 0 0.002277023857459426
of O 0 0.000811214093118906
a O 0 0.007466535549610853
founder O 0 0.03263840079307556
effect O 0 0.023137465119361877
. O 0 0.0073031093925237656

While O 0 0.005077309440821409
very O 0 0.0031708553433418274
few O 0 0.006511576473712921
patients O 1 0.9996700286865234
with O 0 0.008839364163577557
AGU B-Disease 1 0.9999841451644897
have O 0 0.0016878590686246753
been O 0 0.00137597625143826
reported O 0 0.00426552165299654
from O 0 0.0016282107681035995
non O 0 0.007790445350110531
- O 0 0.01432991586625576
Finnish O 0 0.019250893965363503
origin O 0 0.006222091615200043
, O 0 0.0015270966105163097
we O 0 0.00259584398008883
diagnosed O 1 0.9999833106994629
the O 0 0.0055463360622525215
disorder O 1 0.9999887943267822
in O 0 0.003149561118334532
8 O 0 0.019179221242666245
patients O 1 0.9996480941772461
originating O 0 0.029737617820501328
from O 0 0.0025236820802092552
3 O 0 0.008446330204606056
unrelated O 1 0.7822378873825073
families O 0 0.00458947429433465
, O 0 0.000857942330185324
all O 0 0.0005242819897830486
Palestinian O 0 0.00490414397791028
Arabs O 0 0.005410960875451565
from O 0 0.0011646919883787632
the O 0 0.0011575744720175862
region O 0 0.0023089777678251266
of O 0 0.0010966778500005603
Jerusalem O 0 0.008506668731570244
. O 0 0.005507463123649359

The O 0 0.01340901292860508
clinical O 1 0.9997382760047913
diagnosis O 1 0.9998985528945923
of O 0 0.0056188371963799
AGU B-Disease 1 0.9999943971633911
is O 0 0.0031964066438376904
often O 0 0.002515060594305396
difficult O 0 0.004482797347009182
, O 0 0.0008019417873583734
in O 0 0.0008427266729995608
particular O 0 0.0028491669800132513
early O 0 0.0023741798941046
in O 0 0.0008034861530177295
the O 0 0.0009162106434814632
course O 0 0.0035988346207886934
of O 0 0.0009589416440576315
the O 0 0.0046914382837712765
disease O 1 0.9999986886978149
, O 0 0.0014620403526350856
and O 0 0.000587433751206845
most O 0 0.0006095195421949029
of O 0 0.0006373971118591726
the O 0 0.002956985728815198
patients O 1 0.9999624490737915
are O 0 0.0037762976717203856
diagnosed O 1 0.9999955892562866
after O 0 0.004354504868388176
the O 0 0.0012689908035099506
age O 0 0.0028763164300471544
of O 0 0.0011072508059442043
5 O 0 0.007210190407931805
years O 0 0.0033971338998526335
. O 0 0.005041979718953371

However O 0 0.006194788496941328
, O 0 0.0019062217324972153
since O 0 0.0035431329160928726
these O 0 0.0033805074635893106
patients O 1 0.9997923970222473
excrete O 1 0.9969677329063416
early O 0 0.004066644702106714
large O 0 0.002910069888457656
amounts O 0 0.006041491404175758
of O 0 0.0014493416529148817
aspartylglucosamine O 1 0.9814943075180054
in O 0 0.0032149143517017365
urine O 1 0.99906986951828
, O 0 0.004194757901132107
biochemical O 1 0.9997465014457703
screening O 1 0.9101550579071045
is O 0 0.001891023013740778
easy O 0 0.00759580172598362
by O 0 0.004821359179913998
urine O 1 0.9991722106933594
chromatography O 1 0.9946308135986328
. O 0 0.004682809114456177
. O 0 0.005424038041383028

Detection O 0 0.12363391369581223
of O 0 0.005029063206166029
heterozygous O 1 0.9988999366760254
carriers O 0 0.05226939171552658
of O 0 0.0019696829840540886
the O 0 0.006502300966531038
ataxia B-Disease 1 0.9999992847442627
- I-Disease 1 0.9951003193855286
telangiectasia I-Disease 1 0.999975323677063
( O 0 0.011998608708381653
ATM O 1 0.9890433549880981
) O 0 0.008664176799356937
gene O 1 0.999061644077301
by O 0 0.007479150779545307
G2 O 1 0.9997950196266174
phase O 1 0.5453304648399353
chromosomal O 1 0.999879002571106
radiosensitivity O 1 0.9208741188049316
of O 0 0.006536880042403936
peripheral O 1 0.9999278783798218
blood O 1 0.9999291896820068
lymphocytes O 1 0.9997945427894592
. O 0 0.016068438068032265

In O 0 0.02609841898083687
ataxia B-Disease 1 0.9999932050704956
- I-Disease 1 0.9802221655845642
telangiectasia I-Disease 1 0.9999572038650513
( O 0 0.01131987851113081
A B-Disease 0 0.4410884380340576
- I-Disease 1 0.9844627380371094
T I-Disease 1 0.9999626874923706
) O 0 0.012334369122982025
patients O 1 0.9993667006492615
, O 0 0.004069824703037739
mutations O 1 0.9999183416366577
in O 0 0.0014869322767481208
a O 0 0.0046576205641031265
single O 0 0.03291298821568489
gene O 1 0.9999552965164185
, O 0 0.003013788489624858
ATM O 1 0.9875125288963318
, O 0 0.0014627010095864534
result O 0 0.004602296743541956
in O 0 0.0019557378254830837
an O 0 0.035971786826848984
autosomal B-Disease 1 1.0
recessive I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999994039535522
that O 0 0.0023040364030748606
embraces O 0 0.034965984523296356
a O 0 0.004392413422465324
variety O 0 0.004708200227469206
of O 0 0.0018004707526415586
clinical O 1 0.9993640780448914
features O 0 0.005856159143149853
and O 0 0.0015094989212229848
manifests O 1 0.9549509286880493
extreme O 0 0.028615441173315048
radiosensitivity O 1 0.9953426122665405
and O 0 0.0015648610424250364
a O 0 0.004556161351501942
strong O 0 0.006749654654413462
pre O 0 0.3082389235496521
- O 0 0.03668155521154404
disposition O 0 0.35742008686065674
to O 0 0.007221039850264788
malignancy B-Disease 1 0.9999587535858154
. O 0 0.008390833623707294

Heterozygotes O 1 0.9771426916122437
for O 0 0.0028493835125118494
the O 0 0.002662542974576354
ATM O 1 0.9981938004493713
gene O 1 0.9995762705802917
have O 0 0.0019142292439937592
no O 0 0.003290846711024642
clinical O 1 0.9957391023635864
expression O 0 0.015357927419245243
of O 0 0.001578987343236804
A B-Disease 1 0.7036747932434082
- I-Disease 1 0.9761030077934265
T I-Disease 1 0.9999496936798096
but O 0 0.003107650438323617
may O 0 0.005495861638337374
be O 0 0.0044110179878771305
cancer B-Disease 1 0.9999983310699463
prone O 1 0.9889996647834778
with O 0 0.0026386845856904984
a O 0 0.005143347661942244
moderate O 0 0.01471056416630745
increase O 0 0.0055007426999509335
in O 0 0.0021977934520691633
in O 0 0.00493783550336957
vitro O 1 0.9984921216964722
radiosensitivity O 1 0.9793771505355835
. O 0 0.011582324281334877

We O 0 0.003740692511200905
performed O 0 0.008072927594184875
a O 0 0.00846603512763977
blind O 1 0.9056019186973572
chromosomal O 1 0.9998940229415894
analysis O 0 0.01679053343832493
on O 0 0.0045939902774989605
G2 O 1 0.9999274015426636
- O 0 0.07383685559034348
phase O 1 0.6055173277854919
lymphocytes O 1 0.9996930360794067
from O 0 0.0031720977276563644
7 O 0 0.00920858234167099
unrelated O 1 0.8945779800415039
A B-Disease 1 0.7675475478172302
- I-Disease 1 0.9973378777503967
T I-Disease 1 0.9999899864196777
patients O 1 0.9994664788246155
, O 0 0.0021126875653862953
13 O 0 0.006821860559284687
obligate O 1 0.9953067898750305
A B-Disease 0 0.3771495819091797
- I-Disease 1 0.979017972946167
T I-Disease 1 0.9999688863754272
heterozygotes O 1 0.9996520280838013
( O 0 0.003648038487881422
parents O 0 0.004504604730755091
of O 0 0.0008828186546452343
the O 0 0.0035557718947529793
patients O 1 0.9999570846557617
) O 0 0.003263226244598627
, O 0 0.000980315962806344
and O 0 0.0008737585158087313
14 O 0 0.004521485418081284
normal O 0 0.015589448623359203
controls O 0 0.016937438398599625
following O 0 0.007514367811381817
X O 1 0.9635560512542725
- O 0 0.049406781792640686
irradiation O 1 0.989174485206604
with O 0 0.004197799134999514
1 O 0 0.009109921753406525
Gy O 1 0.9937450289726257
in O 0 0.001841362682171166
order O 0 0.0022677485831081867
to O 0 0.0010758328717201948
evaluate O 0 0.015453888103365898
this O 0 0.0025906579103320837
cytogenetic O 1 0.9996410608291626
method O 0 0.013065969571471214
as O 0 0.0015994444256648421
a O 0 0.0047332183457911015
tool O 0 0.015151404775679111
for O 0 0.002740380121394992
detection O 1 0.552209734916687
of O 0 0.003175365272909403
ATM O 1 0.9961308240890503
carriers O 1 0.6271741986274719
. O 0 0.00923355296254158

Both O 0 0.009699981659650803
A B-Disease 0 0.08776495605707169
- I-Disease 1 0.8737121224403381
T I-Disease 1 0.9997718930244446
homozygotes O 1 0.9987848401069641
and O 0 0.003598105860874057
heterozygotes O 1 0.9964260458946228
showed O 0 0.008823886513710022
significantly O 0 0.016568265855312347
increased O 0 0.005626214202493429
levels O 0 0.00766928493976593
of O 0 0.0027453063521534204
radiation O 1 0.9999209642410278
- O 1 0.9795459508895874
induced O 1 0.9999580383300781
chromatid O 1 0.9999402761459351
damage O 1 0.6638206243515015
relative O 0 0.00901799462735653
to O 0 0.0009812642820179462
that O 0 0.00084644032176584
of O 0 0.0013452619314193726
normal O 0 0.03685281425714493
controls O 0 0.032432910054922104
. O 0 0.0074766939505934715

These O 0 0.0033056100364774466
results O 0 0.007287641987204552
show O 0 0.0022850846871733665
that O 0 0.0011061796685680747
the O 0 0.003737604944035411
G2 O 1 0.9997318387031555
- O 0 0.062356822192668915
phase O 1 0.8235771059989929
chromosomal O 1 0.9999760389328003
radiosensitivity O 1 0.9982479810714722
assay O 1 0.9907100200653076
can O 0 0.00279092020355165
be O 0 0.0006742917466908693
used O 0 0.0015084162587299943
for O 0 0.0007725396426394582
the O 0 0.00142893276643008
detection O 1 0.7401913404464722
of O 0 0.002186730969697237
A B-Disease 0 0.43701663613319397
- I-Disease 1 0.9467874765396118
T I-Disease 1 0.9998127818107605
heterozygotes O 1 0.9967984557151794
. O 0 0.011986116878688335

In O 0 0.004977811127901077
combination O 0 0.14017291367053986
with O 0 0.006629250943660736
molecular O 1 0.9997530579566956
genetic O 1 0.9999064207077026
analyses O 0 0.04085716977715492
, O 0 0.00104662892408669
this O 0 0.0010515492176637053
test O 0 0.011539902538061142
may O 0 0.0026920163072645664
be O 0 0.0005453862831927836
of O 0 0.0004161478136666119
value O 0 0.0013017040910199285
in O 0 0.0009903550380840898
studies O 0 0.006524405907839537
of O 0 0.002252219943329692
familial B-Disease 1 0.9999926090240479
and I-Disease 0 0.003912132233381271
sporadic I-Disease 1 0.998497486114502
cancers I-Disease 1 0.9999934434890747
aimed O 0 0.011432120576500893
at O 0 0.002035861136391759
determination O 0 0.004140201490372419
of O 0 0.0005552436341531575
the O 0 0.0010567150311544538
potential O 0 0.009672700427472591
involvement O 0 0.011208958923816681
of O 0 0.001997685059905052
ATM O 1 0.9998132586479187
mutations O 1 0.9999914169311523
in O 0 0.010984801687300205
tumor B-Disease 1 0.9999992847442627
risk O 1 0.9966766834259033
or O 0 0.004383701831102371
development O 0 0.005962600000202656
. O 0 0.0027356226928532124
. O 0 0.004705745726823807

Ataxia B-Disease 1 0.9999897480010986
- I-Disease 1 0.9825380444526672
telangiectasia I-Disease 1 0.9999368190765381
: O 0 0.00766979344189167
identification O 0 0.016448646783828735
and O 0 0.0017030660528689623
detection O 1 0.6692031621932983
of O 0 0.001939561334438622
founder O 0 0.07075440883636475
- O 0 0.030559632927179337
effect O 0 0.03480559214949608
mutations O 1 0.9999231100082397
in O 0 0.001470373710617423
the O 0 0.002574437065050006
ATM O 1 0.9995847344398499
gene O 1 0.9997221827507019
in O 0 0.00246812729164958
ethnic O 0 0.006977050565183163
populations O 0 0.03929775953292847
. O 0 0.005372978281229734

To O 0 0.003992551006376743
facilitate O 0 0.014172258786857128
the O 0 0.0017215907573699951
evaluation O 0 0.01531206164509058
of O 0 0.0023065083660185337
ATM O 1 0.9960145950317383
heterozygotes O 1 0.9987523555755615
for O 0 0.005460273940116167
susceptibility O 1 0.9999179840087891
to O 0 0.002190379658713937
other O 0 0.0035289826337248087
diseases O 1 0.9999923706054688
, O 0 0.0015229798154905438
such O 0 0.0026496131904423237
as O 0 0.052458591759204865
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
, O 0 0.001733098761178553
we O 0 0.0007572658942081034
have O 0 0.0007351533859036863
attempted O 0 0.00681902514770627
to O 0 0.0009680133080109954
define O 0 0.005468771327286959
the O 0 0.0008560735150240362
most O 0 0.0013265187153592706
common O 0 0.06039891764521599
mutations O 1 0.9999697208404541
and O 0 0.0009679500362835824
their O 0 0.0015912553062662482
frequencies O 0 0.030488820746541023
in O 0 0.007372236344963312
ataxia B-Disease 1 0.9999990463256836
- I-Disease 1 0.9917895793914795
telangiectasia I-Disease 1 0.9999748468399048
( O 0 0.011020850390195847
A B-Disease 0 0.4985945522785187
- I-Disease 1 0.9570132493972778
T I-Disease 1 0.9998797178268433
) O 0 0.009940838441252708
homozygotes O 1 0.9976770281791687
from O 0 0.003243860090151429
10 O 0 0.0037240926176309586
ethnic O 0 0.007162320427596569
populations O 0 0.03259745612740517
. O 0 0.0072192722000181675

Both O 0 0.017995182424783707
genomic O 1 0.9997767806053162
mutations O 1 0.9999310970306396
and O 0 0.0015887038316577673
their O 0 0.0021800159011036158
effects O 0 0.031759992241859436
on O 0 0.0025041347835212946
cDNA O 1 0.9888918995857239
were O 0 0.00337359681725502
characterized O 0 0.14288756251335144
. O 0 0.007054049521684647

Protein O 1 0.9969340562820435
- O 0 0.05859050899744034
truncation O 1 0.9907562136650085
testing O 0 0.02547924593091011
of O 0 0.0009931292152032256
the O 0 0.0014796961331740022
entire O 0 0.014371206983923912
ATM O 1 0.9890064001083374
cDNA O 1 0.9922000765800476
detected O 1 0.6543615460395813
92 O 0 0.03559894114732742
( O 0 0.005169454496353865
66 O 0 0.02000419795513153
% O 0 0.006487054750323296
) O 0 0.005941480398178101
truncating O 1 0.9984717965126038
mutations O 1 0.9996534585952759
in O 0 0.0034046003129333258
140 O 0 0.025012746453285217
mutant O 1 0.999203622341156
alleles O 1 0.9997275471687317
screened O 0 0.0872998833656311
. O 0 0.008380386047065258

The O 0 0.006866778247058392
haplotyping O 1 0.7881012558937073
of O 0 0.004429053049534559
patients O 1 0.9985862970352173
with O 0 0.004946016240864992
identical O 1 0.9543924927711487
mutations O 1 0.9999933242797852
indicates O 0 0.0144703583791852
that O 0 0.0007614796049892902
almost O 0 0.0010572104947641492
all O 0 0.000393443537177518
of O 0 0.00045869749737903476
these O 0 0.0007466947427019477
represent O 0 0.002550812903791666
common O 0 0.012582494877278805
ancestry O 0 0.15590068697929382
and O 0 0.0008875664207153022
that O 0 0.0009825676679611206
very O 0 0.002297620289027691
few O 0 0.004072442650794983
spontaneously O 1 0.9834589958190918
recurring O 1 0.996820330619812
ATM O 1 0.9992897510528564
mutations O 1 0.9999040365219116
exist O 0 0.011059376411139965
. O 0 0.0055852411314845085

Assays O 1 0.7193429470062256
requiring O 0 0.03853870555758476
minimal O 0 0.02767367474734783
amounts O 0 0.008883765898644924
of O 0 0.002680605510249734
genomic O 1 0.9997190833091736
DNA O 1 0.994945228099823
were O 0 0.0012825271114706993
designed O 0 0.0040443819016218185
to O 0 0.0008706519147381186
allow O 0 0.0052395048551261425
rapid O 0 0.4917992651462555
screening O 0 0.382083922624588
for O 0 0.002083058003336191
common O 0 0.01354577112942934
ethnic O 0 0.015127131715416908
mutations O 1 0.9998928308486938
. O 0 0.009757459163665771

These O 0 0.006373122800141573
rapid O 0 0.07038302719593048
assays O 1 0.9928218722343445
detected O 1 0.9893559813499451
mutations O 1 0.9998950958251953
in O 0 0.0021083131432533264
76 O 0 0.014551200903952122
% O 0 0.0029708361253142357
of O 0 0.0014847400598227978
Costa O 0 0.08493940532207489
Rican O 1 0.8704125881195068
patients O 1 0.9997716546058655
( O 0 0.005437320098280907
3 O 0 0.007755716796964407
) O 0 0.0024019877891987562
, O 0 0.0009447364718653262
50 O 0 0.0020780127961188555
% O 0 0.002416694536805153
of O 0 0.0013096655020490289
Norwegian O 1 0.5175177454948425
patients O 1 0.999913215637207
( O 0 0.004742075223475695
1 O 0 0.005142449866980314
) O 0 0.002222913783043623
, O 0 0.000895109842531383
25 O 0 0.002380088437348604
% O 0 0.0021526990458369255
of O 0 0.0011981436982750893
Polish O 1 0.5171382427215576
patients O 1 0.9999135732650757
( O 0 0.004049462266266346
4 O 0 0.006864792201668024
) O 0 0.0023392976727336645
, O 0 0.0008154402021318674
and O 0 0.0008850737940520048
14 O 0 0.0032249558717012405
% O 0 0.002621039282530546
of O 0 0.0014913836494088173
Italian O 0 0.27851739525794983
patients O 1 0.9998235106468201
( O 0 0.005077218171209097
1 O 0 0.006647240370512009
) O 0 0.0025195791386067867
, O 0 0.0007381551549769938
as O 0 0.0008349052513949573
well O 0 0.0009258041973225772
as O 0 0.0012735429918393493
in O 0 0.0025745374150574207
patients O 1 0.9973793029785156
of O 0 0.002638876438140869
Amish O 1 0.9873355031013489
/ O 1 0.8965345025062561
Mennonite O 1 0.5045741200447083
and O 0 0.002247073221951723
Irish O 0 0.019561147317290306
English O 0 0.006855234038084745
backgrounds O 0 0.01598629169166088
. O 0 0.0063172075897455215

Additional O 0 0.03097558580338955
mutations O 1 0.9993137121200562
were O 0 0.001948250224813819
observed O 0 0.008119460195302963
in O 0 0.0014032110339030623
Japanese O 0 0.004847327712923288
, O 0 0.0019053148571401834
Utah O 0 0.016188597306609154
Mormon O 0 0.029522014781832695
, O 0 0.0016764753963798285
and O 0 0.001637053326703608
African O 0 0.013175122439861298
American O 0 0.013860702514648438
patients O 1 0.999031662940979
. O 0 0.008436762727797031

These O 0 0.0057354760356247425
assays O 0 0.30972734093666077
should O 0 0.0031454558484256268
facilitate O 0 0.020486505702137947
screening O 0 0.15011204779148102
for O 0 0.0029064377304166555
A B-Disease 0 0.2984939515590668
- I-Disease 1 0.9657658934593201
T I-Disease 1 0.9999459981918335
heterozygotes O 1 0.9979220032691956
in O 0 0.002022441243752837
the O 0 0.002137043746188283
populations O 0 0.02671460062265396
studied O 0 0.008178752847015858
. O 0 0.0028893540147691965
. O 0 0.004633876960724592

The O 0 0.01647206023335457
von B-Disease 1 0.9709230065345764
Hippel I-Disease 1 0.9995989203453064
- I-Disease 1 0.9908004403114319
Lindau I-Disease 1 0.9999603033065796
tumor I-Disease 1 0.9999957084655762
suppressor O 1 0.9999812841415405
gene O 1 0.9992536902427673
is O 0 0.0032727504149079323
required O 0 0.0038094855844974518
for O 0 0.0024233574513345957
cell O 1 0.9973880648612976
cycle O 0 0.17317445576190948
exit O 0 0.035382844507694244
upon O 0 0.008745015598833561
serum O 1 0.9991210103034973
withdrawal O 0 0.0751490592956543
. O 0 0.008034574799239635

The O 0 0.007034017704427242
inactivation O 1 0.9746828675270081
of O 0 0.0018525815103203058
the O 0 0.004382212180644274
von B-Disease 1 0.9963994026184082
Hippel I-Disease 1 0.9999016523361206
- I-Disease 1 0.8661341667175293
Lindau I-Disease 1 0.9996638298034668
( I-Disease 0 0.0196983739733696
VHL I-Disease 1 0.999971866607666
) I-Disease 0 0.05104878917336464
tumor I-Disease 1 0.9999982118606567
suppressor O 1 0.999993085861206
gene O 1 0.9999690055847168
predisposes O 1 0.9996386766433716
affected O 0 0.016234589740633965
individuals O 0 0.002309905830770731
to O 0 0.0009723099647089839
the O 0 0.0024826449807733297
human O 1 0.9919803142547607
VHL B-Disease 1 0.9999998807907104
cancer I-Disease 1 1.0
syndrome I-Disease 1 0.9999994039535522
and O 0 0.001692010904662311
is O 0 0.0014378627529367805
associated O 0 0.006692603696137667
with O 0 0.004561012145131826
sporadic B-Disease 1 0.9994656443595886
renal I-Disease 1 0.9999998807907104
cell I-Disease 1 0.9999781847000122
carcinomas I-Disease 1 0.999996542930603
( O 0 0.019752228632569313
RCC B-Disease 1 0.9997856020927429
) O 0 0.008567013777792454
and O 0 0.0059186057187616825
brain B-Disease 1 0.9998102784156799
hemangioblastomas I-Disease 1 0.9828000068664551
. O 0 0.01292886771261692

VHL O 1 0.9991849064826965
- O 0 0.07306969165802002
negative O 0 0.04888204485177994
786 O 1 0.9940729737281799
- O 0 0.06157342344522476
0 O 0 0.12515690922737122
RCC B-Disease 1 0.9998855590820312
cells O 1 0.9974721074104309
are O 0 0.0020919940434396267
tumorigenic O 1 0.9619913697242737
in O 0 0.0028953268192708492
nude O 1 0.9799832701683044
mice O 1 0.99986732006073
which O 0 0.001826131483539939
is O 0 0.0019255317747592926
suppressed O 0 0.02489592507481575
by O 0 0.0022283238358795643
the O 0 0.002485265489667654
reintroduction O 1 0.9800828099250793
of O 0 0.007120909634977579
VHL B-Disease 1 0.9998973608016968
. O 0 0.0129548953846097

Remarkably O 0 0.07956776767969131
, O 0 0.002666026121005416
this O 0 0.002034460660070181
occurs O 0 0.029452595859766006
without O 0 0.003913364373147488
affecting O 0 0.02457401342689991
the O 0 0.0014393191086128354
growth O 0 0.008856568485498428
rate O 0 0.006282193586230278
and O 0 0.0019973875023424625
cell O 1 0.9991793036460876
cycle O 1 0.6425362229347229
profile O 0 0.018556950613856316
of O 0 0.0008857897482812405
these O 0 0.002340358681976795
cells O 1 0.9994094371795654
in O 0 0.0020866175182163715
culture O 0 0.00678690942004323
. O 0 0.005195988807827234

The O 0 0.012627671472728252
786 O 1 0.991787850856781
- O 0 0.04536246880888939
0 O 0 0.04170755296945572
cell O 1 0.9952700734138489
line O 0 0.00635566096752882
, O 0 0.001106601906940341
like O 0 0.0041388277895748615
many O 0 0.006696538534015417
cancer B-Disease 1 0.9999997615814209
cells O 1 0.9998875856399536
, O 0 0.001852700486779213
fails O 0 0.01588660106062889
to O 0 0.0014541521668434143
exit O 0 0.018080951645970345
the O 0 0.0030959786381572485
cell O 1 0.9979725480079651
cycle O 0 0.3616495430469513
upon O 0 0.009920144453644753
serum O 1 0.9991918206214905
withdrawal O 0 0.07362347096204758
. O 0 0.008122384548187256

Here O 0 0.004657350946217775
, O 0 0.0014860094524919987
it O 0 0.0009521889733150601
is O 0 0.0011738647008314729
shown O 0 0.004168692044913769
that O 0 0.001207089750096202
reintroduction O 1 0.6654870510101318
of O 0 0.0011473080376163125
the O 0 0.0019198384834453464
wild O 0 0.05182385817170143
- O 0 0.17651648819446564
type O 1 0.9958128333091736
VHL B-Disease 1 0.9999873638153076
gene O 1 0.9998589754104614
restores O 1 0.5590265393257141
the O 0 0.0020823285449296236
ability O 0 0.009259802289307117
of O 0 0.0038514649495482445
VHL O 1 0.9999873638153076
- O 1 0.5654804110527039
negative O 1 0.962491512298584
RCC B-Disease 1 0.9999827146530151
cancer I-Disease 1 0.9999969005584717
cells O 1 0.997386634349823
to O 0 0.002078101970255375
exit O 0 0.018483487889170647
the O 0 0.0033216429874300957
cell O 1 0.9989075660705566
cycle O 0 0.12522591650485992
and O 0 0.0020065295975655317
enter O 0 0.025079594925045967
G0 O 1 0.999858021736145
/ O 1 0.8974175453186035
quiescence O 1 0.9936863780021667
in O 0 0.005155253689736128
low O 0 0.036383047699928284
serum O 1 0.9979830980300903
. O 0 0.01041374821215868

Both O 0 0.023855293169617653
VHL O 1 0.9999229907989502
- O 0 0.03481266275048256
positive O 0 0.01650664396584034
and O 0 0.005792670417577028
VHL O 1 0.9999809265136719
- O 0 0.11585427820682526
negative O 0 0.12514016032218933
RCC B-Disease 1 0.9996716976165771
cells O 1 0.9979355335235596
exit O 0 0.03098069503903389
the O 0 0.00370539678260684
cell O 1 0.9982654452323914
cycle O 0 0.10789729654788971
by O 0 0.0052115400321781635
contact O 0 0.18682238459587097
inhibition O 1 0.9992631077766418
. O 0 0.009073295630514622

The O 0 0.014275718480348587
cyclin O 1 0.9993076324462891
- O 0 0.06710295379161835
dependent O 0 0.19677969813346863
kinase O 1 0.9999175071716309
inhibitor O 1 0.9997918009757996
, O 0 0.006994691677391529
p27 O 1 0.9995813965797424
, O 0 0.004392880480736494
accumulates O 1 0.9256778359413147
upon O 0 0.010143712162971497
serum O 1 0.9993259906768799
withdrawal O 0 0.07905923575162888
, O 0 0.0011998740956187248
only O 0 0.0007024357910268009
in O 0 0.0006360897095873952
the O 0 0.001107282005250454
presence O 0 0.006234814878553152
of O 0 0.002926571760326624
VHL B-Disease 1 0.9999887943267822
, O 0 0.00183104386087507
as O 0 0.001169405528344214
a O 0 0.003083420917391777
result O 0 0.004587461706250906
of O 0 0.0007091511506587267
the O 0 0.001368763973005116
stabilization O 0 0.02812781371176243
of O 0 0.001278955489397049
the O 0 0.004069024696946144
protein O 1 0.9991663694381714
. O 0 0.008625833317637444

We O 0 0.004332913551479578
propose O 0 0.016673121601343155
that O 0 0.0010771244997158647
the O 0 0.0013887467794120312
loss O 0 0.01328527182340622
of O 0 0.001475179917179048
wild O 0 0.2315860539674759
- O 1 0.5191315412521362
type O 1 0.9985199570655823
VHL B-Disease 1 0.999988317489624
gene O 1 0.9999172687530518
results O 0 0.009544354863464832
in O 0 0.0012070874217897654
a O 0 0.0038816179148852825
specific O 0 0.009739737026393414
cellular O 1 0.9996856451034546
defect O 1 0.9995361566543579
in O 0 0.005524932406842709
serum O 1 0.999872088432312
- O 0 0.031495437026023865
dependent O 0 0.020906560122966766
growth O 0 0.013819492422044277
control O 0 0.011943444609642029
, O 0 0.0011584250023588538
which O 0 0.001476155943237245
may O 0 0.00866288784891367
initiate O 1 0.9973438382148743
tumor B-Disease 1 0.999988317489624
formation O 0 0.2245546132326126
. O 0 0.008564701303839684

This O 0 0.004086130298674107
is O 0 0.0026053390465676785
corrected O 0 0.04125715419650078
by O 0 0.0016764027532190084
the O 0 0.001644439296796918
reintroduction O 1 0.7961872220039368
of O 0 0.002520855749025941
wild O 0 0.08494604378938675
- O 0 0.3835751712322235
type O 1 0.9965446591377258
VHL B-Disease 1 0.9999754428863525
, O 0 0.005260268226265907
implicating O 1 0.9973166584968567
VHL B-Disease 1 0.9998842477798462
as O 0 0.002106906147673726
the O 0 0.001617077854461968
first O 0 0.010251406580209732
tumor B-Disease 1 0.9999990463256836
suppressor O 1 0.9999560117721558
involved O 0 0.0073366425931453705
in O 0 0.0009121611365117133
the O 0 0.0010835169814527035
regulation O 0 0.020438650622963905
of O 0 0.0020930394530296326
cell O 1 0.9997501969337463
cycle O 1 0.9762493371963501
exit O 0 0.2554178535938263
, O 0 0.0012398554245010018
which O 0 0.0007234944496303797
is O 0 0.0010812644613906741
consistent O 0 0.006076151039451361
with O 0 0.0016751702642068267
its O 0 0.003078956389799714
gatekeeper O 1 0.9996155500411987
function O 0 0.02254626154899597
in O 0 0.0020055605564266443
the O 0 0.0056664650328457355
kidney O 1 0.9999970197677612
. O 0 0.004946996923536062
. O 0 0.0053345696069300175

Piebaldism B-Disease 1 0.9901571273803711
with O 0 0.020146429538726807
deafness B-Disease 1 0.9999904632568359
: O 0 0.010830405168235302
molecular O 1 0.9967442750930786
evidence O 0 0.0033413551282137632
for O 0 0.0012838549446314573
an O 0 0.003132918616756797
expanded O 0 0.07000292092561722
syndrome O 1 0.9999933242797852
. O 0 0.012277211993932724

In O 0 0.004010338801890612
a O 0 0.005867351777851582
South O 0 0.003858441486954689
African O 0 0.011044729501008987
girl O 0 0.02374822273850441
of O 0 0.0026966531295329332
Xhosa O 1 0.9983416795730591
stock O 0 0.025430504232645035
with O 0 0.006300888489931822
severe O 1 0.9977917671203613
piebaldism B-Disease 1 0.9969664216041565
and O 0 0.006261737551540136
profound O 1 0.9991549253463745
congenital O 1 1.0
sensorineural B-Disease 1 0.9999970197677612
deafness I-Disease 1 0.9999948740005493
we O 0 0.002959660952910781
identified O 0 0.008764274418354034
a O 0 0.006133689545094967
novel O 0 0.029087761417031288
missense O 1 0.9991160035133362
substitution O 0 0.1872134953737259
at O 0 0.002312467899173498
a O 0 0.00446389801800251
highly O 0 0.009961189702153206
conserved O 0 0.37880489230155945
residue O 0 0.10408759117126465
in O 0 0.0015990615356713533
the O 0 0.003116344101727009
intracellular O 1 0.9997366070747375
kinase O 1 0.9995402097702026
domain O 0 0.018888043239712715
of O 0 0.0009936761343851686
the O 0 0.002899531042203307
KIT O 1 0.9968193769454956
proto O 1 0.9991436004638672
- O 1 0.9219222068786621
oncogene O 1 0.9998698234558105
, O 0 0.010465904138982296
R796G O 1 0.9802080988883972
. O 0 0.009755639359354973

Though O 0 0.021837100386619568
auditory B-Disease 1 0.9965907335281372
anomalies I-Disease 1 0.9877533316612244
have O 0 0.0016168191796168685
been O 0 0.0014433996984735131
observed O 0 0.007394350599497557
in O 0 0.0031538414768874645
mice O 1 0.9998757839202881
with O 0 0.0054963515140116215
dominant O 1 0.6123610138893127
white O 0 0.10487361997365952
spotting O 1 0.9993891716003418
( O 0 0.01056186854839325
W O 1 0.9988253712654114
) O 0 0.0034104457590729
due O 0 0.0037380401045084
to O 0 0.0023227857891470194
KIT O 1 0.9995949864387512
mutations O 1 0.9999946355819702
, O 0 0.008284718729555607
deafness B-Disease 1 0.9999972581863403
is O 0 0.0025804031174629927
not O 0 0.0012669262941926718
typical O 0 0.010943576693534851
in O 0 0.0023793752770870924
human O 0 0.02080860175192356
piebaldism B-Disease 1 0.9967054724693298
. O 0 0.008388441987335682

Thus O 0 0.011704901233315468
, O 0 0.0018720637308433652
the O 0 0.0019128896528854966
occurrence O 0 0.12922632694244385
of O 0 0.005698370281606913
sensorineural B-Disease 1 0.9999961853027344
deafness I-Disease 1 0.9999974966049194
in O 0 0.0038310254458338022
this O 0 0.0036840687971562147
patient O 1 0.9948445558547974
extends O 0 0.01985873654484749
considerably O 0 0.016401056200265884
the O 0 0.0020092977210879326
phenotypic O 1 0.9912290573120117
range O 0 0.0034512642305344343
of O 0 0.0015267460839822888
piebaldism B-Disease 1 0.977982759475708
due O 0 0.005500758066773415
to O 0 0.0026940114330500364
KIT O 1 0.9995402097702026
gene O 1 0.9999810457229614
mutation O 1 0.9999817609786987
in O 0 0.003431848483160138
humans O 0 0.1982077807188034
and O 0 0.0023044124245643616
tightens O 1 0.9987426400184631
the O 0 0.003467228962108493
clinical O 1 0.9991481304168701
similarity O 0 0.30484864115715027
between O 0 0.00392792047932744
piebaldism B-Disease 1 0.9386091232299805
and O 0 0.0008538918336853385
the O 0 0.0007017345633357763
various O 0 0.001333933905698359
forms O 0 0.010676474310457706
of O 0 0.008874052204191685
Waardenburg B-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999991655349731
. O 0 0.006008008029311895
. O 0 0.0068899113684892654

Cycloheximide O 1 0.9571100473403931
facilitates O 0 0.10374625027179718
the O 0 0.0022542569786310196
identification O 0 0.011316762305796146
of O 0 0.0021502464078366756
aberrant O 1 0.9984104633331299
transcripts O 0 0.05019928887486458
resulting O 0 0.023096982389688492
from O 0 0.002490806160494685
a O 0 0.00680225295946002
novel O 0 0.033627912402153015
splice O 1 0.9996546506881714
- O 0 0.029668549075722694
site O 0 0.015156807377934456
mutation O 1 0.9999171495437622
in O 0 0.003854290582239628
COL17A1 O 1 0.9913665652275085
in O 0 0.0028501166962087154
a O 0 0.010645727626979351
patient O 1 0.9964820146560669
with O 0 0.010377617552876472
generalized O 1 0.9994029998779297
atrophic B-Disease 1 0.9999459981918335
benign I-Disease 1 0.9998924732208252
epidermolysis I-Disease 1 0.9999804496765137
bullosa I-Disease 1 0.9998453855514526
. O 0 0.021196274086833

Patients O 1 0.9952170848846436
with O 0 0.01281884778290987
generalized O 1 0.9995599389076233
atrophic B-Disease 1 0.9999793767929077
benign I-Disease 1 0.9999186992645264
epidermolysis I-Disease 1 0.999988317489624
bullosa I-Disease 1 0.999894380569458
often O 0 0.007012492511421442
show O 0 0.005017222836613655
decreased O 0 0.030029602348804474
expression O 0 0.01766417920589447
of O 0 0.00208528945222497
type O 1 0.9937863349914551
XVII O 1 0.99972003698349
collagen O 1 0.9999358654022217
, O 0 0.003521956969052553
a O 0 0.011094456538558006
transmembrane O 1 0.9973053932189941
hemidesmosomal O 1 0.9892529845237732
protein O 1 0.9955553412437439
encoded O 0 0.09549529105424881
by O 0 0.007314596325159073
COL17A1 O 1 0.9740061163902283
. O 0 0.009421645663678646

This O 0 0.002753408392891288
report O 0 0.002283585024997592
documents O 0 0.002628076821565628
a O 0 0.006005411967635155
novel O 0 0.027504481375217438
splice O 1 0.9995912909507751
- O 0 0.02831193059682846
site O 0 0.013290486298501492
mutation O 1 0.9998862743377686
in O 0 0.0038981966208666563
COL17A1 O 1 0.9877231121063232
in O 0 0.0024225227534770966
a O 0 0.009777890518307686
patient O 1 0.9965097308158875
with O 0 0.008748369291424751
generalized O 1 0.9998030066490173
atrophic B-Disease 1 0.999984622001648
benign I-Disease 1 0.9999580383300781
epidermolysis I-Disease 1 0.9999936819076538
bullosa I-Disease 1 0.9999699592590332
, O 0 0.003599263494834304
and O 0 0.0013160462258383632
applies O 0 0.008513085544109344
a O 0 0.0038120937533676624
new O 0 0.002251744270324707
methodology O 0 0.013406194746494293
to O 0 0.0013325358740985394
define O 0 0.009077729657292366
and O 0 0.0013012728886678815
characterize O 0 0.0329895056784153
the O 0 0.0025597820058465004
resulting O 0 0.08430670946836472
mRNA O 1 0.9925284385681152
splice O 1 0.9978616833686829
variants O 1 0.86443030834198
. O 0 0.009809191338717937

Mutational O 1 0.9925980567932129
analysis O 0 0.02355492301285267
of O 0 0.0029528134036809206
COL17A1 O 1 0.9805269241333008
identified O 0 0.015496642328798771
a O 0 0.011106348596513271
maternally O 1 0.9992119073867798
inherited O 1 0.9994213581085205
G O 1 0.9988428354263306
- O 0 0.025951432064175606
to O 0 0.004290299024432898
- O 1 0.6754875779151917
T O 1 0.9997832179069519
transversion O 1 0.9831917881965637
at O 0 0.003399267327040434
the O 0 0.0022652531042695045
- O 0 0.012508573941886425
1 O 0 0.005113743245601654
position O 0 0.002328471513465047
of O 0 0.0019242402631789446
exon O 1 0.9962355494499207
32 O 0 0.02341490611433983
. O 0 0.007412796374410391

This O 0 0.009851236827671528
acceptor O 1 0.9964678287506104
splice O 1 0.999042809009552
- O 0 0.033049385994672775
site O 0 0.014869020320475101
mutation O 1 0.9998723268508911
led O 0 0.004403418395668268
to O 0 0.000750465493183583
the O 0 0.0013849178794771433
formation O 0 0.020920634269714355
of O 0 0.0021916558034718037
aberrant O 1 0.9987882971763611
transcripts O 0 0.035617683082818985
present O 0 0.0031362457666546106
at O 0 0.0030338503420352936
extremely O 0 0.014966249465942383
low O 0 0.01822911947965622
levels O 0 0.02122429944574833
. O 0 0.007105996832251549

Based O 0 0.007311590947210789
on O 0 0.0014064835850149393
our O 0 0.0022989953868091106
recent O 0 0.004398543853312731
finding O 0 0.008781466633081436
that O 0 0.0029120645485818386
cycloheximide O 1 0.9901500940322876
stabilized O 1 0.988044798374176
mutant O 1 0.9987460374832153
COL17A1 O 1 0.9937625527381897
transcripts O 0 0.03869900852441788
in O 0 0.004556083586066961
keratinocytes O 1 0.9977163076400757
homozygous O 1 0.998224675655365
for O 0 0.003541133366525173
a O 0 0.014713329263031483
frameshift O 1 0.999992847442627
mutation O 1 0.999982476234436
, O 0 0.0015069411601871252
the O 0 0.0012332246406003833
effects O 0 0.026011427864432335
of O 0 0.0010142485843971372
the O 0 0.0031374043319374323
splice O 1 0.9998263716697693
- O 0 0.02456148900091648
site O 0 0.010580028407275677
mutation O 1 0.999862551689148
on O 0 0.003327680518850684
splicing O 1 0.9974215030670166
of O 0 0.003378459485247731
COL17A1 O 1 0.9927797913551331
transcripts O 0 0.0251503624022007
were O 0 0.0011321373749524355
determined O 0 0.006567745469510555
using O 0 0.010127590969204903
reverse O 1 0.6449545621871948
transcriptase O 1 0.9996309280395508
polymerase O 1 0.9992214441299438
chain O 1 0.6078599691390991
reaction O 0 0.01875787228345871
of O 0 0.0012804545694962144
total O 0 0.005655047483742237
RNA O 1 0.9994747042655945
from O 0 0.007327060215175152
keratinocytes O 1 0.9971120357513428
incubated O 0 0.47077563405036926
for O 0 0.0034119277261197567
2 O 0 0.00977751612663269
. O 0 0.005434541497379541

5 O 0 0.021117910742759705
h O 0 0.1372068077325821
in O 0 0.0016515306197106838
the O 0 0.0016548114363104105
presence O 0 0.007674199994653463
or O 0 0.003149830736219883
absence O 0 0.012639829888939857
of O 0 0.0016235265647992492
10 O 0 0.008037775754928589
microg O 1 0.9933798313140869
cycloheximide O 1 0.9680503010749817
per O 0 0.012673663906753063
ml O 1 0.9846386313438416
. O 0 0.010522282682359219

Using O 0 0.010267134755849838
this O 0 0.0019435513531789184
approach O 0 0.006901102140545845
, O 0 0.001407069619745016
an O 0 0.003688451834022999
abnormally O 1 0.9991652965545654
spliced O 1 0.9996916055679321
transcript O 1 0.883278489112854
was O 0 0.003219644073396921
identified O 0 0.006385896820574999
that O 0 0.0009734435589052737
contains O 0 0.0028594760224223137
an O 0 0.0013808023650199175
extra O 0 0.008379125967621803
264 O 0 0.04094034060835838
bases O 0 0.012541600503027439
upstream O 0 0.03110714629292488
from O 0 0.00505082868039608
exon O 1 0.9938158988952637
32 O 0 0.014258256182074547
, O 0 0.002108016051352024
resulting O 0 0.021870410069823265
in O 0 0.002351229777559638
a O 0 0.01024687010794878
premature O 1 0.9988019466400146
termination O 1 0.9942477941513062
codon O 1 0.9773585796356201
27 O 0 0.016082527115941048
bp O 0 0.06258730590343475
downstream O 0 0.03802292048931122
from O 0 0.002607378177344799
the O 0 0.004002952016890049
cryptic O 1 0.9933130145072937
splice O 1 0.9974574446678162
site O 0 0.017567763105034828
. O 0 0.008470379747450352

Three O 0 0.005946799647063017
other O 0 0.0034827259369194508
splice O 1 0.9996778964996338
variants O 1 0.9816763401031494
, O 0 0.0016810570377856493
including O 0 0.0017054141499102116
one O 0 0.0013092845911160111
derived O 0 0.009242173284292221
from O 0 0.0012290622107684612
the O 0 0.0013153989566490054
skipping O 1 0.5779365301132202
of O 0 0.0025448459200561047
exon O 1 0.9986347556114197
32 O 0 0.013287009671330452
, O 0 0.0013129457365721464
were O 0 0.0006205615936778486
also O 0 0.0014909293968230486
identified O 0 0.014788122847676277
. O 0 0.005101408343762159

These O 0 0.003723445348441601
results O 0 0.00749730272218585
indicate O 0 0.006285591050982475
the O 0 0.0014609318459406495
usefulness O 0 0.04939062148332596
of O 0 0.002687429077923298
cycloheximide O 1 0.99944669008255
treatment O 1 0.9527426958084106
in O 0 0.0017107746098190546
evaluating O 0 0.020528076216578484
the O 0 0.002696960000321269
abnormal O 1 0.9990761280059814
processing O 0 0.011133083142340183
of O 0 0.0019717952236533165
mRNA O 1 0.9456603527069092
due O 0 0.005463970825076103
to O 0 0.003110217396169901
splice O 1 0.9997301697731018
- O 0 0.05796092376112938
site O 0 0.01740564964711666
mutations O 1 0.999980092048645
, O 0 0.0026787437964230776
because O 0 0.003697729902341962
( O 0 0.003466963768005371
i O 0 0.003684749361127615
) O 0 0.006459253374487162
aberrant O 1 0.9975899457931519
splicing O 1 0.996894359588623
often O 0 0.006386369466781616
generates O 0 0.027147097513079643
a O 0 0.012927673757076263
premature O 1 0.9986855387687683
termination O 1 0.9964864253997803
codon O 1 0.9931232333183289
, O 0 0.0036220417823642492
( O 0 0.005218758713454008
ii O 0 0.015974560752511024
) O 0 0.004037160892039537
transcripts O 0 0.023556794971227646
with O 0 0.0058994656428694725
premature O 1 0.9995624423027039
termination O 1 0.9980424642562866
codons O 1 0.9941627383232117
can O 0 0.004596201702952385
occur O 0 0.012199809774756432
at O 0 0.002129259752109647
low O 0 0.011074808426201344
or O 0 0.005691430997103453
undetectable O 1 0.9987805485725403
levels O 0 0.012224836274981499
due O 0 0.0035942888353019953
to O 0 0.001972947968170047
nonsense O 1 0.530876874923706
- O 0 0.042387448251247406
mediated O 1 0.9969161748886108
mRNA O 1 0.9966074228286743
decay O 1 0.9526617527008057
, O 0 0.0017418954521417618
and O 0 0.0013357792049646378
( O 0 0.0044768135994672775
iii O 1 0.7462635636329651
) O 0 0.0020088311284780502
the O 0 0.0007603470585308969
levels O 0 0.004602077417075634
of O 0 0.0005571399233303964
these O 0 0.0010944444220513105
transcripts O 0 0.024789607152342796
can O 0 0.0020463080145418644
be O 0 0.0008864832925610244
increased O 0 0.006000193301588297
by O 0 0.004338081460446119
cycloheximide O 1 0.9843318462371826
. O 0 0.006678888574242592

A O 0 0.04353716969490051
deletion O 1 0.9995453953742981
mutation O 1 0.9997935891151428
in O 0 0.005630588624626398
COL17A1 O 1 0.9820832014083862
in O 0 0.0021677527111023664
five O 0 0.0032517602667212486
Austrian O 0 0.031143154948949814
families O 0 0.00783269852399826
with O 0 0.007468839641660452
generalized O 1 0.9998008608818054
atrophic B-Disease 1 0.999985933303833
benign I-Disease 1 0.999921441078186
epidermolysis I-Disease 1 0.9999822378158569
bullosa I-Disease 1 0.9998517036437988
represents O 0 0.024164102971553802
propagation O 0 0.04739345982670784
of O 0 0.0013571446761488914
an O 0 0.0028772808145731688
ancestral O 1 0.8913875818252563
allele O 1 0.9993160963058472
. O 0 0.010837673209607601

Patients O 1 0.9967710375785828
with O 0 0.015301596373319626
generalized O 1 0.9996753931045532
atrophic B-Disease 1 0.9999852180480957
benign I-Disease 1 0.9999600648880005
epidermolysis I-Disease 1 0.9999960660934448
bullosa I-Disease 1 0.99996018409729
, O 0 0.00502471998333931
a O 0 0.006167849060148001
usually O 0 0.006335180718451738
nonlethal O 1 0.7113608717918396
form O 0 0.01126057282090187
of O 0 0.005423644557595253
junctional B-Disease 1 0.9999721050262451
epidermolysis I-Disease 1 0.9999881982803345
bullosa I-Disease 1 0.9999371767044067
, O 0 0.004020709544420242
have O 0 0.002816216554492712
generalized O 1 0.9968923926353455
blistering B-Disease 1 0.9871513843536377
, O 0 0.010737268254160881
nail B-Disease 1 0.9999706745147705
dystrophy I-Disease 1 0.9999991655349731
, O 0 0.011334509588778019
patchy B-Disease 1 0.9998443126678467
alopecia I-Disease 1 0.9999942779541016
, O 0 0.005700096487998962
and O 0 0.00614536227658391
dental B-Disease 1 0.9999821186065674
abnormalities I-Disease 1 0.9999715089797974
. O 0 0.013759703375399113

Skin B-Disease 1 0.9999135732650757
fragility I-Disease 1 0.9952359795570374
in O 0 0.0024234058801084757
most O 0 0.001666174503043294
cases O 0 0.0061548324301838875
is O 0 0.0014068217715248466
due O 0 0.0037881105672568083
to O 0 0.002130031818524003
mutations O 1 0.9999171495437622
in O 0 0.0015160085167735815
the O 0 0.002990537555888295
gene O 1 0.9998983144760132
encoding O 1 0.9962045550346375
type O 1 0.9895911812782288
XVII O 1 0.9995036125183105
collagen O 1 0.9999748468399048
( O 0 0.017298610880970955
COL17A1 O 1 0.9969182014465332
) O 0 0.008670528419315815
. O 0 0.005446455907076597

Recently O 0 0.021036826074123383
, O 0 0.002227397635579109
we O 0 0.001213795505464077
reported O 0 0.004717849660664797
five O 0 0.0029334002174437046
Austrian O 0 0.029898609966039658
families O 0 0.007246396504342556
with O 0 0.0069440254010260105
generalized O 1 0.999841570854187
atrophic B-Disease 1 0.9999892711639404
benign I-Disease 1 0.9999698400497437
epidermolysis I-Disease 1 0.9999948740005493
bullosa I-Disease 1 0.999934196472168
who O 0 0.004556221421808004
share O 0 0.005467096343636513
the O 0 0.0018658691551536322
same O 0 0.006685127038508654
COL17A1 O 1 0.999596893787384
mutation O 1 0.9999659061431885
. O 0 0.00928932148963213

Affected O 0 0.03412377089262009
individuals O 0 0.005023506470024586
in O 0 0.0012661187211051583
three O 0 0.0018833659123629332
families O 0 0.004143403843045235
are O 0 0.0016129829455167055
homozygous O 1 0.9997575879096985
for O 0 0.0037724748253822327
4003delTC O 1 0.9988559484481812
, O 0 0.0017052118200808764
whereas O 0 0.006857081316411495
those O 0 0.000899714243132621
in O 0 0.0009262793464586139
two O 0 0.0014804163947701454
others O 0 0.002434330992400646
are O 0 0.0013701629359275103
compound O 0 0.3779950737953186
heterozygotes O 1 0.9977560639381409
. O 0 0.007963818497955799

To O 0 0.0030497636180371046
determine O 0 0.006008394993841648
if O 0 0.0019084912491962314
the O 0 0.0014057228108868003
occurrence O 0 0.07360198348760605
of O 0 0.0016134054167196155
4003delTC O 1 0.9961099028587341
in O 0 0.0017466023564338684
these O 0 0.0017909279558807611
unrelated O 1 0.5111448764801025
families O 0 0.007407871540635824
signifies O 0 0.06017068773508072
propagation O 0 0.04807072877883911
of O 0 0.000887281377799809
an O 0 0.002572378609329462
ancestral O 1 0.6076064109802246
allele O 1 0.9996669292449951
or O 0 0.005649151746183634
a O 0 0.012030543759465218
mutational O 1 0.9997662901878357
hot O 0 0.02623986080288887
spot O 0 0.01748163066804409
, O 0 0.0035216021351516247
haplotypes O 1 0.999433696269989
were O 0 0.0012581474147737026
determined O 0 0.00632795924320817
for O 0 0.002774497726932168
polymorphisms O 1 0.9992803931236267
both O 0 0.0021736014168709517
within O 0 0.00274596712552011
and O 0 0.003031859640032053
flanking O 1 0.9932917356491089
COL17A1 O 1 0.9952919483184814
. O 0 0.011199956759810448

Five O 0 0.021390216425061226
intragenic O 1 0.9899965524673462
polymorphisms O 1 0.9982764720916748
were O 0 0.0013912938302382827
chosen O 0 0.0033298542257398367
based O 0 0.0022176068741828203
on O 0 0.0012332727201282978
their O 0 0.0034124983940273523
informativeness O 1 0.9786167740821838
. O 0 0.010487299412488937

One O 0 0.0030014878138899803
of O 0 0.0009154301369562745
these O 0 0.0010767903877422214
, O 0 0.000897834135685116
not O 0 0.0007965966942720115
previously O 0 0.0025357422418892384
reported O 0 0.00511575024574995
, O 0 0.0010933902813121676
was O 0 0.002256128005683422
2988 O 1 0.9918981790542603
A O 0 0.009934494271874428
or O 0 0.004852531012147665
C O 0 0.2676245868206024
that O 0 0.0015134506393224
introduces O 0 0.02396097593009472
a O 0 0.0035843891091644764
new O 0 0.0027229124680161476
restriction O 0 0.01996230147778988
site O 0 0.005364562850445509
for O 0 0.0034075432922691107
Eco0109 O 1 0.9881376624107361
I O 0 0.009336368180811405
. O 0 0.007420834619551897

All O 0 0.002378008095547557
the O 0 0.0037543862126767635
4003delTC O 1 0.9984416365623474
alleles O 1 0.9987069368362427
showed O 0 0.006331807002425194
the O 0 0.00143427774310112
same O 0 0.004530209582298994
haplotype O 1 0.9997932314872742
for O 0 0.001874868874438107
these O 0 0.0014878883957862854
five O 0 0.007055749651044607
polymorphic O 1 0.9996300935745239
markers O 1 0.9487746357917786
. O 0 0.008154543116688728

Fourteen O 0 0.050296612083911896
microsatellite O 1 0.9993336796760559
polymorphisms O 1 0.9987435936927795
were O 0 0.0012928327778354287
selected O 0 0.002225632546469569
based O 0 0.0017891922034323215
on O 0 0.0007969106081873178
their O 0 0.0015571838011965156
high O 0 0.005735894665122032
heterozygosity O 1 0.9992942810058594
and O 0 0.0009530031238682568
their O 0 0.0011224525514990091
location O 0 0.0038554277271032333
within O 0 0.004546678625047207
10q23 O 1 0.9964330196380615
- O 0 0.048355549573898315
q25 O 1 0.957433819770813
near O 0 0.022930774837732315
COL17A1 O 1 0.9870120882987976
. O 0 0.011575975455343723

Three O 0 0.006344501860439777
families O 0 0.007664735894650221
shared O 0 0.018878091126680374
microsatellite O 1 0.9998595714569092
polymorphisms O 1 0.9996764659881592
covering O 0 0.009419976733624935
at O 0 0.0023658019490540028
most O 0 0.0017969503533095121
19 O 0 0.011069310829043388
cM O 0 0.3004288077354431
, O 0 0.0015976689755916595
whereas O 0 0.0068074543960392475
the O 0 0.0011346807004883885
others O 0 0.0024533465038985014
shared O 0 0.0052881971932947636
smaller O 0 0.007220645900815725
regions O 0 0.005887662526220083
consistent O 0 0.00985534954816103
with O 0 0.0031406511552631855
cross O 0 0.013211464509367943
- O 0 0.010922584682703018
over O 0 0.0018396020168438554
events O 0 0.0027369859162718058
during O 0 0.002037039492279291
passage O 0 0.00522588612511754
of O 0 0.0008815284236334264
this O 0 0.0027117542922496796
mutation O 1 0.9999361038208008
through O 0 0.005245351232588291
several O 0 0.0032121986150741577
generations O 0 0.01931973733007908
. O 0 0.0068028392270207405

These O 0 0.0037604710087180138
results O 0 0.009624684229493141
indicate O 0 0.008759954944252968
that O 0 0.002209459664300084
4003delTC O 1 0.9945031404495239
occurs O 0 0.01972442865371704
on O 0 0.0009721969836391509
a O 0 0.0037271599285304546
single O 0 0.0121265584602952
ancestral O 1 0.8813717365264893
allele O 1 0.9997648596763611
. O 0 0.0045959437265992165
. O 0 0.0056989965960383415

The O 0 0.01258835569024086
haptoglobin O 1 0.9970644116401672
- O 1 0.6962001919746399
gene O 1 0.9997699856758118
deletion O 1 0.9981856942176819
responsible O 0 0.016690010204911232
for O 0 0.004562385380268097
anhaptoglobinemia B-Disease 1 0.9776895642280579
. O 0 0.009720095433294773

We O 0 0.002737665781751275
have O 0 0.0011126905446872115
found O 0 0.0028726605232805014
an O 0 0.0026081993710249662
allelic O 1 0.9987396597862244
deletion O 1 0.9967578053474426
of O 0 0.0017597752157598734
the O 0 0.003053267253562808
haptoglobin O 1 0.9993795156478882
( O 0 0.008037642575800419
Hp O 1 0.9816682934761047
) O 0 0.008069423027336597
gene O 1 0.9997174143791199
from O 0 0.0016252625500783324
an O 0 0.0013922944199293852
individual O 0 0.0048487442545592785
with O 0 0.004896652419120073
anhaptoglobinemia B-Disease 1 0.9884108304977417
. O 0 0.01034034974873066

The O 0 0.010892247781157494
Hp O 1 0.9754518866539001
gene O 1 0.9995098114013672
cluster O 0 0.052568793296813965
consists O 0 0.00456650648266077
of O 0 0.0014751729322597384
coding O 1 0.9959599375724792
regions O 0 0.004747341386973858
of O 0 0.0007546480046585202
the O 0 0.0019208996091037989
alpha O 1 0.7357003092765808
chain O 0 0.35757961869239807
and O 0 0.0021048758644610643
beta O 1 0.9438000321388245
chain O 0 0.03391960263252258
of O 0 0.0010085764806717634
the O 0 0.0038536274805665016
haptoglobin O 1 0.9997852444648743
gene O 1 0.9999288320541382
( O 0 0.00886564701795578
Hp O 1 0.9353033900260925
) O 0 0.0030020412523299456
and O 0 0.0007160385139286518
of O 0 0.0006933691329322755
the O 0 0.0018428100738674402
alpha O 1 0.8296998143196106
chain O 0 0.3671548068523407
and O 0 0.002424800070002675
beta O 1 0.929763674736023
chain O 0 0.030809372663497925
of O 0 0.0008965266752056777
the O 0 0.0025080805644392967
haptoglobin O 1 0.9998284578323364
- O 0 0.14123573899269104
related O 0 0.21487897634506226
gene O 1 0.9999328851699829
( O 0 0.01191087905317545
Hpr O 1 0.999724805355072
) O 0 0.004146062768995762
, O 0 0.0011867382563650608
in O 0 0.00190906529314816
tandem O 1 0.5019427537918091
from O 0 0.002216341206803918
the O 0 0.001772237243130803
5 O 0 0.007121759466826916
side O 0 0.008033380843698978
. O 0 0.006117232609540224

Southern O 0 0.026217278093099594
blot O 1 0.8875677585601807
and O 0 0.0067534479312598705
PCR O 1 0.9991401433944702
analyses O 0 0.027917830273509026
have O 0 0.0014470249880105257
indicated O 0 0.00397164560854435
that O 0 0.0006111576803959906
the O 0 0.0008125748136080801
individual O 0 0.003864998696371913
with O 0 0.0034764856100082397
anhaptoglobinemia B-Disease 1 0.993842363357544
was O 0 0.003943926654756069
homozygous O 1 0.998747706413269
for O 0 0.001885666511952877
the O 0 0.002921922132372856
gene O 1 0.9999645948410034
deletion O 1 0.9990909099578857
and O 0 0.0011417114874348044
that O 0 0.0008565239259041846
the O 0 0.0024185162037611008
gene O 1 0.9999805688858032
deletion O 1 0.9992708563804626
was O 0 0.002408582018688321
included O 0 0.0016189805464819074
at O 0 0.0011416433844715357
least O 0 0.001963549293577671
from O 0 0.0011982446303591132
the O 0 0.0018338722875341773
promoter O 1 0.9396716952323914
region O 0 0.0031983652152121067
of O 0 0.0012535289861261845
Hp O 1 0.7339527010917664
to O 0 0.0042870682664215565
Hpr O 1 0.9995716214179993
alpha O 0 0.44509947299957275
but O 0 0.0017719764728099108
not O 0 0.001062998198904097
to O 0 0.00294681079685688
Hpr O 1 0.9996446371078491
beta O 1 0.9964350461959839
( O 0 0.009637192822992802
Hpdel O 1 0.9936972260475159
) O 0 0.006606508512049913
. O 0 0.0049300906248390675

In O 0 0.005185234360396862
addition O 0 0.005186897236853838
, O 0 0.001284850644879043
we O 0 0.00082109629875049
found O 0 0.002741236472502351
seven O 0 0.002213687403127551
individuals O 0 0.00339940725825727
with O 0 0.0026458343490958214
hypohaptoglobinemia B-Disease 1 0.9910481572151184
in O 0 0.0012668550480157137
three O 0 0.001664161216467619
families O 0 0.003445104928687215
, O 0 0.0008692037663422525
and O 0 0.0006979978643357754
the O 0 0.0017964370781555772
genotypes O 1 0.9997174143791199
of O 0 0.0008077168022282422
six O 0 0.0017061348771676421
of O 0 0.00047120446106418967
the O 0 0.0009226520778611302
seven O 0 0.0019862784538418055
individuals O 0 0.0023834356106817722
were O 0 0.0006297436193563044
found O 0 0.0027625137008726597
to O 0 0.0012981891632080078
be O 0 0.002852178644388914
Hp2 O 1 0.9990878105163574
/ O 1 0.9255210161209106
Hpdel O 1 0.9826923608779907
. O 0 0.009600571356713772

The O 0 0.01288606133311987
phenotypes O 1 0.9993879795074463
and O 0 0.004956232849508524
genotypes O 1 0.9994526505470276
in O 0 0.0016242510173469782
one O 0 0.0008345115929841995
of O 0 0.0004990933230146766
these O 0 0.0007754678372293711
three O 0 0.0014783806400373578
families O 0 0.0036901328712701797
showed O 0 0.004317339044064283
the O 0 0.0013516645412892103
father O 0 0.00420200452208519
to O 0 0.0013692118227481842
be O 0 0.0020472879987210035
hypohaptoglobinemic B-Disease 1 0.9956112504005432
( O 0 0.008224958553910255
Hp2 O 1 0.992976188659668
) O 0 0.004844002891331911
and O 0 0.0027037221007049084
Hp2 O 1 0.9995161294937134
/ O 1 0.9779035449028015
Hpdel O 1 0.9920414090156555
, O 0 0.00154715811368078
the O 0 0.001280511962249875
mother O 0 0.008607625961303711
to O 0 0.0012856813846156001
be O 0 0.0022960214409977198
Hp2 O 1 0.9974485039710999
- O 0 0.024055982008576393
1 O 0 0.006675649434328079
and O 0 0.0035681906156241894
Hp1 O 1 0.9996727705001831
/ O 1 0.9751538634300232
Hp2 O 1 0.9897767305374146
, O 0 0.001501451013609767
one O 0 0.0008174015092663467
of O 0 0.00045493757352232933
the O 0 0.0007167772273533046
two O 0 0.0013960904907435179
children O 0 0.0035091813188046217
to O 0 0.0011660095769912004
be O 0 0.002074736636132002
hypohaptoglobinemic B-Disease 1 0.9974759221076965
( O 0 0.006461165379732847
Hp2 O 1 0.9968575239181519
) O 0 0.0039998735301196575
and O 0 0.002944773295894265
Hp2 O 1 0.999755322933197
/ O 1 0.9872390627861023
Hpdel O 1 0.9943298101425171
, O 0 0.0016684666043147445
and O 0 0.0007150988094508648
the O 0 0.0009376831003464758
other O 0 0.0011852785246446729
child O 0 0.008463295176625252
to O 0 0.0011280972976237535
be O 0 0.0015885229222476482
Hp1 O 1 0.9918376803398132
and O 0 0.0035362406633794308
Hp1 O 1 0.9997445940971375
/ O 1 0.9845825433731079
Hpdel O 1 0.9898961782455444
, O 0 0.0020769452676177025
showing O 0 0.006357382982969284
an O 0 0.0025068901013582945
anomalous O 1 0.9791863560676575
inheritance O 1 0.848353385925293
of O 0 0.002581734210252762
Hp O 1 0.9947832226753235
phenotypes O 1 0.9995287656784058
in O 0 0.0018534016562625766
the O 0 0.0021809712052345276
child O 0 0.032774366438388824
with O 0 0.006933084223419428
Hp1 O 1 0.9935355186462402
. O 0 0.008924347348511219

The O 0 0.014062660746276379
Hp2 O 1 0.9957214593887329
/ O 1 0.9543483257293701
Hpdel O 1 0.9899870753288269
individuals O 0 0.00545922527089715
had O 0 0.0018647414399310946
an O 0 0.0015380115946754813
extremely O 0 0.009096411056816578
low O 0 0.008764240890741348
level O 0 0.0030398170929402113
of O 0 0.0016614143969491124
Hp O 1 0.9153754711151123
( O 0 0.0058986409567296505
mean O 0 0.019033057615160942
+ O 1 0.9956947565078735
/ O 1 0.9227835536003113
- O 0 0.066620372235775
SD O 1 0.9954202175140381
= O 0 0.12221634387969971
0 O 0 0.022223997861146927
. O 0 0.006715849973261356
049 O 1 0.9995026588439941
+ O 1 0.9941021800041199
/ O 1 0.5468329191207886
- O 0 0.023235740140080452
0 O 0 0.024461325258016586
. O 0 0.0067570144310593605
043 O 1 0.9988455772399902
mg O 1 0.9996059536933899
/ O 1 0.990877091884613
ml O 1 0.9967494010925293
; O 0 0.009572862647473812
n O 0 0.15236340463161469
= O 0 0.24791111052036285
6 O 0 0.008331207558512688
) O 0 0.002792556770145893
, O 0 0.0009979502065107226
compared O 0 0.0042505101300776005
with O 0 0.0014972391072660685
the O 0 0.0011074718786403537
level O 0 0.003323401790112257
( O 0 0.002397652016952634
1 O 0 0.004030968993902206
. O 0 0.0018845422891899943
64 O 0 0.02346525527536869
+ O 1 0.9972718358039856
/ O 1 0.7160851955413818
- O 0 0.016410280019044876
1 O 0 0.0060981628485023975
. O 0 0.0031952382996678352
07 O 1 0.9708496332168579
mg O 1 0.999467670917511
/ O 1 0.9923715591430664
ml O 1 0.9967145919799805
) O 0 0.004884548019617796
obtained O 0 0.003893258050084114
from O 0 0.0017842657398432493
52 O 0 0.015176906250417233
healthy O 1 0.5896947979927063
volunteers O 0 0.018797283992171288
having O 0 0.013107768259942532
phenotype O 1 0.9999817609786987
Hp2 O 1 0.9972174167633057
, O 0 0.0020049279555678368
whereas O 0 0.008608716540038586
the O 0 0.0032121024560183287
serum O 1 0.9998025298118591
Hp O 1 0.8040533065795898
level O 0 0.002775288186967373
of O 0 0.0005255412543192506
an O 0 0.001092161750420928
individual O 0 0.0038594603538513184
with O 0 0.005292738787829876
Hp1 O 1 0.9998564720153809
/ O 1 0.9872984290122986
Hpdel O 1 0.9944380521774292
was O 0 0.004282856360077858
0 O 0 0.021907653659582138
. O 0 0.006472213193774223

50 O 0 0.030599037185311317
mg O 1 0.9992539286613464
/ O 1 0.9944633841514587
ml O 1 0.9977912902832031
, O 0 0.0021961755119264126
which O 0 0.0010665769223123789
was O 0 0.0010732990922406316
approximately O 0 0.002104860730469227
half O 0 0.002106518018990755
the O 0 0.0008006746647879481
level O 0 0.002436533337458968
of O 0 0.0012561811599880457
Hp O 1 0.863842248916626
in O 0 0.0024159473832696676
control O 0 0.015624918974936008
sera O 0 0.11871065944433212
from O 0 0.002140720607712865
the O 0 0.0033957248087972403
Hp1 O 1 0.9997829794883728
phenotype O 1 0.9999886751174927
( O 0 0.0050319102592766285
1 O 0 0.005127220414578915
. O 0 0.0020466360729187727
26 O 0 0.01280889566987753
+ O 1 0.9968008995056152
/ O 1 0.8609617948532104
- O 0 0.020980650559067726
0 O 0 0.018121596425771713
. O 0 0.0029375662561506033
33 O 0 0.02287641540169716
mg O 1 0.9994282126426697
/ O 1 0.9854387044906616
ml O 1 0.9978461265563965
; O 0 0.008449297398328781
n O 0 0.18153522908687592
= O 0 0.24652089178562164
9 O 0 0.00859847106039524
) O 0 0.002210285048931837
, O 0 0.0009609656990505755
showing O 0 0.007925139740109444
a O 0 0.018499154597520828
gene O 1 0.9999474287033081
- O 0 0.47359904646873474
dosage O 1 0.9955171942710876
effect O 0 0.02738005854189396
. O 0 0.007442906964570284

The O 0 0.004495483357459307
other O 0 0.006116531323641539
allele O 1 0.999777615070343
( O 0 0.009441666305065155
Hp2 O 1 0.9932570457458496
) O 0 0.002344573149457574
of O 0 0.0007328888168558478
individuals O 0 0.0036792252212762833
with O 0 0.004763208795338869
Hp2 O 1 0.9998425245285034
/ O 1 0.9909493327140808
Hpdel O 1 0.997883141040802
was O 0 0.0019879955798387527
found O 0 0.0026711924001574516
to O 0 0.000676019350066781
have O 0 0.000746630656067282
, O 0 0.0006409079651348293
in O 0 0.0007189184543676674
all O 0 0.0011067725718021393
exons O 1 0.9988237023353577
, O 0 0.002279028994962573
no O 0 0.00489919725805521
mutation O 1 0.9999624490737915
, O 0 0.0020516766235232353
by O 0 0.004855721723288298
DNA O 1 0.9991549253463745
sequencing O 1 0.9910956621170044
. O 0 0.008874110877513885

On O 0 0.0024350499734282494
the O 0 0.0010475089075043797
basis O 0 0.0018066002521663904
of O 0 0.0004881899803876877
the O 0 0.0008719420875422657
present O 0 0.00227803410962224
study O 0 0.004718801472336054
, O 0 0.0008143360028043389
the O 0 0.001063237781636417
mechanism O 0 0.10355029255151749
of O 0 0.0014055235078558326
anhaptoglobinemia B-Disease 1 0.9936512112617493
and O 0 0.0008142494480125606
the O 0 0.001029511564411223
mechanism O 0 0.12841778993606567
of O 0 0.0012203737860545516
anomalous O 1 0.9970477223396301
inheritance O 1 0.9666780829429626
of O 0 0.0029379476327449083
Hp O 1 0.9982593655586243
phenotypes O 1 0.9996943473815918
were O 0 0.001325972960330546
well O 0 0.002507217926904559
explained O 0 0.013546542264521122
. O 0 0.00555705651640892

However O 0 0.00567850936204195
, O 0 0.0013910353882238269
the O 0 0.0015301461098715663
mechanism O 0 0.04144725948572159
of O 0 0.0025458205491304398
hypohaptoglobinemia B-Disease 1 0.9849774837493896
remains O 0 0.015345514751970768
unknown O 0 0.0329727865755558

ATM O 1 0.9890433549880981
mutations O 1 0.9996671676635742
and O 0 0.007106689270585775
phenotypes O 1 0.9997617602348328
in O 0 0.015252860262989998
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9935930371284485
telangiectasia I-Disease 1 0.9999716281890869
families O 0 0.00800580345094204
in O 0 0.0012909153010696173
the O 0 0.0015179963083937764
British O 0 0.006854257546365261
Isles O 0 0.07191883772611618
: O 0 0.0031381233129650354
expression O 0 0.012347200885415077
of O 0 0.0019272390054538846
mutant O 1 0.999693751335144
ATM O 1 0.9734110236167908
and O 0 0.0012564611388370395
the O 0 0.001852363464422524
risk O 1 0.9909588098526001
of O 0 0.0073966677300632
leukemia B-Disease 1 0.9999998807907104
, O 0 0.24266885221004486
lymphoma B-Disease 1 0.9999998807907104
, O 0 0.007811380084604025
and O 0 0.022487126290798187
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999923706054688
. O 0 0.012329548597335815

We O 0 0.002873119432479143
report O 0 0.0019938291516155005
the O 0 0.0011839534854516387
spectrum O 0 0.01654367707669735
of O 0 0.0013161866227164865
59 O 0 0.03145388141274452
ATM O 1 0.9989080429077148
mutations O 1 0.9999434947967529
observed O 0 0.01727120950818062
in O 0 0.007266717962920666
ataxia B-Disease 1 0.9999994039535522
- I-Disease 1 0.9842914342880249
telangiectasia I-Disease 1 0.999976634979248
( O 0 0.009225376881659031
A B-Disease 1 0.9091132283210754
- I-Disease 1 0.9967228770256042
T I-Disease 1 0.9999762773513794
) O 0 0.011584392748773098
patients O 1 0.9986334443092346
in O 0 0.0015293360920622945
the O 0 0.001598785980604589
British O 0 0.009165659546852112
Isles O 0 0.07020673155784607
. O 0 0.008539855480194092

Of O 0 0.005050972569733858
51 O 0 0.04362253472208977
ATM O 1 0.9988202452659607
mutations O 1 0.9999035596847534
identified O 0 0.0128044243901968
in O 0 0.001247419510036707
families O 0 0.003720872336998582
native O 0 0.0021564755588769913
to O 0 0.0006759801181033254
the O 0 0.001198425074107945
British O 0 0.006968403235077858
Isles O 0 0.03194211795926094
, O 0 0.0014076761435717344
11 O 0 0.0030369097366929054
were O 0 0.0011631399393081665
founder O 1 0.7689517140388489
mutations O 1 0.9999881982803345
, O 0 0.0017091173212975264
and O 0 0.0006804674048908055
2 O 0 0.0028206377755850554
of O 0 0.0005872751353308558
these O 0 0.0008957341779023409
11 O 0 0.0037116899620741606
conferred O 0 0.014988387003540993
a O 0 0.009927031584084034
milder O 1 0.9992629885673523
clinical O 1 0.9999593496322632
phenotype O 1 0.9999858140945435
with O 0 0.002696236362680793
respect O 0 0.002069806447252631
to O 0 0.0016294345259666443
both O 0 0.006146254483610392
cerebellar B-Disease 1 0.9999946355819702
degeneration I-Disease 1 0.9999982118606567
and O 0 0.005721854977309704
cellular O 1 0.9986017346382141
features O 0 0.013909903354942799
. O 0 0.006661382503807545

We O 0 0.0024482845328748226
report O 0 0.0019667905289679766
, O 0 0.0008027667645365
in O 0 0.000821626977995038
two O 0 0.0023844330571591854
A B-Disease 0 0.40457895398139954
- I-Disease 1 0.8761841654777527
T I-Disease 1 0.9997338652610779
families O 0 0.005187079310417175
, O 0 0.0013005342334508896
an O 0 0.0032546562142670155
ATM O 1 0.9992018342018127
mutation O 1 0.9999411106109619
( O 0 0.007562711369246244
7271T O 1 0.9985878467559814
- O 1 0.7417085766792297
- O 1 0.8911986947059631
> O 1 0.9996981620788574
G O 1 0.9989702701568604
) O 0 0.003618424292653799
that O 0 0.0012022043811157346
may O 0 0.0025198617950081825
be O 0 0.0008444419363513589
associated O 0 0.004105499945580959
with O 0 0.0012143023777753115
an O 0 0.0013375148409977555
increased O 0 0.010221501812338829
risk O 1 0.9962775111198425
of O 0 0.007661645766347647
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999997615814209
in O 0 0.002637634053826332
both O 0 0.0033947695046663284
homozygotes O 1 0.9998605251312256
and O 0 0.004013191442936659
heterozygotes O 1 0.9992156028747559
( O 0 0.004816931672394276
relative O 0 0.020710162818431854
risk O 1 0.979442298412323
12 O 0 0.005010688677430153
. O 0 0.0018639358459040523
7 O 0 0.008739887736737728
; O 0 0.007073590997606516
P O 1 0.9938116073608398
= O 1 0.5855731964111328
. O 0 0.006212098058313131
0025 O 1 0.9997872710227966
) O 0 0.004452229477465153
, O 0 0.001212077448144555
although O 0 0.0013547511771321297
there O 0 0.0005998393753543496
is O 0 0.0008808390120975673
a O 0 0.003399081062525511
less O 0 0.00517851859331131
severe O 1 0.9990026354789734
A B-Disease 1 0.8779137134552002
- I-Disease 1 0.995585560798645
T I-Disease 1 0.999988317489624
phenotype O 1 0.9999673366546631
in O 0 0.001859543495811522
terms O 0 0.0012414732482284307
of O 0 0.0005075773224234581
the O 0 0.0011755963787436485
degree O 0 0.008073871023952961
of O 0 0.00470359530299902
cerebellar B-Disease 1 0.9999943971633911
degeneration I-Disease 1 0.9999891519546509
. O 0 0.013476183637976646

This O 0 0.012879573740065098
mutation O 1 0.9998327493667603
( O 0 0.013934727758169174
7271T O 1 0.9985949397087097
- O 1 0.7172764539718628
- O 1 0.9011024832725525
> O 1 0.9995402097702026
G O 1 0.9974321722984314
) O 0 0.003107018070295453
also O 0 0.0011372128501534462
allows O 0 0.005995604675263166
expression O 0 0.012590804137289524
of O 0 0.0009867290500551462
full O 0 0.005086830351501703
- O 0 0.018139280378818512
length O 0 0.026912054046988487
ATM O 1 0.9974722266197205
protein O 1 0.9969128370285034
at O 0 0.002812457736581564
a O 0 0.003829273162409663
level O 0 0.0035697477869689465
comparable O 0 0.010459843091666698
with O 0 0.0015922262100502849
that O 0 0.001118026557378471
in O 0 0.002525941003113985
unaffected O 1 0.9825701117515564
individuals O 0 0.009075361303985119
. O 0 0.005664477590471506

In O 0 0.004328044597059488
addition O 0 0.004318686202168465
, O 0 0.0010044219670817256
we O 0 0.0005905657890252769
have O 0 0.0005677124136127532
studied O 0 0.003533711191266775
18 O 0 0.005397893488407135
A B-Disease 1 0.8816074132919312
- I-Disease 1 0.9987109899520874
T I-Disease 1 0.9999980926513672
patients O 1 0.999812662601471
, O 0 0.001521396916359663
in O 0 0.0011619525030255318
15 O 0 0.0037171198055148125
families O 0 0.004169398918747902
, O 0 0.001524301478639245
who O 0 0.003667681012302637
developed O 1 0.9981581568717957
leukemia B-Disease 1 0.9999998807907104
, O 0 0.028665510937571526
lymphoma B-Disease 1 0.9999998807907104
, O 0 0.006442642770707607
preleukemic O 1 0.9996243715286255
T O 1 0.9999456405639648
- O 1 0.872465193271637
cell O 1 0.9997003078460693
proliferation O 1 0.9930732846260071
, O 0 0.004641938488930464
or O 1 0.7940534949302673
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 0.9999998807907104
, O 0 0.0032623426523059607
mostly O 0 0.0023203117307275534
in O 0 0.0029552376363426447
childhood O 1 0.9129624962806702
. O 0 0.00764040881767869

A O 0 0.01584489829838276
wide O 0 0.00971467699855566
variety O 0 0.005472359247505665
of O 0 0.002603701548650861
ATM O 1 0.9994180202484131
mutation O 1 0.999961256980896
types O 0 0.016895433887839317
, O 0 0.0016283767763525248
including O 0 0.0048843068070709705
missense O 1 0.9999774694442749
mutations O 1 0.9999767541885376
and O 0 0.0017772652208805084
in O 0 0.0018777159275487065
- O 0 0.02171787992119789
frame O 0 0.21711990237236023
deletions O 1 0.9993311166763306
, O 0 0.001781737431883812
were O 0 0.0006408508634194732
seen O 0 0.0034893250558525324
in O 0 0.001713327132165432
these O 0 0.0035820568446069956
patients O 1 0.9991382360458374
. O 0 0.006409700959920883

We O 0 0.0030811848118901253
also O 0 0.0012598298490047455
show O 0 0.001970769604668021
that O 0 0.0008733535069040954
25 O 0 0.0023008619900792837
% O 0 0.0018482641316950321
of O 0 0.0006514320848509669
all O 0 0.0012299434747546911
A B-Disease 1 0.768397867679596
- I-Disease 1 0.9982341527938843
T I-Disease 1 0.9999903440475464
patients O 1 0.9993487000465393
carried O 0 0.0063035436905920506
in O 0 0.0018646136159077287
- O 0 0.015456237830221653
frame O 0 0.04334605112671852
deletions O 1 0.9976866245269775
or O 0 0.012748596258461475
missense O 1 0.9999823570251465
mutations O 1 0.999983549118042
, O 0 0.0013234956422820687
many O 0 0.0005199363804422319
of O 0 0.00043566670501604676
which O 0 0.0005694786086678505
were O 0 0.0004956700722686946
also O 0 0.001013286178931594
associated O 0 0.00511314207687974
with O 0 0.002072366653010249
expression O 0 0.01671639457345009
of O 0 0.0025020071770995855
mutant O 1 0.9996517896652222
ATM O 1 0.9970108270645142
protein O 1 0.9976418018341064
. O 0 0.008987718261778355

The O 0 0.009419464506208897
DMPK O 1 0.9974452257156372
gene O 1 0.9989044666290283
of O 0 0.004299395717680454
severely O 1 0.9958609938621521
affected O 1 0.9970837235450745
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999998807907104
patients O 1 0.9998445510864258
is O 0 0.008088414557278156
hypermethylated O 1 0.996167004108429
proximal O 1 0.999077320098877
to O 0 0.0016279804985970259
the O 0 0.0013569159200415015
largely O 0 0.004880489315837622
expanded O 0 0.015152599662542343
CTG O 1 0.9975454211235046
repeat O 0 0.30328163504600525
. O 0 0.009822692722082138

Using O 0 0.02938814088702202
methylation O 1 0.9924728870391846
- O 0 0.026434753090143204
sensitive O 0 0.020829951390624046
restriction O 0 0.10242808610200882
enzymes O 1 0.9952530860900879
, O 0 0.001791470916941762
we O 0 0.0010501292999833822
characterized O 0 0.01917651854455471
the O 0 0.002612799173220992
methylation O 1 0.9987326264381409
pattern O 0 0.049806881695985794
on O 0 0.0011851928429678082
the O 0 0.0014478637604042888
5 O 0 0.003977557644248009
side O 0 0.002154861344024539
of O 0 0.0006569824181497097
the O 0 0.0023670087102800608
CTG O 1 0.9982995390892029
repeat O 0 0.10962432622909546
in O 0 0.0016832702094689012
the O 0 0.0025384919717907906
DMPK O 1 0.9998121857643127
gene O 1 0.999607264995575
of O 0 0.0018539149314165115
normal O 0 0.018133260309696198
individuals O 0 0.003163306275382638
and O 0 0.0011332891881465912
of O 0 0.0021339240483939648
patients O 1 0.9998514652252197
affected O 0 0.19713197648525238
with O 0 0.1209205910563469
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999983310699463
, O 0 0.003922369331121445
showing O 0 0.009646781720221043
expansions O 0 0.030961204320192337
of O 0 0.0012062420137226582
the O 0 0.0032179690897464752
repetitive O 1 0.9981278777122498
sequence O 0 0.2218473255634308
. O 0 0.008064772933721542

The O 0 0.011909992434084415
gene O 1 0.998498797416687
segment O 0 0.0408547967672348
analyzed O 0 0.020435312762856483
corresponds O 0 0.011003254912793636
to O 0 0.001439377898350358
the O 0 0.0032879842910915613
genomic O 1 0.9997788071632385
SacI O 1 0.9963436722755432
- O 0 0.050118278712034225
HindIII O 1 0.957480251789093
fragment O 0 0.2184988260269165
carrying O 0 0.0212846789509058
exons O 1 0.9888926148414612
11 O 0 0.015832925215363503
- O 0 0.020631203427910805
15 O 0 0.011129552498459816
. O 0 0.007688051089644432

There O 0 0.0034713237546384335
is O 0 0.0033796161878854036
constitutive O 1 0.9694311618804932
methylation O 1 0.9858442544937134
in O 0 0.007269729860126972
intron O 1 0.9995613694190979
12 O 0 0.008590572513639927
at O 0 0.0026968251913785934
restriction O 0 0.01436787098646164
sites O 0 0.0031343542505055666
of O 0 0.0015994360437616706
SacII O 1 0.9912347793579102
and O 0 0.0031317202374339104
HhaI O 1 0.9954214692115784
, O 0 0.004404083359986544
localized O 1 0.997996985912323
1 O 0 0.006933402735739946
, O 0 0.0029852448496967554
159 O 0 0.24109028279781342
- O 0 0.020451638847589493
1 O 0 0.006649945396929979
, O 0 0.0024151592515408993
232 O 0 0.04175426438450813
bp O 0 0.05379920452833176
upstream O 0 0.025205636397004128
of O 0 0.001217484474182129
the O 0 0.0025822350289672613
CTG O 1 0.9997283816337585
repeat O 1 0.8305360674858093
, O 0 0.0017554472433403134
whereas O 0 0.009104792028665543
most O 0 0.0011525409063324332
, O 0 0.0009362400160171092
if O 0 0.0013212759513407946
not O 0 0.0005409141886048019
all O 0 0.0003978139429818839
, O 0 0.0005028775776736438
of O 0 0.00041160083492286503
the O 0 0.0007061874493956566
other O 0 0.0008349900017492473
sites O 0 0.0023815492168068886
of O 0 0.001646917313337326
SacII O 1 0.9981173276901245
, O 0 0.003528194734826684
HhaI O 1 0.9981536269187927
, O 0 0.0018596939044073224
and O 0 0.001668700366280973
HpaII O 1 0.9917830228805542
in O 0 0.0014208549400791526
this O 0 0.0010174394119530916
region O 0 0.0022145439870655537
are O 0 0.0013307799817994237
unmethylated O 1 0.9996336698532104
, O 0 0.0015123843913897872
in O 0 0.0016726258909329772
normal O 0 0.029385758563876152
individuals O 0 0.0033943464513868093
and O 0 0.0006020653527230024
most O 0 0.0006632761214859784
of O 0 0.0009158189059235156
the O 0 0.003959482070058584
patients O 1 0.999824583530426
. O 0 0.0073178960010409355

In O 0 0.0037831293884664774
a O 0 0.003391820006072521
number O 0 0.0011572868097573519
of O 0 0.0011158058186993003
young O 0 0.007647270802408457
and O 0 0.003131234785541892
severely O 1 0.9980071187019348
affected O 1 0.9759918451309204
patients O 1 0.9999074935913086
, O 0 0.0018480205908417702
however O 0 0.0015938476426526904
, O 0 0.001078789122402668
complete O 0 0.009575512260198593
methylation O 1 0.9958836436271667
of O 0 0.0008857744978740811
these O 0 0.0008796234033070505
restriction O 0 0.013260558247566223
sites O 0 0.0028088504914194345
was O 0 0.0011389923747628927
found O 0 0.0032115972135215998
in O 0 0.0014106029411777854
the O 0 0.004243291448801756
mutated O 1 0.9999477863311768
allele O 1 0.9990867376327515
. O 0 0.011911103501915932

In O 0 0.0026319921016693115
most O 0 0.0008860859670676291
of O 0 0.0008410584414377809
these O 0 0.0022997402120381594
patients O 1 0.999822199344635
, O 0 0.0013027169043198228
the O 0 0.0018107598880305886
onset O 1 0.9998328685760498
of O 0 0.0018084144685417414
the O 0 0.005835377611219883
disease O 1 0.9999978542327881
was O 0 0.028164980933070183
congenital O 1 0.9999986886978149
. O 0 0.010862820781767368

Preliminary O 0 0.025176292285323143
in O 0 0.006319213192909956
vivo O 1 0.998779833316803
footprinting O 1 0.9989148378372192
data O 0 0.006705016363412142
gave O 0 0.0030258549377322197
evidence O 0 0.002746831625699997
for O 0 0.0027462244033813477
protein O 1 0.999789297580719
- O 0 0.3025045692920685
DNA O 1 0.9994267225265503
contact O 0 0.01923452876508236
in O 0 0.0025520503986626863
normal O 0 0.09767647832632065
genes O 1 0.9974840879440308
at O 0 0.0031020010355859995
an O 0 0.0032168528996407986
Sp1 O 1 0.9994937181472778
consensus O 0 0.012122088111937046
binding O 0 0.0207911878824234
site O 0 0.0035651063080877066
upstream O 0 0.01622837781906128
of O 0 0.0009914827533066273
the O 0 0.003003783291205764
CTG O 1 0.9993559718132019
repeat O 0 0.33691245317459106
and O 0 0.0011477782391011715
for O 0 0.0009842260042205453
a O 0 0.0026660733856260777
significant O 0 0.004685437306761742
reduction O 0 0.01196043286472559
of O 0 0.000598092214204371
this O 0 0.0010692604118958116
interaction O 0 0.02199261635541916
in O 0 0.002184399403631687
cells O 1 0.9990725517272949
with O 0 0.002474891720339656
a O 0 0.009036345407366753
hypermethylated O 1 0.9989194869995117
DMPK O 1 0.9996259212493896
gene O 1 0.9997859597206116
. O 0 0.005350351333618164
. O 0 0.00547292223200202

The O 0 0.01871868036687374
hemochromatosis B-Disease 1 0.9999839067459106
gene O 1 0.9996154308319092
product O 0 0.022208115085959435
complexes O 0 0.049171727150678635
with O 0 0.002362713683396578
the O 0 0.0032695138361305
transferrin O 1 0.9994199275970459
receptor O 1 0.9974798560142517
and O 0 0.003848410677164793
lowers O 1 0.9526812434196472
its O 0 0.0045457873493433
affinity O 1 0.5794267058372498
for O 0 0.004827290773391724
ligand O 1 0.99769526720047
binding O 0 0.06040571630001068
. O 0 0.007044273428618908

We O 0 0.00386229925788939
recently O 0 0.0077294097281992435
reported O 0 0.006277590058743954
the O 0 0.002454147208482027
positional O 1 0.9857364296913147
cloning O 1 0.8505014181137085
of O 0 0.001186229637823999
a O 0 0.005510519724339247
candidate O 0 0.02164536342024803
gene O 1 0.9997676014900208
for O 0 0.011181487701833248
hereditary B-Disease 1 0.9999641180038452
hemochromatosis I-Disease 1 0.9999953508377075
called O 0 0.06299500167369843
HFE O 1 0.9988293051719666
. O 0 0.016121400520205498

The O 0 0.011343881487846375
gene O 1 0.9998323917388916
product O 0 0.012668056413531303
, O 0 0.001349276746623218
a O 0 0.002520256442949176
member O 0 0.0013848975067958236
of O 0 0.0004816509026568383
the O 0 0.0013503270456567407
major O 0 0.012762684375047684
histocompatibility O 1 0.9999589920043945
complex O 0 0.023623621091246605
class O 0 0.017510367557406425
I O 0 0.009113838896155357
- O 0 0.02072622813284397
like O 0 0.006300625391304493
family O 0 0.009208492003381252
, O 0 0.0011981562711298466
was O 0 0.0009953646222129464
found O 0 0.0020580580458045006
to O 0 0.0007490861462429166
have O 0 0.0011533040087670088
a O 0 0.008561596274375916
mutation O 1 0.9999480247497559
, O 0 0.007220236584544182
Cys O 1 0.9997974038124084
- O 0 0.09191092848777771
282 O 1 0.9847420454025269
- O 1 0.5917062163352966
- O 1 0.5128155946731567
> O 1 0.99863201379776
Tyr O 1 0.9994227886199951
( O 0 0.010738028213381767
C282Y O 1 0.9972547888755798
) O 0 0.003786383895203471
, O 0 0.0010879251640290022
in O 0 0.0011322853388264775
85 O 0 0.009246636182069778
% O 0 0.004083345178514719
of O 0 0.0028757324907928705
patient O 1 0.9996384382247925
chromosomes O 1 0.9987233281135559
. O 0 0.00849513802677393

This O 0 0.008433276787400246
mutation O 1 0.9998077750205994
eliminates O 0 0.18797118961811066
the O 0 0.0020338527392596006
ability O 0 0.008574736304581165
of O 0 0.002512850798666477
HFE O 1 0.9998828172683716
to O 0 0.0029672463424503803
associate O 0 0.011000453494489193
with O 0 0.004772191401571035
beta2 O 1 0.9980238676071167
- O 0 0.1484554260969162
microglobulin O 1 0.9950811862945557
( O 0 0.008063890971243382
beta2m O 1 0.9939175248146057
) O 0 0.0036859542597085238
and O 0 0.0033865468576550484
prevents O 1 0.9994402527809143
cell O 1 0.9995855689048767
- O 0 0.02621883898973465
surface O 0 0.022398464381694794
expression O 0 0.04733717441558838
. O 0 0.00813339464366436

A O 0 0.01740422286093235
second O 0 0.013758448883891106
mutation O 1 0.9999656677246094
that O 0 0.00150324497371912
has O 0 0.0012019277783110738
no O 0 0.001883185119368136
effect O 0 0.008074883371591568
on O 0 0.0022239158861339092
beta2m O 1 0.9971062541007996
association O 0 0.010959968902170658
, O 0 0.003196098143234849
H63D O 1 0.9993663430213928
, O 0 0.002063583116978407
was O 0 0.0016771936789155006
found O 0 0.0028266150038689375
in O 0 0.0009543398045934737
eight O 0 0.001721985754556954
out O 0 0.001320608309470117
of O 0 0.0010173260234296322
nine O 0 0.008939187973737717
patients O 1 0.9999020099639893
heterozygous O 1 0.9989222288131714
for O 0 0.002201155060902238
the O 0 0.0032991322223097086
C282Y O 1 0.9981297850608826
mutant O 1 0.9975314140319824
. O 0 0.011141480877995491

In O 0 0.0042052422650158405
this O 0 0.0015806088922545314
report O 0 0.0023744339123368263
, O 0 0.000826746691018343
we O 0 0.0007760714506730437
demonstrate O 0 0.0059874942526221275
in O 0 0.0025165861006826162
cultured O 1 0.9855493903160095
293 O 1 0.988098680973053
cells O 1 0.9995525479316711
overexpressing O 1 0.9995455145835876
wild O 0 0.06866951286792755
- O 0 0.028148312121629715
type O 0 0.06022776663303375
or O 0 0.007829130627214909
mutant O 1 0.999806821346283
HFE O 1 0.9999145269393921
proteins O 1 0.9876497387886047
that O 0 0.0010445481166243553
both O 0 0.0008623834000900388
the O 0 0.0011656403075903654
wild O 0 0.09057126194238663
- O 0 0.04007119685411453
type O 0 0.22334925830364227
and O 0 0.00336461141705513
H63D O 1 0.999197781085968
HFE O 1 0.9997943043708801
proteins O 1 0.988422691822052
form O 0 0.012430403381586075
stable O 0 0.11719553917646408
complexes O 0 0.04672645404934883
with O 0 0.002139628864824772
the O 0 0.003366985125467181
transferrin O 1 0.9995729327201843
receptor O 1 0.9995132684707642
( O 0 0.01386589091271162
TfR O 1 0.999036431312561
) O 0 0.008190613240003586
. O 0 0.006125146988779306

The O 0 0.011366038583219051
C282Y O 1 0.9892779588699341
mutation O 1 0.9995672106742859
nearly O 0 0.0093203354626894
completely O 0 0.014197209849953651
prevents O 0 0.3998578190803528
the O 0 0.001406744820997119
association O 0 0.0031037500593811274
of O 0 0.000951076508499682
the O 0 0.0028455278370529413
mutant O 1 0.9996758699417114
HFE O 1 0.9999250173568726
protein O 1 0.9982851147651672
with O 0 0.004921272862702608
the O 0 0.0048279110342264175
TfR O 1 0.9974918365478516
. O 0 0.008295794948935509

Studies O 0 0.020798128098249435
on O 0 0.004880385007709265
cell O 1 0.9994298815727234
- O 0 0.037038952112197876
associated O 0 0.02016371861100197
transferrin O 1 0.99752277135849
at O 0 0.0040825773030519485
37 O 0 0.014351125806570053
degrees O 0 0.009621186181902885
C O 0 0.12133292108774185
suggest O 0 0.005358193069696426
that O 0 0.0008730078116059303
the O 0 0.002106542233377695
overexpressed O 1 0.9998010993003845
wild O 0 0.07806539535522461
- O 0 0.08298178017139435
type O 1 0.9762691259384155
HFE O 1 0.9998383522033691
protein O 1 0.9976498484611511
decreases O 0 0.043854087591171265
the O 0 0.0018698839703574777
affinity O 0 0.04829249531030655
of O 0 0.0010777013376355171
the O 0 0.002551623387262225
TfR O 1 0.9990081191062927
for O 0 0.00643541244789958
transferrin O 1 0.9976771473884583
. O 0 0.010987367480993271

The O 0 0.014252159744501114
overexpressed O 1 0.9982959628105164
H63D O 1 0.9979700446128845
protein O 1 0.9990164041519165
does O 0 0.004680753685534
not O 0 0.0008802995434962213
have O 0 0.0006961902254261076
this O 0 0.000877830374520272
effect O 0 0.007142961025238037
, O 0 0.0008549746125936508
providing O 0 0.0034517613239586353
the O 0 0.0007976525230333209
first O 0 0.001313907210715115
direct O 0 0.004274413920938969
evidence O 0 0.0022510653361678123
for O 0 0.0010699261911213398
a O 0 0.00428615789860487
functional O 0 0.47060835361480713
consequence O 0 0.014144704677164555
of O 0 0.001029280130751431
the O 0 0.004110435023903847
H63D O 1 0.9998465776443481
mutation O 1 0.9999618530273438
. O 0 0.010122017934918404

Addition O 0 0.009431084617972374
of O 0 0.003070368431508541
soluble O 1 0.9953768253326416
wild O 0 0.07539365440607071
- O 0 0.09980780631303787
type O 1 0.9657449126243591
HFE O 1 0.9997089505195618
/ O 1 0.9399093389511108
beta2m O 1 0.9931721687316895
heterodimers O 1 0.9976971745491028
to O 0 0.006127167027443647
cultured O 1 0.998879611492157
cells O 1 0.9990209341049194
also O 0 0.0018423768924549222
decreased O 0 0.01706290990114212
the O 0 0.001652523991651833
apparent O 0 0.0999591052532196
affinity O 0 0.4126034677028656
of O 0 0.0009807341266423464
the O 0 0.002042181557044387
TfR O 1 0.9982166886329651
for O 0 0.0017445225967094302
its O 0 0.002525199670344591
ligand O 1 0.986936628818512
under O 0 0.0033137656282633543
steady O 0 0.03222157061100006
- O 0 0.013403136283159256
state O 0 0.0022270807530730963
conditions O 0 0.005903692916035652
, O 0 0.000988240004517138
both O 0 0.0012123729102313519
in O 0 0.0017929049208760262
293 O 1 0.9971390962600708
cells O 1 0.999128520488739
and O 0 0.0019828337244689465
in O 0 0.005405141040682793
HeLa O 1 0.9999706745147705
cells O 1 0.9991305470466614
. O 0 0.01166178472340107

Furthermore O 0 0.030367931351065636
, O 0 0.0027516374830156565
at O 0 0.003113734070211649
4 O 0 0.00855717808008194
degrees O 0 0.010867771692574024
C O 0 0.22553452849388123
, O 0 0.000958838383667171
the O 0 0.001104762777686119
added O 0 0.004963229410350323
soluble O 1 0.9943100214004517
complex O 0 0.01251041330397129
of O 0 0.0036961562000215054
HFE O 1 0.9999527931213379
/ O 1 0.8880049586296082
beta2m O 1 0.9927417039871216
inhibited O 1 0.9884535670280457
binding O 0 0.02434816025197506
of O 0 0.0020051186438649893
transferrin O 1 0.997340738773346
to O 0 0.0070218355394899845
HeLa O 1 0.9998823404312134
cell O 1 0.9987039566040039
TfR O 1 0.9968321919441223
in O 0 0.0025682966224849224
a O 0 0.006946902722120285
concentration O 0 0.2705676257610321
- O 0 0.026804842054843903
dependent O 0 0.026416871696710587
manner O 0 0.019027860835194588
. O 0 0.008790610358119011

Scatchard O 0 0.43729716539382935
plots O 0 0.02341824397444725
of O 0 0.0009545397479087114
these O 0 0.0008132820948958397
data O 0 0.002803896088153124
indicate O 0 0.0042534698732197285
that O 0 0.0005785558605566621
the O 0 0.0012166522210463881
added O 0 0.005568813532590866
heterodimer O 1 0.9990828037261963
substantially O 0 0.032847288995981216
reduced O 0 0.011387070640921593
the O 0 0.001867655897513032
affinity O 0 0.4148409068584442
of O 0 0.0030068233609199524
TfR O 1 0.9981732368469238
for O 0 0.006351103540509939
transferrin O 1 0.9974519610404968
. O 0 0.010316028259694576

These O 0 0.0037955548614263535
results O 0 0.008101049810647964
establish O 0 0.008490584790706635
a O 0 0.0079426821321249
molecular O 1 0.9979931116104126
link O 0 0.05719656124711037
between O 0 0.005057991947978735
HFE O 1 0.99968421459198
and O 0 0.0015643961960449815
a O 0 0.004374911542981863
key O 0 0.009545237757265568
protein O 1 0.9989724159240723
involved O 0 0.007540825288742781
in O 0 0.0016361208399757743
iron O 0 0.04555574432015419
transport O 0 0.011549371294677258
, O 0 0.0013424308272078633
the O 0 0.0023557820823043585
TfR O 1 0.9997491240501404
, O 0 0.0014743780484423041
and O 0 0.0008687505032867193
raise O 0 0.005196353420615196
the O 0 0.0012584254145622253
possibility O 0 0.008280371315777302
that O 0 0.0012653435114771128
alterations O 0 0.43498027324676514
in O 0 0.001216998789459467
this O 0 0.0015854155644774437
regulatory O 1 0.9915626645088196
mechanism O 1 0.8852781653404236
may O 0 0.0034828500356525183
play O 0 0.002091245725750923
a O 0 0.002862683730199933
role O 0 0.003841310041025281
in O 0 0.0011185825569555163
the O 0 0.0033451062627136707
pathogenesis O 1 0.9999628067016602
of O 0 0.010050138458609581
hereditary B-Disease 1 0.9999940395355225
hemochromatosis I-Disease 1 0.9999983310699463
. O 0 0.00951340887695551
. O 0 0.0077340267598629

Genomic O 1 0.988291323184967
organization O 0 0.008316163904964924
of O 0 0.0011138200061395764
the O 0 0.004016289487481117
UBE3A O 1 0.9999326467514038
/ O 1 0.9969998002052307
E6 O 1 0.9998385906219482
- O 0 0.2509825825691223
AP O 0 0.3980879485607147
gene O 1 0.9997677206993103
and O 0 0.0033278323244303465
related O 0 0.026210343465209007
pseudogenes O 1 0.9978712797164917
. O 0 0.009954589419066906

The O 0 0.015293474309146404
UBE3A O 1 0.9984182119369507
gene O 1 0.9972097277641296
encodes O 1 0.7176851630210876
the O 0 0.007405320182442665
E6 O 1 0.9984819293022156
- O 0 0.04221077635884285
AP O 0 0.06619026511907578
ubiquitin O 1 0.9976651668548584
- O 0 0.24423126876354218
protein O 1 0.9992485642433167
ligase O 1 0.9433801770210266
and O 0 0.0017655811971053481
has O 0 0.0014692442491650581
recently O 0 0.0035682839807122946
been O 0 0.0011241767788305879
shown O 0 0.0025879002641886473
to O 0 0.0010735036339610815
be O 0 0.0024091419763863087
mutated O 1 0.9999792575836182
in O 0 0.21616743505001068
Angelman B-Disease 1 0.9999998807907104
syndrome I-Disease 1 1.0
patients O 1 0.9996627569198608
who O 0 0.003746785456314683
lack O 0 0.017086045816540718
15q11 O 1 0.9983630776405334
- O 0 0.16027292609214783
q13 O 1 0.9972932934761047
deletions O 1 0.9982807636260986
or O 0 0.01648890972137451
chromosome O 1 0.9998552799224854
15 O 0 0.020535621792078018
paternal O 1 0.9958903193473816
uniparental B-Disease 1 0.999853253364563
disomy I-Disease 1 0.9856810569763184
. O 0 0.012573303654789925

Previous O 0 0.03184466436505318
UBE3A O 1 0.9983069896697998
cDNA O 1 0.9857950210571289
analysis O 0 0.01689765974879265
has O 0 0.0018024027813225985
shown O 0 0.004732748959213495
a O 0 0.007187249138951302
coding O 1 0.9866695404052734
region O 0 0.0036660206969827414
of O 0 0.0010825481731444597
approximately O 0 0.00481065921485424
2 O 0 0.009636053815484047
. O 0 0.006051131524145603

6 O 0 0.021766724064946175
kb O 0 0.3229658305644989
and O 0 0.0022832080721855164
a O 0 0.007685115560889244
3 O 0 0.014150797389447689
- O 0 0.032210804522037506
untranslated O 1 0.9727214574813843
region O 0 0.008165831677615643
( O 0 0.006932132411748171
UTR O 1 0.9976352453231812
) O 0 0.003202365944162011
of O 0 0.0015135010471567512
< O 1 0.9881567358970642
50 O 0 0.007140814326703548
bp O 0 0.05708405748009682
, O 0 0.00210901559330523
whereas O 0 0.009405256249010563
Northern O 0 0.004083073232322931
analysis O 0 0.010481640696525574
has O 0 0.0020724039059132338
indicated O 0 0.011494340375065804
mRNA O 1 0.831364631652832
sizes O 0 0.011059480719268322
of O 0 0.0019419360905885696
5 O 0 0.011398736387491226
- O 0 0.021614687517285347
8 O 0 0.017317596822977066
kb O 1 0.9291033148765564
. O 0 0.009895049966871738

We O 0 0.0029525861609727144
have O 0 0.0014772070571780205
analyzed O 0 0.016520939767360687
additional O 0 0.009234542958438396
cDNA O 1 0.9974594712257385
clones O 1 0.994637668132782
and O 0 0.0014099227264523506
provide O 0 0.0028045892249792814
evidence O 0 0.0020125294104218483
for O 0 0.000938977173063904
an O 0 0.0015741392271593213
additional O 0 0.006924491375684738
0 O 0 0.019777493551373482
. O 0 0.006759181618690491

5 O 0 0.020807800814509392
kb O 0 0.11161870509386063
of O 0 0.00333397276699543
5 O 0 0.014694600366055965
- O 0 0.03923903778195381
UTR O 1 0.9887654781341553
and O 0 0.004575312603265047
> O 1 0.9666236042976379
2 O 0 0.010636451654136181
kb O 0 0.46144670248031616
of O 0 0.002616321900859475
3 O 0 0.015493671409785748
- O 0 0.045006927102804184
UTR O 1 0.9884042739868164
. O 0 0.011472894810140133

We O 0 0.002469306346029043
have O 0 0.0009665502002462745
established O 0 0.0022413565311580896
the O 0 0.002091408707201481
genomic O 1 0.9993923902511597
organization O 0 0.005020592827349901
of O 0 0.002745612058788538
UBE3A O 1 0.9994598031044006
and O 0 0.001406164956279099
the O 0 0.0014883086550980806
sequence O 0 0.03140733763575554
of O 0 0.003940288908779621
intron O 1 0.9999560117721558
- O 0 0.3402318060398102
exon O 1 0.9957408905029297
borders O 0 0.03121374361217022
. O 0 0.00845241453498602

We O 0 0.0030367812141776085
have O 0 0.0009472814272157848
also O 0 0.0010988074354827404
mapped O 0 0.013110741041600704
two O 0 0.0022089541889727116
highly O 0 0.013077626004815102
homologous O 1 0.9992832541465759
processed O 0 0.0456097237765789
pseudogenes O 1 0.9989781379699707
, O 0 0.004799271933734417
UBE3AP1 O 1 0.9950979351997375
and O 0 0.0033169121015816927
UBE3AP2 O 1 0.9962371587753296
, O 0 0.001721970271319151
to O 0 0.002193775726482272
chromosomes O 1 0.9992052912712097
2 O 0 0.006279901601374149
and O 0 0.0013417494483292103
21 O 0 0.005981625989079475
, O 0 0.0016535382019355893
respectively O 0 0.003365440061315894
, O 0 0.00098069803789258
and O 0 0.0009788274765014648
determined O 0 0.0065721990540623665
their O 0 0.0037226034328341484
genomic O 1 0.9995657801628113
organization O 0 0.012682187370955944
. O 0 0.0060426658019423485

These O 0 0.0041831498965620995
results O 0 0.008739784359931946
will O 0 0.00125959946308285
form O 0 0.004018193576484919
the O 0 0.0008445184794254601
basis O 0 0.0016825627535581589
for O 0 0.001124840578995645
studies O 0 0.006802465301007032
of O 0 0.0022232134360820055
mutation O 1 0.9999654293060303
and O 0 0.004351698327809572
imprinting O 1 0.9994181394577026
of O 0 0.006686798296868801
UBE3A O 1 0.9990122318267822
. O 0 0.012602725066244602

Mutation O 1 0.9994254112243652
spectrum O 0 0.07613996416330338
and O 0 0.007889418862760067
genotype O 1 0.9999121427536011
- O 1 0.8158504962921143
phenotype O 1 0.9999107122421265
analyses O 0 0.08075415343046188
in O 0 0.008194836787879467
Cowden B-Disease 1 0.9999827146530151
disease I-Disease 1 0.9999686479568481
and O 0 0.007119180168956518
Bannayan B-Disease 1 0.9998847246170044
- I-Disease 1 0.9982401132583618
Zonana I-Disease 1 0.999991774559021
syndrome I-Disease 1 0.9999967813491821
, O 0 0.005006556399166584
two O 0 0.010770890861749649
hamartoma B-Disease 1 0.9999699592590332
syndromes I-Disease 1 0.999975323677063
with O 0 0.025751709938049316
germline O 1 0.9999923706054688
PTEN O 1 0.9999754428863525
mutation O 1 0.9998633861541748
. O 0 0.012976027093827724

The O 0 0.029436735436320305
tumour B-Disease 1 0.9999922513961792
suppressor O 1 0.9999792575836182
gene O 1 0.9999760389328003
PTEN O 1 0.9999183416366577
, O 0 0.002717080060392618
which O 0 0.0013457878958433867
maps O 0 0.0066856020130217075
to O 0 0.002517832675948739
10q23 O 1 0.9758731126785278
. O 0 0.00855928286910057

3 O 0 0.015509289689362049
and O 0 0.003051512874662876
encodes O 1 0.6420620679855347
a O 0 0.010303382761776447
403 O 0 0.08332724124193192
amino O 1 0.8634188771247864
acid O 1 0.985903263092041
dual O 0 0.05459141358733177
specificity O 1 0.9447305202484131
phosphatase O 1 0.99951171875
( O 0 0.012762311846017838
protein O 1 0.999342143535614
tyrosine O 1 0.9995064735412598
phosphatase O 1 0.9999129772186279
; O 0 0.012472984381020069
PTPase O 1 0.9989560842514038
) O 0 0.0032834913581609726
, O 0 0.0009356621303595603
was O 0 0.0010621065739542246
shown O 0 0.003571129869669676
recently O 0 0.003668952966108918
to O 0 0.0008825592813082039
play O 0 0.0020289297681301832
a O 0 0.003878216026350856
broad O 0 0.013667553663253784
role O 0 0.0059281038120388985
in O 0 0.0027298915665596724
human O 0 0.21271319687366486
malignancy B-Disease 1 0.9999732971191406
. O 0 0.00859930831938982

Somatic O 1 0.999135434627533
PTEN O 1 0.9995474219322205
deletions O 1 0.9906823635101318
and O 0 0.005960316862910986
mutations O 1 0.9997770190238953
were O 0 0.0012103872140869498
observed O 0 0.007319143507629633
in O 0 0.0034165093675255775
sporadic B-Disease 1 0.9989696741104126
breast I-Disease 1 0.9999972581863403
, I-Disease 0 0.010886264964938164
brain I-Disease 1 0.9999881982803345
, I-Disease 0 0.01287958025932312
prostate I-Disease 1 0.9999998807907104
and I-Disease 1 0.5548343062400818
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
cell O 1 0.9997808337211609
lines O 0 0.009595030918717384
and O 0 0.0007670624181628227
in O 0 0.0008149193017743528
several O 0 0.0019410352688282728
primary O 0 0.18939678370952606
tumours B-Disease 1 0.9999895095825195
such O 0 0.004306264221668243
as O 0 0.010202321223914623
endometrial B-Disease 1 0.9999996423721313
carcinomas I-Disease 1 0.9999983310699463
, O 1 0.7865930199623108
malignant B-Disease 1 1.0
melanoma I-Disease 1 0.9999998807907104
and O 0 0.315276175737381
thyroid B-Disease 1 0.9999997615814209
tumours I-Disease 1 0.999988317489624
. O 0 0.011790541931986809

In O 0 0.005250956863164902
addition O 0 0.0063543058931827545
, O 0 0.004801257513463497
PTEN O 1 0.9999185800552368
was O 0 0.00360668427310884
identified O 0 0.005684944801032543
as O 0 0.0013358969008550048
the O 0 0.0035594450309872627
susceptibility O 1 0.9999793767929077
gene O 1 0.9997168183326721
for O 0 0.00348032359033823
two O 0 0.012950415723025799
hamartoma B-Disease 1 0.9999986886978149
syndromes I-Disease 1 0.9999998807907104
Cowden B-Disease 1 0.9999984502792358
disease I-Disease 1 0.9999957084655762
( O 0 0.007702991366386414
CD B-Disease 0 0.09587980061769485
; O 0 0.011691339313983917
MIM O 1 0.999817430973053
158350 O 1 0.9864461421966553
) O 0 0.00448824604973197
and O 0 0.002751264488324523
Bannayan B-Disease 1 0.9990279674530029
- I-Disease 1 0.569888710975647
Zonana I-Disease 1 0.999286949634552
( I-Disease 0 0.01023929100483656
BZS I-Disease 1 0.9961344003677368
) I-Disease 0 0.006868219003081322
or I-Disease 0 0.008945802226662636
Ruvalcaba I-Disease 1 0.9996864795684814
- I-Disease 0 0.46811914443969727
Riley I-Disease 1 0.991500735282898
- I-Disease 1 0.9251680374145508
Smith I-Disease 1 0.994972825050354
syndrome I-Disease 1 0.9999980926513672
( O 0 0.01936911791563034
MIM O 1 0.9998173117637634
153480 O 1 0.9919193983078003
) O 0 0.008328942582011223
. O 0 0.00676914444193244

Constitutive O 1 0.9772974252700806
DNA O 1 0.984095573425293
from O 0 0.004315798636525869
37 O 0 0.015391399152576923
CD B-Disease 0 0.02069384790956974
families O 0 0.004553754813969135
and O 0 0.0012834233930334449
seven O 0 0.005058819428086281
BZS B-Disease 1 0.9976643323898315
families O 0 0.006155998911708593
was O 0 0.002499045804142952
screened O 0 0.028440406545996666
for O 0 0.009483280591666698
germline O 1 0.9999779462814331
PTEN O 1 0.9999547004699707
mutations O 1 0.9998195767402649
. O 0 0.013397147879004478

PTEN O 1 0.9998664855957031
mutations O 1 0.9997612833976746
were O 0 0.0026366934180259705
identified O 0 0.006854004226624966
in O 0 0.001219407538883388
30 O 0 0.002830601530149579
of O 0 0.0012478716671466827
37 O 0 0.011384467594325542
( O 0 0.004241375718265772
81 O 0 0.0232765544205904
% O 0 0.005636855028569698
) O 0 0.0032394533045589924
CD B-Disease 0 0.019444724544882774
families O 0 0.0038506363052874804
, O 0 0.0014568030601367354
including O 0 0.004029158037155867
missense O 1 0.9989489912986755
and O 0 0.0023518807720392942
nonsense O 0 0.0769512876868248
point O 0 0.009434845298528671
mutations O 1 0.9999158382415771
, O 0 0.0038408031687140465
deletions O 1 0.9956721067428589
, O 0 0.0035750260576605797
insertions O 1 0.9976141452789307
, O 0 0.0026989178732037544
a O 0 0.01194378174841404
deletion O 1 0.9997187256813049
/ O 1 0.8015032410621643
insertion O 1 0.9791018962860107
and O 0 0.004274866543710232
splice O 1 0.9981364011764526
site O 0 0.027635158970952034
mutations O 1 0.9998471736907959
. O 0 0.00991696584969759

These O 0 0.008400662802159786
mutations O 1 0.9996631145477295
were O 0 0.001301235519349575
scattered O 0 0.004703943617641926
over O 0 0.0011442432878538966
the O 0 0.0009745897259563208
entire O 0 0.0051896539516747
length O 0 0.010187092237174511
of O 0 0.003000477561727166
PTEN O 1 0.9999916553497314
, O 0 0.001815768308006227
with O 0 0.0015911002410575747
the O 0 0.0010453006252646446
exception O 0 0.003955974709242582
of O 0 0.0006883826572448015
the O 0 0.0008455184288322926
first O 0 0.0018533980473876
, O 0 0.0013727727346122265
fourth O 0 0.006852497346699238
and O 0 0.0017607201589271426
last O 0 0.007495908532291651
exons O 1 0.9940671920776367
. O 0 0.009790400974452496

A O 0 0.019164176657795906
hot O 0 0.017321128398180008
spot O 0 0.015257559716701508
for O 0 0.007187176961451769
PTEN O 1 0.9999901056289673
mutation O 1 0.999954104423523
in O 0 0.0025755479000508785
CD B-Disease 0 0.015910064801573753
was O 0 0.0017612384399399161
identified O 0 0.006480310577899218
in O 0 0.0022428305819630623
exon O 1 0.9976690411567688
5 O 0 0.004532735329121351
that O 0 0.0008006815332919359
contains O 0 0.0025671671610325575
the O 0 0.001821037381887436
PTPase O 1 0.9949453473091125
core O 0 0.02322981506586075
motif O 1 0.9851092100143433
, O 0 0.0013550420990213752
with O 0 0.0016641824040561914
13 O 0 0.003655780106782913
of O 0 0.0008867151336744428
30 O 0 0.003990682773292065
( O 0 0.002995459595695138
43 O 0 0.010014894418418407
% O 0 0.005586003884673119
) O 0 0.004883301444351673
CD B-Disease 1 0.7534734010696411
mutations O 1 0.9999306201934814
identified O 0 0.011060512624680996
in O 0 0.0016579743241891265
this O 0 0.0029017857741564512
exon O 1 0.9965046644210815
. O 0 0.008652767166495323

Seven O 0 0.0073072765953838825
of O 0 0.0017428526189178228
30 O 0 0.0053938888013362885
( O 0 0.0039393664337694645
23 O 0 0.006894872523844242
% O 0 0.004147697240114212
) O 0 0.0015647121472284198
were O 0 0.00038722241879440844
within O 0 0.001191294752061367
the O 0 0.0009867234621196985
core O 0 0.01400869619101286
motif O 1 0.9793572425842285
, O 0 0.0010646608425304294
the O 0 0.001205193460918963
majority O 0 0.004469097126275301
( O 0 0.0020784945227205753
five O 0 0.0012136716395616531
of O 0 0.0006475115078501403
seven O 0 0.0022236546501517296
) O 0 0.001382252899929881
of O 0 0.0005256449221633375
which O 0 0.0008978011319413781
were O 0 0.0021389336325228214
missense O 1 0.9999765157699585
mutations O 1 0.9999872446060181
, O 0 0.0024230140261352062
possibly O 0 0.008551548235118389
pointing O 0 0.00580373452976346
to O 0 0.0007686814642511308
the O 0 0.0012845332967117429
functional O 0 0.23609034717082977
significance O 0 0.004474909510463476
of O 0 0.0008254403946921229
this O 0 0.0015022975858300924
region O 0 0.005145681090652943
. O 0 0.004655304830521345

Germline O 1 0.9999459981918335
PTEN O 1 0.9999070167541504
mutations O 1 0.9998365640640259
were O 0 0.0018161882180720568
identified O 0 0.006658707279711962
in O 0 0.0010069969575852156
four O 0 0.0013824200723320246
of O 0 0.0008711361442692578
seven O 0 0.0034682387486100197
( O 0 0.003959959372878075
57 O 0 0.016509344801306725
% O 0 0.007723523769527674
) O 0 0.007241698447614908
BZS B-Disease 1 0.9929829835891724
families O 0 0.011260746978223324
studied O 0 0.010174804367125034
. O 0 0.005946796853095293

Interestingly O 0 0.13040584325790405
, O 0 0.002477444941177964
none O 0 0.0030464082956314087
of O 0 0.0008710850379429758
these O 0 0.0027012713253498077
mutations O 1 0.9999889135360718
was O 0 0.002224953146651387
observed O 0 0.00597161753103137
in O 0 0.0011074244976043701
the O 0 0.0025150629226118326
PTPase O 1 0.9919467568397522
core O 0 0.032388970255851746
motif O 1 0.91451096534729
. O 0 0.010196398943662643

It O 0 0.0029935131315141916
is O 0 0.0014831750886514783
also O 0 0.0012460260186344385
worthy O 0 0.012776912190020084
of O 0 0.0010325241601094604
note O 0 0.006371764466166496
that O 0 0.000791478727478534
a O 0 0.0032017999328672886
single O 0 0.006680951453745365
nonsense O 0 0.08240833133459091
point O 0 0.008959890343248844
mutation O 1 0.9999923706054688
, O 0 0.003619428724050522
R233X O 1 0.9974429607391357
, O 0 0.0013066366082057357
was O 0 0.0011615287512540817
observed O 0 0.004410904832184315
in O 0 0.0011396496556699276
the O 0 0.0034744939766824245
germline O 1 0.999994158744812
DNA O 1 0.9982709884643555
from O 0 0.0025735204108059406
two O 0 0.0026354112196713686
unrelated O 1 0.919098973274231
CD B-Disease 0 0.03207475319504738
families O 0 0.004647471942007542
and O 0 0.00143332255538553
one O 0 0.0045266589149832726
BZS B-Disease 1 0.997222900390625
family O 0 0.025511421263217926
. O 0 0.008194277994334698

Genotype O 1 0.9998350143432617
- O 1 0.9829880595207214
phenotype O 1 0.9999672174453735
studies O 0 0.01301191933453083
were O 0 0.0008122992585413158
not O 0 0.0009438259876333177
performed O 0 0.0037587438710033894
on O 0 0.0007903809892013669
this O 0 0.001020793104544282
small O 0 0.003320773597806692
group O 0 0.00483287125825882
of O 0 0.0030244109220802784
BZS B-Disease 1 0.9980278611183167
families O 0 0.015044324100017548
. O 0 0.006460768170654774

However O 0 0.009811865165829659
, O 0 0.006635612808167934
genotype O 1 0.999906063079834
- O 1 0.7799280881881714
phenotype O 1 0.999906063079834
analysis O 0 0.031130246818065643
inthe O 1 0.9898306727409363
group O 0 0.005388716701418161
of O 0 0.0011831996962428093
CD B-Disease 0 0.02574293129146099
families O 0 0.005536651238799095
revealed O 0 0.009504126384854317
two O 0 0.00179000583011657
possible O 0 0.005375571083277464
associations O 0 0.006832239683717489
worthy O 0 0.01586659625172615
of O 0 0.0012794402427971363
follow O 0 0.009454214945435524
- O 0 0.013121665455400944
up O 0 0.0031015463173389435
in O 0 0.002014764118939638
independent O 0 0.005614786874502897
analyses O 0 0.03534502163529396
. O 0 0.006925297901034355

The O 0 0.0039173271507024765
first O 0 0.0024005849845707417
was O 0 0.001677819062024355
an O 0 0.0016767666675150394
association O 0 0.00431976281106472
noted O 0 0.002104271901771426
in O 0 0.0007656358066014946
the O 0 0.0009045393671840429
group O 0 0.002821246860548854
of O 0 0.0010581233073025942
CD B-Disease 0 0.04161724075675011
families O 0 0.011541122570633888
with O 0 0.1595880389213562
breast B-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999892711639404
. O 0 0.009936698712408543

A O 0 0.02720479480922222
correlation O 0 0.35262393951416016
was O 0 0.0026285869535058737
observed O 0 0.006078006234019995
between O 0 0.0014451141469180584
the O 0 0.0013974574394524097
presence O 0 0.009974016807973385
/ O 0 0.2691941559314728
absence O 0 0.009460742585361004
of O 0 0.0012107158545404673
a O 0 0.013173493556678295
PTEN O 1 0.999991774559021
mutation O 1 0.999956488609314
and O 0 0.0015992579283192754
the O 0 0.0013850214891135693
type O 0 0.1981467455625534
of O 0 0.004955911077558994
breast O 1 0.9999972581863403
involvement O 1 0.5156198740005493
( O 0 0.008426032029092312
unaffected O 1 0.992317795753479
versus O 1 0.832942008972168
benign O 1 0.9995591044425964
versus O 1 0.9950660467147827
malignant O 1 0.9999946355819702
) O 0 0.008746900595724583
. O 0 0.005843286868184805

Specifically O 0 0.012864165008068085
and O 0 0.0012273096945136786
more O 0 0.0010863355128094554
directly O 0 0.002758317394182086
, O 0 0.001184362219646573
an O 0 0.001956238644197583
association O 0 0.004588707350194454
was O 0 0.0015007277252152562
also O 0 0.0011376478942111135
observed O 0 0.005470322445034981
between O 0 0.0012794500216841698
the O 0 0.0008273550774902105
presence O 0 0.00387879041954875
of O 0 0.0010417257435619831
a O 0 0.01964762806892395
PTEN O 1 0.9999939203262329
mutation O 1 0.999991774559021
and O 0 0.38670119643211365
malignant B-Disease 1 1.0
breast I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999927282333374
. O 0 0.010847414843738079

Secondly O 0 0.16789689660072327
, O 0 0.0020202461164444685
there O 0 0.0009774165228009224
appeared O 0 0.002606515306979418
to O 0 0.0007482706569135189
be O 0 0.0006653233431279659
an O 0 0.00210136198438704
interdependent O 1 0.9851624369621277
association O 0 0.008856127969920635
between O 0 0.006416890304535627
mutations O 1 0.9999675750732422
upstream O 0 0.032802022993564606
and O 0 0.0009105625795200467
within O 0 0.0016282417345792055
the O 0 0.0017163752345368266
PTPase O 1 0.9939086437225342
core O 0 0.026018327102065086
motif O 1 0.9482776522636414
, O 0 0.001019719522446394
the O 0 0.0009376321686431766
core O 0 0.011758344247937202
motif O 1 0.5453836917877197
containing O 0 0.006375716999173164
the O 0 0.0010383521439507604
majority O 0 0.003295628586784005
of O 0 0.0030267557594925165
missense O 1 0.9999926090240479
mutations O 1 0.9999892711639404
, O 0 0.001478725578635931
and O 0 0.000623414758592844
the O 0 0.0009911441011354327
involvement O 0 0.008701392449438572
of O 0 0.0006239081267267466
all O 0 0.0008234907872974873
major O 0 0.009589921683073044
organ O 1 0.9982489347457886
systems O 0 0.05590682104229927
( O 0 0.003480801824480295
central O 0 0.005146398209035397
nervous O 1 0.9994428753852844
system O 0 0.02278801053762436
, O 0 0.007173980586230755
thyroid O 1 0.9999991655349731
, O 0 0.02086414396762848
breast O 1 0.9999986886978149
, O 0 0.010455174371600151
skin O 1 0.999987006187439
and O 0 0.04235305264592171
gastrointestinal O 1 0.9999996423721313
tract O 1 0.9999570846557617
) O 0 0.0077925873920321465
. O 0 0.006351301446557045

However O 0 0.00716371089220047
, O 0 0.0013771725352853537
these O 0 0.0008337527979165316
observations O 0 0.005215656012296677
would O 0 0.0011335944291204214
need O 0 0.002137991599738598
to O 0 0.0007558672223240137
be O 0 0.0008532786159776151
confirmed O 0 0.0048441956751048565
by O 0 0.0013020985061302781
studying O 0 0.003722332650795579
a O 0 0.002878646133467555
larger O 0 0.004371579270809889
number O 0 0.0011957637034356594
of O 0 0.0012559712631627917
CD B-Disease 0 0.04150750860571861
families O 0 0.010440758429467678
. O 0 0.00643273675814271

Molecular O 1 0.9993859529495239
defects O 1 0.9994578957557678
leading O 0 0.008136621676385403
to O 0 0.0015169429825618863
human O 0 0.008665517903864384
complement B-Disease 1 0.8218048214912415
component I-Disease 1 0.9968321919441223
C6 I-Disease 1 0.9999982118606567
deficiency I-Disease 1 0.999998927116394
in O 0 0.0027359607629477978
an O 0 0.002400269964709878
African O 0 0.015605144202709198
- O 0 0.021597186103463173
American O 0 0.009162177331745625
family O 0 0.014779642224311829
. O 0 0.00717703765258193

Complement B-Disease 1 0.5929574966430664
component I-Disease 1 0.9848928451538086
C6 I-Disease 1 0.9999878406524658
deficiency I-Disease 1 0.9999980926513672
( O 0 0.015178310684859753
C6D B-Disease 1 0.9986201524734497
) O 0 0.006113125942647457
was O 0 0.005472683347761631
diagnosed O 1 0.9999593496322632
in O 0 0.0018049729987978935
a O 0 0.005176575854420662
16 O 0 0.008095437660813332
- O 0 0.015591571107506752
year O 0 0.0052565522491931915
- O 0 0.015184961259365082
old O 0 0.011186978779733181
African O 0 0.015393661335110664
- O 0 0.015852250158786774
American O 0 0.006925934460014105
male O 0 0.12756812572479248
with O 0 0.0785801112651825
meningococcal B-Disease 1 0.9999996423721313
meningitis I-Disease 1 0.9999980926513672
. O 0 0.013463473878800869

The O 0 0.010385926812887192
patients O 1 0.9985772371292114
father O 0 0.008683730848133564
and O 0 0.001425481867045164
two O 0 0.002996716881170869
brothers O 0 0.019649242982268333
also O 0 0.0015537714352831244
had O 0 0.0037502471823245287
C6D B-Disease 1 0.9989847540855408
, O 0 0.0018811371410265565
but O 0 0.0012098443694412708
gave O 0 0.0030324214603751898
no O 0 0.0012065833434462547
history O 0 0.002437341259792447
of O 0 0.0030280190985649824
meningitis B-Disease 1 0.9999986886978149
or O 0 0.008811546489596367
other O 0 0.006138816475868225
neisserial B-Disease 1 0.9997448325157166
infection I-Disease 1 0.9999899864196777
. O 0 0.011191768571734428

By O 0 0.009269601665437222
using O 0 0.016619201749563217
exon O 1 0.99178546667099
- O 0 0.026059910655021667
specific O 0 0.015945371240377426
polymerase O 1 0.9993686079978943
chain O 1 0.8834826946258545
reaction O 0 0.07703142613172531
( O 0 0.008055291138589382
PCR O 1 0.9996626377105713
) O 0 0.0072841825895011425
/ O 0 0.12849746644496918
single O 0 0.011713845655322075
- O 0 0.03891058638691902
strand O 1 0.9969744682312012
conformation O 1 0.9965426325798035
polymorphism O 1 0.9952524900436401
as O 0 0.0024825220461934805
a O 0 0.00603914400562644
screening O 0 0.2213152050971985
step O 0 0.009610740467905998
and O 0 0.0019886684603989124
nucleotide O 1 0.99309903383255
sequencing O 1 0.7957693338394165
of O 0 0.0017772861756384373
target O 0 0.01407164242118597
exons O 1 0.9985828399658203
, O 0 0.001306002726778388
we O 0 0.0006936294957995415
determined O 0 0.0033057183027267456
that O 0 0.000664109829813242
the O 0 0.0013891502749174833
proband O 1 0.9864567518234253
was O 0 0.0021532520186156034
a O 0 0.006349764298647642
compound O 0 0.038770318031311035
heterozygote O 1 0.9941412806510925
for O 0 0.003638053312897682
two O 0 0.0082596056163311
C6 O 1 0.9999586343765259
gene O 1 0.9999094009399414
mutations O 1 0.9999009370803833
. O 0 0.010245544835925102

The O 0 0.004005942028015852
first O 0 0.0027004480361938477
, O 0 0.0027500372380018234
1195delC O 1 0.8037098050117493
located O 0 0.005007076542824507
in O 0 0.003523436840623617
exon O 1 0.9990039467811584
7 O 0 0.010232198983430862
, O 0 0.0011978020193055272
is O 0 0.0012159014586359262
a O 0 0.00524468719959259
novel O 0 0.2568502724170685
mutation O 1 0.9999881982803345
, O 0 0.0016401417087763548
while O 0 0.001048579695634544
the O 0 0.0009564906940795481
second O 0 0.004135192837566137
, O 0 0.0026396310422569513
1936delG O 1 0.9931216835975647
in O 0 0.0033684975933283567
exon O 1 0.9993783235549927
12 O 0 0.007233242504298687
, O 0 0.0013922268990427256
has O 0 0.0011184967588633299
been O 0 0.0012916881823912263
described O 0 0.004489750601351261
before O 0 0.002010297030210495
to O 0 0.002157852752134204
cause O 1 0.9810117483139038
C6D B-Disease 1 0.9970406889915466
in O 0 0.00179998145904392
an O 0 0.0027482295408844948
unrelated O 1 0.9567620158195496
African O 0 0.02394687384366989
- O 0 0.02075023762881756
American O 0 0.006580101326107979
individual O 0 0.00983801856637001
. O 0 0.006597120780497789

Both O 0 0.014897768385708332
mutations O 1 0.9998664855957031
result O 0 0.0167401023209095
in O 0 0.004585502669215202
premature O 1 0.9991587400436401
termination O 1 0.9970943927764893
codons O 1 0.9920821189880371
and O 0 0.0070676254108548164
C6 O 1 0.9995819926261902
null O 1 0.9813474416732788
alleles O 1 0.998435914516449
. O 0 0.01013124268501997

Allele O 1 0.9993048906326294
- O 0 0.046053197234869
specific O 0 0.01449517160654068
PCR O 1 0.9990015625953674
indicated O 0 0.007816897705197334
that O 0 0.0009278286015614867
the O 0 0.0017766974633559585
probands O 1 0.9549179077148438
two O 0 0.003110123099759221
brothers O 0 0.017867889255285263
also O 0 0.001997841987758875
inherited O 1 0.9849362969398499
the O 0 0.0034269026946276426
1195delC O 1 0.9996814727783203
mutation O 1 0.9998680353164673
from O 0 0.002488325582817197
their O 0 0.0034388930071145296
heterozygous O 1 0.9997101426124573
mother O 0 0.01670782081782818
and O 0 0.0015078597934916615
the O 0 0.0033882518764585257
1936delG O 1 0.9992659687995911
mutation O 1 0.9999291896820068
from O 0 0.002858062507584691
their O 0 0.004266995936632156
homozygous O 1 0.999670147895813
father O 0 0.01745787262916565
. O 0 0.004050329327583313
. O 0 0.0061386446468532085

PAX6 O 1 0.9990587830543518
mutations O 1 0.9993059635162354
reviewed O 0 0.03697817400097847
. O 0 0.01009159255772829

Mutations O 1 0.9997190833091736
in O 0 0.008662381209433079
PAX6 O 1 0.9995261430740356
are O 0 0.0020241790916770697
responsible O 0 0.007054643705487251
for O 0 0.002266514115035534
human O 0 0.016161877661943436
aniridia B-Disease 1 0.9989619255065918
and O 0 0.001232548151165247
have O 0 0.0007519853534176946
also O 0 0.0007023387006483972
been O 0 0.0010704287560656667
found O 0 0.00354936090297997
in O 0 0.0030803533736616373
patients O 1 0.9998531341552734
with O 0 0.006374404300004244
Peters B-Disease 1 0.9981184005737305
anomaly I-Disease 1 0.9996930360794067
, O 0 0.003712907200679183
with O 0 0.08053582906723022
congenital B-Disease 1 1.0
cataracts I-Disease 1 0.9999978542327881
, O 0 0.003973452840000391
with O 0 0.013667795807123184
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9993765950202942
keratitis I-Disease 1 0.9999963045120239
, O 0 0.0018176964949816465
and O 0 0.0010066700633615255
with O 0 0.0038934655021876097
isolated B-Disease 1 0.988387405872345
foveal I-Disease 1 0.9998829364776611
hypoplasia I-Disease 1 0.9999697208404541
. O 0 0.010455464944243431

No O 0 0.009516020305454731
locus O 1 0.9931259155273438
other O 0 0.0021820354741066694
than O 0 0.004520758055150509
chromosome O 1 0.9999805688858032
11p13 O 1 0.9877865314483643
has O 0 0.002274575177580118
been O 0 0.002342918422073126
implicated O 1 0.8368405103683472
in O 0 0.0038031262811273336
aniridia B-Disease 1 0.998956561088562
, O 0 0.002361095743253827
and O 0 0.002913233358412981
PAX6 O 1 0.9999586343765259
is O 0 0.0021782522089779377
clearly O 0 0.00271213473752141
the O 0 0.0010845300275832415
major O 0 0.004641909152269363
, O 0 0.0011601378209888935
if O 0 0.0013130176812410355
not O 0 0.0007132115424610674
only O 0 0.0010793323162943125
, O 0 0.0029422163497656584
gene O 1 0.9999195337295532
responsible O 0 0.020454175770282745
. O 0 0.006058923434466124

Twenty O 0 0.0324103906750679
- O 0 0.015841972082853317
eight O 0 0.003693403908982873
percent O 0 0.003265625098720193
of O 0 0.0016744607128202915
identified O 0 0.05694199725985527
PAX6 O 1 0.9999653100967407
mutations O 1 0.9999403953552246
are O 0 0.004359751008450985
C O 1 0.9959402084350586
- O 0 0.2622743844985962
T O 1 0.9947404265403748
changes O 0 0.010907897725701332
at O 0 0.006081907078623772
CpG O 1 0.9988368153572083
dinucleotides O 1 0.9935177564620972
, O 0 0.0020270217210054398
20 O 0 0.002925942884758115
% O 0 0.003335581161081791
are O 0 0.0016757739940658212
splicing O 1 0.9998317956924438
errors O 0 0.3417147994041443
, O 0 0.00120177969802171
and O 0 0.000631578965112567
more O 0 0.0008963262662291527
than O 0 0.0013106762198731303
30 O 0 0.00335118779912591
% O 0 0.0033893545623868704
are O 0 0.0016719220438972116
deletion O 1 0.9996271133422852
or O 0 0.00827530212700367
insertion O 1 0.9909550547599792
events O 0 0.009829968214035034
. O 0 0.006511591840535402

There O 0 0.0033533258829265833
is O 0 0.0020622469019144773
a O 0 0.006310087628662586
noticeably O 0 0.3105003833770752
elevated O 0 0.2616654634475708
level O 0 0.0035415946040302515
of O 0 0.0018816441297531128
mutation O 1 0.9999686479568481
in O 0 0.001473229960538447
the O 0 0.0016437920276075602
paired O 1 0.9743316769599915
domain O 0 0.06836722046136856
compared O 0 0.004308867733925581
with O 0 0.0012341433903202415
the O 0 0.0008914481149986386
rest O 0 0.002404166618362069
of O 0 0.0010103513486683369
the O 0 0.004148733336478472
gene O 1 0.9997891783714294
. O 0 0.008207297883927822

Increased O 0 0.045809339731931686
mutation O 1 0.9997009038925171
in O 0 0.002735047833994031
the O 0 0.0027431012131273746
homeodomain O 1 0.9988682270050049
is O 0 0.002475579036399722
accounted O 0 0.007962420582771301
for O 0 0.001108389114961028
by O 0 0.0014863689430058002
the O 0 0.0030518434941768646
hypermutable O 1 0.9950817823410034
CpG O 1 0.9971930384635925
dinucleotide O 1 0.9490126967430115
in O 0 0.007741532288491726
codon O 1 0.948727011680603
240 O 0 0.03798087313771248
. O 0 0.009533995762467384

Very O 0 0.0056935572065413
nearly O 0 0.005311088636517525
all O 0 0.0026412822771817446
mutations O 1 0.999971866607666
appear O 0 0.006798871327191591
to O 0 0.0020603863522410393
cause O 1 0.8814573287963867
loss O 0 0.0158305112272501
of O 0 0.0008838555659167469
function O 0 0.009482336230576038
of O 0 0.0007711903308518231
the O 0 0.002953490475192666
mutant O 1 0.9999390840530396
allele O 1 0.9999476671218872
, O 0 0.001669177203439176
and O 0 0.00065745844040066
more O 0 0.0007059496128931642
than O 0 0.0010651473421603441
80 O 0 0.003968191333115101
% O 0 0.0029981876723468304
of O 0 0.0016341654118150473
exonic O 1 0.9915660619735718
substitutions O 0 0.24886412918567657
result O 0 0.00925534963607788
in O 0 0.002994586480781436
nonsense O 1 0.6240023374557495
codons O 1 0.9906213283538818
. O 0 0.009043239988386631

In O 0 0.00456033693626523
a O 0 0.01185387559235096
gene O 1 0.999646782875061
with O 0 0.0027939274441450834
such O 0 0.0024819637183099985
extraordinarily O 0 0.044915713369846344
high O 0 0.005774847697466612
sequence O 0 0.046355780214071274
conservation O 0 0.010541502386331558
throughout O 0 0.0024790246970951557
evolution O 0 0.01635732129216194
, O 0 0.0009877727134153247
there O 0 0.0007294988026842475
are O 0 0.0010310043580830097
presumed O 0 0.3923318684101105
undiscovered O 1 0.9961108565330505
missense O 1 0.9999533891677856
mutations O 1 0.9999799728393555
, O 0 0.0017901728861033916
these O 0 0.0010293483501300216
are O 0 0.0009205254609696567
hypothesized O 1 0.8374531865119934
to O 0 0.0012222416698932648
exist O 0 0.0028900851029902697
in O 0 0.0010185970459133387
as O 0 0.0021651717834174633
- O 0 0.017567994073033333
yet O 0 0.009110790677368641
unidentified O 0 0.29935765266418457
phenotypes O 1 0.9991089701652527
. O 0 0.006336933467537165
. O 0 0.006947699468582869

Genetic O 1 0.998325765132904
heterogeneity O 1 0.9715234041213989
and O 0 0.005342627409845591
penetrance O 1 0.9985631108283997
analysis O 0 0.008710342459380627
of O 0 0.001033279811963439
the O 0 0.003519427962601185
BRCA1 O 1 0.9999982118606567
and O 0 0.010269014164805412
BRCA2 O 1 0.9999984502792358
genes O 1 0.9999065399169922
in O 0 0.07663336396217346
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999967813491821
families O 0 0.01603667065501213
. O 0 0.006872354540973902

The O 0 0.11792591214179993
Breast B-Disease 1 0.9999996423721313
Cancer I-Disease 1 0.9999995231628418
Linkage O 1 0.9987622499465942
Consortium O 1 0.572209894657135
. O 0 0.00864456593990326

The O 0 0.003836191724985838
contribution O 0 0.00808184128254652
of O 0 0.00468585267663002
BRCA1 O 1 0.9999914169311523
and O 0 0.010792195796966553
BRCA2 O 1 0.999997615814209
to O 0 0.01718842424452305
inherited B-Disease 1 0.9999982118606567
breast I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999978542327881
was O 0 0.00378288677893579
assessed O 0 0.0127415107563138
by O 0 0.003689735196530819
linkage O 1 0.9942768216133118
and O 0 0.004780441522598267
mutation O 1 0.9999899864196777
analysis O 0 0.011736699379980564
in O 0 0.0019613003823906183
237 O 0 0.24330705404281616
families O 0 0.004645738285034895
, O 0 0.0008347234688699245
each O 0 0.0009370279149152339
with O 0 0.001134601654484868
at O 0 0.000907618785277009
least O 0 0.001959505956619978
four O 0 0.0021969196386635303
cases O 0 0.010157366283237934
of O 0 0.007233835756778717
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
, O 0 0.0015041743172332644
collected O 0 0.0022794660180807114
by O 0 0.0028041894547641277
the O 0 0.019249530509114265
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999996423721313
Linkage O 1 0.9994056224822998
Consortium O 1 0.9149521589279175
. O 0 0.007247432135045528

Families O 0 0.01211466733366251
were O 0 0.0011778307380154729
included O 0 0.002179492963477969
without O 0 0.0022564800456166267
regard O 0 0.0029186124447733164
to O 0 0.0007710448116995394
the O 0 0.0015449211932718754
occurrence O 0 0.34079450368881226
of O 0 0.005597834940999746
ovarian B-Disease 1 0.9999992847442627
or I-Disease 0 0.010400958359241486
other I-Disease 0 0.007729950826615095
cancers I-Disease 1 0.999988317489624
. O 0 0.01027444377541542

Overall O 0 0.031547654420137405
, O 0 0.006277608219534159
disease O 1 0.9999611377716064
was O 0 0.0030879052355885506
linked O 0 0.26772603392601013
to O 0 0.003690965473651886
BRCA1 O 1 0.9999973773956299
in O 0 0.001950779347680509
an O 0 0.0012465452309697866
estimated O 0 0.0045865257270634174
52 O 0 0.008222890086472034
% O 0 0.002597138285636902
of O 0 0.0008408080320805311
families O 0 0.0035070895683020353
, O 0 0.001286348677240312
to O 0 0.0030491810757666826
BRCA2 O 1 0.9999974966049194
in O 0 0.0021464067976921797
32 O 0 0.006374065298587084
% O 0 0.002469517756253481
of O 0 0.0007968191057443619
families O 0 0.0033207840751856565
, O 0 0.0008137441473081708
and O 0 0.000581034051720053
to O 0 0.0012230472639203072
neither O 0 0.014595616608858109
gene O 1 0.9998088479042053
in O 0 0.0018501272425055504
16 O 0 0.005060295574367046
% O 0 0.004249757621437311
( O 0 0.0028461164329200983
95 O 0 0.008754975162446499
% O 0 0.004663791973143816
confidence O 0 0.011637231335043907
interval O 0 0.27967867255210876
[ O 0 0.04961115121841431
CI O 1 0.9984934329986572
] O 0 0.04247811436653137
6 O 0 0.009070389904081821
% O 0 0.007657728623598814
- O 0 0.01574702560901642
28 O 0 0.008999157696962357
% O 0 0.006389428861439228
) O 0 0.0028992225416004658
, O 0 0.001447611371986568
suggesting O 0 0.01385146751999855
other O 0 0.004572722129523754
predisposition O 1 0.9999117851257324
genes O 1 0.9985916018486023
. O 0 0.01233755238354206

The O 0 0.005479932297021151
majority O 0 0.008287329226732254
( O 0 0.004372754134237766
81 O 0 0.019001975655555725
% O 0 0.004149044398218393
) O 0 0.0017660737503319979
of O 0 0.000997530180029571
the O 0 0.01016438752412796
breast B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999696016311646
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 0.005067731253802776
were O 0 0.0007982535171322525
due O 0 0.004953673109412193
to O 0 0.0045777843333780766
BRCA1 O 1 0.9999995231628418
, O 0 0.0023156527895480394
with O 0 0.001848696731030941
most O 0 0.0012283406686037779
others O 0 0.003388745943084359
( O 0 0.0032280657906085253
14 O 0 0.00543228117749095
% O 0 0.005274697206914425
) O 0 0.0029723774641752243
due O 0 0.0057127452455461025
to O 0 0.005175239872187376
BRCA2 O 1 0.9999908208847046
. O 0 0.011674447916448116

Conversely O 0 0.11803388595581055
, O 0 0.001787674380466342
the O 0 0.0010293141240254045
majority O 0 0.002890960779041052
of O 0 0.0006970482063479722
families O 0 0.003333749482408166
with O 0 0.0022785868495702744
male B-Disease 0 0.0901748389005661
and I-Disease 0 0.003134619677439332
female I-Disease 1 0.998941957950592
breast I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999966621398926
were O 0 0.001684362068772316
due O 0 0.0058015030808746815
to O 0 0.005319733638316393
BRCA2 O 1 0.9999986886978149
( O 0 0.007902789860963821
76 O 0 0.03523401543498039
% O 0 0.009265999309718609
) O 0 0.004563156049698591
. O 0 0.005801299586892128

The O 0 0.004071015398949385
largest O 0 0.007967035286128521
proportion O 0 0.016553401947021484
( O 0 0.005213770549744368
67 O 0 0.021403038874268532
% O 0 0.005332442466169596
) O 0 0.0017809740966185927
of O 0 0.0007736923289485276
families O 0 0.004059941507875919
due O 0 0.0031332538928836584
to O 0 0.0009275430929847062
other O 0 0.0017285055946558714
genes O 1 0.9993219375610352
was O 0 0.0018163354834541678
found O 0 0.0028611011803150177
in O 0 0.0011463107075542212
families O 0 0.003443731926381588
with O 0 0.0015357016818597913
four O 0 0.0016252656932920218
or O 0 0.0019378518918529153
five O 0 0.0018931247759610415
cases O 0 0.004940304905176163
of O 0 0.0022624311968684196
female O 1 0.999302864074707
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999957084655762
only O 0 0.003843003651127219
. O 0 0.005287652835249901

These O 0 0.0030313520692288876
estimates O 0 0.004715839400887489
were O 0 0.0007264182786457241
not O 0 0.0013793552061542869
substantially O 0 0.04039799049496651
affected O 0 0.013256835751235485
either O 0 0.0037912880070507526
by O 0 0.0019046873785555363
changing O 0 0.005385068245232105
the O 0 0.0017722125630825758
assumed O 0 0.017507383599877357
penetrance O 1 0.999566376209259
model O 0 0.01449112594127655
for O 0 0.0047706421464681625
BRCA1 O 1 0.9999982118606567
or O 0 0.0038550267927348614
by O 0 0.0015480327419936657
including O 0 0.002266007475554943
or O 0 0.004519551992416382
excluding O 0 0.28377148509025574
BRCA1 O 1 0.9999995231628418
mutation O 1 0.9999408721923828
data O 0 0.015152336098253727
. O 0 0.006497589405626059

Among O 0 0.004857574589550495
those O 0 0.0015422262949869037
families O 0 0.005179820116609335
with O 0 0.010205325670540333
disease O 1 0.9999963045120239
due O 0 0.006180687807500362
to O 0 0.0031533031724393368
BRCA1 O 1 0.9999994039535522
that O 0 0.0014221231685951352
were O 0 0.0008076836238615215
tested O 0 0.017677105963230133
by O 0 0.0009520280291326344
one O 0 0.0007030050619505346
of O 0 0.0005367553094401956
the O 0 0.0012541302712634206
standard O 0 0.017193790525197983
screening O 1 0.8429763913154602
methods O 0 0.010455372743308544
, O 0 0.002790523460134864
mutations O 1 0.9999591112136841
were O 0 0.0015879460843279958
detected O 0 0.19304338097572327
in O 0 0.0013192740734666586
the O 0 0.0022995651233941317
coding O 1 0.9978727102279663
sequence O 0 0.046937115490436554
or O 0 0.0052719502709805965
splice O 1 0.9968096613883972
sites O 0 0.0045663719065487385
in O 0 0.0009389884071424603
an O 0 0.0012783384881913662
estimated O 0 0.005508043337613344
63 O 0 0.017458852380514145
% O 0 0.00493977777659893
( O 0 0.0031719680409878492
95 O 0 0.011208556592464447
% O 0 0.008150996640324593
CI O 1 0.9967754483222961
51 O 0 0.02546200528740883
% O 0 0.009105687029659748
- O 0 0.023899883031845093
77 O 0 0.02762576751410961
% O 0 0.008574262261390686
) O 0 0.006507705897092819
. O 0 0.007140905596315861

The O 0 0.004310808144509792
estimated O 0 0.007663930766284466
sensitivity O 0 0.03288475424051285
was O 0 0.0027460649143904448
identical O 0 0.014362440444529057
for O 0 0.0018111857352778316
direct O 0 0.010652223601937294
sequencing O 1 0.9822184443473816
and O 0 0.0017899334197863936
other O 0 0.001811472000554204
techniques O 0 0.015568803995847702
. O 0 0.0054299961775541306

The O 0 0.009601532481610775
penetrance O 1 0.9957836866378784
of O 0 0.009997143410146236
BRCA2 O 1 0.9999878406524658
was O 0 0.004643555730581284
estimated O 0 0.004317478742450476
by O 0 0.0022784629836678505
maximizing O 0 0.043682824820280075
the O 0 0.0027114448603242636
LOD O 1 0.990975558757782
score O 0 0.007930908352136612
in O 0 0.007843243889510632
BRCA2 O 1 0.9999994039535522
- O 1 0.983654797077179
mutation O 1 0.9999638795852661
families O 0 0.008532898500561714
, O 0 0.0011234531411901116
over O 0 0.001130711636506021
all O 0 0.0011250698007643223
possible O 0 0.01352138351649046
penetrance O 1 0.9988120794296265
functions O 0 0.01877027004957199
. O 0 0.006305359303951263

The O 0 0.004290963988751173
estimated O 0 0.008354293182492256
cumulative O 0 0.46191439032554626
risk O 1 0.9817028641700745
of O 0 0.008197968825697899
breast B-Disease 1 0.9999996423721313
cancer I-Disease 1 0.9999978542327881
reached O 0 0.005593955982476473
28 O 0 0.006953347474336624
% O 0 0.004812448751181364
( O 0 0.0031937367748469114
95 O 0 0.01024961844086647
% O 0 0.008116427809000015
CI O 1 0.9981335997581482
9 O 0 0.009924894198775291
% O 0 0.006992482580244541
- O 0 0.013910997658967972
44 O 0 0.012314424850046635
% O 0 0.0050124190747737885
) O 0 0.00237995944917202
by O 0 0.001648768549785018
age O 0 0.003843053011223674
50 O 0 0.003189179813489318
years O 0 0.0018703965470194817
and O 0 0.0011704452335834503
84 O 0 0.016372712329030037
% O 0 0.004846131894737482
( O 0 0.002928283764049411
95 O 0 0.011580604128539562
% O 0 0.008129832334816456
CI O 1 0.9972800016403198
43 O 0 0.017610643059015274
% O 0 0.007706476375460625
- O 0 0.016738006845116615
95 O 0 0.01346867997199297
% O 0 0.00537610100582242
) O 0 0.002559532644227147
by O 0 0.0016475345473736525
age O 0 0.004857966210693121
70 O 0 0.007299311459064484
years O 0 0.0037841652520000935
. O 0 0.005470141302794218

The O 0 0.012042677029967308
corresponding O 1 0.9960371851921082
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999991655349731
risks O 1 0.8067132234573364
were O 0 0.0021792578045278788
0 O 0 0.02248019352555275
. O 0 0.006146542262285948

4 O 0 0.018863772973418236
% O 0 0.007854806259274483
( O 0 0.004420936107635498
95 O 0 0.013123585842549801
% O 0 0.010554781183600426
CI O 1 0.9977890253067017
0 O 0 0.02106635458767414
% O 0 0.00748659810051322
- O 0 0.016560746356844902
1 O 0 0.006741393357515335
% O 0 0.004864401649683714
) O 0 0.0021285393740981817
by O 0 0.0014308677054941654
age O 0 0.0036953219678252935
50 O 0 0.0031529644038528204
years O 0 0.0014970166375860572
and O 0 0.0010703559964895248
27 O 0 0.007432758808135986
% O 0 0.004742574878036976
( O 0 0.0034061747137457132
95 O 0 0.012026588432490826
% O 0 0.00903433095663786
CI O 1 0.9984346032142639
0 O 0 0.018843425437808037
% O 0 0.007805542089045048
- O 0 0.019136331975460052
47 O 0 0.017466198652982712
% O 0 0.006609479431062937
) O 0 0.0029307883232831955
by O 0 0.0022252833005040884
age O 0 0.0054849134758114815
70 O 0 0.007387665566056967
years O 0 0.003473922610282898
. O 0 0.00489641772583127

The O 0 0.006556759588420391
lifetime O 0 0.06076833978295326
risk O 1 0.9860963225364685
of O 0 0.013053570874035358
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999984502792358
appears O 0 0.01492047868669033
similar O 0 0.004209971521049738
to O 0 0.0009628866100683808
the O 0 0.001995969796553254
risk O 1 0.9893189072608948
in O 0 0.007928539998829365
BRCA1 O 1 0.9999998807907104
carriers O 1 0.9974199533462524
, O 0 0.001702409703284502
but O 0 0.0009483478497713804
there O 0 0.0006806694436818361
was O 0 0.000891584437340498
some O 0 0.0008225277997553349
suggestion O 0 0.006932864896953106
of O 0 0.0008329135016538203
a O 0 0.004650989081710577
lower O 0 0.012667685747146606
risk O 1 0.9834597706794739
in O 0 0.00861800741404295
BRCA2 O 1 0.9999992847442627
carriers O 1 0.9973342418670654
< O 1 0.9872560501098633
50 O 0 0.0054663862101733685
years O 0 0.0019735582172870636
of O 0 0.0011583826271817088
age O 0 0.008224288932979107
. O 0 0.005549114663153887

Eye B-Disease 1 0.9518911242485046
movement I-Disease 0 0.03642049804329872
abnormalities I-Disease 1 0.9999381303787231
correlate O 1 0.8363659381866455
with O 0 0.00805587787181139
genotype O 1 0.9998352527618408
in O 0 0.01180464681237936
autosomal O 1 0.9999984502792358
dominant O 1 0.9972406625747681
cerebellar B-Disease 1 0.999992847442627
ataxia I-Disease 1 0.9999978542327881
type I-Disease 1 0.9519630670547485
I I-Disease 0 0.011652746237814426
. O 0 0.006432062946259975

We O 0 0.005709354300051928
compared O 0 0.017493961378932
horizontal O 1 0.851508617401123
eye O 1 0.9549981355667114
movements O 0 0.015882590785622597
( O 0 0.0061916811391711235
visually O 0 0.08262654393911362
guided O 0 0.03362690657377243
saccades O 1 0.9991807341575623
, O 0 0.00435972586274147
antisaccades O 1 0.9798832535743713
, O 0 0.0020900042727589607
and O 0 0.0016033111605793238
smooth O 1 0.7971789240837097
pursuit O 0 0.14428114891052246
) O 0 0.0024291095323860645
in O 0 0.0014312418643385172
control O 0 0.010219554416835308
subjects O 0 0.007589148357510567
( O 0 0.004222345072776079
n O 0 0.42711079120635986
= O 0 0.15638095140457153
14 O 0 0.00684394221752882
) O 0 0.003312787739560008
and O 0 0.001906494959257543
patients O 1 0.9990288019180298
with O 0 0.0017999206902459264
three O 0 0.001478335470892489
forms O 0 0.005873591173440218
of O 0 0.003145333379507065
autosomal O 1 0.999998927116394
dominant O 1 0.9737191200256348
cerebellar B-Disease 1 0.9999715089797974
ataxias I-Disease 1 0.9982141256332397
type I-Disease 1 0.8181408047676086
I I-Disease 0 0.028065700083971024
spinocerebellar B-Disease 1 0.9999662637710571
ataxias I-Disease 1 0.9948444366455078
1 I-Disease 0 0.007531855721026659
and I-Disease 0 0.0015455731190741062
2 I-Disease 0 0.007658941671252251
( O 0 0.005300735589116812
SCA1 B-Disease 1 0.9975793957710266
, O 0 0.0036342423409223557
n O 0 0.07736656069755554
= O 0 0.058126308023929596
11 O 0 0.009442228823900223
; O 0 0.006624185014516115
SCA2 B-Disease 1 0.9939099550247192
, O 0 0.003301260992884636
n O 0 0.056024663150310516
= O 0 0.046436384320259094
10 O 0 0.003817604389041662
) O 0 0.003049656515941024
and O 0 0.002932541538029909
SCA3 B-Disease 1 0.9998631477355957
/ O 1 0.989395797252655
Machado B-Disease 1 0.9970821738243103
- I-Disease 1 0.7602185010910034
Joseph I-Disease 1 0.9837257266044617
disease I-Disease 1 0.9999915361404419
( O 0 0.010614355094730854
MJD B-Disease 1 0.9998014569282532
) O 0 0.006548415403813124
( O 0 0.005508584436029196
n O 0 0.18531294167041779
= O 0 0.08330291509628296
16 O 0 0.00923644658178091
) O 0 0.00540828937664628
. O 0 0.005779304075986147

In O 0 0.01118473056703806
SCA1 B-Disease 1 0.9844197630882263
, O 0 0.007401184644550085
saccade O 1 0.9946743249893188
amplitude O 0 0.3420361578464508
was O 0 0.004193146713078022
significantly O 0 0.02532258816063404
increased O 0 0.008488067425787449
, O 0 0.0021059508435428143
resulting O 0 0.04158420115709305
in O 0 0.004612946882843971
hypermetria B-Disease 1 0.9890924692153931
. O 0 0.009940885938704014

The O 0 0.006779257208108902
smooth O 0 0.10949813574552536
pursuit O 0 0.0451236218214035
gain O 0 0.013640445657074451
was O 0 0.004453410394489765
decreased O 0 0.07788823544979095
. O 0 0.007826590910553932

In O 0 0.01070515438914299
SCA2 B-Disease 1 0.9870680570602417
, O 0 0.008875464089214802
saccade O 1 0.9944686889648438
velocity O 0 0.060645826160907745
was O 0 0.00817885808646679
markedly O 1 0.5667095184326172
decreased O 0 0.12643539905548096
. O 0 0.008959920145571232

The O 0 0.003780441591516137
percentage O 0 0.007189501076936722
of O 0 0.0015774170169606805
errors O 0 0.0872805044054985
in O 0 0.002822555135935545
antisaccades O 1 0.9859738349914551
was O 0 0.0030586468055844307
greatly O 0 0.010529300197958946
increased O 0 0.00602033082395792
and O 0 0.0012296248460188508
was O 0 0.002312802243977785
significantly O 0 0.08285726606845856
correlated O 1 0.9085263013839722
with O 0 0.0035923239775002003
age O 0 0.009921817108988762
at O 0 0.023825643584132195
disease O 1 0.9999986886978149
onset O 1 0.9998681545257568
. O 0 0.01082080602645874

In O 0 0.00469755195081234
addition O 0 0.004535425454378128
, O 0 0.0015843110159039497
a O 0 0.005729638040065765
correlation O 1 0.5183030366897583
between O 0 0.003821492427960038
smooth O 1 0.6172483563423157
pursuit O 0 0.14341509342193604
gain O 0 0.0061400821432471275
and O 0 0.0005587858613580465
the O 0 0.0006414123927243054
number O 0 0.0011626314371824265
of O 0 0.0021930669900029898
trinucleotide O 1 0.9996156692504883
repeats O 1 0.849875271320343
was O 0 0.002807810204103589
found O 0 0.00685401726514101
. O 0 0.005107820965349674

In O 0 0.013212136924266815
SCA3 B-Disease 1 0.9957672357559204
, O 0 0.006890430580824614
gaze B-Disease 1 0.6937023401260376
- I-Disease 0 0.15621623396873474
evoked I-Disease 1 0.9745755195617676
nystagmus I-Disease 1 0.9998835325241089
was O 0 0.003353752661496401
often O 0 0.0021005473099648952
present O 0 0.0018625401426106691
as O 0 0.0015349963214248419
was O 0 0.004526201635599136
saccade O 1 0.998687207698822
hypometria O 1 0.9539445638656616
and O 0 0.0029702582396566868
smooth O 0 0.16579008102416992
pursuit O 0 0.03168012946844101
gain O 0 0.01034750510007143
was O 0 0.005536293610930443
markedly O 1 0.8971319198608398
decreased O 0 0.16684336960315704
. O 0 0.00813792273402214

Three O 0 0.007484544068574905
major O 0 0.00837401207536459
criteria O 0 0.010578416287899017
, O 0 0.0036154105328023434
saccade O 1 0.9982731342315674
amplitude O 1 0.6258947253227234
, O 0 0.0063646528869867325
saccade O 1 0.998191773891449
velocity O 0 0.04390517994761467
, O 0 0.0014226664789021015
and O 0 0.0009660274372436106
presence O 0 0.006439988035708666
of O 0 0.002177590038627386
gaze B-Disease 1 0.8981575965881348
- I-Disease 0 0.10327701270580292
evoked I-Disease 1 0.9782273769378662
nystagmus I-Disease 1 0.9998573064804077
, O 0 0.0022670235484838486
permitted O 0 0.0030102503951638937
the O 0 0.0016000423347577453
correct O 0 0.021282026544213295
assignment O 0 0.010980208404362202
of O 0 0.0009119600872509181
90 O 0 0.004605675116181374
% O 0 0.002290154341608286
of O 0 0.0006818887195549905
the O 0 0.001847504056058824
SCA1 B-Disease 1 0.9993975162506104
, O 0 0.0016634466592222452
90 O 0 0.004387828521430492
% O 0 0.0022512890864163637
of O 0 0.0007509856368415058
the O 0 0.0018065975746139884
SCA2 B-Disease 1 0.9992369413375854
, O 0 0.0017589284107089043
and O 0 0.0009797627571970224
93 O 0 0.01062853168696165
% O 0 0.0024147650692611933
of O 0 0.0007937733898870647
the O 0 0.00248528434894979
patients O 1 0.9995833039283752
with O 0 0.004072550684213638
SCA3 B-Disease 1 0.9988887906074524
to O 0 0.0013241618871688843
their O 0 0.002233353676274419
genetically O 1 0.9995418787002563
confirmed O 0 0.44284215569496155
patient O 1 0.9996403455734253
group O 0 0.005775781814008951
and O 0 0.001059021451510489
, O 0 0.001123132649809122
therefore O 0 0.0027693675365298986
, O 0 0.0012515151174739003
may O 0 0.004151941742748022
help O 0 0.008047841489315033
orient O 0 0.08083103597164154
diagnoses O 1 0.9996320009231567
of O 0 0.003219927428290248
SCA1 B-Disease 1 0.9989175796508789
, O 0 0.00484464131295681
SCA2 B-Disease 1 0.9986522793769836
, O 0 0.0024203620851039886
and O 0 0.0021806061267852783
SCA3 B-Disease 1 0.9991294741630554
at O 0 0.0036498033441603184
early O 0 0.008866090327501297
clinical O 1 0.998479425907135
stages O 0 0.024785775691270828
of O 0 0.0014560013078153133
the O 0 0.005721423774957657
diseases O 1 0.9999940395355225
. O 0 0.0039575230330228806
. O 0 0.005369006656110287

Genetic O 1 0.9930464625358582
basis O 0 0.006141595542430878
and O 0 0.002596029080450535
molecular O 1 0.996778666973114
mechanism O 1 0.8510514497756958
for O 0 0.01489474531263113
idiopathic B-Disease 1 0.9999991655349731
ventricular I-Disease 1 0.9999938011169434
fibrillation I-Disease 1 0.9999908208847046
. O 0 0.015291929244995117

Ventricular B-Disease 1 0.9999356269836426
fibrillation I-Disease 1 0.9999872446060181
causes O 1 0.9747275710105896
more O 0 0.0017989932093769312
than O 0 0.0015832115896046162
300 O 0 0.004895602818578482
, O 0 0.0020140584092587233
000 O 0 0.025451472029089928
sudden O 1 0.9924353957176208
deaths O 0 0.05011584237217903
each O 0 0.0019049964612349868
year O 0 0.0018961229361593723
in O 0 0.0012357985833659768
the O 0 0.0018432846991345286
USA O 0 0.025606291368603706
alone O 0 0.009842702187597752
. O 0 0.005896583199501038

In O 0 0.004349390976130962
approximately O 0 0.004942769650369883
5 O 0 0.00981853622943163
- O 0 0.011356380768120289
12 O 0 0.003910034894943237
% O 0 0.0023134087678045034
of O 0 0.0005808652495034039
these O 0 0.0011776973260566592
cases O 0 0.006211856845766306
, O 0 0.0006879711290821433
there O 0 0.0005904323188588023
are O 0 0.0006152975838631392
no O 0 0.0038015313912183046
demonstrable O 1 0.9999610185623169
cardiac O 1 0.9999970197677612
or O 0 0.006534056272357702
non O 0 0.13015833497047424
- O 1 0.9986000657081604
cardiac O 1 0.9999992847442627
causes O 1 0.9954197406768799
to O 0 0.0014671394601464272
account O 0 0.0025303817819803953
for O 0 0.0009855180978775024
the O 0 0.0011863777181133628
episode O 0 0.01399187184870243
, O 0 0.0010570432059466839
which O 0 0.000656394986435771
is O 0 0.0010104861576110125
therefore O 0 0.00302855484187603
classified O 0 0.01542277168482542
as O 0 0.011503280140459538
idiopathic B-Disease 1 0.9999995231628418
ventricular I-Disease 1 0.9999970197677612
fibrillation I-Disease 1 0.9999991655349731
( O 0 0.026005757972598076
IVF B-Disease 1 0.9999570846557617
) O 0 0.009446047246456146
. O 0 0.006820724345743656

A O 0 0.017537303268909454
distinct O 0 0.018322499468922615
group O 0 0.008320695720613003
of O 0 0.005009386222809553
IVF B-Disease 1 0.9999985694885254
patients O 1 0.9997095465660095
has O 0 0.001739510684274137
been O 0 0.0012320962268859148
found O 0 0.002128064399585128
to O 0 0.0007522666710428894
present O 0 0.001878411159850657
with O 0 0.002003813860937953
a O 0 0.006576063111424446
characteristic O 1 0.6926932334899902
electrocardiographic O 1 0.9967736601829529
pattern O 1 0.5614875555038452
. O 0 0.007671026978641748

Because O 0 0.006487319711595774
of O 0 0.0009101419127546251
the O 0 0.0010248335311189294
small O 0 0.0028426351491361856
size O 0 0.004348513204604387
of O 0 0.0008507140446454287
most O 0 0.0017545794835314155
pedigrees O 1 0.9744136333465576
and O 0 0.0010653361678123474
the O 0 0.0014498173259198666
high O 0 0.007577528245747089
incidence O 1 0.999292254447937
of O 0 0.002565844915807247
sudden B-Disease 1 0.9994334578514099
death I-Disease 0 0.04389136657118797
, O 0 0.0012268293648958206
however O 0 0.0015488062053918839
, O 0 0.0022008309606462717
molecular O 1 0.9998846054077148
genetic O 1 0.9998914003372192
studies O 0 0.01031546387821436
of O 0 0.002150197047740221
IVF B-Disease 1 0.99998939037323
have O 0 0.001586706843227148
not O 0 0.000921134720556438
yet O 0 0.0023334668949246407
been O 0 0.001599287730641663
done O 0 0.005337475799024105
. O 0 0.006093719974160194

Because O 0 0.053312018513679504
IVF B-Disease 1 0.9999725818634033
causes O 1 0.9998342990875244
cardiac O 1 0.9999958276748657
rhythm O 1 0.9988119602203369
disturbance O 1 0.9955825209617615
, O 0 0.0017390388529747725
we O 0 0.0011399443028494716
investigated O 0 0.01161528192460537
whether O 0 0.0055983467027544975
malfunction O 1 0.9980810880661011
of O 0 0.0023209331557154655
ion O 1 0.9709008932113647
channels O 0 0.02107681892812252
could O 0 0.0038727447390556335
cause O 1 0.5625966191291809
the O 0 0.0036401646211743355
disorder O 1 0.9999653100967407
by O 0 0.003105184528976679
studying O 0 0.014102178625762463
mutations O 1 0.9999425411224365
in O 0 0.0019725363235920668
the O 0 0.005219276528805494
cardiac O 1 0.999993085861206
sodium O 1 0.9991768002510071
channel O 0 0.3067360520362854
gene O 1 0.9997617602348328
SCN5A O 1 0.9909307360649109
. O 0 0.010636110790073872

We O 0 0.0026169377379119396
have O 0 0.0010815132409334183
now O 0 0.001728521310724318
identified O 0 0.00777403125539422
a O 0 0.009707330726087093
missense O 1 0.9998892545700073
mutation O 1 0.9998801946640015
, O 0 0.0027186053339391947
a O 0 0.010031974874436855
splice O 1 0.9998618364334106
- O 1 0.8781258463859558
donor O 1 0.999624490737915
mutation O 1 0.999972939491272
, O 0 0.0019687581807374954
and O 0 0.0012602269416674972
a O 0 0.01148777175694704
frameshift O 1 0.9999600648880005
mutation O 1 0.9999226331710815
in O 0 0.0019505082163959742
the O 0 0.0022116019390523434
coding O 1 0.9961387515068054
region O 0 0.0037458851002156734
of O 0 0.00153359305113554
SCN5A O 1 0.9973437190055847
in O 0 0.0023776949383318424
three O 0 0.007443671580404043
IVF B-Disease 1 0.9999250173568726
families O 0 0.014319708570837975
. O 0 0.007605117280036211

We O 0 0.002466147765517235
show O 0 0.0029920758679509163
that O 0 0.0024710099678486586
sodium O 1 0.9943417310714722
channels O 0 0.015019713900983334
with O 0 0.0020667877979576588
the O 0 0.003918846137821674
missense O 1 0.9999381303787231
mutation O 1 0.999981164932251
recover O 0 0.2208714485168457
from O 0 0.004457020666450262
inactivation O 1 0.9989420771598816
more O 0 0.002060758648440242
rapidly O 0 0.012533762492239475
than O 0 0.0014718298334628344
normal O 0 0.012087229639291763
and O 0 0.0006462519522756338
that O 0 0.0010038462933152914
the O 0 0.0034854277037084103
frameshift O 1 0.9999926090240479
mutation O 1 0.9999916553497314
causes O 1 0.8932924866676331
the O 0 0.0030226458329707384
sodium O 1 0.9959767460823059
channel O 0 0.01762012392282486
to O 0 0.0011904495768249035
be O 0 0.0012343751732259989
non O 0 0.010469707660377026
- O 0 0.027176203206181526
functional O 1 0.6082702875137329
. O 0 0.007418615743517876

Our O 0 0.006485976278781891
results O 0 0.009372996166348457
indicate O 0 0.007890159264206886
that O 0 0.003206957131624222
mutations O 1 0.9999692440032959
in O 0 0.008135886862874031
cardiac O 1 0.9999978542327881
ion O 1 0.9974009990692139
- O 0 0.03594722971320152
channel O 0 0.03946644440293312
genes O 1 0.9990723133087158
contribute O 0 0.010043839924037457
to O 0 0.0008047643350437284
the O 0 0.0016533052548766136
risk O 1 0.7800794839859009
of O 0 0.0023160469718277454
developing O 1 0.9511229991912842
IVF B-Disease 1 0.9999758005142212
. O 0 0.004482362885028124
. O 0 0.005560511723160744

Molecular O 1 0.994868278503418
heterogeneity O 1 0.9828885793685913
in O 0 0.005375312641263008
mucopolysaccharidosis B-Disease 1 0.9994820952415466
IVA I-Disease 1 0.9996892213821411
in O 0 0.0018823345890268683
Australia O 0 0.0021691808942705393
and O 0 0.0008413497125729918
Northern O 0 0.0033278840128332376
Ireland O 0 0.0055040824227035046
: O 0 0.002677673939615488
nine O 0 0.005067829973995686
novel O 0 0.12813597917556763
mutations O 1 0.9999709129333496
including O 0 0.005512080155313015
T312S O 1 0.9889678359031677
, O 0 0.0017118359683081508
a O 0 0.005339471157640219
common O 0 0.01661105453968048
allele O 1 0.9994451403617859
that O 0 0.0033251193817704916
confers O 1 0.9846083521842957
a O 0 0.016081228852272034
mild O 1 0.9987952709197998
phenotype O 1 0.9999634027481079
. O 0 0.013055894523859024

Mucopolysaccharidosis B-Disease 1 0.9965566396713257
IVA I-Disease 1 0.9989625215530396
( O 0 0.01359172910451889
MPS B-Disease 1 0.6494110822677612
IVA I-Disease 1 0.9998568296432495
) O 0 0.005148247350007296
is O 0 0.0021113266702741385
an O 0 0.0074109164997935295
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 0.9999994039535522
lysosomal I-Disease 1 0.9999794960021973
storage I-Disease 1 0.9805623292922974
disorder I-Disease 1 0.9999799728393555
caused O 0 0.07152945548295975
by O 0 0.002357876393944025
a O 0 0.012531960383057594
genetic B-Disease 1 0.9999935626983643
defect I-Disease 1 0.9999011754989624
in O 0 0.004112859722226858
N O 1 0.8888348937034607
- O 0 0.08633577078580856
acetylgalactosamine O 1 0.9979713559150696
- O 0 0.0374029166996479
6 O 0 0.02051571197807789
- O 0 0.49861082434654236
sulfate O 1 0.9998595714569092
sulfatase O 1 0.9998823404312134
( O 0 0.014309737831354141
GALNS O 1 0.9977512955665588
) O 0 0.007050306536257267
. O 0 0.005791813600808382

Previous O 0 0.010573281906545162
studies O 0 0.008140932768583298
of O 0 0.0018159619066864252
patients O 1 0.999024510383606
from O 0 0.002002666238695383
a O 0 0.004924330394715071
British O 0 0.010168314911425114
- O 0 0.01740613952279091
Irish O 0 0.014505419880151749
population O 0 0.0017646360211074352
showed O 0 0.00307632889598608
that O 0 0.0007181272958405316
the O 0 0.0021962434984743595
I113F O 1 0.9998782873153687
mutation O 1 0.9999916553497314
is O 0 0.001330150873400271
the O 0 0.0005889092572033405
most O 0 0.0009866129839792848
common O 0 0.008187576197087765
single O 0 0.01950596459209919
mutation O 1 0.9999723434448242
among O 0 0.007800255436450243
MPS B-Disease 1 0.9886248111724854
IVA I-Disease 1 0.9999949932098389
patients O 1 0.9997034668922424
and O 0 0.0023253674153238535
produces O 0 0.06985727697610855
a O 0 0.018609952181577682
severe O 1 0.9997499585151672
clinical O 1 0.9999390840530396
phenotype O 1 0.9999562501907349
. O 0 0.010358008556067944

We O 0 0.004919690079987049
studied O 0 0.012820531614124775
mutations O 1 0.9998195767402649
in O 0 0.0019049321999773383
the O 0 0.0025187127757817507
GALNS O 1 0.9993436932563782
gene O 1 0.9991076588630676
from O 0 0.0024677468463778496
23 O 0 0.006898353807628155
additional O 0 0.007425676565617323
MPS B-Disease 1 0.9695234894752502
IVA I-Disease 1 0.9999940395355225
patients O 1 0.9998581409454346
( O 0 0.004673332907259464
15 O 0 0.0039422824047505856
from O 0 0.0014261112082749605
Australia O 0 0.0018553457921370864
, O 0 0.001086711185052991
8 O 0 0.004125974141061306
from O 0 0.001574933179654181
Northern O 0 0.004010137170553207
Ireland O 0 0.006762640085071325
) O 0 0.002129945671185851
, O 0 0.0007624017889611423
with O 0 0.0012953422265127301
various O 0 0.003374664578586817
clinical O 1 0.9999725818634033
phenotypes O 1 0.999993085861206
( O 0 0.008632654324173927
severe O 1 0.9987173080444336
, O 0 0.0019917618483304977
16 O 0 0.00687932875007391
cases O 0 0.013399976305663586
; O 0 0.00434458814561367
intermediate O 1 0.5814366936683655
, O 0 0.001817492418922484
4 O 0 0.009090477600693703
cases O 0 0.02835092321038246
; O 0 0.008187341503798962
mild O 1 0.9969550371170044
, O 0 0.002391438465565443
3 O 0 0.00964330043643713
cases O 0 0.013346531428396702
) O 0 0.005067912396043539
. O 0 0.00556422583758831

We O 0 0.002889394061639905
found O 0 0.0034445682540535927
two O 0 0.002597097074612975
common O 0 0.026592131704092026
mutations O 1 0.9999616146087646
that O 0 0.0014270030660554767
together O 0 0.0024664923548698425
accounted O 0 0.008012425154447556
for O 0 0.0012827720493078232
32 O 0 0.005625981837511063
% O 0 0.0021329475566744804
of O 0 0.0005438777152448893
the O 0 0.0014089904725551605
44 O 0 0.017038878053426743
unrelated O 1 0.9871612191200256
alleles O 1 0.9998301267623901
in O 0 0.0027841716073453426
these O 0 0.003868089523166418
patients O 1 0.9994729161262512
. O 0 0.007019927259534597

One O 0 0.0044864933006465435
is O 0 0.0021377159282565117
the O 0 0.0030774991028010845
T312S O 1 0.99872225522995
mutation O 1 0.9999521970748901
, O 0 0.0024207294918596745
a O 0 0.006113882642239332
novel O 0 0.08767766505479813
mutation O 1 0.9999667406082153
found O 0 0.007082364056259394
exclusively O 0 0.007372790947556496
in O 0 0.005169756710529327
milder O 1 0.9995706677436829
patients O 1 0.9994057416915894
. O 0 0.009039822034537792

The O 0 0.003414360573515296
other O 0 0.0011786624090746045
is O 0 0.001047663390636444
the O 0 0.0010405885986983776
previously O 0 0.0028614955954253674
described O 0 0.008623297326266766
I113F O 1 0.981573224067688
that O 0 0.002287243725731969
produces O 0 0.030021492391824722
a O 0 0.02008127234876156
severe O 1 0.9994944334030151
phenotype O 1 0.9999629259109497
. O 0 0.011818832717835903

The O 0 0.007542124018073082
I113F O 1 0.7376303672790527
and O 0 0.0044329906813800335
T312S O 1 0.9987245202064514
mutations O 1 0.9999679327011108
accounted O 0 0.013579345308244228
for O 0 0.0018572267144918442
8 O 0 0.006760782562196255
( O 0 0.002735471585765481
18 O 0 0.00417333235964179
% O 0 0.003890326013788581
) O 0 0.002382936654612422
and O 0 0.0011384283425286412
6 O 0 0.005529084242880344
( O 0 0.0023823108058422804
14 O 0 0.0045510511845350266
% O 0 0.003495106240734458
) O 0 0.0016765845939517021
of O 0 0.0010388275841251016
44 O 0 0.016917038708925247
unrelated O 1 0.9958556294441223
alleles O 1 0.9998729228973389
, O 0 0.0033624630887061357
respectively O 0 0.00790006760507822
. O 0 0.005845042876899242

The O 0 0.004882406443357468
relatively O 0 0.010834942571818829
high O 0 0.01030239649116993
residual O 1 0.9807730913162231
GALNS O 1 0.995032787322998
activity O 0 0.012456895783543587
seen O 0 0.0043662297539412975
when O 0 0.002475851448252797
the O 0 0.0029193453956395388
T312S O 1 0.9878586530685425
mutant O 1 0.9960707426071167
cDNA O 1 0.9843036532402039
is O 0 0.005758501123636961
overexpressed O 1 0.9925974607467651
in O 0 0.005912526044994593
mutant O 1 0.9997634291648865
cells O 1 0.9994825124740601
provides O 0 0.006668712943792343
an O 0 0.001447188900783658
explanation O 0 0.008264892734587193
for O 0 0.0011493476340547204
the O 0 0.0029176082462072372
mild O 1 0.9998832941055298
phenotype O 1 0.999996542930603
in O 0 0.005431405268609524
patients O 1 0.9990561604499817
with O 0 0.003773338859900832
this O 0 0.004362719599157572
mutation O 1 0.9999805688858032
. O 0 0.008956465870141983

The O 0 0.004484921228140593
distribution O 0 0.012336241081357002
and O 0 0.0014481635298579931
relative O 0 0.00831565260887146
frequencies O 0 0.013706834055483341
of O 0 0.0008565654861740768
the O 0 0.0018476342083886266
I113F O 1 0.9881812930107117
and O 0 0.0042670611292123795
T312S O 1 0.9996380805969238
mutations O 1 0.9998089671134949
in O 0 0.0020000545773655176
Australia O 0 0.0028145713731646538
corresponded O 0 0.011087940074503422
to O 0 0.000921627739444375
those O 0 0.0010073718149214983
observed O 0 0.005869755055755377
in O 0 0.0009991942206397653
Northern O 0 0.0029995993245393038
Ireland O 0 0.0043784393928945065
and O 0 0.0007136579370126128
are O 0 0.0004602201224770397
unique O 0 0.0023866593837738037
to O 0 0.0005301427445374429
these O 0 0.0006607285467907786
two O 0 0.0015011951327323914
populations O 0 0.028720129281282425
, O 0 0.0012680117506533861
suggesting O 0 0.008540820330381393
that O 0 0.000905946537386626
both O 0 0.0029550492763519287
mutations O 1 0.999977707862854
were O 0 0.0011003996478393674
probably O 0 0.0037270360626280308
introduced O 0 0.0037456394638866186
to O 0 0.0008726689266040921
Australia O 0 0.0016480513149872422
by O 0 0.0020763089414685965
Irish O 0 0.013298830017447472
migrants O 0 0.007086959667503834
during O 0 0.002358613768592477
the O 0 0.0014924443094059825
19th O 0 0.006423255428671837
century O 0 0.006033462006598711
. O 0 0.00594870001077652

Haplotype O 1 0.9977509379386902
analysis O 0 0.021599113941192627
using O 0 0.008538531139492989
6 O 0 0.008578036911785603
RFLPs O 1 0.9587367177009583
provides O 0 0.005852057132869959
additional O 0 0.002761393552646041
data O 0 0.002464871620759368
that O 0 0.0007910466520115733
the O 0 0.0023028277792036533
I113F O 1 0.9991018772125244
mutation O 1 0.9999592304229736
originated O 0 0.018698379397392273
from O 0 0.0016351740341633558
a O 0 0.005380649119615555
common O 0 0.015242901630699635
ancestor O 1 0.7365846633911133
. O 0 0.006980590056627989

The O 0 0.003317057155072689
other O 0 0.0019147953717038035
9 O 0 0.009355435147881508
novel O 0 0.15431158244609833
mutations O 1 0.9999814033508301
identified O 0 0.010210885666310787
in O 0 0.00115154217928648
these O 0 0.0014474239433184266
23 O 0 0.010632127523422241
patients O 1 0.9989169836044312
were O 0 0.0006525760400108993
each O 0 0.0013066304381936789
limited O 0 0.0025776131078600883
to O 0 0.0009086463833227754
a O 0 0.003997716121375561
single O 0 0.010206473059952259
family O 0 0.013653147965669632
. O 0 0.006997079588472843

These O 0 0.002022100379690528
data O 0 0.0031769927591085434
provide O 0 0.00249681924469769
further O 0 0.002011384116485715
evidence O 0 0.0019424749771133065
for O 0 0.0017672545509412885
extensive O 0 0.022221915423870087
allelic O 1 0.9983561635017395
heterogeneity O 1 0.9923251867294312
in O 0 0.0037070713005959988
MPS B-Disease 1 0.5731625556945801
IVA I-Disease 1 0.999904990196228
in O 0 0.0032277267891913652
British O 0 0.012001525610685349
- O 0 0.294102281332016
Irish O 1 0.7734102010726929
patients O 1 0.9996243715286255
and O 0 0.0010936497710645199
provide O 0 0.0022696100641041994
evidence O 0 0.0017052817856892943
for O 0 0.0009074709960259497
their O 0 0.0019024142529815435
transmission O 1 0.9782182574272156
to O 0 0.0010141120292246342
Australia O 0 0.0020688371732831
by O 0 0.0023551727645099163
British O 0 0.010421150363981724
- O 0 0.021195443347096443
Irish O 0 0.019801411777734756
migrants O 0 0.013217832893133163
. O 0 0.0025760100688785315
. O 0 0.005272787995636463

Identification O 0 0.028992652893066406
of O 0 0.002465818077325821
constitutional O 0 0.02356286533176899
WT1 O 1 0.9999873638153076
mutations O 1 0.9999778270721436
, O 0 0.002441086806356907
in O 0 0.00274503231048584
patients O 1 0.9995778203010559
with O 0 0.005829875823110342
isolated O 1 0.9953792095184326
diffuse B-Disease 1 0.9999921321868896
mesangial I-Disease 1 0.9999992847442627
sclerosis I-Disease 1 0.9999996423721313
, O 0 0.003568807616829872
and O 0 0.0012680129148066044
analysis O 0 0.010925241746008396
of O 0 0.003409091616049409
genotype O 1 0.9999898672103882
/ O 1 0.9980127811431885
phenotype O 1 0.9999750852584839
correlations O 1 0.9515233635902405
by O 0 0.0019710182677954435
use O 0 0.001990680582821369
of O 0 0.0009132687118835747
a O 0 0.007667812053114176
computerized O 1 0.9982290863990784
mutation O 1 0.9999475479125977
database O 0 0.08287990838289261
. O 0 0.007781223859637976

Constitutional O 0 0.030818914994597435
mutations O 1 0.9985238909721375
of O 0 0.00186249113176018
the O 0 0.005093270447105169
WT1 O 1 0.9999668598175049
gene O 1 0.999441921710968
, O 0 0.003211954375728965
encoding O 1 0.804951548576355
a O 0 0.011745220981538296
zinc O 1 0.9986886382102966
- O 0 0.06339295953512192
finger O 1 0.9892001152038574
transcription O 1 0.9991362690925598
factor O 0 0.03819786757230759
involved O 0 0.009276059456169605
in O 0 0.0053769806399941444
renal O 1 0.999998927116394
and O 0 0.005891856271773577
gonadal O 1 0.9999678134918213
development O 0 0.008413192816078663
, O 0 0.0010285823373124003
are O 0 0.00047190210898406804
found O 0 0.002503808354958892
in O 0 0.001043490250594914
most O 0 0.0026294097770005465
patients O 1 0.9994499087333679
with O 0 0.008652043528854847
Denys B-Disease 1 0.9999778270721436
- I-Disease 1 0.997689962387085
Drash I-Disease 1 0.9999707937240601
syndrome I-Disease 1 0.9999995231628418
( O 0 0.019193777814507484
DDS B-Disease 1 0.9999709129333496
) O 0 0.005320288706570864
, O 0 0.002433811081573367
or O 0 0.012393773533403873
diffuse B-Disease 1 0.9999890327453613
mesangial I-Disease 1 0.999998927116394
sclerosis I-Disease 1 0.9999998807907104
( O 0 0.0246408861130476
DMS B-Disease 1 0.9999005794525146
) O 0 0.005892420187592506
associated O 0 0.00750085199251771
with O 0 0.003189790528267622
pseudohermaphroditism B-Disease 1 0.9992786049842834
and O 0 0.0038977875374257565
/ O 1 0.9741645455360413
or O 0 0.128288134932518
Wilms B-Disease 1 0.9999984502792358
tumor I-Disease 1 0.9999961853027344
( O 0 0.019355174154043198
WT B-Disease 1 0.9995980858802795
) O 0 0.009570606052875519
. O 0 0.007635710295289755

Most O 0 0.013088634237647057
mutations O 1 0.999824583530426
in O 0 0.010611331090331078
DDS B-Disease 1 0.9999744892120361
patients O 1 0.9995104074478149
lie O 0 0.012357579544186592
in O 0 0.0032285552006214857
exon O 1 0.9982948899269104
8 O 0 0.011429356411099434
or O 0 0.006201765034347773
exon O 1 0.9962279796600342
9 O 0 0.009864679537713528
, O 0 0.002834158483892679
encoding O 1 0.9921848177909851
zinc O 1 0.9974462985992432
finger O 1 0.9196181893348694
2 O 0 0.010439051315188408
or O 0 0.007467425428330898
zinc O 1 0.9994145631790161
finger O 1 0.9960737228393555
3 O 0 0.007937506772577763
, O 0 0.0014332818100228906
respectively O 0 0.0030235457234084606
, O 0 0.0009375418885610998
with O 0 0.0015550465323030949
a O 0 0.004202217794954777
hot O 0 0.012902799993753433
spot O 0 0.014912093058228493
( O 0 0.005692475009709597
R394W O 1 0.993482768535614
) O 0 0.0043647559359669685
in O 0 0.003288345178589225
exon O 1 0.9954884648323059
9 O 0 0.01789572648704052
. O 0 0.007224366534501314

We O 0 0.004058260004967451
analyzed O 0 0.01726394332945347
a O 0 0.004953076131641865
series O 0 0.004841458518058062
of O 0 0.0014002209063619375
24 O 0 0.01327694021165371
patients O 1 0.9996343851089478
, O 0 0.0017690202221274376
10 O 0 0.0031754346564412117
with O 0 0.003951665014028549
isolated B-Disease 1 0.9083497524261475
DMS I-Disease 1 0.9999531507492065
( O 0 0.016090383753180504
IDMS B-Disease 1 0.9999799728393555
) O 0 0.004617153201252222
, O 0 0.001290606684051454
10 O 0 0.0031144500244408846
with O 0 0.005944985430687666
DDS B-Disease 1 0.9999147653579712
, O 0 0.0018337360816076398
and O 0 0.0011371446307748556
4 O 0 0.0066849300637841225
with O 0 0.007096972782164812
urogenital B-Disease 1 0.9999865293502808
abnormalities I-Disease 1 0.9999951124191284
and O 0 0.004291843622922897
/ O 1 0.899398684501648
or O 0 0.012464911676943302
WT B-Disease 1 0.9995313882827759
. O 0 0.010864892043173313

We O 0 0.004979507066309452
report O 0 0.010139045305550098
WT1 O 1 0.9998631477355957
heterozygous O 1 0.9998007416725159
mutations O 1 0.9999016523361206
in O 0 0.004318005405366421
16 O 0 0.014136089943349361
patients O 1 0.999861478805542
, O 0 0.001553841750137508
4 O 0 0.004030853975564241
of O 0 0.000875706784427166
whom O 0 0.0032203802838921547
presented O 0 0.0042877476662397385
with O 0 0.007454784587025642
IDMS B-Disease 1 0.9998883008956909
. O 0 0.010327660478651524

One O 0 0.005937913432717323
male O 0 0.017598889768123627
and O 0 0.0014256861759349704
two O 0 0.0030523876193910837
female O 1 0.7361905574798584
IDMS B-Disease 1 0.9999918937683105
patients O 1 0.9995030164718628
with O 0 0.014085992239415646
WT1 O 1 0.999984622001648
mutations O 1 0.9999821186065674
underwent O 1 0.9990200996398926
normal O 1 0.6988885998725891
puberty O 1 0.9989542961120605
. O 0 0.00981634110212326

Two O 0 0.01396254263818264
mutations O 1 0.9999359846115112
associated O 0 0.016498887911438942
with O 0 0.005833276081830263
IDMS B-Disease 1 0.9998751878738403
are O 0 0.0011272318661212921
different O 0 0.0010945715475827456
from O 0 0.0011691598920151591
those O 0 0.001267320360057056
described O 0 0.008390874601900578
in O 0 0.007156740874052048
DDS B-Disease 1 0.9999901056289673
patients O 1 0.9995394945144653
. O 0 0.009449095465242863

No O 0 0.02749655954539776
WT1 O 1 0.9999017715454102
mutations O 1 0.9998206496238708
were O 0 0.0029943829867988825
detected O 0 0.08488815277814865
in O 0 0.0010640687542036176
the O 0 0.0010892001446336508
six O 0 0.004273263271898031
other O 0 0.006019783206284046
IDMS B-Disease 1 0.9999977350234985
patients O 1 0.9997273087501526
, O 0 0.0025131579022854567
suggesting O 0 0.08767957240343094
genetic O 1 0.999933123588562
heterogeneity O 1 0.9960739612579346
of O 0 0.001732839155010879
this O 0 0.00486264331266284
disease O 1 0.9999895095825195
. O 0 0.008204245008528233

We O 0 0.006544929463416338
analyzed O 0 0.07020276039838791
genotype O 1 0.9999194145202637
/ O 1 0.998578667640686
phenotype O 1 0.9999901056289673
correlations O 1 0.9935187697410583
, O 0 0.0011613508686423302
on O 0 0.0006494459812529385
the O 0 0.0006698766374029219
basis O 0 0.0015161356423050165
of O 0 0.0005110235651955009
the O 0 0.0007819139864295721
constitution O 0 0.002223839983344078
of O 0 0.0008616761770099401
a O 0 0.011953772976994514
WT1 O 1 0.9999774694442749
mutation O 1 0.9998370409011841
database O 0 0.029531100764870644
of O 0 0.0021941587328910828
84 O 0 0.07150997966527939
germ O 1 0.9996160268783569
- O 0 0.04942016303539276
line O 0 0.020657725632190704
mutations O 1 0.9999730587005615
, O 0 0.0015590889379382133
to O 0 0.0009395499364472926
compare O 0 0.008104000240564346
the O 0 0.0009643206722103059
distribution O 0 0.007918431423604488
and O 0 0.0010173115879297256
type O 0 0.15966147184371948
of O 0 0.0028948215767741203
mutations O 1 0.9999947547912598
, O 0 0.0014459063531830907
according O 0 0.0010727319167926908
to O 0 0.0008095606463029981
the O 0 0.00147343915887177
different O 0 0.006775951478630304
symptoms O 1 0.9998652935028076
. O 0 0.00969957746565342

This O 0 0.003931967541575432
demonstrated O 0 0.015738682821393013
( O 0 0.004321593325585127
1 O 0 0.004878940526396036
) O 0 0.0017665326595306396
the O 0 0.000972996698692441
association O 0 0.004395408555865288
between O 0 0.004742898512631655
mutations O 1 0.9999533891677856
in O 0 0.0037290602922439575
exons O 1 0.9983720183372498
8 O 0 0.006735846400260925
and O 0 0.0011637925636023283
9 O 0 0.00714366789907217
and O 0 0.003548871725797653
DMS B-Disease 1 0.9999755620956421
; O 0 0.006042877212166786
( O 0 0.00325757940299809
2 O 0 0.00667224545031786
) O 0 0.0030913434457033873
among O 0 0.004193493165075779
patients O 1 0.9996927976608276
with O 0 0.006128659937530756
DMS B-Disease 1 0.9999305009841919
, O 0 0.0017947329906746745
a O 0 0.003263521008193493
higher O 0 0.004096108954399824
frequency O 0 0.016520164906978607
of O 0 0.002077906159684062
exon O 1 0.9990309476852417
8 O 0 0.02109229378402233
mutations O 1 0.9999141693115234
among O 0 0.004240437410771847
46 O 0 0.014708628877997398
, O 0 0.005082597024738789
XY O 1 0.9999819993972778
patients O 1 0.9990405440330505
with O 0 0.004394361283630133
female O 0 0.26924780011177063
phenotype O 1 0.9999682903289795
than O 0 0.002132267691195011
among O 0 0.0024481425061821938
46 O 0 0.01447626855224371
, O 0 0.005105836316943169
XY O 1 0.9999897480010986
patients O 1 0.9992356300354004
with O 0 0.003546090330928564
sexual O 0 0.01569044031202793
ambiguity O 0 0.16993556916713715
or O 0 0.006701796315610409
male O 1 0.9976955056190491
phenotype O 1 0.9999982118606567
; O 0 0.004327142611145973
and O 0 0.0013617296935990453
( O 0 0.0036346949636936188
3 O 0 0.006312103010714054
) O 0 0.002244218485429883
statistically O 0 0.012902593240141869
significant O 0 0.0026664268225431442
evidence O 0 0.002406636020168662
that O 0 0.0022668796591460705
mutations O 1 0.9998661279678345
in O 0 0.003393527353182435
exons O 1 0.9975161552429199
8 O 0 0.007046741899102926
and O 0 0.0015189946861937642
9 O 0 0.008707044646143913
preferentially O 1 0.7099304795265198
affect O 0 0.03223460167646408
amino O 1 0.9890521168708801
acids O 1 0.9593789577484131
with O 0 0.0021448417101055384
different O 0 0.0019257355015724897
functions O 0 0.007739612832665443
. O 0 0.002514470601454377
. O 0 0.004858447704464197

The O 0 0.01630956120789051
185delAG O 1 0.9987651109695435
BRCA1 O 1 0.999995231628418
mutation O 1 0.9999409914016724
originated O 0 0.022704649716615677
before O 0 0.0025299296248704195
the O 0 0.001421178225427866
dispersion O 0 0.4705311954021454
of O 0 0.0009912386303767562
Jews O 0 0.0018877247348427773
in O 0 0.0009470409131608903
the O 0 0.0013521789805963635
diaspora O 0 0.01694302074611187
and O 0 0.001109384116716683
is O 0 0.0011097679380327463
not O 0 0.000907989451661706
limited O 0 0.0035910271108150482
to O 0 0.0024321863893419504
Ashkenazim O 1 0.9737522602081299
. O 0 0.007523608859628439

The O 0 0.01021510735154152
185delAG O 1 0.9962795376777649
mutation O 1 0.9999254941940308
in O 0 0.009272133931517601
BRCA1 O 1 0.9999971389770508
is O 0 0.004380497615784407
detected O 0 0.27536705136299133
in O 0 0.002203013515099883
Ashkenazi O 1 0.8765031695365906
Jews O 0 0.002964722691103816
both O 0 0.0018092409009113908
in O 0 0.006029786076396704
familial B-Disease 1 0.9999996423721313
breast I-Disease 1 0.9999997615814209
and I-Disease 1 0.9639885425567627
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
and O 0 0.0017001283122226596
in O 0 0.0010178980883210897
the O 0 0.0013455438893288374
general O 0 0.0032611736096441746
population O 0 0.004742038901895285
. O 0 0.006122769322246313

All O 0 0.0054369643330574036
tested O 0 0.17891529202461243
Ashkenazi O 1 0.998035728931427
mutation O 1 0.9999732971191406
carriers O 0 0.4014826714992523
share O 0 0.004842756316065788
the O 0 0.001305108773522079
same O 0 0.0042596482671797276
allelic O 1 0.9980517625808716
pattern O 0 0.043255314230918884
at O 0 0.0043152738362550735
the O 0 0.0069044651463627815
BRCA1 O 1 0.9999984502792358
locus O 1 0.9991607666015625
. O 0 0.011482845060527325

Our O 0 0.005687076598405838
previous O 0 0.0043112351559102535
study O 0 0.004995062947273254
showed O 0 0.003152446122840047
that O 0 0.0009544689091853797
this O 0 0.0022658598609268665
Ashkenazi O 1 0.999835729598999
mutation O 1 0.9999854564666748
also O 0 0.0028156409971415997
occurs O 0 0.018843555822968483
in O 0 0.0012262774398550391
Iraqi O 0 0.004026748239994049
Jews O 0 0.002413048641756177
with O 0 0.0018719726940616965
a O 0 0.005309323314577341
similar O 0 0.013300213031470776
allelic O 1 0.9992803931236267
pattern O 0 0.4040864408016205
. O 0 0.008243962191045284

We O 0 0.003268006956204772
extended O 0 0.005451474338769913
our O 0 0.002362396800890565
analysis O 0 0.006069522351026535
to O 0 0.000848359486553818
other O 0 0.0011086830636486411
non O 0 0.008694171905517578
- O 0 0.02965373918414116
Ashkenazi O 1 0.9740543961524963
subsets O 0 0.1441093534231186
354 O 0 0.04437550529837608
of O 0 0.0017663175240159035
Moroccan O 0 0.02968299388885498
origin O 0 0.0069104391150176525
, O 0 0.0013929257402196527
200 O 0 0.005999038927257061
Yemenites O 1 0.9635130763053894
and O 0 0.0019047744572162628
150 O 0 0.005971410311758518
Iranian O 0 0.005137092899531126
Jews O 0 0.004996802657842636
. O 0 0.006141574587672949

Heteroduplex O 1 0.7931559681892395
analysis O 0 0.027677692472934723
complemented O 0 0.03815221041440964
by O 0 0.003556616371497512
direct O 0 0.01415183488279581
DNA O 1 0.9961341619491577
sequencing O 1 0.9863955974578857
of O 0 0.0035508652217686176
abnormally O 1 0.9986931681632996
migrating O 0 0.2107456475496292
bands O 0 0.011018002405762672
were O 0 0.0014176719123497605
employed O 0 0.008817207999527454
. O 0 0.004866572562605143

Four O 0 0.004415201488882303
of O 0 0.001584614161401987
Moroccan O 0 0.030643491074442863
origin O 0 0.009615771472454071
( O 0 0.0034833746030926704
1 O 0 0.004794224631041288
. O 0 0.0012680267682299018
1 O 0 0.004477555397897959
% O 0 0.004145088139921427
) O 0 0.0017040222883224487
and O 0 0.0005790645373053849
none O 0 0.0019400101155042648
of O 0 0.0005615285481326282
the O 0 0.0018771403701975942
Yemenites O 1 0.9974853992462158
or O 0 0.0033550728112459183
Iranians O 0 0.005629573483020067
was O 0 0.0012685793917626143
a O 0 0.004388828761875629
carrier O 0 0.029574040323495865
of O 0 0.0013489555567502975
the O 0 0.0039377762004733086
185delAG O 1 0.9990637898445129
mutation O 1 0.9999524354934692
. O 0 0.011088347062468529

BRCA1 O 1 0.9999529123306274
allelic O 1 0.9975066781044006
patterns O 0 0.042043089866638184
were O 0 0.0012794937938451767
determined O 0 0.004760411102324724
for O 0 0.0009087402722798288
four O 0 0.0010900377528741956
of O 0 0.0004524441610556096
these O 0 0.0009422150906175375
individuals O 0 0.0024599579628556967
and O 0 0.0006645796820521355
for O 0 0.0009150735568255186
12 O 0 0.003061725292354822
additional O 0 0.004377010278403759
non O 0 0.010067974217236042
- O 0 0.07997262477874756
Ashkenazi O 1 0.9986155033111572
185delAG O 1 0.999055802822113
mutation O 1 0.9999662637710571
carriers O 1 0.6138549447059631
who O 0 0.0055277650244534016
had O 0 0.07518964260816574
breast B-Disease 1 0.9999995231628418
/ I-Disease 1 0.9999773502349854
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999974966049194
. O 0 0.013288134709000587

Six O 0 0.017979102209210396
non O 0 0.021673480048775673
- O 0 0.038760956376791
Ashkenazi O 1 0.9047696590423584
individuals O 0 0.005175660829991102
shared O 0 0.004288448486477137
the O 0 0.0016888612881302834
common O 0 0.030947932973504066
Ashkenazi O 1 0.9997598528862
haplotype O 1 0.999936580657959
, O 0 0.0017517388332635164
four O 0 0.0015950220404192805
had O 0 0.0012224498204886913
a O 0 0.003367614233866334
closely O 0 0.006424329709261656
related O 0 0.013575449585914612
pattern O 0 0.4516972601413727
, O 0 0.0009401153074577451
and O 0 0.000746196776162833
the O 0 0.00118497502990067
rest O 0 0.004733314737677574
( O 0 0.004943494684994221
n O 1 0.5689026117324829
= O 0 0.14551590383052826
6 O 0 0.00603492371737957
) O 0 0.0021145520731806755
displayed O 0 0.004190449602901936
a O 0 0.007278241217136383
distinct O 0 0.3313598334789276
BRCA1 O 1 0.9999942779541016
allelic O 1 0.9991127848625183
pattern O 1 0.507359504699707
. O 0 0.010721033439040184

We O 0 0.0032863894011825323
conclude O 0 0.011637166142463684
that O 0 0.001336938701570034
the O 0 0.003490038216114044
185delAG O 1 0.9997931122779846
BRCA1 O 1 0.9999994039535522
mutation O 1 0.9999896287918091
occurs O 0 0.06544789671897888
in O 0 0.001172996824607253
some O 0 0.001369099016301334
non O 0 0.010486655868589878
- O 0 0.1075768917798996
Ashkenazi O 1 0.9969683289527893
populations O 0 0.023271799087524414
at O 0 0.003473432268947363
rates O 0 0.01138389389961958
comparable O 0 0.012674493715167046
with O 0 0.002061819890514016
that O 0 0.001124679110944271
of O 0 0.002631081035360694
Ashkenazim O 1 0.9833136200904846
. O 0 0.010269527323544025

The O 0 0.0030688359402120113
majority O 0 0.004065841436386108
of O 0 0.0014324261574074626
Jewish O 0 0.013818744570016861
185delAG O 1 0.9994953870773315
mutation O 1 0.9999852180480957
carriers O 0 0.28868257999420166
have O 0 0.0012663104571402073
a O 0 0.004427076783031225
common O 0 0.02046680636703968
allelic O 1 0.9996949434280396
pattern O 0 0.4856204688549042
, O 0 0.0017884456319734454
supporting O 0 0.004985552281141281
the O 0 0.0015229579294100404
founder O 0 0.021294811740517616
effect O 0 0.013203423470258713
notion O 0 0.010621507652103901
, O 0 0.00118635268881917
but O 0 0.0010077423648908734
dating O 0 0.0069936844520270824
the O 0 0.002794161206111312
mutations O 1 0.9999692440032959
origin O 0 0.004043957684189081
to O 0 0.0007172111072577536
an O 0 0.0010375679703429341
earlier O 0 0.0025157041382044554
date O 0 0.002875549253076315
than O 0 0.0009928386425599456
currently O 0 0.0016461411723867059
estimated O 0 0.0075929732993245125
. O 0 0.005138450767844915

However O 0 0.00540480250492692
, O 0 0.0010688615730032325
the O 0 0.0008773620356805623
different O 0 0.0031817227136343718
allelic O 1 0.9989529848098755
pattern O 0 0.04401538148522377
at O 0 0.0027489394415169954
the O 0 0.0050671761855483055
BRCA1 O 1 0.9999986886978149
locus O 1 0.9993245601654053
even O 0 0.0027342671528458595
in O 0 0.0009273027535527945
some O 0 0.0014116296079009771
Jewish O 0 0.019003231078386307
mutation O 1 0.9999959468841553
carriers O 1 0.9639266133308411
, O 0 0.0017862831009551883
might O 0 0.0033937806729227304
suggest O 0 0.004446625243872404
that O 0 0.0011147031327709556
the O 0 0.003181982785463333
mutation O 1 0.9999837875366211
arose O 0 0.029335718601942062
independently O 0 0.011006238870322704
. O 0 0.003020412288606167
. O 0 0.004830748774111271

Crystal O 0 0.05835682898759842
structure O 0 0.011956483125686646
of O 0 0.0016596349887549877
the O 0 0.006806422024965286
hemochromatosis B-Disease 1 0.9999961853027344
protein O 1 0.9997705817222595
HFE O 1 0.999521017074585
and O 0 0.003169564064592123
characterization O 0 0.025098150596022606
of O 0 0.0009021839941851795
its O 0 0.002122166333720088
interaction O 0 0.025140944868326187
with O 0 0.006745404563844204
transferrin O 1 0.9995641112327576
receptor O 1 0.9989092350006104
. O 0 0.008870374411344528

HFE O 1 0.99755859375
is O 0 0.00538512971252203
an O 0 0.006925757043063641
MHC O 1 0.9999219179153442
- O 0 0.03946894034743309
related O 0 0.02210177481174469
protein O 1 0.9975872039794922
that O 0 0.001813472481444478
is O 0 0.0023823485244065523
mutated O 1 0.9993919134140015
in O 0 0.001691534067504108
the O 0 0.002608284819871187
iron B-Disease 1 0.9923391342163086
- I-Disease 1 0.9978756904602051
overload I-Disease 1 0.9999772310256958
disease I-Disease 1 0.9999980926513672
hereditary B-Disease 1 0.9999876022338867
hemochromatosis I-Disease 1 0.9999936819076538
. O 0 0.02173997089266777

HFE O 1 0.9969793558120728
binds O 1 0.8876323103904724
to O 0 0.008043887093663216
transferrin O 1 0.998777449131012
receptor O 1 0.9992443323135376
( O 0 0.011221712455153465
TfR O 1 0.9994139671325684
) O 0 0.0032525286078453064
and O 0 0.0012170292902737856
reduces O 1 0.5333046317100525
its O 0 0.0032444610260427
affinity O 1 0.8053935766220093
for O 0 0.003346298821270466
iron O 0 0.20393647253513336
- O 0 0.025038693100214005
loaded O 0 0.03230816125869751
transferrin O 1 0.992742657661438
, O 0 0.005643803160637617
implicating O 1 0.9891828894615173
HFE O 1 0.99915611743927
in O 0 0.006861440371721983
iron O 1 0.6092126965522766
metabolism O 1 0.9993916749954224
. O 0 0.010581305250525475

The O 0 0.0089114336296916
2 O 0 0.015455837361514568
. O 0 0.008388143964111805

6 O 0 0.016818039119243622
A O 0 0.013400217518210411
crystal O 0 0.03588792681694031
structure O 0 0.011755308136343956
of O 0 0.0024878960102796555
HFE O 1 0.9997896552085876
reveals O 0 0.018473906442523003
the O 0 0.0011602157028391957
locations O 0 0.005233211442828178
of O 0 0.003939556889235973
hemochromatosis B-Disease 1 0.999998927116394
mutations O 1 0.9999645948410034
and O 0 0.0019529288401827216
a O 0 0.0068086888641119
patch O 1 0.9986017346382141
of O 0 0.0022570202127099037
histidines O 1 0.9955398440361023
that O 0 0.0013800825690850616
could O 0 0.0014552173670381308
be O 0 0.0009153677383437753
involved O 0 0.0045122550800442696
in O 0 0.003860393539071083
pH O 1 0.9998134970664978
- O 0 0.03299621492624283
dependent O 0 0.03125742822885513
interactions O 0 0.1925303041934967
. O 0 0.006091299932450056

We O 0 0.0024882748257368803
also O 0 0.0011736551532521844
demonstrate O 0 0.007226924411952496
that O 0 0.0028466186486184597
soluble O 1 0.9990240335464478
TfR O 1 0.9986786246299744
and O 0 0.005772239062935114
HFE O 1 0.9999176263809204
bind O 1 0.9884588122367859
tightly O 0 0.02481100894510746
at O 0 0.0016742980806156993
the O 0 0.0010438805911689997
basic O 0 0.007417063694447279
pH O 1 0.9974741339683533
of O 0 0.0010023810900747776
the O 0 0.00259058247320354
cell O 1 0.9997420907020569
surface O 0 0.01550480630248785
, O 0 0.0012480837758630514
but O 0 0.0009376947418786585
not O 0 0.0006339655956253409
at O 0 0.0012530513340607285
the O 0 0.002641077386215329
acidic O 1 0.9976512789726257
pH O 1 0.9978511333465576
of O 0 0.004601099994033575
intracellular O 1 0.999657392501831
vesicles O 1 0.9984142780303955
. O 0 0.010564913973212242

TfR O 1 0.9897444844245911
HFE O 1 0.9985785484313965
stoichiometry O 1 0.9855822920799255
( O 0 0.009983613155782223
2 O 0 0.009110025130212307
1 O 0 0.00643940782174468
) O 0 0.0030056957621127367
differs O 0 0.021544991061091423
from O 0 0.0051107946783304214
TfR O 1 0.9988448619842529
transferrin O 1 0.9991487264633179
stoichiometry O 1 0.9964750409126282
( O 0 0.005606727674603462
2 O 0 0.007505740970373154
2 O 0 0.006837379187345505
) O 0 0.0023095288779586554
, O 0 0.0012840537820011377
implying O 0 0.021711058914661407
a O 0 0.0033475745003670454
different O 0 0.0019597767386585474
mode O 0 0.015236539766192436
of O 0 0.001047771773301065
binding O 0 0.04641469195485115
for O 0 0.003480310318991542
HFE O 1 0.9997572302818298
and O 0 0.00370895117521286
transferrin O 1 0.9985876083374023
to O 0 0.003814827185124159
TfR O 1 0.9991374015808105
, O 0 0.00228467071428895
consistent O 0 0.00698814308270812
with O 0 0.0013730942737311125
our O 0 0.001924335490912199
demonstration O 0 0.009843282401561737
that O 0 0.0036347173154354095
HFE O 1 0.9998502731323242
, O 0 0.0053468914702534676
transferrin O 1 0.9988691210746765
, O 0 0.002295628422871232
and O 0 0.002428474137559533
TfR O 1 0.9988893866539001
form O 0 0.010578161105513573
a O 0 0.008366911672055721
ternary O 1 0.9832627773284912
complex O 0 0.0241417046636343
. O 0 0.006652673706412315

Identification O 0 0.023585259914398193
of O 0 0.0013005293440073729
three O 0 0.0031725589651614428
novel O 0 0.1260630488395691
mutations O 1 0.9999480247497559
and O 0 0.0013010057155042887
a O 0 0.00451835710555315
high O 0 0.003956957254558802
frequency O 0 0.0124007947742939
of O 0 0.0008846636046655476
the O 0 0.00269248872064054
Arg778Leu O 1 0.9997279047966003
mutation O 1 0.999967098236084
in O 0 0.003536360105499625
Korean O 0 0.11583637446165085
patients O 1 0.9994102716445923
with O 0 0.009278172627091408
Wilson B-Disease 1 0.9966633915901184
disease I-Disease 1 0.9999773502349854
. O 0 0.00995444692671299

Four O 0 0.027459731325507164
mutations O 1 0.9999547004699707
- O 0 0.28554126620292664
- O 0 0.0867295041680336
R778L O 1 0.9756472110748291
, O 0 0.005322797689586878
A874V O 1 0.9911333918571472
, O 0 0.0035320997703820467
L1083F O 1 0.9838354587554932
, O 0 0.0026175491511821747
and O 0 0.003018114482983947
2304delC O 1 0.9989365935325623
- O 0 0.04084550961852074
- O 0 0.01324786338955164
in O 0 0.0016094560269266367
the O 0 0.0016114249592646956
copper O 0 0.036800090223550797
- O 0 0.022051464766263962
transporting O 0 0.04476384446024895
enzyme O 1 0.999342143535614
, O 0 0.005174135323613882
P O 1 0.9916481971740723
- O 0 0.13147084414958954
type O 1 0.9746673703193665
ATPase O 1 0.99983811378479
( O 0 0.010889509692788124
ATP7B O 1 0.9993504881858826
) O 0 0.003574472852051258
, O 0 0.0007115109474398196
were O 0 0.0005261206533759832
identified O 0 0.006296880077570677
in O 0 0.0019483837531879544
Korean O 0 0.07879633456468582
Patients O 1 0.9998457431793213
with O 0 0.009864809922873974
Wilson B-Disease 1 0.9971866011619568
disease I-Disease 1 0.9999701976776123
. O 0 0.009349210187792778

Arg778Leu O 1 0.9714411497116089
, O 0 0.0020580755081027746
the O 0 0.0010407933732494712
most O 0 0.0010557721834629774
frequently O 0 0.00411967420950532
reported O 0 0.01199409831315279
mutation O 1 0.999916672706604
of O 0 0.0014419881626963615
this O 0 0.0021894127130508423
enzyme O 1 0.9999014139175415
, O 0 0.0012916537234559655
was O 0 0.0011197669664397836
found O 0 0.002196794142946601
in O 0 0.0008072016062214971
six O 0 0.0017593380762264132
of O 0 0.0008799515780992806
eight O 0 0.006892711389809847
unrelated O 1 0.999150276184082
patients O 1 0.999702513217926
studied O 0 0.006569885648787022
, O 0 0.0012954211561009288
an O 0 0.00329062482342124
allele O 1 0.999715268611908
frequency O 0 0.031446389853954315
of O 0 0.0019493779400363564
37 O 0 0.016802819445729256
. O 0 0.007259141653776169

5 O 0 0.016682207584381104
% O 0 0.006291931960731745
, O 0 0.0013427049852907658
which O 0 0.0010846371296793222
is O 0 0.0015874238451942801
considerably O 0 0.016997918486595154
higher O 0 0.003672627732157707
than O 0 0.0009352610213682055
those O 0 0.0008284161449410021
in O 0 0.0010673500364646316
other O 0 0.0017136754468083382
Asian O 0 0.017701566219329834
populations O 0 0.05227437987923622
. O 0 0.007412073668092489

The O 0 0.004525266587734222
novel O 0 0.014634725637733936
single O 0 0.015964537858963013
nucleotide O 1 0.9978378415107727
deletion O 1 0.9995236396789551
, O 0 0.005583572667092085
2304delC O 1 0.9937566518783569
, O 0 0.001849626307375729
was O 0 0.001507434295490384
found O 0 0.003561432706192136
in O 0 0.0019050362752750516
one O 0 0.004672812297940254
patient O 1 0.9979737401008606
. O 0 0.006899004336446524

Since O 0 0.010526006110012531
a O 0 0.01714598573744297
mutation O 1 0.9988866448402405
at O 0 0.010318057611584663
cDNA O 1 0.9960286617279053
nucleotide O 1 0.9991850256919861
2302 O 1 0.9995651841163635
( O 0 0.013294480741024017
2302insC O 1 0.9942888021469116
) O 0 0.003917859401553869
had O 0 0.0015743063995614648
been O 0 0.001396970939822495
previously O 0 0.0028921659104526043
described O 0 0.005072785075753927
, O 0 0.0008945350418798625
this O 0 0.0007585280109196901
region O 0 0.0016375754494220018
of O 0 0.0007294928655028343
the O 0 0.002664010738953948
ATP7B O 1 0.9998798370361328
gene O 1 0.9999661445617676
may O 0 0.00548779359087348
be O 0 0.001777434372343123
susceptible O 1 0.9971363544464111
to O 0 0.006285746116191149
gene O 1 0.9999308586120605
rearrangements O 1 0.9998371601104736
causing O 1 0.9982693195343018
Wilson B-Disease 1 0.9951661825180054
disease I-Disease 1 0.9999696016311646
. O 0 0.01020864024758339

Disruption O 0 0.10994715988636017
of O 0 0.00396544998511672
splicing O 1 0.9981746673583984
regulated O 0 0.03127662464976311
by O 0 0.0030919897835701704
a O 0 0.010590155608952045
CUG O 1 0.9961714148521423
- O 0 0.03899604454636574
binding O 0 0.49188563227653503
protein O 1 0.9988868832588196
in O 0 0.018754318356513977
myotonic B-Disease 1 0.9999971389770508
dystrophy I-Disease 1 0.9999977350234985
. O 0 0.017724497243762016

Myotonic B-Disease 1 0.9999951124191284
dystrophy I-Disease 1 0.9999986886978149
( O 0 0.0471586212515831
DM B-Disease 1 0.9999599456787109
) O 0 0.006582739297300577
is O 0 0.0022758846171200275
caused O 0 0.02149318903684616
by O 0 0.0025049117393791676
a O 0 0.008242051117122173
CTG O 1 0.9945703148841858
expansion O 0 0.012897426262497902
in O 0 0.0012862293515354395
the O 0 0.001616195891983807
3 O 0 0.008433248847723007
untranslated O 1 0.8392757177352905
region O 0 0.0039152661338448524
of O 0 0.001130970660597086
the O 0 0.006152700167149305
DM B-Disease 1 0.9999841451644897
gene O 1 0.9995298385620117
. O 0 0.01433075126260519

One O 0 0.0046297418884932995
model O 0 0.011695140972733498
of O 0 0.005983023438602686
DM B-Disease 1 0.9999932050704956
pathogenesis O 1 0.999976396560669
suggests O 0 0.021275384351611137
that O 0 0.003041161224246025
RNAs O 1 0.9811174273490906
from O 0 0.0017065760912373662
the O 0 0.0013416402507573366
expanded O 0 0.007837616838514805
allele O 1 0.998728334903717
create O 0 0.011130286380648613
a O 0 0.005199115723371506
gain O 0 0.010107715614140034
- O 0 0.01293252594769001
of O 0 0.0021631349809467793
- O 0 0.04180600494146347
function O 1 0.5636156797409058
mutation O 1 0.9999284744262695
by O 0 0.0023115603253245354
the O 0 0.0016570354346185923
inappropriate O 0 0.022197300568223
binding O 0 0.022357488051056862
of O 0 0.001755041186697781
proteins O 1 0.9622460603713989
to O 0 0.0018020302522927523
the O 0 0.0034093037247657776
CUG O 1 0.9975411891937256
repeats O 1 0.6570931077003479
. O 0 0.008608098141849041

Data O 0 0.01040053740143776
presented O 0 0.004008570220321417
here O 0 0.0011272587580606341
indicate O 0 0.004517004359513521
that O 0 0.0008204525802284479
the O 0 0.0014734433498233557
conserved O 1 0.7907713651657104
heterogeneous O 1 0.9546668529510498
nuclear O 0 0.023836368694901466
ribonucleoprotein O 1 0.9985155463218689
, O 0 0.005164864007383585
CUG O 1 0.9970985651016235
- O 0 0.03697618842124939
binding O 0 0.36921101808547974
protein O 1 0.9991229176521301
( O 0 0.009195984341204166
CUG O 1 0.9987523555755615
- O 0 0.09977598488330841
BP O 1 0.9571675658226013
) O 0 0.004047304857522249
, O 0 0.0014128340408205986
may O 0 0.00392926624044776
mediate O 1 0.7473214268684387
the O 0 0.004508954007178545
trans O 1 0.9992850422859192
- O 0 0.027279900386929512
dominant O 0 0.033240772783756256
effect O 0 0.008247174322605133
of O 0 0.0013504511443898082
the O 0 0.005270647816359997
RNA O 1 0.9994214773178101
. O 0 0.010215609334409237

CUG O 1 0.9944618344306946
- O 0 0.0493144728243351
BP O 0 0.288395494222641
was O 0 0.0026374096050858498
found O 0 0.003350537968799472
to O 0 0.0013983938843011856
bind O 0 0.3173827528953552
to O 0 0.0010963608510792255
the O 0 0.0021477655973285437
human O 1 0.7405043244361877
cardiac O 1 0.9999991655349731
troponin O 1 0.9999855756759644
T O 1 0.9996883869171143
( O 0 0.009120723232626915
cTNT O 1 0.9781030416488647
) O 0 0.006890557706356049
pre O 0 0.04116666316986084
- O 0 0.0395246222615242
messenger O 1 0.9928826093673706
RNA O 1 0.998969316482544
and O 0 0.002349263522773981
regulate O 0 0.04202372580766678
its O 0 0.0037584800738841295
alternative O 0 0.031506188213825226
splicing O 1 0.9977905750274658
. O 0 0.011576946824789047

Splicing O 1 0.971724271774292
of O 0 0.005976252257823944
cTNT O 1 0.7563827633857727
was O 0 0.005296588409692049
disrupted O 0 0.21362486481666565
in O 0 0.010734250769019127
DM B-Disease 1 0.9999902248382568
striated O 1 0.9999717473983765
muscle O 1 0.9997252821922302
and O 0 0.002219641115516424
in O 0 0.002292827470228076
normal O 0 0.23675347864627838
cells O 1 0.9994059801101685
expressing O 0 0.016759760677814484
transcripts O 0 0.02290770597755909
that O 0 0.0023006838746368885
contain O 0 0.024489788338541985
CUG O 1 0.9962192177772522
repeats O 1 0.7089777588844299
. O 0 0.007525759283453226

Altered O 0 0.07747109234333038
expression O 0 0.02473192662000656
of O 0 0.0024446460884064436
genes O 1 0.9974749684333801
regulated O 0 0.07178667187690735
posttranscriptionally O 1 0.9359110593795776
by O 0 0.008585372008383274
CUG O 1 0.999038577079773
- O 0 0.044377248734235764
BP O 0 0.2978562116622925
therefore O 0 0.005453439429402351
may O 0 0.004529706668108702
contribute O 0 0.01589958555996418
to O 0 0.006550947204232216
DM B-Disease 1 0.999991774559021
pathogenesis O 1 0.9999499320983887
. O 0 0.0056704808957874775
. O 0 0.005087023600935936

Identification O 0 0.023536818102002144
of O 0 0.0014494741335511208
a O 0 0.005243647377938032
novel O 0 0.02264225482940674
nonsense O 1 0.8514087200164795
mutation O 1 0.9998779296875
and O 0 0.002022393047809601
a O 0 0.00831681676208973
missense O 1 0.998706579208374
substitution O 0 0.14960020780563354
in O 0 0.001977421110495925
the O 0 0.003983981441706419
vasopressin O 1 0.9997950196266174
- O 0 0.16754288971424103
neurophysin O 1 0.9947007894515991
II O 1 0.6370046734809875
gene O 1 0.9992050528526306
in O 0 0.0019966920372098684
two O 0 0.0023404473904520273
Spanish O 0 0.01661069318652153
kindreds O 1 0.9980487823486328
with O 0 0.020718015730381012
familial B-Disease 1 0.9999957084655762
neurohypophyseal I-Disease 1 0.9999358654022217
diabetes I-Disease 1 0.9999991655349731
insipidus I-Disease 1 0.9999086856842041
. O 0 0.01689235493540764

Familial B-Disease 1 0.9999727010726929
neurohypophyseal I-Disease 1 0.9999169111251831
diabetes I-Disease 1 0.9999995231628418
insipidus I-Disease 1 0.9999651908874512
( O 0 0.01533281709998846
FNDI B-Disease 1 0.9995328187942505
) O 0 0.0036935757379978895
is O 0 0.0018024009186774492
an O 0 0.006202608812600374
autosomal B-Disease 1 0.9999996423721313
dominant I-Disease 1 0.9992464780807495
disease I-Disease 1 0.999995231628418
caused O 1 0.9410324692726135
by O 0 0.009442504495382309
deficiency O 1 0.9999948740005493
in O 0 0.0027957281563431025
the O 0 0.004756833892315626
antidiuretic O 1 0.9997817873954773
hormone O 1 0.9997469782829285
arginine O 1 0.9987762570381165
vasopressin O 1 0.9986063838005066
( O 0 0.009889132343232632
AVP O 1 0.9975892305374146
) O 0 0.005598853807896376
encoded O 0 0.04037272557616234
by O 0 0.0023928415030241013
the O 0 0.002984448801726103
AVP O 1 0.9992640614509583
- O 0 0.09890365600585938
neurophysin O 1 0.9915642738342285
II O 0 0.06984532624483109
( O 0 0.012698772363364697
AVP O 1 0.9990295171737671
- O 0 0.24827909469604492
NPII O 1 0.9955912828445435
) O 0 0.011339860036969185
gene O 1 0.9993258714675903
on O 0 0.009512076154351234
chromosome O 1 0.9998859167098999
20p13 O 1 0.9676014184951782
. O 0 0.011902240104973316

In O 0 0.0045952810905873775
this O 0 0.0015678752679377794
study O 0 0.005703924689441919
, O 0 0.001232308684848249
we O 0 0.0009085303754545748
analyzed O 0 0.011263550259172916
two O 0 0.0019966689869761467
families O 0 0.004417442716658115
with O 0 0.0036584138870239258
FNDI B-Disease 1 0.9943673014640808
using O 0 0.00722590833902359
direct O 0 0.011241931468248367
automated O 0 0.2078656256198883
fluorescent O 1 0.9796544909477234
, O 0 0.002820417983457446
solid O 0 0.016658803448081017
phase O 0 0.02794586308300495
, O 0 0.0017824729438871145
single O 0 0.009399918839335442
- O 0 0.02248317189514637
stranded O 0 0.33520764112472534
DNA O 1 0.996208667755127
sequencing O 1 0.8778822422027588
of O 0 0.0042280531488358974
PCR O 1 0.9983409643173218
- O 0 0.0490935780107975
amplified O 1 0.9156853556632996
AVP O 1 0.9987982511520386
- O 0 0.4714556634426117
NPII O 1 0.9979707598686218
DNA O 1 0.9937990307807922
. O 0 0.010088643990457058

In O 0 0.0026367453392595053
one O 0 0.0011885047424584627
of O 0 0.0006421494763344526
the O 0 0.0014636183623224497
families O 0 0.005111541599035263
, O 0 0.0016004873905330896
affected O 0 0.011853606440126896
individuals O 0 0.004025948699563742
presented O 0 0.00323888985440135
a O 0 0.00492279976606369
novel O 0 0.021812068298459053
nonsense O 1 0.9122118353843689
mutation O 1 0.9999319314956665
in O 0 0.004597454331815243
exon O 1 0.995316743850708
3 O 0 0.005282255355268717
of O 0 0.0008853112813085318
the O 0 0.0026967572048306465
gene O 1 0.9999350309371948
, O 0 0.0014353578444570303
consisting O 0 0.003714357502758503
in O 0 0.0012820861302316189
a O 0 0.00737049849703908
G O 1 0.9977617263793945
to O 0 0.0038874021265655756
T O 1 0.9978704452514648
transition O 0 0.022081542760133743
at O 0 0.005213332828134298
nucleotide O 1 0.9993625283241272
2101 O 1 0.9984846711158752
, O 0 0.0018042240990325809
which O 0 0.0012973641278222203
produces O 0 0.013613661751151085
a O 0 0.004399062134325504
stop O 0 0.009042812511324883
signal O 0 0.019186154007911682
in O 0 0.0029653229285031557
codon O 1 0.9886926412582397
82 O 0 0.030726678669452667
( O 0 0.010875067673623562
Glu O 1 0.99968421459198
) O 0 0.005214166361838579
of O 0 0.0024617151357233524
NPII O 1 0.994654655456543
. O 0 0.009794451296329498

The O 0 0.013654625974595547
premature O 1 0.9962615370750427
termination O 1 0.9934619665145874
eliminates O 0 0.31404680013656616
part O 0 0.0024251563008874655
of O 0 0.0009909599320963025
the O 0 0.0032958302181214094
C O 1 0.9961254000663757
- O 0 0.0383896566927433
terminal O 0 0.46070441603660583
domain O 0 0.021375438198447227
of O 0 0.002117494121193886
NPII O 1 0.9958708882331848
, O 0 0.0017004390247166157
including O 0 0.0020673591643571854
a O 0 0.0067063430324196815
cysteine O 1 0.9955971837043762
residue O 1 0.6843172311782837
in O 0 0.001556576113216579
position O 0 0.002773926593363285
85 O 0 0.009655637666583061
, O 0 0.0012292851461097598
which O 0 0.0009360900730825961
could O 0 0.0015649475390091538
be O 0 0.0007576304487884045
involved O 0 0.003012013854458928
in O 0 0.0009349323227070272
the O 0 0.0013476849999278784
correct O 0 0.02859366685152054
folding O 0 0.34858402609825134
of O 0 0.001479844213463366
the O 0 0.003919963259249926
prohormone O 1 0.9995943903923035
. O 0 0.011112907901406288

In O 0 0.003425683593377471
the O 0 0.0016970379510894418
second O 0 0.005114719271659851
family O 0 0.00810399278998375
, O 0 0.0014691853430122137
a O 0 0.006282276939600706
G279A O 1 0.9862517714500427
substitution O 1 0.6111049652099609
at O 0 0.0027963679749518633
position O 0 0.004226712044328451
- O 0 0.009338966570794582
1 O 0 0.00286428933031857
of O 0 0.0005758707993663847
the O 0 0.0013616994256153703
signal O 0 0.1977563202381134
peptide O 1 0.9992445707321167
was O 0 0.002671610563993454
observed O 0 0.007122608833014965
in O 0 0.0010172611800953746
all O 0 0.001100166467949748
affected O 0 0.019174935296177864
individuals O 0 0.007459778804332018
. O 0 0.005891048349440098

This O 0 0.010933341458439827
missense O 1 0.9997257590293884
mutation O 1 0.9999057054519653
, O 0 0.002811973448842764
which O 0 0.0025929564144462347
replaces O 1 0.9501793384552002
Ala O 1 0.9954079985618591
with O 0 0.007917854934930801
Thr O 1 0.9999128580093384
, O 0 0.002011612057685852
is O 0 0.0020588163752108812
frequent O 0 0.02350805141031742
among O 0 0.008714851923286915
FNDI B-Disease 1 0.9999756813049316
patients O 1 0.9997792840003967
and O 0 0.0013848169473931193
is O 0 0.0012674146564677358
thought O 0 0.00375775876455009
to O 0 0.0010373395634815097
reduce O 0 0.0096437968313694
the O 0 0.0014913836494088173
efficiency O 0 0.012703998014330864
of O 0 0.002331833355128765
cleavage O 1 0.9997264742851257
by O 0 0.0053516561165452
signal O 0 0.09843910485506058
peptidases O 1 0.9936718940734863
. O 0 0.004366594832390547
. O 0 0.005800578743219376

Genetic O 1 0.9977987408638
heterogeneity O 1 0.9061731696128845
of O 0 0.005851319525390863
Saethre B-Disease 1 0.9994277358055115
- I-Disease 1 0.9908340573310852
Chotzen I-Disease 1 0.999954342842102
syndrome I-Disease 1 0.999998927116394
, O 0 0.003203387837857008
due O 0 0.005100945942103863
to O 0 0.0023407379630953074
TWIST O 1 0.9447526335716248
and O 0 0.005957848392426968
FGFR O 1 0.9998167157173157
mutations O 1 0.9999344348907471
. O 0 0.009902149438858032

Thirty O 0 0.03092406690120697
- O 0 0.020103102549910545
two O 0 0.005489941220730543
unrelated O 1 0.9949480295181274
patients O 1 0.9979768395423889
with O 0 0.0023156560491770506
features O 0 0.004785687196999788
of O 0 0.0022801775485277176
Saethre B-Disease 1 0.9998458623886108
- I-Disease 1 0.9945876598358154
Chotzen I-Disease 1 0.9999719858169556
syndrome I-Disease 1 0.9999984502792358
, O 0 0.002378052333369851
a O 0 0.007079748902469873
common O 1 0.8366243243217468
autosomal B-Disease 1 0.9999992847442627
dominant I-Disease 1 0.7718462944030762
condition I-Disease 1 0.6454903483390808
of O 0 0.0032999743707478046
craniosynostosis B-Disease 1 0.9999916553497314
and O 0 0.008710084483027458
limb B-Disease 1 0.9999957084655762
anomalies I-Disease 1 0.9992468357086182
, O 0 0.0013656411319971085
were O 0 0.0008068132447078824
screened O 0 0.026546312496066093
for O 0 0.0037132208235561848
mutations O 1 0.9999680519104004
in O 0 0.004747975151985884
TWIST O 1 0.9924445748329163
, O 0 0.003799758618697524
FGFR2 O 1 0.9981685876846313
, O 0 0.0036170685198158026
and O 0 0.0033743330277502537
FGFR3 O 1 0.995926022529602
. O 0 0.009516649879515171

Nine O 0 0.013434043154120445
novel O 0 0.0133423563092947
and O 0 0.001700994442217052
three O 0 0.004630623385310173
recurrent O 1 0.9998562335968018
TWIST O 1 0.9992666840553284
mutations O 1 0.999975323677063
were O 0 0.0015085346531122923
found O 0 0.004119080025702715
in O 0 0.0015550784301012754
12 O 0 0.006694531533867121
families O 0 0.00852223951369524
. O 0 0.005924365483224392

Seven O 0 0.008869200944900513
families O 0 0.0043394966050982475
were O 0 0.0007436141604557633
found O 0 0.0022759689018130302
to O 0 0.0007672075880691409
have O 0 0.0009499617735855281
the O 0 0.0027226468082517385
FGFR3 O 1 0.9997923970222473
P250R O 1 0.9997542500495911
mutation O 1 0.9999899864196777
, O 0 0.0017682320903986692
and O 0 0.0007962461095303297
one O 0 0.0011413564207032323
individual O 0 0.0029202031437307596
was O 0 0.001071561244316399
found O 0 0.0026940267998725176
to O 0 0.0008300655754283071
have O 0 0.0008829936268739402
an O 0 0.0034264500718563795
FGFR2 O 1 0.999316930770874
VV269 O 1 0.9968187808990479
- O 0 0.04248479753732681
270 O 0 0.08032112568616867
deletion O 1 0.9955397248268127
. O 0 0.01317113172262907

To O 0 0.004475397989153862
date O 0 0.004177515860646963
, O 0 0.001270261243917048
our O 0 0.0029011445585638285
detection O 1 0.9440112113952637
rate O 0 0.008079501800239086
for O 0 0.002382535021752119
TWIST O 1 0.9613628387451172
or O 0 0.00892110075801611
FGFR O 1 0.999921441078186
mutations O 1 0.999975323677063
is O 0 0.0027850151527673006
68 O 0 0.012342073023319244
% O 0 0.0029922935646027327
in O 0 0.0012374264188110828
our O 0 0.0049162269569933414
Saethre B-Disease 1 0.9997498393058777
- I-Disease 1 0.99826580286026
Chotzen I-Disease 1 0.9999880790710449
syndrome I-Disease 1 0.9999998807907104
patients O 1 0.9998334646224976
, O 0 0.0013592971954494715
including O 0 0.0014454424381256104
our O 0 0.002110903151333332
five O 0 0.004850364755839109
patients O 1 0.9997404217720032
elsewhere O 0 0.006359028164297342
reported O 0 0.0067278374917805195
with O 0 0.005206658039242029
TWIST O 1 0.9991123080253601
mutations O 1 0.999971866607666
. O 0 0.009998191148042679

More O 0 0.0030948999337852
than O 0 0.0019680489785969257
35 O 0 0.006677287630736828
different O 0 0.004161087796092033
TWIST O 1 0.9991486072540283
mutations O 1 0.9999713897705078
are O 0 0.0012231954606249928
now O 0 0.0015991072868928313
known O 0 0.002857637358829379
in O 0 0.0010694853262975812
the O 0 0.001652403618209064
literature O 0 0.0075126043520867825
. O 0 0.0051865354180336

The O 0 0.0027980997692793608
most O 0 0.0019351632799953222
common O 0 0.013470499776303768
phenotypic O 1 0.9994598031044006
features O 0 0.006414297502487898
, O 0 0.0009276146301999688
present O 0 0.0012797730742022395
in O 0 0.0007051897700875998
more O 0 0.0007075680769048631
than O 0 0.0008406781707890332
a O 0 0.00257509364746511
third O 0 0.002926833461970091
of O 0 0.0008387190755456686
our O 0 0.00388559652492404
patients O 1 0.9996401071548462
with O 0 0.005578626878559589
TWIST O 1 0.9993672966957092
mutations O 1 0.9999819993972778
, O 0 0.0017935435753315687
are O 0 0.0016781402518972754
coronal B-Disease 1 0.9991733431816101
synostosis I-Disease 1 0.9928898811340332
, O 0 0.0052178483456373215
brachycephaly B-Disease 1 0.9687341451644897
, O 0 0.005177639424800873
low B-Disease 0 0.04715430364012718
frontal I-Disease 1 0.9998964071273804
hairline I-Disease 1 0.9999865293502808
, O 0 0.011468678712844849
facial B-Disease 1 0.9999582767486572
asymmetry I-Disease 1 0.9994943141937256
, O 0 0.009895261377096176
ptosis B-Disease 1 0.9999902248382568
, O 0 0.007756189908832312
hypertelorism B-Disease 1 0.9995437264442444
, O 0 0.0032902637030929327
broad B-Disease 0 0.015859005972743034
great I-Disease 0 0.00690155616030097
toes I-Disease 1 0.9861778020858765
, O 0 0.0024606415536254644
and O 0 0.0030364058911800385
clinodactyly B-Disease 1 0.9934096932411194
. O 0 0.00904424861073494

Significant O 0 0.027475666254758835
intra O 1 0.8630974292755127
- O 0 0.025237204506993294
and O 0 0.0036783183459192514
interfamilial O 1 0.9910796284675598
phenotypic O 1 0.9989320635795593
variability O 1 0.977715790271759
is O 0 0.0017008488066494465
present O 0 0.0018346371361985803
for O 0 0.0013716603862121701
either O 0 0.007810769136995077
TWIST O 1 0.9975549578666687
mutations O 1 0.9999567270278931
or O 0 0.015198037959635258
FGFR O 1 0.9995967745780945
mutations O 1 0.9999178647994995
. O 0 0.0107624102383852

The O 0 0.0053597488440573215
overlap O 0 0.037448130548000336
in O 0 0.003323950571939349
clinical O 1 0.9988358616828918
features O 0 0.004583270289003849
and O 0 0.0007037939503788948
the O 0 0.0011202070163562894
presence O 0 0.006639140658080578
, O 0 0.0006874441169202328
in O 0 0.0006505671772174537
the O 0 0.000879347266163677
same O 0 0.0037638829089701176
genes O 1 0.9997013211250305
, O 0 0.0013696594396606088
of O 0 0.001659928122535348
mutations O 1 0.9999829530715942
for O 0 0.0013753465609624982
more O 0 0.000742171541787684
than O 0 0.0012390492483973503
one O 0 0.00298252678476274
craniosynostotic B-Disease 1 0.9997637867927551
condition I-Disease 1 0.987506628036499
- O 0 0.012325432151556015
such O 0 0.0024898129049688578
as O 0 0.0037401949521154165
Saethre B-Disease 1 0.9993347525596619
- I-Disease 0 0.20835919678211212
Chotzen I-Disease 1 0.9941869974136353
, I-Disease 0 0.004420104902237654
Crouzon I-Disease 1 0.9887005686759949
, I-Disease 0 0.0032362197525799274
and I-Disease 0 0.005463475361466408
Pfeiffer I-Disease 1 0.9999690055847168
syndromes I-Disease 1 0.9999972581863403
- O 0 0.020112628117203712
support O 0 0.0030776483472436666
the O 0 0.0017200222937390208
hypothesis O 0 0.44199326634407043
that O 0 0.0023286263458430767
TWIST O 1 0.9061862826347351
and O 0 0.0022600730881094933
FGFRs O 1 0.9783478379249573
are O 0 0.000888508977368474
components O 0 0.006092295981943607
of O 0 0.0005233425763435662
the O 0 0.0008823178941383958
same O 0 0.0036323866806924343
molecular O 1 0.9996739625930786
pathway O 1 0.9991270899772644
involved O 0 0.004709604196250439
in O 0 0.0009013402159325778
the O 0 0.0016835714923217893
modulation O 1 0.9973254203796387
of O 0 0.003909203223884106
craniofacial O 1 0.9999730587005615
and O 0 0.005210799165070057
limb O 1 0.9999634027481079
development O 0 0.00836783368140459
in O 0 0.0026536663062870502
humans O 0 0.4181241989135742
. O 0 0.003077311906963587
. O 0 0.004905747715383768

Mutation O 1 0.9993246793746948
analysis O 0 0.020780112594366074
of O 0 0.004579747561365366
UBE3A O 1 0.9998645782470703
in O 0 0.3150351941585541
Angelman B-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999998807907104
patients O 1 0.9998204112052917
. O 0 0.009159079752862453

Angelman B-Disease 1 0.9999984502792358
syndrome I-Disease 1 0.9999988079071045
( O 0 0.011361740529537201
AS B-Disease 0 0.0051100910641252995
) O 0 0.0028144146781414747
is O 0 0.001988705014809966
caused O 0 0.06436319649219513
by O 0 0.008139658719301224
chromosome O 1 0.9999902248382568
15q11 O 1 0.9976569414138794
- O 0 0.04651287570595741
q13 O 1 0.9807379841804504
deletions O 1 0.9896577000617981
of O 0 0.0029998014215379953
maternal O 1 0.9845535755157471
origin O 0 0.00823475793004036
, O 0 0.0018275637412443757
by O 0 0.004453169647604227
paternal O 1 0.9993195533752441
uniparental B-Disease 1 0.9999706745147705
disomy I-Disease 1 0.999092698097229
( O 0 0.017445033416152
UPD B-Disease 1 0.9999483823776245
) O 0 0.004847161937505007
15 O 0 0.0036965282633900642
, O 0 0.0013272971846163273
by O 0 0.005185150541365147
imprinting O 1 0.9999810457229614
defects O 1 0.9999717473983765
, O 0 0.0018841379787772894
and O 0 0.0010750049259513617
by O 0 0.0035716304555535316
mutations O 1 0.9999239444732666
in O 0 0.002786167897284031
the O 0 0.005667567253112793
UBE3A O 1 0.9999164342880249
gene O 1 0.9995642304420471
. O 0 0.010754097253084183

UBE3A O 1 0.9818450212478638
encodes O 1 0.8196805119514465
a O 0 0.022290227934718132
ubiquitin O 1 0.995510458946228
- O 0 0.07545432448387146
protein O 1 0.9981185793876648
ligase O 1 0.6792497634887695
and O 0 0.002637915313243866
shows O 0 0.013490562327206135
brain O 1 0.9998894929885864
- O 0 0.028540978208184242
specific O 0 0.016489814966917038
imprinting O 1 0.998354434967041
. O 0 0.00999362301081419

Here O 0 0.003593858564272523
we O 0 0.0023399419151246548
describe O 0 0.024867117404937744
UBE3A O 1 0.9993407130241394
coding O 1 0.9988774657249451
- O 0 0.042816340923309326
region O 0 0.015562732703983784
mutations O 1 0.999984860420227
detected O 1 0.7650426626205444
by O 0 0.004718369338661432
SSCP O 1 0.9959979057312012
analysis O 0 0.01425955817103386
in O 0 0.0016824755584821105
13 O 0 0.00489464309066534
AS B-Disease 0 0.003376978449523449
individuals O 0 0.004863635636866093
or O 0 0.0036944271996617317
families O 0 0.007540143560618162
. O 0 0.005656949244439602

Two O 0 0.007083607837557793
identical O 0 0.0326177179813385
de O 0 0.027305597439408302
novo O 1 0.8994819521903992
5 O 0 0.012995266355574131
- O 0 0.025229010730981827
bp O 0 0.22655729949474335
duplications O 1 0.9905081987380981
in O 0 0.004828484263271093
exon O 1 0.9945793151855469
16 O 0 0.007469072472304106
were O 0 0.0013774026883766055
found O 0 0.006318880710750818
. O 0 0.005135789047926664

Among O 0 0.0035757534205913544
the O 0 0.0010630965698510408
other O 0 0.0011680427705869079
11 O 0 0.004797092638909817
unique O 0 0.015491856262087822
mutations O 1 0.9999867677688599
, O 0 0.001783166197128594
8 O 0 0.0037032831460237503
were O 0 0.0007788945804350078
small O 0 0.005412882659584284
deletions O 1 0.9984756112098694
or O 0 0.007645928300917149
insertions O 1 0.9964532852172852
predicted O 0 0.016711847856640816
to O 0 0.0032535505015403032
cause O 1 0.9894780516624451
frameshifts O 1 0.9975312352180481
, O 0 0.002018875675275922
1 O 0 0.0030133386608213186
was O 0 0.0015418181428685784
a O 0 0.006770494394004345
mutation O 1 0.9998242259025574
to O 0 0.0015304010594263673
a O 0 0.00445855688303709
stop O 0 0.012636510655283928
codon O 1 0.9819336533546448
, O 0 0.0018381770933046937
1 O 0 0.0030162096954882145
was O 0 0.0015222519868984818
a O 0 0.01051940768957138
missense O 1 0.999967098236084
mutation O 1 0.9999818801879883
, O 0 0.002423232886940241
and O 0 0.0010916723404079676
1 O 0 0.0034915106371045113
was O 0 0.001530876150354743
predicted O 0 0.008148953318595886
to O 0 0.0019627849105745554
cause O 1 0.7246897220611572
insertion O 1 0.9829097390174866
of O 0 0.001144906273111701
an O 0 0.0024848661851137877
isoleucine O 1 0.9982107877731323
in O 0 0.0014822720550000668
the O 0 0.0023424054961651564
hect O 1 0.9236287474632263
domain O 0 0.01645057462155819
of O 0 0.001057709683664143
the O 0 0.003721434623003006
UBE3A O 1 0.9999560117721558
protein O 1 0.9996237754821777
, O 0 0.0014480085810646415
which O 0 0.0008650477975606918
functions O 0 0.004969077650457621
in O 0 0.0024970390368252993
E2 O 1 0.9996695518493652
binding O 0 0.04646489769220352
and O 0 0.003169998060911894
ubiquitin O 1 0.9933011531829834
transfer O 0 0.017089106142520905
. O 0 0.005765202920883894

Eight O 0 0.0055037508718669415
of O 0 0.0010420187609270215
the O 0 0.0013774957042187452
cases O 0 0.007570094428956509
were O 0 0.002257640240713954
familial O 1 0.9999943971633911
, O 0 0.0015302799874916673
and O 0 0.0007707139593549073
five O 0 0.0020486824214458466
were O 0 0.001413873047567904
sporadic O 0 0.23836733400821686
. O 0 0.006400960963219404

In O 0 0.00613496033474803
two O 0 0.008182796649634838
familial O 1 0.9999833106994629
cases O 0 0.011892935261130333
and O 0 0.0012281512608751655
one O 0 0.0027065351605415344
sporadic O 1 0.5798341035842896
case O 0 0.008189710788428783
, O 0 0.0036419755779206753
mosaicism O 1 0.9997585415840149
for O 0 0.0076508792117238045
UBE3A O 1 0.9999339580535889
mutations O 1 0.9999583959579468
was O 0 0.004862608853727579
detected O 0 0.28386378288269043
in O 0 0.0012341957772150636
the O 0 0.0010943750385195017
mother O 0 0.0070885103195905685
of O 0 0.0007363235927186906
three O 0 0.0019106623949483037
AS B-Disease 0 0.004452300723642111
sons O 0 0.1309402883052826
, O 0 0.0010993272298946977
in O 0 0.001088168821297586
the O 0 0.00197544414550066
maternal O 1 0.9980783462524414
grandfather O 0 0.014859048649668694
of O 0 0.0009237833437509835
two O 0 0.0015062139136716723
AS B-Disease 0 0.0028118800837546587
first O 0 0.002805024152621627
cousins O 1 0.9456624984741211
, O 0 0.0012200977653265
and O 0 0.0006063763867132366
in O 0 0.0009094119886867702
the O 0 0.0013769285287708044
mother O 0 0.009401548653841019
of O 0 0.0010310723446309566
an O 0 0.0023035879712551832
AS B-Disease 0 0.006001930683851242
daughter O 0 0.20127643644809723
. O 0 0.007874567992985249

The O 0 0.005062997341156006
frequencies O 0 0.02221294306218624
with O 0 0.002083676401525736
which O 0 0.0010564704425632954
we O 0 0.0019964734092354774
detected O 1 0.9945846199989319
mutations O 1 0.9999074935913086
were O 0 0.0017800260102376342
5 O 0 0.006423289887607098
( O 0 0.0032665939070284367
14 O 0 0.005267899017781019
% O 0 0.004486437886953354
) O 0 0.0016584369586780667
of O 0 0.0007402720511890948
35 O 0 0.004789011552929878
in O 0 0.0020626101177185774
sporadic O 1 0.8772947192192078
cases O 0 0.00880851037800312
and O 0 0.001401881454512477
8 O 0 0.006312551908195019
( O 0 0.0027630117256194353
80 O 0 0.0051589179784059525
% O 0 0.003447196213528514
) O 0 0.0015369391767308116
of O 0 0.0007360625895671546
10 O 0 0.0033135011326521635
in O 0 0.004372515715658665
familial O 1 0.999992847442627
cases O 0 0.022330891340970993
. O 0 0.00334834773093462
. O 0 0.005188570357859135

The O 0 0.0288099255412817
hemochromatosis B-Disease 1 0.9999431371688843
845 O 1 0.9961658716201782
G O 1 0.9981511235237122
- O 0 0.1368480771780014
- O 0 0.04370478540658951
> O 1 0.9795081615447998
A O 0 0.009561765938997269
and O 0 0.0025561563670635223
187 O 0 0.07461623847484589
C O 1 0.9909345507621765
- O 0 0.3352968096733093
- O 1 0.5745659470558167
> O 1 0.9990943670272827
G O 1 0.9993756413459778
mutations O 1 0.9999552965164185
: O 0 0.009699856862425804
prevalence O 1 0.9972888231277466
in O 0 0.003175371326506138
non O 0 0.015767155215144157
- O 0 0.11063071340322495
Caucasian O 1 0.9972801208496094
populations O 0 0.05893700569868088
. O 0 0.008177032694220543

Hemochromatosis B-Disease 1 0.9998739957809448
, O 0 0.004679922945797443
the O 0 0.005446735303848982
inherited B-Disease 1 0.999953031539917
disorder I-Disease 1 0.9999701976776123
of I-Disease 0 0.003055466804653406
iron I-Disease 1 0.957146167755127
metabolism I-Disease 1 0.9999372959136963
, O 0 0.0028311533387750387
leads O 0 0.06294719874858856
, O 0 0.0023062836844474077
if O 0 0.005048922263085842
untreated O 1 0.9997685551643372
, O 0 0.0014264413621276617
to O 0 0.0018303805263713002
progressive O 1 0.6009891033172607
iron B-Disease 1 0.9477691650390625
overload I-Disease 1 0.9991922974586487
and O 0 0.006978199817240238
premature B-Disease 1 0.9988545179367065
death I-Disease 0 0.03735005855560303
. O 0 0.010300743393599987

The O 0 0.02179223857820034
hemochromatosis B-Disease 1 0.9999891519546509
gene O 1 0.9998385906219482
, O 0 0.010377558879554272
HFE O 1 0.9998972415924072
, O 0 0.003144161542877555
recently O 0 0.006089579779654741
has O 0 0.0013929244596511126
been O 0 0.0014890393940731883
identified O 0 0.007089318707585335
, O 0 0.0010265759192407131
and O 0 0.000814270053524524
characterization O 0 0.03447083383798599
of O 0 0.0008289624820463359
this O 0 0.0022247950546443462
gene O 1 0.9999719858169556
has O 0 0.0018042277079075575
shown O 0 0.0033460711129009724
that O 0 0.0006676980410702527
it O 0 0.0006803364376537502
contains O 0 0.0029659406282007694
two O 0 0.0029705718625336885
mutations O 1 0.999974250793457
that O 0 0.001406139344908297
result O 0 0.004919376689940691
in O 0 0.002324672881513834
amino O 1 0.9953877329826355
acid O 1 0.9968960285186768
substitutions O 0 0.21313099563121796
- O 0 0.041797101497650146
cDNA O 1 0.9848185777664185
nucleotides O 1 0.992576003074646
845 O 1 0.9939484596252441
G O 1 0.9988683462142944
- O 0 0.19885829091072083
- O 0 0.12907356023788452
> O 1 0.9943333864212036
A O 0 0.016022780910134315
( O 0 0.00668726721778512
C282Y O 1 0.9872254729270935
) O 0 0.0034788192715495825
and O 0 0.0016850485699251294
187 O 0 0.2228160947561264
C O 1 0.9972904920578003
- O 0 0.4533956050872803
- O 1 0.7066555619239807
> O 1 0.9993308782577515
G O 1 0.9986251592636108
( O 0 0.010811041109263897
H63D O 1 0.9962872266769409
) O 0 0.007076787296682596
. O 0 0.005759554915130138

Although O 0 0.02434060536324978
hemochromatosis B-Disease 1 0.9999865293502808
is O 0 0.004134912509471178
common O 0 0.009320798330008984
in O 0 0.002625720575451851
Caucasians O 1 0.9979361295700073
, O 0 0.00345181068405509
affecting O 1 0.9668635725975037
> O 1 0.9996134638786316
= O 0 0.4965735971927643
1 O 0 0.008629920892417431
/ O 0 0.04142695292830467
300 O 0 0.004158148542046547
individuals O 0 0.002064942382276058
of O 0 0.0006009815842844546
northern O 0 0.0021688484121114016
European O 0 0.002671393333002925
origin O 0 0.0045843059197068214
, O 0 0.0009160125628113747
it O 0 0.0008197196293622255
has O 0 0.0008242256008088589
not O 0 0.0007738121203146875
been O 0 0.001280894735828042
recognized O 0 0.0047230287455022335
in O 0 0.0011933264322578907
other O 0 0.002000876236706972
populations O 0 0.03421855717897415
. O 0 0.006590321194380522

The O 0 0.0031439850572496653
present O 0 0.0029833379667252302
study O 0 0.005614650901407003
used O 0 0.005155866965651512
PCR O 1 0.9972487092018127
and O 0 0.00243395590223372
restriction O 0 0.14699207246303558
- O 1 0.5394259691238403
enzyme O 1 0.9999432563781738
digestion O 1 0.9991565942764282
to O 0 0.0017202507006004453
analyze O 0 0.012347684241831303
the O 0 0.0013417693553492427
frequency O 0 0.012512946501374245
of O 0 0.0009424561867490411
the O 0 0.0031239334493875504
845 O 1 0.9991410970687866
G O 1 0.9997405409812927
- O 0 0.35503724217414856
- O 0 0.0820465236902237
> O 1 0.9858157634735107
A O 0 0.007825138978660107
and O 0 0.0019745351746678352
187 O 0 0.16373014450073242
C O 1 0.9937746524810791
- O 0 0.21230867505073547
- O 0 0.40875765681266785
> O 1 0.998940646648407
G O 1 0.9992167949676514
mutations O 1 0.9998928308486938
in O 0 0.00775913055986166
HLA O 1 0.9999215602874756
- O 0 0.03600070998072624
typed O 0 0.09166077524423599
samples O 0 0.02465810440480709
from O 0 0.003693772479891777
non O 0 0.013406616635620594
- O 0 0.087330162525177
Caucasian O 1 0.9958959817886353
populations O 0 0.022127335891127586
, O 0 0.0014166433829814196
comprising O 0 0.004153503105044365
Australian O 0 0.007429782766848803
Aboriginal O 0 0.015855344012379646
, O 0 0.0012930163647979498
Chinese O 0 0.0025251025799661875
, O 0 0.001444454537704587
and O 0 0.0018543326295912266
Pacific O 0 0.020673880353569984
Islanders O 0 0.12882298231124878
. O 0 0.006558405235409737

Results O 0 0.017862394452095032
showed O 0 0.005320743191987276
that O 0 0.001143622794188559
the O 0 0.0028159930370748043
845 O 1 0.9983927607536316
G O 1 0.9997316002845764
- O 1 0.5549569129943848
- O 0 0.2567739486694336
> O 1 0.9979840517044067
A O 0 0.033079009503126144
mutation O 1 0.9999644756317139
was O 0 0.0017941180849447846
present O 0 0.0015060132136568427
in O 0 0.0009495852864347398
these O 0 0.0013941108481958508
populations O 0 0.038358788937330246
( O 0 0.006192737724632025
allele O 1 0.9999117851257324
frequency O 0 0.054810069501399994
0 O 0 0.014061154797673225
. O 0 0.0017099881079047918
32 O 0 0.007667724043130875
% O 0 0.004964114632457495
) O 0 0.0025193907786160707
, O 0 0.001005745492875576
and O 0 0.0008193978574126959
, O 0 0.0012314643245190382
furthermore O 0 0.010015915147960186
, O 0 0.0008927197777666152
it O 0 0.0007726519834250212
was O 0 0.0009340356336906552
always O 0 0.001543093821965158
seen O 0 0.0025317880790680647
in O 0 0.001525936764664948
conjunction O 0 0.04421285167336464
with O 0 0.007936781272292137
HLA O 1 0.9999923706054688
haplotypes O 1 0.9999134540557861
common O 0 0.014934439212083817
in O 0 0.002757690381258726
Caucasians O 1 0.9954330921173096
, O 0 0.001994089921936393
suggesting O 0 0.013186696916818619
that O 0 0.0035252536181360483
845 O 1 0.9991869330406189
G O 1 0.9997130036354065
- O 1 0.6231898665428162
- O 0 0.2681446075439453
> O 1 0.998603880405426
A O 0 0.01228945329785347
may O 0 0.004059231374412775
have O 0 0.0008509601466357708
been O 0 0.000974479247815907
introduced O 0 0.0042087179608643055
into O 0 0.0023277734871953726
these O 0 0.0014974017394706607
populations O 0 0.019338764250278473
by O 0 0.006738415453583002
Caucasian O 1 0.9985554814338684
admixture O 1 0.999427318572998
. O 0 0.009663104079663754

187 O 0 0.17074941098690033
C O 1 0.9760410189628601
- O 0 0.4075927138328552
- O 1 0.6046392917633057
> O 1 0.9984921216964722
G O 1 0.992179274559021
was O 0 0.0024830312468111515
present O 0 0.0020508861634880304
at O 0 0.0016791534144431353
an O 0 0.0036339368671178818
allele O 1 0.9995986819267273
frequency O 0 0.0262428130954504
of O 0 0.0018910346552729607
2 O 0 0.009027204476296902
. O 0 0.005624819081276655

68 O 0 0.042101651430130005
% O 0 0.005589930806308985
in O 0 0.0010356411803513765
the O 0 0.0008486983715556562
two O 0 0.002150799846276641
populations O 0 0.031085172668099403
analyzed O 0 0.027229532599449158
( O 0 0.003339702496305108
Australian O 0 0.00815403088927269
Aboriginal O 0 0.015609482303261757
and O 0 0.0015090075321495533
Chinese O 0 0.004190742503851652
) O 0 0.005405866540968418
. O 0 0.006115998141467571

In O 0 0.003351482329890132
the O 0 0.0018452791264280677
Australian O 0 0.008851386606693268
Aboriginal O 0 0.023848066106438637
samples O 0 0.03485976904630661
, O 0 0.003816969459876418
187 O 0 0.3191431760787964
C O 1 0.9955188035964966
- O 1 0.5396161079406738
- O 1 0.59292072057724
> O 1 0.9993574023246765
G O 1 0.9930413961410522
was O 0 0.0019442923367023468
found O 0 0.0024982732720673084
to O 0 0.0007080689538270235
be O 0 0.0009752220939844847
associated O 0 0.0058037531562149525
with O 0 0.005839166231453419
HLA O 1 0.9999959468841553
haplotypes O 1 0.9999518394470215
common O 0 0.01878504641354084
in O 0 0.0032425711397081614
Caucasians O 1 0.9986237287521362
, O 0 0.0022027872037142515
suggesting O 0 0.010565273463726044
that O 0 0.0009215406607836485
it O 0 0.0008957872050814331
was O 0 0.001332295942120254
introduced O 0 0.005528124514967203
by O 0 0.003011746099218726
recent O 0 0.010592678561806679
admixture O 1 0.9994221925735474
. O 0 0.009560455568134785

In O 0 0.003071606159210205
the O 0 0.0012682054657489061
Chinese O 0 0.003072459017857909
samples O 0 0.022917982190847397
analyzed O 0 0.021450426429510117
, O 0 0.003074254607781768
187 O 1 0.5010154247283936
C O 1 0.9961358904838562
- O 0 0.35685408115386963
- O 0 0.43480366468429565
> O 1 0.9992780089378357
G O 1 0.9928798079490662
was O 0 0.002030246891081333
present O 0 0.0018871893407776952
in O 0 0.001221063663251698
association O 0 0.003485540160909295
with O 0 0.0018314255867153406
a O 0 0.0032695229165256023
wide O 0 0.006396600976586342
variety O 0 0.005210697650909424
of O 0 0.0032613007351756096
HLA O 1 0.9999986886978149
haplotypes O 1 0.9999524354934692
, O 0 0.0015188588295131922
showing O 0 0.005334431771188974
this O 0 0.002283351495862007
mutation O 1 0.9999842643737793
to O 0 0.0012614381266757846
be O 0 0.0008783859084360301
widespread O 0 0.00791941024363041
and O 0 0.0010105842957273126
likely O 0 0.0033449584152549505
to O 0 0.0013209738535806537
predate O 0 0.3221879303455353
the O 0 0.001095639425329864
more O 0 0.0019231800688430667
genetically O 1 0.9919392466545105
restricted O 0 0.02642500214278698
845 O 1 0.9983372688293457
G O 1 0.9995728135108948
- O 0 0.23049716651439667
- O 0 0.17956073582172394
> O 1 0.9930303692817688
A O 0 0.0399530790746212
mutation O 1 0.9996626377105713
. O 0 0.010694222524762154

Genotype O 1 0.9995793700218201
- O 1 0.7951613664627075
phenotype O 1 0.9998562335968018
correlations O 1 0.9810619950294495
in O 0 0.017157817259430885
attenuated B-Disease 1 0.9999353885650635
adenomatous I-Disease 1 0.9999985694885254
polyposis I-Disease 1 0.9999935626983643
coli I-Disease 1 0.9999411106109619
. O 0 0.020973943173885345

Germ O 1 0.9975661039352417
- O 0 0.043310150504112244
line O 0 0.01878947578370571
mutations O 1 0.9979992508888245
of O 0 0.0022368342615664005
the O 0 0.007319669704884291
tumor B-Disease 1 0.9999972581863403
suppressor O 1 0.9999746084213257
APC O 1 0.9978109002113342
are O 0 0.002910346956923604
implicated O 1 0.8024671673774719
in O 0 0.010485710576176643
attenuated B-Disease 1 0.9999849796295166
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999990463256836
coli I-Disease 1 0.9999959468841553
( O 0 0.025997238233685493
AAPC B-Disease 1 0.9998929500579834
) O 0 0.004513836931437254
, O 0 0.0012192026479169726
a O 0 0.006031228695064783
variant O 1 0.9972912669181824
of O 0 0.010953810065984726
familial B-Disease 1 0.9999995231628418
adenomatous I-Disease 1 0.9999994039535522
polyposis I-Disease 1 0.9999990463256836
( O 0 0.03839986398816109
FAP B-Disease 1 0.9998262524604797
) O 0 0.011090721935033798
. O 0 0.007151268422603607

AAPC B-Disease 1 0.9981316924095154
is O 0 0.005276693496853113
recognized O 0 0.005537792574614286
by O 0 0.0017056753858923912
the O 0 0.001480583450756967
occurrence O 0 0.0603896901011467
of O 0 0.0023722529876977205
< O 1 0.9967047572135925
100 O 0 0.012556922622025013
colonic B-Disease 1 0.9999382495880127
adenomas I-Disease 1 0.9998364448547363
and O 0 0.0018510520458221436
a O 0 0.005469544790685177
later O 0 0.006447345018386841
onset O 1 0.999901533126831
of O 0 0.16712459921836853
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
( O 0 0.009630385786294937
age O 0 0.015621012076735497
> O 1 0.9936949610710144
40 O 0 0.008942171931266785
years O 0 0.003827021922916174
) O 0 0.004923541098833084
. O 0 0.005895546637475491

The O 0 0.003416122868657112
aim O 0 0.010131181217730045
of O 0 0.0008922321139834821
this O 0 0.0011779884807765484
study O 0 0.004868221469223499
was O 0 0.001350158592686057
to O 0 0.001980852335691452
assess O 0 0.20613670349121094
genotype O 1 0.9999605417251587
- O 1 0.9013686180114746
phenotype O 1 0.9999518394470215
correlations O 1 0.9899660348892212
in O 0 0.00808784831315279
AAPC B-Disease 1 0.9995046854019165
families O 0 0.015527909621596336
. O 0 0.007705874741077423

By O 0 0.01822570525109768
protein O 1 0.9973247051239014
- O 0 0.05239670351147652
truncation O 1 0.9925178289413452
test O 0 0.027906224131584167
( O 0 0.006269751116633415
PTT O 1 0.947649359703064
) O 0 0.00660906545817852
assay O 1 0.8886479139328003
, O 0 0.0010421208571642637
the O 0 0.000894776254426688
entire O 0 0.007387417368590832
coding O 1 0.996771514415741
region O 0 0.0026362561620771885
of O 0 0.0007396198343485594
the O 0 0.002968015382066369
APC B-Disease 1 0.9999675750732422
gene O 1 0.9999322891235352
was O 0 0.003260798519477248
screened O 0 0.024622591212391853
in O 0 0.0019274646183475852
affected O 0 0.01364297978579998
individuals O 0 0.004166049882769585
from O 0 0.0029315294232219458
11 O 0 0.017547378316521645
AAPC B-Disease 1 0.999940037727356
kindreds O 1 0.9983227849006653
, O 0 0.0020684474147856236
and O 0 0.0008570031495764852
their O 0 0.002624388551339507
phenotypic O 1 0.9979670643806458
differences O 0 0.011725240387022495
were O 0 0.0015332031762227416
examined O 0 0.033671360462903976
. O 0 0.006800815928727388

Five O 0 0.012659996747970581
novel O 0 0.04172391816973686
germ O 1 0.9990113973617554
- O 0 0.04691717401146889
line O 0 0.023839056491851807
APC B-Disease 1 0.999782383441925
mutations O 1 0.9997153878211975
were O 0 0.0018461734289303422
identified O 0 0.008525216951966286
in O 0 0.0018408098258078098
seven O 0 0.007568597327917814
kindreds O 1 0.9949430823326111
. O 0 0.010490044951438904

Mutations O 1 0.9993451237678528
were O 0 0.0020686700008809566
located O 0 0.0026365017984062433
in O 0 0.0007727944757789373
three O 0 0.0012715316843241453
different O 0 0.0012454427778720856
regions O 0 0.0029592192731797695
of O 0 0.0008410912123508751
the O 0 0.003366891061887145
APC B-Disease 1 0.9999881982803345
gene O 1 0.9999885559082031
( O 0 0.00544995442032814
1 O 0 0.005826377775520086
) O 0 0.0022116207983344793
at O 0 0.001152868033386767
the O 0 0.0011855348711833358
5 O 0 0.0043734158389270306
end O 0 0.004423440434038639
spanning O 0 0.02245676890015602
exons O 1 0.9941222071647644
4 O 0 0.007640415802598
and O 0 0.0015133866108953953
5 O 0 0.005098637193441391
, O 0 0.0014584949240088463
( O 0 0.0029609249904751778
2 O 0 0.005417156033217907
) O 0 0.0024800319224596024
within O 0 0.003539710072800517
exon O 1 0.9986317753791809
9 O 0 0.008531562983989716
, O 0 0.0013870852999389172
and O 0 0.0013493018923327327
( O 0 0.004105713684111834
3 O 0 0.006973123177886009
) O 0 0.0023223073221743107
at O 0 0.001250560744665563
the O 0 0.0014536085072904825
3 O 0 0.010771171189844608
distal O 1 0.9994115829467773
end O 0 0.003286998486146331
of O 0 0.001011827145703137
the O 0 0.003438438754528761
gene O 1 0.9998894929885864
. O 0 0.009561801329255104

Variability O 1 0.6462001800537109
in O 0 0.0014766445383429527
the O 0 0.0009006680338643491
number O 0 0.0019176906207576394
of O 0 0.007148689590394497
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999970197677612
was O 0 0.002377789933234453
most O 0 0.0012724160915240645
apparent O 0 0.05244124308228493
in O 0 0.0013849085662513971
individuals O 0 0.0039778887294232845
with O 0 0.004931468982249498
mutations O 1 0.9999796152114868
in O 0 0.002155082765966654
region O 0 0.0033162280451506376
1 O 0 0.003978653345257044
, O 0 0.0010885156225413084
and O 0 0.001829396584071219
upper O 1 0.9800332188606262
- O 1 0.9985637068748474
gastrointestinal O 1 0.9999986886978149
manifestations O 1 0.8510276675224304
were O 0 0.001179024577140808
more O 0 0.002010519150644541
severe O 1 0.997381865978241
in O 0 0.001843118923716247
them O 0 0.00261112698353827
. O 0 0.005330151878297329

In O 0 0.004337234888225794
individuals O 0 0.0063912272453308105
with O 0 0.006587222218513489
mutations O 1 0.9999667406082153
in O 0 0.001809186884202063
either O 0 0.004187283106148243
region O 0 0.0035042609088122845
2 O 0 0.0059810783714056015
or O 0 0.0029898295179009438
region O 0 0.0032047536224126816
3 O 0 0.004347714129835367
, O 0 0.0007523121894337237
the O 0 0.0007387701771222055
average O 0 0.0025724652223289013
number O 0 0.0011651652166619897
of O 0 0.00211165240034461
adenomas B-Disease 1 0.9999855756759644
tended O 0 0.012806689366698265
to O 0 0.0009235008619725704
be O 0 0.0008791754371486604
lower O 0 0.003836116986349225
than O 0 0.0009103423217311502
those O 0 0.0006510273669846356
in O 0 0.0007621751283295453
individuals O 0 0.003030510386452079
with O 0 0.004178219009190798
mutations O 1 0.9999927282333374
in O 0 0.001777387922629714
region O 0 0.003187808208167553
1 O 0 0.004063756670802832
, O 0 0.001121054170653224
although O 0 0.0022878553718328476
age O 0 0.005649554077535868
at O 0 0.00624136021360755
diagnosis O 1 0.9999716281890869
was O 0 0.003596694441512227
similar O 0 0.00981735996901989
. O 0 0.006023621652275324

In O 0 0.005027767736464739
all O 0 0.004516241140663624
AAPC B-Disease 1 0.9997394680976868
kindreds O 1 0.9940502047538757
, O 0 0.0024729983415454626
a O 0 0.004980454687029123
predominance O 1 0.5343345403671265
of O 0 0.00242801895365119
right O 0 0.019208217039704323
- O 1 0.9388974905014038
sided O 1 0.9994895458221436
colorectal B-Disease 1 0.9999998807907104
adenomas I-Disease 1 0.9999921321868896
and O 0 0.02498759515583515
rectal B-Disease 1 0.9999945163726807
polyp I-Disease 1 0.999981164932251
sparing O 1 0.9845028519630432
was O 0 0.006707252003252506
observed O 0 0.01632213406264782
. O 0 0.006190064828842878

No O 0 0.020031562075018883
desmoid B-Disease 1 0.9989134073257446
tumors I-Disease 1 0.999976634979248
were O 0 0.001603632583282888
found O 0 0.0038302356842905283
in O 0 0.0015157933812588453
these O 0 0.0032767222728580236
kindreds O 1 0.9988237023353577
. O 0 0.010094897821545601

Our O 0 0.006783696822822094
data O 0 0.005049518775194883
suggest O 0 0.006690775044262409
that O 0 0.0011290707625448704
, O 0 0.0011944955913349986
in O 0 0.0032897801138460636
AAPC B-Disease 1 0.999954342842102
families O 0 0.006388932466506958
, O 0 0.000908155576325953
the O 0 0.0007789926021359861
location O 0 0.0021041296422481537
of O 0 0.0007393625564873219
the O 0 0.0037091467529535294
APC B-Disease 1 0.9999812841415405
mutation O 1 0.9999810457229614
may O 0 0.010993260890245438
partially O 0 0.03470280021429062
predict O 0 0.02477540820837021
specific O 0 0.012093694880604744
phenotypic O 1 0.9964549541473389
expression O 0 0.060375336557626724
. O 0 0.007905750535428524

This O 0 0.0031157545745372772
should O 0 0.0017734600696712732
help O 0 0.003955185879021883
in O 0 0.0007841397309675813
the O 0 0.0008790857973508537
design O 0 0.004701657686382532
of O 0 0.0017763847718015313
tailored O 1 0.9981920123100281
clinical O 1 0.9998698234558105
- O 0 0.14978252351284027
management O 0 0.028535347431898117
protocols O 0 0.0704565942287445
in O 0 0.0010360032320022583
this O 0 0.0011513096978887916
subset O 0 0.4699666500091553
of O 0 0.0054273661226034164
FAP B-Disease 1 0.9999954700469971
patients O 1 0.9997358918190002
. O 0 0.004588237032294273
. O 0 0.005787576083093882

Wilms B-Disease 1 0.9998210072517395
' I-Disease 0 0.33902984857559204
tumor I-Disease 1 0.9999434947967529
1 O 0 0.012499901466071606
and O 0 0.0032965289428830147
Dax O 0 0.4402446746826172
- O 0 0.022757448256015778
1 O 0 0.01150798611342907
modulate O 1 0.9843633770942688
the O 0 0.0057829516008496284
orphan O 1 0.9965721368789673
nuclear O 0 0.06044777110219002
receptor O 1 0.9998281002044678
SF O 1 0.9988883137702942
- O 0 0.02691524848341942
1 O 0 0.006234938744455576
in O 0 0.0027147787623107433
sex O 0 0.04464370757341385
- O 0 0.027747679501771927
specific O 0 0.01810227334499359
gene O 1 0.9997583031654358
expression O 0 0.04966862499713898
. O 0 0.0066377753391861916

Products O 0 0.02131495624780655
of O 0 0.004434647504240274
steroidogenic O 1 0.9993603825569153
factor O 0 0.14031392335891724
1 O 0 0.010251251980662346
( O 0 0.008526373654603958
SF O 1 0.9994217157363892
- O 0 0.02527293562889099
1 O 0 0.00818863045424223
) O 0 0.004217992536723614
and O 0 0.005481228698045015
Wilms B-Disease 1 0.9999972581863403
tumor I-Disease 1 0.9999926090240479
1 O 0 0.012644139118492603
( O 0 0.00884048268198967
WT1 O 1 0.9999397993087769
) O 0 0.007463391404598951
genes O 1 0.9957996010780334
are O 0 0.0009227346745319664
essential O 0 0.00609341636300087
for O 0 0.002867152914404869
mammalian O 1 0.9988428354263306
gonadogenesis O 1 0.9841808080673218
prior O 0 0.007003101985901594
to O 0 0.0021624905057251453
sexual O 0 0.07338002324104309
differentiation O 1 0.9994677901268005
. O 0 0.00776843773201108

In O 0 0.00714649586006999
males O 0 0.035267431288957596
, O 0 0.005895999260246754
SF O 1 0.999332845211029
- O 0 0.026424966752529144
1 O 0 0.0074417018331587315
participates O 0 0.031223805621266365
in O 0 0.0018694193568080664
sexual O 0 0.012363565154373646
development O 0 0.004250362981110811
by O 0 0.0025927445385605097
regulating O 0 0.10455019772052765
expression O 0 0.014932628720998764
of O 0 0.001150687923654914
the O 0 0.0044687469489872456
polypeptide O 1 0.9998167157173157
hormone O 1 0.9998120665550232
Mullerian O 1 0.9998728036880493
inhibiting O 1 0.9996079802513123
substance O 1 0.9788922071456909
( O 0 0.01847383752465248
MIS O 1 0.9998488426208496
) O 0 0.00907166302204132
. O 0 0.005495252087712288

Here O 0 0.0040247938595712185
, O 0 0.001382923685014248
we O 0 0.0008755715098232031
show O 0 0.0032820263877511024
that O 0 0.004398139659315348
WT1 O 1 0.9999313354492188
- O 1 0.7336560487747192
KTS O 1 0.9995087385177612
isoforms O 1 0.9856319427490234
associate O 0 0.015441739931702614
and O 0 0.003050839761272073
synergize O 1 0.99888676404953
with O 0 0.011103185825049877
SF O 1 0.9992861151695251
- O 0 0.025273675099015236
1 O 0 0.005647370591759682
to O 0 0.0023210581857711077
promote O 0 0.015462661162018776
MIS O 1 0.9992103576660156
expression O 0 0.07228740304708481
. O 0 0.007738140877336264

In O 0 0.0059427535161376
contrast O 0 0.01595945842564106
, O 0 0.008274019695818424
WT1 O 1 0.9999624490737915
missense O 1 0.9999227523803711
mutations O 1 0.999975323677063
, O 0 0.002622477011755109
associated O 0 0.006968663539737463
with O 0 0.002435183385387063
male B-Disease 0 0.16596229374408722
pseudohermaphroditism I-Disease 1 0.9981274008750916
in O 0 0.007456752937287092
Denys B-Disease 1 0.9998977184295654
- I-Disease 1 0.9944637417793274
Drash I-Disease 1 0.9999407529830933
syndrome I-Disease 1 0.9999986886978149
, O 0 0.004162139259278774
fail O 0 0.026298198848962784
to O 0 0.0031341337598860264
synergize O 1 0.9992971420288086
with O 0 0.012743046507239342
SF O 1 0.9994786381721497
- O 0 0.03296791762113571
1 O 0 0.011934798210859299
. O 0 0.00680486299097538

Additionally O 0 0.01966477371752262
, O 0 0.001996875973418355
the O 0 0.0031102264765650034
X O 1 0.9948868155479431
- O 0 0.05178173631429672
linked O 0 0.24182264506816864
, O 0 0.0024103892501443624
candidate O 0 0.017360715195536613
dosage O 1 0.9992285966873169
- O 0 0.029195347800850868
sensitive O 0 0.019070295616984367
sex O 0 0.07790524512529373
- O 0 0.0658402144908905
reversal O 1 0.990787923336029
gene O 1 0.9998818635940552
, O 0 0.006053268443793058
Dax O 1 0.9448213577270508
- O 0 0.02642371505498886
1 O 0 0.008604750037193298
, O 0 0.003301016055047512
antagonizes O 1 0.9963282942771912
synergy O 1 0.9892888069152832
between O 0 0.012714331969618797
SF O 1 0.9996273517608643
- O 0 0.029912834987044334
1 O 0 0.007649026345461607
and O 0 0.003484470536932349
WT1 O 1 0.9999651908874512
, O 0 0.0020473580807447433
most O 0 0.0010667620226740837
likely O 0 0.0036429341416805983
through O 0 0.0022327564656734467
a O 0 0.003743718145415187
direct O 0 0.00868641771376133
interaction O 0 0.030313411727547646
with O 0 0.00623345049098134
SF O 1 0.9994451403617859
- O 0 0.03346352279186249
1 O 0 0.011407067067921162
. O 0 0.0064740413799881935

We O 0 0.004770470783114433
propose O 0 0.02608107216656208
that O 0 0.004816814791411161
WT1 O 1 0.9997734427452087
and O 0 0.004280238412320614
Dax O 1 0.9330310821533203
- O 0 0.02629990689456463
1 O 0 0.01205820869654417
functionally O 1 0.9109157919883728
oppose O 0 0.008996126241981983
each O 0 0.001289605861529708
other O 0 0.0008759937481954694
in O 0 0.0022957941982895136
testis O 1 0.999815046787262
development O 0 0.008309807628393173
by O 0 0.006529906764626503
modulating O 1 0.9997929930686951
SF O 1 0.9995900988578796
- O 0 0.04065000265836716
1 O 0 0.016490008682012558
- O 0 0.08877430111169815
mediated O 1 0.997780978679657
transactivation O 1 0.9982516169548035
. O 0 0.0052992175333201885
. O 0 0.0055792611092329025

A O 0 0.0335068553686142
mouse O 1 0.9921342134475708
model O 0 0.020053470507264137
for O 0 0.00988783035427332
Prader B-Disease 1 0.9999746084213257
- I-Disease 1 0.9979997277259827
Willi I-Disease 1 0.9999903440475464
syndrome I-Disease 1 0.9999991655349731
imprinting O 1 0.999875545501709
- O 0 0.2054184526205063
centre O 0 0.04497518017888069
mutations O 1 0.9999468326568604
. O 0 0.009403452277183533

Imprinting O 1 0.9940035939216614
in O 0 0.003628367790952325
the O 0 0.003917505964636803
15q11 O 1 0.9951949715614319
- O 0 0.043952200561761856
q13 O 1 0.9451234936714172
region O 0 0.007867373526096344
involves O 0 0.022517962381243706
an O 0 0.00449540838599205
imprinting O 1 0.9998466968536377
centre O 0 0.01825665310025215
( O 0 0.007197439670562744
IC O 1 0.99895179271698
) O 0 0.0036556755658239126
, O 0 0.0012295187916606665
mapping O 0 0.022563746199011803
in O 0 0.0011723689967766404
part O 0 0.0014163717860355973
to O 0 0.000867535243742168
the O 0 0.0016160012455657125
promoter O 1 0.9541128873825073
and O 0 0.0015044879401102662
first O 0 0.00379706802777946
exon O 1 0.995486319065094
of O 0 0.005410906858742237
SNRPN O 1 0.9936869740486145
. O 0 0.01012507639825344

Deletion O 1 0.9731485843658447
of O 0 0.0028766514733433723
this O 0 0.0034491217229515314
IC O 1 0.9885744452476501
abolishes O 1 0.9427674412727356
local O 0 0.010463595390319824
paternally O 1 0.9930781722068787
derived O 0 0.07055259495973587
gene O 1 0.9995880722999573
expression O 0 0.023900628089904785
and O 0 0.0016677338862791657
results O 0 0.011677759699523449
in O 0 0.007174225058406591
Prader B-Disease 1 0.9999980926513672
- I-Disease 1 0.9997147917747498
Willi I-Disease 1 0.9999973773956299
syndrome I-Disease 1 0.9999992847442627
( O 0 0.02864750660955906
PWS B-Disease 1 0.9999301433563232
) O 0 0.010405764915049076
. O 0 0.0065846797078847885

We O 0 0.002551343059167266
have O 0 0.0011011683382093906
created O 0 0.004523599985986948
two O 0 0.004276463761925697
deletion O 1 0.9999274015426636
mutations O 1 0.9999134540557861
in O 0 0.004776115529239178
mice O 1 0.9998117089271545
to O 0 0.002739871619269252
understand O 0 0.016016894951462746
PWS B-Disease 1 0.9998925924301147
and O 0 0.0017718422459438443
the O 0 0.0015746932476758957
mechanism O 0 0.04984687268733978
of O 0 0.001305830548517406
this O 0 0.0028014532290399075
IC O 1 0.9957138299942017
. O 0 0.008981718681752682

Mice O 1 0.9990835189819336
harbouring O 1 0.8025102019309998
an O 0 0.006761824246495962
intragenic O 1 0.9925745725631714
deletion O 1 0.9985795021057129
in O 0 0.00460312282666564
Snrpn O 1 0.9910162687301636
are O 0 0.002466705162078142
phenotypically O 1 0.998336672782898
normal O 0 0.022763287648558617
, O 0 0.0016684207366779447
suggesting O 0 0.012219717726111412
that O 0 0.0029703290201723576
mutations O 1 0.999958872795105
of O 0 0.002455223584547639
SNRPN O 1 0.9972700476646423
are O 0 0.001184383756481111
not O 0 0.0011677257716655731
sufficient O 0 0.0054113916121423244
to O 0 0.003447574796155095
induce O 1 0.9995554089546204
PWS B-Disease 1 0.999860405921936
. O 0 0.013666949234902859

Mice O 1 0.9982983469963074
with O 0 0.004111004993319511
a O 0 0.005757753737270832
larger O 0 0.015186915174126625
deletion O 1 0.9979864358901978
involving O 0 0.018819423392415047
both O 0 0.0030504472088068724
Snrpn O 1 0.9581722021102905
and O 0 0.0018582792254164815
the O 0 0.003764921799302101
putative O 1 0.9998321533203125
PWS O 1 0.9999631643295288
- O 0 0.15681374073028564
IC O 1 0.9726642966270447
lack O 0 0.012548446655273438
expression O 0 0.012287312187254429
of O 0 0.0010205561993643641
the O 0 0.0030906805768609047
imprinted O 1 0.9994613528251648
genes O 1 0.9994158744812012
Zfp127 O 1 0.9928896427154541
( O 0 0.009500176645815372
mouse O 1 0.9989713430404663
homologue O 1 0.9984342455863953
of O 0 0.00474116625264287
ZNF127 O 1 0.9991695880889893
) O 0 0.005923491902649403
, O 0 0.004081654362380505
Ndn O 1 0.9994596838951111
and O 0 0.0031429268419742584
Ipw O 1 0.996187150478363
, O 0 0.001842677709646523
and O 0 0.00112472428008914
manifest O 0 0.04194563254714012
several O 0 0.005115709267556667
phenotypes O 1 0.9999014139175415
common O 0 0.01671499013900757
to O 0 0.006187994033098221
PWS B-Disease 1 0.9999606609344482
infants O 1 0.9981392621994019
. O 0 0.013025711290538311

These O 0 0.002848214702680707
data O 0 0.004376158118247986
demonstrate O 0 0.005876387003809214
that O 0 0.0008145312312990427
both O 0 0.0006789338076487184
the O 0 0.0007026969105936587
position O 0 0.0013782974565401673
of O 0 0.0005613947287201881
the O 0 0.0017946739681065083
IC O 1 0.9980706572532654
and O 0 0.001125731854699552
its O 0 0.0015393176581710577
role O 0 0.003763968823477626
in O 0 0.0007609581225551665
the O 0 0.001088583841919899
coordinate O 0 0.01849988102912903
expression O 0 0.016776245087385178
of O 0 0.0015823360299691558
genes O 1 0.9992037415504456
is O 0 0.0024606180377304554
conserved O 1 0.5202104449272156
between O 0 0.005123727023601532
mouse O 1 0.9997026324272156
and O 0 0.0015969063388183713
human O 0 0.007653606124222279
, O 0 0.001136078150011599
and O 0 0.0007395661668851972
indicate O 0 0.005063052289187908
that O 0 0.0008786764228716493
the O 0 0.0019989460706710815
mouse O 1 0.9994922876358032
is O 0 0.0019543783273547888
a O 0 0.003604404628276825
suitable O 0 0.012675323523581028
model O 0 0.010321434587240219
system O 0 0.006699637975543737
in O 0 0.0009638816118240356
which O 0 0.0006483395118266344
to O 0 0.000751617131754756
investigate O 0 0.005262724123895168
the O 0 0.002019552979618311
molecular O 1 0.9984434247016907
mechanisms O 0 0.27135756611824036
of O 0 0.002167418599128723
imprinting O 1 0.9998724460601807
in O 0 0.0015206451062113047
this O 0 0.0008967428002506495
region O 0 0.001658231602050364
of O 0 0.0007094992906786501
the O 0 0.002560507971793413
genome O 1 0.9998138546943665
. O 0 0.0043868618085980415
. O 0 0.005142659414559603

Mutations O 1 0.9970045685768127
of O 0 0.0020180619321763515
the O 0 0.0037454706616699696
ATM O 1 0.9992150068283081
gene O 1 0.9998489618301392
detected O 0 0.31864744424819946
in O 0 0.003300401382148266
Japanese O 0 0.12548582255840302
ataxia B-Disease 1 0.9999995231628418
- I-Disease 1 0.9995810389518738
telangiectasia I-Disease 1 0.9999985694885254
patients O 1 0.9998905658721924
: O 0 0.004403216298669577
possible O 0 0.005639336071908474
preponderance O 0 0.4120303690433502
of O 0 0.0007484850939363241
the O 0 0.0010421640472486615
two O 0 0.002865795511752367
founder O 1 0.6030926704406738
mutations O 1 0.9999767541885376
4612del165 O 1 0.9896232485771179
and O 0 0.005741461180150509
7883del5 O 1 0.9817356467247009
. O 0 0.010862882249057293

The O 0 0.007948792539536953
ATM O 1 0.9767553210258484
( O 0 0.008134135976433754
A O 0 0.08819088339805603
- O 1 0.721457302570343
T O 1 0.9996057152748108
, O 0 0.008449205197393894
mutated O 1 0.999870777130127
) O 0 0.010031047277152538
gene O 1 0.9991613626480103
on O 0 0.0033227752428501844
human O 0 0.03299860283732414
chromosome O 1 0.9999524354934692
11q22 O 1 0.9851847887039185
. O 0 0.012171042151749134

3 O 0 0.014782935380935669
has O 0 0.0023008575662970543
recently O 0 0.005505457986146212
been O 0 0.0013067995896562934
identified O 0 0.004914599005132914
as O 0 0.001031986204907298
the O 0 0.0021422358695417643
gene O 1 0.9998334646224976
responsible O 0 0.006381073035299778
for O 0 0.0010325177572667599
the O 0 0.0023226002231240273
human O 1 0.9866356253623962
recessive B-Disease 1 1.0
disease I-Disease 1 0.9999996423721313
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9980453252792358
telangiectasia I-Disease 1 0.9999908208847046
( O 0 0.011169644072651863
A B-Disease 1 0.6013084053993225
- I-Disease 1 0.9446225166320801
T I-Disease 1 0.9997697472572327
) O 0 0.009205525740981102
. O 0 0.006204443052411079

In O 0 0.00400862330570817
order O 0 0.00262393057346344
to O 0 0.0009397226967848837
define O 0 0.005283110309392214
the O 0 0.001314400346018374
types O 0 0.012264780700206757
of O 0 0.003794231917709112
disease O 1 0.9999984502792358
- O 1 0.5678014755249023
causing O 1 0.9959105253219604
ATM O 1 0.9988177418708801
mutations O 1 0.999872088432312
in O 0 0.0022748305927962065
Japanese O 0 0.0069275181740522385
A B-Disease 1 0.7581647634506226
- I-Disease 1 0.998501181602478
T I-Disease 1 0.9999947547912598
patients O 1 0.9995222091674805
as O 0 0.0016856405418366194
well O 0 0.0010348703945055604
as O 0 0.000984114478342235
to O 0 0.001083272392861545
look O 0 0.0036431679036468267
for O 0 0.0016520606586709619
possible O 0 0.013572410680353642
mutational O 1 0.9997865557670593
hotspots O 1 0.9727837443351746
, O 0 0.004348116926848888
reverse O 1 0.6479470729827881
- O 0 0.041022222489118576
transcribed O 1 0.9837177395820618
RNA O 1 0.999138355255127
derived O 0 0.015050792135298252
from O 0 0.002018909901380539
ten O 0 0.0057551064528524876
patients O 1 0.9987162351608276
belonging O 0 0.008056449703872204
to O 0 0.0010267895413562655
eight O 0 0.004003845155239105
unrelated O 0 0.20605149865150452
Japanese O 0 0.01089217234402895
A B-Disease 0 0.23968055844306946
- I-Disease 1 0.8452301025390625
T I-Disease 1 0.9995438456535339
families O 0 0.007813637144863605
was O 0 0.0028018062002956867
analyzed O 0 0.019948685541749
for O 0 0.004152178298681974
mutations O 1 0.9996824264526367
by O 0 0.0034565164241939783
the O 0 0.0032241956796497107
restriction O 0 0.0745464339852333
endonuclease O 1 0.9966899156570435
fingerprinting O 1 0.6990416646003723
method O 0 0.032420262694358826
. O 0 0.0075419750064611435

As O 0 0.004408319480717182
has O 0 0.0018451815703883767
been O 0 0.0016623835545033216
reported O 0 0.005229238420724869
by O 0 0.0017924493877217174
others O 0 0.0029201172292232513
, O 0 0.0025911801494657993
mutations O 1 0.9999676942825317
that O 0 0.001657524611800909
lead O 0 0.009100610390305519
to O 0 0.0022919573821127415
exon O 1 0.9987616539001465
skipping O 1 0.8584510684013367
or O 0 0.011246776208281517
premature O 1 0.9991669654846191
protein O 1 0.9994122982025146
truncation O 1 0.991611659526825
were O 0 0.0014144177548587322
also O 0 0.0014351166319102049
predominant O 0 0.0204963069409132
in O 0 0.0017987602623179555
our O 0 0.004684251733124256
mutants O 1 0.9879727363586426
. O 0 0.00981844961643219

Six O 0 0.009635371156036854
different O 0 0.005786355119198561
mutations O 1 0.9998936653137207
were O 0 0.0014316732995212078
identified O 0 0.005654399283230305
on O 0 0.0008655296987853944
12 O 0 0.0025525896344333887
of O 0 0.0007805299828760326
the O 0 0.0017358761979267001
16 O 0 0.014022376388311386
alleles O 1 0.9998693466186523
examined O 0 0.05634330213069916
. O 0 0.007248280569911003

Four O 0 0.006084646563977003
were O 0 0.0022783915046602488
deletions O 1 0.9937005043029785
involving O 0 0.018496694043278694
a O 0 0.006242607720196247
loss O 0 0.01396641694009304
of O 0 0.0010663860011845827
a O 0 0.005163942463696003
single O 0 0.017207002267241478
exon O 1 0.9987603425979614
exon O 1 0.9926417469978333
7 O 0 0.013177319429814816
, O 0 0.003510500770062208
exon O 1 0.9939829707145691
16 O 0 0.010478559881448746
, O 0 0.0038925923872739077
exon O 1 0.9928996562957764
33 O 0 0.022985555231571198
or O 0 0.010516862384974957
exon O 1 0.9883605241775513
35 O 0 0.022668693214654922
. O 0 0.009125289507210255

The O 0 0.003991971258074045
others O 0 0.003682540962472558
were O 0 0.001122513902373612
minute O 0 0.017150413244962692
deletions O 1 0.9929456114768982
, O 0 0.0042472947388887405
4649delA O 1 0.9404468536376953
in O 0 0.0049385870806872845
exon O 1 0.9917518496513367
33 O 0 0.016927318647503853
and O 0 0.002531368751078844
7883del5 O 1 0.8646653294563293
in O 0 0.005392154678702354
exon O 1 0.9959893822669983
55 O 0 0.027359580621123314
. O 0 0.007955229841172695

The O 0 0.015635721385478973
mutations O 1 0.9999253749847412
4612del165 O 1 0.9907221794128418
and O 0 0.003558240830898285
7883del5 O 1 0.9150943756103516
were O 0 0.0013052411377429962
found O 0 0.0032952241599559784
in O 0 0.0008784043602645397
more O 0 0.0007487739203497767
than O 0 0.00104583112988621
two O 0 0.0020570633932948112
unrelated O 1 0.9229269027709961
families O 0 0.006690768525004387
; O 0 0.0029842176008969545
44 O 0 0.00940237008035183
% O 0 0.004700038116425276
( O 0 0.002510916208848357
7 O 0 0.003871234832331538
of O 0 0.0008128947229124606
16 O 0 0.004008960444480181
) O 0 0.0013676122762262821
of O 0 0.00047822840861044824
the O 0 0.002090760041028261
mutant O 1 0.9998915195465088
alleles O 1 0.9998836517333984
had O 0 0.0021327061112970114
one O 0 0.0008210446685552597
of O 0 0.0005453194607980549
the O 0 0.0013674331130459905
two O 0 0.006931085139513016
mutations O 1 0.9999709129333496
. O 0 0.008015052415430546

The O 0 0.010256842710077763
4612del165 O 1 0.9988917708396912
mutations O 1 0.9999371767044067
in O 0 0.0018568821251392365
three O 0 0.0011541679268702865
different O 0 0.0011838586069643497
families O 0 0.0019747475162148476
were O 0 0.00036537120467983186
all O 0 0.0005661580944433808
ascribed O 0 0.01913168467581272
to O 0 0.0006670550792478025
the O 0 0.0010384327033534646
same O 0 0.0077788433991372585
T O 1 0.9999735355377197
- O 0 0.32400083541870117
- O 0 0.0471094511449337
> O 1 0.9736087322235107
A O 0 0.012196349911391735
substitution O 0 0.057880256325006485
at O 0 0.002105091232806444
the O 0 0.0026464348193258047
splice O 1 0.9996564388275146
donor O 1 0.9726898074150085
site O 0 0.008009091019630432
in O 0 0.004379682708531618
intron O 1 0.99959796667099
33 O 0 0.03148882836103439
. O 0 0.009144498035311699

Microsatellite O 1 0.9966741800308228
genotyping O 1 0.9853396415710449
around O 0 0.004908381029963493
the O 0 0.0036763965617865324
ATM O 1 0.9955957531929016
locus O 1 0.9993805885314941
also O 0 0.0020494391210377216
indicated O 0 0.005312005989253521
that O 0 0.0009627709514461458
a O 0 0.005043621640652418
common O 0 0.0419582799077034
haplotype O 1 0.9997274279594421
was O 0 0.0022513428702950478
shared O 0 0.003926756791770458
by O 0 0.0012965659843757749
the O 0 0.0022839251905679703
mutant O 1 0.9998175501823425
alleles O 1 0.9998656511306763
in O 0 0.0027945758774876595
both O 0 0.006518007721751928
mutations O 1 0.9999651908874512
. O 0 0.009733590297400951

This O 0 0.0037551959976553917
suggests O 0 0.009067230857908726
that O 0 0.0008712094859220088
these O 0 0.000982529716566205
two O 0 0.002818566281348467
founder O 1 0.9152103066444397
mutations O 1 0.9999934434890747
may O 0 0.004279567394405603
be O 0 0.000995110021904111
predominant O 0 0.020035594701766968
among O 0 0.0025891857221722603
Japanese O 0 0.011976904235780239
ATM O 1 0.9965556859970093
mutant O 1 0.9987670183181763
alleles O 1 0.9985163807868958
. O 0 0.012968665920197964

W474C O 1 0.8984784483909607
amino O 1 0.9772213697433472
acid O 1 0.9972164630889893
substitution O 1 0.8901146650314331
affects O 0 0.4858679473400116
early O 0 0.004263383336365223
processing O 0 0.006950516253709793
of O 0 0.0006945747300051153
the O 0 0.002047168090939522
alpha O 1 0.843332827091217
- O 0 0.021384654566645622
subunit O 1 0.9766014218330383
of O 0 0.0029130892362445593
beta O 1 0.9976277947425842
- O 0 0.038757532835006714
hexosaminidase O 1 0.9927088022232056
A O 0 0.007470664102584124
and O 0 0.0010306568583473563
is O 0 0.0016191378235816956
associated O 0 0.009562965482473373
with O 0 0.009698652662336826
subacute O 1 0.9999840259552002
G B-Disease 1 0.9990689158439636
( I-Disease 0 0.010889485478401184
M2 I-Disease 1 0.9963107705116272
) I-Disease 0 0.011596672236919403
gangliosidosis I-Disease 1 0.9062370657920837
. O 0 0.008793440647423267

Mutations O 1 0.9991477727890015
in O 0 0.004259428009390831
the O 0 0.006803181022405624
HEXA O 1 0.9999306201934814
gene O 1 0.9993533492088318
, O 0 0.003591278102248907
encoding O 0 0.1510496884584427
the O 0 0.003076189896091819
alpha O 0 0.43446075916290283
- O 0 0.03135424107313156
subunit O 1 0.9371778964996338
of O 0 0.0032252208329737186
beta O 1 0.9949510097503662
- O 0 0.03332385793328285
hexosaminidase O 1 0.9639591574668884
A O 0 0.014455758966505527
( O 0 0.005391842685639858
Hex O 1 0.7764976620674133
A O 0 0.011722312308847904
) O 0 0.0024721669033169746
, O 0 0.0008512690546922386
that O 0 0.0010210960172116756
abolish O 0 0.029868919402360916
Hex O 0 0.2307523638010025
A O 0 0.017829246819019318
enzyme O 1 0.9995244741439819
activity O 0 0.07344752550125122
cause O 1 0.9997557997703552
Tay B-Disease 1 0.9999984502792358
- I-Disease 1 0.999339759349823
Sachs I-Disease 1 0.9999822378158569
disease I-Disease 1 0.9999960660934448
( O 0 0.014209575019776821
TSD B-Disease 1 0.9999542236328125
) O 0 0.00440535694360733
, O 0 0.001342489500530064
the O 0 0.0035247227642685175
fatal O 1 0.99996018409729
infantile B-Disease 1 0.9999603033065796
form I-Disease 0 0.011184061877429485
of I-Disease 0 0.0026578924153000116
G I-Disease 1 0.9993646740913391
( I-Disease 0 0.008766611106693745
M2 I-Disease 1 0.998291552066803
) I-Disease 0 0.007085333112627268
gangliosidosis I-Disease 1 0.9920381307601929
, I-Disease 0 0.004120446741580963
Type I-Disease 1 0.5623845458030701
1 I-Disease 0 0.010933521203696728
. O 0 0.006400860846042633

Less O 0 0.023440424352884293
severe O 1 0.9861720204353333
, O 0 0.009058361873030663
subacute O 1 0.9999682903289795
( O 0 0.01673024147748947
juvenile O 1 0.9999221563339233
- O 1 0.9908294677734375
onset O 1 0.999964714050293
) O 0 0.005898224655538797
and O 0 0.0037668701261281967
chronic O 1 0.9999940395355225
( O 0 0.007770059630274773
adult O 1 0.9904136061668396
- O 1 0.9804396033287048
onset O 1 0.9999762773513794
) O 0 0.005444565787911415
variants O 1 0.9746568202972412
are O 0 0.0011402914533391595
characterized O 0 0.029971031472086906
by O 0 0.0016771865775808692
a O 0 0.0042535895481705666
broad O 0 0.012500225566327572
spectrum O 0 0.03728897497057915
of O 0 0.002375225070863962
clinical O 1 0.9998822212219238
manifestations O 1 0.8599136471748352
and O 0 0.0011792245786637068
are O 0 0.0010273174848407507
associated O 0 0.007001155987381935
with O 0 0.0028734609950333834
residual O 0 0.412555992603302
levels O 0 0.008575811050832272
of O 0 0.0014669708907604218
Hex O 1 0.8908097743988037
A O 0 0.021499039605259895
enzyme O 1 0.9992142915725708
activity O 0 0.02019396238029003
. O 0 0.006238709669560194

We O 0 0.004491508938372135
identified O 0 0.013190793804824352
a O 0 0.013883459381759167
1422 O 1 0.9992757439613342
G O 1 0.999333918094635
- O 1 0.6062210202217102
- O 0 0.4360644817352295
> O 1 0.995819091796875
C O 0 0.36288946866989136
( O 0 0.007025154307484627
amino O 1 0.9954822063446045
acid O 1 0.9993107318878174
W474C O 1 0.9968435764312744
) O 0 0.003914559725672007
substitution O 0 0.09912004321813583
in O 0 0.0010449487017467618
the O 0 0.0006848617922514677
first O 0 0.0012125172652304173
position O 0 0.0014694645069539547
of O 0 0.0014290278777480125
exon O 1 0.995072066783905
13 O 0 0.007935087196528912
of O 0 0.0024570415262132883
HEXA O 1 0.9995744824409485
of O 0 0.0017900244565680623
a O 0 0.0066619571298360825
non O 0 0.009993085637688637
- O 0 0.018080689013004303
Jewish O 0 0.01420584786683321
proband O 1 0.903982400894165
who O 0 0.004069341346621513
manifested O 1 0.585970938205719
a O 0 0.0175364688038826
subacute O 1 0.9998838901519775
variant O 1 0.9970552921295166
of O 0 0.00471421517431736
G B-Disease 1 0.9967380166053772
( I-Disease 0 0.012791536748409271
M2 I-Disease 1 0.9957485795021057
) I-Disease 0 0.010896426625549793
gangliosidosis I-Disease 1 0.9710960388183594
. O 0 0.009727456606924534

On O 0 0.0027239497285336256
the O 0 0.0024984420742839575
second O 0 0.012233540415763855
maternally O 1 0.9995914101600647
inherited O 1 0.9993270635604858
allele O 1 0.9997797608375549
, O 0 0.0015962990000844002
we O 0 0.0007643732242286205
identified O 0 0.005236285272985697
the O 0 0.0020985284354537725
common O 1 0.9365265369415283
infantile O 1 0.9999988079071045
disease O 1 0.9999984502792358
- O 1 0.8065877556800842
causing O 1 0.9893171191215515
4 O 0 0.019332995638251305
- O 0 0.03283165767788887
bp O 1 0.5182234048843384
insertion O 1 0.9943538904190063
, O 0 0.007312640082091093
+ O 1 0.993021547794342
TATC O 1 0.9978588223457336
1278 O 1 0.9910531640052795
, O 0 0.0033579724840819836
in O 0 0.00396544998511672
exon O 1 0.9922877550125122
11 O 0 0.014534554444253445
. O 0 0.00666382210329175

Pulse O 1 0.9775477647781372
- O 0 0.05210966244339943
chase O 0 0.1487310528755188
analysis O 0 0.014931962825357914
using O 0 0.011902514845132828
proband O 1 0.9948613047599792
fibroblasts O 1 0.9993046522140503
revealed O 0 0.01355027686804533
that O 0 0.0012609667610377073
the O 0 0.002415227238088846
W474C O 1 0.9914482831954956
- O 0 0.01869487762451172
containing O 0 0.02192670665681362
alpha O 1 0.6949094533920288
- O 0 0.048631392419338226
subunit O 1 0.994347870349884
precursor O 1 0.8094233870506287
was O 0 0.0028950790874660015
normally O 0 0.009346291422843933
synthesized O 1 0.9761438369750977
, O 0 0.001354928594082594
but O 0 0.0010468967957422137
not O 0 0.0017209764337167144
phosphorylated O 1 0.9919375777244568
or O 0 0.005727285519242287
secreted O 1 0.9975976347923279
, O 0 0.001108489348553121
and O 0 0.0006992107955738902
the O 0 0.00194822798948735
mature O 1 0.9905430674552917
lysosomal O 1 0.9999164342880249
alpha O 1 0.984353244304657
- O 0 0.05860600247979164
subunit O 1 0.9885812401771545
was O 0 0.0037532984279096127
not O 0 0.0026128054596483707
detected O 0 0.4973858594894409
. O 0 0.00686264643445611

When O 0 0.00786767527461052
the O 0 0.0034989831037819386
W474C O 1 0.9590937495231628
- O 0 0.024249184876680374
containing O 0 0.024510029703378677
alpha O 1 0.6176882982254028
- O 0 0.0339706651866436
subunit O 1 0.985529899597168
was O 0 0.006827571429312229
transiently O 1 0.9970411658287048
co O 0 0.1804535835981369
- O 0 0.013507028110325336
expressed O 0 0.003420505439862609
with O 0 0.0017012375174090266
the O 0 0.0023395614698529243
beta O 1 0.994049072265625
- O 0 0.029507005587220192
subunit O 1 0.9831498265266418
to O 0 0.0017496811924502254
produce O 0 0.00891791470348835
Hex O 1 0.7134035229682922
A O 0 0.010212239809334278
( O 0 0.005359362345188856
alphabeta O 1 0.9922792911529541
) O 0 0.003916759975254536
in O 0 0.003503856249153614
COS O 1 0.999860405921936
- O 0 0.04713596776127815
7 O 0 0.018877403810620308
cells O 1 0.9981945157051086
, O 0 0.0013464405201375484
the O 0 0.0018254980677738786
mature O 1 0.9132611751556396
alpha O 1 0.943857729434967
- O 0 0.05563906952738762
subunit O 1 0.9948747754096985
was O 0 0.002601959742605686
present O 0 0.0019628971349447966
, O 0 0.0009968146914616227
but O 0 0.00089359498815611
its O 0 0.0012517821742221713
level O 0 0.0020721142645925283
was O 0 0.0010142616229131818
much O 0 0.0017918043304234743
lower O 0 0.0038715272676199675
than O 0 0.000866433372721076
that O 0 0.0009078908478841186
from O 0 0.0018462189473211765
normal O 0 0.050133075565099716
alpha O 1 0.978295624256134
- O 0 0.2714466154575348
subunit O 1 0.9989357590675354
transfections O 1 0.9904032945632935
, O 0 0.0018941207090392709
although O 0 0.0016102914232760668
higher O 0 0.0029196615796536207
than O 0 0.0009917072020471096
in O 0 0.001108732889406383
those O 0 0.0025799223221838474
cells O 1 0.9998379945755005
transfected O 1 0.9995830655097961
with O 0 0.0028154721949249506
an O 0 0.002721494762226939
alpha O 1 0.9005610346794128
- O 0 0.0706096738576889
subunit O 1 0.9966620206832886
associated O 0 0.01760517992079258
with O 0 0.014755805023014545
infantile O 1 0.9999568462371826
TSD B-Disease 1 0.9996347427368164
. O 0 0.01584205962717533

Furthermore O 0 0.023983847349882126
, O 0 0.0016463097417727113
the O 0 0.001566229504533112
precursor O 1 0.8998619914054871
level O 0 0.0026238705031573772
of O 0 0.0006882268935441971
the O 0 0.0023200390860438347
W474C O 1 0.9962202906608582
alpha O 1 0.9492067694664001
- O 0 0.05177016928792
subunit O 1 0.9958953857421875
was O 0 0.0025504163932055235
found O 0 0.0030109386425465345
to O 0 0.0014036440989002585
accumulate O 1 0.9602137804031372
in O 0 0.0012443317100405693
comparison O 0 0.004928173031657934
to O 0 0.0010031493147835135
the O 0 0.0016262347344309092
normal O 0 0.03351851552724838
alpha O 1 0.9106172323226929
- O 0 0.10593749582767487
subunit O 1 0.9958009123802185
precursor O 1 0.9601233005523682
levels O 0 0.023178407922387123
. O 0 0.006648742128163576

We O 0 0.004189661704003811
conclude O 0 0.01326585840433836
that O 0 0.0013989161234349012
the O 0 0.003734676633030176
1422 O 1 0.9995561242103577
G O 1 0.9996334314346313
- O 1 0.5898765921592712
- O 1 0.6844251751899719
> O 1 0.9992582201957703
C O 1 0.9965255856513977
mutation O 1 0.999906063079834
is O 0 0.0016929591074585915
the O 0 0.0012172652641311288
cause O 0 0.06170099973678589
of O 0 0.0018066174816340208
Hex B-Disease 1 0.9762579798698425
A I-Disease 0 0.187454953789711
enzyme I-Disease 1 0.9999927282333374
deficiency I-Disease 1 0.9999972581863403
in O 0 0.002755120163783431
the O 0 0.004074328113347292
proband O 1 0.9924628734588623
. O 0 0.009549914859235287

The O 0 0.007943417876958847
resulting O 0 0.05206914618611336
W474C O 1 0.9384893178939819
substitution O 0 0.11248967796564102
clearly O 0 0.0100227827206254
interferes O 1 0.9348055720329285
with O 0 0.006226459052413702
alpha O 1 0.9305883049964905
- O 0 0.06142382323741913
subunit O 1 0.9955171942710876
processing O 0 0.016696622595191002
, O 0 0.0013572565512731671
but O 0 0.0010824439814314246
because O 0 0.0016183253610506654
the O 0 0.001193437841720879
base O 0 0.0073371874168515205
substitution O 1 0.7936791181564331
falls O 0 0.013226517476141453
at O 0 0.0015423879958689213
the O 0 0.0007237938116304576
first O 0 0.0012236888287588954
position O 0 0.0019641765393316746
of O 0 0.001761586288921535
exon O 1 0.9979124665260315
13 O 0 0.009081238880753517
, O 0 0.0033869461622089148
aberrant O 1 0.9994327425956726
splicing O 1 0.9995878338813782
may O 0 0.004797752946615219
also O 0 0.0012158226454630494
contribute O 0 0.007833242416381836
to O 0 0.002093183808028698
Hex B-Disease 1 0.9832452535629272
A I-Disease 0 0.22020189464092255
deficiency I-Disease 1 0.9999943971633911
in O 0 0.002156450878828764
this O 0 0.002614953787997365
proband O 1 0.989624559879303
. O 0 0.004103686660528183
. O 0 0.0054410165175795555

Two O 0 0.011319792829453945
frequent O 0 0.06476365774869919
missense O 1 0.999764621257782
mutations O 1 0.9999524354934692
in O 0 0.016361849382519722
Pendred B-Disease 1 0.999931812286377
syndrome I-Disease 1 0.9999982118606567
. O 0 0.01708432473242283

Pendred B-Disease 1 0.9998028874397278
syndrome I-Disease 1 0.9999973773956299
is O 0 0.00833150651305914
an O 0 0.08005328476428986
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 0.9999990463256836
characterized O 1 0.8456512689590454
by O 0 0.004539954476058483
early O 0 0.014573795720934868
childhood O 1 0.9992141723632812
deafness B-Disease 1 0.9999974966049194
and O 0 0.013444270007312298
goiter B-Disease 1 0.9999629259109497
. O 0 0.013806423172354698

A O 0 0.01620464399456978
century O 0 0.00357267283834517
after O 0 0.0031810998916625977
its O 0 0.0017181562725454569
recognition O 0 0.0090107973664999
as O 0 0.0023907856084406376
a O 0 0.019988805055618286
syndrome O 1 0.9999979734420776
by O 0 0.0058320676907896996
Vaughan O 1 0.8886674046516418
Pendred O 1 0.9959374666213989
, O 0 0.0033395627979189157
the O 0 0.00730552664026618
disease O 1 0.9999988079071045
gene O 1 0.9999778270721436
( O 0 0.010231112129986286
PDS O 1 0.9994921684265137
) O 0 0.00307118589989841
was O 0 0.0018012020736932755
mapped O 0 0.02130269445478916
to O 0 0.005474464036524296
chromosome O 1 0.9999675750732422
7q22 O 1 0.9977735877037048
- O 0 0.061352819204330444
q31 O 1 0.9572501182556152
. O 0 0.011590324342250824

1 O 0 0.01237284392118454
and O 0 0.0018462806474417448
, O 0 0.0017668784130364656
recently O 0 0.006619417108595371
, O 0 0.0012011530343443155
found O 0 0.003214841242879629
to O 0 0.0017523192800581455
encode O 0 0.07946231961250305
a O 0 0.01277290191501379
putative O 1 0.997456967830658
sulfate O 1 0.9991335272789001
transporter O 1 0.9979275465011597
. O 0 0.013812084682285786

We O 0 0.005577245727181435
performed O 0 0.015463083051145077
mutation O 1 0.9998887777328491
analysis O 0 0.00780258746817708
of O 0 0.0007554711191914976
the O 0 0.0029093825723975897
PDS B-Disease 1 0.9999345541000366
gene O 1 0.9999421834945679
in O 0 0.005464882589876652
patients O 1 0.9975010752677917
from O 0 0.0035301095340400934
14 O 0 0.010087904520332813
Pendred B-Disease 1 0.9867894053459167
families O 0 0.009253697469830513
originating O 0 0.020841844379901886
from O 0 0.001661870046518743
seven O 0 0.0021966248750686646
countries O 0 0.0007617473602294922
and O 0 0.0010023495415225625
identified O 0 0.0076286932453513145
all O 0 0.0025486070662736893
mutations O 1 0.9999440908432007
. O 0 0.007980188354849815

The O 0 0.008685899898409843
mutations O 1 0.9996944665908813
include O 0 0.0053780111484229565
three O 0 0.00207143765874207
single O 0 0.006916343700140715
base O 0 0.009269006550312042
deletions O 1 0.994436502456665
, O 0 0.001815133960917592
one O 0 0.002514567691832781
splice O 1 0.9992576241493225
site O 0 0.01640409417450428
mutation O 1 0.9998623132705688
and O 0 0.003148261923342943
10 O 0 0.013207264244556427
missense O 1 0.9998291730880737
mutations O 1 0.9998131394386292
. O 0 0.011182385496795177

One O 0 0.020969003438949585
missense O 1 0.9996142387390137
mutation O 1 0.9999505281448364
( O 0 0.011263550259172916
L236P O 1 0.9927296042442322
) O 0 0.0034195873886346817
was O 0 0.001463647815398872
found O 0 0.003074261825531721
in O 0 0.0013467642711475492
a O 0 0.006303065922111273
homozygous O 1 0.9991932511329651
state O 0 0.001997897168621421
in O 0 0.0011791458819061518
two O 0 0.0035114868078380823
consanguineous O 1 0.9988828301429749
families O 0 0.0066924262791872025
and O 0 0.0008868448785506189
in O 0 0.0011700306786224246
a O 0 0.007571391295641661
heterozygous O 1 0.9992808699607849
state O 0 0.0018180720508098602
in O 0 0.0009416613029316068
five O 0 0.0021969403605908155
additional O 0 0.005621068179607391
non O 0 0.01408955454826355
- O 0 0.07895791530609131
consanguineous O 1 0.9944434762001038
families O 0 0.015305600129067898
. O 0 0.007988750003278255

Another O 0 0.03758874908089638
missense O 1 0.999647855758667
mutation O 1 0.9999562501907349
( O 0 0.010182438418269157
T416P O 1 0.9943965673446655
) O 0 0.003558157943189144
was O 0 0.0014509562170132995
found O 0 0.002753285225480795
in O 0 0.0011922386474907398
a O 0 0.006367805413901806
homozygous O 1 0.9996994733810425
state O 0 0.0019001802429556847
in O 0 0.0008942069252952933
one O 0 0.001347065786831081
family O 0 0.005118806380778551
and O 0 0.0007615108625032008
in O 0 0.0011089150793850422
a O 0 0.006374250166118145
heterozygous O 1 0.9992606043815613
state O 0 0.002641617553308606
in O 0 0.0015875566750764847
four O 0 0.003419948276132345
families O 0 0.008039204403758049
. O 0 0.006092654075473547

Pendred B-Disease 1 0.9957342743873596
patients O 1 0.9931406378746033
in O 0 0.00243361690081656
three O 0 0.003278435906395316
non O 0 0.015276176854968071
- O 0 0.16919265687465668
consanguineous O 1 0.9978675842285156
families O 0 0.006703402381390333
were O 0 0.0008600741275586188
shown O 0 0.0038206102326512337
to O 0 0.0009417115361429751
be O 0 0.00140187272336334
compound O 0 0.05456554889678955
heterozygotes O 1 0.9974107146263123
for O 0 0.00411271583288908
L236P O 1 0.9928135275840759
and O 0 0.0055188341066241264
T416P O 1 0.9731723070144653
. O 0 0.010175111703574657

In O 0 0.003373582847416401
total O 0 0.002814610255882144
, O 0 0.001162507338449359
one O 0 0.0013319230638444424
or O 0 0.0016473156865686178
both O 0 0.0007284782477654517
of O 0 0.0005970055353827775
these O 0 0.0020902040414512157
mutations O 1 0.9999815225601196
were O 0 0.0007582320249639452
found O 0 0.0024967018980532885
in O 0 0.0008270661346614361
nine O 0 0.0018634452717378736
of O 0 0.0007096277549862862
the O 0 0.001219649100676179
14 O 0 0.006600386928766966
families O 0 0.008066873997449875
analyzed O 0 0.03095613420009613
. O 0 0.006654252298176289

The O 0 0.0036269198171794415
identification O 0 0.013310371898114681
of O 0 0.0010765421902760863
two O 0 0.0028092539869248867
frequent O 0 0.23066812753677368
PDS B-Disease 1 0.9998370409011841
mutations O 1 0.9998571872711182
will O 0 0.0016654243227094412
facilitate O 0 0.011242699809372425
the O 0 0.0029427704866975546
molecular O 1 0.9998890161514282
diagnosis O 1 0.99994957447052
of O 0 0.00729132117703557
Pendred B-Disease 1 0.9999814033508301
syndrome I-Disease 1 0.9999990463256836
. O 0 0.013658363372087479

Insertional O 1 0.9903773665428162
mutation O 1 0.9991768002510071
by O 0 0.008404350839555264
transposable O 1 0.9973089694976807
element O 0 0.029465189203619957
, O 0 0.0035326536744832993
L1 O 1 0.9994540810585022
, O 0 0.0018002282595261931
in O 0 0.0015427044127136469
the O 0 0.0057839141227304935
DMD B-Disease 1 0.9999988079071045
gene O 1 0.9998477697372437
results O 0 0.013090706430375576
in O 0 0.0032268508803099394
X B-Disease 1 0.995360791683197
- I-Disease 1 0.6705400347709656
linked I-Disease 1 0.9947965741157532
dilated I-Disease 1 0.9998273253440857
cardiomyopathy I-Disease 1 0.9999845027923584
. O 0 0.012584635056555271

X B-Disease 1 0.9016335010528564
- I-Disease 0 0.29683253169059753
linked I-Disease 1 0.9889681935310364
dilated I-Disease 1 0.9999136924743652
cardiomyopathy I-Disease 1 0.999997615814209
( O 0 0.015348555520176888
XLDCM B-Disease 1 0.9975882768630981
) O 0 0.0036901873536407948
is O 0 0.001622842508368194
a O 0 0.00868269708007574
clinical O 1 0.9998517036437988
phenotype O 1 0.9999618530273438
of O 0 0.0018155971774831414
dystrophinopathy B-Disease 1 0.9973033666610718
which O 0 0.0015841798158362508
is O 0 0.0018246624385938048
characterized O 0 0.05398094654083252
by O 0 0.004519258625805378
preferential O 1 0.9940783977508545
myocardial B-Disease 1 0.9999948740005493
involvement I-Disease 0 0.03417989984154701
without O 0 0.0031860037706792355
any O 0 0.0026357972528785467
overt O 1 0.9595972299575806
clinical O 1 0.9986361861228943
signs O 0 0.020997637882828712
of O 0 0.00605671526864171
skeletal B-Disease 1 0.9999960660934448
myopathy I-Disease 1 0.9999934434890747
. O 0 0.015977201983332634

To O 0 0.0025610935408622026
date O 0 0.0034338340628892183
, O 0 0.0011873466428369284
several O 0 0.002988856052979827
mutations O 1 0.999927282333374
in O 0 0.00292400736361742
the O 0 0.009599591605365276
Duchenne B-Disease 1 0.9999986886978149
muscular I-Disease 1 0.9999986886978149
dystrophy I-Disease 1 0.9999998807907104
gene O 1 0.999992847442627
, O 0 0.014358939602971077
DMD O 1 0.9999967813491821
, O 0 0.0026685174088925123
have O 0 0.0009359634714201093
been O 0 0.0013027831446379423
identified O 0 0.008601255714893341
in O 0 0.0028129485435783863
patients O 1 0.9998144507408142
with O 0 0.004920441657304764
XLDCM B-Disease 1 0.9991357922554016
, O 0 0.001671836944296956
but O 0 0.0011676684953272343
a O 0 0.006113641895353794
pathogenic O 1 0.9995005130767822
correlation O 0 0.14946860074996948
of O 0 0.0009501282474957407
these O 0 0.0023806339595466852
cardiospecific O 1 0.9995321035385132
mutations O 1 0.9999750852584839
in O 0 0.006585412193089724
DMD O 1 0.9999943971633911
with O 0 0.003677729517221451
the O 0 0.004053002689033747
XLDCM B-Disease 1 0.9998409748077393
phenotype O 1 0.9999654293060303
has O 0 0.0031399957370013
remained O 0 0.002641245722770691
to O 0 0.0012029645731672645
be O 0 0.0022131893783807755
elucidated O 1 0.9911454319953918
. O 0 0.00708033936098218

We O 0 0.0034251445904374123
report O 0 0.002316758967936039
here O 0 0.0008503039134666324
the O 0 0.001053792075254023
identification O 0 0.009578904137015343
of O 0 0.0010552654275670648
a O 0 0.004451537970453501
unique O 0 0.008651421405375004
de O 0 0.02200646512210369
novo O 1 0.9928939938545227
L1 O 1 0.9991986155509949
insertion O 1 0.9758185744285583
in O 0 0.0024859821423888206
the O 0 0.004530052654445171
muscle O 1 0.9999251365661621
exon O 1 0.9986258745193481
1 O 0 0.009854912757873535
in O 0 0.005298631265759468
DMD O 1 0.9999910593032837
in O 0 0.0034999793861061335
three O 0 0.006422626785933971
XLDCM B-Disease 1 0.9998852014541626
patients O 1 0.9984134435653687
from O 0 0.002522549359127879
two O 0 0.003300783922895789
unrelated O 0 0.44942963123321533
Japanese O 0 0.009957635775208473
families O 0 0.009543742053210735
. O 0 0.006266421638429165

The O 0 0.007116871420294046
insertion O 1 0.9669145345687866
was O 0 0.004529573023319244
a O 0 0.007258065510541201
5 O 0 0.010294289328157902
- O 0 0.01843443140387535
truncated O 0 0.33018290996551514
form O 0 0.008089561946690083
of O 0 0.00146680255420506
human O 0 0.014864075928926468
L1 O 1 0.9994989633560181
inversely O 1 0.5702610611915588
integrated O 0 0.021573958918452263
in O 0 0.0011896934593096375
the O 0 0.0014700117753818631
5 O 0 0.010217301547527313
- O 0 0.024414069950580597
untranslated O 1 0.9360009431838989
region O 0 0.0038650301285088062
in O 0 0.001372024999000132
the O 0 0.004037464037537575
muscle O 1 0.9999890327453613
exon O 1 0.9996811151504517
1 O 0 0.0064685409888625145
, O 0 0.0012589865364134312
which O 0 0.0010590733727440238
affected O 0 0.008681888692080975
the O 0 0.002483963267877698
transcription O 1 0.9992318153381348
or O 0 0.002183342818170786
the O 0 0.0009945948841050267
stability O 0 0.006120187696069479
of O 0 0.0006918180151842535
the O 0 0.002363048493862152
muscle O 1 0.9999440908432007
form O 0 0.008727218955755234
of O 0 0.0026722915936261415
dystrophin O 1 0.9999817609786987
transcripts O 0 0.04287705197930336
but O 0 0.0014044609852135181
not O 0 0.0005221078172326088
that O 0 0.0004924944369122386
of O 0 0.0006248495192267001
the O 0 0.0028530159033834934
brain O 1 0.9999669790267944
or O 0 0.014287332072854042
Purkinje O 1 0.9999880790710449
cell O 1 0.9998658895492554
form O 0 0.01591655984520912
, O 0 0.0012291301973164082
probably O 0 0.003354738000780344
due O 0 0.002647611778229475
to O 0 0.0005873193149454892
its O 0 0.0011790662538260221
unique O 0 0.0035556668881326914
site O 0 0.0030516579281538725
of O 0 0.001409390359185636
integration O 0 0.027754059061408043
. O 0 0.00630246801301837

We O 0 0.0047317384742200375
speculate O 0 0.017838627099990845
that O 0 0.0011194470571354032
this O 0 0.0014524057041853666
insertion O 1 0.6517122387886047
of O 0 0.0014678079169243574
an O 0 0.003565311199054122
L1 O 1 0.9996788501739502
sequence O 0 0.38278481364250183
in O 0 0.005547822453081608
DMD O 1 0.9999974966049194
is O 0 0.002837641164660454
responsible O 0 0.0052678086794912815
for O 0 0.0008491816115565598
some O 0 0.0005448479787446558
of O 0 0.0005135152605362236
the O 0 0.0008819594513624907
population O 0 0.0016828535590320826
of O 0 0.0013132916064932942
Japanese O 0 0.015800220891833305
patients O 1 0.9996800422668457
with O 0 0.007343660574406385
XLDCM B-Disease 1 0.9982568621635437
. O 0 0.004916670266538858
. O 0 0.006598967593163252

Severe O 1 0.9927186965942383
early O 0 0.034727271646261215
- O 1 0.9950944185256958
onset O 1 0.9999854564666748
obesity B-Disease 1 0.9999878406524658
, O 0 0.01749797910451889
adrenal B-Disease 1 0.9999961853027344
insufficiency I-Disease 1 0.9999841451644897
and O 0 0.005124905612319708
red O 1 0.8482334613800049
hair O 1 0.99986732006073
pigmentation O 1 0.9999803304672241
caused O 1 0.709108829498291
by O 0 0.012487971223890781
POMC O 1 0.9999779462814331
mutations O 1 0.9999262094497681
in O 0 0.006235258653759956
humans O 0 0.3944728672504425
. O 0 0.006114212796092033

Sequential O 1 0.731989860534668
cleavage O 1 0.9866645336151123
of O 0 0.0016366980271413922
the O 0 0.002757498761638999
precursor O 1 0.9951658248901367
protein O 1 0.9987010955810547
pre O 0 0.07360830903053284
- O 0 0.027178004384040833
pro O 0 0.031177185475826263
- O 0 0.06548076868057251
opiomelanocortin O 1 0.9944199919700623
( O 0 0.01340466272085905
POMC O 1 0.9998314380645752
) O 0 0.005246926099061966
generates O 0 0.018171843141317368
the O 0 0.004345546010881662
melanocortin O 1 0.9993584752082825
peptides O 1 0.997913658618927
adrenocorticotrophin O 1 0.9929057359695435
( O 0 0.013137432746589184
ACTH O 1 0.9987795948982239
) O 0 0.006585786119103432
, O 0 0.004825199954211712
melanocyte O 1 0.9998316764831543
- O 0 0.3714722990989685
stimulating O 1 0.997500479221344
hormones O 1 0.99941086769104
( O 0 0.014950229786336422
MSH O 1 0.9997978806495667
) O 0 0.008549187332391739
alpha O 0 0.22244296967983246
, O 0 0.0036405501887202263
beta O 1 0.9538280963897705
and O 0 0.002973714377731085
gamma O 1 0.8586629629135132
as O 0 0.0012712930329144
well O 0 0.0009284980478696525
as O 0 0.0010543278185650706
the O 0 0.0031551504507660866
opioid O 1 0.9998064637184143
- O 1 0.6046208739280701
receptor O 1 0.9996479749679565
ligand O 1 0.9986894726753235
beta O 1 0.9964885711669922
- O 0 0.19906891882419586
endorphin O 1 0.9986636638641357
. O 0 0.013556880876421928

While O 0 0.005963278468698263
a O 0 0.004954145289957523
few O 0 0.0023368627298623323
cases O 0 0.005435239523649216
of O 0 0.0018073638202622533
isolated O 1 0.9959281086921692
ACTH B-Disease 1 0.9999924898147583
deficiency I-Disease 1 0.9999979734420776
have O 0 0.002154746325686574
been O 0 0.002117703901603818
reported O 0 0.012190324254333973
( O 0 0.011524699628353119
OMIM O 1 0.9999734163284302
201400 O 1 0.9952988028526306
) O 0 0.004400587175041437
, O 0 0.0011929390020668507
an O 0 0.0034545641392469406
inherited O 1 0.9999443292617798
POMC O 1 0.9999938011169434
defect O 1 0.9998577833175659
has O 0 0.002156241796910763
not O 0 0.001058048801496625
been O 0 0.0012602858478203416
described O 0 0.005735986400395632
so O 0 0.0023475035559386015
far O 0 0.0036982251331210136
. O 0 0.006175833288580179

Recent O 0 0.017588216811418533
studies O 0 0.010427101515233517
in O 0 0.0021245749667286873
animal O 0 0.033415958285331726
models O 0 0.018244624137878418
elucidated O 1 0.9907997250556946
a O 0 0.004685965832322836
central O 0 0.0024374499917030334
role O 0 0.005065251141786575
of O 0 0.002363920910283923
alpha O 1 0.9886110424995422
- O 0 0.4452110528945923
MSH O 1 0.9996496438980103
in O 0 0.0023582761641591787
the O 0 0.001740198233164847
regulation O 0 0.019700583070516586
of O 0 0.0015047708293423057
food O 0 0.01041199266910553
intake O 1 0.5514667630195618
by O 0 0.0036942511796951294
activation O 1 0.9769436717033386
of O 0 0.0012470113579183817
the O 0 0.0036387809086591005
brain O 1 0.9999898672103882
melanocortin O 1 0.9998524188995361
- O 0 0.03835016116499901
4 O 0 0.016720140352845192
- O 0 0.20062902569770813
receptor O 1 0.9996730089187622
( O 0 0.0145308468490839
MC4 O 1 0.9998493194580078
- O 0 0.20665954053401947
R O 1 0.69536292552948
; O 0 0.009288285858929157
refs O 1 0.8560439944267273
3 O 0 0.016258999705314636
- O 0 0.01724597066640854
5 O 0 0.007700713351368904
) O 0 0.0021754316985607147
and O 0 0.0005967503529973328
the O 0 0.0011919939424842596
linkage O 1 0.905444860458374
of O 0 0.0014607334742322564
human O 0 0.3541420102119446
obesity B-Disease 1 0.9999896287918091
to O 0 0.005181531421840191
chromosome O 1 0.9999724626541138
2 O 0 0.005153126548975706
in O 0 0.0009412885410711169
close O 0 0.002986286533996463
proximity O 0 0.009920623153448105
to O 0 0.0012484255712479353
the O 0 0.00400790199637413
POMC O 1 0.9999853372573853
locus O 1 0.9996495246887207
, O 0 0.001874013221822679
led O 0 0.00330109940841794
to O 0 0.0007129448349587619
the O 0 0.000907868321519345
proposal O 0 0.003119879635050893
of O 0 0.0006413213559426367
an O 0 0.0011761871865019202
association O 0 0.0042780255898833275
of O 0 0.002818232635036111
POMC O 1 0.9999558925628662
with O 0 0.008339760825037956
human O 0 0.2791857421398163
obesity B-Disease 1 0.9999613761901855
. O 0 0.01080592256039381

The O 0 0.004531291779130697
dual O 0 0.025250092148780823
role O 0 0.007288256194442511
of O 0 0.0023161256685853004
alpha O 1 0.9941294193267822
- O 0 0.34366098046302795
MSH O 1 0.9995785355567932
in O 0 0.0048795235343277454
regulating O 1 0.5086631774902344
food O 0 0.01577502302825451
intake O 1 0.6961345076560974
and O 0 0.004256156738847494
influencing O 1 0.9098189473152161
hair O 1 0.9996389150619507
pigmentation O 1 0.9999629259109497
predicts O 0 0.25712770223617554
that O 0 0.0017282578628510237
the O 0 0.0030264765955507755
phenotype O 1 0.9999860525131226
associated O 0 0.009405123069882393
with O 0 0.0025933191645890474
a O 0 0.008503073826432228
defect O 1 0.9993090629577637
in O 0 0.0060611264780163765
POMC O 1 0.9999386072158813
function O 0 0.024337967857718468
would O 0 0.0021981887985020876
include O 0 0.010357867926359177
obesity B-Disease 1 0.9999721050262451
, O 0 0.003384452313184738
alteration O 1 0.9967511892318726
in O 0 0.0054175653494894505
pigmentation O 1 0.9999730587005615
and O 0 0.010759638622403145
ACTH B-Disease 1 0.9999752044677734
deficiency I-Disease 1 0.9999926090240479
. O 0 0.013745525851845741

The O 0 0.004138418938964605
observation O 0 0.011004418134689331
of O 0 0.0013506306568160653
these O 0 0.0029580292757600546
symptoms O 1 0.9999362230300903
in O 0 0.001492560957558453
two O 0 0.00257665803655982
probands O 1 0.9929274916648865
prompted O 0 0.019190797582268715
us O 0 0.0024215413723140955
to O 0 0.0009814364602789283
search O 0 0.00812925212085247
for O 0 0.0037339208647608757
mutations O 1 0.9998949766159058
within O 0 0.0034420760348439217
their O 0 0.005275850649923086
POMC O 1 0.9999207258224487
genes O 1 0.9983116388320923
. O 0 0.009405629709362984

Patient O 1 0.9969326257705688
1 O 0 0.008877277374267578
was O 0 0.0018537704600021243
found O 0 0.002497953362762928
to O 0 0.0007532580057159066
be O 0 0.0007539194775745273
a O 0 0.0038372615817934275
compound O 0 0.04254908859729767
heterozygote O 1 0.9982354640960693
for O 0 0.002092740498483181
two O 0 0.0035177343524992466
mutations O 1 0.9999322891235352
in O 0 0.004984937142580748
exon O 1 0.9993366599082947
3 O 0 0.010326924733817577
( O 0 0.005390428937971592
G7013T O 1 0.9948069453239441
, O 0 0.004313666373491287
C7133delta O 1 0.9971814155578613
) O 0 0.003182023763656616
which O 0 0.001251268433406949
interfere O 0 0.018822964280843735
with O 0 0.0021380821708589792
appropriate O 0 0.007337416522204876
synthesis O 1 0.9012708067893982
of O 0 0.0026605797465890646
ACTH O 1 0.9996614456176758
and O 0 0.004341099411249161
alpha O 1 0.9809346795082092
- O 1 0.7019494771957397
MSH O 1 0.999393105506897
. O 0 0.013246597722172737

Patient O 1 0.9926787614822388
2 O 0 0.010358665138483047
was O 0 0.0036790594458580017
homozygous O 1 0.9972358345985413
for O 0 0.0019338816637173295
a O 0 0.00773488637059927
mutation O 1 0.9999352693557739
in O 0 0.0038639765698462725
exon O 1 0.999000608921051
2 O 0 0.012526534497737885
( O 0 0.006544657051563263
C3804A O 1 0.9907922744750977
) O 0 0.005129889119416475
which O 0 0.0037654172629117966
abolishes O 1 0.9971565008163452
POMC O 1 0.9993911981582642
translation O 0 0.034364111721515656
. O 0 0.006814298685640097

These O 0 0.003111906349658966
findings O 0 0.006834912579506636
represent O 0 0.0016533209709450603
the O 0 0.0006664967513643205
first O 0 0.0010343489702790976
examples O 0 0.002820525085553527
of O 0 0.0008987229666672647
a O 0 0.01186051219701767
genetic B-Disease 1 0.9999903440475464
defect I-Disease 1 0.9997263550758362
within O 0 0.003316637594252825
the O 0 0.004052409436553717
POMC O 1 0.9999792575836182
gene O 1 0.9997071623802185
and O 0 0.0013334169052541256
define O 0 0.00893888808786869
a O 0 0.005193130113184452
new O 0 0.009301585145294666
monogenic B-Disease 1 0.9999929666519165
endocrine I-Disease 1 0.9999992847442627
disorder I-Disease 1 0.999981164932251
resulting O 0 0.08352833241224289
in O 0 0.002476687543094158
early O 0 0.012282231822609901
- O 1 0.9932897686958313
onset O 1 0.9999929666519165
obesity B-Disease 1 0.9999949932098389
, O 0 0.012353437952697277
adrenal B-Disease 1 0.9999964237213135
insufficiency I-Disease 1 0.9999818801879883
and O 0 0.0059824138879776
red O 1 0.8814104199409485
hair O 1 0.999847412109375
pigmentation O 1 0.9999731779098511
. O 0 0.005171623080968857
. O 0 0.0066013154573738575

A O 0 0.020222041755914688
European O 0 0.009857955388724804
multicenter O 1 0.9977449178695679
study O 0 0.008714085444808006
of O 0 0.0037358729168772697
phenylalanine B-Disease 1 0.9999281167984009
hydroxylase I-Disease 1 0.9999711513519287
deficiency I-Disease 1 0.9999986886978149
: O 0 0.008463402278721333
classification O 0 0.030701544135808945
of O 0 0.0017839777283370495
105 O 0 0.03219150751829147
mutations O 1 0.9999347925186157
and O 0 0.0011476841755211353
a O 0 0.003034662688151002
general O 0 0.0021979231387376785
system O 0 0.010232942178845406
for O 0 0.004618240054696798
genotype O 1 0.9999678134918213
- O 0 0.026552420109510422
based O 0 0.005729757249355316
prediction O 0 0.0693974569439888
of O 0 0.0054250857792794704
metabolic O 1 0.999993085861206
phenotype O 1 0.9999688863754272
. O 0 0.00998951867222786

Phenylketonuria B-Disease 1 0.9999285936355591
( O 0 0.03312760218977928
PKU B-Disease 1 0.9999755620956421
) O 0 0.006593296304345131
and O 0 0.0034552074503153563
mild B-Disease 1 0.9990919828414917
hyperphenylalaninemia I-Disease 1 0.9997385144233704
( O 0 0.014167684130370617
MHP B-Disease 1 0.9999643564224243
) O 0 0.005516379605978727
are O 0 0.003347361460328102
allelic B-Disease 1 0.9999665021896362
disorders I-Disease 1 0.9999955892562866
caused O 0 0.3881379961967468
by O 0 0.0059167565777897835
mutations O 1 0.9998449087142944
in O 0 0.0021691538859158754
the O 0 0.0035039461217820644
gene O 1 0.99985671043396
encoding O 1 0.9913071990013123
phenylalanine O 1 0.9985180497169495
hydroxylase O 1 0.9988799691200256
( O 0 0.02933795005083084
PAH O 1 0.9999251365661621
) O 0 0.010007712058722973
. O 0 0.006785864941775799

Previous O 0 0.010402991436421871
studies O 0 0.0090705007314682
have O 0 0.0010984318796545267
suggested O 0 0.0035662278532981873
that O 0 0.0007776223937980831
the O 0 0.0011739005567505956
highly O 0 0.012626293115317822
variable O 1 0.9932780861854553
metabolic O 1 0.9999879598617554
phenotypes O 1 0.999798595905304
of O 0 0.012196775525808334
PAH B-Disease 1 0.9999986886978149
deficiency I-Disease 1 0.9999970197677612
correlate O 1 0.9875622987747192
with O 0 0.02389839105308056
PAH O 1 0.9999819993972778
genotypes O 1 0.9991156458854675
. O 0 0.014435221441090107

We O 0 0.003862082725390792
identified O 0 0.009551510214805603
both O 0 0.004358057864010334
causative O 1 0.9998385906219482
mutations O 1 0.9999563694000244
in O 0 0.006059558130800724
686 O 1 0.999049961566925
patients O 1 0.9982728958129883
from O 0 0.002421119948849082
seven O 0 0.003082579467445612
European O 0 0.005873551592230797
centers O 0 0.0159304141998291
. O 0 0.005424982402473688

On O 0 0.002255718456581235
the O 0 0.0011265621287748218
basis O 0 0.0016795778647065163
of O 0 0.0006467466591857374
the O 0 0.0016174482880160213
phenotypic O 1 0.9958441853523254
characteristics O 0 0.012935107573866844
of O 0 0.0019950123969465494
297 O 1 0.9965895414352417
functionally O 1 0.9997604489326477
hemizygous O 1 0.9997362494468689
patients O 1 0.9991816878318787
, O 0 0.0018704936373978853
105 O 0 0.00832738634198904
of O 0 0.0009482797468081117
the O 0 0.002910853596404195
mutations O 1 0.9999536275863647
were O 0 0.0009630590211600065
assigned O 0 0.0035990069154649973
to O 0 0.0007141756941564381
one O 0 0.0009368190658278763
of O 0 0.0007389071397483349
four O 0 0.0030166814103722572
arbitrary O 0 0.034171298146247864
phenotype O 1 0.999974250793457
categories O 0 0.01821102574467659
. O 0 0.007694929838180542

We O 0 0.0035871576983481646
proposed O 0 0.005568842403590679
and O 0 0.0016779147554188967
tested O 0 0.024244399741292
a O 0 0.004128530155867338
simple O 0 0.007658764719963074
model O 0 0.00728961918503046
for O 0 0.0018117866711691022
correlation O 1 0.8118456602096558
between O 0 0.007138999179005623
genotype O 1 0.9998618364334106
and O 0 0.003442944958806038
phenotypic O 1 0.9949254989624023
outcome O 0 0.026182010769844055
. O 0 0.006524189375340939

The O 0 0.0057617975398898125
observed O 0 0.025796761736273766
phenotype O 1 0.9998569488525391
matched O 0 0.03711581602692604
the O 0 0.0027295593172311783
predicted O 0 0.1541619598865509
phenotype O 1 0.999975323677063
in O 0 0.002322227694094181
79 O 0 0.013921773992478848
% O 0 0.002386661944910884
of O 0 0.0005901283002458513
the O 0 0.001630714861676097
cases O 0 0.011477266438305378
, O 0 0.001029450329951942
and O 0 0.0006621928769163787
in O 0 0.0007039114134386182
only O 0 0.0008613337995484471
5 O 0 0.0033050819765776396
of O 0 0.0015027225017547607
184 O 1 0.9028627276420593
patients O 1 0.9989468455314636
was O 0 0.0016565717523917556
the O 0 0.0017012051539495587
observed O 0 0.044414084404706955
phenotype O 1 0.9999836683273315
more O 0 0.0013417929876595736
than O 0 0.0010410696268081665
one O 0 0.0013997008791193366
category O 0 0.007389563601464033
away O 0 0.003533378941938281
from O 0 0.0012992870761081576
that O 0 0.0012574022402986884
expected O 0 0.0035830456763505936
. O 0 0.005167901981621981

Among O 0 0.004134292248636484
the O 0 0.00147514627315104
seven O 0 0.0039378320798277855
contributing O 0 0.01656690612435341
centers O 0 0.00815125834196806
, O 0 0.0007997577777132392
the O 0 0.000950509449467063
proportion O 0 0.008545885793864727
of O 0 0.0018796202493831515
patients O 1 0.999457061290741
for O 0 0.0012438815319910645
whom O 0 0.0024821467231959105
the O 0 0.0016203137347474694
observed O 0 0.08793982863426208
phenotype O 1 0.9999892711639404
did O 0 0.0025540031492710114
not O 0 0.0007883890648372471
match O 0 0.003210916416719556
the O 0 0.0017007612623274326
predicted O 0 0.10036980360746384
phenotype O 1 0.9999738931655884
was O 0 0.003970548044890165
4 O 0 0.0077582490630447865
% O 0 0.006844386458396912
- O 0 0.01486985757946968
23 O 0 0.00923967082053423
% O 0 0.00690119992941618
( O 0 0.007225755136460066
P O 1 0.994945228099823
< O 1 0.9951636791229248
. O 0 0.006875043269246817
0001 O 1 0.9977983832359314
) O 0 0.003957038279622793
, O 0 0.0012866968754678965
suggesting O 0 0.009078594855964184
that O 0 0.0009806042071431875
differences O 0 0.004734695423394442
in O 0 0.0009692756575532258
methods O 0 0.005756767932325602
used O 0 0.0026854020543396473
for O 0 0.003934978973120451
mutation O 1 0.9999898672103882
detection O 1 0.9977166652679443
or O 0 0.0168314166367054
phenotype O 1 0.9999935626983643
classification O 1 0.7738524079322815
may O 0 0.0036915147211402655
account O 0 0.00216810149140656
for O 0 0.000782407762017101
a O 0 0.0026780152693390846
considerable O 0 0.005534038878977299
proportion O 0 0.008994018658995628
of O 0 0.0038508956786245108
genotype O 1 0.9999772310256958
- O 1 0.947357714176178
phenotype O 1 0.9998737573623657
inconsistencies O 1 0.570148766040802
. O 0 0.009983070194721222

Our O 0 0.004977421369403601
data O 0 0.004207792691886425
indicate O 0 0.00652749789878726
that O 0 0.0014174255775287747
the O 0 0.005426669958978891
PAH O 1 0.9999935626983643
- O 1 0.9919925928115845
mutation O 1 0.99998939037323
genotype O 1 0.9995885491371155
is O 0 0.001876429421827197
the O 0 0.0010073449229821563
main O 0 0.003572968067601323
determinant O 1 0.9221527576446533
of O 0 0.004026027396321297
metabolic O 1 0.9999979734420776
phenotype O 1 0.9999885559082031
in O 0 0.0025873908307403326
most O 0 0.0033928293269127607
patients O 1 0.9999492168426514
with O 0 0.3039717674255371
PAH B-Disease 1 0.9999991655349731
deficiency I-Disease 1 0.9999971389770508
. O 0 0.01327089499682188

In O 0 0.0033499165438115597
the O 0 0.0014055982464924455
present O 0 0.002195308217778802
study O 0 0.00411170395091176
, O 0 0.0007024364313110709
the O 0 0.0010284342570230365
classification O 0 0.024815518409013748
of O 0 0.002507381374016404
105 O 1 0.9580844640731812
PAH O 1 0.9999990463256836
mutations O 1 0.999988317489624
may O 0 0.005165951792150736
allow O 0 0.0029635175596922636
the O 0 0.0010783466277644038
prediction O 0 0.022311801090836525
of O 0 0.0009779721731320024
the O 0 0.0030023909639567137
biochemical O 1 0.9999082088470459
phenotype O 1 0.9999904632568359
in O 0 0.00428069569170475
> O 1 0.9968721270561218
10 O 0 0.0036143679171800613
, O 0 0.0018551365938037634
000 O 0 0.02778884582221508
genotypes O 1 0.9997411370277405
, O 0 0.002084375824779272
which O 0 0.0012895922409370542
may O 0 0.002597671700641513
be O 0 0.0006801225244998932
useful O 0 0.0038885013200342655
for O 0 0.0008520875126123428
the O 0 0.001403598696924746
management O 0 0.011473474092781544
of O 0 0.0022655613720417023
hyperphenylalaninemia B-Disease 1 0.9992045760154724
in O 0 0.006686003413051367
newborns O 1 0.9995731711387634
. O 0 0.011381394229829311

Somatic O 1 0.9966474175453186
instability O 0 0.06719686090946198
of O 0 0.0014891484752297401
the O 0 0.002563804155215621
CTG O 1 0.9984897375106812
repeat O 0 0.15195037424564362
in O 0 0.0041366019286215305
mice O 1 0.9999152421951294
transgenic O 1 0.9982722997665405
for O 0 0.003008733969181776
the O 0 0.008035365492105484
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999994039535522
region O 0 0.008873464539647102
is O 0 0.0021251917351037264
age O 0 0.005877027288079262
dependent O 0 0.014335143379867077
but O 0 0.0013817184371873736
not O 0 0.0013236494269222021
correlated O 0 0.4603748619556427
to O 0 0.0010775179835036397
the O 0 0.0012655706377699971
relative O 0 0.016046401113271713
intertissue O 1 0.9980154037475586
transcription O 1 0.9992402791976929
levels O 0 0.02159718982875347
and O 0 0.005218603648245335
proliferative O 1 0.9998703002929688
capacities O 0 0.03815586492419243
. O 0 0.007841778919100761

A O 0 0.029846923425793648
( O 0 0.012470952235162258
CTG O 1 0.9960647225379944
) O 0 0.007187953218817711
nexpansion O 1 0.7117905020713806
in O 0 0.0016663330607116222
the O 0 0.0022390573285520077
3 O 0 0.011958501301705837
- O 0 0.03141374513506889
untranslated O 1 0.9897176027297974
region O 0 0.008024320006370544
( O 0 0.0059647089801728725
UTR O 1 0.9901559352874756
) O 0 0.0023622324224561453
of O 0 0.0010511134751141071
the O 0 0.004664227832108736
DM O 1 0.999981164932251
protein O 1 0.9998829364776611
kinase O 1 0.9999592304229736
gene O 1 0.9997555613517761
( O 0 0.009654414840042591
DMPK O 1 0.9979504942893982
) O 0 0.0029350437689572573
is O 0 0.0010931084398180246
responsible O 0 0.006272044964134693
for O 0 0.004410488065332174
causing O 1 0.9998615980148315
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999996423721313
( O 0 0.04333887994289398
DM B-Disease 1 0.9999485015869141
) O 0 0.011807188391685486
. O 0 0.00771304639056325

Major O 0 0.026788169518113136
instability O 1 0.9164294004440308
, O 0 0.002073486102744937
with O 0 0.001862663310021162
very O 0 0.0018907476915046573
large O 0 0.003456547623500228
expansions O 0 0.0986698791384697
between O 0 0.0027816230431199074
generations O 0 0.007285261992365122
and O 0 0.0007992396713234484
high O 0 0.0028820179868489504
levels O 0 0.0077578118070960045
of O 0 0.002606973983347416
somatic O 1 0.999983549118042
mosaicism O 1 0.9999812841415405
, O 0 0.002741068135946989
is O 0 0.0019036803860217333
observed O 0 0.01088697835803032
in O 0 0.004348608665168285
patients O 1 0.9993569254875183
. O 0 0.0072234803810715675

There O 0 0.003217793069779873
is O 0 0.0015406374586746097
a O 0 0.004341965541243553
good O 0 0.005294971168041229
correlation O 1 0.7330438494682312
between O 0 0.00390323786996305
repeat O 1 0.5707297325134277
size O 0 0.007830578833818436
( O 0 0.0023402704391628504
at O 0 0.0014123946893960238
least O 0 0.002867596223950386
in O 0 0.0022712356876581907
leucocytes O 1 0.9995107650756836
) O 0 0.004800310358405113
, O 0 0.003965975716710091
clinical O 1 0.999954104423523
severity O 1 0.9952411651611328
and O 0 0.0013839778257533908
age O 0 0.005284513812512159
of O 0 0.0035562380217015743
onset O 1 0.9998642206192017
. O 0 0.010969050228595734

The O 0 0.012996207922697067
trinucleotide O 1 0.9932357668876648
repeat O 1 0.7901195883750916
instability O 1 0.9171268343925476
mechanisms O 1 0.6752012968063354
involved O 0 0.008341901004314423
in O 0 0.0033512224908918142
DM B-Disease 1 0.9999575614929199
and O 0 0.0014698579907417297
other O 0 0.001860770513303578
human O 1 0.9362010955810547
genetic B-Disease 1 0.9999995231628418
diseases I-Disease 1 0.9999963045120239
are O 0 0.0026521410327404737
unknown O 0 0.01617899164557457
. O 0 0.005482053384184837

We O 0 0.0058470298536121845
studied O 0 0.017030999064445496
somatic O 1 0.9993681311607361
instability O 1 0.5493621826171875
by O 0 0.0029606642201542854
measuring O 0 0.01429083850234747
the O 0 0.004034010227769613
CTG O 1 0.9992818236351013
repeat O 0 0.3107932507991791
length O 0 0.0096589345484972
at O 0 0.001528017339296639
several O 0 0.001350892591290176
ages O 0 0.005350823979824781
in O 0 0.0008734146831557155
various O 0 0.001946105039678514
tissues O 1 0.9988460540771484
of O 0 0.0029138424433767796
transgenic O 1 0.9998611211776733
mice O 1 0.9996596574783325
carrying O 0 0.012005981989204884
a O 0 0.008202560245990753
( O 0 0.007785942405462265
CTG O 1 0.9989587068557739
) O 0 0.007224174682050943
55expansion O 1 0.8273064494132996
surrounded O 0 0.010016681626439095
by O 0 0.002654279815033078
45 O 0 0.006585122086107731
kb O 0 0.22964556515216827
of O 0 0.0010751934023573995
the O 0 0.001902927877381444
human O 0 0.1937958300113678
DM B-Disease 1 0.9999892711639404
region O 0 0.006183731835335493
, O 0 0.0012901058653369546
using O 0 0.005520063918083906
small O 0 0.007640430703759193
- O 0 0.027425767853856087
pool O 0 0.06782739609479904
PCR O 1 0.9967304468154907
. O 0 0.009396246634423733

These O 0 0.009130485355854034
mice O 1 0.9996250867843628
have O 0 0.002010469324886799
been O 0 0.0012598983012139797
shown O 0 0.003389607649296522
to O 0 0.0010945292888209224
reproduce O 0 0.13691870868206024
the O 0 0.002746919170022011
intergenerational O 1 0.9984000325202942
and O 0 0.0033825223799794912
somatic O 1 0.9997785687446594
instability O 0 0.4384094476699829
of O 0 0.0009556112345308065
the O 0 0.0016455425648018718
55 O 0 0.016423402354121208
CTG O 1 0.9991894364356995
repeat O 1 0.6002987027168274
suggesting O 0 0.011615971103310585
that O 0 0.0012808033498004079
surrounding O 0 0.005751797929406166
sequences O 0 0.047730740159749985
and O 0 0.0009590663248673081
the O 0 0.0018919648136943579
chromatin O 1 0.999057948589325
environment O 0 0.006358805112540722
are O 0 0.0008455003262497485
involved O 0 0.0047235628589987755
in O 0 0.0026753328274935484
instability O 1 0.9938242435455322
mechanisms O 1 0.953540027141571
. O 0 0.006734277121722698

As O 0 0.004924545530229807
observed O 0 0.0072391037829220295
in O 0 0.0008990398491732776
some O 0 0.0005496041267178953
of O 0 0.0006263813120312989
the O 0 0.0021792566403746605
tissues O 1 0.9999128580093384
of O 0 0.00752591947093606
DM B-Disease 1 0.9999994039535522
patients O 1 0.9999202489852905
, O 0 0.0016516548348590732
there O 0 0.0007911333814263344
is O 0 0.0010898394975811243
a O 0 0.004522925708442926
tendency O 0 0.027796678245067596
for O 0 0.002302523236721754
repeat O 0 0.11092709749937057
length O 0 0.011193516664206982
and O 0 0.0028577677439898252
somatic O 1 0.999944806098938
mosaicism O 1 0.9997920393943787
to O 0 0.0020913081243634224
increase O 0 0.00403170008212328
with O 0 0.0012741454411298037
the O 0 0.0008078160462900996
age O 0 0.002680195029824972
of O 0 0.0008901762194000185
the O 0 0.003220946528017521
mouse O 1 0.9994155168533325
. O 0 0.007845957763493061

Furthermore O 0 0.029168741777539253
, O 0 0.001831639208830893
we O 0 0.001037869486026466
observed O 0 0.005343869794160128
no O 0 0.0019766422919929028
correlation O 0 0.22343392670154572
between O 0 0.002029356313869357
the O 0 0.002947210567072034
somatic O 1 0.9999613761901855
mutation O 1 0.9999734163284302
rate O 0 0.014579269103705883
and O 0 0.004013522993773222
tissue O 1 0.9999722242355347
proliferation O 1 0.8971306085586548
capacity O 0 0.008582883514463902
. O 0 0.005962713155895472

The O 0 0.014023326337337494
somatic O 1 0.9996756315231323
mutation O 1 0.9999552965164185
rates O 0 0.014209708198904991
in O 0 0.0016161144012585282
different O 0 0.0031827862840145826
tissues O 1 0.99962317943573
were O 0 0.0008182937745004892
also O 0 0.0008975993259809911
not O 0 0.0011065228609368205
correlated O 0 0.23257970809936523
to O 0 0.000859633379150182
the O 0 0.0013148598372936249
relative O 0 0.01384222973138094
inter O 1 0.6857174038887024
- O 1 0.5146603584289551
tissue O 1 0.9998359680175781
difference O 0 0.009118672460317612
in O 0 0.002040180843323469
transcriptional O 1 0.9984622001647949
levels O 0 0.005158115178346634
of O 0 0.00049624900566414
the O 0 0.0010032027494162321
three O 0 0.004467661026865244
genes O 1 0.999862551689148
( O 0 0.00647368561476469
DMAHP O 1 0.9990962743759155
, O 0 0.0041949013248085976
DMPK O 1 0.9973748922348022
and O 0 0.002306062960997224
59 O 0 0.016302432864904404
) O 0 0.0030616552103310823
surrounding O 0 0.00543389655649662
the O 0 0.0020180793944746256
repeat O 1 0.7372508645057678
. O 0 0.0034765221644192934
. O 0 0.004756694193929434

A O 0 0.023633643984794617
novel O 0 0.04992620274424553
missense O 1 0.9998006224632263
mutation O 1 0.9999492168426514
in O 0 0.00651221489533782
patients O 1 0.9982655644416809
from O 0 0.0030556991696357727
a O 0 0.014781850390136242
retinoblastoma B-Disease 1 0.9999816417694092
pedigree O 1 0.9868075251579285
showing O 0 0.008135609328746796
only O 0 0.0022626658901572227
mild O 1 0.9308928847312927
expression O 0 0.017860695719718933
of O 0 0.0016739052953198552
the O 0 0.007192602381110191
tumor B-Disease 1 0.9999994039535522
phenotype O 1 0.999983549118042
. O 0 0.01104105357080698

We O 0 0.0020939172245562077
have O 0 0.0010786924976855516
used O 0 0.0025003200862556696
single O 0 0.012814558111131191
strand O 1 0.9981209635734558
conformation O 1 0.9977957010269165
polymorphism O 1 0.9982201457023621
analysis O 0 0.012072406709194183
to O 0 0.0011905538849532604
study O 0 0.003456524573266506
the O 0 0.001159080769866705
27 O 0 0.008526260033249855
exons O 1 0.9866483807563782
of O 0 0.0017835897160694003
the O 0 0.005510449409484863
RB1 O 1 0.9999899864196777
gene O 1 0.9997277855873108
in O 0 0.002014719881117344
individuals O 0 0.003327074460685253
from O 0 0.0016333222156390548
a O 0 0.004568843171000481
family O 0 0.008920788764953613
showing O 0 0.014732185751199722
mild O 1 0.9870113134384155
expression O 0 0.018502844497561455
of O 0 0.001666210824623704
the O 0 0.006721454672515392
retinoblastoma B-Disease 1 0.9999949932098389
phenotype O 1 0.9999600648880005
. O 0 0.010847358964383602

In O 0 0.0038111847825348377
this O 0 0.0019531259313225746
family O 0 0.010419587604701519
affected O 0 0.01565309427678585
individuals O 0 0.0074095833115279675
developed O 0 0.2682783007621765
unilateral B-Disease 1 0.9987292885780334
tumors I-Disease 1 0.9999970197677612
and O 0 0.0020721005275845528
, O 0 0.0009449102799408138
as O 0 0.0009856719989329576
a O 0 0.003150995820760727
result O 0 0.004128102213144302
of O 0 0.0013731438666582108
linkage O 1 0.9977927207946777
analysis O 0 0.016506975516676903
, O 0 0.003356517991051078
unaffected O 1 0.9994404911994934
mutation O 1 0.9999943971633911
carriers O 1 0.6021654605865479
were O 0 0.0008939986582845449
also O 0 0.0009414980886504054
identified O 0 0.006741776596754789
within O 0 0.002138398354873061
the O 0 0.0026783912908285856
pedigree O 1 0.9802240133285522
. O 0 0.006694090086966753

A O 0 0.01726548932492733
single O 0 0.011233539320528507
band O 0 0.01371670700609684
shift O 0 0.02013540081679821
using O 0 0.012513641268014908
SSCP O 1 0.9894272685050964
was O 0 0.002605665009468794
identified O 0 0.008701356127858162
in O 0 0.0028002120088785887
exon O 1 0.9967781901359558
21 O 0 0.007758068852126598
which O 0 0.0013950550928711891
resulted O 0 0.00816707219928503
in O 0 0.001191362738609314
a O 0 0.009332187473773956
missense O 1 0.9998205304145813
mutation O 1 0.9995855689048767
converting O 0 0.032456256449222565
a O 0 0.015395843423902988
cys O 1 0.9998787641525269
- O 1 0.604392945766449
- O 0 0.473628431558609
> O 1 0.9974265694618225
arg O 1 0.9792760610580444
at O 0 0.006799038033932447
nucleotide O 1 0.9865847826004028
position O 0 0.004263990558683872
28 O 0 0.004249434918165207
in O 0 0.0014633751707151532
the O 0 0.0032391315326094627
exon O 1 0.9980676770210266
. O 0 0.01112451497465372

The O 0 0.010554253123700619
mutation O 1 0.9994058609008789
destroyed O 0 0.016467921435832977
an O 0 0.00446512084454298
NdeI O 1 0.9851205945014954
restriction O 0 0.07809975743293762
enzyme O 1 0.9970614314079285
site O 0 0.012943785637617111
. O 0 0.007016331888735294

Analysis O 0 0.01699838787317276
of O 0 0.001008567400276661
all O 0 0.0008076786180026829
family O 0 0.004774152301251888
members O 0 0.001223324565216899
demonstrated O 0 0.005396534688770771
that O 0 0.0009985655779018998
the O 0 0.003482861677184701
missense O 1 0.999974250793457
mutation O 1 0.9999910593032837
co O 1 0.8470441699028015
- O 0 0.02659069560468197
segregated O 0 0.18976125121116638
with O 0 0.008112751878798008
patients O 1 0.9998341798782349
with O 0 0.024823885411024094
tumors B-Disease 1 0.9999996423721313
or O 0 0.004376805853098631
who O 0 0.0013953535817563534
, O 0 0.0007788875955156982
as O 0 0.0008849798468872905
a O 0 0.003287453204393387
result O 0 0.005653988569974899
of O 0 0.0013282968429848552
linkage O 1 0.9993730187416077
analysis O 0 0.012865787371993065
had O 0 0.001539639662951231
been O 0 0.0011968017788603902
predicted O 0 0.005208204500377178
to O 0 0.0008788543054834008
carry O 0 0.005177654325962067
the O 0 0.004493904300034046
predisposing O 1 0.9999487400054932
mutation O 1 0.9999326467514038
. O 0 0.010323825292289257

These O 0 0.003336356719955802
observations O 0 0.00662167789414525
point O 0 0.002001431304961443
to O 0 0.0007649168255738914
another O 0 0.002202959032729268
region O 0 0.0017539613181725144
of O 0 0.0008440875681117177
the O 0 0.004506404977291822
RB1 O 1 0.9999790191650391
gene O 1 0.9997217059135437
where O 0 0.005792228039354086
mutations O 1 0.999887228012085
only O 0 0.0016886875964701176
modify O 0 0.027478666976094246
the O 0 0.001078018918633461
function O 0 0.00798031035810709
of O 0 0.0007284494349732995
the O 0 0.00244969897903502
gene O 1 0.9998822212219238
and O 0 0.001226499443873763
raise O 0 0.005259701982140541
important O 0 0.0011849619913846254
questions O 0 0.0029763111378997564
for O 0 0.0025525055825710297
genetic O 1 0.9999892711639404
counseling O 1 0.9913506507873535
in O 0 0.0012664335081353784
families O 0 0.0031474961433559656
with O 0 0.0018498006975278258
these O 0 0.001823790604248643
distinctive O 1 0.8753754496574402
phenotypes O 1 0.9999152421951294
. O 0 0.004441007040441036
. O 0 0.005860041361302137

Maternal B-Disease 1 0.9838886260986328
disomy I-Disease 1 0.976085901260376
and O 0 0.016918377950787544
Prader B-Disease 1 0.9999885559082031
- I-Disease 1 0.9985326528549194
Willi I-Disease 1 0.9999891519546509
syndrome I-Disease 1 0.9999924898147583
consistent O 0 0.02411118522286415
with O 0 0.006969426292926073
gamete O 1 0.9997109770774841
complementation O 1 0.9999072551727295
in O 0 0.002309034811332822
a O 0 0.003640688257291913
case O 0 0.005072018131613731
of O 0 0.0035285581834614277
familial O 1 0.9999943971633911
translocation O 1 0.9999500513076782
( O 0 0.007639613468199968
3 O 0 0.00951812881976366
; O 0 0.0037758778780698776
15 O 0 0.005270889960229397
) O 0 0.003990686032921076
( O 0 0.006622364744544029
p25 O 1 0.9992446899414062
; O 0 0.009435371495783329
q11 O 1 0.9804741144180298
. O 0 0.0038071589078754187
2 O 0 0.008639451116323471
) O 0 0.0048262071795761585
. O 0 0.005126150790601969

Maternal B-Disease 1 0.9898952841758728
uniparental I-Disease 1 0.9993129968643188
disomy I-Disease 1 0.9898204803466797
( I-Disease 0 0.01786498911678791
UPD I-Disease 1 0.999482274055481
) I-Disease 0 0.006160726770758629
for I-Disease 0 0.004140293691307306
chromosome I-Disease 1 0.9999537467956543
15 I-Disease 0 0.004573701415210962
is O 0 0.0012676711194217205
responsible O 0 0.0038394969888031483
for O 0 0.0007878007018007338
an O 0 0.0009470354998484254
estimated O 0 0.003715686034411192
30 O 0 0.0025624569971114397
% O 0 0.002321458887308836
of O 0 0.0009258310310542583
cases O 0 0.007619064301252365
of O 0 0.004835532512515783
Prader B-Disease 1 0.9999988079071045
- I-Disease 1 0.9996871948242188
Willi I-Disease 1 0.9999971389770508
syndrome I-Disease 1 0.9999995231628418
( O 0 0.02479572221636772
PWS B-Disease 1 0.9999731779098511
) O 0 0.00909380242228508
. O 0 0.005932536441832781

We O 0 0.003013312816619873
report O 0 0.002038311678916216
on O 0 0.0008503266144543886
an O 0 0.0012748591834679246
unusual O 0 0.0064174155704677105
case O 0 0.0039154780097305775
of O 0 0.0020277441944926977
maternal B-Disease 1 0.9995102882385254
disomy I-Disease 1 0.99745112657547
15 I-Disease 0 0.006139977369457483
in O 0 0.00379368057474494
PWS B-Disease 1 0.9999740123748779
that O 0 0.0018055522814393044
is O 0 0.0010934892343357205
most O 0 0.0010169482557103038
consistent O 0 0.007398645859211683
with O 0 0.00217075040563941
adjacent O 0 0.014842166565358639
- O 0 0.013272938318550587
1 O 0 0.005525610875338316
segregation O 0 0.02173450216650963
of O 0 0.0012847173493355513
a O 0 0.008630087599158287
paternal O 1 0.999703586101532
t O 1 0.9997013211250305
( O 0 0.005202339496463537
3 O 0 0.008037688210606575
; O 0 0.0038281516171991825
15 O 0 0.005157645791769028
) O 0 0.0042269048281013966
( O 0 0.0067326948046684265
p25 O 1 0.9993451237678528
; O 0 0.009042026475071907
q11 O 1 0.9796274900436401
. O 0 0.002812687773257494
2 O 0 0.004933744203299284
) O 0 0.0022269566543400288
with O 0 0.0024896254763007164
simultaneous O 0 0.13412566483020782
maternal O 1 0.9976050853729248
meiotic O 1 0.9998819828033447
nondisjunction O 1 0.9917656779289246
for O 0 0.009085877798497677
chromosome O 1 0.999845027923584
15 O 0 0.01405806839466095
. O 0 0.006816196255385876

The O 0 0.013155769556760788
patient O 1 0.9989232420921326
( O 0 0.012030962854623795
J O 1 0.9996238946914673
. O 0 0.004959587939083576
B O 1 0.9515276551246643
. O 0 0.002182152820751071
) O 0 0.002322783460840583
, O 0 0.0012204388622194529
a O 0 0.004685158375650644
17 O 0 0.010956469923257828
- O 0 0.017467672005295753
year O 0 0.005583937745541334
- O 0 0.017110247164964676
old O 0 0.011910991743206978
white O 0 0.014623143710196018
male O 0 0.0770011618733406
with O 0 0.007601633667945862
PWS B-Disease 1 0.9999881982803345
, O 0 0.002276198472827673
was O 0 0.001235912786796689
found O 0 0.0024046197067946196
to O 0 0.0008227084763348103
have O 0 0.0013006979133933783
47 O 0 0.014563254080712795
chromosomes O 1 0.9867684245109558
with O 0 0.0034047910012304783
a O 0 0.009276792407035828
supernumerary O 1 0.9986876845359802
, O 0 0.004607371985912323
paternal O 1 0.9975357055664062
der O 1 0.7225775122642517
( O 0 0.004234150052070618
15 O 0 0.004923452157527208
) O 0 0.0017283509951084852
consisting O 0 0.002610871335491538
of O 0 0.0005777719197794795
the O 0 0.0013843515189364552
short O 0 0.010892228223383427
arm O 1 0.5355892181396484
and O 0 0.0011289003305137157
the O 0 0.0028672132175415754
proximal O 1 0.999869704246521
long O 0 0.011617793701589108
arm O 1 0.604567289352417
of O 0 0.0034438378643244505
chromosome O 1 0.9999650716781616
15 O 0 0.006877055857330561
, O 0 0.0020316571462899446
and O 0 0.004102661740034819
distal O 1 0.9999622106552124
chromosome O 1 0.9999783039093018
arm O 1 0.9825431108474731
3p O 1 0.9951820969581604
. O 0 0.01230976264923811

The O 0 0.013586923480033875
t O 1 0.9963119626045227
( O 0 0.0075941020622849464
3 O 0 0.010354152880609035
; O 0 0.003772354917600751
15 O 0 0.0039680590853095055
) O 0 0.0018015758832916617
was O 0 0.0011328236432746053
present O 0 0.0013270574854686856
in O 0 0.0007900207419879735
the O 0 0.0011561368592083454
balanced O 0 0.012612412683665752
state O 0 0.001518484321422875
in O 0 0.0013791944365948439
the O 0 0.0032632388174533844
patients O 1 0.9998124241828918
father O 0 0.008336739614605904
and O 0 0.0016369192162528634
a O 0 0.008847760036587715
sister O 0 0.06636295467615128
. O 0 0.007860676385462284

Fluorescent O 1 0.9439342617988586
in O 0 0.00876905582845211
situ O 1 0.9925657510757446
hybridization O 1 0.9834114909172058
analysis O 0 0.01560148224234581
demonstrated O 0 0.008959523402154446
that O 0 0.0014072618214413524
the O 0 0.0036459225229918957
PWS B-Disease 1 0.9999595880508423
critical O 0 0.014984630048274994
region O 0 0.004230470396578312
resided O 0 0.008740474469959736
on O 0 0.0010967307025566697
the O 0 0.00261777569539845
derivative O 1 0.9993559718132019
chromosome O 1 0.999981164932251
3 O 0 0.006744874641299248
and O 0 0.0006804593140259385
that O 0 0.0006357421516440809
there O 0 0.0005491043557412922
was O 0 0.0011270568938925862
no O 0 0.0024909842759370804
deletion O 1 0.9986023306846619
of O 0 0.0012979790335521102
the O 0 0.0029031934682279825
PWS B-Disease 1 0.9999513626098633
region O 0 0.004505397751927376
on O 0 0.0010047766845673323
the O 0 0.0015689124120399356
normal O 0 0.015443247742950916
pair O 0 0.012035706080496311
of O 0 0.0019959083292633295
15s O 1 0.996060311794281
present O 0 0.004185100551694632
in O 0 0.004884575493633747
J O 1 0.9992902278900146
. O 0 0.00843179039657116

B O 1 0.775547206401825
. O 0 0.01395337376743555

Methylation O 1 0.971643328666687
analysis O 0 0.02219291962683201
at O 0 0.005169670097529888
exon O 1 0.986120343208313
alpha O 0 0.046306200325489044
of O 0 0.001158478087745607
the O 0 0.0010850912658497691
small O 0 0.005102698225528002
nuclear O 0 0.0241507887840271
ribonucleoprotein O 1 0.9989011287689209
- O 0 0.03229575604200363
associated O 0 0.023344913497567177
polypeptide O 1 0.9995762705802917
N O 1 0.5780242085456848
( O 0 0.008344280533492565
SNRPN O 1 0.9978291392326355
) O 0 0.009725025855004787
gene O 1 0.9994227886199951
showed O 0 0.007439205888658762
a O 0 0.006306171882897615
pattern O 0 0.15698643028736115
characteristic O 0 0.015098091214895248
of O 0 0.0005678358138538897
only O 0 0.0008437365759164095
the O 0 0.0024115866981446743
maternal O 1 0.9996228218078613
chromosome O 1 0.9999747276306152
15 O 0 0.008674640208482742
in O 0 0.00422672787681222
J O 1 0.9984092116355896
. O 0 0.00930885598063469

B O 0 0.460039883852005
. O 0 0.012359523214399815

Maternal B-Disease 1 0.9865553379058838
disomy I-Disease 1 0.955867350101471
was O 0 0.004173534456640482
confirmed O 0 0.010232556611299515
by O 0 0.0057990532368421555
polymerase O 1 0.9997203946113586
chain O 1 0.8159664273262024
reaction O 0 0.029212599620223045
analysis O 0 0.0110640749335289
of O 0 0.0026386796962469816
microsatellite O 1 0.9997606873512268
repeats O 0 0.17672845721244812
at O 0 0.0023556286469101906
the O 0 0.003021640470251441
gamma O 1 0.9931495785713196
- O 0 0.04986569657921791
aminobutyric O 1 0.9951907396316528
acid O 1 0.9987714886665344
receptor O 1 0.9977003931999207
beta3 O 1 0.9863475561141968
subunit O 1 0.9950679540634155
( O 0 0.011547771282494068
GABRB3 O 1 0.9971168041229248
) O 0 0.011624022386968136
locus O 1 0.9946368336677551
. O 0 0.009969986975193024

A O 0 0.042161837220191956
niece O 1 0.9762328863143921
( O 0 0.010557723231613636
B O 1 0.9819390177726746
. O 0 0.00417292257770896
B O 1 0.9497998952865601
. O 0 0.0019042739877477288
) O 0 0.0018462208099663258
with O 0 0.0015347229782491922
45 O 0 0.006076326593756676
chromosomes O 1 0.9982514977455139
and O 0 0.0010251689236611128
the O 0 0.0014725161017850041
derivative O 1 0.9749435186386108
3 O 0 0.005514020565897226
but O 0 0.001210783957503736
without O 0 0.001969100208953023
the O 0 0.0016367594944313169
der O 0 0.4990311861038208
( O 0 0.003929443657398224
15 O 0 0.0048233745619654655
) O 0 0.002340743551030755
demonstrated O 0 0.008027266710996628
a O 0 0.010773645713925362
phenotype O 1 0.9999828338623047
consistent O 0 0.011784548871219158
with O 0 0.0019513450097292662
that O 0 0.0011964677833020687
reported O 0 0.006042030639946461
for O 0 0.0021270106080919504
haploinsufficiency O 1 0.9276756048202515
of O 0 0.004897191189229488
distal O 1 0.9997970461845398
3 O 0 0.026061953976750374
p O 0 0.3798999488353729
. O 0 0.007348507177084684

Uniparental B-Disease 1 0.9998225569725037
disomy I-Disease 1 0.994082510471344
associated O 0 0.018688451498746872
with O 0 0.004218198824673891
unbalanced O 1 0.8980258703231812
segregation O 0 0.0318005234003067
of O 0 0.0015527908690273762
non O 0 0.011662944220006466
- O 0 0.3527735769748688
Robertsonian O 1 0.9991563558578491
translocations O 1 0.9996053576469421
has O 0 0.002956985728815198
been O 0 0.0017741150222718716
reported O 0 0.0057417256757617
previously O 0 0.0025000632740557194
but O 0 0.0011262433836236596
has O 0 0.0009486009366810322
not O 0 0.000652466609608382
, O 0 0.000515454332344234
to O 0 0.0006213711458258331
our O 0 0.001495862496085465
knowledge O 0 0.004848091397434473
, O 0 0.0010439488105475903
been O 0 0.0013205601135268807
observed O 0 0.006197106558829546
in O 0 0.0010703812586143613
a O 0 0.004648627247661352
case O 0 0.0056907725520431995
of O 0 0.003900491399690509
PWS B-Disease 1 0.9998332262039185
. O 0 0.011578759178519249

Furthermore O 0 0.027045829221606255
, O 0 0.0015362881822511554
our O 0 0.002058786805719137
findings O 0 0.008107162080705166
are O 0 0.0007451833225786686
best O 0 0.0020045835990458727
interpreted O 0 0.006816916633397341
as O 0 0.001892714062705636
true O 0 0.015986332669854164
gamete O 1 0.9994727969169617
complementation O 1 0.9998451471328735
resulting O 0 0.07022202014923096
in O 0 0.00532513577491045
maternal B-Disease 1 0.9990469813346863
UPD I-Disease 1 0.9995487332344055
15 I-Disease 0 0.018233798444271088
and O 0 0.006999201141297817
PWS B-Disease 1 0.9996380805969238

Schwartz B-Disease 1 0.9710374474525452
- I-Disease 1 0.8895644545555115
Jampel I-Disease 1 0.9996763467788696
syndrome I-Disease 1 0.999997615814209
type I-Disease 1 0.6973859071731567
2 I-Disease 0 0.007931976579129696
and O 0 0.0032180456910282373
Stuve B-Disease 1 0.9998565912246704
- I-Disease 1 0.9979312419891357
Wiedemann I-Disease 1 0.9999818801879883
syndrome I-Disease 1 0.9999978542327881
: O 0 0.006864190101623535
a O 0 0.005294029600918293
case O 0 0.005796615034341812
for O 0 0.0017496185610070825
" O 0 0.004750783555209637
lumping O 1 0.851052463054657
" O 0 0.007291565649211407
. O 0 0.007039444986730814

Recent O 0 0.014581235125660896
studies O 0 0.00924005638808012
demonstrated O 0 0.006356609519571066
the O 0 0.0008251418475992978
existence O 0 0.0027354455087333918
of O 0 0.0007958049536682665
a O 0 0.006808144506067038
genetically O 1 0.9990887641906738
distinct O 0 0.017290223389863968
, O 0 0.0015443571610376239
usually O 0 0.004382519982755184
lethal O 1 0.8739248514175415
form O 0 0.005207374691963196
of O 0 0.0010369493393227458
the O 0 0.0033896383829414845
Schwartz B-Disease 1 0.9995575547218323
- I-Disease 1 0.9953148365020752
Jampel I-Disease 1 0.9999650716781616
syndrome I-Disease 1 0.9999994039535522
( O 0 0.022335372865200043
SJS B-Disease 1 0.9999550580978394
) O 0 0.004714595153927803
of O 0 0.002974680159240961
myotonia B-Disease 1 0.9999656677246094
and O 0 0.00966145284473896
skeletal B-Disease 1 0.999994158744812
dysplasia I-Disease 1 0.9999995231628418
, O 0 0.002288729650899768
which O 0 0.0011252718977630138
we O 0 0.0017484764102846384
called O 0 0.022648675367236137
SJS B-Disease 1 0.9999464750289917
type I-Disease 0 0.40583470463752747
2 I-Disease 0 0.012056766077876091
. O 0 0.0067119295708835125

This O 0 0.01515840832144022
disorder O 1 0.999924898147583
is O 0 0.0029110985342413187
reminiscent O 0 0.020885201171040535
of O 0 0.0013361703604459763
another O 0 0.006284906063228846
rare O 0 0.3072702884674072
condition O 1 0.669719398021698
, O 0 0.0014058835804462433
the O 0 0.003105547744780779
Stuve B-Disease 1 0.99982750415802
- I-Disease 1 0.9990279674530029
Wiedemann I-Disease 1 0.9999912977218628
syndrome I-Disease 1 0.9999995231628418
( O 0 0.020074034109711647
SWS B-Disease 1 0.9999569654464722
) O 0 0.0044197337701916695
, O 0 0.001092536374926567
which O 0 0.0010544764809310436
comprises O 0 0.006061522290110588
campomelia B-Disease 1 0.9322426915168762
at O 0 0.004241454415023327
birth O 0 0.23198002576828003
with O 0 0.012170067057013512
skeletal B-Disease 1 0.9999969005584717
dysplasia I-Disease 1 0.9999997615814209
, O 0 0.01115701999515295
contractures B-Disease 1 0.9999692440032959
, O 0 0.0025913871359080076
and O 0 0.001497352379374206
early B-Disease 0 0.006419231649488211
death I-Disease 0 0.024789201095700264
. O 0 0.007179941050708294

To O 0 0.003680179826915264
test O 0 0.009655861184000969
for O 0 0.001520163263194263
possible O 0 0.007386018987745047
nosologic O 1 0.9613370895385742
identity O 0 0.017448099330067635
between O 0 0.0027398092206567526
these O 0 0.0032881167717278004
disorders O 1 0.9999967813491821
, O 0 0.0013279691338539124
we O 0 0.0007885119412094355
reviewed O 0 0.0039148759096860886
the O 0 0.0008894568309187889
literature O 0 0.0027772155590355396
and O 0 0.0007920857169665396
obtained O 0 0.00422430457547307
a O 0 0.004528657533228397
follow O 0 0.00756629416719079
- O 0 0.007796817924827337
up O 0 0.0015563908964395523
of O 0 0.0004831667465623468
the O 0 0.0006467210478149354
only O 0 0.0009036335977725685
two O 0 0.0024790281895548105
surviving O 1 0.9543278813362122
patients O 1 0.9997640252113342
, O 0 0.0012315341737121344
one O 0 0.0020637321285903454
with O 0 0.00916342530399561
SJS B-Disease 1 0.9999960660934448
type I-Disease 1 0.7269680500030518
2 I-Disease 0 0.007476486265659332
at O 0 0.002175146248191595
age O 0 0.0038335504941642284
10 O 0 0.0028993324376642704
years O 0 0.0014732995769008994
and O 0 0.0008828043937683105
another O 0 0.004943192005157471
with O 0 0.006797563750296831
SWS B-Disease 1 0.9999327659606934
at O 0 0.004435895476490259
age O 0 0.005925578065216541
7 O 0 0.008981573395431042
years O 0 0.004004521295428276
. O 0 0.005260198377072811

Patients O 1 0.9989885687828064
reported O 0 0.008687320165336132
as O 0 0.0018163449130952358
having O 0 0.006481344811618328
either O 0 0.04028202220797539
neonatal O 1 0.9999983310699463
SJS B-Disease 1 0.9999756813049316
or O 0 0.017258670181035995
SWS B-Disease 1 0.9980862140655518
presented O 0 0.006061810068786144
a O 0 0.004962867125868797
combination O 0 0.029434146359562874
of O 0 0.001164293265901506
a O 0 0.008923023007810116
severe O 1 0.9989853501319885
, O 0 0.008992972783744335
prenatal O 1 0.9999960660934448
- O 1 0.9992362260818481
onset O 1 0.9999973773956299
neuromuscular B-Disease 1 0.9999997615814209
disorder I-Disease 1 0.9999943971633911
( O 0 0.007751662749797106
with O 0 0.023921750485897064
congenital B-Disease 1 1.0
joint I-Disease 1 0.9988075494766235
contractures I-Disease 1 0.9999954700469971
, O 0 0.010303343646228313
respiratory O 1 0.999996542930603
and O 0 0.0030424916185438633
feeding O 1 0.9122109413146973
difficulties O 0 0.02421547845005989
, O 0 0.002144167199730873
tendency O 0 0.3620656430721283
to O 0 0.00390461552888155
hyperthermia B-Disease 1 0.9999837875366211
, O 0 0.002288500079885125
and O 0 0.0015790315810590982
frequent O 0 0.02812754362821579
death O 0 0.019552314653992653
in O 0 0.003701065434142947
infancy O 1 0.9971669316291809
) O 0 0.0028283896390348673
with O 0 0.0017104847356677055
a O 0 0.005496039055287838
distinct O 0 0.09342480450868607
campomelic B-Disease 1 0.9988164901733398
- I-Disease 1 0.765507698059082
metaphyseal I-Disease 1 0.9995181560516357
skeletal I-Disease 1 0.9999618530273438
dysplasia I-Disease 1 0.9999953508377075
. O 0 0.014277310110628605

The O 0 0.0033354749903082848
similarity O 0 0.02415875717997551
of O 0 0.0009597724420018494
the O 0 0.0020967398304492235
clinical O 1 0.9988956451416016
and O 0 0.0024258382618427277
radiographic O 1 0.9998611211776733
findings O 0 0.011026177555322647
is O 0 0.0010141263483092189
so O 0 0.0012507191859185696
extensive O 0 0.00778257567435503
that O 0 0.0010964589891955256
these O 0 0.0028875344432890415
disorders O 1 0.9999957084655762
appear O 0 0.0056945886462926865
to O 0 0.0007570684538222849
be O 0 0.0008421767270192504
a O 0 0.00378184812143445
single O 0 0.00906449370086193
entity O 0 0.024103272706270218
. O 0 0.005151393357664347

The O 0 0.005680528469383717
follow O 0 0.011782272718846798
- O 0 0.011572699062526226
up O 0 0.003191070631146431
observation O 0 0.009237685240805149
of O 0 0.0007219015387818217
an O 0 0.00142939283978194
identical O 0 0.013421864248812199
and O 0 0.0010503103258088231
unique O 0 0.004871477372944355
pattern O 0 0.03337767720222473
of O 0 0.0028210573364049196
progressive O 1 0.9996628761291504
bone B-Disease 1 0.9999995231628418
dysplasia I-Disease 1 0.9999994039535522
in O 0 0.0017115043010562658
the O 0 0.001417791354469955
two O 0 0.003763180458918214
patients O 1 0.9998014569282532
( O 0 0.0024777608923614025
one O 0 0.002138718031346798
with O 0 0.010812138207256794
SJS B-Disease 1 0.999995231628418
type I-Disease 1 0.7446852326393127
2 I-Disease 0 0.005119594279676676
, O 0 0.0009511996759101748
one O 0 0.0017620449652895331
with O 0 0.006095562595874071
SWS B-Disease 1 0.9998177886009216
) O 0 0.006436320953071117
surviving O 0 0.026585565879940987
beyond O 0 0.010352677665650845
infancy O 1 0.9855825901031494
adds O 0 0.016479268670082092
to O 0 0.0008379059727303684
the O 0 0.000890629249624908
evidence O 0 0.0023680932354182005
in O 0 0.0012011014623567462
favor O 0 0.004539428744465113
of O 0 0.0014152335934340954
identity O 0 0.031654275953769684
. O 0 0.004884074907749891

The O 0 0.004892253316938877
hypothesis O 0 0.22243013978004456
that O 0 0.005755306221544743
SWS B-Disease 1 0.9998219609260559
and O 0 0.010000569745898247
SJS B-Disease 1 0.9999775886535645
type I-Disease 0 0.37339216470718384
2 I-Disease 0 0.0043406980112195015
are O 0 0.0005085981683805585
the O 0 0.0010653005447238684
same O 0 0.005303170531988144
disorder O 1 0.9999852180480957
should O 0 0.0015523398760706186
be O 0 0.0010567321442067623
testable O 1 0.6640629768371582
by O 0 0.0041525838896632195
molecular O 1 0.9989089965820312
methods O 0 0.010849472135305405
. O 0 0.0027805969584733248
. O 0 0.005365598481148481

A O 0 0.028985487297177315
mouse O 1 0.9907534122467041
model O 0 0.013382242992520332
of O 0 0.0038101656828075647
severe O 1 0.9999384880065918
von B-Disease 1 0.9999810457229614
Willebrand I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9999986886978149
: O 0 0.01405761856585741
defects O 1 0.9999396800994873
in O 0 0.006951681338250637
hemostasis O 1 0.9999539852142334
and O 0 0.015268833376467228
thrombosis B-Disease 1 0.9999970197677612
. O 0 0.011521914042532444

von B-Disease 1 0.9862391352653503
Willebrand I-Disease 1 0.9998319149017334
factor I-Disease 0 0.25118115544319153
( I-Disease 0 0.016676701605319977
vWf I-Disease 1 0.9997276663780212
) I-Disease 0 0.11678029596805573
deficiency I-Disease 1 0.9999994039535522
causes O 1 0.9999220371246338
severe O 1 0.9998956918716431
von B-Disease 1 0.9999711513519287
Willebrand I-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999961853027344
in O 0 0.006630101706832647
humans O 1 0.784720778465271
. O 0 0.0073137409053742886

We O 0 0.003919810056686401
generated O 0 0.010138562880456448
a O 0 0.009370701387524605
mouse O 1 0.9972350001335144
model O 0 0.01138351857662201
for O 0 0.0017760448390617967
this O 0 0.0033585315104573965
disease O 1 0.9999523162841797
by O 0 0.003268705913797021
using O 0 0.015316641889512539
gene O 1 0.9997795224189758
targeting O 0 0.04537048190832138
. O 0 0.006811846047639847

vWf B-Disease 1 0.9989911913871765
- I-Disease 1 0.8606963157653809
deficient I-Disease 1 0.9994645714759827
mice O 1 0.9996243715286255
appeared O 0 0.012098584324121475
normal O 0 0.0322272926568985
at O 0 0.0042347777634859085
birth O 1 0.9286288619041443
; O 0 0.0023439459037035704
they O 0 0.0005875046481378376
were O 0 0.000747773505281657
viable O 0 0.07314614951610565
and O 0 0.002180777257308364
fertile O 0 0.13816337287425995
. O 0 0.008014142513275146

Neither O 0 0.055962275713682175
vWf O 1 0.9945874214172363
nor O 0 0.04499722272157669
vWf O 1 0.9974349141120911
propolypeptide O 1 0.975820779800415
( O 0 0.018394753336906433
von B-Disease 1 0.9988271594047546
Willebrand I-Disease 1 0.9999964237213135
antigen O 1 0.9999876022338867
II O 0 0.11498717218637466
) O 0 0.0028124642558395863
were O 0 0.0009298446821048856
detectable O 1 0.9589712619781494
in O 0 0.002418649848550558
plasma O 1 0.9992486834526062
, O 0 0.004384284373372793
platelets O 1 0.9999783039093018
, O 0 0.0030786199495196342
or O 0 0.008807161822915077
endothelial O 1 0.9999785423278809
cells O 1 0.9931439161300659
of O 0 0.001430200762115419
the O 0 0.004152038134634495
homozygous O 1 0.9999018907546997
mutant O 1 0.9995744824409485
mice O 1 0.9994820952415466
. O 0 0.011455542407929897

The O 0 0.012247572652995586
mutant O 1 0.9991388320922852
mice O 1 0.9997562766075134
exhibited O 0 0.04811733216047287
defects O 1 0.9997944235801697
in O 0 0.00516058225184679
hemostasis O 1 0.9998816251754761
with O 0 0.0035448975395411253
a O 0 0.0069838655181229115
highly O 0 0.028714537620544434
prolonged O 1 0.9992678761482239
bleeding O 1 0.9999868869781494
time O 0 0.0033813880290836096
and O 0 0.003084279829636216
spontaneous O 1 0.9997127652168274
bleeding O 1 0.9999688863754272
events O 0 0.0052102599292993546
in O 0 0.0012378429528325796
approximately O 0 0.0028882897458970547
10 O 0 0.0031242973636835814
% O 0 0.004046399146318436
of O 0 0.002988564781844616
neonates O 1 0.9994681477546692
. O 0 0.009616234339773655

As O 0 0.002809750847518444
in O 0 0.0012764002894982696
the O 0 0.002383479615673423
human O 1 0.7564553022384644
disease O 1 0.9999943971633911
, O 0 0.0015533919213339686
the O 0 0.0015194527804851532
factor O 1 0.7173606753349304
VIII O 1 0.9966015815734863
level O 0 0.003073908621445298
in O 0 0.0011825495166704059
these O 0 0.0027261334471404552
mice O 1 0.9999370574951172
was O 0 0.0027177187148481607
reduced O 0 0.01014686282724142
strongly O 0 0.003876053960993886
as O 0 0.001209986163303256
a O 0 0.0031272887717932463
result O 0 0.003936717286705971
of O 0 0.0005562914302572608
the O 0 0.0010170325404033065
lack O 0 0.0058166771195828915
of O 0 0.0012312610633671284
protection O 0 0.010688967071473598
provided O 0 0.0063065397553145885
by O 0 0.00609233882278204
vWf O 1 0.9977766871452332
. O 0 0.011283337138593197

Defective O 1 0.9997773766517639
thrombosis B-Disease 1 0.9999709129333496
in O 0 0.013150706887245178
mutant O 1 0.9997522234916687
mice O 1 0.9999390840530396
was O 0 0.002920265542343259
also O 0 0.0013004321372136474
evident O 0 0.0077958363108336926
in O 0 0.0009455865947529674
an O 0 0.0012081596069037914
in O 0 0.0023125724401324987
vivo O 1 0.9991982579231262
model O 0 0.020992685109376907
of O 0 0.008977686055004597
vascular B-Disease 1 0.9999991655349731
injury I-Disease 1 0.9988287091255188
. O 0 0.011411839164793491

In O 0 0.003465408692136407
this O 0 0.0014231996610760689
model O 0 0.00849959347397089
, O 0 0.0012772481422871351
the O 0 0.00286157731898129
exteriorized O 1 0.9954847097396851
mesentery O 1 0.9974752068519592
was O 0 0.0056051649153232574
superfused O 1 0.8338050842285156
with O 0 0.009008487686514854
ferric O 1 0.9997846484184265
chloride O 1 0.997463583946228
and O 0 0.0013029563706368208
the O 0 0.0016091419383883476
accumulation O 1 0.6161776781082153
of O 0 0.0033205272629857063
fluorescently O 1 0.9987865090370178
labeled O 1 0.9614108800888062
platelets O 1 0.999785840511322
was O 0 0.004201691132038832
observed O 0 0.011760040186345577
by O 0 0.005980012007057667
intravital O 1 0.9903109073638916
microscopy O 0 0.48846063017845154
. O 0 0.010640506632626057

We O 0 0.003463894361630082
conclude O 0 0.012065095826983452
that O 0 0.0011148168705403805
these O 0 0.0017866094131022692
mice O 1 0.999861478805542
very O 0 0.003711174940690398
closely O 0 0.010995973832905293
mimic O 1 0.9994238615036011
severe O 1 0.9994586110115051
human O 1 0.9528247117996216
von B-Disease 1 0.9999897480010986
Willebrand I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999988079071045
and O 0 0.0014475947245955467
will O 0 0.0009031558874994516
be O 0 0.0006760118994861841
very O 0 0.0015530908713117242
useful O 0 0.004822894930839539
for O 0 0.0009673623135313392
investigating O 0 0.005650985054671764
the O 0 0.0011285111540928483
role O 0 0.0045363097451627254
of O 0 0.0019311963114887476
vWf O 1 0.9996663331985474
in O 0 0.003311632201075554
normal O 0 0.15790870785713196
physiology O 1 0.999091625213623
and O 0 0.0024935638066381216
in O 0 0.005816853605210781
disease O 1 0.9999940395355225
models O 0 0.020737428218126297
. O 0 0.003104948438704014
. O 0 0.005334256682544947

Oral O 1 0.9686242938041687
contraceptives O 1 0.9360697865486145
and O 0 0.0023250076919794083
the O 0 0.002548176795244217
risk O 1 0.98042231798172
of O 0 0.009050721302628517
hereditary B-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.011956410482525826

Hereditary B-Disease 1 0.9999933242797852
Ovarian I-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999992847442627
Clinical O 1 0.999690055847168
Study O 0 0.01972428895533085
Group O 0 0.011635839007794857
. O 0 0.0061246734112501144

BACKGROUND O 0 0.030428096652030945
Women O 0 0.007631751708686352
with O 0 0.005370726343244314
mutations O 1 0.9999210834503174
in O 0 0.0016417024889960885
either O 0 0.0031596559565514326
the O 0 0.0028620520606637
BRCA1 O 1 0.9999986886978149
or O 0 0.006256140302866697
the O 0 0.0057812961749732494
BRCA2 O 1 0.9999992847442627
gene O 1 0.9997603297233582
have O 0 0.0014057308435440063
a O 0 0.0033670382108539343
high O 0 0.006299757398664951
lifetime O 1 0.6585566997528076
risk O 1 0.9977086782455444
of O 0 0.019446052610874176
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999983310699463
. O 0 0.013799828477203846

Oral O 1 0.8739899396896362
contraceptives O 1 0.9901055693626404
protect O 0 0.05825379490852356
against O 1 0.6845781207084656
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
in O 0 0.002718627220019698
general O 0 0.0027769487351179123
, O 0 0.0011779323685914278
but O 0 0.0011269854148849845
it O 0 0.0008304219809360802
is O 0 0.0010182104306295514
not O 0 0.0008539585396647453
known O 0 0.0024970509111881256
whether O 0 0.001496899756602943
they O 0 0.000541427347343415
also O 0 0.0008275442523881793
protect O 0 0.006691133137792349
against O 0 0.004009221214801073
hereditary B-Disease 1 0.999862551689148
forms I-Disease 0 0.04490611329674721
of I-Disease 0 0.05585305765271187
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
. O 0 0.013850955292582512

METHODS O 0 0.021556809544563293
We O 0 0.002638912992551923
enrolled O 0 0.0171121247112751
207 O 0 0.3344704508781433
women O 0 0.008890217170119286
with O 0 0.03565918281674385
hereditary B-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
and O 0 0.002340818289667368
161 O 0 0.022221582010388374
of O 0 0.0008971320348791778
their O 0 0.0015436889370903373
sisters O 0 0.01713664084672928
as O 0 0.0012295551132410765
controls O 0 0.01108495332300663
in O 0 0.0015817409148439765
a O 0 0.006098122801631689
case O 0 0.011967884376645088
- O 0 0.025223612785339355
control O 0 0.01999608986079693
study O 0 0.013123641721904278
. O 0 0.005339962430298328

All O 0 0.0022773011587560177
the O 0 0.0026931441389024258
patients O 1 0.989388108253479
carried O 0 0.007992981001734734
a O 0 0.01025756448507309
pathogenic O 1 0.999839186668396
mutation O 1 0.9999072551727295
in O 0 0.0030312598682940006
either O 0 0.01683802902698517
BRCA1 O 1 0.9999988079071045
( O 0 0.007173831574618816
179 O 0 0.08422060310840607
women O 0 0.006575159728527069
) O 0 0.005092492792755365
or O 0 0.013865877874195576
BRCA2 O 1 0.9999978542327881
( O 0 0.008330265991389751
28 O 0 0.009454398415982723
women O 0 0.007135126739740372
) O 0 0.005922554060816765
. O 0 0.0055493381805717945

The O 0 0.006004409398883581
control O 0 0.01459331065416336
women O 0 0.0036576702259480953
were O 0 0.0010292689548805356
enrolled O 0 0.011458870954811573
regardless O 0 0.004656884353607893
of O 0 0.00080865592462942
whether O 0 0.0025982337538152933
or O 0 0.002079823287203908
not O 0 0.0007847534725442529
they O 0 0.0006589376134797931
had O 0 0.002101070247590542
either O 0 0.010501941666007042
mutation O 1 0.9999643564224243
. O 0 0.008394517004489899

Lifetime O 0 0.05135270580649376
histories O 0 0.028594279661774635
of O 0 0.003519501071423292
oral O 1 0.9978876709938049
- O 1 0.861023485660553
contraceptive O 1 0.9999123811721802
use O 0 0.0042261118069291115
were O 0 0.000824421236757189
obtained O 0 0.004232298582792282
by O 0 0.0018615241860970855
interview O 0 0.007110930513590574
or O 0 0.002549597527831793
by O 0 0.0016045307274907827
written O 0 0.003063059877604246
questionnaire O 0 0.029339119791984558
and O 0 0.0009165974915958941
were O 0 0.0007864063372835517
compared O 0 0.007010161876678467
between O 0 0.006155801005661488
patients O 1 0.9997512698173523
and O 0 0.0020458134822547436
control O 0 0.015160024166107178
women O 0 0.00432537030428648
, O 0 0.001391658210195601
after O 0 0.004237520974129438
adjustment O 0 0.02041134238243103
for O 0 0.001185462693683803
year O 0 0.0017446107231080532
of O 0 0.0012955137062817812
birth O 0 0.20128214359283447
and O 0 0.0024670641869306564
parity O 0 0.4558243751525879
. O 0 0.007082256954163313

RESULTS O 0 0.021784096956253052
The O 0 0.0024414837826043367
adjusted O 0 0.011630806140601635
odds O 0 0.035434577614068985
ratio O 0 0.23564974963665009
for O 0 0.28518208861351013
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
associated O 0 0.014901910908520222
with O 0 0.0015332832699641585
any O 0 0.0011754513252526522
past O 0 0.0014738228637725115
use O 0 0.002221228089183569
of O 0 0.0014030198799446225
oral O 1 0.994146466255188
contraceptives O 1 0.9976615905761719
was O 0 0.004827173892408609
0 O 0 0.023815719410777092
. O 0 0.0063561005517840385

5 O 0 0.01750134862959385
( O 0 0.0045790281146764755
95 O 0 0.011460365727543831
percent O 0 0.005767996422946453
confidence O 0 0.013151400722563267
interval O 0 0.2104770690202713
, O 0 0.002056238939985633
0 O 0 0.0118614062666893
. O 0 0.0015597230521962047
3 O 0 0.004787338897585869
to O 0 0.0015209552366286516
0 O 0 0.01427394151687622
. O 0 0.0020284552592784166
8 O 0 0.007755639031529427
) O 0 0.005077133886516094
. O 0 0.0053161876276135445

The O 0 0.008636548183858395
risk O 1 0.9556962847709656
decreased O 0 0.036445919424295425
with O 0 0.002572067780420184
increasing O 0 0.007216907572001219
duration O 0 0.014351969584822655
of O 0 0.000981388264335692
use O 0 0.003869791515171528
( O 0 0.004275391809642315
P O 1 0.869235634803772
for O 0 0.002563273534178734
trend O 0 0.019908154383301735
, O 0 0.003948850091546774
< O 1 0.9981744289398193
0 O 0 0.018707318231463432
. O 0 0.0038919635117053986
001 O 1 0.9957625269889832
) O 0 0.0038547080475836992
; O 0 0.0020586811006069183
use O 0 0.0018411434721201658
for O 0 0.0008628477808088064
six O 0 0.002115157898515463
or O 0 0.0018774655181914568
more O 0 0.0009164236835204065
years O 0 0.0013932586880400777
was O 0 0.0013700748095288873
associated O 0 0.005031924694776535
with O 0 0.0013088604900985956
a O 0 0.0033270386047661304
60 O 0 0.005444347858428955
percent O 0 0.006281907670199871
reduction O 0 0.16145585477352142
in O 0 0.004033107776194811
risk O 1 0.973518431186676
. O 0 0.008033263497054577

Oral O 1 0.953869640827179
- O 0 0.15269847214221954
contraceptive O 1 0.9990713596343994
use O 0 0.009037635289132595
protected O 0 0.021704647690057755
against O 0 0.29058825969696045
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
both O 0 0.002466771751642227
for O 0 0.0013495972380042076
carriers O 0 0.03304367884993553
of O 0 0.0013929210836067796
the O 0 0.006722473073750734
BRCA1 O 1 0.9999996423721313
mutation O 1 0.9999872446060181
( O 0 0.008273365907371044
odds O 0 0.05649798735976219
ratio O 0 0.030068647116422653
, O 0 0.0026461011730134487
0 O 0 0.01498186495155096
. O 0 0.0019203878473490477
5 O 0 0.005478099919855595
; O 0 0.002506809076294303
95 O 0 0.0076400041580200195
percent O 0 0.004181376192718744
confidence O 0 0.010555488988757133
interval O 0 0.10135822743177414
, O 0 0.001993258949369192
0 O 0 0.011818877421319485
. O 0 0.0015320349484682083
3 O 0 0.004052811302244663
to O 0 0.0014505402650684118
0 O 0 0.01212566252797842
. O 0 0.001630788785405457
9 O 0 0.006105103529989719
) O 0 0.0016992746386677027
and O 0 0.0006191236316226423
for O 0 0.0012929638614878058
carriers O 0 0.026498377323150635
of O 0 0.0011415770277380943
the O 0 0.006509096827358007
BRCA2 O 1 0.9999998807907104
mutation O 1 0.999987006187439
( O 0 0.0060937111265957355
odds O 0 0.05411861091852188
ratio O 0 0.025260765105485916
, O 0 0.001971401972696185
0 O 0 0.012224404141306877
. O 0 0.001586425001733005
4 O 0 0.006564130540937185
; O 0 0.0031729950569570065
95 O 0 0.008307650685310364
percent O 0 0.005036190617829561
confidence O 0 0.01033816859126091
interval O 0 0.31044429540634155
, O 0 0.0025419124867767096
0 O 0 0.011953222565352917
. O 0 0.0016259381081908941
2 O 0 0.0037221312522888184
to O 0 0.0012096575228497386
1 O 0 0.004874147474765778
. O 0 0.0019252554047852755
1 O 0 0.006474209018051624
) O 0 0.004096334800124168
. O 0 0.004756538197398186

CONCLUSIONS O 0 0.055738482624292374
Oral O 1 0.9927404522895813
- O 1 0.6239405870437622
contraceptive O 1 0.9998700618743896
use O 0 0.006224635988473892
may O 0 0.004543742630630732
reduce O 0 0.01392222661525011
the O 0 0.0025390740483999252
risk O 1 0.9980877041816711
of O 0 0.03480181843042374
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
in O 0 0.0026182050351053476
women O 0 0.0049831923097372055
with O 0 0.007504342123866081
pathogenic O 1 0.9999477863311768
mutations O 1 0.9999222755432129
in O 0 0.0026239631697535515
the O 0 0.00667751207947731
BRCA1 O 1 0.9999977350234985
or O 0 0.11769617348909378
BRCA2 O 1 0.9999940395355225
gene O 1 0.9995861649513245

A O 0 0.022270886227488518
Japanese O 0 0.010069389827549458
family O 0 0.013858278281986713
with O 0 0.008420173078775406
adrenoleukodystrophy B-Disease 1 0.9999533891677856
with O 0 0.004424127284437418
a O 0 0.008587847463786602
codon O 1 0.9936110377311707
291 O 1 0.9425366520881653
deletion O 1 0.9993765950202942
: O 0 0.004946439061313868
a O 0 0.008715404197573662
clinical O 1 0.9995222091674805
, O 0 0.003132004290819168
biochemical O 1 0.999661922454834
, O 0 0.003897033864632249
pathological O 1 0.9989013671875
, O 0 0.002130249748006463
and O 0 0.002590212970972061
genetic O 1 0.9998076558113098
report O 0 0.007115052547305822
. O 0 0.005539586301892996

We O 0 0.0027311041485518217
report O 0 0.002436588751152158
a O 0 0.003560921410098672
Japanese O 0 0.005373664200305939
family O 0 0.01199775468558073
with O 0 0.012401479296386242
adrenoleukodystrophy B-Disease 1 0.9999967813491821
( O 0 0.029559779912233353
ALD B-Disease 1 0.9999979734420776
) O 0 0.003721629036590457
with O 0 0.001517387805506587
a O 0 0.0028788477648049593
three O 0 0.0019190465100109577
base O 0 0.006797405891120434
pair O 0 0.039548493921756744
deletion O 1 0.9995771050453186
( O 0 0.009038040414452553
delGAG O 1 0.9959664344787598
291 O 1 0.6543475389480591
) O 0 0.003962520509958267
in O 0 0.0021678046323359013
the O 0 0.00769202783703804
ALD B-Disease 1 0.9999947547912598
gene O 1 0.9997238516807556
. O 0 0.013524829410016537

A O 0 0.01388100627809763
variety O 0 0.0063735549338161945
of O 0 0.002149376552551985
phenotypes O 1 0.9995405673980713
were O 0 0.0014671414392068982
observed O 0 0.0072267199866473675
within O 0 0.0023394611198455095
this O 0 0.0018407965544611216
family O 0 0.011885255575180054
. O 0 0.006215255241841078

While O 0 0.005281048361212015
the O 0 0.004225701093673706
proband O 1 0.997956395149231
( O 0 0.013439668342471123
patient O 1 0.999384880065918
1 O 0 0.007444855757057667
) O 0 0.0022931613493710756
was O 0 0.0013216986553743482
classified O 0 0.0072091734036803246
as O 0 0.0010631511686369777
having O 0 0.0027725063264369965
a O 0 0.004406398627907038
rare O 0 0.019892338663339615
intermediate O 0 0.23808199167251587
type O 0 0.02708783745765686
of O 0 0.002197559457272291
adult O 1 0.9470880627632141
cerebral O 1 0.9999529123306274
and O 0 0.004469737876206636
cerebello O 1 0.9998797178268433
- O 1 0.9970445036888123
brain O 1 0.9999951124191284
stem O 1 0.9992673993110657
forms O 0 0.008325752802193165
, O 0 0.0012625055387616158
his O 0 0.0033481342252343893
younger O 0 0.43827229738235474
brother O 0 0.20496226847171783
( O 0 0.009803149849176407
patient O 1 0.9996490478515625
2 O 0 0.00768150994554162
) O 0 0.0027179201133549213
and O 0 0.001989599084481597
nephew O 1 0.9961775541305542
( O 0 0.009512119926512241
patient O 1 0.9996659755706787
3 O 0 0.008223752491176128
) O 0 0.002570761600509286
had O 0 0.0022299233824014664
a O 0 0.01092546433210373
childhood O 1 0.9991053938865662
ALD B-Disease 1 0.999994158744812
type O 1 0.7789632081985474
. O 0 0.007227657362818718

Another O 0 0.03180703893303871
nephew O 1 0.9687774181365967
( O 0 0.010569879785180092
patient O 1 0.9986598491668701
4 O 0 0.009332138113677502
) O 0 0.002629279624670744
of O 0 0.0018494556425139308
patient O 1 0.9996732473373413
1 O 0 0.005088010337203741
was O 0 0.0016068912809714675
classified O 0 0.008105963468551636
as O 0 0.0013422523625195026
having O 0 0.0037091218400746584
an O 0 0.0040671974420547485
adolescent O 1 0.9992503523826599
form O 0 0.020932143554091454
. O 0 0.006804101634770632

The O 0 0.006388605572283268
tau O 1 0.6463278532028198
level O 0 0.004606881644576788
in O 0 0.0015386290615424514
the O 0 0.004371470771729946
cerebrospinal O 1 0.9999737739562988
fluid O 1 0.9994401335716248
( O 0 0.015251313336193562
CSF O 1 0.9999557733535767
) O 0 0.005537932273000479
in O 0 0.0034574344754219055
patient O 1 0.9993140697479248
1 O 0 0.004446538630872965
was O 0 0.0012204429367557168
as O 0 0.0009622670477256179
high O 0 0.0018900188151746988
as O 0 0.0009139436879195273
that O 0 0.0007962954114191234
of O 0 0.0024577262811362743
patients O 1 0.999968409538269
with O 1 0.9136150479316711
Alzheimers B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999971389770508
( O 0 0.008786057122051716
AD B-Disease 0 0.07863502949476242
) O 0 0.0060656312853097916
. O 0 0.006092269904911518

His O 0 0.02520132251083851
brain O 1 0.9991114735603333
magnetic O 0 0.06755746901035309
resonance O 1 0.863326370716095
image O 0 0.033178381621837616
( O 0 0.008357344195246696
MRI O 1 0.9997633099555969
) O 0 0.005135529208928347
showed O 0 0.01256200298666954
abnormalities B-Disease 1 0.9999500513076782
in I-Disease 0 0.0017357903998345137
the I-Disease 0 0.002137705683708191
bilateral I-Disease 0 0.05545726418495178
cerebellar I-Disease 1 0.9999676942825317
hemispheres I-Disease 1 0.9922174215316772
and O 0 0.008203697390854359
brain O 1 0.9999969005584717
stem O 1 0.9991412162780762
, O 0 0.001654508407227695
but O 0 0.0009087512153200805
not O 0 0.0007638466777279973
in O 0 0.001017355127260089
the O 0 0.0037013012915849686
cerebral O 1 0.9999946355819702
white O 0 0.021108515560626984
matter O 0 0.003344910917803645
, O 0 0.0008827308192849159
where O 0 0.001154614263214171
marked O 0 0.0060462383553385735
reductions O 0 0.012074419297277927
of O 0 0.0010992309544235468
the O 0 0.004074721597135067
cerebral O 1 0.9999896287918091
blood O 1 0.999721109867096
flow O 0 0.026622284203767776
and O 0 0.003083591116592288
oxygen O 1 0.9993568062782288
metabolism O 1 0.9995346069335938
were O 0 0.0011929927859455347
clearly O 0 0.003582361387088895
demonstrated O 0 0.00919652171432972
by O 0 0.005802661646157503
positron O 1 0.9996910095214844
emission O 1 0.9796658158302307
tomography O 1 0.9987937211990356
( O 0 0.011851171031594276
PET O 1 0.9950637221336365
) O 0 0.006786582060158253
. O 0 0.006177144590765238

In O 0 0.013695305213332176
patients O 1 0.9991857409477234
2 O 0 0.00735504599288106
and O 0 0.0013344046892598271
3 O 0 0.004581729881465435
, O 0 0.0009066166821867228
the O 0 0.0015164201613515615
autopsy O 1 0.9832916855812073
findings O 0 0.012811152264475822
showed O 0 0.009734849445521832
massive O 1 0.6157843470573425
demyelination B-Disease 1 0.9999157190322876
of I-Disease 0 0.0019625916611403227
the I-Disease 0 0.004717540927231312
cerebral I-Disease 1 0.9999761581420898
white I-Disease 0 0.013084299862384796
matter I-Disease 0 0.003970298916101456
with O 0 0.0025335876271128654
sparing O 1 0.7482585310935974
of O 0 0.001183213316835463
the O 0 0.002480999333783984
U O 1 0.9971407651901245
- O 1 0.7113349437713623
fibers O 1 0.9992794394493103
, O 0 0.0026922004763036966
compatible O 0 0.028959624469280243
with O 0 0.0017388834385201335
the O 0 0.001064615324139595
findings O 0 0.009745826944708824
of O 0 0.003834787290543318
childhood O 1 0.9991419315338135
ALD B-Disease 1 0.9999674558639526
. O 0 0.016628367826342583

Oleic O 1 0.974143385887146
and O 0 0.013138503767549992
erucic O 1 0.9983545541763306
acids O 1 0.9930182695388794
( O 0 0.010133896954357624
Lorenzos O 1 0.965578019618988
Oil O 0 0.00940303597599268
) O 0 0.002571206772699952
were O 0 0.000897974765393883
administered O 0 0.018768854439258575
to O 0 0.003358062356710434
patients O 1 0.9996181726455688
1 O 0 0.006076001096516848
and O 0 0.0012474451214075089
4 O 0 0.005116078071296215
, O 0 0.0011779683409258723
but O 0 0.0010503288358449936
sufficient O 0 0.008134148083627224
effectiveness O 0 0.19617971777915955
was O 0 0.001709398115053773
not O 0 0.0011897942749783397
obtained O 0 0.0067804716527462006
. O 0 0.005042714532464743

The O 0 0.003808812238276005
findings O 0 0.009861893020570278
in O 0 0.0013765232870355248
this O 0 0.0013408464146777987
family O 0 0.0069893281906843185
suggest O 0 0.006878925021737814
that O 0 0.0017220554873347282
delGAG291 O 1 0.9915825724601746
is O 0 0.0013728588819503784
part O 0 0.0012667049886658788
of O 0 0.0006020644796080887
the O 0 0.0017480826936662197
cause O 1 0.5951133370399475
of O 0 0.001963624032214284
Japanese O 0 0.020682264119386673
ALD B-Disease 1 0.9999864101409912
with O 0 0.009261023253202438
phenotypic O 1 0.990880012512207
variations O 0 0.04523925855755806
. O 0 0.007209459785372019

Moreover O 0 0.025967257097363472
, O 0 0.0018169458489865065
although O 0 0.0014072016347199678
the O 0 0.0008127742330543697
scale O 0 0.005230387207120657
of O 0 0.0006561996415257454
the O 0 0.001245440449565649
study O 0 0.005006805527955294
is O 0 0.0012895222753286362
limited O 0 0.003194791730493307
, O 0 0.000747443235013634
there O 0 0.0006906457128934562
is O 0 0.00080734898801893
a O 0 0.002899671671912074
possibility O 0 0.008368502371013165
that O 0 0.0017511533806100488
PET O 1 0.9969528913497925
can O 0 0.004550537560135126
detect O 1 0.6723816990852356
an O 0 0.004883698187768459
insidious B-Disease 1 0.9997065663337708
lesion I-Disease 1 0.9999696016311646
which O 0 0.002272888319566846
is O 0 0.002958487719297409
undetectable O 1 0.9911487102508545
by O 0 0.0054510245099663734
computed O 1 0.9747464060783386
tomogram O 1 0.9984058737754822
( O 0 0.015887534245848656
CT O 1 0.9999778270721436
) O 0 0.006250389385968447
or O 0 0.007133543025702238
MRI O 1 0.9998914003372192
analysis O 0 0.015298846177756786
, O 0 0.0008942586136981845
and O 0 0.0005056756199337542
that O 0 0.0005718604661524296
the O 0 0.0007410742109641433
higher O 0 0.0030068063642829657
level O 0 0.0023482476826757193
of O 0 0.001279443851672113
tau O 1 0.9856001138687134
reflects O 0 0.006392062641680241
the O 0 0.0013124620309099555
process O 0 0.004882791079580784
of O 0 0.002840400440618396
neuronal B-Disease 1 0.9999890327453613
degeneration I-Disease 1 0.999995231628418
in O 0 0.01557883433997631
ALD B-Disease 1 0.9999780654907227
. O 0 0.013835369609296322

Lorenzos O 1 0.9552648663520813
Oil O 0 0.010363254696130753
should O 0 0.0018843405414372683
be O 0 0.0007740237633697689
given O 0 0.0013911910355091095
in O 0 0.0008599254069849849
the O 0 0.001515525160357356
early O 0 0.005920962896198034
stage O 0 0.0272771455347538
. O 0 0.0034782534930855036
. O 0 0.006514875218272209

Nonsense O 1 0.8936488032341003
mutation O 1 0.9996505975723267
in O 0 0.005804526619613171
exon O 1 0.9882301092147827
4 O 0 0.0066566006280481815
of O 0 0.001263747806660831
human O 0 0.011585812084376812
complement O 1 0.9925748109817505
C9 O 1 0.9999676942825317
gene O 1 0.999768078327179
is O 0 0.0018064015312120318
the O 0 0.0012074854457750916
major O 0 0.005560314282774925
cause O 0 0.15611205995082855
of O 0 0.0014098769752308726
Japanese O 0 0.010313808917999268
complement B-Disease 1 0.9962961077690125
C9 I-Disease 1 0.9999823570251465
deficiency I-Disease 1 0.9999926090240479
. O 0 0.011703024618327618

Deficiency B-Disease 1 0.9999345541000366
of I-Disease 0 0.002197776921093464
the I-Disease 0 0.001771067618392408
ninth I-Disease 0 0.01619791053235531
component I-Disease 0 0.020785516127943993
of I-Disease 0 0.0013043489307165146
human I-Disease 0 0.011112446896731853
complement I-Disease 1 0.6824260950088501
( O 0 0.010044120252132416
C9 O 1 0.9999569654464722
) O 0 0.003618539310991764
is O 0 0.0008076098165474832
the O 0 0.0006540810572914779
most O 0 0.0011892584152519703
common O 0 0.21429257094860077
complement B-Disease 1 0.9998914003372192
deficiency I-Disease 1 0.9999997615814209
in O 0 0.0018749588634818792
Japan O 0 0.00206691469065845
but O 0 0.0010093163000419736
is O 0 0.0015420002164319158
rare O 0 0.013785014860332012
in O 0 0.0011469048913568258
other O 0 0.0012238204944878817
countries O 0 0.0015383199788630009
. O 0 0.005015026777982712

We O 0 0.002806629054248333
studied O 0 0.0036959596909582615
the O 0 0.001743495580740273
molecular O 1 0.959456741809845
basis O 0 0.004216517321765423
of O 0 0.0033801121171563864
C9 B-Disease 1 0.9999899864196777
deficiency I-Disease 1 0.999997615814209
in O 0 0.0019477523164823651
four O 0 0.00327714323066175
Japanese O 0 0.0195501409471035
C9 B-Disease 1 0.9999905824661255
- I-Disease 1 0.9962487816810608
deficient I-Disease 1 0.99992835521698
patients O 1 0.9987260699272156
who O 0 0.0031424162443727255
had O 0 0.004100305028259754
suffered O 1 0.9951076507568359
from O 0 0.08020255714654922
meningococcal B-Disease 1 0.9999996423721313
meningitis I-Disease 1 0.9999982118606567
. O 0 0.01492781937122345

Direct O 0 0.026612035930156708
sequencing O 0 0.3326355516910553
of O 0 0.00418571662157774
amplified O 1 0.8167585730552673
C9 O 1 0.9989470839500427
cDNA O 1 0.9777806401252747
and O 0 0.005160445347428322
DNA O 1 0.9931476712226868
revealed O 0 0.014337326399981976
a O 0 0.006647743284702301
nonsense O 0 0.066338911652565
substitution O 1 0.530651867389679
( O 0 0.008853419683873653
CGA O 1 0.9897897839546204
- O 1 0.5595552921295166
- O 1 0.7729341387748718
> O 1 0.9995564818382263
TGA O 1 0.9992836117744446
) O 0 0.005094669759273529
at O 0 0.0032442298252135515
codon O 1 0.9490271210670471
95 O 0 0.01193329133093357
in O 0 0.0028772808145731688
exon O 1 0.9964298605918884
4 O 0 0.006441397126764059
in O 0 0.001157237682491541
the O 0 0.0015816702507436275
four O 0 0.008206851780414581
C9 B-Disease 1 0.9999555349349976
- I-Disease 1 0.834431529045105
deficient I-Disease 1 0.9982726573944092
individuals O 0 0.013568351045250893
. O 0 0.007307961583137512

An O 0 0.014952128753066063
allele O 1 0.9988195300102234
- O 0 0.028118357062339783
specific O 0 0.014978375285863876
polymerase O 1 0.9993307590484619
chain O 1 0.944295346736908
reaction O 0 0.03804945573210716
system O 0 0.009415741078555584
designed O 0 0.005800449755042791
to O 0 0.0014459973899647593
detect O 1 0.5162661075592041
exclusively O 0 0.003020509844645858
only O 0 0.0005793074960820377
one O 0 0.0006619314081035554
of O 0 0.0004441110068000853
the O 0 0.0011399588547647
normal O 0 0.01668320968747139
and O 0 0.0021699736826121807
mutant O 1 0.9999037981033325
alleles O 1 0.9999420642852783
indicated O 0 0.008544476702809334
that O 0 0.0007193660130724311
all O 0 0.00048081690329127014
the O 0 0.0010039303451776505
four O 0 0.004357531666755676
patients O 1 0.9984366297721863
were O 0 0.0016651698388159275
homozygous O 1 0.9991027116775513
for O 0 0.00185221282299608
the O 0 0.003160692285746336
mutation O 1 0.9999866485595703
in O 0 0.0035768013913184404
exon O 1 0.9991418123245239
4 O 0 0.006133614107966423
and O 0 0.0007912411820143461
that O 0 0.0007501848740503192
the O 0 0.0010950617725029588
parents O 0 0.006191834341734648
of O 0 0.0022636770736426115
patient O 1 0.9988152980804443
2 O 0 0.007789730094373226
were O 0 0.003039857605472207
heterozygous O 1 0.9982209801673889
. O 0 0.009353340603411198

The O 0 0.007216053083539009
common O 0 0.02593602053821087
mutation O 1 0.999786913394928
at O 0 0.0064902277663350105
codon O 1 0.9828861355781555
95 O 0 0.012582856230437756
in O 0 0.0030384098645299673
exon O 1 0.9989558458328247
4 O 0 0.008475178852677345
might O 0 0.00342405098490417
be O 0 0.0007666726596653461
responsible O 0 0.0038225692696869373
for O 0 0.0011372679146006703
most O 0 0.0020157259423285723
Japanese O 0 0.027897221967577934
C9 B-Disease 1 0.9999920129776001
deficiency I-Disease 1 0.9999973773956299
. O 0 0.006969753187149763
. O 0 0.007650386542081833

BRCA1 O 1 0.9998502731323242
required O 0 0.0142489243298769
for O 0 0.005095639266073704
transcription O 1 0.9983892440795898
- O 0 0.02930581383407116
coupled O 0 0.0566742867231369
repair O 1 0.8654556274414062
of O 0 0.004984518047422171
oxidative O 1 0.999951958656311
DNA O 1 0.9995989203453064
damage O 1 0.5882254242897034
. O 0 0.008444909006357193

The O 0 0.02093951217830181
breast B-Disease 1 0.9999874830245972
and I-Disease 0 0.35749930143356323
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
susceptibility O 1 0.999990701675415
gene O 1 0.9999785423278809
BRCA1 O 1 0.9999927282333374
encodes O 1 0.9878476858139038
a O 0 0.016597341746091843
zinc O 1 0.997505247592926
finger O 1 0.985282301902771
protein O 1 0.9921852946281433
of O 0 0.0025025426875799894
unknown O 0 0.01612205058336258
function O 0 0.029013387858867645
. O 0 0.005953715182840824

Association O 0 0.008944276720285416
of O 0 0.0013175437925383449
the O 0 0.004199224058538675
BRCA1 O 1 0.9999974966049194
protein O 1 0.9981940388679504
with O 0 0.002197716385126114
the O 0 0.002745636971667409
DNA O 1 0.9998130202293396
repair O 1 0.9981740713119507
protein O 1 0.9997773766517639
Rad51 O 1 0.9996175765991211
and O 0 0.002061280654743314
changes O 0 0.004375958349555731
in O 0 0.0009203442605212331
the O 0 0.0016371164238080382
phosphorylation O 1 0.9882782101631165
and O 0 0.002417657058686018
cellular O 1 0.9956094622612
localization O 0 0.14269804954528809
of O 0 0.0008306249510496855
the O 0 0.0022932083811610937
protein O 1 0.9994062185287476
after O 0 0.007636107970029116
exposure O 1 0.9504167437553406
to O 0 0.004121685866266489
DNA O 1 0.9998776912689209
- O 0 0.07111552357673645
damaging O 0 0.39946556091308594
agents O 0 0.011906160041689873
are O 0 0.0010008581448346376
consistent O 0 0.00712170172482729
with O 0 0.0016050179256126285
a O 0 0.0038785291835665703
role O 0 0.006836514454334974
for O 0 0.004693410824984312
BRCA1 O 1 0.9999959468841553
in O 0 0.008192518725991249
DNA O 1 0.9996851682662964
repair O 1 0.9870725274085999
. O 0 0.008711804635822773

Here O 0 0.0045227366499602795
, O 0 0.0014166097389534116
it O 0 0.0008668543887324631
is O 0 0.0011245356872677803
shown O 0 0.004081165883690119
that O 0 0.0030093686655163765
mouse O 1 0.9998014569282532
embryonic O 1 0.999858021736145
stem O 1 0.9995719790458679
cells O 1 0.9998949766159058
deficient B-Disease 1 0.9996758699417114
in I-Disease 0 0.0076273647136986256
BRCA1 I-Disease 1 0.9999961853027344
are O 0 0.0034575825557112694
defective O 1 0.9993078708648682
in O 0 0.001406112452968955
the O 0 0.0009880558354780078
ability O 0 0.005208589136600494
to O 0 0.0007797505822964013
carry O 0 0.004986370448023081
out O 0 0.004550887271761894
transcription O 1 0.999771773815155
- O 0 0.028958871960639954
coupled O 0 0.16292406618595123
repair O 1 0.9379053711891174
of O 0 0.0037242486141622066
oxidative O 1 0.9999912977218628
DNA O 1 0.9999276399612427
damage O 1 0.7459738254547119
, O 0 0.0014965920709073544
and O 0 0.0006686251726932824
are O 0 0.0012467328924685717
hypersensitive O 1 0.997721254825592
to O 0 0.005010270047932863
ionizing O 1 0.9980598092079163
radiation O 1 0.9863980412483215
and O 0 0.004228671547025442
hydrogen O 1 0.9925442934036255
peroxide O 1 0.9985746145248413
. O 0 0.007920567877590656

These O 0 0.0031094723381102085
results O 0 0.007996069267392159
suggest O 0 0.00903821550309658
that O 0 0.004845161456614733
BRCA1 O 1 0.9999988079071045
participates O 1 0.7344072461128235
, O 0 0.0019323399756103754
directly O 0 0.003636420238763094
or O 0 0.0028770563658326864
indirectly O 0 0.013345286250114441
, O 0 0.001586627447977662
in O 0 0.0030344000551849604
transcription O 1 0.9997177720069885
- O 0 0.0325721800327301
coupled O 0 0.21301864087581635
repair O 1 0.9235513806343079
of O 0 0.0046750460751354694
oxidative O 1 0.999988317489624
DNA O 1 0.9998396635055542
damage O 1 0.7144572734832764
. O 0 0.004137078765779734
. O 0 0.006042749620974064

Truncation O 1 0.998221218585968
mutations O 1 0.9996156692504883
in O 0 0.002605823799967766
the O 0 0.0025797919370234013
transactivation O 1 0.9980955719947815
region O 0 0.0053012738935649395
of O 0 0.002706811996176839
PAX6 O 1 0.9999426603317261
result O 0 0.012341691181063652
in O 0 0.0024997317232191563
dominant O 1 0.677956759929657
- O 0 0.03825235739350319
negative O 0 0.059794019907712936
mutants O 1 0.9924039244651794
. O 0 0.009258565492928028

PAX6 O 1 0.996282160282135
is O 0 0.007514947559684515
a O 0 0.011699910275638103
transcription O 1 0.9932804703712463
factor O 0 0.021405475214123726
with O 0 0.0021132645197212696
two O 0 0.004186336882412434
DNA O 1 0.9998016953468323
- O 0 0.028410524129867554
binding O 0 0.20601336658000946
domains O 1 0.8114442825317383
( O 0 0.004568673670291901
paired O 1 0.7813721895217896
box O 0 0.01846395805478096
and O 0 0.003190121380612254
homeobox O 1 0.999985933303833
) O 0 0.0031239930540323257
and O 0 0.00108465610537678
a O 0 0.009012268856167793
proline O 1 0.9989204406738281
- O 0 0.12918956577777863
serine O 1 0.9975221753120422
- O 0 0.09812469780445099
threonine O 1 0.996749758720398
( O 0 0.01399687398225069
PST O 1 0.9959982633590698
) O 0 0.008973691612482071
- O 0 0.023126889020204544
rich O 0 0.026551347225904465
transactivation O 1 0.9951921701431274
domain O 0 0.06415815651416779
. O 0 0.007061400916427374

PAX6 O 1 0.999237060546875
regulates O 1 0.9805369973182678
eye O 1 0.8646231293678284
development O 0 0.007379850372672081
in O 0 0.0019905411172658205
animals O 0 0.011837320402264595
ranging O 0 0.009089378640055656
from O 0 0.0035226563923060894
jellyfish O 1 0.9968116879463196
to O 0 0.0039781490340828896
Drosophila O 1 0.9930537343025208
to O 0 0.004311399534344673
humans O 0 0.12052873522043228
. O 0 0.007495085708796978

Heterozygous O 1 0.9983789920806885
mutations O 1 0.9993237257003784
in O 0 0.0026248316280543804
the O 0 0.002275867387652397
human O 0 0.06222667172551155
PAX6 O 1 0.9999802112579346
gene O 1 0.999883770942688
result O 0 0.010133490897715092
in O 0 0.0014810044085606933
various O 0 0.0036514229141175747
phenotypes O 1 0.9998798370361328
, O 0 0.0023545653093606234
including O 0 0.0047261822037398815
aniridia B-Disease 1 0.9994308352470398
, O 0 0.0052743591368198395
Peters B-Disease 1 0.9962276220321655
anomaly I-Disease 1 0.9995548129081726
, O 0 0.011743820272386074
autosomal B-Disease 1 0.9999990463256836
dominant I-Disease 1 0.9949393272399902
keratitis I-Disease 1 0.999985933303833
, O 0 0.0036263426300138235
and O 0 0.0054280711337924
familial B-Disease 1 0.9999957084655762
foveal I-Disease 1 0.999862790107727
dysplasia I-Disease 1 0.9999959468841553
. O 0 0.013184829615056515

It O 0 0.003108146833255887
is O 0 0.0013968859566375613
believed O 0 0.003116268664598465
that O 0 0.0008761432254686952
the O 0 0.0025031715631484985
mutated O 1 0.9999145269393921
allele O 1 0.9987339377403259
of O 0 0.004623787011951208
PAX6 O 1 0.9998733997344971
produces O 0 0.02516505867242813
an O 0 0.0032479017972946167
inactive O 1 0.897065281867981
protein O 1 0.9986324906349182
and O 0 0.0030578472651541233
aniridia B-Disease 1 0.998256266117096
is O 0 0.0036815230268985033
caused O 0 0.04488673806190491
due O 0 0.006416975054889917
to O 0 0.004056807141751051
genetic O 1 0.9998408555984497
haploinsufficiency O 1 0.9898557662963867
. O 0 0.008659818209707737

However O 0 0.004963318817317486
, O 0 0.0015059449942782521
several O 0 0.003837822936475277
truncation O 1 0.9998775720596313
mutations O 1 0.9999735355377197
have O 0 0.0015523347537964582
been O 0 0.0011429133592173457
found O 0 0.0025946812238544226
to O 0 0.001135759986937046
occur O 0 0.01208642777055502
in O 0 0.0010390200186520815
the O 0 0.0026853906456381083
C O 1 0.9952268600463867
- O 0 0.027862755581736565
terminal O 0 0.11636514216661453
half O 0 0.0046917167492210865
of O 0 0.00252146041020751
PAX6 O 1 0.999854564666748
in O 0 0.006205301731824875
patients O 1 0.9990969896316528
with O 0 0.003990162629634142
Aniridia B-Disease 1 0.9993621706962585
resulting O 0 0.04755639284849167
in O 0 0.0023087006993591785
mutant O 1 0.9995593428611755
proteins O 1 0.9842904806137085
that O 0 0.0014946579467505217
retain O 0 0.008486085571348667
the O 0 0.0025977310724556446
DNA O 1 0.9998051524162292
- O 0 0.0404939129948616
binding O 0 0.4795861840248108
domains O 1 0.7469770908355713
but O 0 0.0014646133640781045
have O 0 0.0008907884475775063
lost O 0 0.003844026243314147
most O 0 0.0007777902064844966
of O 0 0.0008560335845686495
the O 0 0.003100143512710929
transactivation O 1 0.9984146356582642
domain O 0 0.07824675738811493
. O 0 0.00873798318207264

It O 0 0.0037466648500412703
is O 0 0.0015723102260380983
not O 0 0.0009523155749775469
clear O 0 0.002798892557621002
whether O 0 0.0026354112196713686
such O 0 0.0023612594231963158
mutants O 1 0.9972143769264221
really O 0 0.007206542417407036
behave O 0 0.0641234889626503
as O 0 0.002633947879076004
loss O 1 0.5701069831848145
- O 0 0.013807599432766438
of O 0 0.0019564928952604532
- O 0 0.027860717847943306
function O 0 0.11195635050535202
mutants O 1 0.991769552230835
as O 0 0.002901718718931079
predicted O 0 0.015117041766643524
by O 0 0.005211990792304277
haploinsufficiency O 1 0.9813694953918457
. O 0 0.0098037701100111

Contrary O 0 0.011543367058038712
to O 0 0.0013501972425729036
this O 0 0.0009868079796433449
theory O 0 0.00678971316665411
, O 0 0.0007374727865681052
our O 0 0.0011311904527246952
data O 0 0.0025687413290143013
showed O 0 0.0033143279142677784
that O 0 0.0008055249927565455
these O 0 0.001420582178980112
mutants O 1 0.9868209958076477
are O 0 0.0016541264485567808
dominant O 0 0.2522412836551666
- O 0 0.01704670861363411
negative O 0 0.01370286289602518
in O 0 0.004072337877005339
transient O 1 0.9990367889404297
transfection O 1 0.999911904335022
assays O 1 0.9912093877792358
when O 0 0.0026179796550422907
they O 0 0.0007656468078494072
are O 0 0.001168929971754551
coexpressed O 1 0.9784985184669495
with O 0 0.005442386958748102
wild O 0 0.05873497202992439
- O 0 0.132281094789505
type O 1 0.9849084615707397
PAX6 O 1 0.9995673298835754
. O 0 0.013812138698995113

We O 0 0.0030645267106592655
found O 0 0.0035390479024499655
that O 0 0.0009279638179577887
the O 0 0.001868855208158493
dominant O 1 0.5250239372253418
- O 0 0.06083322688937187
negative O 0 0.02701687067747116
effects O 0 0.38445568084716797
result O 0 0.004938100464642048
from O 0 0.001105622504837811
the O 0 0.0017965099541470408
enhanced O 1 0.7760644555091858
DNA O 1 0.9992284774780273
binding O 0 0.03374890610575676
ability O 0 0.006749582011252642
of O 0 0.0009433630621060729
these O 0 0.002295998390763998
mutants O 1 0.9887492656707764
. O 0 0.00815540086477995

Kinetic O 0 0.09365414083003998
studies O 0 0.010171492584049702
of O 0 0.0011512257624417543
binding O 0 0.03276233747601509
and O 0 0.002092242706567049
dissociation O 1 0.9980794191360474
revealed O 0 0.010468068532645702
that O 0 0.00099674251396209
various O 0 0.0022910861298441887
truncation O 1 0.9993708729743958
mutants O 1 0.9914363026618958
have O 0 0.0024147112853825092
3 O 0 0.010492703877389431
- O 0 0.01648656651377678
5 O 0 0.009464116767048836
- O 0 0.016716033220291138
fold O 0 0.03117961809039116
higher O 0 0.00651657534763217
affinity O 0 0.11091727018356323
to O 0 0.0012063119793310761
various O 0 0.003373625921085477
DNA O 1 0.9998413324356079
- O 0 0.023177484050393105
binding O 0 0.028912419453263283
sites O 0 0.00420933123677969
when O 0 0.0021263165399432182
compared O 0 0.004244200419634581
with O 0 0.0014611725928261876
the O 0 0.001982065849006176
wild O 0 0.0772237628698349
- O 0 0.2737789452075958
type O 1 0.9835934042930603
PAX6 O 1 0.9996243715286255
. O 0 0.015567656606435776

These O 0 0.002751549705862999
results O 0 0.007343844976276159
provide O 0 0.003415934508666396
a O 0 0.003209936898201704
new O 0 0.0024320532102137804
insight O 0 0.018837518990039825
into O 0 0.0020957770757377148
the O 0 0.0010714964009821415
role O 0 0.004378055222332478
of O 0 0.0020606822799891233
mutant O 1 0.999876856803894
PAX6 O 1 0.9998914003372192
in O 0 0.007129741366952658
causing O 1 0.9952912330627441
aniridia B-Disease 1 0.9989301562309265
. O 0 0.004735186696052551
. O 0 0.005436481907963753

Reversal O 0 0.16159121692180634
of O 0 0.007334055844694376
severe O 1 0.9998886585235596
hypertrophic B-Disease 1 0.9999992847442627
cardiomyopathy I-Disease 1 0.9999954700469971
and O 0 0.0037899487651884556
excellent O 0 0.018126877024769783
neuropsychologic O 1 0.9900566935539246
outcome O 0 0.01227602083235979
in O 0 0.0014810916036367416
very B-Disease 0 0.004242854658514261
- I-Disease 0 0.02044416218996048
long I-Disease 0 0.01618596725165844
- I-Disease 0 0.0699089840054512
chain I-Disease 1 0.9918469190597534
acyl I-Disease 1 0.9997000694274902
- I-Disease 0 0.3629259169101715
coenzyme I-Disease 1 0.9994080066680908
A I-Disease 0 0.4610987901687622
dehydrogenase I-Disease 1 0.999983549118042
deficiency I-Disease 1 0.9999912977218628
. O 0 0.014612194150686264

Very B-Disease 0 0.016062505543231964
- I-Disease 0 0.0297248475253582
long I-Disease 0 0.02038615196943283
- I-Disease 0 0.06522615253925323
chain I-Disease 1 0.9773094654083252
acyl I-Disease 1 0.9986088871955872
- I-Disease 0 0.06689745932817459
coenzyme I-Disease 1 0.9971298575401306
A I-Disease 0 0.03604806959629059
dehydrogenase I-Disease 1 0.9997977614402771
( I-Disease 0 0.012232537381350994
VLCAD I-Disease 1 0.9990260601043701
) I-Disease 0 0.015122657641768456
deficiency I-Disease 1 0.999996542930603
is O 0 0.0026619061827659607
a O 0 0.008426868356764317
disorder O 1 0.9997990727424622
of O 0 0.004613677971065044
fatty O 1 0.999975323677063
acid O 1 0.999901533126831
beta O 1 0.9986182451248169
oxidation O 1 0.9980190992355347
that O 0 0.0018334273481741548
reportedly O 0 0.005934530403465033
has O 0 0.001304934616200626
high O 0 0.0035923393443226814
rates O 0 0.010251518338918686
of O 0 0.0031964113004505634
morbidity O 1 0.9999306201934814
and O 0 0.005163442809134722
mortality O 1 0.9980897307395935
. O 0 0.00968320295214653

We O 0 0.0032304541673511267
describe O 0 0.007135752122849226
the O 0 0.001132326782681048
outcome O 0 0.005996284075081348
of O 0 0.0008860328234732151
a O 0 0.004445679020136595
5 O 0 0.009482353925704956
- O 0 0.016575710847973824
year O 0 0.003962827380746603
- O 0 0.014656256884336472
old O 0 0.011160050518810749
girl O 0 0.23686471581459045
with O 0 0.010948743671178818
VLCAD B-Disease 1 0.9999951124191284
deficiency I-Disease 1 0.9999992847442627
who O 0 0.0027088953647762537
was O 0 0.0014862514799460769
first O 0 0.0016403712797909975
seen O 0 0.003509698435664177
at O 0 0.0018940126756206155
5 O 0 0.00439940020442009
months O 0 0.002749417908489704
of O 0 0.0008760041673667729
age O 0 0.005819846410304308
with O 0 0.010833327658474445
severe O 1 0.9999743700027466
hypertrophic B-Disease 1 0.9999996423721313
cardiomyopathy I-Disease 1 0.999998927116394
, O 0 0.016123609617352486
hepatomegaly B-Disease 1 0.9999890327453613
, O 0 0.01859656535089016
encephalopathy B-Disease 1 0.9999984502792358
, O 0 0.004521975293755531
and O 0 0.004774886649101973
hypotonia B-Disease 1 0.9997066855430603
. O 0 0.011302324011921883

Biochemical O 1 0.9911437034606934
studies O 0 0.03370244428515434
indicated O 0 0.1746266633272171
VLCAD B-Disease 1 0.999947190284729
deficiency I-Disease 1 0.9999986886978149
caused O 0 0.1709035187959671
by O 0 0.003642761381343007
a O 0 0.007582894526422024
stable O 0 0.04015960916876793
yet O 0 0.009226684458553791
inactive O 1 0.8364840149879456
enzyme O 1 0.9982122182846069
. O 0 0.010599582456052303

Molecular O 1 0.9980201721191406
genetic O 1 0.9973735809326172
analysis O 0 0.010705003514885902
of O 0 0.0015662995865568519
her O 0 0.011063950136303902
VLCAD O 1 0.9995291233062744
gene O 1 0.9995070695877075
revealed O 0 0.022231873124837875
a O 0 0.01113956980407238
T1372C O 1 0.9865108132362366
( O 0 0.009181526489555836
F458L O 1 0.9859606027603149
) O 0 0.011385622434318066
missense O 1 0.9996851682662964
mutation O 1 0.9998369216918945
and O 0 0.0030103474855422974
a O 0 0.012836329638957977
1668 O 1 0.9971550703048706
ACAG O 1 0.9942190647125244
1669 O 1 0.9759659767150879
splice O 1 0.9949408769607544
site O 0 0.03946063295006752
mutation O 1 0.9997281432151794
. O 0 0.010951102711260319

After O 0 0.015885572880506516
initial O 0 0.022630248218774796
treatment O 1 0.680118978023529
with O 0 0.006581156048923731
intravenous O 1 0.999936580657959
glucose O 1 0.9998263716697693
and O 0 0.005139508750289679
carnitine O 1 0.9999436140060425
, O 0 0.0022965315729379654
the O 0 0.002796021057292819
patient O 1 0.9985347986221313
has O 0 0.0022954358719289303
thrived O 0 0.01935369148850441
on O 0 0.0014253814006224275
a O 0 0.006181622389703989
low O 0 0.023821143433451653
- O 0 0.04864202067255974
fat O 1 0.9917258024215698
diet O 1 0.8939376473426819
supplemented O 0 0.03356928005814552
with O 0 0.004485905636101961
medium O 0 0.022973759099841118
- O 0 0.039150264114141464
chain O 1 0.9766293168067932
triglyceride O 1 0.9984045624732971
oil O 0 0.007864615879952908
and O 0 0.0034182402305305004
carnitine O 1 0.9996192455291748
and O 0 0.004406331572681665
avoidance O 1 0.9921332597732544
of O 0 0.003219097852706909
fasting O 1 0.5600351095199585
. O 0 0.007663397118449211

Her O 0 0.07325492054224014
ventricular O 1 0.9999065399169922
hypertrophy O 1 0.9999492168426514
resolved O 0 0.03759000077843666
significantly O 0 0.022719135507941246
over O 0 0.0020013987086713314
1 O 0 0.0046876161359250546
year O 0 0.0019373093964532018
, O 0 0.0014105370501056314
and O 0 0.002150395419448614
cognitively O 1 0.9997046589851379
, O 0 0.0019244637805968523
she O 0 0.0015477740671485662
is O 0 0.0009957564761862159
in O 0 0.0008414820185862482
the O 0 0.0014889357844367623
superior O 0 0.01503179594874382
range O 0 0.0038352571427822113
for O 0 0.002006221329793334
age O 0 0.007664133794605732
. O 0 0.00583882350474596

Clinical O 1 0.98825603723526
recognition O 0 0.016389688476920128
of O 0 0.005809738300740719
VLCAD B-Disease 1 0.999996542930603
deficiency I-Disease 1 0.9999996423721313
is O 0 0.0025333028752356768
important O 0 0.001748488051816821
because O 0 0.0018935682019218802
it O 0 0.000629119691438973
is O 0 0.0007820242317393422
one O 0 0.0007355167181231081
of O 0 0.0005610010703094304
the O 0 0.000965416431427002
few O 0 0.0026836770121008158
directly O 0 0.0125800259411335
treatable O 1 0.9999949932098389
causes O 1 0.9978991746902466
of O 0 0.005507351364940405
cardiomyopathy B-Disease 1 0.9999985694885254
in O 0 0.003994666039943695
children O 0 0.010831504128873348
. O 0 0.0032498799264431
. O 0 0.006031887140125036

Cloning O 1 0.5976357460021973
of O 0 0.0020602724980562925
a O 0 0.005098256282508373
novel O 0 0.010080821812152863
member O 0 0.0020464053377509117
of O 0 0.0007069803541526198
the O 0 0.0019490310223773122
low O 0 0.022280625998973846
- O 0 0.03683246299624443
density O 1 0.5177128911018372
lipoprotein O 1 0.999954104423523
receptor O 1 0.9995294809341431
family O 0 0.02255629189312458
. O 0 0.007806680165231228

A O 0 0.03901035711169243
gene O 1 0.9965452551841736
encoding O 0 0.3294551372528076
a O 0 0.009837341494858265
novel O 0 0.02607119269669056
transmembrane O 1 0.9964356422424316
protein O 1 0.9959391355514526
was O 0 0.0022664840798825026
identified O 0 0.007431600242853165
by O 0 0.003415356855839491
DNA O 1 0.9964939951896667
sequence O 0 0.02793078124523163
analysis O 0 0.007435558829456568
within O 0 0.0021910362411290407
the O 0 0.004478400573134422
insulin B-Disease 1 0.9999918937683105
- I-Disease 1 0.9775550365447998
dependent I-Disease 1 0.99769127368927
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.999994158744812
( O 0 0.015535828657448292
IDDM B-Disease 1 0.9965527057647705
) O 0 0.01188269630074501
locus O 1 0.9989431500434875
IDDM4 O 1 0.9890180826187134
on O 0 0.009925204329192638
chromosome O 1 0.9999105930328369
11q13 O 1 0.9632671475410461
. O 0 0.012159007601439953

Based O 0 0.006370801478624344
on O 0 0.001551268738694489
its O 0 0.003989330492913723
chromosomal O 1 0.999950647354126
position O 0 0.004256847780197859
, O 0 0.0012566819787025452
this O 0 0.002139951568096876
gene O 1 0.9998751878738403
is O 0 0.001499426318332553
a O 0 0.0030781913083046675
candidate O 0 0.0054875826463103294
for O 0 0.0025330139324069023
conferring O 1 0.9913126826286316
susceptibility O 1 0.9999797344207764
to O 0 0.012392178177833557
diabetes B-Disease 1 0.9999953508377075
. O 0 0.01068374328315258

The O 0 0.010397220030426979
gene O 1 0.9990994930267334
, O 0 0.004591328091919422
termed O 0 0.05493645742535591
low O 0 0.02272929809987545
- O 0 0.026818860322237015
density O 0 0.06687774509191513
lipoprotein O 1 0.9998719692230225
receptor O 1 0.99954754114151
related O 0 0.04170232266187668
protein O 1 0.9988172054290771
5 O 0 0.010993592441082
( O 0 0.005932204890996218
LRP5 O 1 0.9967801570892334
) O 0 0.003584539284929633
, O 0 0.0018941700691357255
encodes O 1 0.8845605850219727
a O 0 0.007526720408350229
protein O 1 0.9854771494865417
of O 0 0.0027463105507194996
1615 O 1 0.9090905785560608
amino O 1 0.9897733330726624
acids O 1 0.9272485375404358
that O 0 0.0010249082697555423
contains O 0 0.004223497584462166
conserved O 0 0.33470556139945984
modules O 0 0.0240381620824337
which O 0 0.0007844988722354174
are O 0 0.0005795357865281403
characteristic O 0 0.011294616386294365
of O 0 0.0006998211611062288
the O 0 0.001389174722135067
low O 0 0.021409690380096436
- O 0 0.03157588839530945
density O 0 0.19161660969257355
lipoprotein O 1 0.999894380569458
( O 0 0.019801858812570572
LDL O 1 0.9999873638153076
) O 0 0.014844006858766079
receptor O 1 0.9993984699249268
family O 0 0.019312512129545212
. O 0 0.006339711137115955

These O 0 0.004011955112218857
modules O 0 0.02909119985997677
include O 0 0.005279948003590107
a O 0 0.006699624937027693
putative O 1 0.9827749133110046
signal O 0 0.05222732573747635
peptide O 1 0.9951093792915344
for O 0 0.003273973474279046
protein O 1 0.9964326620101929
export O 0 0.0049956482835114
, O 0 0.001221934100612998
four O 0 0.004957891069352627
epidermal O 1 0.9999264478683472
growth O 0 0.0559329092502594
factor O 0 0.2408452183008194
( O 0 0.008703678846359253
EGF O 1 0.9997912049293518
) O 0 0.005701961927115917
repeats O 0 0.06693273037672043
with O 0 0.003677425440400839
associated O 0 0.01352041494101286
spacer O 1 0.9984121322631836
domains O 0 0.18838612735271454
, O 0 0.0025510070845484734
three O 0 0.0076309684664011
LDL O 1 0.9999886751174927
- O 1 0.8559929132461548
receptor O 1 0.9996873140335083
( O 0 0.009952009655535221
LDLR O 1 0.9985013008117676
) O 0 0.005184951703995466
repeats O 0 0.14239157736301422
, O 0 0.0011142869479954243
a O 0 0.003606660757213831
single O 0 0.010255656205117702
transmembrane O 1 0.993054211139679
spanning O 0 0.023979248479008675
domain O 0 0.026269981637597084
, O 0 0.0014321471098810434
and O 0 0.0008936277590692043
a O 0 0.008300624787807465
cytoplasmic O 1 0.9991519451141357
domain O 0 0.052674856036901474
. O 0 0.007019751239567995

The O 0 0.006575378589332104
encoded O 0 0.31046077609062195
protein O 1 0.9905264377593994
has O 0 0.0020553194917738438
a O 0 0.002969097811728716
unique O 0 0.0040832944214344025
organization O 0 0.003923080861568451
of O 0 0.0023359914775937796
EGF O 1 0.9998021721839905
and O 0 0.006063849199563265
LDLR O 1 0.9989748001098633
repeats O 1 0.8796060681343079
; O 0 0.005373987834900618
therefore O 0 0.004129110835492611
, O 0 0.0024273351300507784
LRP5 O 1 0.9977721571922302
likely O 0 0.0061446065083146095
represents O 0 0.00487293628975749
a O 0 0.0035232356749475002
new O 0 0.0019785065669566393
category O 0 0.0058980342000722885
of O 0 0.0008631269447505474
the O 0 0.0030073407106101513
LDLR O 1 0.9995332956314087
family O 0 0.02025020681321621
. O 0 0.006858786102384329

Both O 0 0.0065980711951851845
human O 0 0.011638745665550232
and O 0 0.004440451040863991
mouse O 1 0.9994633793830872
LRP5 O 1 0.9985455274581909
cDNAs O 1 0.9778844714164734
have O 0 0.0023143598809838295
been O 0 0.0020595714449882507
isolated O 0 0.014526182785630226
and O 0 0.0010023524519056082
the O 0 0.0017982535064220428
encoded O 1 0.8335164785385132
mature O 1 0.8956385254859924
proteins O 1 0.9756163358688354
are O 0 0.0009168796823360026
95 O 0 0.007164256647229195
% O 0 0.0038727906066924334
identical O 0 0.01900201290845871
, O 0 0.0014761199709028006
indicating O 0 0.013578987680375576
a O 0 0.0045550172217190266
high O 0 0.004147772211581469
degree O 0 0.005586046259850264
of O 0 0.0015897629782557487
evolutionary O 1 0.984109103679657
conservation O 0 0.016312720254063606
. O 0 0.00292195868678391
. O 0 0.004464001394808292

The O 0 0.010406953282654285
APC B-Disease 1 0.9981778860092163
variants O 1 0.9568661451339722
I1307K O 1 0.9207929372787476
and O 0 0.002644302323460579
E1317Q O 1 0.9129366874694824
are O 0 0.0019724813755601645
associated O 0 0.024576883763074875
with O 1 0.897845983505249
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999998807907104
, O 0 0.0026004209648817778
but O 0 0.0012483812170103192
not O 0 0.0008279031608253717
always O 0 0.0013625724241137505
with O 0 0.0019669020548462868
a O 0 0.005403019022196531
family O 0 0.008466760627925396
history O 0 0.0049494109116494656
. O 0 0.005851208698004484

Classical O 1 0.5556881427764893
familial B-Disease 1 0.9999977350234985
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999982118606567
( O 0 0.026349786669015884
FAP B-Disease 1 0.9997864365577698
) O 0 0.005018123425543308
is O 0 0.0014551833737641573
a O 0 0.004824020899832249
high O 0 0.01032210048288107
- O 1 0.7525584697723389
penetrance O 1 0.9999650716781616
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9992699027061462
disease I-Disease 1 0.9999905824661255
that O 0 0.0031211520545184612
predisposes O 1 0.9997120499610901
to O 0 0.0014897591900080442
hundreds O 0 0.003513920120894909
or O 0 0.0021228608675301075
thousands O 0 0.004882385954260826
of O 0 0.007923940196633339
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999984502792358
and I-Disease 0 0.014949190430343151
carcinoma I-Disease 1 0.9999996423721313
and O 0 0.0019712960347533226
that O 0 0.0012796047376468778
results O 0 0.0064333342015743256
from O 0 0.0034991728607565165
truncating O 1 0.9997836947441101
mutations O 1 0.9999428987503052
in O 0 0.0025814808905124664
the O 0 0.005448794458061457
APC B-Disease 1 0.9998772144317627
gene O 1 0.9995872378349304
. O 0 0.012810331769287586

A O 0 0.027993589639663696
variant O 1 0.96136075258255
of O 0 0.006148730870336294
FAP B-Disease 1 0.9997482895851135
is O 0 0.022207440808415413
attenuated B-Disease 1 0.999976396560669
adenomatous I-Disease 1 0.9999996423721313
polyposis I-Disease 1 0.9999991655349731
coli I-Disease 1 0.9999892711639404
, O 0 0.0031880021560937166
which O 0 0.0014624795876443386
results O 0 0.007322410587221384
from O 0 0.003886242862790823
germ O 1 0.9998648166656494
- O 0 0.03047061711549759
line O 0 0.01617450639605522
mutations O 1 0.9999115467071533
in O 0 0.0016368709038943052
the O 0 0.0013458565808832645
5 O 0 0.0046650986187160015
and O 0 0.0010300105204805732
3 O 0 0.005099939182400703
regions O 0 0.003539527067914605
of O 0 0.0010035668965429068
the O 0 0.004719009157270193
APC B-Disease 1 0.9999511241912842
gene O 1 0.9996064305305481
. O 0 0.011138067580759525

Attenuated B-Disease 1 0.9999544620513916
adenomatous I-Disease 1 0.9999992847442627
polyposis I-Disease 1 0.9999992847442627
coli I-Disease 1 0.9999982118606567
patients O 1 0.9993689656257629
have O 0 0.0018600302282720804
" O 0 0.003746189409866929
multiple O 1 0.7915698885917664
" O 0 0.49406322836875916
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999929666519165
( O 0 0.0068849534727633
typically O 0 0.004666489083319902
fewer O 0 0.005295945797115564
than O 0 0.0010651139309629798
100 O 0 0.0024988579098135233
) O 0 0.0021077273413538933
without O 0 0.0022060940973460674
the O 0 0.002840673550963402
florid O 1 0.9993306398391724
phenotype O 1 0.999914288520813
of O 0 0.0032301945611834526
classical O 0 0.026609765365719795
FAP B-Disease 1 0.9998494386672974
. O 0 0.011545049026608467

Another O 0 0.013395584188401699
group O 0 0.0075258519500494
of O 0 0.0023705672938376665
patients O 1 0.9991130232810974
with O 0 0.004810011014342308
multiple O 1 0.9456253051757812
adenomas B-Disease 1 0.9999680519104004
has O 0 0.002705218968912959
no O 0 0.003797499230131507
mutations O 1 0.999932050704956
in O 0 0.0017054796917364001
the O 0 0.0033986950293183327
APC B-Disease 1 0.9999852180480957
gene O 1 0.9999282360076904
, O 0 0.0019392688991501927
and O 0 0.0010335781844332814
their O 0 0.004215205553919077
phenotype O 1 0.9999901056289673
probably O 0 0.007018458563834429
results O 0 0.006823996547609568
from O 0 0.0018464800668880343
variation O 0 0.07833276689052582
at O 0 0.0025304744485765696
a O 0 0.00906059704720974
locus O 1 0.9998242259025574
, O 0 0.003030176507309079
or O 0 0.006913129240274429
loci O 1 0.999586284160614
, O 0 0.0019492832943797112
elsewhere O 0 0.0035168598406016827
in O 0 0.001093924161978066
the O 0 0.0028138526249676943
genome O 1 0.998783528804779
. O 0 0.00966767780482769

Recently O 0 0.021358121186494827
, O 0 0.0019631427712738514
however O 0 0.001754408935084939
, O 0 0.001381881651468575
a O 0 0.007710419595241547
missense O 1 0.9995666146278381
variant O 1 0.9937834739685059
of O 0 0.004113145172595978
APC B-Disease 1 0.9997510313987732
( O 0 0.00894959457218647
I1307K O 1 0.9972217082977295
) O 0 0.003049342194572091
was O 0 0.0013570794835686684
described O 0 0.004106615204364061
that O 0 0.0013263076543807983
confers O 1 0.731157660484314
an O 0 0.0021901626605540514
increased O 0 0.010748608969151974
risk O 1 0.9956733584403992
of O 0 0.014565416611731052
colorectal B-Disease 1 1.0
tumors I-Disease 1 0.9999996423721313
, O 0 0.0030704704113304615
including O 0 0.004376045893877745
multiple O 1 0.992453396320343
adenomas B-Disease 1 0.9999693632125854
, O 0 0.003109268145635724
in O 0 0.0034441917669028044
Ashkenazim O 1 0.9848784804344177
. O 0 0.008130524307489395

We O 0 0.0027909250929951668
have O 0 0.0012119231978431344
studied O 0 0.002723680343478918
a O 0 0.001994911814108491
set O 0 0.0013016484444960952
of O 0 0.0012655484024435282
164 O 1 0.8819984793663025
patients O 1 0.9996041655540466
with O 0 0.008121054619550705
multiple O 1 0.9997429251670837
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.999997615814209
and I-Disease 0 0.006457799579948187
/ I-Disease 1 0.9895607233047485
or I-Disease 0 0.022171473130583763
carcinoma I-Disease 1 0.9999995231628418
and O 0 0.00425742007791996
analyzed O 0 0.05326228588819504
codons O 1 0.9973341226577759
1263 O 1 0.9968522191047668
- O 0 0.09297420084476471
1377 O 1 0.9906463623046875
( O 0 0.011141013354063034
exon O 1 0.9986997842788696
15G O 1 0.993868887424469
) O 0 0.003069889498874545
of O 0 0.0007906819228082895
the O 0 0.003044088836759329
APC B-Disease 1 0.9999279975891113
gene O 1 0.9999312162399292
for O 0 0.007132299710065126
germ O 1 0.9997199177742004
- O 0 0.0301731638610363
line O 0 0.014412575401365757
variants O 1 0.9356293678283691
. O 0 0.007733825594186783

Three O 0 0.015650780871510506
patients O 1 0.9905485510826111
with O 0 0.0026351078413426876
the O 0 0.002612635027617216
I1307K O 1 0.9980169534683228
allele O 1 0.999700665473938
were O 0 0.0025210764724761248
detected O 0 0.47794219851493835
, O 0 0.0011318856850266457
each O 0 0.0014115194790065289
of O 0 0.0017405478283762932
Ashkenazi O 1 0.9842627048492432
descent O 0 0.04543532058596611
. O 0 0.00801276694983244

Four O 0 0.016556141898036003
patients O 1 0.9947360157966614
had O 0 0.003631924046203494
a O 0 0.012654733844101429
germ O 1 0.999152660369873
- O 0 0.028348032385110855
line O 0 0.016098424792289734
E1317Q O 1 0.9929773211479187
missense O 1 0.9995900988578796
variant O 1 0.9940318465232849
of O 0 0.003859476884827018
APC O 1 0.9992997646331787
that O 0 0.0021086670458316803
was O 0 0.0011863969266414642
not O 0 0.0007636283989995718
present O 0 0.0016569211147725582
in O 0 0.0015031145885586739
controls O 0 0.020418263971805573
; O 0 0.002335249213501811
one O 0 0.0010327774798497558
of O 0 0.0006548638921231031
these O 0 0.0009188858675770462
individuals O 0 0.0022670836187899113
had O 0 0.0013976843329146504
an O 0 0.0015101063763722777
unusually O 0 0.015106857754290104
large O 0 0.002464959630742669
number O 0 0.0013340335572138429
of O 0 0.0021350698079913855
metaplastic B-Disease 1 0.9996694326400757
polyps I-Disease 1 0.9999184608459473
of I-Disease 0 0.0020925654098391533
the I-Disease 0 0.0035296634305268526
colorectum I-Disease 1 0.988089382648468
. O 0 0.008987000212073326

There O 0 0.0033019469119608402
is O 0 0.0016325513133779168
increasing O 0 0.004657023120671511
evidence O 0 0.0022439020685851574
that O 0 0.0008083819993771613
there O 0 0.0012206394458189607
exist O 0 0.009153023362159729
germ O 1 0.9996739625930786
- O 0 0.01821918785572052
line O 0 0.00802601221948862
variants O 0 0.07608969509601593
of O 0 0.0009856208926066756
the O 0 0.002876313403248787
APC B-Disease 1 0.9999747276306152
gene O 1 0.9999418258666992
that O 0 0.003338039852678776
predispose O 1 0.9994633793830872
to O 0 0.0008727204403840005
the O 0 0.000690873886924237
development O 0 0.0026646533515304327
of O 0 0.00242806738242507
multiple O 1 0.9998805522918701
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999991655349731
and I-Disease 0 0.035796113312244415
carcinoma I-Disease 1 0.9999998807907104
, O 0 0.002857527229934931
but O 0 0.0013833302073180676
without O 0 0.001976829022169113
the O 0 0.0024745475966483355
florid O 1 0.9993022680282593
phenotype O 1 0.9999516010284424
of O 0 0.0023398150224238634
classical O 0 0.023443274199962616
FAP B-Disease 1 0.9999707937240601
, O 0 0.0018899757415056229
and O 0 0.0008554864907637239
possibly O 0 0.007450830657035112
with O 0 0.0016286791069433093
importance O 0 0.004978947341442108
for O 0 0.3134309947490692
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
risk O 1 0.9978125095367432
in O 0 0.001468203729018569
the O 0 0.0013901268830522895
general O 0 0.0028026218060404062
population O 0 0.0034755407832562923
. O 0 0.003376512788236141
. O 0 0.0057526263408362865

Genomic O 1 0.9897985458374023
structure O 0 0.011957413516938686
of O 0 0.0010200608521699905
the O 0 0.002382495440542698
human O 1 0.90584397315979
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999884366989136
diarrhea I-Disease 1 0.9999992847442627
( O 0 0.027694199234247208
CLD B-Disease 1 0.9999449253082275
) O 0 0.01807551644742489
gene O 1 0.9993593096733093
. O 0 0.008580941706895828

Congenital B-Disease 1 0.9999995231628418
chloride I-Disease 1 0.9999758005142212
diarrhea I-Disease 1 0.9999986886978149
( O 0 0.024498436599969864
CLD B-Disease 1 0.9998894929885864
) O 0 0.005316475406289101
is O 0 0.0021420379634946585
caused O 0 0.02254212647676468
by O 0 0.005422263406217098
mutations O 1 0.9999544620513916
in O 0 0.002432582899928093
a O 0 0.00829023402184248
gene O 1 0.9996525049209595
which O 0 0.0024727077689021826
encodes O 1 0.993485152721405
an O 0 0.010196374729275703
intestinal O 1 0.9999938011169434
anion O 1 0.9993921518325806
transporter O 1 0.997386634349823
. O 0 0.01230955496430397

We O 0 0.0023606219328939915
report O 0 0.0016302033327519894
here O 0 0.0007590915774926543
the O 0 0.0010481876088306308
complete O 0 0.011758111417293549
genomic O 1 0.9995524287223816
organization O 0 0.0039059456903487444
of O 0 0.000737263064365834
the O 0 0.00209883414208889
human O 0 0.22035469114780426
CLD B-Disease 1 0.9999732971191406
gene O 1 0.9996914863586426
which O 0 0.0026054319459944963
spans O 0 0.01537433359771967
approximately O 0 0.005736824590712786
39kb O 1 0.9863156676292419
, O 0 0.0017104408470913768
and O 0 0.0010813494445756078
comprises O 0 0.006248239427804947
21 O 0 0.015429969877004623
exons O 1 0.9940620064735413
. O 0 0.00759959127753973

All O 0 0.009299073368310928
exon O 1 0.9950118064880371
/ O 1 0.527975857257843
intron O 1 0.9943417310714722
boundaries O 0 0.009319706819951534
conform O 0 0.012239476665854454
to O 0 0.0017301134066656232
the O 0 0.004040891770273447
GT O 1 0.999742329120636
/ O 1 0.9940853118896484
AG O 1 0.9985964894294739
rule O 0 0.01787508837878704
. O 0 0.00687490263953805

An O 0 0.004213537089526653
analysis O 0 0.007923636585474014
of O 0 0.0008641847525723279
the O 0 0.002653849544003606
putative O 1 0.9989333748817444
promoter O 1 0.901986300945282
region O 0 0.0051512932404875755
sequence O 0 0.027488315477967262
shows O 0 0.0044774869456887245
a O 0 0.008356157690286636
putative O 1 0.9993470311164856
TATA O 1 0.9971883893013
box O 0 0.025679830461740494
and O 0 0.002744644647464156
predicts O 0 0.09991925954818726
multiple O 0 0.10622251778841019
transcription O 1 0.9986215829849243
factor O 0 0.04190026596188545
binding O 0 0.03259266912937164
sites O 0 0.007935711182653904
. O 0 0.0055986554361879826

The O 0 0.008351599797606468
genomic O 1 0.9955965876579285
structure O 0 0.011107605881989002
was O 0 0.001624532276764512
determined O 0 0.005082390271127224
using O 0 0.007041711825877428
DNA O 1 0.9957082271575928
from O 0 0.0014792036963626742
several O 0 0.001451356103643775
sources O 0 0.002807237673550844
including O 0 0.0024401741102337837
multiple O 0 0.025272149592638016
large O 0 0.007483732886612415
- O 0 0.02845746837556362
insert O 1 0.9872826337814331
libaries O 1 0.9761264324188232
and O 0 0.003459544852375984
genomic O 1 0.999660849571228
DNA O 1 0.9970513582229614
from O 0 0.0054962546564638615
Finnish O 1 0.9306267499923706
CLD B-Disease 1 0.9999823570251465
patients O 1 0.9992570281028748
and O 0 0.0033101800363510847
controls O 0 0.030973834916949272
. O 0 0.007850776426494122

Exon O 1 0.9961603879928589
- O 0 0.04331878572702408
specific O 0 0.0152266975492239
primers O 1 0.9699333310127258
developed O 0 0.013501012697815895
in O 0 0.0010995477205142379
this O 0 0.0008705731597729027
study O 0 0.0036469532642513514
will O 0 0.0017975113587453961
facilitate O 0 0.3460666537284851
mutation O 1 0.9999915361404419
screening O 1 0.9357292652130127
studies O 0 0.008450919762253761
of O 0 0.002087577013298869
patients O 1 0.999421238899231
with O 0 0.003662034636363387
the O 0 0.005849006120115519
disease O 1 0.9999891519546509
. O 0 0.010347560048103333

Genomic O 1 0.9931054711341858
sequencing O 0 0.41806545853614807
of O 0 0.003825664520263672
a O 0 0.01882787048816681
BAC O 1 0.9997134804725647
clone O 1 0.9996881484985352
H O 1 0.9981465339660645
_ O 0 0.010956869460642338
RG364P16 O 1 0.9745612144470215
revealed O 0 0.00880375038832426
the O 0 0.0010352047393098474
presence O 0 0.003913650754839182
of O 0 0.0007928382256068289
another O 0 0.003931865096092224
, O 0 0.0018003706354647875
highly O 0 0.01843509078025818
homologous O 1 0.9999208450317383
gene O 1 0.9996898174285889
3 O 0 0.004856115207076073
of O 0 0.0008354500168934464
the O 0 0.004002423491328955
CLD B-Disease 1 0.999983549118042
gene O 1 0.9998124241828918
, O 0 0.001767716254107654
with O 0 0.0015665313694626093
a O 0 0.004387428052723408
similar O 0 0.010089924558997154
genomic O 1 0.9997932314872742
structure O 0 0.013333188369870186
, O 0 0.0013070885324850678
recently O 0 0.004483720753341913
identified O 0 0.0061455778777599335
as O 0 0.0017520238179713488
the O 0 0.006202276796102524
Pendred B-Disease 1 0.9999936819076538
syndrome I-Disease 1 1.0
gene O 1 0.9999817609786987
( O 0 0.013631685636937618
PDS B-Disease 1 0.9998831748962402
) O 0 0.00529369805008173
. O 0 0.0024321572855114937
. O 0 0.004586577881127596

The O 0 0.01176444161683321
APCI1307K O 1 0.9976879358291626
allele O 1 0.9998503923416138
and O 0 0.015986545011401176
cancer B-Disease 1 0.9999984502792358
risk O 1 0.9564841389656067
in O 0 0.0014684937195852399
a O 0 0.0049462467432022095
community O 0 0.005554614122956991
- O 0 0.012284819036722183
based O 0 0.002930729417130351
study O 0 0.005324231926351786
of O 0 0.001981019042432308
Ashkenazi O 1 0.9910004734992981
Jews O 0 0.008984018117189407
. O 0 0.006134910974651575

Mutations O 1 0.9996837377548218
in O 0 0.008771601133048534
APC O 1 0.9977545142173767
are O 0 0.003861365607008338
classically O 1 0.9765332341194153
associated O 0 0.020124811679124832
with O 0 0.023108916357159615
familial B-Disease 1 0.9999991655349731
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999992847442627
( O 0 0.025755232200026512
FAP B-Disease 1 0.9999322891235352
) O 0 0.0049648163840174675
, O 0 0.0013815679121762514
a O 0 0.006694192532449961
highly O 0 0.14641496539115906
penetrant O 1 0.9999898672103882
autosomal B-Disease 1 0.9999996423721313
dominant I-Disease 1 0.9986875653266907
disorder I-Disease 1 0.9999947547912598
characterized O 0 0.4728430509567261
by O 0 0.0074849254451692104
multiple O 1 0.9988982677459717
intestinal O 1 0.9999997615814209
polyps B-Disease 1 0.9999932050704956
and O 0 0.0027668916154652834
, O 0 0.0016351474914699793
without O 0 0.006034360267221928
surgical O 1 0.9997790455818176
intervention O 0 0.06133546680212021
, O 0 0.0009844833984971046
the O 0 0.000946921412833035
development O 0 0.006770651787519455
of O 0 0.03436115384101868
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
( O 0 0.015108304098248482
CRC B-Disease 1 0.9997304081916809
) O 0 0.007938121445477009
. O 0 0.00560426153242588

APC B-Disease 1 0.9847144484519958
is O 0 0.006202785763889551
a O 0 0.026642048731446266
tumour O 1 0.9999973773956299
- O 1 0.9942165613174438
suppressor O 1 0.9999878406524658
gene O 1 0.9997844099998474
, O 0 0.0028815055266022682
and O 0 0.0025413623079657555
somatic O 1 0.9999479055404663
loss O 1 0.8558459877967834
occurs O 0 0.3650088608264923
in O 0 0.006786585319787264
tumours B-Disease 1 0.9999749660491943
. O 0 0.012842463329434395

The O 0 0.022769562900066376
germline O 1 0.9999496936798096
T O 1 0.9995293617248535
- O 0 0.023265201598405838
to O 0 0.003119891509413719
- O 0 0.016512108966708183
A O 0 0.014276457019150257
transversion O 1 0.9872400164604187
responsible O 0 0.007977455854415894
for O 0 0.0013724170858040452
the O 0 0.0031640215311199427
APC O 1 0.9994953870773315
I1307K O 1 0.9932305812835693
allele O 1 0.9973638653755188
converts O 0 0.030562620609998703
the O 0 0.0026169302873313427
wild O 0 0.030421817675232887
- O 0 0.021581405773758888
type O 0 0.05124908685684204
sequence O 0 0.02689981646835804
to O 0 0.001544127007946372
a O 0 0.009292668662965298
homopolymer O 1 0.9995167255401611
tract O 1 0.99980229139328
( O 0 0.009971407242119312
A8 O 1 0.9998934268951416
) O 0 0.0031677824445068836
that O 0 0.0010151632595807314
is O 0 0.0023234884720295668
genetically O 1 0.9993306398391724
unstable O 1 0.962136447429657
and O 0 0.0021008183248341084
prone O 1 0.6318630576133728
to O 0 0.005926249548792839
somatic O 1 0.9999732971191406
mutation O 1 0.9999258518218994
. O 0 0.010890326462686062

The O 0 0.009603731334209442
I1307K O 1 0.9879656434059143
allele O 1 0.9990214109420776
was O 0 0.0038566712755709887
found O 0 0.004974887706339359
in O 0 0.002158427145332098
6 O 0 0.01003346685320139
. O 0 0.006846237927675247

1 O 0 0.012202411890029907
% O 0 0.0052831522189080715
of O 0 0.002365114400163293
unselected O 1 0.9901739358901978
Ashkenazi O 1 0.9103248715400696
Jews O 0 0.004343920387327671
and O 0 0.001011120853945613
higher O 0 0.004851778037846088
proportions O 0 0.17404092848300934
of O 0 0.0019084594678133726
Ashkenazim O 1 0.9931411147117615
with O 0 0.003971181344240904
family O 0 0.007966437377035618
or O 0 0.002842310816049576
personal O 0 0.007164721842855215
histories O 0 0.03690271079540253
of O 0 0.003038089256733656
CRC B-Disease 1 0.9997654557228088
( O 0 0.008788568899035454
ref O 1 0.997641921043396
. O 0 0.003974626772105694
2 O 0 0.009578850120306015
) O 0 0.0048845731653273106
. O 0 0.00546169001609087

To O 0 0.004177420865744352
evaluate O 0 0.015723032876849174
the O 0 0.0012263708049431443
role O 0 0.004666798748075962
of O 0 0.0018417721148580313
I1307K O 1 0.999086856842041
in O 0 0.008971842005848885
cancer B-Disease 1 0.9999980926513672
, O 0 0.002311207354068756
we O 0 0.0018181881168857217
genotyped O 1 0.9869685769081116
5 O 0 0.009892028756439686
, O 0 0.0038793988060206175
081 O 1 0.9983465671539307
Ashkenazi O 1 0.9741377234458923
volunteers O 0 0.014002322219312191
in O 0 0.0015586228109896183
a O 0 0.004759575240314007
community O 0 0.005259814206510782
survey O 0 0.009631223045289516
. O 0 0.005918543320149183

Risk O 0 0.47824424505233765
of O 0 0.005020026117563248
developing O 1 0.988598108291626
colorectal B-Disease 1 0.9999997615814209
, I-Disease 0 0.012747216038405895
breast I-Disease 1 0.9999949932098389
and I-Disease 0 0.002535224659368396
other I-Disease 0 0.00433469470590353
cancers I-Disease 1 0.9999911785125732
were O 0 0.0013367005158215761
compared O 0 0.006510598119348288
between O 0 0.00505346804857254
genotyped O 1 0.998907208442688
I1307K O 1 0.9985204339027405
carriers O 1 0.8542024493217468
and O 0 0.002135547110810876
non O 0 0.012745866551995277
- O 0 0.05054101347923279
carriers O 0 0.2593521773815155
and O 0 0.001167411101050675
their O 0 0.0016106348484754562
first O 0 0.004414401017129421
- O 0 0.025358757004141808
degree O 0 0.014207664877176285
relatives O 0 0.021083541214466095
. O 0 0.007647309917956591

Sperm O 1 0.9974990487098694
DNA O 1 0.9947602152824402
analysis O 0 0.014290548861026764
in O 0 0.0024011286441236734
a O 0 0.016282636672258377
Friedreich B-Disease 1 0.9999361038208008
ataxia I-Disease 1 0.9999915361404419
premutation O 1 0.9982668161392212
carrier O 1 0.5698183178901672
suggests O 0 0.016421867534518242
both O 0 0.004146003630012274
meiotic O 1 0.9996547698974609
and O 0 0.0038034061435610056
mitotic O 1 0.9984281063079834
expansion O 0 0.012879560701549053
in O 0 0.001991059398278594
the O 0 0.004741145763546228
FRDA B-Disease 1 0.998702883720398
gene O 1 0.9989120960235596
. O 0 0.012279733084142208

Friedreich B-Disease 1 0.999768078327179
ataxia I-Disease 1 0.9999499320983887
is O 0 0.007467998657375574
usually O 0 0.006932571996003389
caused O 0 0.04763998091220856
by O 0 0.0016734398668631911
an O 0 0.0013075467431917787
expansion O 0 0.006039885804057121
of O 0 0.0010018112370744348
a O 0 0.007401056122034788
GAA O 1 0.7882200479507446
trinucleotide O 1 0.9989399313926697
repeat O 0 0.3311626613140106
in O 0 0.004660395905375481
intron O 1 0.9997678399085999
1 O 0 0.004924842156469822
of O 0 0.0008985269232653081
the O 0 0.003995614591985941
FRDA B-Disease 1 0.9995481371879578
gene O 1 0.9997878670692444
. O 0 0.010060049593448639

Occasionally O 0 0.015415444038808346
, O 0 0.001665318151935935
a O 0 0.0038558137603104115
fully O 0 0.004914151504635811
expanded O 0 0.011192618869245052
allele O 1 0.999512791633606
has O 0 0.0018591406987980008
been O 0 0.0011483719572424889
found O 0 0.002933050272986293
to O 0 0.0015855892561376095
arise O 0 0.04942331463098526
from O 0 0.0017645006300881505
a O 0 0.0051534296944737434
premutation O 1 0.9270339608192444
of O 0 0.0011059483513236046
100 O 0 0.003041809191927314
or O 0 0.003241770202293992
less O 0 0.00726722739636898
triplet O 1 0.9996927976608276
repeats O 1 0.7036531567573547
. O 0 0.008470496162772179

We O 0 0.002416220959275961
have O 0 0.0013549852883443236
examined O 0 0.012653768062591553
the O 0 0.002843549009412527
sperm O 1 0.9984270334243774
DNA O 1 0.9888694286346436
of O 0 0.0018698989879339933
a O 0 0.008971733041107655
premutation O 1 0.9966540336608887
carrier O 1 0.7586992383003235
. O 0 0.009148812852799892

This O 0 0.007025390863418579
mans O 1 0.5062578916549683
leucocyte O 1 0.9927496910095215
DNA O 1 0.9962574243545532
showed O 0 0.008272838778793812
one O 0 0.0032642644364386797
normal O 0 0.035705845803022385
allele O 1 0.9992807507514954
and O 0 0.0017156775575131178
one O 0 0.0029329457320272923
allele O 1 0.9983323216438293
of O 0 0.001619664952158928
approximately O 0 0.0036032109055668116
100 O 0 0.005427306052297354
repeats O 0 0.21532626450061798
. O 0 0.007790990639477968

His O 0 0.013383546844124794
sperm O 1 0.987823486328125
showed O 0 0.008801423944532871
an O 0 0.00244502373971045
expanded O 0 0.008901694789528847
allele O 1 0.9988396763801575
in O 0 0.0020043461117893457
a O 0 0.005925072822719812
tight O 0 0.016020137816667557
range O 0 0.004565643612295389
centering O 0 0.027115704491734505
on O 0 0.0011444123229011893
a O 0 0.0036348348949104548
size O 0 0.004510616883635521
of O 0 0.0011823039967566729
approximately O 0 0.0060090129263699055
320 O 0 0.061038218438625336
trinucleotide O 1 0.9979528188705444
repeats O 1 0.6516820788383484
. O 0 0.007428527344018221

His O 0 0.015038278885185719
affected O 0 0.02619416080415249
son O 0 0.02305150404572487
has O 0 0.0031732392963021994
repeat O 0 0.046325910836458206
sizes O 0 0.012994631193578243
of O 0 0.002689364831894636
1040 O 1 0.9984135627746582
and O 0 0.003407934680581093
540 O 0 0.13115134835243225
. O 0 0.007130301557481289

These O 0 0.0026555992662906647
data O 0 0.003961618989706039
suggest O 0 0.00576404295861721
that O 0 0.0011341641657054424
expansion O 0 0.010900882072746754
occurs O 0 0.04024333879351616
in O 0 0.0009693528991192579
two O 0 0.0016471102135255933
stages O 0 0.05255347862839699
, O 0 0.0009679105132818222
the O 0 0.0008987400797195733
first O 0 0.0023423724342137575
during O 0 0.004464771598577499
meiosis O 1 0.9993079900741577
followed O 0 0.007681887596845627
by O 0 0.001972756115719676
a O 0 0.004655026365071535
second O 0 0.008033537305891514
mitotic O 1 0.9976061582565308
expansion O 0 0.02557435631752014
. O 0 0.007714805193245411

We O 0 0.0030005518347024918
also O 0 0.0011142418952658772
show O 0 0.002024231944233179
that O 0 0.0007747355266474187
in O 0 0.0007499915082007647
all O 0 0.0009151680860668421
informative O 0 0.049230169504880905
carrier O 1 0.6275777220726013
father O 0 0.0059812371619045734
to O 0 0.00185954081825912
affected O 0 0.027174564078450203
child O 0 0.31345489621162415
transmissions O 1 0.9871327877044678
, O 0 0.0015828197356313467
with O 0 0.0012890177313238382
the O 0 0.0008480847463943064
notable O 0 0.0027280410286039114
exception O 0 0.003467045957222581
of O 0 0.0006074621342122555
the O 0 0.002117934636771679
premutation O 1 0.9993895292282104
carrier O 1 0.8780392408370972
, O 0 0.0013361196033656597
the O 0 0.0013314149109646678
expansion O 0 0.010798431932926178
size O 0 0.01226009614765644
decreases O 1 0.6011790037155151
. O 0 0.0032469278667122126
. O 0 0.005232302937656641

The O 0 0.008807607926428318
R496H O 1 0.989604115486145
mutation O 1 0.9996583461761475
of O 0 0.0037003762554377317
arylsulfatase O 1 0.9859113693237305
A O 0 0.009310861118137836
does O 0 0.004328570328652859
not O 0 0.0028268045280128717
cause O 1 0.9936229586601257
metachromatic B-Disease 1 0.999785840511322
leukodystrophy I-Disease 1 0.9998950958251953
. O 0 0.016765451058745384

Deficiency B-Disease 1 0.9999415874481201
of I-Disease 0 0.004915802739560604
arylsulfatase I-Disease 1 0.9799962043762207
A I-Disease 0 0.016022732481360435
( O 0 0.009492829442024231
ARSA O 1 0.9997356534004211
) O 0 0.009593921713531017
enzyme O 1 0.9994623064994812
activity O 0 0.030136410146951675
causes O 1 0.9986799359321594
metachromatic B-Disease 1 0.9995989203453064
leukodystrophy I-Disease 1 0.9999786615371704
( O 0 0.022886820137500763
MLD B-Disease 1 0.9996165037155151
) O 0 0.009133397601544857
. O 0 0.006241809576749802

A O 0 0.012210036627948284
number O 0 0.002844912000000477
of O 0 0.004829758312553167
ARSA O 1 0.9999359846115112
gene O 1 0.9999655485153198
mutations O 1 0.9999046325683594
responsible O 0 0.015787744894623756
for O 0 0.004228514153510332
MLD B-Disease 1 0.9998175501823425
have O 0 0.0021792110055685043
been O 0 0.002247218508273363
identified O 0 0.01299113966524601
. O 0 0.005578346084803343

Recently O 0 0.015857182443141937
, O 0 0.0020831867586821318
the O 0 0.003524984000250697
R496H O 1 0.9973999261856079
mutation O 1 0.9998455047607422
of O 0 0.004165235441178083
ARSA O 1 0.9993540644645691
was O 0 0.002658811630681157
proposed O 0 0.004110290668904781
to O 0 0.000671140558551997
be O 0 0.0007707132026553154
a O 0 0.004357371013611555
cause O 0 0.4902249276638031
of O 0 0.003127447562292218
MLD B-Disease 1 0.9999264478683472
( O 0 0.010457267053425312
Draghia O 1 0.9982045888900757
et O 1 0.8504297733306885
al O 0 0.014433003030717373
. O 0 0.002252050908282399
, O 0 0.0019462625496089458
1997 O 0 0.014158700592815876
) O 0 0.00482438737526536
. O 0 0.006315381731837988

We O 0 0.0028680991381406784
have O 0 0.001556823612190783
investigated O 0 0.010186595842242241
the O 0 0.0028848820365965366
R496H O 1 0.9989951252937317
mutation O 1 0.9999542236328125
and O 0 0.0016909672413021326
found O 0 0.003587075974792242
this O 0 0.00276326690800488
mutation O 1 0.999975323677063
at O 0 0.002479212125763297
a O 0 0.003796260105445981
relatively O 0 0.0058550708927214146
high O 0 0.0032924239058047533
frequency O 0 0.016873635351657867
in O 0 0.0008308383403345942
an O 0 0.0011957103852182627
African O 0 0.006281591951847076
American O 0 0.003913042601197958
population O 0 0.0039344485849142075
( O 0 0.0057798707857728004
f O 1 0.7338172197341919
= O 0 0.1384689211845398
0 O 0 0.01350500900298357
. O 0 0.002405894221737981
09 O 0 0.0536934956908226
, O 0 0.003362814662978053
n O 0 0.06307046115398407
= O 0 0.08687317371368408
61 O 0 0.022965045645833015
subjects O 0 0.011229969561100006
) O 0 0.005225818604230881
. O 0 0.005150945857167244

The O 0 0.01666724495589733
ARSA O 1 0.9989427924156189
enzyme O 1 0.9989396929740906
activity O 0 0.013917925767600536
in O 0 0.0016492176800966263
subjects O 0 0.005519289057701826
with O 0 0.0018690377473831177
and O 0 0.000818294589407742
without O 0 0.0022971543949097395
the O 0 0.0026833682786673307
R496H O 1 0.9996845722198486
mutation O 1 0.9999818801879883
was O 0 0.0033427495509386063
determined O 0 0.006029797717928886
and O 0 0.0009404544252902269
found O 0 0.003200842998921871
to O 0 0.0011898260563611984
be O 0 0.0018733781762421131
normal O 0 0.023982737213373184
. O 0 0.006784169003367424

It O 0 0.0031332417856901884
is O 0 0.001693972502835095
therefore O 0 0.002982946578413248
concluded O 0 0.005788945127278566
that O 0 0.0008976976969279349
the O 0 0.002312499564141035
R496H O 1 0.9987623691558838
mutation O 1 0.9999592304229736
of O 0 0.004856528248637915
ARSA O 1 0.9998918771743774
does O 0 0.004866363946348429
not O 0 0.0014476535143330693
negatively O 0 0.017639093101024628
influence O 0 0.0035582459531724453
the O 0 0.001352393999695778
activity O 0 0.005627508275210857
of O 0 0.002683415310457349
ARSA O 1 0.9999524354934692
and O 0 0.0017370731802657247
is O 0 0.0012553090928122401
not O 0 0.001075433217920363
a O 0 0.006268877536058426
cause O 0 0.33860236406326294
of O 0 0.006545810494571924
MLD B-Disease 1 0.9991477727890015

Down O 0 0.026269730180501938
- O 0 0.022792311385273933
regulation O 0 0.028925547376275063
of O 0 0.0030915020033717155
transmembrane O 1 0.998629093170166
carbonic O 1 0.9992697834968567
anhydrases O 1 0.9945980310440063
in O 0 0.020093079656362534
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.99998939037323
carcinoma I-Disease 1 0.9999997615814209
cell O 1 0.9981813430786133
lines O 0 0.014026815071702003
by O 0 0.0035157923121005297
wild O 0 0.1286560744047165
- O 0 0.3120366930961609
type O 1 0.989890456199646
von B-Disease 1 0.9943751096725464
Hippel I-Disease 1 0.9996380805969238
- I-Disease 1 0.7510903477668762
Lindau I-Disease 1 0.9986841082572937
transgenes O 1 0.9862256050109863
. O 0 0.0159468911588192

To O 0 0.006874277256429195
discover O 0 0.0655553787946701
genes O 1 0.9872109889984131
involved O 0 0.009058289229869843
in O 0 0.0042465245351195335
von B-Disease 1 0.9955055713653564
Hippel I-Disease 1 0.999785840511322
- I-Disease 1 0.92583829164505
Lindau I-Disease 1 0.9998478889465332
( O 0 0.01605544611811638
VHL B-Disease 1 0.9999773502349854
) O 0 0.012863450683653355
- O 0 0.2587563097476959
mediated O 1 0.999281108379364
carcinogenesis O 1 0.9998044371604919
, O 0 0.002183387288823724
we O 0 0.0015692150918766856
used O 0 0.019429747015237808
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.9999918937683105
carcinoma I-Disease 1 0.9999997615814209
cell O 1 0.9990767240524292
lines O 0 0.031069057062268257
stably O 1 0.9939509630203247
transfected O 1 0.9986374974250793
with O 0 0.006422766484320164
wild O 0 0.040147073566913605
- O 0 0.13603632152080536
type O 1 0.989885687828064
VHL O 1 0.999886155128479
- O 0 0.05910605937242508
expressing O 0 0.04562132805585861
transgenes O 1 0.995391845703125
. O 0 0.011227057315409184

Large O 0 0.01791786402463913
- O 0 0.027257587760686874
scale O 0 0.03147522732615471
RNA O 1 0.9989823698997498
differential O 0 0.40681836009025574
display O 0 0.005607279017567635
technology O 0 0.006325192749500275
applied O 0 0.0029188329353928566
to O 0 0.0007631962653249502
these O 0 0.0016383780166506767
cell O 1 0.9978511333465576
lines O 0 0.010104694403707981
identified O 0 0.007698057685047388
several O 0 0.0026139402762055397
differentially O 1 0.9657900333404541
expressed O 0 0.01000180747359991
genes O 1 0.9988021850585938
, O 0 0.0014696323778480291
including O 0 0.001965475268661976
an O 0 0.0028593563474714756
alpha O 1 0.9655066132545471
carbonic O 1 0.9995682835578918
anhydrase O 1 0.9997339844703674
gene O 1 0.9998058676719666
, O 0 0.006105861626565456
termed O 0 0.4068438708782196
CA12 O 1 0.9912316203117371
. O 0 0.010975642129778862

The O 0 0.005902545992285013
deduced O 0 0.0854983925819397
protein O 1 0.9978964328765869
sequence O 0 0.039565932005643845
was O 0 0.0021454880479723215
classified O 0 0.008896278217434883
as O 0 0.0013206630246713758
a O 0 0.004534247796982527
one O 0 0.0029041944071650505
- O 0 0.01927112601697445
pass O 0 0.025124579668045044
transmembrane O 1 0.9971458315849304
CA O 0 0.021275024861097336
possessing O 0 0.015571558848023415
an O 0 0.0022097101900726557
apparently O 0 0.012762058526277542
intact O 0 0.03785572946071625
catalytic O 1 0.9951404333114624
domain O 0 0.02268599346280098
in O 0 0.0013812902616336942
the O 0 0.0026184008456766605
extracellular O 1 0.9966664910316467
CA O 0 0.03955678269267082
module O 0 0.12094255536794662
. O 0 0.007093256805092096

Reintroduced O 0 0.2981194853782654
wild O 0 0.08194032311439514
- O 0 0.1405051201581955
type O 1 0.9639721512794495
VHL B-Disease 1 0.9997487664222717
strongly O 0 0.015045808628201485
inhibited O 1 0.7705209851264954
the O 0 0.0037032621912658215
overexpression O 1 0.9979808926582336
of O 0 0.0016493117436766624
the O 0 0.0031763871666043997
CA12 O 1 0.9997339844703674
gene O 1 0.9996139407157898
in O 0 0.0022476869635283947
the O 0 0.0052378056570887566
parental O 1 0.9999232292175293
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.999993085861206
carcinoma I-Disease 1 0.9999997615814209
cell O 1 0.9986873269081116
lines O 0 0.028518954291939735
. O 0 0.007767923641949892

Similar O 0 0.017076104879379272
results O 0 0.008363882079720497
were O 0 0.0010481637436896563
obtained O 0 0.006155138369649649
with O 0 0.0049006640911102295
CA9 O 1 0.9995558857917786
, O 0 0.003918268717825413
encoding O 1 0.9510608911514282
another O 0 0.013179476372897625
transmembrane O 1 0.9976517558097839
CA O 0 0.01611238718032837
with O 0 0.0021215062588453293
an O 0 0.0020642310846596956
intact O 0 0.07815790176391602
catalytic O 1 0.995270311832428
domain O 0 0.05295080319046974
. O 0 0.008026632480323315

Although O 0 0.007146711926907301
both O 0 0.002409691922366619
domains O 0 0.028683342039585114
of O 0 0.001282246201299131
the O 0 0.004573605954647064
VHL B-Disease 1 0.9999678134918213
protein O 1 0.998117208480835
contribute O 0 0.014318718574941158
to O 0 0.0016237968811765313
regulation O 0 0.02250492200255394
of O 0 0.002476269146427512
CA12 O 1 0.9979668259620667
expression O 0 0.028991391882300377
, O 0 0.0013216936495155096
the O 0 0.0018279289361089468
elongin O 1 0.9927801489830017
binding O 0 0.07660631835460663
domain O 0 0.028445424512028694
alone O 0 0.006440421566367149
could O 0 0.004434851463884115
effectively O 0 0.02560739777982235
regulate O 1 0.7554866075515747
CA9 O 1 0.9974437952041626
expression O 0 0.07794790714979172
. O 0 0.007833223789930344

We O 0 0.0064582363702356815
mapped O 0 0.04317700117826462
CA12 O 1 0.9610491394996643
and O 0 0.007403325755149126
CA9 O 1 0.9985716342926025
loci O 1 0.9981276392936707
to O 0 0.008050095289945602
chromosome O 1 0.9998062252998352
bands O 0 0.028440378606319427
15q22 O 1 0.950502336025238
and O 0 0.0053792051039636135
17q21 O 1 0.9553881287574768
. O 0 0.009102649986743927

2 O 0 0.014847668819129467
respectively O 0 0.00614360673353076
, O 0 0.0020620126742869616
regions O 0 0.008367910049855709
prone O 1 0.5392057299613953
to O 0 0.0023888645227998495
amplification O 1 0.996436357498169
in O 0 0.0018454942619428039
some O 0 0.002629701979458332
human O 0 0.44306257367134094
cancers B-Disease 1 0.9999926090240479
. O 0 0.010689637623727322

Additional O 0 0.012247318401932716
experiments O 0 0.021774495020508766
are O 0 0.001182532636448741
needed O 0 0.00410043727606535
to O 0 0.0010024307994171977
define O 0 0.006338152568787336
the O 0 0.0010858739260584116
role O 0 0.004527969751507044
of O 0 0.001636448665522039
CA O 0 0.2025744915008545
IX O 1 0.9966603517532349
and O 0 0.003061001654714346
CA O 0 0.032121073454618454
XII O 1 0.9887009859085083
enzymes O 1 0.9960342049598694
in O 0 0.0015003418084234
the O 0 0.0013777941931039095
regulation O 0 0.024323606863617897
of O 0 0.0020187189802527428
pH O 1 0.9982879757881165
in O 0 0.0015673647867515683
the O 0 0.0022595226764678955
extracellular O 1 0.999133288860321
microenvironment O 1 0.9991605281829834
and O 0 0.0011751764686778188
its O 0 0.0014292586129158735
potential O 0 0.01203877478837967
impact O 0 0.010601532645523548
on O 0 0.006585758179426193
cancer B-Disease 1 0.9999994039535522
cell O 1 0.9996521472930908
growth O 0 0.02429652027785778
. O 0 0.006222985219210386

A O 0 0.033482007682323456
gene O 1 0.9976150989532471
encoding O 0 0.4056782126426697
a O 0 0.012270783074200153
transmembrane O 1 0.9978322386741638
protein O 1 0.9979435801506042
is O 0 0.004061246756464243
mutated O 1 0.9999405145645142
in O 0 0.0047433399595320225
patients O 1 0.9999394416809082
with O 1 0.7333813309669495
diabetes B-Disease 1 1.0
mellitus I-Disease 1 0.9999983310699463
and O 0 0.021396785974502563
optic B-Disease 1 0.9999974966049194
atrophy I-Disease 1 0.9999932050704956
( O 0 0.3504931330680847
Wolfram B-Disease 1 0.9999966621398926
syndrome I-Disease 1 0.9999996423721313
) O 0 0.011254298500716686
. O 0 0.006454273592680693

Wolfram B-Disease 1 0.9999674558639526
syndrome I-Disease 1 0.9999991655349731
( O 0 0.026535844430327415
WFS B-Disease 1 0.9998315572738647
; O 0 0.019263576716184616
OMIM O 1 0.9999414682388306
222300 O 1 0.9945434331893921
) O 0 0.004251061473041773
is O 0 0.002480369294062257
an O 0 0.012056124396622181
autosomal B-Disease 1 1.0
recessive I-Disease 1 0.9999998807907104
neurodegenerative I-Disease 1 0.9999997615814209
disorder I-Disease 1 0.9999814033508301
defined O 0 0.008233504369854927
by O 0 0.0028853164985775948
young O 0 0.019400998950004578
- O 1 0.7956899404525757
onset O 1 0.999950647354126
non O 0 0.2854336202144623
- O 1 0.9973214268684387
immune O 1 0.9999977350234985
insulin B-Disease 1 0.9999918937683105
- I-Disease 1 0.9883219599723816
dependent I-Disease 1 0.9976711869239807
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.999994158744812
and O 0 0.010093992576003075
progressive O 1 0.9962093830108643
optic B-Disease 1 0.9999799728393555
atrophy I-Disease 1 0.9998409748077393
. O 0 0.01639166660606861

Linkage O 1 0.6846259832382202
to O 0 0.004459623713046312
markers O 0 0.06769394129514694
on O 0 0.005912666209042072
chromosome O 1 0.9999737739562988
4p O 1 0.99750816822052
was O 0 0.004599832929670811
confirmed O 0 0.007622901350259781
in O 0 0.0014752292772755027
five O 0 0.0035664145834743977
families O 0 0.00893081072717905
. O 0 0.007715580053627491

On O 0 0.00216293940320611
the O 0 0.0014374800957739353
basis O 0 0.002844898495823145
of O 0 0.002945923013612628
meiotic O 1 0.9999419450759888
recombinants O 1 0.9994224309921265
and O 0 0.014166729524731636
disease O 1 0.9999957084655762
- O 0 0.154820516705513
associated O 0 0.031233621761202812
haplotypes O 1 0.9994445443153381
, O 0 0.0027964517939835787
the O 0 0.004568529315292835
WFS B-Disease 1 0.9998434782028198
gene O 1 0.9995777010917664
was O 0 0.004403893370181322
localized O 1 0.9838061332702637
to O 0 0.0020913053303956985
a O 0 0.014650996774435043
BAC O 1 0.9998897314071655
/ O 1 0.978727400302887
P1 O 1 0.9974464178085327
contig O 1 0.7071652412414551
of O 0 0.0016971640288829803
less O 0 0.0028260801918804646
than O 0 0.0021069508511573076
250 O 0 0.014274483546614647
kb O 1 0.8867707848548889
. O 0 0.01029729750007391

Mutations O 1 0.9992108345031738
in O 0 0.0029910278972238302
a O 0 0.007117896340787411
novel O 0 0.11165112257003784
gene O 1 0.9999245405197144
( O 0 0.007628310471773148
WFS1 O 1 0.9905810952186584
) O 0 0.004887770861387253
encoding O 0 0.2101060003042221
a O 0 0.009974788874387741
putative O 1 0.997433602809906
transmembrane O 1 0.9983662962913513
protein O 1 0.9976840019226074
were O 0 0.001045261975377798
found O 0 0.002865272108465433
in O 0 0.0008053811616264284
all O 0 0.0009213019511662424
affected O 0 0.009285609237849712
individuals O 0 0.003371571423485875
in O 0 0.0013631993206217885
six O 0 0.008106495253741741
WFS B-Disease 1 0.9999282360076904
families O 0 0.005683578085154295
, O 0 0.0010408052476122975
and O 0 0.0008219018345698714
these O 0 0.0020559104159474373
mutations O 1 0.9999479055404663
were O 0 0.001178725971840322
associated O 0 0.005303454119712114
with O 0 0.0022718627005815506
the O 0 0.007373444270342588
disease O 1 0.999997615814209
phenotype O 1 0.9999791383743286
. O 0 0.010958915576338768

WFS1 O 1 0.9815325140953064
appears O 0 0.01972457766532898
to O 0 0.0016969877760857344
function O 0 0.011694342829287052
in O 0 0.0014900030801072717
survival O 0 0.2245531678199768
of O 0 0.002453632652759552
islet O 1 0.9998125433921814
beta O 1 0.9997410178184509
- O 1 0.8224343061447144
cells O 1 0.9996365308761597
and O 0 0.0036559016443789005
neurons O 1 0.9986444115638733
. O 0 0.004196949303150177
. O 0 0.0062639303505420685

Stable O 0 0.09401338547468185
interaction O 0 0.022672971710562706
between O 0 0.001990428427234292
the O 0 0.001173696480691433
products O 0 0.004769280087202787
of O 0 0.0010414549615234137
the O 0 0.004418460186570883
BRCA1 O 1 0.9999983310699463
and O 0 0.018181921914219856
BRCA2 O 1 0.9999997615814209
tumor B-Disease 1 0.9999983310699463
suppressor O 1 0.9999549388885498
genes O 1 0.9951501488685608
in O 0 0.0037087094970047474
mitotic O 1 0.9992033839225769
and O 0 0.008812075480818748
meiotic O 1 0.9999371767044067
cells O 1 0.9992799162864685
. O 0 0.010275889188051224

BRCA1 O 1 0.9999599456787109
and O 0 0.012689431197941303
BRCA2 O 1 0.9999806880950928
account O 0 0.005674391053617001
for O 0 0.001094873994588852
most O 0 0.0011044797720387578
cases O 0 0.0052092960104346275
of O 0 0.002147062448784709
familial O 1 0.999988317489624
, O 0 0.0027651989366859198
early O 0 0.05895526707172394
onset O 1 0.9999972581863403
breast B-Disease 1 0.9999982118606567
and I-Disease 0 0.004809152334928513
/ I-Disease 1 0.9996292591094971
or I-Disease 1 0.9878623485565186
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
and O 0 0.002654408570379019
encode O 1 0.9442641139030457
products O 0 0.007082236930727959
that O 0 0.000913323019631207
each O 0 0.0017597718397155404
interact O 0 0.04502218961715698
with O 0 0.005185896065086126
hRAD51 O 1 0.9896978735923767
. O 0 0.010103940963745117

Results O 0 0.018969496712088585
presented O 0 0.004502597730606794
here O 0 0.0012132093543186784
show O 0 0.003316420130431652
that O 0 0.005276469048112631
BRCA1 O 1 0.9999970197677612
and O 0 0.009718745946884155
BRCA2 O 1 0.9999934434890747
coexist O 0 0.24170754849910736
in O 0 0.001975366147235036
a O 0 0.007110132835805416
biochemical O 1 0.9967926144599915
complex O 0 0.013040916994214058
and O 0 0.002051598858088255
colocalize O 1 0.9592503905296326
in O 0 0.0036395795177668333
subnuclear O 1 0.9972234964370728
foci O 1 0.9966198205947876
in O 0 0.006819283124059439
somatic O 1 0.999958872795105
cells O 1 0.9988232254981995
and O 0 0.0012137166922912002
on O 0 0.0008725142106413841
the O 0 0.0018340912647545338
axial O 1 0.9419585466384888
elements O 0 0.0059936982579529285
of O 0 0.0016140997176989913
developing O 0 0.03454843908548355
synaptonemal O 1 0.9924904704093933
complexes O 0 0.4546593725681305
. O 0 0.007236623205244541

Like O 0 0.051000162959098816
BRCA1 O 1 0.9999672174453735
and O 0 0.013994148001074791
RAD51 O 1 0.9997420907020569
, O 0 0.013192755170166492
BRCA2 O 1 0.9999783039093018
relocates O 1 0.9328792691230774
to O 0 0.006636989768594503
PCNA O 1 0.9997645020484924
+ O 1 0.9879152774810791
replication O 1 0.9981583952903748
sites O 0 0.005905053578317165
following O 0 0.005760262720286846
exposure O 0 0.3687567114830017
of O 0 0.0017465697601437569
S O 1 0.8863471150398254
phase O 1 0.6915117502212524
cells O 1 0.9987909197807312
to O 0 0.006462776567786932
hydroxyurea O 1 0.9995658993721008
or O 0 0.019615130499005318
UV O 1 0.9994218349456787
irradiation O 1 0.9803584814071655
. O 0 0.012294327840209007

Thus O 0 0.015933075919747353
, O 0 0.0073227062821388245
BRCA1 O 1 0.9999971389770508
and O 0 0.008898869156837463
BRCA2 O 1 0.999996542930603
participate O 0 0.0063416613265872
, O 0 0.0013751743827015162
together O 0 0.002153943758457899
, O 0 0.0008754414157010615
in O 0 0.001295253518037498
a O 0 0.008664083667099476
pathway O 1 0.9998288154602051
( O 0 0.005922248121351004
s O 0 0.17177672684192657
) O 0 0.0035179615952074528
associated O 0 0.005342956632375717
with O 0 0.0013600444654002786
the O 0 0.0014803098747506738
activation O 1 0.9939680099487305
of O 0 0.0020334094297140837
double O 0 0.2007264792919159
- O 0 0.19887402653694153
strand O 1 0.9967953562736511
break O 0 0.03134748712182045
repair O 1 0.9817060828208923
and O 0 0.0034549543634057045
/ O 0 0.42155808210372925
or O 0 0.010448703542351723
homologous O 1 0.9998325109481812
recombination O 1 0.9988358616828918
. O 0 0.011807054281234741

Dysfunction O 1 0.9997747540473938
of O 0 0.0021678621415048838
this O 0 0.0028238531667739153
pathway O 1 0.9998587369918823
may O 0 0.003944366704672575
be O 0 0.0009673135355114937
a O 0 0.0031009246595203876
general O 0 0.003013092326000333
phenomenon O 0 0.02226894348859787
in O 0 0.000772645405959338
the O 0 0.0007787832873873413
majority O 0 0.002402645070105791
of O 0 0.0007803195621818304
cases O 0 0.006144970189779997
of O 0 0.0034045714419335127
hereditary B-Disease 1 0.9999963045120239
breast I-Disease 1 0.9999988079071045
and I-Disease 0 0.0059904721565544605
/ I-Disease 1 0.9997586607933044
or I-Disease 1 0.9948943853378296
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.006306082475930452
. O 0 0.00681353360414505

A O 0 0.024139000102877617
novel O 0 0.038870200514793396
Arg362Ser O 1 0.9964319467544556
mutation O 1 0.9998435974121094
in O 0 0.002187819452956319
the O 0 0.0036273954901844263
sterol O 1 0.9994382262229919
27 O 0 0.027129555121064186
- O 1 0.5288276076316833
hydroxylase O 1 0.9998283386230469
gene O 1 0.9998621940612793
( O 0 0.010521030984818935
CYP27 O 1 0.998940646648407
) O 0 0.004128424450755119
: O 0 0.002208048477768898
its O 0 0.0021927382331341505
effects O 0 0.02440997026860714
on O 0 0.002367484150454402
pre O 0 0.04000651463866234
- O 0 0.035262588411569595
mRNA O 1 0.9886928796768188
splicing O 1 0.9982271790504456
and O 0 0.005542941857129335
enzyme O 1 0.9994388222694397
activity O 0 0.01931874267756939
. O 0 0.006293112877756357

A O 0 0.026010993868112564
novel O 0 0.024757681414484978
C O 0 0.06173360347747803
to O 0 0.002205410972237587
A O 0 0.013151189312338829
mutation O 1 0.9997723698616028
in O 0 0.001838999567553401
the O 0 0.002828486729413271
sterol O 1 0.9995346069335938
27 O 0 0.03293018415570259
- O 1 0.5907084941864014
hydroxylase O 1 0.9996316432952881
gene O 1 0.9996969699859619
( O 0 0.012742932885885239
CYP27 O 1 0.9961385130882263
) O 0 0.0034406583290547132
was O 0 0.0018278700299561024
identified O 0 0.0064498200081288815
by O 0 0.0034793561790138483
sequencing O 1 0.9965196847915649
amplified O 1 0.987006425857544
CYP27 O 1 0.9993763566017151
gene O 1 0.999542236328125
products O 0 0.01091768778860569
from O 0 0.0023388226982206106
a O 0 0.008643429726362228
patient O 1 0.9974512457847595
with O 0 0.008929396979510784
cerebrotendinous B-Disease 1 0.9998154044151306
xanthomatosis I-Disease 1 0.9996531009674072
( O 0 0.016564149409532547
CTX B-Disease 1 0.9997488856315613
) O 0 0.008832941763103008
. O 0 0.00576056307181716

The O 0 0.010327236726880074
mutation O 1 0.9994364380836487
changed O 0 0.006904386915266514
the O 0 0.0028062339406460524
adrenodoxin O 1 0.9752700924873352
cofactor O 1 0.9869727492332458
binding O 0 0.0678236335515976
residue O 1 0.7596550583839417
362Arg O 1 0.9128488302230835
to O 0 0.004153627902269363
362Ser O 1 0.985507607460022
( O 0 0.00935013685375452
CGT O 1 0.9745070338249207
362Arg O 1 0.977508008480072
to O 0 0.009199942462146282
AGT O 1 0.9999608993530273
362Ser O 1 0.9982230067253113
) O 0 0.004308511968702078
, O 0 0.000880437612067908
and O 0 0.0006823913427069783
was O 0 0.00141455652192235
responsible O 0 0.007613532245159149
for O 0 0.004806720186024904
deficiency O 1 0.9999972581863403
in O 0 0.0019442331977188587
the O 0 0.003877357579767704
sterol O 1 0.9997430443763733
27 O 0 0.02525278739631176
- O 0 0.14434462785720825
hydroxylase O 1 0.9989228844642639
activity O 0 0.015423291362822056
, O 0 0.0013816921273246408
as O 0 0.0011681400937959552
confirmed O 0 0.005316104274243116
by O 0 0.0017826001858338714
expression O 0 0.01654765196144581
of O 0 0.002046832349151373
mutant O 1 0.9978101849555969
cDNA O 1 0.9902949333190918
into O 0 0.02063514105975628
COS O 1 0.9986825585365295
- O 0 0.0551457442343235
1 O 0 0.02107170969247818
cells O 1 0.9976603984832764
. O 0 0.007683701813220978

Quantitative O 0 0.11512433737516403
analysis O 0 0.014812563546001911
showed O 0 0.0046153077855706215
that O 0 0.0008009932353161275
the O 0 0.00139303645119071
expression O 0 0.01735757291316986
of O 0 0.0029579855035990477
CYP27 O 1 0.9992517828941345
gene O 1 0.9998108744621277
mRNA O 1 0.9218289852142334
in O 0 0.0021526587661355734
the O 0 0.003001387696713209
patient O 1 0.9924076199531555
represented O 0 0.004448884166777134
52 O 0 0.020669439807534218
. O 0 0.006826081313192844

5 O 0 0.012311595492064953
% O 0 0.0036045191809535027
of O 0 0.0009619072661735117
the O 0 0.001880391500890255
normal O 0 0.02342250756919384
level O 0 0.007903057150542736
. O 0 0.005413698963820934

As O 0 0.003991810139268637
the O 0 0.004321908578276634
mutation O 1 0.9999291896820068
occurred O 0 0.010743769817054272
at O 0 0.0015566317597404122
the O 0 0.0018223085207864642
penultimate O 1 0.9915708303451538
nucleotide O 1 0.9942031502723694
of O 0 0.0033345671836286783
exon O 1 0.9991329312324524
6 O 0 0.015024878084659576
( O 0 0.004985007923096418
- O 0 0.011661636643111706
2 O 0 0.004446013364940882
position O 0 0.0022920225746929646
of O 0 0.0021294874604791403
exon O 1 0.9973395466804504
6 O 0 0.019882937893271446
- O 0 0.060345906764268875
intron O 1 0.9995461106300354
6 O 0 0.019851069897413254
splice O 1 0.997717022895813
site O 0 0.0073029096238315105
) O 0 0.0017540748231112957
of O 0 0.0008118280093185604
the O 0 0.0027108779177069664
gene O 1 0.9999246597290039
, O 0 0.0013473096769303083
we O 0 0.0011765104718506336
hypothesized O 1 0.6391154527664185
that O 0 0.0012014065869152546
the O 0 0.0032195523381233215
mutation O 1 0.9999886751174927
may O 0 0.007417628541588783
partially O 0 0.030866708606481552
affect O 0 0.009305937215685844
the O 0 0.0014999654376879334
normal O 0 0.03863367438316345
splicing O 1 0.9993544220924377
efficiency O 0 0.024594822898507118
in O 0 0.003305553225800395
exon O 1 0.9980915188789368
6 O 0 0.007311414927244186
and O 0 0.0018819253891706467
cause O 1 0.7715581059455872
alternative O 0 0.06447318941354752
splicing O 1 0.9997585415840149
elsewhere O 0 0.006575636565685272
, O 0 0.0011806772090494633
which O 0 0.0010247949976474047
resulted O 0 0.009580655954778194
in O 0 0.0017201752634719014
decreased O 1 0.5003203749656677
transcript O 1 0.7078230381011963
in O 0 0.0021322525572031736
the O 0 0.00465495977550745
patient O 1 0.9973334074020386
. O 0 0.009786593727767467

Transfection O 1 0.9894524812698364
of O 0 0.003937495406717062
constructed O 0 0.01283640693873167
minigenes O 1 0.9819210171699524
, O 0 0.00224306620657444
with O 0 0.0019964808598160744
or O 0 0.0024111424572765827
without O 0 0.002363417064771056
the O 0 0.0026521661784499884
mutation O 1 0.9999709129333496
, O 0 0.002167267957702279
into O 0 0.0074152033776044846
COS O 1 0.9996858835220337
- O 0 0.047334056347608566
1 O 0 0.012448017485439777
cells O 1 0.9996699094772339
confirmed O 0 0.006108405534178019
that O 0 0.0009124829084612429
the O 0 0.0018756336066871881
mutant O 1 0.9996564388275146
minigene O 1 0.9959174990653992
was O 0 0.002456022659316659
responsible O 0 0.005515289027243853
for O 0 0.0013381951721385121
a O 0 0.006573783233761787
mRNA O 1 0.9674275517463684
species O 0 0.018510350957512856
alternatively O 1 0.5158731937408447
spliced O 1 0.9962348341941833
at O 0 0.003330332227051258
an O 0 0.0038998094387352467
activated O 1 0.9920362830162048
cryptic O 1 0.9694308042526245
5 O 0 0.014178922399878502
splice O 1 0.9874483942985535
site O 0 0.010441509075462818
88 O 0 0.02043067291378975
bp O 0 0.05001665651798248
upstream O 0 0.027210915461182594
from O 0 0.0018653887091204524
the O 0 0.0013654395006597042
3 O 0 0.0057247173972427845
end O 0 0.0033060654532164335
of O 0 0.002081753220409155
exon O 1 0.9979161620140076
6 O 0 0.016720766201615334
. O 0 0.006500077899545431

Our O 0 0.005876620765775442
data O 0 0.004695079755038023
suggest O 0 0.004893576726317406
that O 0 0.0007190247415564954
the O 0 0.001194154261611402
C O 0 0.32967409491539
to O 0 0.0014954530633985996
A O 0 0.012393557466566563
mutation O 1 0.999913215637207
at O 0 0.0019161927048116922
the O 0 0.0018380448454990983
penultimate O 1 0.9878097772598267
nucleotide O 1 0.9890590906143188
of O 0 0.002459061797708273
exon O 1 0.9962769150733948
6 O 0 0.004462298937141895
of O 0 0.0005853050388395786
the O 0 0.002382716629654169
CYP27 O 1 0.9999133348464966
gene O 1 0.9999337196350098
not O 0 0.001287877094000578
only O 0 0.0013028254033997655
causes O 1 0.8822941184043884
the O 0 0.004009297117590904
deficiency B-Disease 1 0.9999948740005493
in I-Disease 0 0.0019124008249491453
the I-Disease 0 0.003285747254267335
sterol I-Disease 1 0.9998364448547363
27 I-Disease 0 0.025956789031624794
- I-Disease 0 0.4053729176521301
hydroxylase I-Disease 1 0.9993563294410706
activity I-Disease 0 0.013426246121525764
, O 0 0.0014101515989750624
but O 0 0.0011498306412249804
also O 0 0.001359958783723414
partially O 0 0.02559865079820156
leads O 0 0.012949695810675621
to O 0 0.0016145771369338036
alternative O 0 0.012189957313239574
pre O 0 0.03220159932971001
- O 0 0.03129465505480766
mRNA O 1 0.9700128436088562
splicing O 1 0.9884695410728455
of O 0 0.0027318447828292847
the O 0 0.00406110193580389
gene O 1 0.999739944934845
. O 0 0.009251905605196953

To O 0 0.00310326786711812
our O 0 0.002880612388253212
knowledge O 0 0.0051328884437680244
, O 0 0.000921271275728941
this O 0 0.0006638346239924431
is O 0 0.0007779080187901855
the O 0 0.0007896609604358673
first O 0 0.0014264759374782443
report O 0 0.002139344811439514
regarding O 0 0.0033420429099351168
effects O 0 0.02016446366906166
on O 0 0.0018873042427003384
pre O 0 0.03796526789665222
- O 0 0.029991785064339638
mRNA O 1 0.9845860600471497
splicing O 1 0.9908100366592407
of O 0 0.0016686049057170749
a O 0 0.00966682843863964
mutation O 1 0.9999455213546753
at O 0 0.002644292078912258
the O 0 0.002014469588175416
- O 0 0.01224478054791689
2 O 0 0.005809919908642769
position O 0 0.0021355231292545795
of O 0 0.0009449328063055873
a O 0 0.005998427513986826
5 O 0 0.010485958307981491
splice O 1 0.9968243837356567
site O 0 0.01289732288569212
. O 0 0.005823569372296333

ATM O 1 0.9932050704956055
germline O 1 0.9998643398284912
mutations O 1 0.9994277358055115
in O 0 0.00618878286331892
classical O 0 0.24020704627037048
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9993255138397217
telangiectasia I-Disease 1 0.9999960660934448
patients O 1 0.9994912147521973
in O 0 0.0018424805020913482
the O 0 0.0017995215021073818
Dutch O 0 0.01282570417970419
population O 0 0.004587725270539522
. O 0 0.005096171051263809

Germline O 1 0.9998979568481445
mutations O 1 0.9991925358772278
in O 0 0.002869085408747196
the O 0 0.003319122828543186
ATM O 1 0.9980887770652771
gene O 1 0.9994280934333801
are O 0 0.0012873177183791995
responsible O 0 0.005412256810814142
for O 0 0.0020458835642784834
the O 0 0.01405758410692215
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9975371360778809
telangiectasia I-Disease 1 0.9999845027923584
( O 0 0.011832200922071934
A B-Disease 1 0.7786903977394104
- I-Disease 1 0.9731641411781311
T I-Disease 1 0.9998416900634766
) O 0 0.008750631473958492
. O 0 0.006156121380627155

In O 0 0.003264414379373193
our O 0 0.0028914788272231817
study O 0 0.005490433424711227
, O 0 0.0009210807038471103
we O 0 0.0005867382860742509
have O 0 0.000762902433052659
determined O 0 0.004393274895846844
the O 0 0.0021449222695082426
ATM O 1 0.9990628361701965
mutation O 1 0.9999319314956665
spectrum O 0 0.03251698613166809
in O 0 0.0015314420452341437
19 O 0 0.00620237085968256
classical O 0 0.009943898767232895
A B-Disease 1 0.9182611107826233
- I-Disease 1 0.998036801815033
T I-Disease 1 0.9999923706054688
patients O 1 0.9998595714569092
, O 0 0.0014445314882323146
including O 0 0.0015580737963318825
some O 0 0.0013480976922437549
immigrant O 0 0.031704556196928024
populations O 0 0.05723587051033974
, O 0 0.0011827702401205897
as O 0 0.0008587990887463093
well O 0 0.000950127316173166
as O 0 0.0008455555653199553
12 O 0 0.0024711182340979576
of O 0 0.0008617331623099744
Dutch O 0 0.011827239766716957
ethnic O 0 0.006302128080278635
origin O 0 0.011188739910721779
. O 0 0.006240484304726124

Both O 0 0.004298173822462559
the O 0 0.004322540946304798
protein O 1 0.9990940093994141
truncation O 1 0.9969127178192139
test O 0 0.03146692365407944
( O 0 0.006369887385517359
PTT O 1 0.9418123960494995
) O 0 0.0033525608014315367
and O 0 0.0008996858960017562
the O 0 0.001853774068877101
restriction O 0 0.07108994573354721
endonuclease O 1 0.9991230368614197
fingerprinting O 1 0.9627100825309753
( O 0 0.009822427295148373
REF O 1 0.9994400143623352
) O 0 0.0037966661620885134
method O 0 0.006782121956348419
were O 0 0.0006216937326826155
used O 0 0.0018064668402075768
and O 0 0.0008663383196108043
compared O 0 0.0042958431877195835
for O 0 0.0013297770638018847
their O 0 0.0024376288056373596
detection O 1 0.9913219809532166
efficiency O 0 0.021283546462655067
, O 0 0.002069144742563367
identifying O 0 0.12576673924922943
76 O 0 0.022047311067581177
% O 0 0.00358590018004179
and O 0 0.0008488386520184577
60 O 0 0.0036692197900265455
% O 0 0.0023174930829554796
of O 0 0.00088688381947577
the O 0 0.0036224015057086945
mutations O 1 0.9999948740005493
, O 0 0.0029858010821044445
respectively O 0 0.007257835473865271
. O 0 0.0053381952457129955

Most O 0 0.010235212743282318
patients O 1 0.9944084286689758
were O 0 0.0010824708733707666
found O 0 0.0030819689854979515
to O 0 0.0012275547487661242
be O 0 0.0017743413336575031
compound O 0 0.0894269123673439
heterozygote O 1 0.9979941844940186
. O 0 0.010979029349982738

Seventeen O 0 0.06788205355405807
mutations O 1 0.9996719360351562
were O 0 0.0020334271248430014
distinct O 0 0.011891981586813927
, O 0 0.0009876483818516135
of O 0 0.0006190771237015724
which O 0 0.0008842670940794051
10 O 0 0.0018418815452605486
were O 0 0.0005973279476165771
not O 0 0.0012063506292179227
reported O 0 0.007367958780378103
previously O 0 0.006056520156562328
. O 0 0.0062791104428470135

Mutations O 1 0.9987623691558838
are O 0 0.002440424868836999
small O 0 0.006553262937813997
deletions O 1 0.9887002110481262
or O 0 0.004555620718747377
point O 0 0.00763666070997715
mutations O 1 0.9999474287033081
frequently O 0 0.011885792016983032
affecting O 0 0.3701181709766388
splice O 1 0.9981371164321899
sites O 0 0.01344413310289383
. O 0 0.006971973925828934

Moreover O 0 0.03788734972476959
, O 0 0.0028276017401367426
a O 0 0.006852854508906603
16 O 0 0.011447575874626637
. O 0 0.007244729436933994

7 O 0 0.03661590442061424
- O 0 0.04566797986626625
kb O 1 0.9874489307403564
genomic O 1 0.9992997646331787
deletion O 1 0.9925059676170349
of O 0 0.0012111178366467357
the O 0 0.0012338755186647177
3 O 0 0.004861659836024046
end O 0 0.002110965084284544
of O 0 0.0007007047533988953
the O 0 0.002662521554157138
gene O 1 0.9999673366546631
, O 0 0.0012589613907039165
most O 0 0.001028705737553537
likely O 0 0.003434250131249428
a O 0 0.003350155893713236
result O 0 0.0047931852750480175
of O 0 0.0014170529320836067
recombination O 1 0.9997982382774353
between O 0 0.0024478305131196976
two O 0 0.0016945726238191128
LINE O 0 0.0075179776176810265
elements O 0 0.0048865070566535
, O 0 0.0011922403937205672
was O 0 0.0024262869264930487
identified O 0 0.015425450168550014
. O 0 0.006174223963171244

The O 0 0.0027555683627724648
most O 0 0.0016044123331084847
frequently O 0 0.004487377125769854
found O 0 0.012314118444919586
mutation O 1 0.99998939037323
, O 0 0.0016602907562628388
identified O 0 0.0048943874426186085
in O 0 0.0007988726138137281
three O 0 0.0018963930197060108
unrelated O 0 0.4813816249370575
Turkish O 0 0.01332696434110403
A B-Disease 1 0.7933488488197327
- I-Disease 1 0.9803617000579834
T I-Disease 1 0.9999034404754639
individuals O 0 0.004996857140213251
, O 0 0.0011685213539749384
was O 0 0.0013319140998646617
previously O 0 0.0021121506579220295
described O 0 0.002839787397533655
to O 0 0.0006198832998052239
be O 0 0.0006450891960412264
a O 0 0.002733313012868166
Turkish O 0 0.00983793381601572
A B-Disease 0 0.2840753197669983
- I-Disease 1 0.9275742769241333
T I-Disease 1 0.9998854398727417
founder O 1 0.8277314305305481
mutation O 1 0.9998327493667603
. O 0 0.010580198839306831

The O 0 0.003297577379271388
presence O 0 0.005575584713369608
of O 0 0.0012007314944639802
a O 0 0.00784932728856802
founder O 1 0.5556822419166565
mutation O 1 0.9999707937240601
among O 0 0.003678971901535988
relatively O 0 0.0056923432275652885
small O 0 0.0029923305846750736
ethnic O 0 0.003907890524715185
population O 0 0.0020393170416355133
groups O 0 0.0018229070119559765
in O 0 0.0009581617196090519
Western O 0 0.002847443101927638
Europe O 0 0.0026403639931231737
could O 0 0.001958676381036639
indicate O 0 0.005426314659416676
a O 0 0.0037661618553102016
high O 0 0.005151430144906044
carrier O 0 0.3034084141254425
frequency O 0 0.026166941970586777
in O 0 0.00155100435949862
such O 0 0.0021968400105834007
communities O 0 0.007899189367890358
. O 0 0.004888341762125492

In O 0 0.010259413160383701
patients O 1 0.9613512754440308
of O 0 0.0015344942221418023
Dutch O 0 0.012649116106331348
ethnic O 0 0.004889056086540222
origin O 0 0.006655768025666475
, O 0 0.0012104575289413333
however O 0 0.0015973466215655208
, O 0 0.0008966645691543818
no O 0 0.0015544024063274264
significant O 0 0.005790967959910631
founder O 0 0.022471897304058075
effect O 0 0.011124646291136742
could O 0 0.0024921754375100136
be O 0 0.0016614665510132909
identified O 0 0.010834570974111557
. O 0 0.005809735506772995

The O 0 0.005574068054556847
observed O 0 0.023894846439361572
genetic O 1 0.9995104074478149
heterogeneity O 1 0.9872128367424011
including O 0 0.0025268648751080036
the O 0 0.0012480939039960504
relative O 0 0.007245298940688372
high O 0 0.003307329025119543
percentage O 0 0.007097688503563404
of O 0 0.002587883034721017
splice O 1 0.9997460246086121
- O 0 0.03232020139694214
site O 0 0.015933120623230934
mutations O 1 0.999884843826294
had O 0 0.003098299028351903
no O 0 0.002311098389327526
reflection O 0 0.01181535329669714
on O 0 0.0017047483706846833
the O 0 0.005473623052239418
phenotype O 1 0.9999467134475708
. O 0 0.010359358042478561

All O 0 0.005789914168417454
patients O 1 0.9927870631217957
manifested O 0 0.3870931565761566
classical O 0 0.014642318710684776
A B-Disease 0 0.2808435559272766
- I-Disease 1 0.5866422653198242
T I-Disease 1 0.9991961121559143
and O 0 0.0027775601483881474
increased O 0 0.014912541024386883
cellular O 1 0.9985536932945251
radioresistant O 1 0.9945498108863831
DNA O 1 0.9982808828353882
synthesis O 1 0.9575662612915039
. O 0 0.008620535023510456

Determination O 0 0.01634146273136139
of O 0 0.0014845343539491296
the O 0 0.002443488920107484
genomic O 1 0.9984275102615356
structure O 0 0.007150357589125633
of O 0 0.0008748943218961358
the O 0 0.002681893529370427
COL4A4 O 1 0.9997138381004333
gene O 1 0.9992632269859314
and O 0 0.0011610182700678706
of O 0 0.0015591380652040243
novel O 1 0.8382770419120789
mutations O 1 0.9999977350234985
causing O 1 0.9999289512634277
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 0.9999964237213135
syndrome I-Disease 1 0.9999960660934448
. O 0 0.014542028307914734

Autosomal B-Disease 1 0.9999978542327881
recessive I-Disease 1 0.9999984502792358
Alport I-Disease 1 0.9999921321868896
syndrome I-Disease 1 0.9999959468841553
is O 0 0.004817022942006588
a O 0 0.010676585137844086
progressive O 1 0.900982677936554
hematuric B-Disease 1 0.9995195865631104
glomerulonephritis I-Disease 1 0.9999626874923706
characterized O 0 0.4029119312763214
by O 0 0.009071658365428448
glomerular B-Disease 1 0.9999730587005615
basement I-Disease 1 0.9872398972511292
membrane I-Disease 1 0.9997722506523132
abnormalities I-Disease 1 0.9999743700027466
and O 0 0.00240904139354825
associated O 0 0.009276107884943485
with O 0 0.0045428588055074215
mutations O 1 0.9999839067459106
in O 0 0.001597129157744348
either O 0 0.0031120998319238424
the O 0 0.002035193843767047
COL4A3 O 1 0.9975468516349792
or O 0 0.0038083416875451803
the O 0 0.003768670605495572
COL4A4 O 1 0.9997736811637878
gene O 1 0.9998637437820435
, O 0 0.001856040908023715
which O 0 0.0012729791924357414
encode O 0 0.04992002993822098
the O 0 0.0022398324217647314
alpha3 O 1 0.9628718495368958
and O 0 0.0030246637761592865
alpha4 O 1 0.9988227486610413
type O 1 0.9944711923599243
IV O 1 0.9998815059661865
collagen O 1 0.99998939037323
chains O 1 0.9810606241226196
, O 0 0.0032532676123082638
respectively O 0 0.007504537235945463
. O 0 0.0055653550662100315

To O 0 0.0029491293244063854
date O 0 0.005423978436738253
, O 0 0.004192193038761616
mutation O 1 0.9999808073043823
screening O 0 0.28246766328811646
in O 0 0.00114905321970582
the O 0 0.0011137000983580947
two O 0 0.003400212386623025
genes O 1 0.9995113611221313
has O 0 0.002218369860202074
been O 0 0.001932804356329143
hampered O 1 0.560334324836731
by O 0 0.001494433032348752
the O 0 0.0010651042684912682
lack O 0 0.00550667243078351
of O 0 0.0020368145778775215
genomic O 1 0.9998311996459961
structure O 0 0.019237296655774117
information O 0 0.00491739995777607
. O 0 0.005023842677474022

We O 0 0.0029154587537050247
report O 0 0.0020781808998435736
here O 0 0.0007704583695158362
the O 0 0.0010059730848297477
complete O 0 0.008087733760476112
characterization O 0 0.03099360503256321
of O 0 0.0008664712077006698
the O 0 0.001216283650137484
48 O 0 0.011416299268603325
exons O 1 0.9164980053901672
of O 0 0.001151756034232676
the O 0 0.0027186728548258543
COL4A4 O 1 0.9997782111167908
gene O 1 0.9998936653137207
, O 0 0.0014973361976444721
a O 0 0.0051256585866212845
comprehensive O 0 0.20168055593967438
gene O 1 0.9999302625656128
screen O 0 0.01838229037821293
, O 0 0.0009406319004483521
and O 0 0.0005628757062368095
the O 0 0.0010680370032787323
subsequent O 0 0.01516727264970541
detection O 1 0.8234555721282959
of O 0 0.0008865352720022202
10 O 0 0.003208655398339033
novel O 0 0.24862734973430634
mutations O 1 0.9999650716781616
in O 0 0.0024386702571064234
eight O 0 0.016674896702170372
patients O 1 0.9999936819076538
diagnosed O 1 0.9999964237213135
with O 1 0.7628970146179199
autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 0.9999998807907104
Alport I-Disease 1 0.9999958276748657
syndrome I-Disease 1 0.9999966621398926
. O 0 0.015207597054541111

Furthermore O 0 0.02815428003668785
, O 0 0.0015684830723330379
we O 0 0.0010652710916474462
identified O 0 0.005712427664548159
a O 0 0.005026326980441809
glycine O 1 0.9872727990150452
to O 0 0.0032013296149671078
alanine O 1 0.9931948184967041
substitution O 0 0.1798386573791504
in O 0 0.0016742766601964831
the O 0 0.002623089589178562
collagenous O 1 0.9998811483383179
domain O 0 0.03652981296181679
that O 0 0.001225251704454422
is O 0 0.0013353511458262801
apparently O 0 0.007652399595826864
silent O 0 0.012588202022016048
in O 0 0.0014458897057920694
the O 0 0.0033751847222447395
heterozygous O 1 0.9999110698699951
carriers O 1 0.9515547752380371
, O 0 0.0022020370233803988
in O 0 0.002122350037097931
11 O 0 0.00885616522282362
. O 0 0.005540876649320126

5 O 0 0.01072322390973568
% O 0 0.003752831369638443
of O 0 0.0007221949053928256
all O 0 0.0010022971546277404
control O 0 0.01269933395087719
individuals O 0 0.003909657709300518
, O 0 0.0009087389917112887
and O 0 0.0007216128869913518
in O 0 0.0009643518715165555
one O 0 0.0017251215176656842
control O 0 0.011243351735174656
individual O 0 0.008328733965754509
homozygous O 1 0.9991316199302673
for O 0 0.001980368746444583
this O 0 0.002432360779494047
glycine O 1 0.9943755865097046
substitution O 1 0.5852017402648926
. O 0 0.007177846971899271

There O 0 0.0037459549494087696
has O 0 0.0015566354850307107
been O 0 0.0012412769719958305
no O 0 0.0014771788846701384
previous O 0 0.002465513302013278
finding O 0 0.004608874674886465
of O 0 0.0007811491377651691
a O 0 0.005763917695730925
glycine O 1 0.9980958104133606
substitution O 1 0.7570008635520935
that O 0 0.001331055536866188
is O 0 0.0010698068654164672
not O 0 0.0009315201896242797
associated O 0 0.004924124572426081
with O 0 0.0015138741582632065
any O 0 0.002244005911052227
obvious O 0 0.30594244599342346
phenotype O 1 0.9999867677688599
in O 0 0.005838573910295963
homozygous O 1 0.9997096657752991
individuals O 0 0.012090938165783882
. O 0 0.006097879726439714

Founder O 1 0.721662700176239
BRCA1 O 1 0.9999576807022095
and O 0 0.017140425741672516
BRCA2 O 1 0.9999970197677612
mutations O 1 0.9998716115951538
in O 0 0.0035055980551987886
French O 0 0.015499739907681942
Canadian O 1 0.7445430159568787
breast B-Disease 1 0.9999978542327881
and I-Disease 1 0.8515793681144714
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 0.017942054197192192
. O 0 0.007376361638307571

We O 0 0.002674482297152281
have O 0 0.0011979823466390371
identified O 0 0.00630683870986104
four O 0 0.0038606319576501846
mutations O 1 0.9998975992202759
in O 0 0.0009590530535206199
each O 0 0.0008844098774716258
of O 0 0.0009435086976736784
the O 0 0.013642198406159878
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
- O 1 0.9959349632263184
susceptibility O 1 0.9999897480010986
genes O 1 0.9998223185539246
, O 0 0.0066557941026985645
BRCA1 O 1 0.999998927116394
and O 0 0.005902050528675318
BRCA2 O 1 0.9999972581863403
, O 0 0.001806447864510119
in O 0 0.0016770740039646626
French O 0 0.025837847962975502
Canadian O 1 0.9913401007652283
breast B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.999998927116394
and O 1 0.5273250341415405
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999884366989136
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999982118606567
families O 0 0.012268021702766418
from O 0 0.004224392585456371
Quebec O 0 0.03515291213989258
. O 0 0.007726235780864954

To O 0 0.005864323582500219
identify O 0 0.02234102599322796
founder O 0 0.044760122895240784
effects O 0 0.2689823508262634
, O 0 0.001410425640642643
we O 0 0.0010573549661785364
examined O 0 0.015899019315838814
independently O 0 0.010308751836419106
ascertained O 0 0.24671882390975952
French O 0 0.016139820218086243
Canadian O 0 0.2764177620410919
cancer B-Disease 1 0.999993085861206
families O 0 0.0050162021070718765
for O 0 0.0009181083296425641
the O 0 0.0010403121123090386
distribution O 0 0.005405209958553314
of O 0 0.0007266883621923625
these O 0 0.0018005282618105412
eight O 0 0.011515387333929539
mutations O 1 0.9999678134918213
. O 0 0.009298370219767094

Mutations O 1 0.9994841814041138
were O 0 0.002849287586286664
found O 0 0.004364024382084608
in O 0 0.0016968036070466042
41 O 0 0.012353921309113503
of O 0 0.002099250443279743
97 O 0 0.026950225234031677
families O 0 0.009550039656460285
. O 0 0.007325104437768459

Six O 0 0.005956664681434631
of O 0 0.0017623603343963623
eight O 0 0.008286847732961178
mutations O 1 0.9999043941497803
were O 0 0.0016541192308068275
observed O 0 0.0077833011746406555
at O 0 0.002405200619250536
least O 0 0.003912585787475109
twice O 0 0.009399398230016232
. O 0 0.006198883056640625

The O 0 0.022234728559851646
BRCA1 O 1 0.9999845027923584
C4446T O 1 0.998542308807373
mutation O 1 0.9998716115951538
was O 0 0.0022510287817567587
the O 0 0.0008750995039008558
most O 0 0.001537987613119185
common O 0 0.29926857352256775
mutation O 1 0.9999940395355225
found O 0 0.006546325515955687
, O 0 0.0011688488302752376
followed O 0 0.0038309928495436907
by O 0 0.0024168819654732943
the O 0 0.006811697501689196
BRCA2 O 1 0.9999969005584717
8765delAG O 1 0.9993278980255127
mutation O 1 0.9998847246170044
. O 0 0.011883883737027645

Together O 0 0.007046264596283436
, O 0 0.0018117143772542477
these O 0 0.002621687715873122
mutations O 1 0.999923586845398
were O 0 0.001101905363611877
found O 0 0.003185039618983865
in O 0 0.0009714122279547155
28 O 0 0.004020694177597761
of O 0 0.0010693290969356894
41 O 0 0.012595736421644688
families O 0 0.0050577325746417046
identified O 0 0.006881697569042444
to O 0 0.0009672941523604095
have O 0 0.0012799107935279608
a O 0 0.011635410599410534
mutation O 1 0.999954342842102
. O 0 0.006896865088492632

The O 0 0.004760951269418001
odds O 0 0.02045578509569168
of O 0 0.0016095340251922607
detection O 0 0.2593958377838135
of O 0 0.0007081101648509502
any O 0 0.0008231072570197284
of O 0 0.0005222007166594267
the O 0 0.0017604520544409752
four O 0 0.011963926255702972
BRCA1 O 1 0.9999997615814209
mutations O 1 0.9999724626541138
was O 0 0.004180776886641979
18 O 0 0.0069304946810007095
. O 0 0.006037409882992506

7x O 1 0.9949737787246704
greater O 0 0.011629435233771801
if O 0 0.0021357140503823757
one O 0 0.001197475241497159
or O 0 0.0020535383373498917
more O 0 0.0015045960899442434
cases O 0 0.012632629834115505
of O 0 0.03030352294445038
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999991655349731
were O 0 0.0013704415177926421
also O 0 0.0009762694244273007
present O 0 0.001830604742281139
in O 0 0.001253431080840528
the O 0 0.0018749535083770752
family O 0 0.012586050666868687
. O 0 0.006861469708383083

The O 0 0.004249083809554577
odds O 0 0.020245103165507317
of O 0 0.001648575533181429
detection O 0 0.4646584987640381
of O 0 0.0007663077558390796
any O 0 0.000944502477068454
of O 0 0.0005880427197553217
the O 0 0.0018102972535416484
four O 0 0.011991680599749088
BRCA2 O 1 0.9999995231628418
mutations O 1 0.9999663829803467
was O 0 0.004712823778390884
5 O 0 0.009508000686764717
. O 0 0.00584523705765605

3x O 1 0.969176709651947
greater O 0 0.011570554226636887
if O 0 0.0020701370667666197
there O 0 0.0006314037600532174
were O 0 0.0003896266862284392
at O 0 0.0009960263269022107
least O 0 0.0018167285015806556
five O 0 0.002248433418571949
cases O 0 0.009369755163788795
of O 0 0.006936115212738514
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999979734420776
in O 0 0.001863884273916483
the O 0 0.0022320407442748547
family O 0 0.014061300083994865
. O 0 0.006796472705900669

Interestingly O 0 0.06889013946056366
, O 0 0.0017901608953252435
the O 0 0.0009892157977446914
presence O 0 0.004748519975692034
of O 0 0.0019086599349975586
a O 1 0.8614321947097778
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999995231628418
case O 0 0.06590273231267929
< O 1 0.9950295090675354
36 O 0 0.010607396252453327
years O 0 0.0015728987054899335
of O 0 0.0008320315391756594
age O 0 0.0035315253771841526
was O 0 0.0017845543334260583
strongly O 0 0.005842491984367371
predictive O 1 0.9950528740882874
of O 0 0.0006771479966118932
the O 0 0.0008792593143880367
presence O 0 0.0037239687517285347
of O 0 0.0005512501229532063
any O 0 0.0009729169541969895
of O 0 0.0005955628585070372
the O 0 0.0017699431627988815
eight O 0 0.010437159799039364
mutations O 1 0.999983549118042
screened O 0 0.15548619627952576
. O 0 0.007380272727459669

Carriers O 0 0.06008978560566902
of O 0 0.0012482271995395422
the O 0 0.0015511579113081098
same O 0 0.006971779745072126
mutation O 1 0.9999897480010986
, O 0 0.0016486389795318246
from O 0 0.0010660203406587243
different O 0 0.0014241284225136042
families O 0 0.0033837927039712667
, O 0 0.0011477285297587514
shared O 0 0.0059539442881941795
similar O 0 0.012247688136994839
haplotypes O 1 0.9999158382415771
, O 0 0.0017526453593745828
indicating O 0 0.010597982443869114
that O 0 0.0009924108162522316
the O 0 0.002465649275109172
mutant O 1 0.9998605251312256
alleles O 1 0.9996269941329956
were O 0 0.0015302101382985711
likely O 0 0.003596504218876362
to O 0 0.0007841120823286474
be O 0 0.0008847361314110458
identical O 0 0.011506306007504463
by O 0 0.0018573594279587269
descent O 0 0.012470372021198273
for O 0 0.0015965162310749292
a O 0 0.010711210779845715
mutation O 1 0.99997878074646
in O 0 0.0018334412015974522
the O 0 0.002235777908936143
founder O 0 0.023962847888469696
population O 0 0.005177732557058334
. O 0 0.00702992919832468

The O 0 0.0030559522565454245
identification O 0 0.011833371594548225
of O 0 0.0019324521999806166
common O 0 0.08087608218193054
BRCA1 O 1 0.9999960660934448
and O 0 0.013183978386223316
BRCA2 O 1 0.9999994039535522
mutations O 1 0.9999440908432007
will O 0 0.002410382265225053
facilitate O 0 0.023848216980695724
carrier O 1 0.6416990160942078
detection O 1 0.8095805644989014
in O 0 0.0019489688565954566
French O 0 0.026413707062602043
Canadian O 1 0.9899926781654358
breast B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999996423721313
and O 0 0.4705434739589691
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999855756759644
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999983310699463
families O 0 0.022890126332640648
. O 0 0.008952072821557522

Are O 0 0.006335909944027662
Dp71 O 1 0.8958972096443176
and O 0 0.005814490839838982
Dp140 O 1 0.998015284538269
brain O 1 0.9999072551727295
dystrophin O 1 0.9997956156730652
isoforms O 1 0.9950756430625916
related O 0 0.015385786071419716
to O 0 0.0037119868211448193
cognitive B-Disease 1 0.9986579418182373
impairment I-Disease 1 0.9998226761817932
in O 0 0.021519729867577553
Duchenne B-Disease 1 0.9999986886978149
muscular I-Disease 1 0.999985933303833
dystrophy I-Disease 1 0.9999910593032837
? O 0 0.09483971446752548

Molecular O 1 0.9872791767120361
study O 0 0.01223483681678772
and O 0 0.0029986596200615168
neuropsychological O 1 0.9991775155067444
analysis O 0 0.009894018061459064
were O 0 0.0008611652301624417
performed O 0 0.004984128288924694
concurrently O 0 0.0069381254725158215
on O 0 0.002374344738200307
49 O 0 0.050052620470523834
patients O 1 0.9995729327201843
with O 0 0.0352349691092968
Duchenne B-Disease 1 0.999998927116394
muscular I-Disease 1 0.9999971389770508
dystrophy I-Disease 1 0.9999990463256836
( O 0 0.11942237615585327
DMD B-Disease 1 0.9999985694885254
) O 0 0.004879748448729515
in O 0 0.0011161556467413902
order O 0 0.002231948310509324
to O 0 0.0009923620382323861
find O 0 0.003493399592116475
a O 0 0.005283809266984463
molecular O 1 0.9976208806037903
explanation O 0 0.010290863923728466
for O 0 0.001195777440443635
the O 0 0.002751013031229377
cognitive B-Disease 1 0.9995730519294739
impairment I-Disease 1 0.9997425675392151
observed O 0 0.012943712063133717
in O 0 0.0028421138413250446
most O 0 0.009769251570105553
DMD B-Disease 1 0.999997615814209
patients O 1 0.9993312358856201
. O 0 0.011167588643729687

Complete O 0 0.015588133595883846
analysis O 0 0.0070408061146736145
of O 0 0.0008559988928027451
the O 0 0.004117198288440704
dystrophin O 1 0.9999940395355225
gene O 1 0.9998767375946045
was O 0 0.0024352760519832373
performed O 0 0.0039026017766445875
to O 0 0.0009494731202721596
define O 0 0.006681273691356182
the O 0 0.0013020080514252186
localization O 1 0.7100969552993774
of O 0 0.002304140478372574
deletions O 1 0.9971780776977539
and O 0 0.002508023288100958
duplications O 1 0.9985963702201843
in O 0 0.0017341584898531437
relation O 0 0.00709883775562048
to O 0 0.0008738854667171836
the O 0 0.0015723579563200474
different O 0 0.009335705079138279
DMD B-Disease 1 0.9999958276748657
promoters O 1 0.8801002502441406
. O 0 0.009624076075851917

Qualitative O 0 0.06834010779857635
analysis O 0 0.011661526747047901
of O 0 0.0011175483232364058
the O 0 0.002833553357049823
Dp71 O 1 0.9981334805488586
transcript O 1 0.7003426551818848
and O 0 0.001953120343387127
testing O 0 0.015703221783041954
for O 0 0.000959667784627527
the O 0 0.0010745825711637735
specific O 0 0.00425207894295454
first O 0 0.002918133744969964
exon O 1 0.9967239499092102
of O 0 0.0024231949355453253
Dp140 O 1 0.9288621544837952
were O 0 0.001176380319520831
also O 0 0.0014233826659619808
carried O 0 0.006276349537074566
out O 0 0.004879247862845659
. O 0 0.006873405538499355

Neuropsychological O 1 0.9942252039909363
analysis O 0 0.03265834599733353
assessed O 0 0.02401726134121418
verbal O 0 0.0407915860414505
and O 0 0.0039556329138576984
visuospatial O 1 0.9992557168006897
intelligence O 0 0.01906590722501278
, O 0 0.0023925572168082
verbal O 0 0.43642598390579224
memory O 0 0.24576610326766968
, O 0 0.0017078242963179946
and O 0 0.0011695781722664833
reading O 0 0.007055739872157574
skills O 0 0.016884777694940567
. O 0 0.005428454373031855

Comparison O 0 0.015276715159416199
of O 0 0.002476464956998825
molecular O 1 0.989871084690094
and O 0 0.0024494833778589964
psychometric O 1 0.9980002045631409
findings O 0 0.01156407780945301
demonstrated O 0 0.008631446398794651
that O 0 0.002051549730822444
deletions O 1 0.9944679737091064
and O 0 0.002336458070203662
duplications O 1 0.997055172920227
that O 0 0.0013381061144173145
were O 0 0.0010838463203981519
localized O 1 0.9951453804969788
in O 0 0.0014009904116392136
the O 0 0.0020534212235361338
distal O 1 0.9998779296875
part O 0 0.002123481361195445
of O 0 0.0007899329648353159
the O 0 0.0026600798591971397
gene O 1 0.9999685287475586
seemed O 0 0.005488571245223284
to O 0 0.0008312381105497479
be O 0 0.0014085397124290466
preferentially O 1 0.9160352945327759
associated O 0 0.010810612700879574
with O 0 0.006076479330658913
cognitive B-Disease 1 0.9996055960655212
impairment I-Disease 1 0.9996716976165771
. O 0 0.00895529892295599

Two O 0 0.010904718190431595
altered O 0 0.09016932547092438
Dp71 O 1 0.9103590250015259
transcripts O 0 0.0286207627505064
and O 0 0.0014742291532456875
two O 0 0.0031439638696610928
deleted O 0 0.4439197778701782
Dp140 O 1 0.9972336888313293
DNA O 1 0.998860239982605
sequences O 0 0.029533030465245247
were O 0 0.0006643494125455618
found O 0 0.0028228810988366604
in O 0 0.0013140185037627816
four O 0 0.0059686144813895226
patients O 1 0.9999359846115112
with O 0 0.01918017491698265
severe O 1 0.9999655485153198
cerebral B-Disease 1 0.9999955892562866
dysfunction I-Disease 1 0.9999904632568359
. O 0 0.014126031659543514

These O 0 0.004342804662883282
findings O 0 0.010862994939088821
suggest O 0 0.00626520998775959
that O 0 0.00091869494644925
some O 0 0.0012849461054429412
sequences O 0 0.04366954416036606
located O 0 0.0020336739253252745
in O 0 0.0009303780971094966
the O 0 0.0018539662705734372
distal O 1 0.9996908903121948
part O 0 0.002183144213631749
of O 0 0.00080569350393489
the O 0 0.0032010392751544714
gene O 1 0.9999775886535645
and O 0 0.001212793285958469
, O 0 0.0008413497125729918
in O 0 0.0008937308448366821
particular O 0 0.0031484419014304876
, O 0 0.0010689094197005033
some O 0 0.003149106167256832
DMD B-Disease 1 0.9999978542327881
isoforms O 1 0.9941402077674866
expressed O 0 0.004136497154831886
in O 0 0.0013845880748704076
the O 0 0.0032257544808089733
brain O 1 0.9999884366989136
may O 0 0.004199379123747349
be O 0 0.0009588904795236886
related O 0 0.003975763451308012
to O 0 0.0008953980868682265
the O 0 0.0023443251848220825
cognitive B-Disease 1 0.9998834133148193
impairment I-Disease 1 0.999963641166687
associated O 0 0.021607117727398872
with O 0 0.011657525785267353
DMD B-Disease 1 0.9999953508377075
. O 0 0.00602387310937047
. O 0 0.006145878694951534

I1307K O 1 0.9654285907745361
APC O 1 0.9926539659500122
and O 0 0.008217637427151203
hMLH1 O 1 0.997568666934967
mutations O 1 0.9998748302459717
in O 0 0.002511062193661928
a O 0 0.0058049471117556095
non O 0 0.010226459242403507
- O 0 0.014799319207668304
Jewish O 0 0.0073554678820073605
family O 0 0.008704124018549919
with O 0 0.006514988839626312
hereditary B-Disease 1 0.9999125003814697
non I-Disease 1 0.8905521631240845
- I-Disease 1 0.9998194575309753
polyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999934434890747
. O 0 0.01827211305499077

We O 0 0.003044459270313382
describe O 0 0.007937517948448658
a O 0 0.003986738156527281
French O 0 0.009649651125073433
Canadian O 0 0.017426418140530586
hereditary B-Disease 1 0.9998464584350586
non I-Disease 1 0.9132150411605835
- I-Disease 1 0.9998657703399658
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
( O 0 0.04115478694438934
HNPCC B-Disease 1 0.9999938011169434
) O 0 0.009276476688683033
kindred O 1 0.9870471954345703
which O 0 0.002175553934648633
carries O 0 0.011408002115786076
a O 0 0.005886758212000132
novel O 0 0.033512555062770844
truncating O 1 0.9993973970413208
mutation O 1 0.9998918771743774
in O 0 0.006922603119164705
hMLH1 O 1 0.9799668192863464
. O 0 0.00996160227805376

Interestingly O 0 0.0774790421128273
, O 0 0.0032922655809670687
the O 0 0.004076370503753424
I1307K O 1 0.9983048439025879
APC O 1 0.9997979998588562
polymorphism O 1 0.9982215762138367
, O 0 0.002252410864457488
associated O 0 0.005063795018941164
with O 0 0.0013464732328429818
an O 0 0.0013947747647762299
increased O 0 0.011523738503456116
risk O 1 0.9993773102760315
of O 0 0.37762773036956787
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 0.002454437781125307
is O 0 0.0011240023886784911
also O 0 0.0006856739055365324
present O 0 0.0015442173462361097
in O 0 0.0011030592722818255
this O 0 0.001668752753175795
family O 0 0.012098493054509163
. O 0 0.005087776575237513

The O 0 0.009428287856280804
I1307K O 1 0.9903385043144226
polymorphism O 1 0.9950180053710938
has O 0 0.0028721948619931936
previously O 0 0.0024289849679917097
only O 0 0.0008586010662838817
been O 0 0.0011846330016851425
identified O 0 0.005799382925033569
in O 0 0.0011054587084800005
individuals O 0 0.002702099969610572
of O 0 0.001507801003754139
self O 0 0.025732165202498436
- O 0 0.05396301671862602
reported O 0 0.017653491348028183
Ashkenazi O 1 0.9555785059928894
Jewish O 0 0.012792842462658882
origins O 0 0.036301139742136
. O 0 0.00880464818328619

In O 0 0.005030261352658272
addition O 0 0.004113778006285429
, O 0 0.0010366445640102029
in O 0 0.0009773076744750142
this O 0 0.0013650910696014762
family O 0 0.00618252158164978
, O 0 0.001099073444493115
there O 0 0.0008565468015149236
appears O 0 0.005378406494855881
to O 0 0.0007512347074225545
be O 0 0.0008980788988992572
no O 0 0.0018180272309109569
relationship O 0 0.00759465154260397
between O 0 0.0014697711449116468
the O 0 0.0020164386369287968
I1307K O 1 0.9992403984069824
polymorphism O 1 0.9987733960151672
and O 0 0.0008190157823264599
the O 0 0.0010504188248887658
presence O 0 0.006320800166577101
or O 0 0.003150220261886716
absence O 0 0.0266827791929245
of O 0 0.005082218442112207
cancer B-Disease 1 0.9999980926513672
. O 0 0.0038861208595335484
. O 0 0.006553194485604763

Identification O 0 0.025950629264116287
of O 0 0.0014806278049945831
a O 0 0.005745436530560255
novel O 0 0.022204427048563957
mutation O 1 0.9996910095214844
of O 0 0.0013224820140749216
the O 0 0.0028234084602445364
CPO O 1 0.997409999370575
gene O 1 0.9993627667427063
in O 0 0.002404365688562393
a O 0 0.00652683898806572
Japanese O 0 0.01640891097486019
hereditary B-Disease 1 0.9996583461761475
coproporphyria I-Disease 1 0.9945245981216431
family O 0 0.024240508675575256
. O 0 0.006810407619923353

Hereditary B-Disease 1 0.999377965927124
coproporphyria I-Disease 1 0.9966970682144165
( O 0 0.01866770163178444
HCP B-Disease 1 0.9998589754104614
) O 0 0.005533821415156126
is O 0 0.0023090019822120667
an O 0 0.006176840513944626
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9988197684288025
disease I-Disease 1 0.9999879598617554
characterized O 0 0.18404091894626617
by O 0 0.0028089203406125307
a O 0 0.013294201344251633
deficiency B-Disease 1 0.9999953508377075
of I-Disease 0 0.0038648357149213552
coproporphyrinogen I-Disease 1 0.9996166229248047
oxidase I-Disease 1 0.9998879432678223
( O 0 0.008943299762904644
CPO O 1 0.986562967300415
) O 0 0.0051918597891926765
caused O 0 0.025056418031454086
by O 0 0.002242172369733453
a O 0 0.008252914063632488
mutation O 1 0.9999233484268188
in O 0 0.0015602102503180504
the O 0 0.0034085921943187714
CPO O 1 0.9977582097053528
gene O 1 0.9996494054794312
. O 0 0.011592826806008816

Only O 0 0.004412025213241577
11 O 0 0.010279129259288311
mutations O 1 0.9992864727973938
of O 0 0.0010260269045829773
the O 0 0.002622646978124976
gene O 1 0.9999266862869263
have O 0 0.0016154159093275666
been O 0 0.0017348023829981685
reported O 0 0.007937472313642502
in O 0 0.007904640398919582
HCP B-Disease 1 0.9999746084213257
patients O 1 0.9990242719650269
. O 0 0.007847984321415424

We O 0 0.0038962471298873425
report O 0 0.0038394455332309008
another O 0 0.009206334128975868
mutation O 1 0.9998466968536377
in O 0 0.0025170829612761736
a O 0 0.005495828110724688
Japanese O 0 0.008743466809391975
family O 0 0.014864103868603706
. O 0 0.006450595334172249

Polymerase O 1 0.9969038367271423
chain O 1 0.7676776647567749
reaction O 0 0.10898011177778244
- O 0 0.020299475640058517
single O 0 0.019957395270466805
strand O 1 0.9969332218170166
conformational O 1 0.9987733960151672
polymorphism O 1 0.9912399649620056
and O 0 0.0016056523891165853
direct O 0 0.007080657873302698
sequence O 0 0.041880857199430466
analyses O 0 0.01725815236568451
demonstrated O 0 0.008513177745044231
a O 0 0.0061486633494496346
C O 1 0.5878595113754272
to O 0 0.0041451724246144295
T O 1 0.9992951154708862
substitution O 0 0.3111303448677063
in O 0 0.003018415765836835
exon O 1 0.9902758598327637
1 O 0 0.004308051895350218
of O 0 0.0008630887605249882
the O 0 0.0018399389227852225
CPO O 1 0.9969978332519531
gene O 1 0.9995706677436829
at O 0 0.005379799287766218
nucleotide O 1 0.9939509630203247
position O 0 0.00440095504745841
85 O 0 0.009887597523629665
, O 0 0.0010780914453789592
which O 0 0.0008588375640101731
lies O 0 0.002920278115198016
in O 0 0.0010726924519985914
the O 0 0.002310555661097169
putative O 1 0.9986438155174255
presequence O 1 0.9741477966308594
for O 0 0.0025605405680835247
targeting O 0 0.01790902391076088
to O 0 0.0037374633830040693
mitochondria O 1 0.9982625842094421
. O 0 0.009015478193759918

This O 0 0.008931814692914486
mutation O 1 0.9995684027671814
changes O 0 0.007382055278867483
the O 0 0.0019984031096100807
codon O 1 0.9310203790664673
for O 0 0.003980252891778946
glutamine O 1 0.9547611474990845
to O 0 0.0021863437723368406
a O 0 0.0073599983006715775
termination O 1 0.9851506352424622
codon O 1 0.9059944152832031
at O 0 0.006865653675049543
amino O 1 0.9802764654159546
acid O 1 0.9930765628814697
position O 0 0.0061788782477378845
29 O 0 0.013573904521763325
. O 0 0.00569856446236372

MaeI O 1 0.9230002164840698
restriction O 0 0.04558805748820305
analysis O 0 0.014455661177635193
showed O 0 0.005647614132612944
two O 0 0.001826824271120131
other O 0 0.0016433538403362036
carriers O 0 0.18944606184959412
in O 0 0.0016272213542833924
the O 0 0.0020974972285330296
family O 0 0.012970172800123692
. O 0 0.006814140360802412

The O 0 0.011790591292083263
C O 1 0.996192216873169
- O 1 0.9801895022392273
T O 1 0.9999008178710938
mutation O 1 0.9999470710754395
is O 0 0.0020987000316381454
located O 0 0.002010210882872343
within O 0 0.0016732177464291453
a O 0 0.003261677687987685
recently O 0 0.005686774849891663
proposed O 0 0.009692462161183357
putative O 1 0.9743402600288391
alternative O 0 0.016796935349702835
translation O 0 0.025139138102531433
initiation O 1 0.9902576208114624
codon O 1 0.9944479465484619
( O 0 0.016970014199614525
TIC O 1 0.9999037981033325
- O 0 0.036284543573856354
1 O 0 0.00834097433835268
) O 0 0.002961017657071352
, O 0 0.0011715245200321078
supporting O 0 0.0068323686718940735
that O 0 0.004175188485532999
TIC O 1 0.9999042749404907
- O 0 0.02265079878270626
1 O 0 0.005691052880138159
is O 0 0.0013265034649521112
the O 0 0.0016142081003636122
real O 0 0.012889264151453972
TIC O 1 0.9994615912437439
rather O 0 0.007720404304563999
than O 0 0.006875303573906422
TIC O 1 0.9999526739120483
- O 0 0.03506316989660263
2 O 0 0.010579644702374935
. O 0 0.002944986103102565
. O 0 0.005145324394106865

Human B-Disease 0 0.030024128034710884
complement I-Disease 1 0.5633736848831177
factor I-Disease 1 0.9783040285110474
H I-Disease 1 0.9998952150344849
deficiency I-Disease 1 0.9999979734420776
associated O 0 0.21795132756233215
with O 1 0.6669115424156189
hemolytic B-Disease 1 1.0
uremic I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999947547912598
. O 0 0.017940165475010872

This O 0 0.0031516922172158957
study O 0 0.004734771326184273
reports O 0 0.001964715775102377
on O 0 0.0007763713365420699
six O 0 0.002824449213221669
cases O 0 0.0062163653783500195
of O 0 0.0031444330234080553
deficiency B-Disease 1 0.9999983310699463
in I-Disease 0 0.001309044542722404
the I-Disease 0 0.0010277506662532687
human I-Disease 0 0.00886908732354641
complement I-Disease 1 0.5925564765930176
regulatory I-Disease 1 0.9803534746170044
protein I-Disease 1 0.9996868371963501
Factor I-Disease 1 0.9852283000946045
H I-Disease 1 0.999555766582489
( O 0 0.010717513039708138
FH O 1 0.9999276399612427
) O 0 0.003325148019939661
in O 0 0.0006799601251259446
the O 0 0.0008341263746842742
context O 0 0.00477723078802228
of O 0 0.0017429207218810916
an O 0 0.03185001388192177
acute B-Disease 1 0.9999994039535522
renal I-Disease 1 1.0
disease I-Disease 1 0.9999954700469971
. O 0 0.014790402725338936

Five O 0 0.004735550377517939
of O 0 0.0009311407920904458
the O 0 0.0015786534640938044
cases O 0 0.006015256978571415
were O 0 0.0009569611283950508
observed O 0 0.005457115359604359
in O 0 0.001312640612013638
children O 0 0.007516007404774427
presenting O 0 0.07090013474225998
with O 1 0.577933669090271
idiopathic O 1 0.9999998807907104
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 0.9999996423721313
( O 0 0.03053196892142296
HUS B-Disease 1 0.9999700784683228
) O 0 0.010294371284544468
. O 0 0.006289133336395025

Two O 0 0.0027621209155768156
of O 0 0.000809342775028199
the O 0 0.001164706307463348
children O 0 0.006582883186638355
exhibited O 0 0.010411722585558891
a O 0 0.019522611051797867
homozygous O 1 0.9999920129776001
deficiency O 1 0.9999986886978149
characterized O 0 0.31071576476097107
by O 0 0.0019633176270872355
the O 0 0.0011102453572675586
absence O 0 0.0075376289896667
of O 0 0.0007399257738143206
the O 0 0.0014300510520115495
150 O 0 0.009553391486406326
- O 0 0.07549718022346497
kD O 1 0.9959654808044434
form O 0 0.009833309799432755
of O 0 0.0017673283582553267
Factor O 1 0.8770520091056824
H O 1 0.9963330030441284
and O 0 0.0012655978789553046
the O 0 0.0011830668663606048
presence O 0 0.006083493120968342
, O 0 0.0012812296627089381
upon O 0 0.0031918257009238005
immunoblotting O 1 0.9865596294403076
, O 0 0.0008905109134502709
of O 0 0.0005719599430449307
the O 0 0.0015773928025737405
42 O 0 0.02739184908568859
- O 0 0.23845136165618896
kD O 1 0.9990296363830566
Factor O 1 0.7708214521408081
H O 1 0.9971964359283447
- O 0 0.02426459640264511
like O 0 0.010797164402902126
protein O 1 0.9976671934127808
1 O 0 0.009415541775524616
( O 0 0.008565336465835571
FHL O 1 0.9999008178710938
- O 0 0.024244388565421104
1 O 0 0.005092427600175142
) O 0 0.0019133440218865871
and O 0 0.0008813961176201701
other O 0 0.0028669785242527723
FH O 1 0.9999809265136719
- O 0 0.10029025375843048
related O 0 0.0716109499335289
protein O 1 0.9995860457420349
( O 0 0.009235267527401447
FHR O 1 0.9980839490890503
) O 0 0.00589581998065114
bands O 0 0.0139335747808218
. O 0 0.00615040585398674

Southern O 0 0.024068668484687805
blot O 1 0.8082075715065002
and O 0 0.004803596064448357
PCR O 1 0.9971965551376343
analysis O 0 0.011303645558655262
of O 0 0.0013713521184399724
DNA O 1 0.9969345331192017
of O 0 0.001112772268243134
one O 0 0.003220620797947049
patient O 1 0.9991219639778137
with O 0 0.011170990765094757
homozygous O 1 0.9999946355819702
deficiency O 1 0.9999979734420776
ruled O 0 0.014353143982589245
out O 0 0.0016091135330498219
the O 0 0.0008345262613147497
presence O 0 0.004311812110245228
of O 0 0.0006833932129666209
a O 0 0.003158716019243002
large O 0 0.004178413189947605
deletion O 1 0.998812198638916
of O 0 0.0012311472091823816
the O 0 0.00380855705589056
FH O 1 0.9999839067459106
gene O 1 0.999854564666748
as O 0 0.0016005131183192134
the O 0 0.001683893846347928
underlying O 1 0.8852580785751343
defect O 1 0.9993470311164856
for O 0 0.0032809146214276552
the O 0 0.007960474118590355
deficiency O 1 0.9999964237213135
. O 0 0.00989214051514864

The O 0 0.0028197660576552153
other O 0 0.0011064838618040085
four O 0 0.0018825121223926544
children O 0 0.004321665037423372
presented O 0 0.004205632023513317
with O 0 0.007744591683149338
heterozygous O 1 0.9999909400939941
deficiency O 1 0.9999983310699463
and O 0 0.002009510761126876
exhibited O 0 0.008365417830646038
a O 0 0.005887378007173538
normal O 0 0.05076640471816063
immunoblotting O 1 0.9581608176231384
pattern O 0 0.030575407668948174
of O 0 0.0018198590259999037
proteins O 1 0.9327759742736816
of O 0 0.0013405093923211098
the O 0 0.004587164148688316
FH O 1 0.9999027252197266
family O 0 0.024426521733403206
. O 0 0.008137079887092113

Factor B-Disease 1 0.9876666069030762
H I-Disease 1 0.9998455047607422
deficiency I-Disease 1 0.9999891519546509
is O 0 0.001980671426281333
the O 0 0.0013496695319190621
only O 0 0.0031286238227039576
complement B-Disease 1 0.9997236132621765
deficiency I-Disease 1 0.9999996423721313
associated O 0 0.027217773720622063
with O 0 0.010184264741837978
HUS B-Disease 1 0.9998277425765991
. O 0 0.012852448038756847

These O 0 0.0038190989289432764
observations O 0 0.008571663871407509
suggest O 0 0.008040848188102245
a O 0 0.004522196017205715
role O 0 0.005963532719761133
for O 0 0.003650458762422204
FH O 1 0.9999597072601318
and O 0 0.00460547860711813
/ O 1 0.9186789393424988
or O 0 0.011608385480940342
FH O 1 0.9999037981033325
receptors O 1 0.9936138987541199
in O 0 0.0018327345605939627
the O 0 0.0035086728166788816
pathogenesis O 1 0.9999785423278809
of O 0 0.009230168536305428
idiopathic O 1 0.9999979734420776
HUS B-Disease 1 0.9999747276306152
. O 0 0.007453217636793852
. O 0 0.0075621772557497025

Further O 0 0.007164664100855589
evidence O 0 0.0032490012235939503
for O 0 0.0012902619782835245
a O 0 0.003521351143717766
major O 0 0.006080184131860733
ancient O 0 0.010090638883411884
mutation O 1 0.999990701675415
underlying O 1 0.9992961883544922
myotonic B-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999978542327881
from O 0 0.010210755281150341
linkage O 1 0.9993317723274231
disequilibrium O 1 0.9996235370635986
studies O 0 0.011750761419534683
in O 0 0.0010979901999235153
the O 0 0.0013580478262156248
Japanese O 0 0.006044229958206415
population O 0 0.004105271305888891
. O 0 0.006382067687809467

The O 0 0.03301851451396942
myotonic B-Disease 1 0.9999940395355225
dystrophy I-Disease 1 0.9999984502792358
( O 0 0.039065271615982056
DM B-Disease 1 0.9999809265136719
) O 0 0.01295880414545536
mutation O 1 0.9999395608901978
is O 0 0.0023633004166185856
an O 0 0.0027501003351062536
unstable O 1 0.9824851751327515
( O 0 0.00911716092377901
CTG O 1 0.9994865655899048
) O 0 0.006417947821319103
n O 0 0.09162382781505585
repeat O 0 0.2849422097206116
, O 0 0.0011692189145833254
present O 0 0.0013637292431667447
at O 0 0.0012043293099850416
a O 0 0.0036297780461609364
copy O 0 0.01148191373795271
number O 0 0.0010626263683661819
of O 0 0.0011415188200771809
5 O 0 0.008850181475281715
- O 0 0.014959685504436493
37 O 0 0.016656851395964622
repeats O 0 0.04926007241010666
on O 0 0.0025655985809862614
normal O 0 0.030009614303708076
chromosomes O 1 0.9966499209403992
but O 0 0.002558852080255747
amplified O 0 0.08532583713531494
to O 0 0.0018598558381199837
50 O 0 0.00658371252939105
- O 0 0.018177542835474014
3000 O 0 0.04632704704999924
copies O 0 0.010629096999764442
on O 0 0.00610309885814786
DM B-Disease 1 0.9999517202377319
chromosomes O 1 0.9979367256164551
. O 0 0.009230278432369232

Previous O 0 0.010538369417190552
findings O 0 0.012183316051959991
in O 0 0.0030916049145162106
Caucasian O 1 0.9920543432235718
populations O 0 0.01422863733023405
of O 0 0.0017190580256283283
a O 0 0.01356599573045969
DM B-Disease 1 0.9999817609786987
founder O 1 0.8519719839096069
chromosome O 1 0.9999663829803467
raise O 0 0.011068438179790974
a O 0 0.0034353812225162983
question O 0 0.0019731796346604824
about O 0 0.0006975349970161915
the O 0 0.0014955676160752773
molecular O 1 0.9982540011405945
events O 0 0.004084109794348478
involved O 0 0.003493422642350197
in O 0 0.0009147539385594428
the O 0 0.0018318570218980312
expansion O 0 0.057476483285427094
mutation O 1 0.9999724626541138
. O 0 0.007758663967251778

To O 0 0.00399977108463645
investigate O 0 0.00896516814827919
whether O 0 0.0038193061482161283
a O 0 0.007269904483109713
founder O 0 0.051408302038908005
chromosome O 1 0.9997957348823547
for O 0 0.0026343057397753
the O 0 0.006502023432403803
DM B-Disease 1 0.9999970197677612
mutation O 1 0.9999929666519165
exists O 0 0.01052420400083065
in O 0 0.0008825386175885797
the O 0 0.001024203491397202
Japanese O 0 0.003371540689840913
population O 0 0.0018737217178568244
, O 0 0.001101798377931118
we O 0 0.00134093570522964
genotyped O 1 0.8657055497169495
families O 0 0.006769529078155756
using O 0 0.010343511588871479
polymorphic O 1 0.9995895028114319
markers O 0 0.25316280126571655
near O 0 0.005283413454890251
the O 0 0.002027059206739068
( O 0 0.007356877904385328
CTG O 1 0.9995224475860596
) O 0 0.005652843974530697
n O 0 0.034431807696819305
repeat O 0 0.05147269368171692
region O 0 0.00391803402453661
and O 0 0.0016074328450486064
constructed O 0 0.01597653515636921
haplotypes O 1 0.9994935989379883
. O 0 0.008677174337208271

Six O 0 0.010314319282770157
different O 0 0.005299270153045654
haplotypes O 1 0.9968721270561218
were O 0 0.001613754779100418
found O 0 0.0054175700061023235
and O 0 0.004061584360897541
DM B-Disease 1 0.9999864101409912
alleles O 1 0.999735414981842
were O 0 0.0017776340246200562
always O 0 0.006144361104816198
haplotype O 1 0.999690055847168
A O 0 0.015489527024328709
. O 0 0.00618861336261034

To O 0 0.0029475141782313585
find O 0 0.0037027664948254824
an O 0 0.0011478958185762167
origin O 0 0.002811442594975233
of O 0 0.0007251218194141984
the O 0 0.0017095650546252728
( O 0 0.005935282446444035
CTG O 1 0.9993952512741089
) O 0 0.006316597107797861
n O 0 0.2388157695531845
repeat O 1 0.9812154173851013
mutation O 1 0.9999490976333618
and O 0 0.001185575150884688
to O 0 0.0009646808612160385
investigate O 0 0.005320533644407988
the O 0 0.0012951410608366132
mechanism O 0 0.018894439563155174
of O 0 0.0005722958594560623
the O 0 0.0013849904062226415
expansion O 0 0.071495920419693
mutation O 1 0.9999806880950928
in O 0 0.0012654742458835244
the O 0 0.0008788095437921584
Japanese O 0 0.0028355331160128117
population O 0 0.0014389948919415474
we O 0 0.0006544171483255923
have O 0 0.0008372985175810754
studied O 0 0.004140856675803661
90 O 0 0.006869223900139332
Japanese O 0 0.011336210183799267
DM B-Disease 1 0.999866247177124
families O 0 0.00794844701886177
comprising O 0 0.008656981401145458
190 O 0 0.0193317923694849
affected O 0 0.013373393565416336
and O 0 0.0017371524590998888
130 O 0 0.01627182774245739
unaffected O 1 0.6482993364334106
members O 0 0.005165485665202141
. O 0 0.0056523289531469345

The O 0 0.0038451803848147392
results O 0 0.00882754847407341
suggest O 0 0.005372667219489813
that O 0 0.0008893958874978125
a O 0 0.0027425752487033606
few O 0 0.0020543672144412994
common O 0 0.011681893840432167
ancestral O 1 0.9576194882392883
mutations O 1 0.9999614953994751
in O 0 0.0020124525763094425
both O 0 0.002180989133194089
Caucasian O 1 0.998143196105957
and O 0 0.0014170630602166057
Japanese O 0 0.005315020214766264
populations O 0 0.017983783036470413
have O 0 0.0012289626756682992
originated O 0 0.008093802258372307
by O 0 0.0012470410438254476
expansion O 0 0.005140562541782856
of O 0 0.0007230905466713011
an O 0 0.0021831649355590343
ancestral O 1 0.8949277400970459
n O 0 0.13015004992485046
= O 0 0.044193290174007416
5 O 0 0.008105134591460228
repeat O 0 0.03543674945831299
to O 0 0.002752913162112236
n O 0 0.08344853669404984
= O 0 0.08291246742010117
19 O 0 0.013587675988674164
- O 0 0.018071891739964485
37 O 0 0.018269820138812065
copies O 0 0.01456243172287941
. O 0 0.008255025371909142

These O 0 0.003550362540408969
data O 0 0.004837200976908207
support O 0 0.005479412619024515
multistep O 1 0.8966054320335388
models O 0 0.011426775716245174
of O 0 0.0025813868269324303
triplet O 1 0.9997523427009583
repeat O 1 0.5218638181686401
expansion O 0 0.01017225906252861
that O 0 0.0010512126609683037
have O 0 0.000700456730555743
been O 0 0.0009315747302025557
proposed O 0 0.00431791739538312
for O 0 0.0018017491092905402
both O 0 0.005136827938258648
DM B-Disease 1 0.9999699592590332
and O 0 0.010387000627815723
Friedreichs B-Disease 1 0.9998263716697693
ataxia I-Disease 1 0.9999873638153076
. O 0 0.006302793510258198
. O 0 0.006911884993314743

The O 0 0.006537783890962601
molecular O 1 0.5443160533905029
basis O 0 0.006582452915608883
of O 0 0.006901272106915712
C6 B-Disease 1 0.999998927116394
deficiency I-Disease 1 0.9999995231628418
in O 0 0.002296273596584797
the O 0 0.001673125196248293
western O 0 0.004208798054605722
Cape O 0 0.021184751763939857
, O 0 0.002040166174992919
South O 0 0.003643007017672062
Africa O 0 0.009468479081988335
. O 0 0.0067519512958824635

Deficiency B-Disease 1 0.999824583530426
of I-Disease 0 0.0020869472064077854
the I-Disease 0 0.0016845448408275843
sixth I-Disease 0 0.010492467321455479
component I-Disease 0 0.017366711050271988
of I-Disease 0 0.0014242769684642553
human I-Disease 0 0.011679394170641899
complement I-Disease 1 0.7591539621353149
( O 0 0.01023612916469574
C6 O 1 0.9999580383300781
) O 0 0.00382692227140069
has O 0 0.0012205353705212474
been O 0 0.0012662417721003294
reported O 0 0.004129643552005291
in O 0 0.0010536018526181579
a O 0 0.002532977843657136
number O 0 0.0007848035311326385
of O 0 0.0006851415964774787
families O 0 0.003066440112888813
from O 0 0.0012723784893751144
the O 0 0.0013738097622990608
western O 0 0.004644027445465326
Cape O 0 0.022432828322052956
, O 0 0.0020400381181389093
South O 0 0.003386672353371978
Africa O 0 0.009120455943048
. O 0 0.006154411938041449

Meningococcal B-Disease 1 0.9999983310699463
disease I-Disease 1 0.9999879598617554
is O 0 0.004707006737589836
endemic O 1 0.9322038888931274
in O 0 0.0013166592689231038
the O 0 0.001398738706484437
Cape O 0 0.015496945008635521
and O 0 0.0008168306085281074
almost O 0 0.0013538579223677516
all O 0 0.0008682493935339153
pedigrees O 1 0.7332691550254822
of O 0 0.0019102924270555377
total O 0 0.016349397599697113
C6 B-Disease 1 0.9999986886978149
deficiency I-Disease 1 0.9999996423721313
( O 0 0.014597529545426369
C6Q0 O 1 0.9994518160820007
) O 0 0.0031614466570317745
have O 0 0.0009577947785146534
been O 0 0.0014942807611078024
ascertained O 0 0.34208858013153076
because O 0 0.003794253570958972
of O 0 0.004458887502551079
recurrent O 1 0.9999905824661255
disease O 1 0.9999881982803345
. O 0 0.010788998566567898

We O 0 0.0029654696118086576
have O 0 0.0018652377184480429
sequenced O 0 0.4868905544281006
the O 0 0.0017772795399650931
expressed O 0 0.005184845998883247
exons O 1 0.8835936784744263
of O 0 0.0012863653246313334
the O 0 0.0038942827377468348
C6 O 1 0.9999761581420898
gene O 1 0.9996919631958008
from O 0 0.0019188410369679332
selected O 0 0.0030675758607685566
cases O 0 0.004588663578033447
and O 0 0.0006362481508404016
have O 0 0.0007057209149934351
found O 0 0.0030562004540115595
three O 0 0.003803688334301114
molecular O 1 0.9999209642410278
defects O 1 0.9998723268508911
leading O 0 0.005965274292975664
to O 0 0.0012905446346849203
total O 0 0.00951801985502243
deficiency O 1 0.9999996423721313
879delG O 1 0.9992330074310303
, O 0 0.0014545833691954613
which O 0 0.0007191775366663933
is O 0 0.0007402177434414625
the O 0 0.0012814574874937534
common O 0 0.07621777802705765
defect O 1 0.9996943473815918
in O 0 0.0013541118241846561
the O 0 0.0015181769849732518
Cape O 0 0.019538728520274162
and O 0 0.001675963867455721
hitherto O 0 0.2124243676662445
unreported O 0 0.49872860312461853
, O 0 0.0017235849518328905
and O 0 0.0019198731752112508
1195delC O 1 0.9968193769454956
and O 0 0.0026316752191632986
1936delG O 1 0.9990271329879761
, O 0 0.0017186159966513515
which O 0 0.0009353190544061363
have O 0 0.0006527247605845332
been O 0 0.0009461804293096066
previously O 0 0.002820380264893174
reported O 0 0.006723078433424234
in O 0 0.0026358598843216896
African O 0 0.01820429414510727
- O 0 0.02643989771604538
Americans O 0 0.012700184248387814
. O 0 0.007173947524279356

We O 0 0.002893719356507063
also O 0 0.0011464894050732255
show O 0 0.00182068208232522
that O 0 0.0010247704340144992
the O 0 0.0020264938939362764
879delG O 1 0.9968006610870361
and O 0 0.004141261335462332
1195delC O 1 0.9998655319213867
defects O 1 0.999916672706604
are O 0 0.0014380462234839797
associated O 0 0.006218486465513706
with O 0 0.003493393072858453
characteristic O 1 0.9828808307647705
C6 O 1 0.999971866607666
/ O 1 0.9874163269996643
C7 O 1 0.9997255206108093
region O 0 0.013955013826489449
DNA O 1 0.9996495246887207
marker O 1 0.9906049370765686
haplotypes O 1 0.9997815489768982
, O 0 0.0022774008102715015
although O 0 0.0023321262560784817
small O 0 0.00340007315389812
variations O 0 0.015907742083072662
were O 0 0.001495583332143724
observed O 0 0.014435038901865482
. O 0 0.006302253343164921

The O 0 0.009682727977633476
1936delG O 1 0.9957295060157776
defect O 1 0.9991970658302307
was O 0 0.003979252651333809
observed O 0 0.007199869025498629
only O 0 0.0010477143805474043
once O 0 0.001920216833241284
in O 0 0.0010541270021349192
the O 0 0.001445689587853849
Cape O 0 0.03246437758207321
, O 0 0.001500560319982469
but O 0 0.00112608028575778
its O 0 0.0025160068180412054
associated O 0 0.034759119153022766
haplotype O 1 0.9997860789299011
could O 0 0.004000154789537191
be O 0 0.0016472480492666364
deduced O 0 0.052274301648139954
. O 0 0.006091554183512926

The O 0 0.003958709072321653
data O 0 0.003997180610895157
from O 0 0.0015098010189831257
the O 0 0.0025363871827721596
haplotypes O 1 0.9998843669891357
indicate O 0 0.006767711602151394
that O 0 0.0007003783248364925
these O 0 0.0007803994230926037
three O 0 0.0027671456336975098
molecular O 1 0.9999159574508667
defects O 1 0.9999278783798218
account O 0 0.0036286297254264355
for O 0 0.0010969155700877309
the O 0 0.0022943594958633184
defects O 1 0.9999103546142578
in O 0 0.0010409456444904208
all O 0 0.0005032717599533498
the O 0 0.00135585549287498
38 O 0 0.01638711616396904
unrelated O 1 0.9850672483444214
C6Q0 O 1 0.9988278746604919
individuals O 0 0.005254128482192755
we O 0 0.000865609326865524
have O 0 0.0008811085135675967
studied O 0 0.0035142009146511555
from O 0 0.0016785324551165104
the O 0 0.0022294947411864996
Cape O 0 0.03544936701655388
. O 0 0.007816964760422707

We O 0 0.002848341828212142
have O 0 0.001053552725352347
also O 0 0.000882285472471267
observed O 0 0.006183851510286331
the O 0 0.0027603418566286564
879delG O 1 0.9976224303245544
defect O 1 0.9971997737884521
in O 0 0.002251662779599428
two O 0 0.00404348922893405
Dutch O 1 0.7183440923690796
C6 B-Disease 1 0.9999889135360718
- I-Disease 1 0.9738830924034119
deficient I-Disease 1 0.9999428987503052
kindreds O 1 0.9987093210220337
, O 0 0.0022672454360872507
but O 0 0.0009959019953384995
the O 0 0.0022522048093378544
879delG O 1 0.9994493126869202
defect O 1 0.9994149208068848
in O 0 0.0014245794154703617
the O 0 0.001538601005449891
Cape O 0 0.042184263467788696
probably O 0 0.00518999295309186
did O 0 0.001833212561905384
not O 0 0.0007697065593674779
come O 0 0.0013530865544453263
from O 0 0.0011421034578233957
The O 0 0.00186731549911201
Netherlands O 0 0.008425437845289707
. O 0 0.002952921437099576
. O 0 0.004854472819715738

Complement B-Disease 1 0.9920732378959656
C7 I-Disease 1 0.9999940395355225
deficiency I-Disease 1 0.9999949932098389
: O 0 0.006596405059099197
seven O 0 0.004079964943230152
further O 0 0.0071630701422691345
molecular O 1 0.9998216032981873
defects O 1 0.9998492002487183
and O 0 0.0014708568342030048
their O 0 0.0023334380239248276
associated O 0 0.017538636922836304
marker O 1 0.9874529242515564
haplotypes O 1 0.9997161030769348
. O 0 0.010976201854646206

Seven O 0 0.007290671579539776
further O 0 0.005605904385447502
molecular O 1 0.9525647163391113
bases O 0 0.01212313398718834
of O 0 0.00597509928047657
C7 B-Disease 1 0.9999978542327881
deficiency I-Disease 1 0.9999988079071045
are O 0 0.003242709906771779
described O 0 0.011233671568334103
. O 0 0.006122970022261143

All O 0 0.002005846006795764
these O 0 0.0013664794387295842
new O 0 0.004926819819957018
molecular O 1 0.9995185136795044
defects O 1 0.9997952580451965
involve O 0 0.018636440858244896
single O 0 0.013165640644729137
- O 0 0.0320846363902092
nucleotide O 1 0.9954421520233154
events O 0 0.006948390509933233
, O 0 0.002643754007294774
deletions O 1 0.9949510097503662
and O 0 0.0021573398262262344
substitutions O 0 0.04085978493094444
, O 0 0.0010964036919176579
some O 0 0.0006610872806049883
of O 0 0.0007525169639848173
which O 0 0.0018260742072016
alter O 1 0.8870885372161865
splice O 1 0.9993610978126526
sites O 0 0.006842639297246933
, O 0 0.001467634574510157
and O 0 0.0012651713332161307
others O 0 0.006493041757494211
codons O 1 0.995520830154419
. O 0 0.00854919571429491

They O 0 0.002449742052704096
are O 0 0.0008321424247696996
distributed O 0 0.004428615793585777
along O 0 0.002786192810162902
the O 0 0.004506403114646673
C7 O 1 0.9999947547912598
gene O 1 0.9999649524688721
, O 0 0.002024628920480609
but O 0 0.0010855592554435134
predominantly O 0 0.0034170513972640038
towards O 0 0.002982198027893901
the O 0 0.0018766517750918865
3 O 0 0.007969086058437824
end O 0 0.007734359707683325
. O 0 0.006463958416134119

All O 0 0.0018345575081184506
were O 0 0.0008232573745772243
found O 0 0.0033518150448799133
in O 0 0.00230767740868032
compound O 0 0.17527665197849274
heterozygous O 1 0.9994335770606995
individuals O 0 0.010874117724597454
. O 0 0.005962249357253313

The O 0 0.01766866445541382
C6 O 1 0.9996321201324463
/ O 1 0.9812968373298645
C7 O 1 0.999289870262146
marker O 1 0.9807950854301453
haplotypes O 1 0.9993273019790649
associated O 0 0.012883197516202927
with O 0 0.003058856353163719
most O 0 0.004645078908652067
C7 B-Disease 1 0.9999938011169434
defects I-Disease 1 0.9997698664665222
are O 0 0.0017576596001163125
tabulated O 0 0.010731769725680351
. O 0 0.0028902487829327583
. O 0 0.004895699676126242

A O 0 0.039915140718221664
genome O 1 0.9982274174690247
- O 0 0.02048034407198429
wide O 0 0.009116052649915218
search O 0 0.010503542609512806
for O 0 0.005059097893536091
chromosomal O 1 0.9999871253967285
loci O 1 0.9995582699775696
linked O 1 0.5724467039108276
to O 0 0.004747875966131687
mental O 1 0.9990224838256836
health O 1 0.910740852355957
wellness O 1 0.9931420683860779
in O 0 0.0024998527951538563
relatives O 0 0.011621600948274136
at O 0 0.0027099556755274534
high O 0 0.009016112424433231
risk O 1 0.9961250424385071
for O 0 0.014316459186375141
bipolar B-Disease 1 0.9999995231628418
affective I-Disease 1 0.9999839067459106
disorder I-Disease 1 0.9999744892120361
among O 0 0.0036262620706111193
the O 0 0.0017546662129461765
Old O 0 0.010866950266063213
Order O 0 0.00840657576918602
Amish O 0 0.19049395620822906
. O 0 0.007744282949715853

Bipolar B-Disease 1 0.9999889135360718
affective I-Disease 1 0.9999179840087891
disorder I-Disease 1 0.9999842643737793
( O 0 0.01811891421675682
BPAD B-Disease 1 0.9998818635940552
; O 0 0.1881752908229828
manic B-Disease 1 0.9999959468841553
- I-Disease 1 0.9996213912963867
depressive I-Disease 1 0.9999990463256836
illness I-Disease 1 0.9999853372573853
) O 0 0.0055664582177996635
is O 0 0.002211960032582283
characterized O 0 0.032306745648384094
by O 0 0.001956711756065488
episodes O 0 0.014758980832993984
of O 0 0.0030419379472732544
mania B-Disease 1 0.999902606010437
and O 0 0.00485396571457386
/ O 1 0.9777222871780396
or O 0 0.013078723102807999
hypomania B-Disease 1 0.9998695850372314
interspersed O 0 0.08450507372617722
with O 0 0.004504854790866375
periods O 0 0.01067830715328455
of O 0 0.0032504373230040073
depression B-Disease 1 0.9984898567199707
. O 0 0.009613309986889362

Compelling O 0 0.024409398436546326
evidence O 0 0.004566250368952751
supports O 0 0.009338568896055222
a O 0 0.004381175618618727
significant O 0 0.0094562703743577
genetic O 1 0.9996860027313232
component O 0 0.021437926217913628
in O 0 0.0013483531074598432
the O 0 0.0026747582014650106
susceptibility O 1 0.9999164342880249
to O 0 0.0038111722096800804
develop O 1 0.7269960045814514
BPAD B-Disease 1 0.9991241097450256
. O 0 0.00946831051260233

To O 0 0.003986073657870293
date O 0 0.005281524267047644
, O 0 0.0014317298773676157
however O 0 0.002227551070973277
, O 0 0.002098815981298685
linkage O 1 0.9983454942703247
studies O 0 0.008286925032734871
have O 0 0.0009653267334215343
attempted O 0 0.006636608857661486
only O 0 0.0007784724002704024
to O 0 0.0014146792236715555
identify O 0 0.20382869243621826
chromosomal O 1 0.9999940395355225
loci O 1 0.9997157454490662
that O 0 0.003319826442748308
cause O 1 0.7723995447158813
or O 0 0.003088196972385049
increase O 0 0.004668795503675938
the O 0 0.0023055155761539936
risk O 1 0.8809574246406555
of O 0 0.0021772191394120455
developing O 0 0.19910770654678345
BPAD B-Disease 1 0.9987949132919312
. O 0 0.009393349289894104

To O 0 0.0036001871339976788
determine O 0 0.005893604829907417
whether O 0 0.002462602686136961
there O 0 0.0010240910341963172
could O 0 0.0020614443346858025
be O 0 0.0016800889279693365
protective O 1 0.991477906703949
alleles O 1 0.9998717308044434
that O 0 0.0025344325695186853
prevent O 0 0.06551793217658997
or O 0 0.003160653170198202
reduce O 0 0.016028983518481255
the O 0 0.0018328505102545023
risk O 1 0.7868348360061646
of O 0 0.0021357627119868994
developing O 1 0.6005368828773499
BPAD B-Disease 1 0.9997754693031311
, O 0 0.0018493235111236572
similar O 0 0.004155280999839306
to O 0 0.0008091392228379846
what O 0 0.0010416205041110516
is O 0 0.0008184255566447973
observed O 0 0.004515496548265219
in O 0 0.0013757749693468213
other O 0 0.00533926859498024
genetic B-Disease 1 0.9999998807907104
disorders I-Disease 1 0.9999996423721313
, O 0 0.0014463174156844616
we O 0 0.000976603478193283
used O 0 0.005605574231594801
mental O 1 0.9996938705444336
health O 1 0.9913676381111145
wellness O 1 0.9993361830711365
( O 0 0.0039247674867510796
absence O 0 0.010151281021535397
of O 0 0.0013600093079730868
any O 0 0.006930557545274496
psychiatric B-Disease 1 0.9999932050704956
disorder I-Disease 1 0.9999933242797852
) O 0 0.0027659351471811533
as O 0 0.0011236319551244378
the O 0 0.0024498223792761564
phenotype O 1 0.9999754428863525
in O 0 0.0019334850367158651
our O 0 0.0044213575311005116
genome O 1 0.999863862991333
- O 0 0.01950620301067829
wide O 0 0.015367159619927406
linkage O 1 0.9975963234901428
scan O 1 0.7809634208679199
of O 0 0.001001007971353829
several O 0 0.0016107368282973766
large O 0 0.004755976144224405
multigeneration O 1 0.989827036857605
Old O 0 0.01053199265152216
Order O 0 0.006592797581106424
Amish O 1 0.687584638595581
pedigrees O 1 0.9888110160827637
exhibiting O 0 0.060415685176849365
an O 0 0.002379828132688999
extremely O 0 0.013744931668043137
high O 0 0.010747060179710388
incidence O 1 0.9990363121032715
of O 0 0.004981144331395626
BPAD B-Disease 1 0.9989538192749023
. O 0 0.012061310932040215

We O 0 0.0027262852527201176
have O 0 0.0011919530807062984
found O 0 0.0028797260019928217
strong O 0 0.0026409830898046494
evidence O 0 0.002058119745925069
for O 0 0.001215277356095612
a O 0 0.00789148360490799
locus O 1 0.9989412426948547
on O 0 0.009257118217647076
chromosome O 1 0.9999711513519287
4p O 1 0.9969448447227478
at O 0 0.008036497980356216
D4S2949 O 1 0.9342344403266907
( O 0 0.004201654810458422
maximum O 0 0.014524462632834911
GENEHUNTER O 1 0.9971994161605835
- O 0 0.027609121054410934
PLUS O 0 0.02558581903576851
nonparametric O 1 0.968958854675293
linkage O 1 0.9769822359085083
score O 0 0.011488036252558231
= O 0 0.04921569675207138
4 O 0 0.00825223047286272
. O 0 0.002677608747035265
05 O 0 0.3175250291824341
, O 0 0.004823885392397642
P O 1 0.97995924949646
= O 0 0.05186945199966431
5 O 0 0.005994298029690981
. O 0 0.0015278136124834418
22 O 0 0.006210738327354193
x O 0 0.07757656276226044
10 O 0 0.005960854236036539
( O 0 0.004600403364747763
- O 0 0.01982988975942135
4 O 0 0.01059371791779995
) O 0 0.004763593431562185
; O 0 0.006275811232626438
SIBPAL O 1 0.9962318539619446
Pempirical O 1 0.9696966409683228
value O 0 0.009197760373353958
< O 1 0.9604043960571289
3 O 0 0.012535791844129562
x O 0 0.04531412199139595
10 O 0 0.005936317145824432
( O 0 0.005372779443860054
- O 0 0.02910030633211136
5 O 0 0.008372306823730469
) O 0 0.0028959379997104406
) O 0 0.001936497283168137
and O 0 0.001095841871574521
suggestive O 1 0.8894025087356567
evidence O 0 0.0028784903697669506
for O 0 0.001208367757499218
a O 0 0.006013309583067894
locus O 1 0.9985344409942627
on O 0 0.007572981528937817
chromosome O 1 0.9999779462814331
4q O 1 0.9991569519042969
at O 0 0.008898817002773285
D4S397 O 1 0.9911360740661621
( O 0 0.005821165628731251
maximum O 0 0.013140802271664143
GENEHUNTER O 1 0.9946041703224182
- O 0 0.02942492812871933
PLUS O 0 0.02942366898059845
nonparametric O 1 0.9861976504325867
linkage O 1 0.9830011129379272
score O 0 0.011484663002192974
= O 0 0.044149912893772125
3 O 0 0.006723262835294008
. O 0 0.001963530434295535
29 O 0 0.00814725086092949
, O 0 0.003084719879552722
P O 1 0.9765145778656006
= O 0 0.04547647014260292
2 O 0 0.005557138007134199
. O 0 0.0017104839207604527
57 O 0 0.013941444456577301
x O 0 0.04209384322166443
10 O 0 0.005723681300878525
( O 0 0.005465950351208448
- O 0 0.016593923792243004
3 O 0 0.010105711407959461
) O 0 0.003943563438951969
; O 0 0.005736247636377811
SIBPAL O 1 0.9976209998130798
Pempirical O 1 0.9826840758323669
value O 0 0.008784646168351173
< O 1 0.9818898439407349
1 O 0 0.009017777629196644
x O 0 0.039849426597356796
10 O 0 0.005001045763492584
( O 0 0.005722053349018097
- O 0 0.022070547565817833
3 O 0 0.00942389015108347
) O 0 0.002916537458077073
) O 0 0.0017102593556046486
that O 0 0.000608048343565315
are O 0 0.0008274386636912823
linked O 0 0.23297764360904694
to O 0 0.003273578127846122
mental O 1 0.9991101622581482
health O 1 0.9437965154647827
wellness O 1 0.9941655397415161
. O 0 0.010198020376265049

These O 0 0.003452387871220708
findings O 0 0.008670357055962086
are O 0 0.0007941630319692194
consistent O 0 0.005262007936835289
with O 0 0.00123743643052876
the O 0 0.0009420480928383768
hypothesis O 1 0.5756634473800659
that O 0 0.0012919256696477532
certain O 0 0.004789370112121105
alleles O 1 0.999896764755249
could O 0 0.003998319618403912
prevent O 0 0.06109364703297615
or O 0 0.0033426047302782536
modify O 0 0.10371284931898117
the O 0 0.0033450459595769644
clinical O 1 0.9990531802177429
manifestations O 0 0.4894433915615082
of O 0 0.002279785694554448
BPAD B-Disease 1 0.9996882677078247
and O 0 0.0016674050129950047
perhaps O 0 0.005277810152620077
other O 0 0.0031059253960847855
related O 1 0.7940884828567505
affective B-Disease 1 0.9999788999557495
disorders I-Disease 1 0.99998939037323
. O 0 0.012400579638779163

Segregation O 0 0.15917229652404785
distortion O 1 0.807842493057251
in O 0 0.02723664417862892
myotonic B-Disease 1 0.9999945163726807
dystrophy I-Disease 1 0.9999954700469971
. O 0 0.020551007241010666

Myotonic B-Disease 1 0.9999926090240479
dystrophy I-Disease 1 0.9999983310699463
( O 0 0.03615657240152359
DM B-Disease 1 0.9999430179595947
) O 0 0.0047774347476661205
is O 0 0.0020241145975887775
an O 0 0.005905235186219215
autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 0.9997232556343079
disease I-Disease 1 0.9999970197677612
which O 0 0.0014744995860382915
, O 0 0.0008392239105887711
in O 0 0.0009255982004106045
the O 0 0.0014789734268561006
typical O 0 0.03956611081957817
pedigree O 1 0.9961066842079163
, O 0 0.0016189959133043885
shows O 0 0.0030936067923903465
a O 0 0.003885873593389988
three O 0 0.003498745383694768
generation O 0 0.03103524260222912
anticipation O 0 0.06904571503400803
cascade O 1 0.994367778301239
. O 0 0.01034045685082674

This O 0 0.003941679373383522
results O 0 0.011950609274208546
in O 0 0.007434749510139227
infertility B-Disease 1 0.9999955892562866
and O 0 0.16189947724342346
congenital B-Disease 1 1.0
myotonic I-Disease 1 0.9999997615814209
dystrophy I-Disease 1 0.9999997615814209
( O 0 0.022091440856456757
CDM B-Disease 1 0.9997149109840393
) O 0 0.003383296076208353
with O 0 0.001524981576949358
the O 0 0.0014034182531759143
disappearance O 0 0.09209555387496948
of O 0 0.004235855303704739
DM B-Disease 1 0.9999576807022095
in O 0 0.0032807709649205208
that O 0 0.003637388115748763
pedigree O 1 0.9763884544372559
. O 0 0.007493063807487488

The O 0 0.0034453473053872585
concept O 0 0.007062909193336964
of O 0 0.0019459669711068273
segregation O 0 0.34197288751602173
distortion O 1 0.8537610769271851
, O 0 0.0014419531216844916
where O 0 0.0009579047909937799
there O 0 0.0008068551542237401
is O 0 0.0015021258732303977
preferential O 0 0.16183118522167206
transmission O 1 0.7958455085754395
of O 0 0.000756541732698679
the O 0 0.0012121362378820777
larger O 0 0.011138172820210457
allele O 1 0.9996800422668457
at O 0 0.0034506560768932104
the O 0 0.005146908573806286
DM B-Disease 1 0.9999914169311523
locus O 1 0.9997983574867249
, O 0 0.002394790994003415
has O 0 0.0012332263868302107
been O 0 0.001102506648749113
put O 0 0.002811438636854291
forward O 0 0.0028326937463134527
to O 0 0.0011231974931433797
explain O 0 0.008089134469628334
partially O 0 0.015101253055036068
the O 0 0.0018448542105033994
maintenance O 0 0.03851013258099556
of O 0 0.002964223502203822
DM B-Disease 1 0.9999774694442749
in O 0 0.0020217173732817173
the O 0 0.0017972267232835293
population O 0 0.004350543487817049
. O 0 0.006347833201289177

In O 0 0.003771453630179167
a O 0 0.005337280686944723
survey O 0 0.0060264491476118565
of O 0 0.0030009085312485695
DM B-Disease 1 0.9998354911804199
in O 0 0.0031203480903059244
Northern O 0 0.0052956389263272285
Ireland O 0 0.007275398820638657
, O 0 0.00260564754717052
59 O 0 0.024947786703705788
pedigrees O 1 0.8133935928344727
were O 0 0.0028749066404998302
ascertained O 0 0.24830026924610138
. O 0 0.008573431521654129

Sibships O 1 0.8906379342079163
where O 0 0.0024750931188464165
the O 0 0.001025397446937859
status O 0 0.0026307054795324802
of O 0 0.00046933561679907143
all O 0 0.0004601692489814013
the O 0 0.0008345842943526804
members O 0 0.0012048548087477684
had O 0 0.0014616692205891013
been O 0 0.0014204962644726038
identified O 0 0.005338534712791443
were O 0 0.0007521046209149063
examined O 0 0.010798901319503784
to O 0 0.000876738631632179
determine O 0 0.003741791006177664
the O 0 0.0013438783353194594
transmission O 1 0.918641984462738
of O 0 0.0012453936506062746
the O 0 0.0038848898839205503
DM B-Disease 1 0.9999792575836182
expansion O 0 0.01621723547577858
from O 0 0.0025872052647173405
affected O 0 0.015062267892062664
parents O 0 0.0060251927934587
to O 0 0.0013390213716775179
their O 0 0.0034532754216343164
offspring O 1 0.9916656613349915
. O 0 0.008508936502039433

Where O 0 0.004481316544115543
the O 0 0.003487554844468832
transmitting O 1 0.9841177463531494
parent O 1 0.5865026712417603
was O 0 0.004329174291342497
male O 0 0.0304038617759943
, O 0 0.003450670512393117
58 O 0 0.027508294209837914
. O 0 0.008269747719168663

3 O 0 0.011463538743555546
% O 0 0.003829328343272209
of O 0 0.0007736746338196099
the O 0 0.0015886507462710142
offspring O 1 0.9917674660682678
were O 0 0.0013144691474735737
affected O 0 0.013927300460636616
, O 0 0.0011673226254060864
and O 0 0.0006742335390299559
in O 0 0.0008788731065578759
the O 0 0.0010395071003586054
case O 0 0.003188932780176401
of O 0 0.0008597177220508456
a O 0 0.006345941219478846
female O 0 0.09862171113491058
transmitting O 1 0.997868537902832
parent O 1 0.7773568034172058
, O 0 0.00375356781296432
68 O 0 0.03312825784087181
. O 0 0.00820334441959858

7 O 0 0.016049014404416084
% O 0 0.006832743529230356
were O 0 0.001999374944716692
affected O 0 0.02128678373992443
. O 0 0.006718402728438377

Studies O 0 0.018760468810796738
on O 0 0.00445445254445076
meiotic O 1 0.9994754195213318
drive O 0 0.024524712935090065
in O 0 0.005433401558548212
DM B-Disease 1 0.9999210834503174
have O 0 0.0023072161711752415
shown O 0 0.005489651579409838
increased O 0 0.008723300881683826
transmission O 0 0.4684368968009949
of O 0 0.0008573192171752453
the O 0 0.0014707770897075534
larger O 0 0.010962657630443573
allele O 1 0.9991745352745056
at O 0 0.003954342566430569
the O 0 0.0057465373538434505
DM B-Disease 1 0.999964714050293
locus O 1 0.999298095703125
in O 0 0.004432085435837507
non O 0 0.021158447489142418
- O 1 0.8968026638031006
DM O 1 0.9999386072158813
heterozygotes O 1 0.9966975450515747
for O 0 0.007746214512735605
CTGn O 1 0.9868890047073364
. O 0 0.008539844304323196

This O 0 0.003695378080010414
study O 0 0.005899407435208559
provides O 0 0.0054377405904233456
further O 0 0.002588035771623254
evidence O 0 0.0022528148256242275
that O 0 0.0012141948100179434
the O 0 0.003660615300759673
DM B-Disease 1 0.9999758005142212
expansion O 0 0.022536100819706917
tends O 0 0.012374142184853554
to O 0 0.0015497421845793724
be O 0 0.0024873449001461267
transmitted O 1 0.975911557674408
preferentially O 1 0.8795186877250671
. O 0 0.00734722102060914

Diagnosis O 1 0.999108612537384
of O 0 0.012987623922526836
hemochromatosis B-Disease 1 0.9999600648880005
. O 0 0.01530707348138094

If O 0 0.015984468162059784
untreated O 1 0.9993688464164734
, O 0 0.007774943485856056
hemochromatosis B-Disease 1 0.9999990463256836
can O 0 0.012673908844590187
cause O 1 0.9995899796485901
serious O 1 0.997116208076477
illness O 1 0.9999574422836304
and O 0 0.0014997086254879832
early B-Disease 0 0.004723791033029556
death I-Disease 0 0.028297172859311104
, O 0 0.0012076004641130567
but O 0 0.001299798721447587
the O 0 0.003203216940164566
disease O 1 0.9999961853027344
is O 0 0.0019319657003507018
still O 0 0.0019338192651048303
substantially O 0 0.06252364814281464
under O 0 0.006813553161919117
- O 1 0.9858798384666443
diagnosed O 1 0.9999828338623047
. O 0 0.010410736314952374

The O 0 0.004603240173310041
cornerstone O 0 0.03205160051584244
of O 0 0.002096552401781082
screening O 1 0.8048738837242126
and O 0 0.0017400059150531888
case O 0 0.008978433907032013
detection O 1 0.9430363178253174
is O 0 0.0011594230309128761
the O 0 0.001016681781038642
measurement O 0 0.022405847907066345
of O 0 0.0030994522385299206
serum O 1 0.9997966885566711
transferrin O 1 0.9988211989402771
saturation O 1 0.8049118518829346
and O 0 0.0021815327927470207
the O 0 0.003723002737388015
serum O 1 0.9992327690124512
ferritin O 1 0.9967222809791565
level O 0 0.013774542137980461
. O 0 0.008250478655099869

Once O 0 0.01108247134834528
the O 0 0.006274048238992691
diagnosis O 1 0.9999511241912842
is O 0 0.0038660340942442417
suspected O 0 0.044715892523527145
, O 0 0.0022369450889527798
physicians O 0 0.15230697393417358
must O 0 0.0019828330259770155
use O 0 0.0067776525393128395
serum O 1 0.999103844165802
ferritin O 1 0.9970930814743042
levels O 0 0.019818244501948357
and O 0 0.004451518878340721
hepatic O 1 0.999994158744812
iron O 0 0.23940572142601013
stores O 0 0.012930554337799549
on O 0 0.008562276139855385
liver O 1 0.9999996423721313
biopsy O 1 0.9999749660491943
specimens O 0 0.021640561521053314
to O 0 0.002364058280363679
assess O 0 0.2576935589313507
patients O 1 0.9980058073997498
for O 0 0.001137743704020977
the O 0 0.0013360100565478206
presence O 0 0.007323079742491245
of O 0 0.0024595579598098993
iron B-Disease 1 0.8853873610496521
overload I-Disease 1 0.9991495609283447
. O 0 0.010792240500450134

Liver O 1 0.9999990463256836
biopsy O 1 0.9999674558639526
is O 0 0.0027111712843179703
also O 0 0.0010783118195831776
used O 0 0.0014247557846829295
to O 0 0.0006918509607203305
establish O 0 0.0034319174010306597
the O 0 0.00096332241082564
presence O 0 0.004744676873087883
or O 0 0.002669293899089098
absence O 0 0.012782766483724117
of O 0 0.0031863900367170572
cirrhosis B-Disease 1 0.9999991655349731
, O 0 0.0019343310268595815
which O 0 0.0012754494091495872
can O 0 0.004908320959657431
affect O 1 0.6817154288291931
prognosis O 1 0.9999372959136963
and O 0 0.0031954795122146606
management O 0 0.0292852483689785
. O 0 0.00548842316493392

A O 0 0.03456202521920204
DNA O 1 0.9993676543235779
- O 0 0.021105756983160973
based O 0 0.0034910496324300766
test O 0 0.007884014397859573
for O 0 0.0014756352175027132
the O 0 0.004031290300190449
HFE O 1 0.9999829530715942
gene O 1 0.9998655319213867
is O 0 0.0029486888088285923
commercially O 0 0.015054593794047832
available O 0 0.0022281373385339975
, O 0 0.0007975411717779934
but O 0 0.0006331016193144023
its O 0 0.0008853197214193642
place O 0 0.0010865599615499377
in O 0 0.001042199321091175
the O 0 0.002794678322970867
diagnosis O 1 0.9999885559082031
of O 0 0.0052483901381492615
hemochromatosis B-Disease 1 0.9999994039535522
is O 0 0.003793361596763134
still O 0 0.002474816283211112
being O 0 0.0033747453708201647
evaluated O 0 0.04186886548995972
. O 0 0.006745059974491596

Currently O 0 0.005580237600952387
, O 0 0.001262410543859005
the O 0 0.0008641103049740195
most O 0 0.001125856302678585
useful O 0 0.006567645352333784
role O 0 0.0035205967724323273
for O 0 0.0007643451681360602
this O 0 0.0009089490049518645
test O 0 0.0071722762659192085
is O 0 0.0008606077753938735
in O 0 0.00079497997649014
the O 0 0.0016774660907685757
detection O 1 0.9879265427589417
of O 0 0.0035091033205389977
hemochromatosis B-Disease 1 0.9999982118606567
in O 0 0.0017689663218334317
the O 0 0.0010799617739394307
family O 0 0.0044507915154099464
members O 0 0.001545714563690126
of O 0 0.0018613507272675633
patients O 1 0.9996412992477417
with O 0 0.0024460775312036276
a O 0 0.004467340651899576
proven O 0 0.019553961232304573
case O 0 0.0035168565809726715
of O 0 0.0012018970446661115
the O 0 0.005806390196084976
disease O 1 0.9999856948852539
. O 0 0.009525535628199577

It O 0 0.003006886225193739
is O 0 0.0020171217620372772
crucial O 0 0.009161416441202164
to O 0 0.005495913326740265
diagnose O 1 0.9999887943267822
hemochromatosis B-Disease 1 0.9999954700469971
before O 0 0.3994787931442261
hepatic B-Disease 1 0.9999995231628418
cirrhosis I-Disease 1 0.9999984502792358
develops O 1 0.9981575608253479
because O 0 0.02091841585934162
phlebotomy O 1 0.9999074935913086
therapy O 1 0.999925971031189
can O 0 0.008810176514089108
avert O 1 0.9993951320648193
serious O 1 0.9997527003288269
chronic O 1 0.9999998807907104
disease O 1 0.9999963045120239
and O 0 0.0019223344279453158
can O 0 0.002204974414780736
even O 0 0.0018467658665031195
lead O 0 0.009351413697004318
to O 0 0.0018017739057540894
normal O 0 0.06142159551382065
life O 0 0.008488793857395649
expectancy O 1 0.8015764355659485
. O 0 0.003140456974506378
. O 0 0.005366586148738861

Prevalence O 1 0.9602639079093933
of O 0 0.0021006762981414795
the O 0 0.004190193023532629
I1307K O 1 0.9987722039222717
APC B-Disease 1 0.9999219179153442
gene O 1 0.9999338388442993
variant O 1 0.9971094727516174
in O 0 0.0015886606415733695
Israeli O 0 0.0034511443227529526
Jews O 0 0.001956525258719921
of O 0 0.0006129762623459101
differing O 0 0.006210641469806433
ethnic O 0 0.003454910358414054
origin O 0 0.005816241260617971
and O 0 0.0024764223489910364
risk O 1 0.9997004270553589
for O 0 0.22911468148231506
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999979734420776
. O 0 0.01263300608843565

BACKGROUND O 0 0.05114658176898956
& O 0 0.03668336570262909
AIMS O 0 0.022919688373804092
Israeli O 0 0.004604267422109842
Jews O 0 0.0016896059969440103
of O 0 0.0007329232757911086
European O 0 0.00456996401771903
birth O 1 0.8693513870239258
, O 0 0.0015769310994073749
i O 0 0.0024502116721123457
. O 0 0.002186425030231476
e O 0 0.04838145151734352
. O 0 0.0017037058714777231
, O 0 0.0017865389818325639
Ashkenazim O 1 0.917582094669342
, O 0 0.0011053028283640742
have O 0 0.0007533251773566008
the O 0 0.002593190874904394
highest O 1 0.950273334980011
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
incidence O 1 0.9994794726371765
of O 0 0.0012629245175048709
any O 0 0.001960594905540347
Israeli O 0 0.00559841375797987
ethnic O 0 0.005564531311392784
group O 0 0.009007942862808704
. O 0 0.005518045742064714

The O 0 0.011153412982821465
I1307K O 1 0.9948387742042542
APC B-Disease 1 0.9998507499694824
gene O 1 0.9998883008956909
variant O 1 0.9970473647117615
was O 0 0.0035891998559236526
found O 0 0.004411593545228243
in O 0 0.0018274661852046847
6 O 0 0.01057190541177988
. O 0 0.005932261701673269

1 O 0 0.012379107996821404
% O 0 0.0035975147038698196
of O 0 0.0010070368880406022
American O 0 0.003165575908496976
Jews O 0 0.0029239540454000235
, O 0 0.0011483074631541967
28 O 0 0.003552036127075553
% O 0 0.0021899398416280746
of O 0 0.0012625049566850066
their O 0 0.029576122760772705
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.12072072923183441
, O 0 0.0014760905178263783
but O 0 0.0011449622688814998
not O 0 0.000901981140486896
in O 0 0.0014084953581914306
non O 0 0.008724438957870007
- O 0 0.016316663473844528
Jews O 0 0.006523025222122669
. O 0 0.005376666784286499

We O 0 0.003625331912189722
assessed O 0 0.011176171712577343
the O 0 0.00301278755068779
I1307K O 1 0.9979248046875
prevalence O 1 0.9984405636787415
in O 0 0.0015441783471032977
Israeli O 0 0.0037783808074891567
Jews O 0 0.0017980104312300682
of O 0 0.0006800573319196701
differing O 0 0.006583400070667267
ethnic O 0 0.004035715479403734
origin O 0 0.006011568009853363
and O 0 0.0025299459230154753
risk O 1 0.9996470212936401
for O 0 0.36235055327415466
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999984502792358
. O 0 0.013153298757970333

METHODS O 0 0.053759582340717316
DNA O 1 0.9824304580688477
samples O 0 0.025758203119039536
from O 0 0.0023126560263335705
500 O 0 0.007653583772480488
unrelated O 0 0.030193593353033066
Jews O 0 0.0021957021672278643
of O 0 0.0007308254134841263
European O 0 0.003241110360249877
or O 0 0.0029658896382898092
non O 0 0.007929335348308086
- O 0 0.0111422473564744
European O 0 0.0035524109844118357
origin O 0 0.004992037545889616
, O 0 0.0012216577306389809
with O 0 0.0018742899410426617
or O 0 0.0021249004639685154
without O 0 0.002318409737199545
a O 0 0.0034547445829957724
personal O 0 0.006049678195267916
and O 0 0.0020817616023123264
/ O 1 0.6617572903633118
or O 0 0.003768357215449214
family O 0 0.005636645946651697
history O 0 0.0024235108867287636
of O 0 0.002819758141413331
neoplasia B-Disease 1 0.9999916553497314
, O 0 0.0017882565734907985
were O 0 0.0007963200914673507
examined O 0 0.011567692272365093
for O 0 0.0012384462170302868
the O 0 0.0026499975938349962
I1307K O 1 0.9973942041397095
variant O 1 0.9955734014511108
by O 0 0.003284730715677142
the O 0 0.0036911829374730587
allele O 1 0.9997939467430115
- O 0 0.031156783923506737
specific O 0 0.019252419471740723
oligonucleotide O 1 0.9988627433776855
( O 0 0.012886777520179749
ASO O 1 0.9890686869621277
) O 0 0.006764568388462067
method O 0 0.020885273814201355
. O 0 0.006318183150142431

RESULTS O 0 0.02645822986960411
In O 0 0.002683332422748208
persons O 0 0.004048365633934736
at O 0 0.002237242180854082
average O 0 0.010557320900261402
risk O 1 0.9991416931152344
for O 0 0.3800065219402313
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
, O 0 0.004614626988768578
I1307K O 1 0.9952770471572876
was O 0 0.003277549985796213
found O 0 0.004967774264514446
in O 0 0.0019262119894847274
5 O 0 0.010686364956200123
. O 0 0.007347016129642725

0 O 0 0.025041848421096802
% O 0 0.004136679694056511
of O 0 0.0009758411906659603
120 O 0 0.005415055435150862
European O 0 0.0042466456070542336
and O 0 0.0016221327241510153
1 O 0 0.007943767122924328
. O 0 0.005275822710245848

6 O 0 0.013855292461812496
% O 0 0.004234031308442354
of O 0 0.0014824888203293085
188 O 0 0.03301188722252846
non O 0 0.010421918705105782
- O 0 0.011626317165791988
European O 0 0.004800116177648306
Jews O 0 0.005530374124646187
( O 0 0.006545680109411478
P O 1 0.9956390857696533
= O 0 0.25495997071266174
0 O 0 0.019214056432247162
. O 0 0.0031020434107631445
08 O 0 0.09414908289909363
) O 0 0.007488940842449665
. O 0 0.006241126451641321

It O 0 0.005617814604192972
occurred O 0 0.012048102915287018
in O 0 0.0029126987792551517
15 O 0 0.008142734877765179
. O 0 0.006006037350744009

4 O 0 0.012544920668005943
% O 0 0.0041038659401237965
of O 0 0.0013113075401633978
52 O 0 0.01681969128549099
Ashkenazi O 1 0.7739312052726746
Israelis O 0 0.016414916142821312
with O 0 0.014873937703669071
familial O 1 0.9999991655349731
cancer B-Disease 1 0.9999988079071045
( O 0 0.011611171066761017
P O 1 0.9981563687324524
= O 1 0.5782909989356995
0 O 0 0.018985066562891006
. O 0 0.0031334024388343096
02 O 1 0.9912058711051941
) O 0 0.0032516582868993282
and O 0 0.000714629131834954
was O 0 0.001161389984190464
not O 0 0.0012458894634619355
detected O 0 0.20928271114826202
in O 0 0.0015769341262057424
51 O 0 0.01488974317908287
non O 0 0.00830459501594305
- O 0 0.01108690444380045
European O 0 0.003020365023985505
Jews O 0 0.0031542133074253798
at O 0 0.003426664974540472
increased O 1 0.8231297135353088
cancer B-Disease 1 0.9999991655349731
risk O 1 0.996217668056488
. O 0 0.0074416883289813995

Colorectal B-Disease 1 0.9999957084655762
neoplasia I-Disease 1 0.9999268054962158
occurred O 0 0.03643159195780754
personally O 0 0.015205398201942444
or O 0 0.00328235886991024
in O 0 0.0009761081309989095
the O 0 0.0009907750645652413
families O 0 0.0028979708440601826
of O 0 0.0008436111966148019
13 O 0 0.003646972356364131
of O 0 0.0012598874745890498
20 O 0 0.007467595860362053
Ashkenazi O 1 0.9989455342292786
I1307K O 1 0.9994481205940247
carriers O 1 0.9466416239738464
, O 0 0.0018438692204654217
8 O 0 0.003977153450250626
of O 0 0.000773854844737798
whom O 0 0.0022203128319233656
also O 0 0.000798287452198565
had O 0 0.0016383904730901122
a O 0 0.0037080964539200068
personal O 0 0.006030234973877668
or O 0 0.003164054825901985
family O 0 0.005926336627453566
history O 0 0.003221929771825671
of O 0 0.0031241949182003736
noncolonic O 1 0.9996262788772583
neoplasia B-Disease 1 0.9999635219573975
. O 0 0.011944890953600407

CONCLUSIONS O 0 0.02570131979882717
The O 0 0.006017264444380999
I1307K O 1 0.9966186285018921
APC O 1 0.9996378421783447
variant O 1 0.9964029788970947
may O 0 0.004297961015254259
represent O 0 0.00323199899867177
a O 0 0.010958879254758358
susceptibility O 1 0.9999818801879883
gene O 1 0.9999468326568604
for O 0 0.009665874764323235
colorectal B-Disease 1 0.9999998807907104
, I-Disease 0 0.002362138358876109
or I-Disease 0 0.0026532046031206846
other I-Disease 0 0.001387432566843927
, I-Disease 0 0.004009162075817585
cancers I-Disease 1 0.9999983310699463
in O 0 0.0033003368880599737
Ashkenazi O 1 0.9969558715820312
Jews O 0 0.0036079769488424063
, O 0 0.0010153769981116056
and O 0 0.0010877765016630292
partially O 0 0.019343340769410133
explains O 0 0.010293994098901749
the O 0 0.0015266545815393329
higher O 0 0.010742795653641224
incidence O 1 0.9998549222946167
of O 0 0.1160886138677597
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
in O 0 0.003608755301684141
European O 0 0.006359473802149296
Israelis O 0 0.014025785028934479
. O 0 0.005035250913351774

Systematic O 0 0.07822728902101517
analysis O 0 0.014135598205029964
of O 0 0.003285901853814721
coproporphyrinogen O 1 0.9976373910903931
oxidase O 1 0.9999274015426636
gene O 1 0.999882698059082
defects O 1 0.9996870756149292
in O 0 0.006200924515724182
hereditary B-Disease 1 0.999750554561615
coproporphyria I-Disease 1 0.9951732754707336
and O 0 0.007589700631797314
mutation O 1 0.9999648332595825
update O 1 0.6879040002822876
. O 0 0.007052533328533173

Hereditary B-Disease 1 0.9989848732948303
coproporphyria I-Disease 1 0.9926108717918396
( O 0 0.014788839034736156
HC B-Disease 1 0.9899114966392517
) O 0 0.004214679356664419
is O 0 0.0022760762367397547
an O 0 0.0072068762965500355
acute O 1 0.9999898672103882
hepatic B-Disease 1 0.9999996423721313
porphyria I-Disease 1 0.9999948740005493
with O 0 0.025313174352049828
autosomal O 1 0.9999984502792358
dominant O 1 0.8949704170227051
inheritance O 1 0.9979960918426514
caused O 0 0.3937349319458008
by O 0 0.005459106061607599
deficient B-Disease 1 0.9983904361724854
activity I-Disease 0 0.009764072485268116
of I-Disease 0 0.0024551781825721264
coproporphyrinogen I-Disease 1 0.9989513158798218
III I-Disease 1 0.9984972476959229
oxidase I-Disease 1 0.9998109936714172
( O 0 0.012134512886404991
CPO O 1 0.9581872224807739
) O 0 0.008900650776922703
. O 0 0.006241274066269398

Clinical O 1 0.9964014291763306
manifestations O 0 0.04747334122657776
of O 0 0.0017096096416935325
the O 0 0.005302669480443001
disease O 1 0.999987006187439
are O 0 0.0018060454167425632
characterized O 0 0.45242059230804443
by O 0 0.006480043288320303
acute O 1 0.99993896484375
attacks O 0 0.02747376076877117
of O 0 0.005796364974230528
neurological B-Disease 1 0.9999994039535522
dysfunction I-Disease 1 0.999993085861206
often O 0 0.008090970106422901
precipitated O 1 0.99825519323349
by O 0 0.004876930732280016
drugs O 1 0.9682620763778687
, O 0 0.0030550328083336353
fasting O 1 0.6085156202316284
, O 0 0.004077078774571419
cyclical O 1 0.9992521405220032
hormonal O 1 0.9999039173126221
changes O 0 0.016555193811655045
, O 0 0.003914338536560535
or O 0 0.11150489747524261
infectious B-Disease 1 0.9999969005584717
diseases I-Disease 1 0.9999852180480957
. O 0 0.009737267158925533

Skin O 1 0.9999741315841675
photosensitivity O 1 0.9999071359634399
may O 0 0.007973136380314827
also O 0 0.0012610579142346978
be O 0 0.001177720376290381
present O 0 0.003700550412759185
. O 0 0.00536093907430768

The O 0 0.0044507537968456745
seven O 0 0.006654753349721432
exons O 1 0.988815426826477
, O 0 0.0025188615545630455
the O 0 0.002970348810777068
exon O 1 0.9994949102401733
/ O 1 0.9604294896125793
intron O 1 0.9994725584983826
boundaries O 0 0.00582386227324605
and O 0 0.0009800279513001442
part O 0 0.0017165681347250938
of O 0 0.001066451077349484
3 O 0 0.01086517795920372
noncoding O 1 0.996990442276001
sequence O 0 0.02161116898059845
of O 0 0.0007628673338331282
the O 0 0.0018270105356350541
CPO O 1 0.9978048205375671
gene O 1 0.9991999268531799
were O 0 0.0016278923721984029
systematically O 0 0.01988210342824459
analyzed O 0 0.01752491109073162
by O 0 0.002562897279858589
an O 0 0.00353497383184731
exon O 1 0.9992392063140869
- O 0 0.02656501531600952
by O 0 0.007647383492439985
- O 0 0.05396062508225441
exon O 1 0.9963212013244629
denaturing O 1 0.9974672794342041
gradient O 1 0.9937386512756348
gel O 1 0.9997413754463196
electrophoresis O 1 0.9991695880889893
( O 0 0.013759547844529152
DGGE O 1 0.9965116381645203
) O 0 0.005514349788427353
strategy O 0 0.013668137602508068
followed O 0 0.004511047620326281
by O 0 0.0017976766685023904
direct O 0 0.0087076835334301
sequencing O 1 0.8759764432907104
in O 0 0.0019014629069715738
seven O 0 0.005876918788999319
unrelated O 1 0.9896062016487122
heterozygous O 1 0.999931812286377
HC B-Disease 1 0.9996347427368164
patients O 1 0.9994609951972961
from O 0 0.0032371324487030506
France O 0 0.006135599222034216
, O 0 0.002202814444899559
Holland O 0 0.050269242376089096
, O 0 0.0014653680846095085
and O 0 0.0013840851606801152
Czech O 0 0.013147941790521145
Republic O 0 0.005358401220291853
. O 0 0.006842335686087608

Seven O 0 0.013591933995485306
novel O 0 0.04640863835811615
mutations O 1 0.9996626377105713
and O 0 0.0018749652663245797
two O 0 0.0022037820890545845
new O 0 0.005393132101744413
polymorphisms O 1 0.9995359182357788
were O 0 0.0032209744676947594
detected O 1 0.7754473686218262
. O 0 0.0083555206656456

Among O 0 0.006502987816929817
these O 0 0.0036163050681352615
mutations O 1 0.9998927116394043
two O 0 0.002684292383491993
are O 0 0.002027756767347455
missense O 1 0.9997569918632507
( O 0 0.007286152336746454
G197W O 1 0.9975786805152893
, O 0 0.0037832697853446007
W427R O 1 0.9983820915222168
) O 0 0.0031110530253499746
, O 0 0.00075528648449108
two O 0 0.0010058971820399165
are O 0 0.0011979487026110291
nonsense O 1 0.6285676956176758
( O 0 0.005950197111815214
Q306X O 1 0.9975510239601135
, O 0 0.004323725122958422
Q385X O 1 0.9983723759651184
) O 0 0.003234676318243146
, O 0 0.0008424957632087171
two O 0 0.0009055944392457604
are O 0 0.0007262659491971135
small O 0 0.006498676259070635
deletions O 1 0.99904865026474
( O 0 0.007302186917513609
662de14bp O 1 0.9949147701263428
; O 0 0.006621355190873146
1168del3bp O 1 0.9354620575904846
removing O 0 0.0313185416162014
a O 0 0.007041359320282936
glycine O 1 0.9619808793067932
at O 0 0.002695487579330802
position O 0 0.003661935683339834
390 O 0 0.40177270770072937
) O 0 0.0030017103999853134
, O 0 0.000875165278557688
and O 0 0.000560455140657723
one O 0 0.0009359665564261377
is O 0 0.0013397389557212591
a O 0 0.009325268678367138
splicing O 1 0.9998282194137573
mutation O 1 0.9999610185623169
( O 0 0.011714243330061436
IVS1 O 1 0.9986816048622131
- O 0 0.3150809109210968
15c O 1 0.9978837370872498
- O 1 0.702134907245636
- O 1 0.8222391605377197
> O 1 0.9994858503341675
g O 1 0.9902955293655396
) O 0 0.003367577213793993
which O 0 0.0010754193644970655
creates O 0 0.014161976054310799
a O 0 0.004378132056444883
new O 0 0.005745731294155121
acceptor O 1 0.9982965588569641
splice O 1 0.9962283372879028
site O 0 0.015996232628822327
. O 0 0.00851011648774147

The O 0 0.007831442169845104
pathological O 1 0.8811520338058472
significance O 0 0.00567091628909111
of O 0 0.0007497839978896081
the O 0 0.0014514162903651595
point O 0 0.008498789742588997
mutations O 1 0.9999853372573853
G197W O 1 0.9979726672172546
, O 0 0.0037444867193698883
W427R O 1 0.9917137622833252
, O 0 0.0013862678315490484
and O 0 0.0006824777810834348
the O 0 0.001045005046762526
in O 0 0.002054316457360983
- O 0 0.02924402989447117
frame O 1 0.5792627930641174
deletion O 1 0.9997327923774719
390delGly O 1 0.9875669479370117
were O 0 0.0016040648333728313
assessed O 0 0.008877956308424473
by O 0 0.001271645538508892
their O 0 0.0013034683652222157
respective O 0 0.006512806750833988
expression O 0 0.018465375527739525
in O 0 0.001093765371479094
a O 0 0.005065969657152891
prokaryotic O 1 0.9969503283500671
system O 0 0.009803760796785355
using O 0 0.006416941061615944
site O 0 0.008336830884218216
- O 0 0.021278442814946175
directed O 0 0.01788211241364479
mutagenesis O 1 0.9827998876571655
. O 0 0.010145284235477448

These O 0 0.009859142825007439
mutations O 1 0.9998949766159058
resulted O 0 0.016713619232177734
in O 0 0.0013381316093727946
the O 0 0.0014304120559245348
absence O 0 0.01866314373910427
or O 0 0.0029605310410261154
a O 0 0.004605303052812815
dramatic O 0 0.016962235793471336
decrease O 0 0.021818362176418304
of O 0 0.0023447314742952585
CPO O 1 0.9797484278678894
activity O 0 0.022187858819961548
. O 0 0.006948902737349272

The O 0 0.004558579996228218
two O 0 0.0053285569883883
polymorphisms O 1 0.9977754950523376
were O 0 0.0028873919509351254
localized O 1 0.9899919629096985
in O 0 0.00388711947016418
noncoding O 1 0.9984989166259766
part O 0 0.0023230938240885735
of O 0 0.0007992617320269346
the O 0 0.002911604940891266
gene O 1 0.9999556541442871
1 O 0 0.0060802302323281765
) O 0 0.0027467350009828806
a O 0 0.008770519867539406
C O 1 0.9936051964759827
/ O 1 0.9822462797164917
G O 1 0.9983078241348267
polymorphism O 1 0.9936229586601257
in O 0 0.0017220891313627362
the O 0 0.0027191289700567722
promotor O 1 0.9979873895645142
region O 0 0.005712668877094984
, O 0 0.0021256133913993835
142 O 0 0.036802180111408234
bp O 0 0.05703917145729065
upstream O 0 0.028048869222402573
from O 0 0.0015866796020418406
the O 0 0.002562737325206399
transcriptional O 1 0.9955202341079712
initiation O 1 0.8674177527427673
site O 0 0.009509963914752007
( O 0 0.006789813283830881
- O 0 0.33771181106567383
142C O 1 0.9997194409370422
/ O 1 0.9969357252120972
G O 1 0.9989942908287048
) O 0 0.003886657766997814
, O 0 0.0011491304030641913
and O 0 0.0012230671709403396
2 O 0 0.0052952999249100685
) O 0 0.0027706543914973736
a O 0 0.00495112081989646
6 O 0 0.010746851563453674
bp O 0 0.47354599833488464
deletion O 1 0.9992039799690247
polymorphism O 1 0.9915315508842468
in O 0 0.0017894913908094168
the O 0 0.0016040129121392965
3 O 0 0.00954375509172678
noncoding O 1 0.995072066783905
part O 0 0.002288198098540306
of O 0 0.0008100642007775605
the O 0 0.0023624214809387922
CPO O 1 0.9956766963005066
gene O 1 0.9995051622390747
, O 0 0.0053037009201943874
574 O 1 0.5295777320861816
bp O 0 0.06933780014514923
downstream O 0 0.032019395381212234
of O 0 0.0008977549732662737
the O 0 0.0010323766618967056
last O 0 0.002216240158304572
base O 0 0.0028981943614780903
of O 0 0.0009038329008035362
the O 0 0.0019967250991612673
normal O 0 0.2461085468530655
termination O 1 0.9961726069450378
codon O 1 0.9916129112243652
( O 0 0.011642711237072945
+ O 1 0.9773614406585693
574 O 1 0.975141704082489
delATTCTT O 1 0.9892985820770264
) O 0 0.009566332213580608
. O 0 0.006846121046692133

Five O 0 0.02043106220662594
intragenic O 1 0.9843202829360962
dimorphisms O 1 0.9687208533287048
are O 0 0.0014314333675429225
now O 0 0.0018869440536946058
well O 0 0.0018003841396421194
characterized O 0 0.0618700347840786
and O 0 0.0008016209467314184
the O 0 0.0011096568778157234
high O 0 0.003591864835470915
degree O 0 0.005646372213959694
of O 0 0.0018810834735631943
allelic O 1 0.999680757522583
heterogeneity O 1 0.9970346689224243
in O 0 0.003412846941500902
HC B-Disease 1 0.9909879565238953
is O 0 0.0020613931119441986
demonstrated O 0 0.0072405398823320866
with O 0 0.0016345699550583959
seven O 0 0.0020865947008132935
new O 0 0.0018418130930513144
different O 0 0.0030909671913832426
mutations O 1 0.9998993873596191
making O 0 0.0024804070126265287
a O 0 0.0020759927574545145
total O 0 0.0013253102079033852
of O 0 0.0009766197763383389
nineteen O 0 0.03443446755409241
CPO O 1 0.9991523027420044
gene B-Disease 1 0.9999898672103882
defects I-Disease 1 0.9999582767486572
reported O 0 0.012754684314131737
so O 0 0.0029785309452563524
far O 0 0.002991924062371254
. O 0 0.0028060218319296837
. O 0 0.005183788016438484

Coincidence O 0 0.0404464453458786
of O 0 0.001430016360245645
two O 0 0.0025272269267588854
novel O 0 0.020376726984977722
arylsulfatase O 1 0.9782106280326843
A O 0 0.018841546028852463
alleles O 1 0.9994188547134399
and O 0 0.006433437578380108
mutation O 1 0.9999586343765259
459 O 1 0.9904624819755554
+ O 1 0.9958953857421875
1G O 1 0.9994041919708252
> O 1 0.9731929302215576
A O 0 0.008172798901796341
within O 0 0.0020794628653675318
a O 0 0.004165789112448692
family O 0 0.00892956554889679
with O 0 0.00772704416885972
metachromatic B-Disease 1 0.9998552799224854
leukodystrophy I-Disease 1 0.9999699592590332
: O 0 0.009766687639057636
molecular O 1 0.9754776358604431
basis O 0 0.003512387629598379
of O 0 0.0018827843014150858
phenotypic O 1 0.9982128143310547
heterogeneity O 1 0.9944021105766296
. O 0 0.0077283126302063465

In O 0 0.004429538734257221
a O 0 0.0058154696598649025
family O 0 0.008082207292318344
with O 0 0.0024527583736926317
three O 0 0.0035381936468183994
siblings O 1 0.6326128244400024
, O 0 0.0014841287629678845
one O 0 0.0017238105647265911
developed O 0 0.011604727245867252
classical O 0 0.010085790418088436
late O 0 0.014640687964856625
infantile O 1 0.9999929666519165
metachromatic B-Disease 1 0.9999651908874512
leukodystrophy I-Disease 1 0.9999866485595703
( O 0 0.019810674712061882
MLD B-Disease 1 0.9998194575309753
) O 0 0.008143073879182339
, O 0 0.003904076525941491
fatal O 1 0.999708354473114
at O 0 0.0032079415395855904
age O 0 0.00513937184587121
5 O 0 0.00502705667167902
years O 0 0.001685525057837367
, O 0 0.0012915250845253468
with O 0 0.004450815264135599
deficient O 1 0.9996212720870972
arylsulfatase O 1 0.9945290684700012
A O 0 0.01680881530046463
( O 0 0.009999663569033146
ARSA O 1 0.9996765851974487
) O 0 0.004844255745410919
activity O 0 0.0066276718862354755
and O 0 0.0014085175935178995
increased O 0 0.012805761769413948
galactosylsulfatide O 1 0.9971016049385071
( O 0 0.010730636306107044
GS O 1 0.9999141693115234
) O 0 0.013897111639380455
excretion O 1 0.9989540576934814
. O 0 0.00966788362711668

The O 0 0.0032203958835452795
two O 0 0.0026511007454246283
other O 0 0.0019212515326216817
siblings O 1 0.8007866740226746
, O 0 0.002290034666657448
apparently O 0 0.013383666053414345
healthy O 1 0.6179531812667847
at O 0 0.003183845430612564
12 O 0 0.006179012358188629
( O 0 0.004610298201441765
1 O 0 0.010275243781507015
/ O 0 0.29100093245506287
2 O 0 0.006726149003952742
) O 0 0.0023803398944437504
and O 0 0.001037612440995872
15 O 0 0.003941574599593878
years O 0 0.0019068643450737
, O 0 0.0012554844142869115
respectively O 0 0.002954017836600542
, O 0 0.0008768322295509279
and O 0 0.0007175095961429179
their O 0 0.0017426868434995413
father O 0 0.007845412008464336
, O 0 0.002109968103468418
apparently O 0 0.014003909192979336
healthy O 1 0.8791564702987671
as O 0 0.0011445682030171156
well O 0 0.0011856637429445982
, O 0 0.0013692837674170732
presented O 0 0.007044469937682152
ARSA O 1 0.9996809959411621
and O 0 0.004602938890457153
GS O 1 0.9996424913406372
values O 0 0.005394226871430874
within O 0 0.0014913894701749086
the O 0 0.0010010149562731385
range O 0 0.004723266698420048
of O 0 0.004601785447448492
MLD B-Disease 1 0.9999747276306152
patients O 1 0.9993840456008911
. O 0 0.008757569827139378

Mutation O 1 0.9998890161514282
screening O 0 0.32639801502227783
and O 0 0.002502965508028865
sequence O 0 0.039071809500455856
analysis O 0 0.013274350203573704
disclosed O 0 0.013457553461194038
the O 0 0.0011023386614397168
involvement O 0 0.00977648701518774
of O 0 0.0008328663534484804
three O 0 0.002170644933357835
different O 0 0.005871322005987167
ARSA O 1 0.99996018409729
mutations O 1 0.9999322891235352
being O 0 0.002279971493408084
the O 0 0.001522475155070424
molecular O 1 0.985585629940033
basis O 0 0.002774452790617943
of O 0 0.001625393284484744
intrafamilial O 1 0.9975675344467163
phenotypic O 1 0.9986390471458435
heterogeneity O 1 0.9904961585998535
. O 0 0.009950073435902596

The O 0 0.00873776525259018
late O 0 0.027823030948638916
infantile O 1 0.9999847412109375
patient O 1 0.9997430443763733
inherited O 1 0.9915499687194824
from O 0 0.0025817302521318197
his O 0 0.003360718721523881
mother O 0 0.01221875287592411
the O 0 0.0021811339538544416
frequent O 0 0.05729497969150543
0 O 0 0.03291866555809975
- O 0 0.03362410515546799
type O 1 0.9354003071784973
mutation O 1 0.9999254941940308
459 O 1 0.9869280457496643
+ O 1 0.9963186979293823
1G O 1 0.9995723366737366
> O 1 0.9970370531082153
A O 0 0.012908359058201313
, O 0 0.001401042565703392
and O 0 0.0007694501546211541
from O 0 0.0014440810773521662
his O 0 0.0023112616036087275
father O 0 0.006873353384435177
a O 0 0.00569714093580842
novel O 0 0.013507746160030365
, O 0 0.001664291019551456
single O 0 0.009970457293093204
basepair O 1 0.9936075210571289
microdeletion O 1 0.8991994857788086
of O 0 0.0031510796397924423
guanine O 1 0.9891307353973389
at O 0 0.0054709454998373985
nucleotide O 1 0.9929476976394653
7 O 0 0.009024525061249733
in O 0 0.0033597955480217934
exon O 1 0.9981340765953064
1 O 0 0.013006788678467274
( O 0 0.00809879694133997
7delG O 1 0.990704357624054
) O 0 0.0064855278469622135
. O 0 0.004887969698756933

The O 0 0.0051794471219182014
two O 0 0.006465241778641939
clinically O 1 0.9984079003334045
unaffected O 1 0.9485331177711487
siblings O 0 0.045791834592819214
carried O 0 0.006828978657722473
the O 0 0.004539952613413334
maternal O 1 0.9986923336982727
mutation O 1 0.9999504089355469
459 O 1 0.9886520504951477
+ O 1 0.9978898167610168
1G O 1 0.9996592998504639
> O 1 0.995936393737793
A O 0 0.010642404668033123
and O 0 0.0010797965805977583
, O 0 0.0008346200920641422
on O 0 0.0009481405140832067
their O 0 0.0036322902888059616
paternal O 1 0.998579740524292
allele O 1 0.999618649482727
, O 0 0.0025274574290961027
a O 0 0.005871182307600975
novel O 0 0.021202482283115387
cytosine O 1 0.9847820401191711
to O 0 0.0038540654350072145
thymidine O 1 0.9964639544487
transition O 0 0.02706109546124935
at O 0 0.006162216421216726
nucleotide O 1 0.9968648552894592
2435 O 1 0.9944491386413574
in O 0 0.00625030929222703
exon O 1 0.9972438812255859
8 O 0 0.010654094628989697
, O 0 0.0018625116208568215
resulting O 0 0.0196344293653965
in O 0 0.002245563780888915
substitution O 0 0.12148939073085785
of O 0 0.0034618356730788946
alanine O 1 0.995609700679779
464 O 1 0.8350738286972046
by O 0 0.008774964138865471
valine O 1 0.9981411695480347
( O 0 0.011174378916621208
A464V O 1 0.9937112331390381
) O 0 0.007900778204202652
. O 0 0.006906113587319851

The O 0 0.008015590719878674
fathers O 0 0.05956851691007614
genotype O 1 0.9992882609367371
thus O 0 0.012116201221942902
was O 0 0.006750003434717655
7delG O 1 0.9961535334587097
/ O 1 0.8667388558387756
A464V O 1 0.9543956518173218
. O 0 0.012882586568593979

Mutation O 1 0.9999384880065918
A464V O 1 0.9737311601638794
was O 0 0.0030889343470335007
not O 0 0.0010555661283433437
found O 0 0.003268428146839142
in O 0 0.0018629325786605477
18 O 0 0.011680606752634048
unrelated O 1 0.997945249080658
MLD B-Disease 1 0.999971866607666
patients O 1 0.9993683695793152
and O 0 0.00230586645193398
50 O 0 0.007142552174627781
controls O 0 0.027348916977643967
. O 0 0.007307066116482019

A464V O 1 0.937495768070221
, O 0 0.0038886857219040394
although O 0 0.0035531707108020782
clearly O 0 0.009109525009989738
modifying O 1 0.9879816174507141
ARSA O 1 0.9990059733390808
and O 0 0.00697596650570631
GS O 1 0.9999363422393799
levels O 0 0.020382173359394073
, O 0 0.0020845939870923758
apparently O 0 0.008638128638267517
bears O 0 0.008408388122916222
little O 0 0.0036220296751707792
significance O 0 0.004711108282208443
for O 0 0.002506904536858201
clinical O 1 0.9993925094604492
manifestation O 1 0.6220201849937439
of O 0 0.0032011244911700487
MLD B-Disease 1 0.9998260140419006
, O 0 0.003999182488769293
mimicking O 1 0.9547845125198364
the O 0 0.004809159319847822
frequent O 0 0.3643024265766144
ARSA O 1 0.9995319843292236
pseudodeficiency O 1 0.9946348667144775
allele O 1 0.9965267777442932
. O 0 0.014814992435276508

Our O 0 0.007082860451191664
results O 0 0.009887069463729858
demonstrate O 0 0.006624674424529076
that O 0 0.0009962194599211216
in O 0 0.0012642599176615477
certain O 0 0.006430859677493572
genetic O 1 0.9999357461929321
conditions O 0 0.11409736424684525
MLD B-Disease 1 0.9999151229858398
- O 0 0.057309914380311966
like O 0 0.01528407633304596
ARSA O 1 0.9997709393501282
and O 0 0.0066277687437832355
GS O 1 0.999925971031189
values O 0 0.006248332094401121
need O 0 0.0029074756894260645
not O 0 0.0007626985898241401
be O 0 0.0011066024890169501
paralleled O 1 0.501426100730896
by O 0 0.010444282554090023
clinical O 1 0.9999940395355225
disease O 1 0.9999945163726807
, O 0 0.001513178925961256
a O 0 0.004108772147446871
finding O 0 0.008068187162280083
with O 0 0.0036902225110679865
serious O 1 0.8174217939376831
diagnostic O 1 0.9988995790481567
and O 0 0.004886694718152285
prognostic O 1 0.9996440410614014
implications O 0 0.45291078090667725
. O 0 0.009299102239310741

Moreover O 0 0.02974458783864975
, O 0 0.0033116950653493404
further O 0 0.009823564440011978
ARSA O 1 0.999464213848114
alleles O 1 0.9997451901435852
functionally O 1 0.9937729239463806
similar O 0 0.007041986100375652
to O 0 0.0021552713587880135
A464V O 1 0.9972437620162964
might O 0 0.005190251860767603
exist O 0 0.0024389950558543205
which O 0 0.0007219210965558887
, O 0 0.0006471227970905602
together O 0 0.001805445528589189
with O 0 0.002154260640963912
0 O 0 0.1153951957821846
- O 0 0.3209354877471924
type O 1 0.9954044818878174
mutations O 1 0.999988317489624
, O 0 0.0026481254026293755
may O 0 0.007326265797019005
cause O 1 0.9962455630302429
pathological O 1 0.9997941851615906
ARSA O 1 0.9998533725738525
and O 0 0.007094244938343763
GS O 1 0.999923825263977
levels O 0 0.01518302969634533
, O 0 0.001397093292325735
but O 0 0.0013281835708767176
not O 0 0.0022442257031798363
clinical O 1 0.9998770952224731
outbreak O 1 0.9987038373947144
of O 0 0.0016257454408332705
the O 0 0.005092255771160126
disease O 1 0.9999949932098389
. O 0 0.004187690559774637
. O 0 0.005998771637678146

Human O 0 0.40526044368743896
MLH1 O 1 0.999876856803894
deficiency O 1 0.9999943971633911
predisposes O 1 0.9988788962364197
to O 0 0.015870127826929092
hematological B-Disease 1 0.9999417066574097
malignancy I-Disease 1 0.9999707937240601
and O 0 0.013360375538468361
neurofibromatosis B-Disease 1 0.9999915361404419
type I-Disease 1 0.6334251761436462
1 I-Disease 0 0.011587625369429588
. O 0 0.005911676678806543

Heterozygous O 1 0.998802900314331
germ O 1 0.9979642629623413
- O 0 0.035442326217889786
line O 0 0.015703141689300537
mutations O 1 0.9997889399528503
in O 0 0.0017925576539710164
the O 0 0.002930436749011278
DNA O 1 0.9997442364692688
mismatch O 1 0.9991694688796997
repair O 1 0.9951817393302917
genes O 1 0.9972410202026367
lead O 0 0.022248584777116776
to O 0 0.0058389282785356045
hereditary B-Disease 1 0.9999839067459106
nonpolyposis I-Disease 1 0.9999924898147583
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
. O 0 0.014279450289905071

The O 0 0.020671427249908447
disease O 1 0.9999853372573853
susceptibility O 1 0.9997380375862122
of O 0 0.001948585850186646
individuals O 0 0.004257666412740946
who O 0 0.0019669386092573404
constitutionally O 0 0.01957419514656067
lack O 0 0.00712960259988904
both O 0 0.002529154298827052
wild O 0 0.1980162262916565
- O 0 0.4176936447620392
type O 1 0.9908314347267151
alleles O 1 0.9998425245285034
is O 0 0.004503930918872356
unknown O 0 0.018204104155302048
. O 0 0.006139025557786226

We O 0 0.0026132550556212664
have O 0 0.0011289374670013785
identified O 0 0.005970196798443794
three O 0 0.0024248315021395683
offspring O 1 0.8283600211143494
in O 0 0.001954140141606331
a O 0 0.016571762040257454
hereditary B-Disease 1 0.9999918937683105
nonpolyposis I-Disease 1 0.9999898672103882
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
family O 0 0.01852809451520443
who O 0 0.005293050315231085
developed O 1 0.8165878653526306
hematological B-Disease 1 0.9999862909317017
malignancy I-Disease 1 0.999976396560669
at O 0 0.0036744270473718643
a O 0 0.005008425563573837
very O 0 0.0025964316446334124
early O 0 0.004075224511325359
age O 0 0.005334874149411917
, O 0 0.0011865500127896667
and O 0 0.000777583452872932
at O 0 0.0012068357318639755
least O 0 0.0016837544972077012
two O 0 0.0008657511789351702
of O 0 0.00045569214853458107
them O 0 0.0007560710655525327
displayed O 0 0.003151669865474105
signs O 0 0.011238275095820427
of O 0 0.004032527562230825
neurofibromatosis B-Disease 1 0.9999984502792358
type I-Disease 1 0.8778213262557983
1 I-Disease 0 0.014644225127995014
( O 0 0.013134082779288292
NF1 B-Disease 1 0.9998775720596313
) O 0 0.008885558694601059
. O 0 0.005859288852661848

DNA O 1 0.981243908405304
sequence O 0 0.05957948416471481
analysis O 0 0.015611431561410427
and O 0 0.003462343942373991
allele O 1 0.9999041557312012
- O 0 0.023529311642050743
specific O 0 0.010699055157601833
amplification O 1 0.9883252382278442
in O 0 0.001931077684275806
two O 0 0.0027087077032774687
siblings O 0 0.27880215644836426
revealed O 0 0.014874552376568317
a O 0 0.010571046732366085
homozygous O 1 0.9998167157173157
MLH1 O 1 0.9997934699058533
mutation O 1 0.9998669624328613
( O 0 0.017367957159876823
C676T O 1 0.9975864887237549
- O 1 0.7711655497550964
- O 1 0.5757024884223938
> O 1 0.9976462721824646
Arg226Stop O 1 0.9858168363571167
) O 0 0.009299898520112038
. O 0 0.007266436703503132

Thus O 0 0.010968088172376156
, O 0 0.0023365195374935865
a O 0 0.011455094441771507
homozygous O 1 0.9998327493667603
germ O 1 0.9994107484817505
- O 0 0.03851870447397232
line O 0 0.021228943020105362
MLH1 O 1 0.9998065829277039
mutation O 1 0.9998998641967773
and O 0 0.00506981648504734
consequent O 1 0.9973481893539429
mismatch O 1 0.9999281167984009
repair O 1 0.9998630285263062
deficiency O 1 0.9999951124191284
results O 0 0.01240625698119402
in O 0 0.0022125786636024714
a O 0 0.01352818962186575
mutator O 1 0.999935507774353
phenotype O 1 0.9999887943267822
characterized O 1 0.8871117830276489
by O 0 0.016157323494553566
leukemia B-Disease 1 0.9999994039535522
and O 0 0.0054473914206027985
/ O 1 0.9974414110183716
or O 0 0.3194526433944702
lymphoma B-Disease 1 0.9999998807907104
associated O 0 0.03519117832183838
with O 0 0.01115463301539421
neurofibromatosis B-Disease 1 0.999998927116394
type I-Disease 1 0.8068996071815491
1 I-Disease 0 0.007856502197682858
. O 0 0.002551368670538068
. O 0 0.0052350182086229324

Missense O 1 0.9994961023330688
mutations O 1 0.9997735619544983
in O 0 0.0019045440712943673
the O 0 0.0008952636853791773
most O 0 0.0008645727066323161
ancient O 0 0.002589656040072441
residues O 0 0.16069436073303223
of O 0 0.0010441865306347609
the O 0 0.0034733633510768414
PAX6 O 1 0.9998445510864258
paired O 1 0.831615686416626
domain O 0 0.043777089565992355
underlie O 1 0.9638074636459351
a O 0 0.0056685288436710835
spectrum O 0 0.025003092363476753
of O 0 0.002846573945134878
human O 1 0.9885363578796387
congenital B-Disease 1 1.0
eye I-Disease 1 0.9997486472129822
malformations I-Disease 1 0.999968409538269
. O 0 0.01198298204690218

Mutations O 1 0.9971879124641418
of O 0 0.0018333704210817814
the O 0 0.0025110214482992887
human O 0 0.03917425498366356
PAX6 O 1 0.9999725818634033
gene O 1 0.9999145269393921
underlie O 1 0.9990799427032471
aniridia B-Disease 1 0.9992619156837463
( O 0 0.02181435190141201
congenital B-Disease 1 0.999998927116394
absence I-Disease 0 0.016183022409677505
of I-Disease 0 0.0009709260193631053
the I-Disease 0 0.0030481943394988775
iris I-Disease 1 0.9999169111251831
) O 0 0.003463369095697999
, O 0 0.0012138276360929012
a O 0 0.005964668933302164
rare O 0 0.04352611303329468
dominant O 1 0.9355365037918091
malformation B-Disease 1 0.9999597072601318
of I-Disease 0 0.002375120995566249
the I-Disease 0 0.004163914360105991
eye I-Disease 1 0.9898849725723267
. O 0 0.007594752591103315

The O 0 0.004522417206317186
spectrum O 0 0.02758975885808468
of O 0 0.004086728673428297
PAX6 O 1 0.9999786615371704
mutations O 1 0.9999544620513916
in O 0 0.006002204492688179
aniridia B-Disease 1 0.9999065399169922
patients O 1 0.9996237754821777
is O 0 0.0025523360818624496
highly O 0 0.009986333549022675
biased O 0 0.021910449489951134
, O 0 0.00144889613147825
with O 0 0.0020616906695067883
92 O 0 0.01285262405872345
% O 0 0.002120837802067399
of O 0 0.0005367752746678889
all O 0 0.0010520311770960689
reported O 0 0.014580939896404743
mutations O 1 0.9999545812606812
leading O 0 0.00871973019093275
to O 0 0.002519011264666915
premature O 1 0.9974621534347534
truncation O 1 0.9819139838218689
of O 0 0.0012964666821062565
the O 0 0.0030837084632366896
protein O 1 0.9993075132369995
( O 0 0.005060555413365364
nonsense O 0 0.04840754717588425
, O 0 0.0033832930494099855
splicing O 1 0.999504566192627
, O 0 0.003744120243936777
insertions O 1 0.9932924509048462
and O 0 0.0035814677830785513
deletions O 1 0.9991536140441895
) O 0 0.0032036283519119024
and O 0 0.0009666400728747249
just O 0 0.0022432543337345123
2 O 0 0.005042762495577335
% O 0 0.0034273765049874783
leading O 0 0.003931866958737373
to O 0 0.0010023133363574743
substitution O 0 0.032061513513326645
of O 0 0.0010471924906596541
one O 0 0.002690651686862111
amino O 1 0.996782660484314
acid O 1 0.9960218071937561
by O 0 0.0029056239873170853
another O 0 0.0074443272314965725
( O 0 0.008065423928201199
missense O 1 0.9997232556343079
) O 0 0.007271260488778353
. O 0 0.005883999168872833

The O 0 0.00452160369604826
extraordinary O 0 0.008202416822314262
conservation O 0 0.008438856340944767
of O 0 0.0011398628121241927
the O 0 0.003967147320508957
PAX6 O 1 0.9998630285263062
protein O 1 0.9963356256484985
at O 0 0.002208050573244691
the O 0 0.001844170968979597
amino O 1 0.9927955269813538
acid O 1 0.9963927865028381
level O 0 0.00473821023479104
amongst O 0 0.007769070565700531
vertebrates O 1 0.8901710510253906
predicts O 0 0.13410235941410065
that O 0 0.004242483992129564
pathological O 1 0.9996798038482666
missense O 1 0.9999492168426514
mutations O 1 0.999975323677063
should O 0 0.002248310251161456
in O 0 0.001013781176880002
fact O 0 0.0018335389904677868
be O 0 0.000884815352037549
common O 0 0.007527347654104233
even O 0 0.0018742299871519208
though O 0 0.001888461410999298
they O 0 0.0005743480287492275
are O 0 0.0005973379011265934
hardly O 0 0.0057387095876038074
ever O 0 0.002611577743664384
seen O 0 0.0052668992429971695
in O 0 0.005643556360155344
aniridia B-Disease 1 0.9998674392700195
patients O 1 0.9993764758110046
. O 0 0.009863663464784622

This O 0 0.0040725236758589745
indicates O 0 0.010931226424872875
that O 0 0.0010453872382640839
there O 0 0.0008191121160052717
is O 0 0.001102360663935542
a O 0 0.004127003252506256
heavy O 0 0.017743952572345734
ascertainment O 1 0.9992451667785645
bias O 0 0.09672659635543823
in O 0 0.0010633092606440187
the O 0 0.0009508462972007692
selection O 0 0.004784899298101664
of O 0 0.0019244179129600525
patients O 1 0.999704897403717
for O 0 0.006486271973699331
PAX6 O 1 0.9999969005584717
mutation O 1 0.9999865293502808
analysis O 0 0.011878485791385174
and O 0 0.0008269980316981673
that O 0 0.0007195977377705276
the O 0 0.001839943346567452
missing O 0 0.1785954385995865
PAX6 O 1 0.999944806098938
missense O 1 0.9999388456344604
mutations O 1 0.9999294281005859
frequently O 0 0.009263171814382076
may O 0 0.008430322632193565
underlie O 1 0.9987788796424866
phenotypes O 1 0.9997337460517883
distinct O 0 0.022158188745379448
from O 0 0.004409005865454674
textbook O 1 0.8731880187988281
aniridia B-Disease 1 0.9963856935501099
. O 0 0.012709866277873516

Here O 0 0.0027727356646209955
we O 0 0.000902429863344878
present O 0 0.001815886003896594
four O 0 0.004031035583466291
novel O 0 0.16131067276000977
PAX6 O 1 0.9999687671661377
missense O 1 0.999962568283081
mutations O 1 0.999955415725708
, O 0 0.0020109210163354874
two O 0 0.0012845472665503621
in O 0 0.001133251003921032
association O 0 0.006488029845058918
with O 0 0.007240553852170706
atypical O 1 0.9999430179595947
phenotypes O 1 0.9999223947525024
ectopia B-Disease 1 0.9978424310684204
pupillae I-Disease 1 0.994182288646698
( O 0 0.005676872096955776
displaced B-Disease 0 0.024058256298303604
pupils I-Disease 0 0.019965557381510735
) O 0 0.005349712446331978
and O 0 0.00794319249689579
congenital B-Disease 1 0.9999998807907104
nystagmus I-Disease 1 0.9999487400054932
( O 0 0.005895898677408695
searching B-Disease 0 0.024901961907744408
gaze I-Disease 1 0.7460741400718689
) O 0 0.002842396032065153
, O 0 0.0009919599397107959
and O 0 0.0006143258069641888
two O 0 0.001168313785456121
in O 0 0.0011152650695294142
association O 0 0.003947082441300154
with O 0 0.0018614783184602857
more O 0 0.002358177211135626
recognizable O 1 0.9455345869064331
aniridia B-Disease 1 0.9986894726753235
phenotypes O 1 0.9994164705276489
. O 0 0.011278180405497551

Strikingly O 0 0.08499720692634583
, O 0 0.001832687295973301
all O 0 0.000826507224701345
four O 0 0.0044233538210392
mutations O 1 0.9999604225158691
are O 0 0.0008109319023787975
located O 0 0.0015944928163662553
within O 0 0.001716481288895011
the O 0 0.0029407606925815344
PAX6 O 1 0.9998645782470703
paired O 1 0.8077831864356995
domain O 0 0.022855302318930626
and O 0 0.001822686637751758
affect O 0 0.031679995357990265
amino O 1 0.9974237680435181
acids O 1 0.9862275719642639
which O 0 0.0011450251331552863
are O 0 0.0006963862106204033
highly O 0 0.006814869586378336
conserved O 0 0.06999336928129196
in O 0 0.0009550537797622383
all O 0 0.0008179952274076641
known O 0 0.0067736185155808926
paired O 1 0.6991646885871887
domain O 0 0.25664812326431274
proteins O 1 0.9888978600502014
. O 0 0.008324488997459412

Our O 0 0.006559242028743029
results O 0 0.007513694930821657
support O 0 0.0023183899465948343
the O 0 0.0013235314982011914
hypothesis O 0 0.32495367527008057
that O 0 0.0008175486582331359
the O 0 0.00082627177471295
under O 0 0.0014703470515087247
- O 0 0.00691783195361495
representation O 0 0.004128734115511179
of O 0 0.00274641253054142
missense O 1 0.9999754428863525
mutations O 1 0.9999759197235107
is O 0 0.003460230538621545
caused O 0 0.0384494848549366
by O 0 0.0048964316956698895
ascertainment O 1 0.9993718266487122
bias O 0 0.4013766646385193
and O 0 0.0011975362431257963
suggest O 0 0.0046967375092208385
that O 0 0.0007958603673614562
a O 0 0.002851724624633789
substantial O 0 0.007617067079991102
burden O 0 0.022408273071050644
of O 0 0.0035790917463600636
PAX6 B-Disease 1 0.999993085861206
- I-Disease 1 0.9674965143203735
related I-Disease 1 0.918632984161377
disease I-Disease 1 0.9999932050704956
remains O 0 0.0053793094120919704
to O 0 0.0011565644526854157
be O 0 0.0015235098544508219
uncovered O 0 0.02409934811294079
. O 0 0.0025529609993100166
. O 0 0.004612990655004978

The O 0 0.009195205755531788
chromosomal O 1 0.9996646642684937
order O 0 0.00508703850209713
of O 0 0.0019807862117886543
genes O 1 0.9993543028831482
controlling O 0 0.3824383020401001
the O 0 0.0023170211352407932
major O 0 0.014298280701041222
histocompatibility O 1 0.9998853206634521
complex O 0 0.020086554810404778
, O 0 0.003382439026609063
properdin O 1 0.9980714917182922
factor O 1 0.8603172898292542
B O 1 0.9537405967712402
, O 0 0.0019728285260498524
and O 0 0.003156015882268548
deficiency B-Disease 1 0.9999963045120239
of I-Disease 0 0.001188513357192278
the I-Disease 0 0.0011465060524642467
second I-Disease 0 0.00439088698476553
component I-Disease 0 0.02083090879023075
of I-Disease 0 0.001942419563420117
complement I-Disease 0 0.14106565713882446
. O 0 0.006736219394952059

The O 0 0.0034899101592600346
relationship O 0 0.007901330478489399
of O 0 0.0008773026638664305
the O 0 0.003310944652184844
genes O 1 0.9998233914375305
coding O 1 0.9994175434112549
for O 0 0.004946359433233738
HLA O 1 0.9998902082443237
to O 0 0.0018481716979295015
those O 0 0.00210289447568357
coding O 1 0.996260941028595
for O 0 0.003482858184725046
properdin O 1 0.9983510971069336
Factor O 1 0.9396075010299683
B O 1 0.9917633533477783
allotypes O 1 0.9767748713493347
and O 0 0.0020307523664087057
for O 0 0.004266803618520498
deficiency B-Disease 1 0.9999942779541016
of I-Disease 0 0.0009103210177272558
the I-Disease 0 0.0009255683398805559
second I-Disease 0 0.0038292098324745893
component I-Disease 0 0.014389130286872387
of I-Disease 0 0.0011448223376646638
complement I-Disease 1 0.9149672389030457
( O 0 0.00884051714092493
C2 O 1 0.9999669790267944
) O 0 0.0037075448781251907
was O 0 0.0014030212769284844
studied O 0 0.003191419644281268
in O 0 0.0009084861958399415
families O 0 0.0032670083455741405
of O 0 0.0020832642912864685
patients O 1 0.9998867511749268
with O 0 0.0546414814889431
connective O 1 0.9999996423721313
tissue O 1 0.9999985694885254
disorders O 1 0.9999935626983643
. O 0 0.010262299329042435

Patients O 1 0.993347704410553
were O 0 0.0014269365929067135
selected O 0 0.0029431539587676525
because O 0 0.0018455162644386292
they O 0 0.0006244176183827221
were O 0 0.0014559765113517642
heterozygous O 1 0.9992663264274597
or O 0 0.009095908142626286
homozygous O 1 0.999599039554596
for O 0 0.01964879222214222
C2 B-Disease 1 0.9999963045120239
deficiency I-Disease 1 0.999994158744812
. O 0 0.01665380783379078

12 O 0 0.01236063614487648
families O 0 0.0060625397600233555
with O 0 0.003231834853067994
15 O 0 0.007545551750808954
matings O 1 0.9897712469100952
informative O 0 0.038197506219148636
for O 0 0.010389304719865322
C2 B-Disease 1 0.9999983310699463
deficiency I-Disease 1 0.9999988079071045
were O 0 0.002264991169795394
found O 0 0.008577298372983932
. O 0 0.006582115311175585

Of O 0 0.0045177205465734005
57 O 0 0.022178787738084793
informative O 0 0.04950152710080147
meioses O 1 0.9772040843963623
, O 0 0.001890937564894557
two O 0 0.001941693015396595
crossovers O 0 0.03654220327734947
were O 0 0.0009764475980773568
noted O 0 0.0020054890774190426
between O 0 0.0024354916531592607
the O 0 0.008674870245158672
C2 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999998807907104
gene O 1 0.9999170303344727
and O 0 0.002134533366188407
the O 0 0.004794402979314327
HLA O 1 0.9999977350234985
- O 1 0.9649899005889893
B O 1 0.9984288811683655
gene O 1 0.9997588992118835
, O 0 0.0017918574158102274
with O 0 0.002033352619037032
a O 0 0.006708548404276371
recombinant O 1 0.9986138343811035
fraction O 0 0.02166110649704933
of O 0 0.0023740525357425213
0 O 0 0.022667335346341133
. O 0 0.0068625654093921185

035 O 1 0.9554605484008789
. O 0 0.02203572727739811

A O 0 0.030828537419438362
lod O 1 0.6247501969337463
score O 0 0.00475384620949626
of O 0 0.0008559230482205749
13 O 0 0.00358689040876925
was O 0 0.0013229945907369256
calculated O 0 0.005564215127378702
for O 0 0.0021892597433179617
linkage O 1 0.9973011612892151
between O 0 0.022304395213723183
C2 B-Disease 1 0.9999991655349731
deficiency I-Disease 1 0.9999996423721313
and O 0 0.013088333420455456
HLA O 1 0.9999953508377075
- O 1 0.6593172550201416
B O 1 0.8801659345626831
at O 0 0.0025140736252069473
a O 0 0.0038723270408809185
maximum O 0 0.007560056634247303
likelihood O 0 0.022613218054175377
value O 0 0.00148424890358001
of O 0 0.0007028495892882347
the O 0 0.0026843128725886345
recombinant O 1 0.9995563626289368
fraction O 0 0.020423945039510727
of O 0 0.0025316313840448856
0 O 0 0.024327116087079048
. O 0 0.006454367656260729

04 O 0 0.2165677547454834
. O 0 0.016920259222388268

18 O 0 0.010912250727415085
families O 0 0.006233394145965576
with O 0 0.003289250424131751
21 O 0 0.008880257606506348
informative O 0 0.03855949267745018
matings O 1 0.9869109392166138
for O 0 0.002129249507561326
both O 0 0.002675502561032772
properdin O 1 0.9971332550048828
Factor O 1 0.9056882858276367
B O 1 0.9907445311546326
allotype O 1 0.9946972131729126
and O 0 0.00722893001511693
HLA O 1 0.9999936819076538
- O 0 0.3909792900085449
B O 1 0.6456701755523682
were O 0 0.0016933800652623177
found O 0 0.007945910096168518
. O 0 0.005209244322031736

Of O 0 0.004330901429057121
72 O 0 0.024643614888191223
informative O 0 0.04603277146816254
meioses O 1 0.9649251699447632
, O 0 0.002329814014956355
three O 0 0.002719859592616558
recombinants O 1 0.9469631910324097
were O 0 0.0012033631792291999
found O 0 0.0034894279669970274
, O 0 0.0011986375320702791
giving O 0 0.005850756075233221
a O 0 0.007598512805998325
recombinant O 1 0.998518168926239
fraction O 0 0.022346526384353638
of O 0 0.002368407789617777
0 O 0 0.020989632233977318
. O 0 0.0058864508755505085

042 O 1 0.765106737613678
. O 0 0.021233128383755684

A O 0 0.024467814713716507
lod O 0 0.2086271196603775
score O 0 0.004172938410192728
of O 0 0.001075196429155767
16 O 0 0.0064656855538487434
between O 0 0.00840590801090002
HLA O 1 0.9999957084655762
- O 1 0.580413281917572
B O 1 0.9518727660179138
and O 0 0.002950974740087986
Factor O 1 0.9479936361312866
B O 1 0.991752564907074
allotypes O 1 0.9806157946586609
was O 0 0.0019349128706380725
calculated O 0 0.006761570926755667
at O 0 0.00144002097658813
a O 0 0.0036387117579579353
maximum O 0 0.007654869928956032
likelihood O 0 0.026305414736270905
value O 0 0.001580319949425757
of O 0 0.000765458564274013
the O 0 0.002400253200903535
recombinant O 1 0.999175488948822
fraction O 0 0.021624991670250893
of O 0 0.0024688260164111853
0 O 0 0.022162113338708878
. O 0 0.007617502938956022

04 O 0 0.2000931203365326
. O 0 0.016457004472613335

A O 0 0.018621861934661865
crossover O 0 0.04326869547367096
was O 0 0.00274045136757195
shown O 0 0.003983784932643175
to O 0 0.0007443608483299613
have O 0 0.0009368038736283779
occurred O 0 0.006473396439105272
between O 0 0.0029090438038110733
genes O 1 0.9988765120506287
for O 0 0.0019398918375372887
Factor O 1 0.9091823101043701
B O 1 0.987483024597168
and O 0 0.004409152548760176
HLA O 1 0.9999970197677612
- O 1 0.9034563899040222
D O 1 0.9699287414550781
, O 0 0.0015989624662324786
in O 0 0.0017190978396683931
which O 0 0.0046064406633377075
HLA O 1 0.9999855756759644
- O 1 0.689721405506134
D O 1 0.9941115975379944
segregared O 1 0.9945594668388367
with O 0 0.014020041562616825
HLA O 1 0.9999738931655884
- O 0 0.03675032779574394
A O 0 0.01504265796393156
and O 0 0.004302508197724819
B O 1 0.8842652440071106
. O 0 0.009198421612381935

These O 0 0.004440547898411751
studies O 0 0.008791457861661911
suggest O 0 0.005013273563235998
that O 0 0.000743577373214066
the O 0 0.001648461795412004
genes O 1 0.9990535378456116
for O 0 0.0026597105897963047
Factor O 1 0.6093372106552124
B O 1 0.9934216141700745
and O 0 0.008229915983974934
C2 B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.999998927116394
are O 0 0.0012865436729043722
located O 0 0.0017779438057914376
outside O 0 0.0016326738987118006
those O 0 0.0012235670583322644
for O 0 0.003522489219903946
HLA O 1 0.9999850988388062
, O 0 0.0017338249599561095
that O 0 0.0006783995195291936
the O 0 0.0007419970934279263
order O 0 0.0017452443717047572
of O 0 0.0012407226022332907
genese O 1 0.9975638389587402
is O 0 0.006525926757603884
HLA O 1 0.9999901056289673
- O 0 0.02545202150940895
A O 0 0.011964796110987663
, O 0 0.003944885451346636
- O 0 0.4310702383518219
B O 1 0.9937123656272888
, O 0 0.003468394046649337
- O 0 0.21380382776260376
D O 1 0.990574300289154
, O 0 0.00349987274967134
Factor O 1 0.7203311324119568
B O 1 0.991334855556488
allotype O 1 0.9976531863212585
, O 0 0.015196012333035469
C2 B-Disease 1 0.9999978542327881
deficiency I-Disease 1 0.9999985694885254
, O 0 0.002057483186945319
that O 0 0.0010009658290073276
the O 0 0.0023397207260131836
genes O 1 0.9995706677436829
coding O 1 0.9980148077011108
for O 0 0.010832970030605793
C2 B-Disease 1 0.9999985694885254
deficiency I-Disease 1 0.9999990463256836
and O 0 0.004045701585710049
Factor O 1 0.9245052337646484
B O 1 0.9920629858970642
allotypes O 1 0.8156846761703491
are O 0 0.0011500546243041754
approximately O 0 0.003830610541626811
3 O 0 0.012137440964579582
- O 0 0.02419132925570011
- O 0 0.019973695278167725
5 O 0 0.009228612296283245
centimorgans O 1 0.8342621922492981
from O 0 0.0018820550758391619
the O 0 0.0032527989242225885
HLA O 1 0.9999845027923584
- O 0 0.02732500620186329
A O 0 0.011850903742015362
and O 0 0.005282075144350529
HLA O 1 0.9999969005584717
- O 1 0.9363322257995605
B O 1 0.9983514547348022
loci O 1 0.9997219443321228
, O 0 0.0017575258389115334
and O 0 0.0006550242542289197
that O 0 0.0007541548111476004
the O 0 0.0012925508199259639
apparent O 0 0.09254754334688187
lack O 0 0.006889494601637125
of O 0 0.0015700168441981077
recombinants O 1 0.9525399804115295
between O 0 0.0023294484708458185
the O 0 0.0021187742240726948
Factor O 1 0.8447979688644409
B O 1 0.9979565143585205
gene O 1 0.9999200105667114
and O 0 0.012398863211274147
C2 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999998807907104
gene O 1 0.9999226331710815
suggests O 0 0.012541500851511955
that O 0 0.0008442645776085556
these O 0 0.00098570401314646
two O 0 0.0027747696731239557
genes O 1 0.9997361302375793
lie O 0 0.009680405259132385
in O 0 0.0014238321455195546
close O 0 0.004687754437327385
proximity O 0 0.014490500092506409
to O 0 0.0012471206719055772
one O 0 0.0020317004527896643
another O 0 0.007104999851435423
. O 0 0.005560300778597593

Distribution O 0 0.02307434193789959
of O 0 0.00277138059027493
emerin O 1 0.98060142993927
and O 0 0.0033098747953772545
lamins O 1 0.9969683289527893
in O 0 0.002152401953935623
the O 0 0.002970324829220772
heart O 1 0.9977578520774841
and O 0 0.0025785237085074186
implications O 0 0.21063868701457977
for O 0 0.005507795140147209
Emery B-Disease 1 0.9992896318435669
- I-Disease 1 0.9848359227180481
Dreifuss I-Disease 1 0.9997346997261047
muscular I-Disease 1 0.9999798536300659
dystrophy I-Disease 1 0.9999904632568359
. O 0 0.019916828721761703

Emerin O 1 0.598052978515625
is O 0 0.0034493720158934593
a O 0 0.005907653830945492
nuclear O 0 0.016329234465956688
membrane O 1 0.9985520243644714
protein O 1 0.9975977540016174
which O 0 0.0012980488827452064
is O 0 0.0013388569932430983
missing O 0 0.01123544480651617
or O 0 0.004370687063783407
defective O 1 0.999470055103302
in O 0 0.005701913498342037
Emery B-Disease 1 0.9992530941963196
- I-Disease 1 0.9851722717285156
Dreifuss I-Disease 1 0.9998799562454224
muscular I-Disease 1 0.9999947547912598
dystrophy I-Disease 1 0.9999982118606567
( O 0 0.023041149601340294
EDMD B-Disease 1 0.9994000196456909
) O 0 0.008255193009972572
. O 0 0.006469153333455324

It O 0 0.0033518807031214237
is O 0 0.0015651278663426638
one O 0 0.0010496436152607203
member O 0 0.0014060349203646183
of O 0 0.000749354250729084
a O 0 0.004251628182828426
family O 0 0.00707442220300436
of O 0 0.002463400596752763
lamina O 1 0.9998829364776611
- O 0 0.04365069419145584
associated O 0 0.017136409878730774
proteins O 1 0.9864403605461121
which O 0 0.0016862457850947976
includes O 0 0.005968702025711536
LAP1 O 1 0.9974986910820007
, O 0 0.004072477109730244
LAP2 O 1 0.9900770783424377
and O 0 0.0063422806560993195
lamin O 1 0.9997583031654358
B O 1 0.9983494281768799
receptor O 1 0.9997652173042297
( O 0 0.01685722917318344
LBR O 1 0.9983859062194824
) O 0 0.009100154973566532
. O 0 0.00678639579564333

A O 0 0.015955114737153053
panel O 0 0.009914334863424301
of O 0 0.002451865002512932
16 O 0 0.016142571344971657
monoclonal O 1 0.9998388290405273
antibodies O 1 0.9997747540473938
( O 0 0.013675437308847904
mAbs O 1 0.999426007270813
) O 0 0.003530810819938779
has O 0 0.0010905045783147216
been O 0 0.001195366377942264
mapped O 0 0.010464310646057129
to O 0 0.0008874530903995037
six O 0 0.001787958899512887
specific O 0 0.0030489666387438774
sites O 0 0.0019459539325907826
throughout O 0 0.0017748482059687376
the O 0 0.0022347960621118546
emerin O 1 0.9937248826026917
molecule O 1 0.9951653480529785
using O 0 0.018722983077168465
phage O 1 0.9995038509368896
- O 0 0.022001411765813828
displayed O 0 0.01068100705742836
peptide O 1 0.9992706179618835
libraries O 0 0.013812132179737091
and O 0 0.0010801098542287946
has O 0 0.0008678164449520409
been O 0 0.0007536993362009525
used O 0 0.001689454773440957
to O 0 0.002156805945560336
localize O 1 0.9990348815917969
emerin O 1 0.9887785315513611
in O 0 0.0026949841994792223
human O 0 0.011849072761833668
and O 0 0.004345199093222618
rabbit O 1 0.9998841285705566
heart O 1 0.9989894032478333
. O 0 0.00976953748613596

Several O 0 0.01191813312470913
mAbs O 1 0.9806085228919983
against O 0 0.004486590623855591
different O 0 0.004602012690156698
emerin O 1 0.9909986257553101
epitopes O 1 0.9954448938369751
did O 0 0.0042070732451975346
not O 0 0.0015348419547080994
recognize O 0 0.014658922329545021
intercalated O 1 0.997123658657074
discs O 0 0.026510002091526985
in O 0 0.0015982768964022398
the O 0 0.0029068193398416042
heart O 1 0.9996033310890198
, O 0 0.0014777156757190824
though O 0 0.0018647112883627415
they O 0 0.0010706265456974506
recognized O 0 0.007134715095162392
cardiomyocyte O 1 0.9979774355888367
nuclei O 1 0.984963595867157
strongly O 0 0.005917309783399105
, O 0 0.0009493997204117477
both O 0 0.0011000160593539476
at O 0 0.001178857171908021
the O 0 0.001322187134064734
rim O 0 0.05878609046339989
and O 0 0.0013205095892772079
in O 0 0.0025680914986878633
intranuclear O 1 0.9976307153701782
spots O 0 0.027613498270511627
or O 0 0.0063867950811982155
channels O 0 0.030321398749947548
. O 0 0.006156174000352621

A O 0 0.05357961356639862
polyclonal O 1 0.9973577857017517
rabbit O 1 0.9981572031974792
antiserum O 1 0.996081531047821
against O 0 0.012316177599132061
emerin O 1 0.9181172847747803
did O 0 0.0037563731893897057
recognize O 0 0.007630739826709032
both O 0 0.0017806955147534609
nuclear O 0 0.014290206134319305
membrane O 1 0.991008460521698
and O 0 0.002577496226876974
intercalated O 1 0.9990476965904236
discs O 0 0.03631650283932686
but O 0 0.0017924952553585172
, O 0 0.0013953355373814702
after O 0 0.006133183836936951
affinity O 1 0.94938725233078
purification O 1 0.6004165410995483
against O 0 0.003928180318325758
a O 0 0.006226937752217054
pure O 0 0.0358017161488533
- O 0 0.033637214452028275
emerin O 1 0.9551408886909485
band O 0 0.011548710986971855
on O 0 0.0014482229016721249
a O 0 0.004667379427701235
western O 0 0.005459034349769354
blot O 1 0.9939457774162292
, O 0 0.0018078378634527326
it O 0 0.0016594817861914635
stained O 1 0.5322763919830322
only O 0 0.0015333606861531734
the O 0 0.001982342451810837
nuclear O 0 0.0228680819272995
membrane O 1 0.9915242195129395
. O 0 0.007242048159241676

These O 0 0.0033868171740323305
results O 0 0.008337072096765041
would O 0 0.001149601535871625
not O 0 0.0007631243206560612
be O 0 0.0007017188472673297
expected O 0 0.001976127503439784
if O 0 0.0032262851018458605
immunostaining O 1 0.9410294890403748
at O 0 0.005083086434751749
intercalated O 1 0.998404324054718
discs O 0 0.022769547998905182
were O 0 0.0009240192594006658
due O 0 0.0028221590910106897
to O 0 0.0007788960938341916
a O 0 0.0027953265234827995
product O 0 0.00504947267472744
of O 0 0.0008777558105066419
the O 0 0.0030381525866687298
emerin O 1 0.9997329115867615
gene O 1 0.9999508857727051
and O 0 0.001844896120019257
, O 0 0.0013055220479145646
therefore O 0 0.0023891134187579155
, O 0 0.0008392043528147042
cast O 0 0.0028437976725399494
some O 0 0.0007173834019340575
doubt O 0 0.0035781327169388533
upon O 0 0.00124840484932065
the O 0 0.0013883605133742094
hypothesis O 1 0.8938968777656555
that O 0 0.0076808989979326725
cardiac B-Disease 1 0.9999997615814209
defects I-Disease 1 0.999981164932251
in O 0 0.003931296057999134
EDMD B-Disease 1 0.9996160268783569
are O 0 0.0020550533663481474
caused O 0 0.15080884099006653
by O 0 0.002280136104673147
absence O 0 0.011780202388763428
of O 0 0.001841020886786282
emerin O 1 0.9852821826934814
from O 0 0.007280470337718725
intercalated O 1 0.9981206059455872
discs O 0 0.06348247081041336
. O 0 0.007601742632687092

Although O 0 0.014805355109274387
emerin O 1 0.6796165108680725
was O 0 0.002583631779998541
abundant O 0 0.0061724926345050335
in O 0 0.0009207605617120862
the O 0 0.0019909003749489784
membranes O 1 0.9990712404251099
of O 0 0.0024549472145736217
cardiomyocyte O 1 0.9992011189460754
nuclei O 1 0.9887945652008057
, O 0 0.0014581255381926894
it O 0 0.0008990560309030116
was O 0 0.0012746509164571762
absent O 0 0.012305978685617447
from O 0 0.00135845597833395
many O 0 0.0014459945959970355
non O 0 0.012646383605897427
- O 1 0.8310762047767639
myocyte O 1 0.9999159574508667
cells O 1 0.9989479184150696
in O 0 0.002438461408019066
the O 0 0.003744891844689846
heart O 1 0.9971845746040344
. O 0 0.009406287223100662

This O 0 0.0036735734902322292
distribution O 0 0.009602964855730534
of O 0 0.0019125348189845681
emerin O 1 0.9834904670715332
was O 0 0.0023737801238894463
similar O 0 0.0038300957530736923
to O 0 0.0007663797005079687
that O 0 0.00077748455805704
of O 0 0.0017207092605531216
lamin O 1 0.9997690320014954
A O 0 0.008424915373325348
, O 0 0.0013856705045327544
a O 0 0.004618705250322819
candidate O 0 0.01679377630352974
gene O 1 0.9994958639144897
for O 0 0.0023320894688367844
an O 0 0.005592348054051399
autosomal O 1 0.999996542930603
form O 0 0.014020214788615704
of O 0 0.002673275303095579
EDMD B-Disease 1 0.9983059167861938
. O 0 0.008620468899607658

In O 0 0.0061651659198105335
contrast O 0 0.015109965577721596
, O 0 0.006164009682834148
lamin O 1 0.9997746348381042
B1 O 1 0.9995562434196472
was O 0 0.005355106201022863
absent O 0 0.02395057864487171
from O 0 0.004896633792668581
cardiomyocyte O 1 0.9959295392036438
nuclei O 1 0.9258949160575867
, O 0 0.0017461974639445543
showing O 0 0.006313652731478214
that O 0 0.0038659258279949427
lamin O 1 0.9999451637268066
B1 O 1 0.9999351501464844
is O 0 0.0023505520075559616
not O 0 0.0010465079685673118
essential O 0 0.006066730245947838
for O 0 0.0018112718826159835
localization O 1 0.5676531791687012
of O 0 0.0019473269348964095
emerin O 1 0.9112067222595215
to O 0 0.0019397460855543613
the O 0 0.002608170732855797
nuclear O 0 0.026345809921622276
lamina O 1 0.9985257983207703
. O 0 0.009100877679884434

Lamin O 1 0.9989774227142334
B1 O 1 0.9987806677818298
is O 0 0.004506839904934168
also O 0 0.0014877085341140628
almost O 0 0.00265846261754632
completely O 0 0.008511648513376713
absent O 0 0.02371424250304699
from O 0 0.0072060683742165565
skeletal O 1 0.9999707937240601
muscle O 1 0.9999603033065796
nuclei O 1 0.9850782155990601
. O 0 0.00926045048981905

In O 0 0.009798096492886543
EDMD B-Disease 1 0.9951460957527161
, O 0 0.0018076383275911212
the O 0 0.001071182661689818
additional O 0 0.003888276871293783
absence O 0 0.012862736359238625
of O 0 0.003456864506006241
lamin O 1 0.9998855590820312
B1 O 1 0.9996602535247803
from O 0 0.007385280914604664
heart O 1 0.9965677261352539
and O 0 0.005087107885628939
skeletal O 1 0.9999721050262451
muscle O 1 0.9999499320983887
nuclei O 1 0.9824274182319641
which O 0 0.0017029234440997243
already O 0 0.003357853041961789
lack O 0 0.01312526036053896
emerin O 1 0.9984063506126404
may O 0 0.0043151346035301685
offer O 0 0.0033400263637304306
an O 0 0.0013148109428584576
alternative O 0 0.009719963185489178
explanation O 0 0.006653256714344025
of O 0 0.0008388517308048904
why O 0 0.0036270238924771547
these O 0 0.0021374481730163097
tissues O 1 0.9997671246528625
are O 0 0.0013845611829310656
particularly O 0 0.0053246584720909595
affected O 0 0.021728109568357468
. O 0 0.0030461298301815987
. O 0 0.005911472253501415

Genetic O 1 0.9921650886535645
mapping O 0 0.03114773891866207
of O 0 0.0013456244487315416
the O 0 0.002706934232264757
copper B-Disease 1 0.5410789251327515
toxicosis I-Disease 1 0.9995840191841125
locus O 1 0.9978753328323364
in O 0 0.00977520365267992
Bedlington O 1 0.9996167421340942
terriers O 1 0.9973045587539673
to O 0 0.005840209778398275
dog O 1 0.9965149164199829
chromosome O 1 0.9999436140060425
10 O 0 0.005182834342122078
, O 0 0.0012836605310440063
in O 0 0.0011368661653250456
a O 0 0.00410862360149622
region O 0 0.00504284119233489
syntenic O 1 0.9620446562767029
to O 0 0.002976147225126624
human O 0 0.025297345593571663
chromosome O 1 0.9999680519104004
region O 0 0.017674947157502174
2p13 O 1 0.9937228560447693
- O 0 0.28525683283805847
p16 O 1 0.9985175728797913
. O 0 0.018904905766248703

Abnormal O 1 0.9998252987861633
hepatic B-Disease 1 0.9999864101409912
copper I-Disease 0 0.39366471767425537
accumulation I-Disease 1 0.935718834400177
is O 0 0.0022234967909753323
recognized O 0 0.003563697449862957
as O 0 0.001308110891841352
an O 0 0.005168765317648649
inherited B-Disease 1 0.9999933242797852
disorder I-Disease 1 0.9999946355819702
in O 0 0.002930729417130351
man O 0 0.011201572604477406
, O 0 0.0033152459654957056
mouse O 1 0.9998906850814819
, O 0 0.005226401146501303
rat O 1 0.99954754114151
and O 0 0.0052428338676691055
dog O 1 0.7981889247894287
. O 0 0.009171987883746624

The O 0 0.004143108613789082
major O 0 0.009328167885541916
cause O 0 0.4762296676635742
of O 0 0.005364560056477785
hepatic B-Disease 1 0.9999980926513672
copper I-Disease 1 0.8092174530029297
accumulation I-Disease 1 0.9908088445663452
in O 0 0.002238175831735134
man O 0 0.006044141016900539
is O 0 0.0017518870299682021
a O 0 0.009819548577070236
dysfunctional O 1 0.9996721744537354
ATP7B O 1 0.9997252821922302
gene O 1 0.9998937845230103
, O 0 0.007189157418906689
causing O 1 0.9974856376647949
Wilson B-Disease 1 0.9980448484420776
disease I-Disease 1 0.9999967813491821
( O 0 0.01935042254626751
WD B-Disease 1 0.9999821186065674
) O 0 0.008589062839746475
. O 0 0.0067329504527151585

Mutations O 1 0.999431312084198
in O 0 0.0031297022942453623
the O 0 0.003744118381291628
ATP7B O 1 0.9993306398391724
genes O 1 0.9987012147903442
have O 0 0.001365964999422431
also O 0 0.0008919817046262324
been O 0 0.0011898260563611984
demonstrated O 0 0.00878850370645523
in O 0 0.003341779112815857
mouse O 1 0.9995948672294617
and O 0 0.005497336853295565
rat O 1 0.9994064569473267
. O 0 0.011265844106674194

The O 0 0.01123118307441473
ATP7B O 1 0.9994915723800659
gene O 1 0.9997567534446716
has O 0 0.0029288518708199263
been O 0 0.0014679079176858068
excluded O 0 0.007340550422668457
in O 0 0.000866872607730329
the O 0 0.0011415248736739159
much O 0 0.0030578558798879385
rarer O 1 0.9963409304618835
human O 0 0.01597002148628235
copper B-Disease 1 0.9858731031417847
overload I-Disease 1 0.999984622001648
disease O 1 0.9999959468841553
non B-Disease 0 0.01674026995897293
- I-Disease 0 0.02468954212963581
Indian I-Disease 0 0.01795979030430317
childhood I-Disease 1 0.9987680315971375
cirrhosis I-Disease 1 0.999995231628418
, O 0 0.004869242664426565
indicating O 0 0.31685739755630493
genetic O 1 0.999893069267273
heterogeneity O 1 0.9937343001365662
. O 0 0.008463314734399319

By O 0 0.005684168078005314
investigating O 0 0.012126577086746693
the O 0 0.0040964907966554165
common O 1 0.7436283230781555
autosomal O 1 0.9999995231628418
recessive O 1 0.9999959468841553
copper B-Disease 1 0.990334689617157
toxicosis I-Disease 1 0.9999418258666992
( O 0 0.021526210010051727
CT B-Disease 1 0.9999158382415771
) O 0 0.00647910637781024
in O 0 0.004721948876976967
Bedlington O 1 0.9998519420623779
terriers O 1 0.999289870262146
, O 0 0.002030464354902506
we O 0 0.0007058796472847462
have O 0 0.0007845374057069421
identified O 0 0.004745794925838709
a O 0 0.0031878307927399874
new O 0 0.003643813543021679
locus O 1 0.9994348883628845
involved O 0 0.012441758066415787
in O 0 0.007566340733319521
progressive O 1 0.9998993873596191
liver B-Disease 1 1.0
disease I-Disease 1 0.9999946355819702
. O 0 0.012110067531466484

We O 0 0.004273049999028444
examined O 0 0.016407571732997894
whether O 0 0.003668793011456728
the O 0 0.005723174195736647
WD B-Disease 1 0.9999890327453613
gene O 1 0.9998520612716675
ATP7B O 1 0.9926389455795288
was O 0 0.0025726365856826305
also O 0 0.0023225536569952965
causative O 1 0.9991579055786133
for O 0 0.005118092522025108
CT B-Disease 1 0.9998244643211365
by O 0 0.003157265717163682
investigating O 0 0.010629141703248024
the O 0 0.00485836248844862
chromosomal O 1 0.9999924898147583
co O 1 0.5210379362106323
- O 0 0.02179053984582424
localization O 1 0.6967502236366272
of O 0 0.002723691053688526
ATP7B O 1 0.996286153793335
and O 0 0.0029474091716110706
C04107 O 1 0.972655713558197
, O 0 0.0020046932622790337
using O 0 0.007341464050114155
fluorescence O 1 0.957862138748169
in O 0 0.005362032447010279
situ O 1 0.997600257396698
hybridization O 1 0.9973204731941223
( O 0 0.007523640990257263
FISH O 0 0.029757145792245865
) O 0 0.005970496218651533
. O 0 0.004956517834216356

C04107 O 1 0.947187602519989
is O 0 0.0033359904773533344
an O 0 0.0029703008476644754
anonymous O 0 0.0641135424375534
microsatellite O 1 0.9992903470993042
marker O 0 0.2506425678730011
closely O 0 0.011301248334348202
linked O 0 0.09585921466350555
to O 0 0.005119370762258768
CT B-Disease 1 0.9996896982192993
. O 0 0.010562826879322529

However O 0 0.009359555318951607
, O 0 0.006064970511943102
BAC O 1 0.9981908202171326
clones O 1 0.9915988445281982
containing O 0 0.02695021778345108
ATP7B O 1 0.9880028963088989
and O 0 0.0037687746807932854
C04107 O 1 0.7890195250511169
mapped O 0 0.019737564027309418
to O 0 0.0018502505263313651
the O 0 0.004539634101092815
canine O 1 0.9999594688415527
chromosome O 1 0.9999680519104004
regions O 0 0.019752243533730507
CFA22q11 O 1 0.9955968260765076
and O 0 0.0027576943393796682
CFA10q26 O 1 0.9948811531066895
, O 0 0.002028086921200156
respectively O 0 0.0032352020498365164
, O 0 0.001353201805613935
demonstrating O 0 0.01317770779132843
that O 0 0.0036115990951657295
WD B-Disease 1 0.9999470710754395
cannot O 0 0.006167557090520859
be O 0 0.002020070096477866
homologous O 1 0.9980555772781372
to O 0 0.0068733301013708115
CT B-Disease 1 0.9995343685150146
. O 0 0.011209433898329735

The O 0 0.0057332925498485565
copper O 0 0.036808233708143234
transport O 0 0.040593650192022324
genes O 1 0.9996734857559204
CTR1 O 1 0.9963726997375488
and O 0 0.003271329216659069
CTR2 O 1 0.9919366836547852
were O 0 0.0010434521827846766
also O 0 0.0011370978318154812
excluded O 0 0.007913211360573769
as O 0 0.001483465894125402
candidate O 0 0.011728505603969097
genes O 1 0.9997637867927551
for O 0 0.005124810617417097
CT B-Disease 1 0.9999654293060303
since O 0 0.0033508562482893467
they O 0 0.0006815139204263687
both O 0 0.0015741294482722878
mapped O 0 0.02145291678607464
to O 0 0.00586326140910387
canine O 1 0.9999452829360962
chromosome O 1 0.9998862743377686
region O 0 0.01661796309053898
CFA11q22 O 1 0.9765915870666504
. O 0 0.010621979832649231

2 O 0 0.03047812171280384
- O 0 0.03050837852060795
22 O 0 0.016677826642990112
. O 0 0.009061752818524837

5 O 0 0.02666836977005005
. O 0 0.009258841164410114

A O 0 0.029203573241829872
transcribed O 0 0.15606413781642914
sequence O 0 0.04464869946241379
identified O 0 0.009226969443261623
from O 0 0.0011822826927527785
the O 0 0.002438027411699295
C04107 O 1 0.9974421262741089
- O 0 0.026353394612669945
containing O 0 0.026617381721735
BAC O 1 0.9994431138038635
was O 0 0.002308666706085205
found O 0 0.002522797789424658
to O 0 0.0007994248298928142
be O 0 0.0013203650014474988
homologous O 1 0.9978430271148682
to O 0 0.0017170582432299852
a O 0 0.00758567126467824
gene O 1 0.9996123909950256
expressed O 0 0.004477920942008495
from O 0 0.002806361997500062
human O 0 0.10247873514890671
chromosome O 1 0.9999841451644897
2p13 O 1 0.9987764954566956
- O 0 0.386017382144928
p16 O 1 0.9996073842048645
, O 0 0.0028610031586140394
a O 0 0.005184336565434933
region O 0 0.0034925397485494614
devoid O 0 0.016434095799922943
of O 0 0.0012037932174280286
any O 0 0.0030361777171492577
positional O 1 0.9740269184112549
candidate O 0 0.025666069239377975
genes O 1 0.9970952272415161
. O 0 0.009039596654474735

Molecular O 1 0.9382839202880859
analysis O 0 0.012574411928653717
of O 0 0.0010582946706563234
the O 0 0.003614356042817235
APC B-Disease 1 0.9998871088027954
gene O 1 0.9996602535247803
in O 0 0.003752027405425906
205 O 0 0.051948025822639465
families O 0 0.0073662856593728065
: O 0 0.005007408559322357
extended O 0 0.01703007146716118
genotype O 1 0.9999637603759766
- O 1 0.9359356760978699
phenotype O 1 0.9999765157699585
correlations O 1 0.994147539138794
in O 0 0.004476832691580057
FAP B-Disease 1 0.9999359846115112
and O 0 0.001584004727192223
evidence O 0 0.002195601584389806
for O 0 0.0007751634111627936
the O 0 0.0008354747551493347
role O 0 0.004061092156916857
of O 0 0.0020455108024179935
APC B-Disease 1 0.9996782541275024
amino O 1 0.9969664216041565
acid O 1 0.9985243678092957
changes O 0 0.02236325293779373
in O 0 0.29201245307922363
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
predisposition O 1 0.9998505115509033
. O 0 0.013456066139042377

BACKGROUND O 0 0.057923782616853714
/ O 0 0.06238749623298645
AIMS O 0 0.01456198189407587
The O 0 0.0017247602809220552
development O 0 0.006794187240302563
of O 0 0.009728796780109406
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
and O 0 0.002507381374016404
a O 0 0.0059089986607432365
variable O 0 0.0580291822552681
range O 0 0.0028807329945266247
of O 0 0.001303228666074574
extracolonic O 1 0.9965459704399109
manifestations O 1 0.9651928544044495
in O 0 0.017810776829719543
familial B-Disease 1 0.9999997615814209
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999996423721313
( O 0 0.03108013980090618
FAP B-Disease 1 0.9999557733535767
) O 0 0.004160459619015455
is O 0 0.0009010019712150097
the O 0 0.0008763506193645298
result O 0 0.003721779678016901
of O 0 0.0005959714762866497
the O 0 0.001405213726684451
dominant O 0 0.45052456855773926
inheritance O 1 0.9979841709136963
of O 0 0.021509407088160515
adenomatous B-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999996423721313
coli I-Disease 1 0.9999959468841553
( O 0 0.02080351673066616
APC B-Disease 1 0.9995108842849731
) O 0 0.023759448900818825
gene O 1 0.9998759031295776
mutations O 1 0.9997490048408508
. O 0 0.0117506617680192

In O 0 0.003377620130777359
this O 0 0.0014325284864753485
study O 0 0.0056253522634506226
, O 0 0.0015556530561298132
direct O 0 0.0165818203240633
mutation O 1 0.9999681711196899
analysis O 0 0.007909514009952545
of O 0 0.0006926964852027595
the O 0 0.0026647397316992283
APC B-Disease 1 0.9999356269836426
gene O 1 0.9996931552886963
was O 0 0.002199229784309864
performed O 0 0.003603690303862095
to O 0 0.001556417322717607
determine O 0 0.01893223635852337
genotype O 1 0.999974250793457
- O 1 0.9045136570930481
phenotype O 1 0.9999775886535645
correlations O 1 0.9391620755195618
for O 0 0.0020690234377980232
nine O 0 0.007305799052119255
extracolonic O 1 0.9976286292076111
manifestations O 0 0.4517137408256531
and O 0 0.0009928576182574034
to O 0 0.0009271313319914043
investigate O 0 0.00608883798122406
the O 0 0.0025869060773402452
incidence O 1 0.9965294003486633
of O 0 0.0041250260546803474
APC B-Disease 1 0.9999645948410034
mutations O 1 0.999974250793457
in O 0 0.003951771650463343
non O 0 0.2107224315404892
- O 1 0.9995606541633606
FAP O 1 0.9999994039535522
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999966621398926
. O 0 0.016447002068161964

METHODS O 0 0.0250563882291317
The O 0 0.007029134314507246
APC B-Disease 1 0.9996620416641235
gene O 1 0.9992026686668396
was O 0 0.0038873946759849787
analysed O 0 0.029990360140800476
in O 0 0.0024346238933503628
190 O 0 0.026716988533735275
unrelated O 1 0.9497919678688049
FAP B-Disease 1 0.9996069073677063
and O 0 0.0028300953563302755
15 O 0 0.007992583326995373
non O 0 0.0763629749417305
- O 1 0.9992382526397705
FAP O 1 0.9999995231628418
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
patients O 1 0.9993353486061096
using O 0 0.022119559347629547
denaturing O 1 0.9991647005081177
gradient O 1 0.9958468079566956
gel O 1 0.9996929168701172
electrophoresis O 1 0.9987101554870605
, O 0 0.0025219134986400604
the O 0 0.0032956392969936132
protein O 1 0.9996011853218079
truncation O 1 0.9978698492050171
test O 0 0.01631803996860981
, O 0 0.001471934956498444
and O 0 0.0016390347154811025
direct O 0 0.014701539650559425
sequencing O 1 0.990809440612793
. O 0 0.008542070165276527

RESULTS O 0 0.0595184788107872
Chain O 1 0.8291252255439758
terminating O 1 0.8056220412254333
signals O 0 0.01938362792134285
were O 0 0.0007286511245183647
only O 0 0.000992562505416572
identified O 0 0.007854818366467953
in O 0 0.0027328787837177515
patients O 1 0.9985405206680298
belonging O 0 0.009079813957214355
to O 0 0.001255664392374456
the O 0 0.0038495115004479885
FAP B-Disease 1 0.9999667406082153
group O 0 0.01570497639477253
( O 0 0.006213537883013487
105 O 0 0.14565178751945496
patients O 1 0.999679446220398
) O 0 0.005844760220497847
. O 0 0.00598495127633214

Amino O 1 0.9939035773277283
acid O 1 0.9950283169746399
changes O 0 0.0057808817364275455
were O 0 0.000732491142116487
identified O 0 0.006105953827500343
in O 0 0.0013462826609611511
four O 0 0.0042428504675626755
patients O 1 0.999734103679657
, O 0 0.0010095267789438367
three O 0 0.0012416040990501642
of O 0 0.0007650975603610277
whom O 0 0.003081958508118987
belonged O 0 0.005545126739889383
to O 0 0.0006020865985192358
the O 0 0.0012990623945370317
non O 0 0.011137121357023716
- O 1 0.6802067756652832
FAP O 1 0.9999538660049438
group O 0 0.02371753565967083
of O 0 0.1224842295050621
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 1 0.9997606873512268
. O 0 0.009765949100255966

Genotype O 1 0.9997175335884094
- O 1 0.9090886116027832
phenotype O 1 0.9999467134475708
correlations O 1 0.9935114979743958
identified O 0 0.011578825302422047
significant O 0 0.004558343440294266
differences O 0 0.005521990824490786
in O 0 0.0008055222569964826
the O 0 0.0010503582889214158
nature O 0 0.002959477948024869
of O 0 0.000999515992589295
certain O 0 0.005672995001077652
extracolonic O 1 0.9967684745788574
manifestations O 1 0.917783260345459
in O 0 0.008113334886729717
FAP B-Disease 1 0.9999922513961792
patients O 1 0.9995622038841248
belonging O 0 0.012464712373912334
to O 0 0.00232525123283267
three O 0 0.00775728328153491
mutation O 1 0.9999644756317139
subgroups O 1 0.904789388179779
. O 0 0.008814199827611446

CONCLUSIONS O 0 0.036811407655477524
Extended O 0 0.03673446550965309
genotype O 1 0.9998875856399536
- O 1 0.9680225849151611
phenotype O 1 0.9999791383743286
correlations O 1 0.9879090189933777
made O 0 0.001967109041288495
in O 0 0.0009710759622976184
this O 0 0.0011800279607996345
study O 0 0.00537614431232214
may O 0 0.002053213072940707
have O 0 0.00048754565068520606
the O 0 0.0007611067849211395
potential O 0 0.006892959587275982
to O 0 0.0007628363091498613
determine O 0 0.0034542486537247896
the O 0 0.0008745247614569962
most O 0 0.0011531184427440166
appropriate O 0 0.005883720703423023
surveillance O 0 0.03416045755147934
and O 0 0.004315945785492659
prophylactic O 1 0.9999381303787231
treatment O 1 0.999366819858551
regimens O 1 0.9996581077575684
for O 0 0.0022542860824614763
those O 0 0.0033448217436671257
patients O 1 0.9998263716697693
with O 0 0.008742115460336208
mutations O 1 0.9999873638153076
associated O 0 0.013908046297729015
with O 0 0.003169301664456725
life O 0 0.01180611364543438
threatening O 1 0.9757847785949707
conditions O 0 0.016082437708973885
. O 0 0.006219329312443733

This O 0 0.00421578623354435
study O 0 0.0062555898912250996
also O 0 0.0010416831355541945
provided O 0 0.002108850749209523
evidence O 0 0.0018744433764368296
for O 0 0.0008701704209670424
the O 0 0.0015476179542019963
pathological O 1 0.9977827668190002
nature O 0 0.004453116562217474
of O 0 0.0016607169527560472
amino O 1 0.9985879063606262
acid O 1 0.9983590245246887
changes O 0 0.0073119476437568665
in O 0 0.002652161056175828
APC O 1 0.99988853931427
associated O 0 0.008981836959719658
with O 0 0.0017907267902046442
both O 0 0.00305926613509655
FAP B-Disease 1 0.9999033212661743
and O 0 0.004409738816320896
non O 0 0.3157445192337036
- O 1 0.9997120499610901
FAP O 1 0.9999996423721313
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
patients O 1 0.9998496770858765
. O 0 0.005445908289402723
. O 0 0.005800710991024971

Inherited B-Disease 1 0.9999051094055176
colorectal I-Disease 1 0.9999995231628418
polyposis I-Disease 1 0.9999960660934448
and O 0 0.032621871680021286
cancer B-Disease 1 0.9999960660934448
risk O 1 0.633488118648529
of O 0 0.0017706409562379122
the O 0 0.004554211162030697
APC O 1 0.9997450709342957
I1307K O 1 0.9957960844039917
polymorphism O 1 0.9963895678520203
. O 0 0.009899003431200981

Germ O 1 0.9964170455932617
- O 0 0.033573977649211884
line O 0 0.009515623562037945
and O 0 0.003269256092607975
somatic O 1 0.9997751116752625
truncating O 1 0.9988434314727783
mutations O 1 0.999698281288147
of O 0 0.0016572229797020555
the O 0 0.003458037506788969
APC B-Disease 1 0.9999406337738037
gene O 1 0.9996662139892578
are O 0 0.0012456249678507447
thought O 0 0.004423178266733885
to O 0 0.0027989379595965147
initiate O 1 0.9993627667427063
colorectal B-Disease 1 0.9999996423721313
tumor I-Disease 1 0.9999911785125732
formation O 1 0.8266674280166626
in O 0 0.023918703198432922
familial B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999985694885254
and O 0 0.011592279188334942
sporadic O 1 0.9997813105583191
colorectal O 1 0.9999998807907104
carcinogenesis O 1 0.999964714050293
, O 0 0.004559041000902653
respectively O 0 0.007197010330855846
. O 0 0.006481129676103592

Recently O 0 0.01956753619015217
, O 0 0.0027244577649980783
an O 0 0.004964679945260286
isoleucine O 1 0.9994046688079834
- O 0 0.2017948180437088
- O 0 0.16724945604801178
> O 1 0.9946803450584412
lysine O 1 0.9941412806510925
polymorphism O 1 0.9724927544593811
at O 0 0.009482218883931637
codon O 1 0.9957329630851746
1307 O 1 0.9974536299705505
( O 0 0.007958579808473587
I1307K O 1 0.9701951742172241
) O 0 0.0019381017191335559
of O 0 0.0007580152596347034
the O 0 0.0029275668784976006
APC B-Disease 1 0.9999666213989258
gene O 1 0.9998788833618164
has O 0 0.002385845873504877
been O 0 0.001511089620180428
identified O 0 0.006870076525956392
in O 0 0.0014528074534609914
6 O 0 0.0067567843943834305
% O 0 0.006325635593384504
- O 0 0.013954856432974339
7 O 0 0.006097504403442144
% O 0 0.002399226650595665
of O 0 0.0006610520067624748
the O 0 0.002131886314600706
Ashkenazi O 1 0.9812541007995605
Jewish O 0 0.00879194401204586
population O 0 0.004571984522044659
. O 0 0.005984696559607983

To O 0 0.0037583729717880487
assess O 0 0.014949494041502476
the O 0 0.0020131729543209076
risk O 0 0.09934967756271362
of O 0 0.0008465833961963654
this O 0 0.001483479398302734
common O 0 0.020177509635686874
APC B-Disease 1 0.9997339844703674
allelic O 1 0.9997619986534119
variant O 1 0.9994416832923889
in O 0 0.02848980575799942
colorectal O 1 0.9999998807907104
carcinogenesis O 1 0.9999743700027466
, O 0 0.0026360456831753254
we O 0 0.0008057111990638077
have O 0 0.0010873816208913922
analyzed O 0 0.011708724312484264
a O 0 0.004116648808121681
large O 0 0.004568969365209341
cohort O 1 0.7561832070350647
of O 0 0.002808069344609976
unselected O 1 0.9892650842666626
Ashkenazi O 1 0.8883344531059265
Jewish O 0 0.00876737292855978
subjects O 0 0.008487417362630367
with O 0 0.013247700408101082
adenomatous B-Disease 1 0.9999997615814209
polyps I-Disease 1 0.9999909400939941
and O 0 0.0024153750855475664
. O 0 0.004113496746867895
or O 1 0.9844485521316528
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
, I-Disease 0 0.002114403061568737
for O 0 0.0015962410252541304
the O 0 0.003968296572566032
APC O 1 0.9997485280036926
I1307K O 1 0.9958063364028931
polymorphism O 1 0.9967294931411743
. O 0 0.012346386909484863

The O 0 0.012072826735675335
APC O 1 0.9986225366592407
I1307K O 1 0.9965707063674927
allele O 1 0.9994370341300964
was O 0 0.0035048252902925014
identified O 0 0.008579254150390625
in O 0 0.0018190103583037853
48 O 0 0.011231272481381893
( O 0 0.0032437301706522703
10 O 0 0.003041036892682314
. O 0 0.0015392745845019817
1 O 0 0.004837526939809322
% O 0 0.004747165832668543
) O 0 0.0029558429960161448
of O 0 0.0027369381859898567
476 O 1 0.9946686625480652
patients O 1 0.9991518259048462
. O 0 0.008139315992593765

Compared O 0 0.0143211018294096
with O 0 0.002609335584565997
the O 0 0.0015797542873769999
frequency O 0 0.016376743093132973
in O 0 0.0009829570772126317
two O 0 0.001356608234345913
separate O 0 0.004754075780510902
population O 0 0.002182699739933014
control O 0 0.008676133118569851
groups O 0 0.0019984550308436155
, O 0 0.0010749137727543712
the O 0 0.0027829091995954514
APC O 1 0.999911904335022
I1307K O 1 0.9992784857749939
allele O 1 0.9998509883880615
is O 0 0.0035475092008709908
associated O 0 0.006649457383900881
with O 0 0.0017620910657569766
an O 0 0.0013722169678658247
estimated O 0 0.006022919435054064
relative O 0 0.0177097599953413
risk O 1 0.6102645993232727
of O 0 0.0016254736110568047
1 O 0 0.009221927262842655
. O 0 0.0065169986337423325

5 O 0 0.03241937980055809
- O 0 0.033494219183921814
1 O 0 0.014581460505723953
. O 0 0.00884170364588499

7 O 0 0.028064381331205368
for O 0 0.019242580980062485
colorectal B-Disease 1 0.9999996423721313
neoplasia I-Disease 1 0.9999759197235107
( O 0 0.0075266677886247635
both O 0 0.004672487732023001
P O 1 0.9977095127105713
= O 0 0.2877383828163147
. O 0 0.005105799995362759
01 O 1 0.9954727292060852
) O 0 0.007942339405417442
. O 0 0.006616363767534494

Furthermore O 0 0.026630625128746033
, O 0 0.0021508275531232357
compared O 0 0.006303537171334028
with O 0 0.003937686327844858
noncarriers O 1 0.9952640533447266
, O 0 0.0057707917876541615
APC O 1 0.9998098015785217
I1307K O 1 0.997138500213623
carriers O 0 0.43759962916374207
had O 0 0.0022669113241136074
increased O 0 0.0036527884658426046
numbers O 0 0.00235541258007288
of O 0 0.0022712009958922863
adenomas B-Disease 1 0.9999911785125732
and O 0 0.04166411980986595
colorectal B-Disease 1 0.9999998807907104
cancers I-Disease 1 0.9999978542327881
per O 0 0.01340382918715477
patient O 1 0.999607264995575
( O 0 0.007458546198904514
P O 1 0.9983288645744324
= O 1 0.5121363997459412
. O 0 0.0038824989460408688
03 O 1 0.9918774366378784
) O 0 0.0032432463485747576
, O 0 0.0010112379677593708
as O 0 0.0007519832579419017
well O 0 0.001056733657605946
as O 0 0.001011185348033905
a O 0 0.005064328201115131
younger O 0 0.022989928722381592
age O 0 0.00791882537305355
at O 0 0.008313454687595367
diagnosis O 1 0.9999526739120483
. O 0 0.008067332208156586

We O 0 0.0031435638666152954
conclude O 0 0.011775895953178406
that O 0 0.001329924096353352
the O 0 0.00270751747302711
APC O 1 0.9996547698974609
I1307K O 1 0.9971554279327393
variant O 1 0.9967982172966003
leads O 0 0.022291677072644234
to O 0 0.002461434109136462
increased O 0 0.026384521275758743
adenoma B-Disease 1 0.9999910593032837
formation O 0 0.045712247490882874
and O 0 0.001121544511988759
directly O 0 0.0032116093207150698
contributes O 0 0.017612777650356293
to O 0 0.0013787747593596578
3 O 0 0.0068228235468268394
% O 0 0.006016391795128584
- O 0 0.010895125567913055
4 O 0 0.004924057517200708
% O 0 0.0020811439026147127
of O 0 0.0006222901865839958
all O 0 0.0018499221187084913
Ashkenazi O 1 0.9994843006134033
Jewish O 1 0.9933338761329651
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999982118606567
. O 0 0.012786611914634705

The O 0 0.004277592990547419
estimated O 0 0.008183155208826065
relative O 0 0.01825794391334057
risk O 1 0.814337968826294
for O 0 0.0028187474235892296
carriers O 1 0.8088846802711487
may O 0 0.005398449953645468
justify O 0 0.013480661436915398
specific O 0 0.012019178830087185
clinical O 1 0.9998008608818054
screening O 1 0.6100088953971863
for O 0 0.0010246109450235963
the O 0 0.0014478587545454502
360 O 0 0.021170755848288536
, O 0 0.0019867802038788795
000 O 0 0.011503544636070728
Americans O 0 0.003489202354103327
expected O 0 0.0016433836426585913
to O 0 0.0010333198588341475
harbor O 0 0.008940540254116058
this O 0 0.0018881596624851227
allele O 1 0.9998321533203125
, O 0 0.0019339186837896705
and O 0 0.0022251117043197155
genetic O 1 0.999962568283081
testing O 0 0.028450796380639076
in O 0 0.0008383435779251158
the O 0 0.0007978342473506927
setting O 0 0.004692787304520607
of O 0 0.001566386898048222
long O 0 0.012791367247700691
- O 0 0.03630942106246948
term O 0 0.018265342339873314
- O 0 0.02066626399755478
outcome O 0 0.01735052466392517
studies O 0 0.00965279620140791
may O 0 0.0035339139867573977
impact O 0 0.010060418397188187
significantly O 0 0.4697248339653015
on O 0 0.24912019073963165
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 0.9996199607849121
in O 0 0.0018134863348677754
this O 0 0.0015467405319213867
population O 0 0.0038125733844935894
. O 0 0.005863283760845661

Localization O 0 0.18710742890834808
of O 0 0.0029047608841210604
human O 0 0.0284250620752573
BRCA1 O 1 0.9999942779541016
and O 0 0.001788433874025941
its O 0 0.00233329925686121
loss O 0 0.039720457047224045
in O 0 0.001994422171264887
high O 0 0.005760492291301489
- O 0 0.021576030179858208
grade O 0 0.02975066937506199
, O 0 0.0028030029498040676
non B-Disease 0 0.023913858458399773
- I-Disease 1 0.9901829361915588
inherited I-Disease 1 0.9999740123748779
breast I-Disease 1 0.9999990463256836
carcinomas I-Disease 1 0.9999836683273315
. O 0 0.01425010897219181

Although O 0 0.004267769865691662
the O 0 0.0014553149230778217
link O 0 0.018754448741674423
between O 0 0.0028746689204126596
the O 0 0.005989555269479752
BRCA1 O 1 0.9999997615814209
tumour B-Disease 1 0.9999979734420776
- O 1 0.9877529144287109
suppressor O 1 0.9999808073043823
gene O 1 0.9998831748962402
and O 0 0.00805180799216032
hereditary B-Disease 1 0.9999959468841553
breast I-Disease 1 0.9999995231628418
and I-Disease 1 0.9247081279754639
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
is O 0 0.0034410508815199137
established O 0 0.0029837647452950478
, O 0 0.0008016133215278387
the O 0 0.0011098766699433327
role O 0 0.0059412019327282906
, O 0 0.0009514648700132966
if O 0 0.0014059317763894796
any O 0 0.0010813705157488585
, O 0 0.0008773085428401828
of O 0 0.002145566511899233
BRCA1 O 1 0.9999992847442627
in O 0 0.003968127071857452
non B-Disease 0 0.0869310051202774
- I-Disease 1 0.9974457025527954
familial I-Disease 1 0.999998927116394
cancers I-Disease 1 0.9999966621398926
is O 0 0.005465287249535322
unclear O 0 0.016626747325062752
. O 0 0.005769940558820963

BRCA1 O 1 0.9999927282333374
mutations O 1 0.9999321699142456
are O 0 0.0023861308582127094
rare O 0 0.014612950384616852
in O 0 0.0034024121705442667
sporadic B-Disease 1 0.9988144636154175
cancers I-Disease 1 0.9999971389770508
, O 0 0.0024217558093369007
but O 0 0.001576153445057571
loss O 0 0.025062458589673042
of O 0 0.003668507095426321
BRCA1 O 1 0.9999977350234985
resulting O 0 0.08228214085102081
from O 0 0.002962003229185939
reduced O 0 0.017515208572149277
expression O 0 0.03217761963605881
or O 0 0.0035674923565238714
incorrect O 0 0.089317686855793
subcellular O 1 0.9939137101173401
localization O 1 0.9230309724807739
is O 0 0.0025097450707107782
postulated O 0 0.05287232622504234
to O 0 0.0007542558014392853
be O 0 0.0004939208156429231
important O 0 0.0009386028395965695
in O 0 0.0014748808462172747
non B-Disease 0 0.06860985606908798
- I-Disease 1 0.9988647699356079
familial I-Disease 1 0.9999992847442627
breast I-Disease 1 0.9999990463256836
and I-Disease 1 0.6934233903884888
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999984502792358
. O 0 0.01432186271995306

Epigenetic O 1 0.9996711015701294
loss O 0 0.3392969071865082
, O 0 0.002230934565886855
however O 0 0.0021503374446183443
, O 0 0.0010843741474673152
has O 0 0.0011140957940369844
not O 0 0.001041245530359447
received O 0 0.0037920447066426277
general O 0 0.004038276616483927
acceptance O 0 0.03171222284436226
due O 0 0.004404095932841301
to O 0 0.0011472107144072652
controversy O 0 0.007253947667777538
regarding O 0 0.003061972325667739
the O 0 0.001848590443842113
subcellular O 1 0.9672156572341919
localization O 1 0.8908917307853699
of O 0 0.006235802546143532
BRCA1 O 1 0.9999992847442627
proteins O 1 0.9982761144638062
, O 0 0.001736497855745256
reports O 0 0.002060843398794532
of O 0 0.0005977064138278365
which O 0 0.0008478161762468517
have O 0 0.0008891568868421018
ranged O 0 0.009045325219631195
from O 0 0.0014630297664552927
exclusively O 0 0.004796721041202545
nuclear O 0 0.008271390572190285
, O 0 0.0010328680509701371
to O 0 0.0013162355171516538
conditionally O 0 0.1665995568037033
nuclear O 0 0.008529909886419773
, O 0 0.0010250190971419215
to O 0 0.0010860334150493145
the O 0 0.0032818629406392574
ER O 1 0.9999111890792847
/ O 1 0.9818223714828491
golgi O 1 0.9992221593856812
, O 0 0.0023504558485001326
to O 0 0.002435908652842045
cytoplasmic O 1 0.9993830919265747
invaginations O 1 0.8611928820610046
into O 0 0.0048209382221102715
the O 0 0.003507070941850543
nucleus O 1 0.9102134108543396
. O 0 0.007687530945986509

In O 0 0.0037662724498659372
an O 0 0.0020276217255741358
attempt O 0 0.008610575459897518
to O 0 0.0015407444443553686
resolve O 0 0.011349738575518131
this O 0 0.0010747703490778804
issue O 0 0.0023096499498933554
, O 0 0.0008711136761121452
we O 0 0.0008104306180030107
have O 0 0.0013400650350376964
comprehensively O 0 0.05397199094295502
characterized O 0 0.08429524302482605
19 O 0 0.019844170659780502
anti O 0 0.23109027743339539
- O 1 0.9924558401107788
BRCA1 O 1 0.999995231628418
antibodies O 1 0.9992788434028625
. O 0 0.010731091722846031

These O 0 0.005638281814754009
reagents O 1 0.8384127616882324
detect O 0 0.11216053366661072
a O 0 0.007622137200087309
220 O 0 0.03307062014937401
- O 0 0.11048877984285355
kD O 1 0.9978112578392029
protein O 1 0.9990004897117615
localized O 1 0.9820811152458191
in O 0 0.0030852346681058407
discrete O 0 0.05027354881167412
nuclear O 0 0.01663217321038246
foci O 1 0.9635816812515259
in O 0 0.0016345076728612185
all O 0 0.0023348447866737843
epithelial O 1 0.9999926090240479
cell O 1 0.9998018145561218
lines O 0 0.011713195592164993
, O 0 0.0009119909373112023
including O 0 0.0015222750371322036
those O 0 0.0015580442268401384
derived O 0 0.02781660109758377
from O 0 0.012419174425303936
breast B-Disease 1 0.9999940395355225
malignancies I-Disease 1 0.9997501969337463
. O 0 0.016890998929739

Immunohistochemical O 1 0.9961517453193665
staining O 1 0.9821773767471313
of O 0 0.004850537050515413
human O 0 0.45099130272865295
breast O 1 0.9999806880950928
specimens O 0 0.024895288050174713
also O 0 0.0026054668705910444
revealed O 0 0.12819933891296387
BRCA1 O 1 0.9999934434890747
nuclear O 0 0.036966342478990555
foci O 1 0.9958947896957397
in O 0 0.007539837155491114
benign O 1 0.9999644756317139
breast O 1 0.9999958276748657
, O 0 0.01604987308382988
invasive B-Disease 1 0.9999970197677612
lobular I-Disease 1 0.9999984502792358
cancers I-Disease 1 0.9999898672103882
and O 0 0.004812903236597776
low B-Disease 0 0.03038310632109642
- I-Disease 0 0.4175278842449188
grade I-Disease 1 0.9922210574150085
ductal I-Disease 1 0.9999945163726807
carcinomas I-Disease 1 0.9999686479568481
. O 0 0.013718100264668465

Conversely O 1 0.5274330973625183
, O 0 0.009793716482818127
BRCA1 O 1 0.9999885559082031
expression O 0 0.04372338578104973
was O 0 0.003358714748173952
reduced O 0 0.015118226408958435
or O 0 0.00646594911813736
undetectable O 1 0.9982829093933105
in O 0 0.0012786855222657323
the O 0 0.0009666165569797158
majority O 0 0.003431781893596053
of O 0 0.0012129885144531727
high O 0 0.007044353522360325
- O 0 0.031096285209059715
grade O 0 0.20294196903705597
, O 0 0.010902764275670052
ductal B-Disease 1 0.9999995231628418
carcinomas I-Disease 1 0.9999960660934448
, O 0 0.0033143842592835426
suggesting O 0 0.010898945853114128
that O 0 0.0012418724363669753
absence O 0 0.013415184803307056
of O 0 0.0036668728571385145
BRCA1 O 1 0.9999995231628418
may O 0 0.006034474819898605
contribute O 0 0.007641218602657318
to O 0 0.0009744429844431579
the O 0 0.002538231434300542
pathogenesis O 1 0.9999608993530273
of O 0 0.0010346609633415937
a O 0 0.002578306943178177
significant O 0 0.003511474933475256
percentage O 0 0.0068749841302633286
of O 0 0.003023008117452264
sporadic B-Disease 1 0.9997531771659851
breast I-Disease 1 0.9999997615814209
cancers I-Disease 1 0.999997615814209
. O 0 0.005050585139542818
. O 0 0.005878961179405451

